data_1puq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1puq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.813 0.34 . . . . 0.44 110.91 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -139.97 142.85 36.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.44 110.884 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.04 134.48 21.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 0.44 110.986 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -102.63 152.86 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.35 0.595 . . . . 0.44 111.937 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.404 ' N ' ' O ' ' A' ' 81' ' ' THR . 4.7 mp -146.5 126.82 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.289 -0.869 . . . . 0.44 110.643 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.603 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.9 125.56 44.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.166 -0.679 . . . . 0.44 109.166 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.6 m -133.78 162.58 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.169 -0.612 . . . . 0.44 112.131 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.69 116.04 0.99 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.342 -0.844 . . . . 0.44 111.818 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.459 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.91 109.05 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.565 -0.531 . . . . 0.44 109.565 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -71.15 126.67 31.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.44 111.613 -178.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -91.18 123.0 34.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.474 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.0 t-20 -79.91 -172.45 3.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.44 111.622 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.478 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.1 tm-20 -81.8 4.29 22.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.463 -1.244 . . . . 0.44 112.418 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -139.5 51.83 1.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.44 111.324 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.2 p30 45.78 24.32 0.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.153 -0.476 . . . . 0.44 111.439 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.4 pt-20 -115.86 137.45 52.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.763 -0.828 . . . . 0.44 108.763 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 7.3 mt -105.88 139.59 26.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.324 0.583 . . . . 0.44 112.146 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.488 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 1.1 t80 -85.31 112.43 20.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.136 -0.938 . . . . 0.44 110.331 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.443 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -128.73 149.93 33.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.16 -0.473 . . . . 0.44 109.921 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 31.2 p -70.63 111.5 6.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.034 -0.358 . . . . 0.44 110.034 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.289 -0.414 . . . . 0.44 111.224 -179.528 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.83 0.348 . . . . 0.44 110.995 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 34' ' ' GLU . 3.1 tmtm? -106.29 26.3 9.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.336 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' A' ' 21' ' ' THR . 2.7 tt -63.11 74.67 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.729 -0.669 . . . . 0.44 110.775 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -117.32 -173.27 2.38 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.014 0.435 . . . . 0.44 111.844 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -119.33 168.49 9.9 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.776 -0.647 . . . . 0.44 111.632 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.61 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 95.3 Cg_endo -81.92 166.74 16.8 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.437 2.758 . . . . 0.44 113.306 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.545 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 101.73 -5.77 54.32 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.607 -0.724 . . . . 0.44 114.384 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -59.25 159.8 18.59 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 117.23 0.515 . . . . 0.44 113.332 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.448 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.11 -2.19 0.73 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.876 0.695 . . . . 0.44 112.876 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.603 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.1 pt -49.97 -27.91 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.544 0.688 . . . . 0.44 110.823 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.542 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -43.53 -61.49 1.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.678 -1.146 . . . . 0.44 111.253 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 41' ' ' GLU . 7.4 mmt 9.64 -81.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.826 0.703 . . . . 0.44 112.582 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.34 32.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.604 -0.808 . . . . 0.44 112.985 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -92.51 -170.67 2.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.713 0.292 . . . . 0.44 111.06 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.52 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -101.22 152.95 38.04 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.387 -0.369 . . . . 0.44 110.284 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.52 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.89 -24.78 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.782 2.321 . . . . 0.44 112.618 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.18 -42.21 6.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.899 0.333 . . . . 0.44 111.899 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -80.3 -18.39 49.4 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.674 0.25 . . . . 0.44 111.674 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -57.41 -49.93 74.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.792 0.33 . . . . 0.44 111.06 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -78.45 -47.87 23.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.302 -0.408 . . . . 0.44 110.719 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 41.6 t -56.7 -36.02 47.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.934 -0.576 . . . . 0.44 111.247 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -52.01 9.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.352 -0.385 . . . . 0.44 110.649 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.0 mm-40 -63.43 -22.1 66.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.689 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.459 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 1.3 tp -58.38 -44.99 89.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.442 -0.345 . . . . 0.44 110.755 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -31.33 71.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.187 0.518 . . . . 0.44 109.681 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -77.4 -25.77 51.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.44 111.243 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.515 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.27 5.84 26.02 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.778 0.659 . . . . 0.44 112.778 -178.501 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.619 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 3.2 t -134.29 -45.1 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.987 0.423 . . . . 0.44 110.111 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.572 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 62.4 -20.4 0.06 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.768 -0.651 . . . . 0.44 114.664 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.557 HG22 ' CD1' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -88.73 -176.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 120.961 0.41 . . . . 0.44 111.629 -179.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.462 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -115.49 87.9 18.16 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 115.761 -0.654 . . . . 0.44 110.162 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.654 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.6 Cg_endo -113.28 145.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 123.611 2.874 . . . . 0.44 113.789 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 36.3 mt-30 -74.9 79.89 2.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.496 -2.038 . . . . 0.44 105.496 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.58 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.05 126.98 49.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.172 -1.377 . . . . 0.44 111.072 -176.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.489 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.1 t80 179.77 166.91 1.2 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.44 111.77 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.7 m 87.31 155.39 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.853 -0.612 . . . . 0.44 110.644 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.4 pp -110.85 137.41 48.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.953 0.406 . . . . 0.44 111.308 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -91.21 -37.55 13.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.44 110.019 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.53 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.2 tt0 -171.77 144.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.626 -0.716 . . . . 0.44 110.45 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 132.12 22.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.483 -0.326 . . . . 0.44 110.345 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.0 151.09 43.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.426 . . . . 0.44 111.336 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -129.93 109.94 11.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.44 110.467 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.417 ' CE2' HG23 ' A' ' 80' ' ' ILE . 55.1 p90 -128.22 149.75 50.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.44 110.739 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -121.15 129.48 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.18 0.514 . . . . 0.44 111.22 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.46 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.7 m-85 -78.81 163.21 61.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.503 -0.771 . . . . 0.44 110.546 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.3 Cg_endo -50.72 83.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.227 2.618 . . . . 0.44 112.238 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 21.1 m-20 93.98 15.45 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.282 -0.872 . . . . 0.44 111.339 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 75' ' ' PHE . 10.5 ttp180 -137.43 150.21 47.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.329 -0.396 . . . . 0.44 110.365 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -126.95 113.47 16.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.44 111.006 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.417 HG23 ' CE2' ' A' ' 73' ' ' TYR . 2.0 tt -124.22 119.44 56.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.44 110.977 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -106.35 118.82 37.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.529 . . . . 0.44 109.82 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -118.39 114.36 22.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.964 0.412 . . . . 0.44 111.798 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -107.64 122.31 46.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.896 -0.593 . . . . 0.44 110.009 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 3.2 m-30 -104.54 120.16 40.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.033 0.444 . . . . 0.44 110.513 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.658 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 16.6 m95 -106.23 149.09 27.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.44 112.049 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.5 tm? -95.52 138.6 32.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.674 -0.694 . . . . 0.44 111.551 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 64' ' ' HIS . 39.1 t -123.4 145.85 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-N 115.484 -0.78 . . . . 0.44 110.117 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -110.57 -26.71 9.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.282 1.216 . . . . 0.44 114.282 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.466 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -162.51 161.71 27.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.491 0.587 . . . . 0.44 111.41 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.654 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -156.91 124.74 5.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.347 -0.388 . . . . 0.44 111.266 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -73.14 142.69 47.45 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.254 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.15 -143.38 26.11 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.0 -0.619 . . . . 0.44 112.704 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 60' ' ' ILE . 2.2 tt0 -107.52 138.01 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 110.402 -0.221 . . . . 0.44 110.402 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.491 ' HA ' HG21 ' A' ' 60' ' ' ILE . 6.6 Cg_exo -74.89 128.97 12.0 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.82 2.347 . . . . 0.44 111.598 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.572 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 52.0 p-90 -121.23 -62.62 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.429 0.529 . . . . 0.44 112.429 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.619 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.93 -97.68 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.096 -0.573 . . . . 0.44 113.21 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 tttt 173.59 39.43 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.724 0.297 . . . . 0.44 111.096 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.87 -49.39 76.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.428 -0.351 . . . . 0.44 110.798 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 148.86 -68.08 0.36 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.466 -0.874 . . . . 0.44 113.118 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -117.72 113.27 38.26 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.033 0.444 . . . . 0.44 111.746 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.6 146.15 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.077 2.518 . . . . 0.44 112.686 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.17 177.39 17.69 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.851 -0.69 . . . . 0.44 112.811 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -124.4 157.18 35.72 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.481 -0.192 . . . . 0.44 110.481 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.467 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.8 OUTLIER -67.65 106.44 2.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.91 0.386 . . . . 0.44 110.17 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.23 163.22 18.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.44 111.211 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.5 t -83.43 114.84 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.44 110.444 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -18.77 55.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.44 111.458 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.89 -8.85 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.589 -0.278 . . . . 0.44 111.656 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.64 51.68 0.84 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.989 -0.624 . . . . 0.44 111.738 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.18 150.16 39.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.652 0.263 . . . . 0.44 110.688 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.407 ' CB ' ' CD1' ' A' ' 33' ' ' LEU . 1.3 t-20 -107.26 97.31 7.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.692 0.627 . . . . 0.44 112.692 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.48 -22.58 61.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.44 110.211 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -78.98 -44.91 21.38 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.043 -0.526 . . . . 0.44 111.401 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.62 -42.74 86.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.199 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.506 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.55 174.32 6.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.438 -0.578 . . . . 0.44 109.438 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.5 Cg_endo -54.07 127.74 26.97 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.889 1.726 . . . . 0.44 112.233 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.03 -36.28 13.06 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.679 2.252 . . . . 0.44 112.503 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.13 -9.67 58.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.42 . . . . 0.44 111.339 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -104.37 21.61 16.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.44 110.798 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.22 -31.29 1.4 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 113.489 0.922 . . . . 0.44 113.489 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.8 Cg_exo -43.83 -32.97 4.68 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.833 1.689 . . . . 0.44 113.003 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 50.0 t -78.02 -51.1 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.121 0.486 . . . . 0.44 110.504 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 23.4 mm -69.17 -30.73 47.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.616 -0.72 . . . . 0.44 111.623 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.78 -27.61 42.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.906 0.384 . . . . 0.44 110.628 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -80.43 -53.11 6.89 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.029 -0.532 . . . . 0.44 111.941 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.19 -33.19 50.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.542 -0.299 . . . . 0.44 111.771 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 31.0 ttpt -53.41 -42.84 67.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.133 0.492 . . . . 0.44 110.837 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -7.36 29.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.62 -0.718 . . . . 0.44 109.83 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.528 0.1 0 CA-C-N 115.861 -0.609 . . . . 0.44 111.32 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.0 tttm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.868 0.366 . . . . 0.44 110.89 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.99 126.76 20.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.44 110.932 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.437 HD12 ' CD1' ' A' ' 6' ' ' ILE . 3.1 pp -146.1 122.49 10.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.939 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 14.2 mt-30 -102.85 155.37 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.41 0.624 . . . . 0.44 112.391 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.437 ' CD1' HD12 ' A' ' 4' ' ' LEU . 3.6 mp -146.99 129.72 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.222 -0.899 . . . . 0.44 110.536 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.576 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.67 125.38 44.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.244 -0.65 . . . . 0.44 109.244 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.9 m -144.28 162.27 14.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.254 -0.578 . . . . 0.44 111.718 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.419 ' N ' HG21 ' A' ' 8' ' ' VAL . . . -149.65 132.14 3.92 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.626 -0.716 . . . . 0.44 112.006 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.54 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.85 114.49 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.523 -0.547 . . . . 0.44 109.523 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.5 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.1 mt -71.38 123.24 25.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.96 0.409 . . . . 0.44 111.513 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.95 122.86 29.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 0.44 111.684 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.465 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 14.7 t30 -82.34 -172.21 3.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.027 -0.988 . . . . 0.44 112.087 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.411 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.3 tt0 -81.61 0.99 35.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.085 -1.416 . . . . 0.44 112.431 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -139.74 52.16 1.71 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.798 0.332 . . . . 0.44 111.432 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 47.56 21.17 0.22 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.154 -0.475 . . . . 0.44 111.588 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 13' ' ' ASN . 17.2 pt-20 -111.79 153.28 26.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.582 -0.896 . . . . 0.44 108.582 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.464 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 4.9 mt -123.61 141.87 42.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.351 0.596 . . . . 0.44 112.438 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.475 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -87.13 117.86 26.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.112 -0.949 . . . . 0.44 109.917 179.268 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.446 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -129.04 145.2 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.29 -0.414 . . . . 0.44 110.567 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 68.4 p -70.78 111.84 6.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.412 -0.358 . . . . 0.44 110.23 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.416 -0.357 . . . . 0.44 111.046 -179.487 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.4 t30 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.779 0.323 . . . . 0.44 111.318 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.22 26.04 10.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.371 -0.377 . . . . 0.44 111.409 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 7.2 tt -64.01 74.76 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.743 -0.662 . . . . 0.44 110.88 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -123.59 -171.22 2.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.896 0.379 . . . . 0.44 111.5 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.494 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.3 168.58 9.68 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.055 -0.52 . . . . 0.44 111.619 -179.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.497 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 92.0 Cg_endo -82.66 167.37 14.95 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.689 2.926 . . . . 0.44 113.307 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.14 -5.24 52.65 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.719 -0.673 . . . . 0.44 114.067 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.82 166.51 17.4 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.274 -0.488 . . . . 0.44 113.263 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.455 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.29 0.25 1.38 Allowed 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.42 0.526 . . . . 0.44 112.42 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.576 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.2 pt -49.9 -29.07 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.682 0.753 . . . . 0.44 110.542 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.574 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.07 -60.37 1.9 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.481 -1.236 . . . . 0.44 110.964 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 8.05 -80.27 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.928 0.767 . . . . 0.44 112.511 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -178.66 32.71 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.844 -0.694 . . . . 0.44 112.725 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.6 mp0 -88.58 -174.11 4.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.796 0.331 . . . . 0.44 111.078 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.528 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.8 153.79 38.55 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.44 110.239 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.86 -25.18 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.805 2.337 . . . . 0.44 112.496 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -104.02 -40.31 6.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.413 -0.358 . . . . 0.44 111.398 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -80.25 -6.79 58.46 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.741 0.275 . . . . 0.44 111.741 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.435 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -61.52 -56.01 24.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.44 110.812 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.453 ' CG1' ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.28 -48.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.166 -0.47 . . . . 0.44 110.872 179.506 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.4 t -51.44 -35.8 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.364 -0.38 . . . . 0.44 111.016 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -52.26 8.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.44 111.255 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.3 mm-40 -66.27 -22.69 66.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.367 -0.379 . . . . 0.44 110.707 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.461 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 10.9 tp -58.01 -44.3 87.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.44 110.697 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -28.41 61.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.055 0.455 . . . . 0.44 109.885 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -77.1 -28.07 54.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.674 -0.694 . . . . 0.44 110.972 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.477 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.7 mp0 -108.39 6.94 26.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.351 0.5 . . . . 0.44 112.351 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.549 ' CG1' HG13 ' A' ' 60' ' ' ILE . 60.9 t -133.18 -44.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.495 -0.557 . . . . 0.44 109.495 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.594 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.85 -39.12 0.24 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.573 -0.74 . . . . 0.44 114.264 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.549 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.34 -176.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.959 0.409 . . . . 0.44 110.847 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.31 88.77 13.32 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-N 115.77 -0.65 . . . . 0.44 110.694 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.684 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.8 Cg_endo -110.46 143.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 123.402 2.735 . . . . 0.44 113.679 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 33.3 mt-30 -74.67 79.9 2.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.434 -2.061 . . . . 0.44 105.434 175.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.663 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.37 132.08 54.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.089 -1.414 . . . . 0.44 111.165 -175.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -179.82 -133.55 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.838 -0.619 . . . . 0.44 110.294 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.23 167.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.017 0.437 . . . . 0.44 111.754 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.7 tt -131.7 108.73 9.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.882 -0.599 . . . . 0.44 110.897 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.85 -44.29 32.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.037 0.446 . . . . 0.44 110.253 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.8 tt0 -171.6 156.89 4.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.738 -0.664 . . . . 0.44 110.316 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.09 106.24 4.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.52 -0.309 . . . . 0.44 110.644 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.425 HD23 ' CE1' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -96.77 124.88 40.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.916 0.389 . . . . 0.44 111.284 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -123.42 109.96 14.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.44 110.413 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 1.8 p90 -138.55 149.55 45.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 0.44 110.828 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.447 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 3.7 pt-20 -121.11 122.15 39.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.089 0.471 . . . . 0.44 111.248 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 77' ' ' ASP . 4.5 m-85 -84.99 162.86 48.23 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 0.44 110.482 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -50.81 81.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.011 2.474 . . . . 0.44 112.224 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 75' ' ' PHE . 12.3 m-20 89.58 12.88 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.401 -0.818 . . . . 0.44 111.475 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 24.3 ttp180 -137.35 93.7 2.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.705 0.288 . . . . 0.44 110.786 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.447 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.8 t-80 -81.49 110.74 17.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.436 -0.347 . . . . 0.44 110.957 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.416 HG21 ' CE2' ' A' ' 73' ' ' TYR . 1.8 tp -114.0 118.52 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.44 110.913 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -111.72 118.77 36.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.913 -0.585 . . . . 0.44 109.763 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 11.8 mt -122.25 114.29 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.929 0.395 . . . . 0.44 111.873 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -106.99 122.32 46.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.44 110.057 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.453 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 3.5 m-30 -103.98 112.99 26.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.018 -0.537 . . . . 0.44 110.776 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.453 ' CZ2' ' CG1' ' A' ' 50' ' ' VAL . 44.4 m95 -94.68 148.68 22.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.109 -0.496 . . . . 0.44 111.212 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.8 tp -99.85 103.05 14.63 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.453 0.644 . . . . 0.44 111.324 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 64' ' ' HIS . 11.6 t -80.84 146.08 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 115.186 -0.915 . . . . 0.44 111.303 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.77 -26.23 8.3 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.976 1.102 . . . . 0.44 113.976 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.1 tpt180 -162.64 162.05 26.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.416 0.553 . . . . 0.44 111.44 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.684 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -155.85 124.32 5.9 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.44 111.449 178.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -73.07 140.34 47.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.132 -0.485 . . . . 0.44 110.914 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.34 -121.68 26.35 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.44 112.55 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.1 tt0 -132.84 142.13 43.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.506 0.193 . . . . 0.44 110.783 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 3.5 Cg_exo -75.8 128.84 11.16 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.824 2.349 . . . . 0.44 111.178 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.594 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 18.4 p-90 -126.24 -64.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.489 -0.484 . . . . 0.44 112.262 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.489 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.57 -94.9 0.01 OUTLIER Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.817 -0.629 . . . . 0.44 113.062 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 170.99 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.674 0.273 . . . . 0.44 111.35 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -50.33 -29.96 11.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.638 0.256 . . . . 0.44 110.794 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.09 -28.77 7.44 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.533 -0.841 . . . . 0.44 113.741 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.03 106.04 6.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 117.206 0.503 . . . . 0.44 112.003 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -43.56 146.28 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.112 2.541 . . . . 0.44 112.66 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.81 177.29 19.19 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.664 -0.779 . . . . 0.44 113.1 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.27 157.42 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.255 -0.276 . . . . 0.44 110.255 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.441 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -68.68 105.98 2.47 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.706 -0.398 . . . . 0.44 110.183 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.7 ptp -120.52 163.29 18.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 0.44 111.012 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.33 114.98 16.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.444 -0.344 . . . . 0.44 110.474 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -71.42 -18.74 62.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.44 111.407 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.0 -13.63 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.528 -0.305 . . . . 0.44 111.619 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.48 55.16 0.63 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.824 -0.703 . . . . 0.44 111.967 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.403 ' CD2' HG22 ' A' ' 123' ' ' ILE . 4.8 tt -61.95 150.54 37.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.896 0.379 . . . . 0.44 110.742 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.22 100.07 11.92 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.794 0.664 . . . . 0.44 112.794 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.468 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -20.93 61.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.14 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.98 -45.15 20.88 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.997 -0.547 . . . . 0.44 111.087 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -41.0 88.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.241 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.478 ' CB ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -78.37 174.2 6.4 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.419 -0.585 . . . . 0.44 109.419 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.08 127.56 26.2 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.82 1.68 . . . . 0.44 112.301 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.27 -34.66 15.7 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.762 2.308 . . . . 0.44 112.415 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.56 58.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.44 111.377 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -103.38 20.54 17.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.954 -0.566 . . . . 0.44 110.955 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.549 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -70.29 -31.16 2.15 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.872 1.064 . . . . 0.44 113.872 -178.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 90.2 Cg_exo -43.99 -37.81 9.67 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 121.704 1.603 . . . . 0.44 113.429 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.453 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 52.2 t -77.81 -51.02 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.517 . . . . 0.44 110.6 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 127' ' ' LYS . 43.1 mm -66.19 -30.03 48.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.44 111.563 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -29.99 57.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.967 0.413 . . . . 0.44 110.254 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -50.79 11.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.44 111.509 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.498 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 3.4 tm? -78.41 -19.93 52.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.375 . . . . 0.44 111.831 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HB2' HG21 ' A' ' 123' ' ' ILE . 8.5 tttt -74.45 -42.61 58.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.235 0.54 . . . . 0.44 110.522 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.74 -9.97 42.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.464 -0.789 . . . . 0.44 110.01 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.498 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.138 0 CA-C-N 116.35 -0.386 . . . . 0.44 110.639 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 tptm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.932 0.396 . . . . 0.44 110.881 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.81 129.04 23.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.44 110.721 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.428 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.3 pp -146.2 136.93 24.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.44 111.329 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -106.64 153.63 22.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.126 0.489 . . . . 0.44 111.648 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.447 ' N ' ' O ' ' A' ' 81' ' ' THR . 4.3 mp -146.32 118.84 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.513 -0.767 . . . . 0.44 110.695 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.94 125.83 44.53 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.426 -0.583 . . . . 0.44 109.426 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -140.08 162.6 24.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.449 -0.5 . . . . 0.44 111.559 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.58 125.69 2.7 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.46 -0.791 . . . . 0.44 112.134 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.81 107.26 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.577 -0.527 . . . . 0.44 109.577 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.455 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -71.23 125.33 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.898 0.38 . . . . 0.44 111.496 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.05 124.44 34.29 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.87 -0.605 . . . . 0.44 111.581 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.472 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 13.5 t30 -79.32 -172.22 3.09 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.261 -0.881 . . . . 0.44 111.834 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -82.57 -1.54 51.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.353 -1.294 . . . . 0.44 112.411 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -129.1 36.15 4.21 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.844 0.312 . . . . 0.44 111.844 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.99 7.29 3.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.452 -0.34 . . . . 0.44 111.601 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 19.2 pt-20 -100.95 146.11 27.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.045 -0.724 . . . . 0.44 109.045 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 6.4 mt -110.61 138.7 37.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.44 111.833 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -86.14 122.52 30.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.357 -0.838 . . . . 0.44 110.686 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.494 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -126.42 162.2 30.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.44 109.804 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.7 p -70.52 154.86 41.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.701 0.286 . . . . 0.44 110.392 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.44 111.197 -179.683 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.632 0.253 . . . . 0.44 111.273 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -114.16 25.96 10.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.045 0.45 . . . . 0.44 111.66 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.2 tt -70.72 72.42 0.53 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.861 -0.608 . . . . 0.44 110.582 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.73 -167.71 1.32 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.995 0.426 . . . . 0.44 111.913 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.532 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.37 168.51 9.88 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.808 -0.633 . . . . 0.44 111.488 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.603 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 91.4 Cg_endo -80.39 167.34 19.39 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.524 2.816 . . . . 0.44 113.327 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.45 -5.79 52.24 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.594 -0.73 . . . . 0.44 114.006 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.48 163.22 18.35 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.207 -0.52 . . . . 0.44 112.852 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.53 -0.18 0.91 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.803 0.441 . . . . 0.44 112.1 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.2 pt -50.83 -28.83 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.728 . . . . 0.44 110.424 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.588 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -42.38 -54.65 3.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.266 -1.334 . . . . 0.44 110.934 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.536 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 0.9 -75.33 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.966 0.791 . . . . 0.44 112.546 179.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 173.04 35.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 0.44 112.806 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.425 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.13 -172.47 3.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.777 0.323 . . . . 0.44 111.08 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.509 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -96.44 153.03 39.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.44 110.309 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.509 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.84 -25.03 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.781 2.32 . . . . 0.44 112.52 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -104.04 -39.38 6.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.426 -0.352 . . . . 0.44 111.569 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -80.11 -12.87 59.63 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.685 0.254 . . . . 0.44 111.685 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -58.45 -52.75 64.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.44 110.806 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -78.37 -48.34 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.44 111.21 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.526 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 36.3 t -57.1 -38.47 60.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.79 -0.641 . . . . 0.44 111.675 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -74.79 -52.06 12.46 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.844 -0.342 . . . . 0.44 110.786 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -63.08 -20.06 65.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.44 110.722 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.456 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 1.3 tp -60.46 -44.68 95.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.905 0.383 . . . . 0.44 110.926 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -68.54 -30.08 68.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.144 -0.48 . . . . 0.44 110.064 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -77.3 -25.63 51.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.44 111.678 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.46 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.85 6.65 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.956 0.725 . . . . 0.44 112.956 -178.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.485 ' CG1' HG13 ' A' ' 60' ' ' ILE . 10.0 t -133.81 -44.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.029 0.442 . . . . 0.44 110.721 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 56.67 6.33 1.63 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 114.846 0.699 . . . . 0.44 114.846 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.485 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.37 -166.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 118.087 0.943 . . . . 0.44 110.406 179.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.496 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -113.86 88.64 14.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.44 110.302 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 20.4 Cg_endo -111.92 137.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 123.529 2.819 . . . . 0.44 114.686 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -74.8 79.15 2.09 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 104.788 -2.301 . . . . 0.44 104.788 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.568 ' HA ' HG11 ' A' ' 87' ' ' VAL . 1.5 t-160 -117.09 124.05 48.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.901 -1.5 . . . . 0.44 110.358 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.5 t80 179.78 163.61 1.03 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.616 -0.434 . . . . 0.44 111.901 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 85.64 154.57 0.08 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.737 -0.665 . . . . 0.44 110.447 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.707 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.2 pp -107.68 121.06 43.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.44 111.616 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.81 -39.0 52.85 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.388 -0.597 . . . . 0.44 109.388 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.87 138.26 1.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.199 -0.91 . . . . 0.44 109.799 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.29 103.99 4.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.583 0.23 . . . . 0.44 110.746 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp -105.81 152.54 23.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.44 111.062 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -135.38 117.39 15.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.44 110.723 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -136.33 152.06 50.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.509 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.422 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.02 139.96 52.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.198 0.523 . . . . 0.44 111.397 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -105.63 163.18 17.63 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 115.375 -0.83 . . . . 0.44 110.278 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.9 Cg_endo -55.63 81.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.819 2.346 . . . . 0.44 112.15 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 4.9 t70 97.08 6.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.482 -0.781 . . . . 0.44 111.676 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -137.32 94.84 2.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.702 0.287 . . . . 0.44 110.796 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.422 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -91.96 101.66 14.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 0.44 110.744 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 1.9 tt -103.52 142.77 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.134 0.493 . . . . 0.44 111.283 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -123.01 118.24 27.33 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.939 -0.764 . . . . 0.44 108.939 178.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.425 HD13 ' CG2' ' A' ' 6' ' ' ILE . 6.4 tp -114.49 114.03 25.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.085 0.469 . . . . 0.44 111.542 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 8.7 m0 -114.15 121.8 44.87 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.71 -0.677 . . . . 0.44 109.83 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.502 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 3.5 m-30 -110.27 117.41 33.57 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.782 -0.644 . . . . 0.44 110.236 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.707 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 16.2 m95 -105.4 148.54 27.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.223 0.535 . . . . 0.44 112.343 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.5 tp -86.14 138.42 31.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.565 -0.743 . . . . 0.44 111.386 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 64' ' ' HIS . 20.7 t -124.11 145.49 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 115.87 -0.605 . . . . 0.44 110.712 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.88 -24.2 10.12 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.598 1.333 . . . . 0.44 114.598 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.548 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.76 163.18 26.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.344 0.974 . . . . 0.44 112.306 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -157.81 123.26 4.53 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.075 -0.511 . . . . 0.44 110.749 178.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.496 ' CB ' HG23 ' A' ' 61' ' ' THR . 6.8 tt0 -74.5 149.39 40.3 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 120.447 -0.501 . . . . 0.44 111.165 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.62 -116.83 6.35 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.852 -0.69 . . . . 0.44 112.593 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -135.33 143.39 45.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.431 0.158 . . . . 0.44 110.697 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.489 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.43 128.76 10.59 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.816 2.344 . . . . 0.44 111.079 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 38.0 p-90 -132.25 -59.75 0.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.202 0.445 . . . . 0.44 112.202 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.499 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.79 -94.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.804 -0.634 . . . . 0.44 112.786 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER 174.77 39.63 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.786 0.327 . . . . 0.44 110.714 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' CA ' ' HG3' ' A' ' 57' ' ' GLU . 26.4 pt-20 -57.64 -45.67 85.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.358 -0.383 . . . . 0.44 110.767 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 131.92 -43.06 1.32 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.53 -0.843 . . . . 0.44 113.248 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.37 108.2 23.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.042 0.449 . . . . 0.44 111.769 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -43.75 146.31 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.004 2.469 . . . . 0.44 112.51 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.64 177.27 17.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.658 -0.782 . . . . 0.44 113.048 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.78 157.38 43.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.383 -0.228 . . . . 0.44 110.383 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.459 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -74.49 106.33 6.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.902 0.382 . . . . 0.44 110.295 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.1 ptp -120.42 163.24 18.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.44 111.13 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.4 p -79.28 114.98 18.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.44 110.509 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -18.7 63.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.44 111.449 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.08 -8.57 3.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.55 -0.295 . . . . 0.44 111.6 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.97 50.46 0.88 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.892 -0.67 . . . . 0.44 112.096 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.17 150.17 39.46 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.388 -0.227 . . . . 0.44 110.388 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.46 115.84 22.93 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.944 0.72 . . . . 0.44 112.944 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.59 -17.97 61.65 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.554 -0.748 . . . . 0.44 110.162 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -78.85 -49.06 13.55 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.062 -0.517 . . . . 0.44 111.075 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -66.93 -18.74 65.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.214 -0.448 . . . . 0.44 111.447 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.82 170.72 5.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.737 -0.468 . . . . 0.44 109.737 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.54 127.69 27.07 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.05 1.833 . . . . 0.44 112.326 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.16 -36.86 11.56 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.619 2.212 . . . . 0.44 112.528 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.57 -9.58 57.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.44 111.487 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -105.8 19.11 21.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.906 -0.588 . . . . 0.44 110.776 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.555 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -66.61 -31.88 4.63 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.796 1.036 . . . . 0.44 113.796 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.0 Cg_exo -44.2 -34.74 7.21 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 121.825 1.683 . . . . 0.44 113.154 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.458 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 39.4 t -77.96 -51.3 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.021 0.439 . . . . 0.44 110.785 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.475 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 26.2 mm -67.49 -31.94 54.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 CA-C-N 115.9 -0.591 . . . . 0.44 111.42 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.49 -26.86 33.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.891 0.377 . . . . 0.44 110.657 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.12 -53.09 7.02 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.44 111.791 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.25 -31.8 49.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.761 0.315 . . . . 0.44 111.744 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 4.7 ttpt -53.95 -42.56 69.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.97 0.414 . . . . 0.44 110.864 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -67.77 -9.22 42.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.786 -0.643 . . . . 0.44 109.825 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-N 115.959 -0.564 . . . . 0.44 111.264 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.828 0.346 . . . . 0.44 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 145.4 55.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.943 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 pp -146.1 127.84 15.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.44 111.236 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -102.58 146.95 27.4 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.281 0.562 . . . . 0.44 111.696 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.436 HG13 ' HA2' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -146.71 132.91 13.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.226 -0.897 . . . . 0.44 110.771 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.589 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.64 124.55 42.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.63 -0.507 . . . . 0.44 109.63 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.543 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 m -119.38 162.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.391 0.615 . . . . 0.44 112.089 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.51 106.23 0.32 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.132 -0.94 . . . . 0.44 111.904 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.72 109.88 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.444 -0.576 . . . . 0.44 109.444 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.473 ' CG2' ' HB3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.34 123.06 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 0.44 111.805 -178.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.72 124.32 32.85 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.773 -0.649 . . . . 0.44 111.591 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 2.2 t-20 -81.41 -172.34 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.778 -1.101 . . . . 0.44 111.644 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.503 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 26.2 tt0 -83.34 9.18 11.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.602 -1.181 . . . . 0.44 112.487 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -141.36 52.24 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.156 -0.34 . . . . 0.44 111.503 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.9 p30 44.71 25.79 0.16 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.997 0.427 . . . . 0.44 111.368 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -117.93 160.16 21.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.12 -0.696 . . . . 0.44 109.12 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.406 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 9.0 mt -130.26 138.04 54.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.048 0.452 . . . . 0.44 111.435 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.464 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -79.02 112.5 16.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.44 110.305 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.28 139.61 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.136 -0.484 . . . . 0.44 110.156 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -70.8 111.88 6.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.824 0.345 . . . . 0.44 110.606 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.44 110.776 -179.871 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 111.604 0.224 . . . . 0.44 111.604 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 26.2 10.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.046 0.451 . . . . 0.44 111.3 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 tp -58.07 86.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.764 -0.653 . . . . 0.44 110.841 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.91 -175.94 3.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.44 111.112 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.63 161.58 36.94 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.44 111.177 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.7 166.7 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.069 2.513 . . . . 0.44 111.525 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 100.97 58.92 0.82 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 119.857 -1.164 . . . . 0.44 113.176 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.603 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.66 122.96 3.55 Favored Glycine 0 C--N 1.312 -0.802 0 CA-C-N 114.941 -0.63 . . . . 0.44 112.339 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.603 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 107.92 2.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.103 0.561 . . . . 0.44 112.296 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.589 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.6 pt -48.83 -28.95 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.541 0.686 . . . . 0.44 110.515 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.56 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.92 -69.72 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.608 -1.178 . . . . 0.44 110.779 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.462 ' C ' ' O ' ' A' ' 41' ' ' GLU . 13.7 mmt 22.43 -86.18 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.868 0.73 . . . . 0.44 112.19 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.88 27.86 0.17 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.991 -0.623 . . . . 0.44 112.502 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.41 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 5.9 mt-10 -93.83 -177.32 4.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.827 0.346 . . . . 0.44 111.108 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.56 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.86 158.44 35.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.44 109.982 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.93 -24.69 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.809 2.339 . . . . 0.44 112.409 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.85 -60.23 2.01 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.11 0.411 . . . . 0.44 112.11 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.48 -6.83 58.75 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.289 0.477 . . . . 0.44 112.289 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -61.74 -54.47 42.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.76 0.314 . . . . 0.44 110.826 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -78.31 -46.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.44 110.977 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.497 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 32.6 t -55.55 -37.62 46.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.113 -0.494 . . . . 0.44 111.223 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.3 -52.02 9.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.336 -0.393 . . . . 0.44 110.998 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.87 -23.55 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.44 111.002 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.481 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -53.79 -44.63 70.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.44 110.532 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -33.93 75.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.069 -0.715 . . . . 0.44 109.069 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.68 -26.12 50.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.251 -0.886 . . . . 0.44 111.188 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 54.2 mm-40 -108.36 4.27 24.28 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.262 0.467 . . . . 0.44 112.262 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.573 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 26.0 t -134.85 -44.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.229 0.538 . . . . 0.44 110.117 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.14 -41.77 0.36 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.292 -0.867 . . . . 0.44 113.723 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.52 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.1 OUTLIER -77.79 -176.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.133 0.492 . . . . 0.44 111.251 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.79 88.79 14.64 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 115.573 -0.739 . . . . 0.44 110.17 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.546 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.2 Cg_endo -110.15 149.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.322 2.681 . . . . 0.44 113.887 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 77.7 mt-30 -74.74 79.78 2.06 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.053 -1.832 . . . . 0.44 106.053 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.561 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.56 129.27 50.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.305 -1.316 . . . . 0.44 110.206 -176.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -176.59 -39.34 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.887 0.699 . . . . 0.44 112.887 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 86' ' ' LEU . 51.8 m -40.74 160.87 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.526 -0.761 . . . . 0.44 111.805 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -115.69 119.32 35.68 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.083 -0.508 . . . . 0.44 110.575 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -86.83 -56.34 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.262 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.539 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -172.03 144.08 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.982 -0.554 . . . . 0.44 110.309 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.443 ' NZ ' ' CZ3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -142.21 112.46 7.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.698 0.285 . . . . 0.44 110.768 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.18 159.39 31.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.968 0.413 . . . . 0.44 111.028 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -135.35 109.93 8.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.592 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.456 ' CE1' ' CG2' ' A' ' 80' ' ' ILE . 30.1 p90 -125.59 151.12 46.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.31 -0.405 . . . . 0.44 110.746 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.12 131.29 54.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.44 111.114 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.455 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-85 -79.89 162.85 60.87 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.695 -0.684 . . . . 0.44 110.622 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.9 Cg_endo -53.6 82.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.203 2.602 . . . . 0.44 112.321 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER 100.43 11.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.895 0.878 . . . . 0.44 111.232 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 17.5 ttp180 -137.3 150.15 47.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.44 110.585 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -127.06 110.87 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.44 110.672 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.456 ' CG2' ' CE1' ' A' ' 73' ' ' TYR . 1.9 tt -120.3 120.69 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.44 111.369 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.02 118.65 37.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.32 -0.622 . . . . 0.44 109.32 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.405 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.1 mp -119.75 114.05 21.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.44 111.768 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.443 ' CZ3' ' NZ ' ' A' ' 70' ' ' LYS . 10.5 m0 -110.1 122.55 47.86 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.068 -0.515 . . . . 0.44 110.348 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.459 ' CD1' HG13 ' A' ' 122' ' ' VAL . 2.2 m-85 -109.98 109.79 20.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.063 -0.517 . . . . 0.44 110.919 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.408 ' NE1' HG13 ' A' ' 50' ' ' VAL . 34.2 m95 -98.02 148.95 22.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.801 -0.636 . . . . 0.44 111.592 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.449 ' HB3' ' CB ' ' A' ' 66' ' ' SER . 3.4 tt -97.83 138.5 35.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.461 0.648 . . . . 0.44 111.664 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.566 ' O ' ' HB2' ' A' ' 12' ' ' ARG . 61.5 t -114.78 146.38 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-N 115.104 -0.953 . . . . 0.44 110.436 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.41 -25.69 10.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 114.024 1.12 . . . . 0.44 114.024 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.4 165.36 24.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.72 0.691 . . . . 0.44 111.505 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.546 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -156.57 123.36 5.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.387 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -79.1 153.69 29.95 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.061 -0.518 . . . . 0.44 111.064 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.56 -131.95 49.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.829 -0.7 . . . . 0.44 112.566 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.4 mt-10 -123.33 144.24 43.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.51 0.195 . . . . 0.44 110.725 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.54 128.76 10.51 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.788 2.325 . . . . 0.44 111.628 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.549 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.9 p-90 -133.4 -58.91 0.88 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.559 -0.457 . . . . 0.44 111.604 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.573 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.07 -98.02 0.01 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.847 -0.692 . . . . 0.44 113.025 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 176.8 36.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.44 111.022 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -44.52 96.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.44 110.882 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.38 -68.5 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.57 -0.824 . . . . 0.44 113.111 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -110.86 106.37 57.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.44 111.554 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -43.58 146.27 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.016 2.477 . . . . 0.44 112.647 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.34 177.04 17.11 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.651 -0.785 . . . . 0.44 112.809 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.82 157.38 37.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.578 0.228 . . . . 0.44 110.568 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -60.14 106.68 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.44 110.258 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.03 163.29 17.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.44 110.93 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.3 p -80.36 114.75 19.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.461 -0.336 . . . . 0.44 110.47 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.25 -18.68 48.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.352 -0.385 . . . . 0.44 111.433 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.13 -14.34 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.468 -0.333 . . . . 0.44 111.801 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.06 53.79 0.67 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.698 -0.763 . . . . 0.44 112.27 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.415 ' CD2' HG21 ' A' ' 123' ' ' ILE . 8.5 tt -62.24 150.37 39.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.371 -0.233 . . . . 0.44 110.371 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -106.36 115.02 29.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.043 0.757 . . . . 0.44 113.043 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.554 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.5 -17.91 61.71 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.585 -0.734 . . . . 0.44 110.049 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.03 -46.29 18.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.086 -0.506 . . . . 0.44 111.029 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -40.13 88.61 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.191 -0.458 . . . . 0.44 111.158 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.554 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.49 174.38 6.13 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.416 -0.587 . . . . 0.44 109.416 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.0 127.76 26.97 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 121.835 1.69 . . . . 0.44 112.435 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.17 -36.94 11.35 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.796 2.331 . . . . 0.44 112.557 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.33 -9.66 54.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.392 . . . . 0.44 111.361 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.428 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 13.2 m-20 -107.38 18.45 21.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.916 -0.584 . . . . 0.44 110.93 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 tt0 -64.78 -31.89 6.14 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 113.791 1.034 . . . . 0.44 113.791 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.3 Cg_exo -44.09 -38.77 10.94 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 121.746 1.631 . . . . 0.44 113.206 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 84' ' ' PHE . 76.8 t -77.66 -51.2 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.829 0.347 . . . . 0.44 111.828 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.517 HG13 ' CE2' ' A' ' 115' ' ' PHE . 32.6 mm -73.04 -43.79 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.953 0.723 . . . . 0.44 112.953 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.19 -26.81 30.16 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.191 0.441 . . . . 0.44 112.191 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -80.32 -53.45 6.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.804 0.298 . . . . 0.44 111.804 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.489 ' HG ' ' CZ ' ' A' ' 68' ' ' PHE . 3.5 mm? -78.47 -28.46 46.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.671 0.248 . . . . 0.44 111.671 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.458 ' HB2' HG23 ' A' ' 123' ' ' ILE . 9.9 ttpp -55.74 -42.19 75.03 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.059 0.457 . . . . 0.44 110.696 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -71.45 -5.79 35.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.662 -0.699 . . . . 0.44 109.99 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 115.978 -0.556 . . . . 0.44 111.112 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.904 0.383 . . . . 0.44 110.904 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.37 129.26 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.969 -0.559 . . . . 0.44 110.608 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.1 pp -146.48 139.37 25.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.913 0.387 . . . . 0.44 111.78 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.445 ' HB2' ' HA ' ' A' ' 41' ' ' GLU . 39.5 mt-30 -106.01 156.0 18.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.44 111.404 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 6' ' ' ILE . 15.0 mt -146.74 126.51 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.44 111.357 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HB2' ' CG1' ' A' ' 40' ' ' ILE . . . -125.17 125.2 43.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.513 -0.551 . . . . 0.44 109.513 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.1 m -144.7 156.49 14.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.994 -0.682 . . . . 0.44 111.999 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.406 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -146.8 124.45 1.99 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.337 -0.847 . . . . 0.44 111.864 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.606 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.57 112.45 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.232 -0.655 . . . . 0.44 109.232 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.44 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -70.81 119.94 17.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.215 0.531 . . . . 0.44 111.381 -178.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -84.3 124.39 31.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 0.44 111.625 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.454 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 23.0 t30 -80.91 -172.25 3.61 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.304 -0.862 . . . . 0.44 111.733 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.432 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.1 tt0 -82.91 5.4 22.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.45 -1.25 . . . . 0.44 112.212 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -139.44 51.23 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.875 0.369 . . . . 0.44 111.503 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 45.88 25.19 0.28 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.277 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.3 pt-20 -119.45 141.63 48.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.288 -0.634 . . . . 0.44 109.288 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 19' ' ' PHE . 10.3 mt -112.51 143.52 22.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.199 0.523 . . . . 0.44 111.749 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.474 ' N ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -90.38 121.65 32.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.57 -0.741 . . . . 0.44 110.352 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.454 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -121.22 134.72 63.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.26 -0.427 . . . . 0.44 110.058 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -70.79 111.97 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.381 . . . . 0.44 110.889 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.44 110.768 -179.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.9 t-20 . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 111.688 0.255 . . . . 0.44 111.688 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.32 26.41 10.28 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.877 0.325 . . . . 0.44 111.877 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -67.93 63.2 0.08 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.183 -0.462 . . . . 0.44 110.67 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.42 -166.93 1.15 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.44 111.445 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.51 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.42 168.23 10.47 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.075 -0.511 . . . . 0.44 111.487 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 59.9 Cg_endo -72.62 167.21 27.72 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.34 2.693 . . . . 0.44 113.162 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.571 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 101.61 -5.49 54.48 Favored Glycine 0 C--O 1.223 -0.545 0 CA-C-N 115.603 -0.726 . . . . 0.44 113.971 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.37 149.3 50.16 Favored Glycine 0 C--N 1.315 -0.602 0 C-N-CA 120.945 -0.645 . . . . 0.44 112.798 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 91.6 -0.98 0.17 Allowed 'General case' 0 C--N 1.342 0.247 0 N-CA-C 112.886 0.698 . . . . 0.44 112.886 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.595 HG13 ' N ' ' A' ' 41' ' ' GLU . 1.1 pt -49.41 -29.81 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.717 0.77 . . . . 0.44 110.584 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.595 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -43.12 -52.71 5.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.28 -1.327 . . . . 0.44 111.04 179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.531 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 0.4 -75.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.928 0.768 . . . . 0.44 112.564 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 176.12 35.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.509 -0.853 . . . . 0.44 112.979 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.468 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -93.56 -171.49 2.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.596 0.236 . . . . 0.44 111.022 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.503 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.04 152.58 38.4 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.464 -0.335 . . . . 0.44 110.294 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.503 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.82 -24.97 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.774 2.316 . . . . 0.44 112.491 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.08 -40.45 6.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.4 -0.364 . . . . 0.44 111.709 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -80.33 -14.18 58.58 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.749 0.278 . . . . 0.44 111.749 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.476 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -58.95 -52.33 66.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.818 0.342 . . . . 0.44 111.089 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.466 HG13 ' CE2' ' A' ' 85' ' ' TRP . 2.0 m -78.74 -49.03 21.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.44 110.632 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.443 ' N ' HG22 ' A' ' 50' ' ' VAL . 39.6 t -54.85 -36.02 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.44 111.392 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -51.99 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.44 110.597 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.1 mm-40 -61.59 -22.04 64.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.123 -0.49 . . . . 0.44 110.694 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.459 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -58.48 -44.48 89.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.344 -0.389 . . . . 0.44 110.867 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -33.87 75.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.44 110.116 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.6 tt0 -77.13 -26.93 53.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.697 -0.683 . . . . 0.44 111.075 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.08 6.33 26.86 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.179 0.437 . . . . 0.44 112.179 -178.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.564 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 48.2 t -133.41 -44.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.57 -0.529 . . . . 0.44 109.57 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.76 -40.66 0.31 Allowed Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.574 -0.739 . . . . 0.44 113.969 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.532 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.47 -177.55 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.084 0.469 . . . . 0.44 111.087 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.22 88.86 13.24 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.575 -0.739 . . . . 0.44 110.058 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.638 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -110.09 145.63 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 123.287 2.658 . . . . 0.44 114.159 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 84.2 mt-30 -74.69 79.96 2.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.485 -2.043 . . . . 0.44 105.485 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.585 ' HA ' HG11 ' A' ' 87' ' ' VAL . 1.7 t-160 -121.53 131.04 53.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.292 -1.322 . . . . 0.44 111.436 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -177.08 -133.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.771 -0.65 . . . . 0.44 110.345 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 54.51 171.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.039 0.447 . . . . 0.44 111.937 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 7.1 tt -136.85 108.07 6.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.44 110.714 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.74 -44.58 32.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.44 109.99 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.533 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.0 tt0 -171.79 142.72 1.57 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.782 -0.645 . . . . 0.44 110.429 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.24 103.86 4.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.376 -0.374 . . . . 0.44 110.213 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp -110.33 151.75 27.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.955 0.407 . . . . 0.44 111.479 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -131.43 109.94 10.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.575 . . . . 0.44 110.393 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.425 ' CZ ' ' HG2' ' A' ' 121' ' ' PRO . 8.1 p90 -127.7 152.99 47.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.44 110.747 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.23 128.83 52.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.213 0.53 . . . . 0.44 111.306 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -94.19 163.38 23.55 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.432 -0.804 . . . . 0.44 110.416 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -52.74 82.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.0 2.467 . . . . 0.44 112.142 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.4 m-20 91.32 9.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.327 -0.852 . . . . 0.44 111.616 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.42 93.85 2.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.616 0.246 . . . . 0.44 110.67 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 10.1 t-160 -89.8 98.78 11.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.44 110.673 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.458 HG21 HD12 ' A' ' 80' ' ' ILE . 2.0 tt -106.04 134.46 47.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.44 111.221 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -111.24 118.57 36.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.263 -0.643 . . . . 0.44 109.263 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.437 ' CD2' ' CG2' ' A' ' 122' ' ' VAL . 4.1 tp -111.7 113.91 26.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.017 0.437 . . . . 0.44 111.393 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -111.3 121.98 46.66 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.854 -0.612 . . . . 0.44 109.76 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.476 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 4.0 m-30 -112.73 111.24 21.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.066 -0.516 . . . . 0.44 111.011 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 14.6 m95 -96.14 149.12 21.98 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.44 111.056 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' PHE . 9.2 tp -97.63 103.31 15.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.515 0.674 . . . . 0.44 112.328 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.606 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 12.1 t -81.16 145.78 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 114.96 -1.018 . . . . 0.44 110.626 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.63 -26.16 8.0 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.448 1.277 . . . . 0.44 114.448 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 90' ' ' TRP . 15.4 ttm-85 -161.98 165.06 27.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.676 0.671 . . . . 0.44 111.782 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.638 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -156.26 126.16 6.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 0.44 111.419 179.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.7 147.98 37.07 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.12 -0.491 . . . . 0.44 110.94 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.2 -119.7 17.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.796 -0.716 . . . . 0.44 112.476 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -134.88 144.94 52.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.516 0.198 . . . . 0.44 110.856 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.461 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.39 128.83 10.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.983 2.455 . . . . 0.44 111.282 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 49.9 p-90 -135.06 -62.8 0.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.284 -0.566 . . . . 0.44 112.328 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.564 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.98 -100.08 0.02 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.869 -0.681 . . . . 0.44 113.02 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER 172.31 38.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.767 0.318 . . . . 0.44 111.103 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -58.53 -48.44 80.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.486 -0.325 . . . . 0.44 110.83 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.34 -60.84 0.21 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.494 -0.86 . . . . 0.44 112.834 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -139.02 126.34 13.1 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.44 111.384 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -43.31 146.2 1.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.164 2.576 . . . . 0.44 112.752 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.1 177.09 17.56 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.751 -0.738 . . . . 0.44 112.733 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -121.17 157.32 30.46 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.404 -0.221 . . . . 0.44 110.404 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -76.44 105.76 7.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.44 110.218 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 17.2 ptm -120.93 163.3 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.947 -0.57 . . . . 0.44 111.019 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.54 114.88 14.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.452 -0.34 . . . . 0.44 110.312 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.3 -18.81 64.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.374 -0.376 . . . . 0.44 111.569 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.1 p -54.91 -15.91 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.473 -0.33 . . . . 0.44 111.729 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.55 48.74 0.95 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.645 -0.788 . . . . 0.44 112.433 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.42 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 6.5 tt -62.28 150.42 39.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.676 0.274 . . . . 0.44 110.452 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.13 114.88 28.45 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.955 0.724 . . . . 0.44 112.955 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.35 -18.7 61.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.632 -0.713 . . . . 0.44 110.113 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.93 -45.58 20.2 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.96 -0.564 . . . . 0.44 110.949 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -66.78 -41.56 87.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.44 110.997 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.588 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -79.01 173.49 7.64 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.537 -0.542 . . . . 0.44 109.537 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.54 127.68 27.03 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 121.857 1.704 . . . . 0.44 112.027 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.02 -37.51 10.84 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.657 2.238 . . . . 0.44 112.667 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.64 -9.83 57.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.326 -0.397 . . . . 0.44 111.526 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -106.31 27.45 8.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.534 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.588 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.04 -30.99 0.95 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 113.957 1.095 . . . . 0.44 113.957 -178.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.2 Cg_exo -43.68 -35.01 6.06 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.966 1.777 . . . . 0.44 113.357 -178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.476 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 95.3 t -77.7 -51.1 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.087 0.47 . . . . 0.44 110.426 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.422 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 39.9 mm -64.61 -32.16 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.725 -0.67 . . . . 0.44 111.205 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.69 -27.37 39.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.9 0.381 . . . . 0.44 110.626 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -80.25 -51.26 9.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.004 -0.544 . . . . 0.44 111.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.2 tp -78.06 -28.23 48.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.722 0.296 . . . . 0.44 111.602 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 123' ' ' ILE . 49.6 tttm -55.27 -42.44 73.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.03 0.443 . . . . 0.44 110.599 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 -67.22 -10.08 46.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.73 -0.668 . . . . 0.44 109.693 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-N 115.85 -0.614 . . . . 0.44 111.294 179.746 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.845 0.355 . . . . 0.44 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -140.08 128.72 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.861 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' A' ' 6' ' ' ILE . 3.1 pp -146.06 128.72 16.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.116 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 13.8 mt-30 -102.69 154.91 18.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.284 0.564 . . . . 0.44 112.204 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.412 HD11 ' CD1' ' A' ' 80' ' ' ILE . 3.2 mp -146.89 130.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.424 -0.807 . . . . 0.44 110.68 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.541 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -125.07 125.69 44.2 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.554 -0.536 . . . . 0.44 109.554 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m -140.28 162.24 24.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 120.497 -0.481 . . . . 0.44 111.394 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.4 ' N ' HG21 ' A' ' 8' ' ' VAL . . . -147.58 129.88 3.35 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.645 -0.707 . . . . 0.44 112.057 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.589 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.7 110.54 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.521 -0.548 . . . . 0.44 109.521 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.492 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -70.94 121.99 21.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.996 0.427 . . . . 0.44 111.57 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.98 124.49 30.44 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.644 -0.707 . . . . 0.44 111.515 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.566 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 23.2 t-20 -70.88 178.26 3.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.924 -1.034 . . . . 0.44 112.006 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.566 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 31.6 tt0 -56.88 -17.24 8.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.345 -1.298 . . . . 0.44 112.76 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -122.49 -82.64 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.023 -0.271 . . . . 0.44 111.598 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.58 13.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.861 0.319 . . . . 0.44 111.861 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.81 160.3 14.48 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.868 -0.79 . . . . 0.44 108.868 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.426 HG22 ' HB ' ' A' ' 10' ' ' ILE . 5.2 mt -132.36 137.32 54.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.123 0.487 . . . . 0.44 111.624 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -83.48 118.29 23.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.44 110.573 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.49 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -121.28 141.42 41.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.44 110.092 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 5.2 p -70.75 111.74 6.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.686 0.279 . . . . 0.44 110.392 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 121.04 0.448 . . . . 0.44 111.407 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.771 0.32 . . . . 0.44 111.124 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -111.83 26.28 10.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.44 111.253 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 21' ' ' THR . 6.7 tt -65.67 69.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.675 -0.693 . . . . 0.44 111.057 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -119.82 -166.97 1.35 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.386 . . . . 0.44 111.233 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.531 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.24 168.53 9.76 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.184 -0.462 . . . . 0.44 111.552 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.598 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 82.8 Cg_endo -78.68 167.68 22.15 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.564 2.842 . . . . 0.44 113.456 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.495 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.92 -3.67 48.84 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.407 -0.815 . . . . 0.44 114.534 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.41 158.13 31.94 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.225 -0.512 . . . . 0.44 113.632 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 88.17 0.34 0.41 Allowed 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.213 0.605 . . . . 0.44 112.429 179.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.606 HG13 ' N ' ' A' ' 41' ' ' GLU . 1.1 pt -49.84 -29.14 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.607 0.718 . . . . 0.44 110.526 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.606 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.62 -57.44 2.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.52 -1.218 . . . . 0.44 110.914 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.536 ' C ' ' O ' ' A' ' 41' ' ' GLU . 9.4 mmt 4.23 -78.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.911 0.757 . . . . 0.44 112.567 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.48 34.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.69 -0.766 . . . . 0.44 112.789 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -89.39 -174.16 4.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.717 0.294 . . . . 0.44 111.049 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.517 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.03 153.45 38.51 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.44 110.248 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.517 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.83 -25.28 0.97 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.828 2.352 . . . . 0.44 112.455 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.04 -40.33 6.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.443 -0.344 . . . . 0.44 111.431 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -80.32 -4.89 55.19 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.792 0.293 . . . . 0.44 111.792 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -62.03 -57.01 13.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.44 110.869 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -78.52 -45.66 25.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.217 -0.447 . . . . 0.44 110.949 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.455 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 44.6 t -53.24 -39.75 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.44 111.237 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -78.02 -48.67 15.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.333 -0.394 . . . . 0.44 110.462 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.5 mm-40 -64.77 -20.05 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.44 110.596 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.453 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 1.2 tp -59.77 -44.39 93.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.44 110.427 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -65.0 -34.75 79.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.372 -0.603 . . . . 0.44 109.372 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.1 tm-20 -77.43 -27.35 52.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.291 -0.868 . . . . 0.44 111.087 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -108.53 5.39 25.1 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.511 0.56 . . . . 0.44 112.511 -178.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.543 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 35.1 t -134.61 -44.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.185 0.517 . . . . 0.44 110.042 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.02 -42.39 0.48 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.538 -0.756 . . . . 0.44 113.472 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.527 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.56 -176.48 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.016 0.436 . . . . 0.44 111.12 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -113.08 89.13 13.34 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.694 -0.685 . . . . 0.44 110.531 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.663 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.3 Cg_endo -107.82 143.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 123.272 2.648 . . . . 0.44 113.936 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.9 mt-30 -74.62 80.1 2.0 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.497 -2.038 . . . . 0.44 105.497 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.579 ' HA ' HG11 ' A' ' 87' ' ' VAL . 2.7 t-160 -122.64 133.32 54.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.041 -1.436 . . . . 0.44 111.474 -175.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.579 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -175.65 -145.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.754 -0.657 . . . . 0.44 110.617 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m 51.96 172.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.009 0.523 . . . . 0.44 112.138 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.821 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -140.26 122.18 15.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.44 110.62 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.55 -44.24 35.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.44 109.966 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -171.68 131.9 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.44 110.395 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -115.65 109.95 18.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.76 0.314 . . . . 0.44 110.552 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.429 HD21 ' CE1' ' A' ' 73' ' ' TYR . 2.8 tp -96.88 121.56 38.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.865 0.365 . . . . 0.44 110.964 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -123.14 109.69 14.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.44 110.442 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.429 ' CE1' HD21 ' A' ' 71' ' ' LEU . 2.0 p90 -141.26 149.84 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.44 110.882 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 2.6 pt-20 -121.23 129.05 52.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.213 0.53 . . . . 0.44 111.062 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 77' ' ' ASP . 1.0 OUTLIER -95.69 163.27 21.73 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.421 -0.809 . . . . 0.44 110.52 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.1 Cg_endo -53.18 82.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.964 2.443 . . . . 0.44 112.337 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER 92.5 8.69 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.419 -0.81 . . . . 0.44 111.618 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -137.25 93.87 2.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.675 0.274 . . . . 0.44 110.896 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.435 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 3.2 t-160 -86.84 93.98 9.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.453 -0.34 . . . . 0.44 110.778 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.412 ' CD1' HD11 ' A' ' 6' ' ' ILE . 1.7 tp -101.24 111.93 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.049 0.452 . . . . 0.44 110.889 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.82 118.81 37.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.792 -0.64 . . . . 0.44 109.751 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.35 114.19 23.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.933 0.397 . . . . 0.44 112.023 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -108.53 122.48 47.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.878 -0.601 . . . . 0.44 110.147 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.546 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.7 m-85 -108.91 111.6 23.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.876 0.369 . . . . 0.44 110.078 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.821 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.5 m95 -94.54 148.91 21.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.087 -0.506 . . . . 0.44 111.704 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.579 ' O ' ' O ' ' A' ' 65' ' ' PHE . 38.0 tp -97.94 102.44 14.19 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 121.342 0.592 . . . . 0.44 111.262 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.589 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 12.2 t -85.5 145.77 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 115.274 -0.875 . . . . 0.44 110.928 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -114.67 -24.12 8.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 114.422 1.267 . . . . 0.44 114.422 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 7.5 tpt180 -162.61 160.76 26.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.787 0.721 . . . . 0.44 111.677 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.663 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -152.06 125.33 8.73 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.184 -0.462 . . . . 0.44 111.244 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -72.83 141.82 48.0 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.171 -0.468 . . . . 0.44 110.996 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.91 -118.92 11.98 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.759 -0.734 . . . . 0.44 112.53 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -131.92 142.86 46.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.552 0.215 . . . . 0.44 110.773 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 3.2 Cg_exo -76.29 128.79 10.72 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.862 2.375 . . . . 0.44 111.412 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.583 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.6 p-90 -132.06 -62.08 0.86 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.46 -0.496 . . . . 0.44 112.097 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.543 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.92 -102.42 0.04 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.812 -0.708 . . . . 0.44 112.784 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 56' ' ' GLU . 6.7 tptp 179.33 35.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.778 0.323 . . . . 0.44 111.097 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -50.85 -37.37 42.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.408 -0.36 . . . . 0.44 110.791 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.4 -31.93 5.78 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.777 -0.725 . . . . 0.44 112.848 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -128.76 97.17 27.87 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.44 111.449 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -43.57 146.11 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.953 2.435 . . . . 0.44 112.475 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.08 177.15 19.35 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.606 -0.807 . . . . 0.44 112.958 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.83 157.42 42.27 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.268 -0.271 . . . . 0.44 110.268 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.75 105.91 3.37 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.622 -0.431 . . . . 0.44 110.19 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.72 163.31 18.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.962 -0.563 . . . . 0.44 110.908 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 t -73.82 114.94 12.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 0.44 110.412 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -18.68 62.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.364 -0.38 . . . . 0.44 111.517 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.94 -12.28 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.506 -0.315 . . . . 0.44 111.732 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.51 53.15 0.74 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.792 -0.718 . . . . 0.44 112.032 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.454 ' CD1' ' CE2' ' A' ' 35' ' ' PHE . 6.0 tt -62.21 150.45 38.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.922 0.392 . . . . 0.44 110.771 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.03 97.75 9.49 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.823 0.675 . . . . 0.44 112.823 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.451 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.42 -20.32 61.44 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.056 -0.52 . . . . 0.44 109.965 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.14 -45.46 19.94 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.948 -0.569 . . . . 0.44 111.203 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.72 -40.61 88.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.221 -0.445 . . . . 0.44 111.274 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.527 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.4 174.24 6.34 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.442 -0.577 . . . . 0.44 109.442 179.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.06 127.79 27.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 121.844 1.696 . . . . 0.44 112.301 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 50.1 Cg_endo -69.01 -35.28 15.16 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.662 2.241 . . . . 0.44 112.505 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.7 -9.51 58.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 0.44 111.218 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -104.1 19.77 19.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.776 -0.647 . . . . 0.44 110.796 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.567 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -74.96 -30.57 1.02 Allowed Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 113.684 0.994 . . . . 0.44 113.684 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.6 Cg_exo -43.19 -36.46 6.02 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 121.887 1.725 . . . . 0.44 113.196 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.448 HG13 ' CD1' ' A' ' 84' ' ' PHE . 23.7 t -77.82 -50.26 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.308 0.575 . . . . 0.44 110.264 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.457 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 48.6 mm -64.17 -33.9 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.279 -0.873 . . . . 0.44 111.701 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.58 44.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.001 0.429 . . . . 0.44 110.616 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -80.13 -50.71 9.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.894 -0.594 . . . . 0.44 111.739 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 2.0 tm? -78.12 -40.06 39.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.439 -0.346 . . . . 0.44 111.741 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.436 ' HB2' HG23 ' A' ' 123' ' ' ILE . 18.0 tttm -53.19 -42.7 66.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.256 -0.429 . . . . 0.44 111.12 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -66.98 -7.34 21.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.44 109.884 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.231 0.119 0 CA-C-N 116.07 -0.514 . . . . 0.44 111.185 179.821 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.924 0.393 . . . . 0.44 110.944 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.99 126.59 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.44 110.606 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.43 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 4.0 pp -146.09 127.05 14.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.44 111.194 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -104.6 152.41 22.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.301 0.572 . . . . 0.44 112.006 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' THR . 5.2 mp -146.44 123.14 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.235 -0.893 . . . . 0.44 110.421 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.62 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -125.09 125.68 44.15 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.466 -0.568 . . . . 0.44 109.466 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.606 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.3 m -131.21 162.49 39.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.38 0.61 . . . . 0.44 112.051 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.43 111.53 0.84 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.077 -0.965 . . . . 0.44 111.677 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.444 ' HB ' ' CD1' ' A' ' 18' ' ' ILE . 8.5 pt -70.41 105.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-O 120.724 0.297 . . . . 0.44 110.412 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.466 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -71.63 125.75 30.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.21 -0.45 . . . . 0.44 111.778 -178.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -98.75 136.02 39.39 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.842 -0.617 . . . . 0.44 111.412 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.731 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.6 p-10 -96.48 -173.3 2.72 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.511 0.672 . . . . 0.44 112.018 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.46 -0.99 9.45 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.885 -1.052 . . . . 0.44 113.642 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.448 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 15.0 t-20 -120.69 33.28 5.63 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.625 -0.43 . . . . 0.44 112.135 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.56 13.78 2.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.44 111.351 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 15' ' ' ASN . 4.9 mt-10 -102.08 161.16 13.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.129 -0.693 . . . . 0.44 109.129 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.455 HG13 ' HG2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -120.7 124.58 72.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.184 0.516 . . . . 0.44 112.012 -178.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -74.2 120.18 19.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.74 . . . . 0.44 110.652 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.411 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -129.08 150.4 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.496 . . . . 0.44 110.287 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 69.2 p -70.83 111.75 6.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.768 0.318 . . . . 0.44 110.593 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.44 110.957 -179.832 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.758 0.313 . . . . 0.44 111.113 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 34' ' ' GLU . 10.7 mttt -114.11 26.14 10.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.938 0.399 . . . . 0.44 111.219 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' THR . 21.7 tp -61.24 77.33 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.697 -0.683 . . . . 0.44 111.033 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' LYS . 2.7 mt-10 -115.75 -170.44 1.78 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.295 -0.411 . . . . 0.44 111.116 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.479 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.26 168.15 10.55 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.44 111.625 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.606 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 94.6 Cg_endo -84.28 166.64 12.44 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.585 2.857 . . . . 0.44 113.307 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.522 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.05 -5.93 53.52 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-N 115.73 -0.668 . . . . 0.44 114.254 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.13 161.99 18.74 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 121.02 -0.61 . . . . 0.44 112.891 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.84 1.62 0.78 Allowed 'General case' 0 C--N 1.341 0.228 0 N-CA-C 112.285 0.476 . . . . 0.44 112.285 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.62 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.2 pt -51.82 -27.69 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.54 0.686 . . . . 0.44 110.294 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.54 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -41.1 -57.78 1.95 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.487 -1.233 . . . . 0.44 110.804 179.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.528 ' C ' ' O ' ' A' ' 41' ' ' GLU . 25.0 mmm 5.86 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.459 -0.791 . . . . 0.44 112.457 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 178.28 33.51 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.733 -0.746 . . . . 0.44 112.755 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -87.94 -174.13 4.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.761 0.315 . . . . 0.44 111.069 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.516 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.08 153.1 38.27 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.427 . . . . 0.44 110.267 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.516 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.76 -25.41 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.873 2.382 . . . . 0.44 112.487 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -104.02 -39.68 6.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.404 -0.362 . . . . 0.44 111.448 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -80.25 -8.48 59.48 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.753 0.279 . . . . 0.44 111.753 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -60.68 -54.62 43.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.7 0.286 . . . . 0.44 110.744 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.4 m -78.09 -47.46 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.44 111.167 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.506 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 38.8 t -54.1 -37.95 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.44 111.176 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -78.38 -51.97 9.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.158 -0.474 . . . . 0.44 111.257 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' GLU . 1.2 mm-40 -65.14 -19.85 66.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.44 111.331 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.459 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -61.2 -44.66 96.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.683 0.277 . . . . 0.44 111.054 -179.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -35.79 82.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.119 -0.697 . . . . 0.44 109.119 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -77.68 -26.34 50.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.353 -0.84 . . . . 0.44 111.209 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 53' ' ' GLU . 7.3 mm-40 -108.32 5.34 25.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.273 0.472 . . . . 0.44 112.273 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.602 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 44.7 t -134.45 -44.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.234 0.54 . . . . 0.44 109.68 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.554 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.29 -41.47 0.37 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.308 -0.86 . . . . 0.44 113.817 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.51 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.84 -177.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.137 0.494 . . . . 0.44 111.42 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.41 89.0 13.97 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 115.432 -0.804 . . . . 0.44 109.896 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.534 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.1 Cg_endo -109.98 150.86 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.339 2.693 . . . . 0.44 114.475 -177.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -74.73 79.82 2.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.972 -1.862 . . . . 0.44 105.972 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.536 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.77 128.0 47.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.329 -1.305 . . . . 0.44 110.155 -176.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -176.31 -40.67 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 112.555 0.576 . . . . 0.44 112.555 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 86' ' ' LEU . 58.4 m -41.4 163.57 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.279 -0.873 . . . . 0.44 111.894 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.404 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.59 120.57 39.1 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.983 -0.553 . . . . 0.44 110.071 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.3 OUTLIER -88.56 -56.65 3.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.347 -0.388 . . . . 0.44 110.807 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -172.27 162.48 5.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.735 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 132.02 22.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.726 0.298 . . . . 0.44 110.774 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 73' ' ' TYR . 3.4 tp -121.62 133.37 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.423 -0.353 . . . . 0.44 110.812 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -130.85 109.66 10.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.44 110.608 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.415 ' CD1' HD22 ' A' ' 71' ' ' LEU . 2.2 p90 -141.24 144.75 34.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.44 110.625 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.08 136.03 55.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.135 0.493 . . . . 0.44 111.373 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -99.58 163.04 19.28 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 0.44 110.32 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 12.8 Cg_endo -56.41 81.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.754 2.303 . . . . 0.44 112.217 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 9.0 t70 99.45 3.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.479 -0.782 . . . . 0.44 111.754 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -137.25 94.76 2.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.685 0.279 . . . . 0.44 110.953 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.5 t-160 -91.3 105.04 17.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.44 110.98 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.452 HG22 HD13 ' A' ' 80' ' ' ILE . 3.8 tt -106.11 132.6 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.233 -0.439 . . . . 0.44 110.91 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.51 118.73 31.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.968 -0.56 . . . . 0.44 109.541 178.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.03 114.25 23.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.96 0.409 . . . . 0.44 111.431 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -107.52 122.59 46.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.002 -0.545 . . . . 0.44 110.191 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.468 ' CE1' HG12 ' A' ' 122' ' ' VAL . 2.4 m-85 -108.08 109.64 21.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.039 0.447 . . . . 0.44 110.627 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -98.15 148.4 23.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.44 111.705 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 66' ' ' SER . 56.0 tp -94.02 138.41 32.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.78 -0.646 . . . . 0.44 111.384 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 64' ' ' HIS . 58.1 t -120.54 145.87 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-N 115.131 -0.94 . . . . 0.44 110.364 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -107.01 -28.5 9.99 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 114.27 1.211 . . . . 0.44 114.27 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.45 165.49 23.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.894 0.77 . . . . 0.44 111.64 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.731 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -155.31 123.63 5.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.354 -0.384 . . . . 0.44 111.356 178.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.63 147.18 44.01 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.046 -0.525 . . . . 0.44 111.048 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.08 -121.97 25.74 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.845 -0.693 . . . . 0.44 112.586 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -131.88 146.29 61.13 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.579 0.228 . . . . 0.44 110.781 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.5 128.74 10.53 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.793 2.329 . . . . 0.44 111.475 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.554 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 51.4 p-90 -130.42 -61.26 0.97 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.412 -0.515 . . . . 0.44 111.869 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.602 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 36.87 -97.69 0.01 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.08 -0.581 . . . . 0.44 113.214 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.58 40.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.651 0.263 . . . . 0.44 110.948 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -25.44 64.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.456 -0.338 . . . . 0.44 111.075 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.42 -86.58 0.27 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.366 -0.921 . . . . 0.44 113.3 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -108.24 115.98 57.41 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.44 111.847 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.63 146.19 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.04 2.493 . . . . 0.44 112.81 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -122.94 177.31 16.56 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.903 -0.665 . . . . 0.44 113.006 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.31 157.52 36.47 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.462 -0.199 . . . . 0.44 110.462 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -64.53 105.99 1.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.915 0.388 . . . . 0.44 110.09 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.5 ptp -120.7 152.2 38.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.069 -0.514 . . . . 0.44 110.865 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.8 p -74.23 118.55 17.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.44 110.55 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -73.04 -18.62 61.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.47 -0.332 . . . . 0.44 111.41 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.64 -11.54 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.694 0.283 . . . . 0.44 111.547 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.13 54.45 0.73 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.465 -0.654 . . . . 0.44 111.465 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.74 150.27 37.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.765 0.317 . . . . 0.44 110.787 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -109.95 103.73 12.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.866 0.691 . . . . 0.44 112.866 -178.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.535 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.54 -18.86 61.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.873 -0.603 . . . . 0.44 110.153 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -79.0 -47.07 16.93 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.963 -0.562 . . . . 0.44 111.45 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.63 -40.52 88.77 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.414 -0.357 . . . . 0.44 111.229 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.535 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.4 174.2 6.4 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.58 -0.526 . . . . 0.44 109.58 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.09 127.73 26.91 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.911 1.74 . . . . 0.44 112.489 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.29 -35.48 13.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.726 2.284 . . . . 0.44 112.465 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.05 -9.75 56.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.44 111.316 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.402 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 14.6 m-20 -107.73 19.73 19.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 0.44 110.997 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -66.67 -31.75 4.45 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 113.761 1.023 . . . . 0.44 113.761 -179.079 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.8 Cg_exo -43.85 -36.57 8.06 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.797 1.665 . . . . 0.44 113.276 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.468 HG12 ' CE1' ' A' ' 84' ' ' PHE . 55.1 t -77.88 -51.14 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.44 111.738 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.506 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 9.5 mm -74.84 -42.0 46.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 112.997 0.74 . . . . 0.44 112.997 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.82 -28.27 34.51 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.922 0.342 . . . . 0.44 111.922 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -80.8 -53.78 6.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.006 0.373 . . . . 0.44 112.006 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.494 ' HG ' ' CZ ' ' A' ' 68' ' ' PHE . 3.5 mm? -78.86 -31.12 45.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.98 0.363 . . . . 0.44 111.98 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 15.9 tttm -54.09 -42.1 68.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.044 0.449 . . . . 0.44 110.684 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -70.41 -6.48 35.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.672 -0.695 . . . . 0.44 109.978 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 115.914 -0.584 . . . . 0.44 111.148 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tttt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.83 0.347 . . . . 0.44 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 139.1 35.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.44 110.812 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 pp -146.23 123.64 11.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.44 111.155 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 39.8 mt-30 -102.69 149.01 24.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.136 0.493 . . . . 0.44 111.612 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 82' ' ' LEU . 2.2 tp -146.59 125.61 4.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.49 -0.777 . . . . 0.44 110.912 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.614 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.98 125.5 43.98 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.223 -0.658 . . . . 0.44 109.223 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.633 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -131.14 162.13 39.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.102 -0.639 . . . . 0.44 112.293 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.13 111.28 0.7 Allowed Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.083 -0.962 . . . . 0.44 111.664 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.64 109.42 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.531 -0.544 . . . . 0.44 109.531 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.464 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -71.18 124.92 28.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.232 0.539 . . . . 0.44 111.785 -178.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.541 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.29 121.13 31.27 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.376 -0.829 . . . . 0.44 111.442 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.697 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.8 p30 -81.35 -172.96 4.08 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 123.704 0.628 . . . . 0.44 111.007 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tt0 -79.31 11.02 3.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.969 0.729 . . . . 0.44 112.969 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -136.4 48.22 2.15 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.988 -0.445 . . . . 0.44 112.128 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 44.85 27.36 0.26 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.319 0.58 . . . . 0.44 111.071 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 105' ' ' MET . 25.9 mt-10 -122.49 161.89 22.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.424 -0.807 . . . . 0.44 109.005 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.474 HG21 ' N ' ' A' ' 19' ' ' PHE . 6.6 mt -128.85 143.62 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.241 0.543 . . . . 0.44 111.83 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.474 ' N ' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.62 118.42 28.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.412 -0.813 . . . . 0.44 110.728 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.474 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -118.29 145.89 23.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.861 -0.422 . . . . 0.44 109.861 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.7 p -70.72 111.95 6.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.71 0.29 . . . . 0.44 110.528 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.44 110.95 -179.736 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.1 t30 . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.506 0.193 . . . . 0.44 111.493 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 34' ' ' GLU . 2.7 mptp? -114.07 26.08 10.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.967 0.413 . . . . 0.44 111.196 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' THR . 22.4 tp -55.71 86.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.707 -0.679 . . . . 0.44 110.943 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -119.11 -170.86 2.0 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.084 0.469 . . . . 0.44 111.872 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.474 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.5 168.33 10.3 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.708 -0.678 . . . . 0.44 111.607 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.633 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 57.8 Cg_endo -72.06 166.93 28.17 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.377 2.718 . . . . 0.44 112.983 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.577 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 101.82 -5.76 54.03 Favored Glycine 0 C--O 1.222 -0.601 0 CA-C-N 115.914 -0.585 . . . . 0.44 113.876 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -61.96 140.97 47.11 Favored Glycine 0 C--N 1.316 -0.571 0 C-N-CA 121.161 -0.543 . . . . 0.44 113.262 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 96.27 3.41 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.776 0.658 . . . . 0.44 112.776 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.614 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.2 pt -51.86 -27.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.489 0.661 . . . . 0.44 110.638 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.539 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.09 -76.53 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.663 -1.153 . . . . 0.44 111.173 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 41' ' ' GLU . 44.2 mmm 24.77 -85.48 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.708 0.63 . . . . 0.44 112.316 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.66 31.85 0.11 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.714 -0.755 . . . . 0.44 112.809 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.452 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.3 mp0 -89.96 -172.83 3.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.662 0.268 . . . . 0.44 111.195 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.52 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.88 153.06 37.95 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.422 -0.354 . . . . 0.44 110.376 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.52 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -44.06 -24.81 0.96 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.704 2.27 . . . . 0.44 112.643 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -103.39 -41.21 6.08 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.936 0.347 . . . . 0.44 111.936 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 12.9 mm-40 -80.2 -18.12 50.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.589 0.233 . . . . 0.44 111.618 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.452 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -58.04 -48.59 79.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.472 -0.331 . . . . 0.44 111.266 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -78.15 -46.95 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.44 110.79 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 45.2 t -54.12 -37.5 35.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.785 -0.643 . . . . 0.44 111.441 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -78.07 -52.06 9.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.44 110.548 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.14 -19.99 62.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.12 -0.491 . . . . 0.44 110.605 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.482 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -61.4 -44.86 96.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.299 -0.41 . . . . 0.44 111.047 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -69.23 -30.0 68.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.204 0.526 . . . . 0.44 109.762 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.7 tt0 -77.33 -29.57 53.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.44 111.062 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.447 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -109.08 6.67 25.19 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.835 0.679 . . . . 0.44 112.835 -178.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.577 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 46.0 t -133.41 -44.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.44 109.939 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.84 -39.17 0.18 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.7 -0.682 . . . . 0.44 114.237 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.508 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.69 -177.53 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.092 0.472 . . . . 0.44 111.33 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.43 88.99 13.99 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.514 -0.766 . . . . 0.44 109.953 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.542 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.5 Cg_endo -110.24 148.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.399 2.733 . . . . 0.44 114.312 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 40.3 mt-30 -74.93 79.81 2.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.962 -1.866 . . . . 0.44 105.962 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.554 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -124.82 128.8 49.27 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.052 -1.431 . . . . 0.44 109.664 -176.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.44 ' N ' ' HD1' ' A' ' 64' ' ' HIS . 1.6 t80 -173.98 -49.77 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.695 0.998 . . . . 0.44 113.695 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 86' ' ' LEU . 2.2 p -38.16 159.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.63 -0.713 . . . . 0.44 111.947 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.32 116.63 26.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.44 110.888 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.96 -54.74 6.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.178 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.549 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.74 142.19 1.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.44 110.447 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HE2' ' CZ3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -139.92 103.87 4.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.525 -0.307 . . . . 0.44 110.432 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pp -111.46 160.79 16.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 0.44 111.174 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -135.14 109.89 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.44 110.653 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -129.36 123.45 31.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.44 110.336 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.411 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 11.2 pt-20 -110.07 133.87 52.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.179 0.514 . . . . 0.44 111.616 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 2.8 m-85 -74.68 163.67 66.65 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.44 109.885 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.458 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.7 Cg_endo -37.38 -29.1 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.642 2.894 . . . . 0.44 113.214 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -139.62 -39.66 0.46 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.657 -0.701 . . . . 0.44 111.076 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -84.75 104.38 14.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.44 111.25 -179.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.411 ' ND1' ' HB3' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -89.37 112.38 23.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.765 0.317 . . . . 0.44 110.572 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.2 tt -118.48 128.99 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.228 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.72 118.56 34.67 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.26 -0.644 . . . . 0.44 109.26 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.642 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -114.28 114.17 25.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.115 0.483 . . . . 0.44 112.031 -178.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.419 ' CZ3' ' HE2' ' A' ' 70' ' ' LYS . 10.5 m0 -110.22 122.08 46.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.58 -0.737 . . . . 0.44 110.201 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.453 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 6.1 m-30 -112.43 111.94 23.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.987 -0.551 . . . . 0.44 110.7 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -100.56 148.98 24.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.912 -0.586 . . . . 0.44 111.718 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 66' ' ' SER . 45.9 tp -93.97 138.69 31.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.768 -0.651 . . . . 0.44 111.514 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.554 ' CG1' ' HB2' ' A' ' 64' ' ' HIS . 44.8 t -120.09 145.7 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-N 115.195 -0.912 . . . . 0.44 110.095 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.99 -24.55 10.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.512 1.301 . . . . 0.44 114.512 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -163.66 164.96 23.78 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.958 0.799 . . . . 0.44 111.508 -178.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.697 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -157.24 123.54 4.89 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.94 0.4 . . . . 0.44 111.326 178.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -76.13 151.7 36.93 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.016 -0.538 . . . . 0.44 111.077 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.97 -122.66 28.17 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 0.44 112.558 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 13.6 mt-10 -132.17 147.87 67.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.516 0.198 . . . . 0.44 110.77 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.48 128.81 10.58 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.845 2.363 . . . . 0.44 111.202 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.55 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 52.5 p-90 -134.43 -64.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.139 -0.624 . . . . 0.44 112.539 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.577 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.85 -96.56 0.01 OUTLIER Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.934 -0.65 . . . . 0.44 113.143 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 173.44 38.83 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.678 0.275 . . . . 0.44 110.93 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -58.45 -49.42 77.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.4 -0.364 . . . . 0.44 110.855 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.44 -63.56 0.36 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.456 -0.878 . . . . 0.44 112.967 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.92 120.21 25.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.004 0.431 . . . . 0.44 111.637 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -43.48 146.28 1.33 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.101 2.534 . . . . 0.44 112.658 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.7 177.11 17.18 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.752 -0.737 . . . . 0.44 112.874 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -130.29 157.43 42.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.533 0.206 . . . . 0.44 110.472 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.466 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -65.28 106.08 1.27 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.926 0.393 . . . . 0.44 110.272 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.515 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -120.83 163.21 18.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.22 -0.445 . . . . 0.44 111.224 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.414 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -77.32 115.96 17.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.44 110.791 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.4 ' HG ' HG22 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -80.05 -18.82 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.449 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.46 -12.62 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.494 -0.321 . . . . 0.44 111.601 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.87 54.88 0.63 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.845 -0.693 . . . . 0.44 111.979 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.84 150.52 37.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.44 110.544 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.02 108.89 20.72 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.942 0.719 . . . . 0.44 112.942 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.545 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -16.96 61.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.686 -0.688 . . . . 0.44 110.062 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.01 -46.82 17.4 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.024 -0.534 . . . . 0.44 111.184 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.79 -40.51 88.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.976 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.545 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.61 174.02 6.72 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.082 -0.508 . . . . 0.44 109.642 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.43 127.71 27.08 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 121.893 1.728 . . . . 0.44 112.321 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.88 -37.49 11.41 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.643 2.229 . . . . 0.44 112.628 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.5 -9.58 56.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.44 111.481 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -104.69 21.78 16.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.861 -0.609 . . . . 0.44 110.829 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -71.87 -31.51 1.8 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.727 1.01 . . . . 0.44 113.727 -178.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 90.9 Cg_exo -44.07 -37.33 9.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.86 1.707 . . . . 0.44 113.188 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.453 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 58.8 t -77.67 -51.0 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.12 0.486 . . . . 0.44 110.63 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 127' ' ' LYS . 43.1 mm -65.48 -30.61 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.677 -0.692 . . . . 0.44 111.33 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.86 -29.43 55.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.121 0.486 . . . . 0.44 110.493 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -78.27 -51.3 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.773 -0.648 . . . . 0.44 111.622 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 3.2 tm? -78.22 -19.91 52.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.369 -0.378 . . . . 0.44 111.814 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 123' ' ' ILE . 4.9 ttpm? -75.18 -42.57 55.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.095 0.474 . . . . 0.44 110.51 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.0 ttm105 -67.77 -9.14 41.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.632 -0.713 . . . . 0.44 110.027 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 116.351 -0.386 . . . . 0.44 110.582 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 tptm . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.824 0.345 . . . . 0.44 110.948 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.26 138.11 34.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.44 110.594 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.446 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.9 pp -146.29 131.26 18.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.44 111.345 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -103.09 153.05 20.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.217 0.532 . . . . 0.44 111.965 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 4' ' ' LEU . 5.0 mp -146.53 134.66 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.455 -0.793 . . . . 0.44 110.854 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.575 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.51 124.29 41.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.1 -0.704 . . . . 0.44 109.1 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.6 m -125.48 162.53 28.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.233 0.539 . . . . 0.44 112.005 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.95 113.5 0.69 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.303 -0.862 . . . . 0.44 112.146 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.585 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -70.69 101.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.205 -0.665 . . . . 0.44 109.205 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.461 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -71.04 123.35 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 121.306 0.574 . . . . 0.44 111.937 -178.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.81 123.62 34.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.347 -0.842 . . . . 0.44 111.482 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.492 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 12.5 t-20 -76.73 -172.31 2.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.08 -0.963 . . . . 0.44 111.865 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.427 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.7 tm-20 -83.15 4.05 28.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.316 -1.311 . . . . 0.44 112.093 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -138.41 50.85 1.87 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.346 . . . . 0.44 111.551 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.71 24.42 0.33 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.305 -0.407 . . . . 0.44 111.384 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 13' ' ' ASN . 23.5 pt-20 -117.74 144.4 45.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.918 -0.771 . . . . 0.44 108.918 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.459 HG21 ' N ' ' A' ' 19' ' ' PHE . 6.1 mt -113.1 138.84 41.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.228 0.537 . . . . 0.44 111.754 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.459 ' N ' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -91.27 108.29 19.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.366 -0.834 . . . . 0.44 110.275 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.532 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -107.86 155.89 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.083 -0.508 . . . . 0.44 110.141 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 p -71.04 111.81 6.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.686 0.279 . . . . 0.44 110.253 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.44 110.955 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.689 0.28 . . . . 0.44 111.348 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -113.71 25.99 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.44 111.259 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.8 tt -70.59 65.83 0.32 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.742 -0.663 . . . . 0.44 110.605 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.86 -169.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.44 111.444 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.532 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 3.0 m-85 -119.13 143.75 34.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.969 -0.559 . . . . 0.44 111.709 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.491 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 17.8 Cg_endo -58.23 165.98 6.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.741 2.294 . . . . 0.44 111.067 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 100.36 58.66 0.85 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 119.72 -1.228 . . . . 0.44 113.359 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -124.84 134.02 8.8 Favored Glycine 0 C--N 1.31 -0.879 0 CA-C-N 114.857 -0.672 . . . . 0.44 112.25 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 101.58 -2.47 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.394 0.516 . . . . 0.44 112.394 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.575 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -50.19 -26.27 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.219 0.533 . . . . 0.44 111.017 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.492 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.59 -68.67 0.16 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.045 -0.98 . . . . 0.44 110.973 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.455 ' C ' ' O ' ' A' ' 41' ' ' GLU . 76.6 mmm 23.54 -86.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.831 0.707 . . . . 0.44 112.318 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.97 29.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.44 112.832 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.438 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.5 mp0 -93.66 -173.7 3.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.792 0.329 . . . . 0.44 111.068 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.542 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.0 155.44 37.61 Favored Pre-proline 0 N--CA 1.456 -0.157 0 CA-C-N 116.435 -0.348 . . . . 0.44 110.327 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 4.1 Cg_endo -45.24 -24.6 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.651 2.234 . . . . 0.44 112.461 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -50.17 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.218 0.451 . . . . 0.44 112.218 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -80.17 -29.55 38.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.721 0.296 . . . . 0.44 111.604 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.438 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -52.42 -45.86 66.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.91 0.386 . . . . 0.44 110.845 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -78.46 -50.55 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.044 -0.526 . . . . 0.44 110.898 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.525 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 55.5 t -54.45 -36.78 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.44 111.875 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -52.02 9.44 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.875 -0.33 . . . . 0.44 110.927 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.9 mm-40 -66.93 -25.0 66.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.334 -0.394 . . . . 0.44 110.722 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.629 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 12.4 tp -52.75 -45.76 67.19 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.874 0.369 . . . . 0.44 110.39 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -62.64 -26.68 68.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.058 -0.519 . . . . 0.44 109.84 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -71.43 -23.65 61.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.44 110.891 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.479 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.0 mm-40 -108.19 5.09 25.49 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.17 0.433 . . . . 0.44 112.17 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -134.61 -44.7 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.424 0.63 . . . . 0.44 109.497 178.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 70.01 -36.6 0.4 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.276 -0.874 . . . . 0.44 114.597 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -84.4 -168.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 120.945 0.403 . . . . 0.44 110.882 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -111.73 89.29 10.87 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.603 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.61 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.3 Cg_endo -107.36 147.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.018 2.478 . . . . 0.44 113.997 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -74.83 80.05 2.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.07 -1.826 . . . . 0.44 106.07 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.6 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -123.87 129.05 50.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.307 -1.315 . . . . 0.44 110.481 -176.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.6 t80 179.6 163.5 0.98 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.932 0.396 . . . . 0.44 112.034 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 84.64 163.62 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.772 -0.649 . . . . 0.44 110.882 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.7 pp -121.8 127.55 50.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.286 -0.415 . . . . 0.44 111.071 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 1.5 p90 -76.81 -44.37 32.84 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.526 -0.469 . . . . 0.44 109.9 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.562 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 12.4 mt-10 -171.43 131.78 0.75 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.845 -0.616 . . . . 0.44 109.859 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HD2' ' CD2' ' A' ' 83' ' ' TRP . 0.9 OUTLIER -132.53 132.0 42.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.592 -0.277 . . . . 0.44 110.635 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -127.34 154.61 44.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.003 0.43 . . . . 0.44 111.23 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -131.8 109.78 10.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.44 110.377 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.451 ' CE2' ' CG2' ' A' ' 80' ' ' ILE . 55.4 p90 -125.97 151.87 46.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.44 110.604 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 5.6 pt-20 -120.16 140.12 51.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.361 0.6 . . . . 0.44 111.493 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.2 m-85 -103.44 162.73 19.15 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 115.355 -0.839 . . . . 0.44 110.085 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.5 Cg_endo -52.61 81.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.919 2.413 . . . . 0.44 112.174 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.2 t70 93.14 10.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.491 -0.777 . . . . 0.44 111.556 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.37 93.82 2.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.735 -0.211 . . . . 0.44 110.679 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.423 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.7 t-80 -85.42 93.94 8.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.745 0.307 . . . . 0.44 110.69 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.46 HG21 HD12 ' A' ' 80' ' ' ILE . 2.7 tt -96.7 111.99 27.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.982 0.42 . . . . 0.44 111.397 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.61 118.54 36.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.857 -0.794 . . . . 0.44 108.857 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.9 mt -120.71 114.12 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.631 -0.428 . . . . 0.44 111.936 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.422 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.4 m0 -110.42 122.11 46.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.814 -0.63 . . . . 0.44 109.838 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.64 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 3.2 m-85 -106.45 133.7 50.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.968 -0.56 . . . . 0.44 110.045 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 11.0 m95 -117.01 148.45 41.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.578 0.585 . . . . 0.44 112.578 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 65' ' ' PHE . 35.4 tp -85.9 138.24 32.17 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.57 -0.741 . . . . 0.44 111.319 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 64' ' ' HIS . 20.5 t -124.2 145.9 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-N 116.053 -0.522 . . . . 0.44 110.427 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -110.44 -32.07 7.06 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 114.268 1.21 . . . . 0.44 114.268 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.1 164.28 25.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.777 0.717 . . . . 0.44 111.843 -178.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.61 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.8 p90 -148.63 126.38 11.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.045 -0.525 . . . . 0.44 111.235 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.95 150.6 35.91 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.292 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.24 -129.98 48.8 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.852 -0.69 . . . . 0.44 112.707 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.555 ' O ' HG12 ' A' ' 60' ' ' ILE . 16.3 mt-10 -120.65 136.57 25.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.421 -0.214 . . . . 0.44 110.421 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.499 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.2 Cg_exo -74.46 128.85 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.573 2.182 . . . . 0.44 111.375 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 39.1 p-90 -130.22 -63.47 0.9 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.315 -0.554 . . . . 0.44 112.48 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 51.25 -109.51 0.79 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.479 -0.867 . . . . 0.44 112.603 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 168.55 41.95 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.769 0.318 . . . . 0.44 111.007 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.32 -46.31 79.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.44 110.861 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.11 -23.56 4.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.67 -0.776 . . . . 0.44 112.89 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.44 100.7 13.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.911 0.386 . . . . 0.44 111.306 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -43.5 143.3 2.58 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.912 2.408 . . . . 0.44 112.581 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.1 177.12 19.38 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.708 -0.758 . . . . 0.44 112.666 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -131.84 157.17 44.62 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.432 -0.21 . . . . 0.44 110.432 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -72.43 106.38 4.51 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.819 -0.353 . . . . 0.44 110.196 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.421 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.5 ptm -120.43 163.16 18.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.44 111.224 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.84 117.94 21.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.592 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -18.84 46.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.392 . . . . 0.44 111.4 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.9 p -58.37 -14.65 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.583 -0.281 . . . . 0.44 111.611 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.33 49.95 0.91 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.953 -0.642 . . . . 0.44 111.785 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.31 150.51 39.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.74 0.305 . . . . 0.44 111.098 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -111.0 92.92 4.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.635 0.605 . . . . 0.44 112.635 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.51 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.5 -19.93 61.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.108 -0.496 . . . . 0.44 110.117 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -79.06 -45.31 20.38 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.927 -0.579 . . . . 0.44 111.394 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -42.16 87.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.268 -0.424 . . . . 0.44 111.112 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.538 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.34 174.37 6.13 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.626 -0.509 . . . . 0.44 109.626 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.09 127.87 27.51 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 121.99 1.793 . . . . 0.44 112.173 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.82 -39.13 11.99 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.727 2.284 . . . . 0.44 112.76 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.63 -9.63 57.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.083 0.468 . . . . 0.44 111.533 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -101.83 20.46 16.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.768 -0.651 . . . . 0.44 110.754 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -72.84 -31.08 1.42 Allowed Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 113.845 1.054 . . . . 0.44 113.845 -178.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.4 Cg_exo -43.71 -36.57 7.64 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.831 1.687 . . . . 0.44 113.011 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.517 HG13 ' CG ' ' A' ' 84' ' ' PHE . 69.9 t -77.91 -51.33 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.092 0.472 . . . . 0.44 110.958 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.493 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 17.8 mm -65.24 -34.63 71.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 115.608 -0.723 . . . . 0.44 111.75 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.23 -27.74 36.56 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.672 -0.411 . . . . 0.44 110.472 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -80.58 -53.04 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.44 111.934 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.417 HD22 ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -78.14 -32.97 50.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.528 -0.305 . . . . 0.44 111.75 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 8.3 ttpt -53.35 -42.21 66.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.978 0.418 . . . . 0.44 110.984 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -71.02 -6.17 36.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.77 -0.65 . . . . 0.44 110.003 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 115.997 -0.547 . . . . 0.44 111.061 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.842 0.353 . . . . 0.44 110.85 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.06 139.57 35.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.44 110.837 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 pp -146.25 122.98 11.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.44 111.194 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -102.57 151.31 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.13 0.491 . . . . 0.44 111.378 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.461 HG21 ' HA ' ' A' ' 82' ' ' LEU . 2.0 tp -146.61 130.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.44 111.332 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.538 ' HB3' ' CG1' ' A' ' 40' ' ' ILE . . . -125.02 125.48 43.93 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.802 -0.814 . . . . 0.44 108.802 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m -139.93 154.8 23.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 119.831 -0.747 . . . . 0.44 112.269 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.05 120.92 2.34 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.856 -1.066 . . . . 0.44 111.461 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.529 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -70.35 108.43 2.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.148 -0.686 . . . . 0.44 109.148 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.542 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.05 124.98 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.155 0.502 . . . . 0.44 111.688 -178.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -100.7 129.25 46.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.242 -0.89 . . . . 0.44 111.3 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.69 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.8 p-10 -84.44 -172.87 4.41 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.43 0.634 . . . . 0.44 111.786 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.3 tm-20 -73.63 4.89 4.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.026 -0.988 . . . . 0.44 113.452 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -128.63 44.39 2.97 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.014 -0.429 . . . . 0.44 112.092 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 48.96 23.13 0.66 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.973 0.416 . . . . 0.44 111.473 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 33.6 mt-10 -114.0 161.61 17.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.156 -0.683 . . . . 0.44 109.156 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -115.03 139.83 39.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.435 0.532 . . . . 0.44 112.435 -178.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.467 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.8 t80 -93.41 97.56 10.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.608 -0.724 . . . . 0.44 110.569 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.464 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -110.01 162.22 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.636 -0.505 . . . . 0.44 109.636 179.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 71.3 p -70.59 134.95 48.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.18 -0.304 . . . . 0.44 110.18 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.44 111.133 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.654 0.264 . . . . 0.44 111.276 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.34 26.39 10.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.44 111.577 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.2 tt -64.77 73.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.929 -0.578 . . . . 0.44 110.768 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -113.66 -172.06 2.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.063 0.459 . . . . 0.44 111.675 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.503 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.45 168.27 10.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.715 -0.675 . . . . 0.44 111.609 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.513 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 60.2 Cg_endo -72.63 166.88 28.63 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.42 2.746 . . . . 0.44 113.162 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 101.68 -5.33 54.15 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 116.011 -0.541 . . . . 0.44 113.99 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.582 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -65.34 132.56 35.76 Favored Glycine 0 C--N 1.315 -0.598 0 C-N-CA 121.094 -0.574 . . . . 0.44 112.727 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 106.36 1.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.273 0.629 . . . . 0.44 112.081 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.612 HG13 ' N ' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -49.16 -29.8 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.672 0.748 . . . . 0.44 110.588 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -41.45 -58.65 1.82 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.338 -1.301 . . . . 0.44 111.105 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.538 ' C ' ' O ' ' A' ' 41' ' ' GLU . 12.6 mmt 2.68 -78.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.591 -0.731 . . . . 0.44 112.656 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.42 33.27 0.07 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.595 -0.812 . . . . 0.44 113.031 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 13.1 mp0 -101.55 -174.96 2.72 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.617 0.246 . . . . 0.44 111.037 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.508 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -105.42 152.39 39.91 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-N 116.554 -0.294 . . . . 0.44 110.283 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.68 -24.57 0.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.73 2.287 . . . . 0.44 112.463 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.39 -50.38 5.26 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.283 0.475 . . . . 0.44 112.283 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -80.42 -29.22 37.67 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.954 0.353 . . . . 0.44 111.954 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.451 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -55.6 -43.88 76.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.522 -0.308 . . . . 0.44 111.184 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.549 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 m -78.27 -48.75 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.89 0.376 . . . . 0.44 110.233 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.459 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 48.7 t -57.16 -35.91 49.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.871 -0.604 . . . . 0.44 110.75 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.4 mmt-85 -77.94 -50.14 12.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.44 110.497 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.71 -21.99 66.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.44 110.626 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -56.88 -44.75 82.6 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.931 0.396 . . . . 0.44 110.289 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -68.36 -28.05 66.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.44 110.348 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.33 -38.65 49.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.44 111.48 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.43 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 1.3 mp0 -104.66 5.16 33.35 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.322 0.49 . . . . 0.44 112.322 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.647 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 11.1 t -134.42 -43.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.048 0.451 . . . . 0.44 109.997 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.544 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.0 -35.06 0.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.706 -0.679 . . . . 0.44 114.418 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.772 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 5.4 tp -77.53 166.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.56 0.219 . . . . 0.44 110.773 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.73 89.05 1.36 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 108.86 -0.792 . . . . 0.44 108.86 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.772 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.0 Cg_endo -114.38 150.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 123.552 2.835 . . . . 0.44 114.525 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -74.94 79.42 2.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.43 -2.063 . . . . 0.44 105.43 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.552 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -123.39 127.61 48.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.565 -1.198 . . . . 0.44 110.492 -176.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -179.1 -134.12 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.44 110.634 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 55.77 166.34 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.918 0.39 . . . . 0.44 111.849 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.9 tt -127.87 110.79 12.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.969 -0.56 . . . . 0.44 111.047 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.79 -45.25 29.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.122 0.486 . . . . 0.44 109.821 179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.52 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.3 tt0 -171.6 156.72 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.44 110.364 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.28 104.32 4.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.501 -0.318 . . . . 0.44 110.453 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.417 HD23 ' CD1' ' A' ' 73' ' ' TYR . 4.7 tp -96.84 135.79 38.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.889 0.376 . . . . 0.44 111.097 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -126.98 109.48 11.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.44 110.615 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.417 ' CD1' HD23 ' A' ' 71' ' ' LEU . 4.2 p90 -141.41 128.64 21.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.44 110.449 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.442 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 7.9 pt-20 -116.02 130.73 56.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 0.44 111.56 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 2.7 m-85 -71.11 163.33 66.44 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 115.595 -0.729 . . . . 0.44 110.026 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.4 Cg_endo -38.06 -29.14 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.598 2.865 . . . . 0.44 113.036 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -139.63 -38.43 0.48 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.633 -0.712 . . . . 0.44 111.009 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.486 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -83.86 99.85 10.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.44 111.284 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 4.1 t60 -87.01 110.33 19.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.785 0.326 . . . . 0.44 110.673 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.403 HD12 ' CD2' ' A' ' 82' ' ' LEU . 2.5 tt -115.27 137.38 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.961 0.41 . . . . 0.44 110.935 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.74 118.43 30.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.045 -0.525 . . . . 0.44 109.656 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.48 HD13 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -107.18 113.87 27.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.44 111.384 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 8.7 m0 -114.99 122.43 46.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.176 0.512 . . . . 0.44 110.32 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.48 ' CE1' HD13 ' A' ' 82' ' ' LEU . 3.9 m-85 -110.68 124.08 51.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.654 -0.703 . . . . 0.44 111.572 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.549 ' CE2' HG11 ' A' ' 50' ' ' VAL . 66.4 m95 -108.58 148.64 30.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.025 -0.534 . . . . 0.44 110.76 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.525 ' O ' ' O ' ' A' ' 65' ' ' PHE . 37.6 tp -99.53 103.21 14.93 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.448 0.642 . . . . 0.44 111.746 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.552 HG13 ' HA ' ' A' ' 64' ' ' HIS . 19.0 t -83.23 145.58 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.155 -0.93 . . . . 0.44 111.515 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -104.27 -50.74 3.27 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.15 1.167 . . . . 0.44 114.15 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.15 165.76 24.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.488 0.586 . . . . 0.44 112.508 -178.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.69 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 24.1 p90 -133.81 159.57 40.22 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.134 -0.485 . . . . 0.44 111.506 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.19 102.15 14.17 Favored 'General case' 0 N--CA 1.46 0.039 0 CA-C-N 116.325 -0.398 . . . . 0.44 111.237 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.4 -112.09 4.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.57 -0.824 . . . . 0.44 112.384 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.1 tt0 -131.53 135.4 26.88 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.212 . . . . 0.44 111.224 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 5.2 Cg_exo -76.5 139.6 20.68 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.856 2.371 . . . . 0.44 111.211 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.544 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 33.4 p-90 -134.59 -63.45 0.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.486 -0.485 . . . . 0.44 112.19 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.647 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.77 -104.68 0.04 OUTLIER Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.614 -0.721 . . . . 0.44 113.308 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt 168.22 40.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.75 0.31 . . . . 0.44 110.897 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -23.68 62.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.472 -0.331 . . . . 0.44 111.081 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 145.3 -86.85 0.17 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.349 -0.929 . . . . 0.44 113.078 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.07 118.78 47.28 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.06 0.457 . . . . 0.44 111.649 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.55 146.19 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.192 2.595 . . . . 0.44 112.802 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.09 177.42 19.14 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.81 -0.709 . . . . 0.44 112.846 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -122.69 157.23 32.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.566 0.222 . . . . 0.44 110.436 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.444 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -68.38 106.37 2.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.976 0.417 . . . . 0.44 110.24 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.9 ptm -120.54 152.02 38.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.44 111.105 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.25 114.9 8.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.44 110.637 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -59.17 -18.5 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.44 111.66 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.7 p -52.75 -14.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 111.758 0.281 . . . . 0.44 111.758 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.83 54.37 0.72 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.97 -0.633 . . . . 0.44 111.635 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.422 HD23 ' CG2' ' A' ' 123' ' ' ILE . 3.8 tt -61.77 150.53 36.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.886 0.374 . . . . 0.44 110.918 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -100.61 93.2 5.48 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.991 0.737 . . . . 0.44 112.991 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.421 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.48 -21.42 61.21 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.704 -0.48 . . . . 0.44 109.704 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -79.22 -44.91 20.89 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.941 -0.572 . . . . 0.44 111.07 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -66.72 -40.11 88.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.138 -0.483 . . . . 0.44 111.372 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.53 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.37 174.39 6.09 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.323 -0.621 . . . . 0.44 109.323 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.8 Cg_endo -53.79 127.78 26.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.899 1.733 . . . . 0.44 112.603 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 49.6 Cg_endo -68.41 -36.11 16.44 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.885 2.39 . . . . 0.44 112.366 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.4 -9.54 58.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.07 0.462 . . . . 0.44 111.071 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -106.02 16.66 24.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.44 111.055 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.576 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -73.44 -30.97 1.29 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 113.5 0.926 . . . . 0.44 113.5 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.1 Cg_exo -43.57 -36.37 7.04 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.847 1.698 . . . . 0.44 113.51 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.462 ' CG1' ' CE1' ' A' ' 84' ' ' PHE . 17.6 t -77.88 -51.27 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.145 0.498 . . . . 0.44 110.534 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.44 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 20.4 mm -65.48 -30.99 51.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.46 -0.791 . . . . 0.44 111.25 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.89 47.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.44 110.614 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -49.83 11.52 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.922 -0.581 . . . . 0.44 111.653 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.3 -28.84 47.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.494 -0.321 . . . . 0.44 111.405 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 123' ' ' ILE . 7.9 ttpt -55.01 -42.54 72.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.109 0.48 . . . . 0.44 110.654 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -64.05 -12.61 40.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.698 -0.683 . . . . 0.44 109.521 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.887 -0.597 . . . . 0.44 110.947 179.681 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.852 0.358 . . . . 0.44 110.962 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -140.11 130.17 24.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.44 110.68 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 6' ' ' ILE . 3.2 pp -146.19 124.72 12.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.393 . . . . 0.44 111.369 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 41' ' ' GLU . 30.4 mt-30 -102.81 151.7 22.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.44 111.419 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.433 ' N ' ' O ' ' A' ' 81' ' ' THR . 2.1 mp -146.53 127.09 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.652 -0.703 . . . . 0.44 110.904 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB1' ' CG1' ' A' ' 40' ' ' ILE . . . -124.77 125.63 44.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.381 -0.6 . . . . 0.44 109.381 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -144.36 162.16 14.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.207 -0.597 . . . . 0.44 111.833 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -147.76 125.62 2.17 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.321 -0.854 . . . . 0.44 111.692 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.475 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.84 110.92 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.455 -0.572 . . . . 0.44 109.455 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.603 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.53 125.31 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-O 121.178 0.513 . . . . 0.44 111.537 -178.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.92 118.93 30.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.542 -0.754 . . . . 0.44 111.194 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.707 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 2.9 p-10 -79.64 -172.22 3.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.331 0.586 . . . . 0.44 111.389 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.6 tm-20 -77.08 13.46 1.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.582 0.956 . . . . 0.44 113.582 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -143.25 51.89 1.37 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.393 -0.523 . . . . 0.44 112.214 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.17 27.62 0.22 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.023 0.439 . . . . 0.44 111.571 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' C ' ' OD1' ' A' ' 13' ' ' ASN . 23.2 mt-10 -122.94 161.75 23.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.052 -0.721 . . . . 0.44 109.052 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 19' ' ' PHE . 8.1 mt -128.22 144.11 38.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.189 0.519 . . . . 0.44 112.186 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.491 ' N ' HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.68 115.21 26.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.57 -0.741 . . . . 0.44 110.446 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.43 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.46 133.34 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.39 -0.368 . . . . 0.44 110.404 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.4 p -70.97 114.44 9.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.39 . . . . 0.44 111.042 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 ptm180 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.44 110.691 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.679 0.276 . . . . 0.44 111.267 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.22 25.94 10.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.983 0.421 . . . . 0.44 111.574 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 38.6 tp -68.68 71.72 0.21 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.902 -0.59 . . . . 0.44 110.449 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.43 -167.21 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.44 111.175 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.517 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -119.12 168.29 10.18 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.44 111.566 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.519 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 85.1 Cg_endo -84.08 167.51 12.45 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.695 2.93 . . . . 0.44 113.695 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.484 ' CA ' ' HG2' ' A' ' 57' ' ' GLU . . . 102.92 -3.23 48.49 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.241 -0.89 . . . . 0.44 114.525 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -64.2 165.04 31.77 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 117.264 0.532 . . . . 0.44 113.793 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.459 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.0 0.51 0.66 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.188 0.595 . . . . 0.44 112.046 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.619 ' HA ' ' HG3' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -50.92 -28.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.675 0.75 . . . . 0.44 110.552 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.582 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.9 -58.23 2.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.427 -1.261 . . . . 0.44 111.161 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.0 mmt 6.96 -79.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.887 0.742 . . . . 0.44 112.579 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 179.56 34.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.541 -0.837 . . . . 0.44 113.03 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -93.76 -170.45 2.34 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.653 0.263 . . . . 0.44 111.045 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.519 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.68 153.19 38.03 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.509 -0.314 . . . . 0.44 110.314 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.9 -25.0 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.796 2.331 . . . . 0.44 112.396 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.57 -42.99 5.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.5 -0.318 . . . . 0.44 111.818 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -11.16 59.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.787 0.292 . . . . 0.44 111.787 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.03 -53.97 51.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.86 0.362 . . . . 0.44 110.81 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -78.27 -50.14 19.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.914 179.401 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.2 t -51.75 -37.76 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.44 111.407 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -78.49 -52.19 8.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.333 -0.394 . . . . 0.44 111.291 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.619 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.1 mm-40 -66.0 -20.02 66.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.358 -0.383 . . . . 0.44 110.586 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.603 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 9.4 tp -55.53 -45.01 77.24 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.405 -0.361 . . . . 0.44 110.282 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -35.89 82.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.174 0.512 . . . . 0.44 109.713 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.1 -25.45 62.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.44 109.968 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.484 ' HG2' ' CA ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -108.36 6.73 26.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.782 -0.644 . . . . 0.44 112.185 -178.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -133.39 -44.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.064 0.459 . . . . 0.44 109.952 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.513 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.54 -37.79 0.22 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.648 -0.705 . . . . 0.44 114.456 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.463 ' H ' ' C ' ' A' ' 58' ' ' VAL . 0.6 OUTLIER -86.76 -174.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 120.853 0.358 . . . . 0.44 110.919 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.78 88.64 14.36 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.902 -0.59 . . . . 0.44 110.498 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.522 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.9 Cg_endo -110.84 146.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.514 2.809 . . . . 0.44 113.811 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.414 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 37.6 mt-30 -74.79 79.83 2.09 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.623 -1.991 . . . . 0.44 105.623 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.535 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -119.3 132.44 55.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.268 -1.333 . . . . 0.44 110.867 -176.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.94 -136.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.183 -0.462 . . . . 0.44 110.651 -179.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 54.08 165.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.079 0.466 . . . . 0.44 111.885 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 7.2 tt -128.02 108.84 11.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.865 -0.607 . . . . 0.44 110.798 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.86 -43.36 36.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.44 110.302 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 11.8 tt0 -171.27 156.11 4.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 0.44 110.553 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.453 ' HD3' ' CE2' ' A' ' 83' ' ' TRP . 1.4 ttmm -143.27 105.73 4.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.165 -0.471 . . . . 0.44 110.657 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.407 HD21 ' CE1' ' A' ' 73' ' ' TYR . 1.1 tp -97.09 136.29 37.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.44 111.054 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -140.02 109.64 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.44 110.409 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.416 ' CZ ' HG22 ' A' ' 80' ' ' ILE . 2.3 p90 -141.18 152.22 44.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.44 110.829 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.1 pt-20 -121.13 135.81 55.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.168 0.509 . . . . 0.44 111.29 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -101.12 163.21 18.39 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.491 -0.777 . . . . 0.44 110.183 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.3 Cg_endo -53.86 82.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.779 2.319 . . . . 0.44 112.068 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.0 m-20 92.96 8.81 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.277 -0.874 . . . . 0.44 111.659 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -137.3 93.83 2.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.601 0.239 . . . . 0.44 110.86 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 20.2 t-80 -90.38 107.45 19.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.44 110.962 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.416 HG22 ' CZ ' ' A' ' 73' ' ' TYR . 3.3 tt -107.53 146.42 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.44 110.762 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.07 118.82 18.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.44 110.02 179.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.409 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -117.21 114.22 23.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.798 0.332 . . . . 0.44 111.169 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.453 ' CE2' ' HD3' ' A' ' 70' ' ' LYS . 8.5 m0 -106.93 122.23 46.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.64 -0.504 . . . . 0.44 109.64 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CE2' ' CG1' ' A' ' 122' ' ' VAL . 2.2 m-85 -111.49 109.9 20.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.084 0.468 . . . . 0.44 111.665 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 58.8 m95 -94.81 148.71 22.01 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.834 -0.621 . . . . 0.44 110.82 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.5 tp -97.84 102.79 14.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.549 0.69 . . . . 0.44 111.367 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 18.0 t -83.53 146.29 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 114.937 -1.029 . . . . 0.44 111.441 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -108.56 -40.15 5.19 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.731 1.382 . . . . 0.44 114.731 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 2.3 ptp180 -163.34 165.72 23.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.064 0.847 . . . . 0.44 112.527 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.707 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 3.3 p90 -145.44 133.35 21.27 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.926 -0.579 . . . . 0.44 111.453 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -81.25 121.18 25.84 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.153 -0.476 . . . . 0.44 110.875 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.98 -128.16 8.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 0.44 112.426 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.1 tt0 -123.43 139.29 31.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 O-C-N 122.886 -0.185 . . . . 0.44 110.818 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.49 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 2.6 Cg_exo -76.2 128.72 10.75 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.885 2.39 . . . . 0.44 111.514 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.513 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 61.4 p-90 -132.86 -61.08 0.85 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.34 -0.544 . . . . 0.44 112.06 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.588 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.83 -104.37 0.05 OUTLIER Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.834 -0.698 . . . . 0.44 113.256 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.24 37.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.684 0.278 . . . . 0.44 111.049 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -26.84 63.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.479 -0.328 . . . . 0.44 111.026 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.32 -67.6 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.553 -0.832 . . . . 0.44 112.939 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.89 110.84 32.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.989 0.423 . . . . 0.44 111.545 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -43.64 146.16 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.973 2.449 . . . . 0.44 112.517 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.42 177.01 18.58 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.653 -0.784 . . . . 0.44 112.856 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -116.49 157.29 25.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.664 0.269 . . . . 0.44 110.56 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.496 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.25 106.57 5.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.91 0.386 . . . . 0.44 110.476 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.8 ptm -120.18 160.71 22.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.44 110.877 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.427 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 22.3 p -73.07 115.25 12.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 0.44 110.928 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.18 -18.92 65.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.44 111.214 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.12 -12.4 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.475 -0.33 . . . . 0.44 111.446 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.97 47.63 1.01 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.954 -0.641 . . . . 0.44 111.892 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.01 150.12 38.96 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.333 -0.247 . . . . 0.44 110.333 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.57 118.57 28.54 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.816 0.672 . . . . 0.44 112.816 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.37 -19.61 61.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.445 -0.798 . . . . 0.44 110.125 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -78.96 -47.27 16.64 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.996 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -20.17 65.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.119 -0.491 . . . . 0.44 111.362 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.47 172.04 4.24 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.675 -0.491 . . . . 0.44 109.675 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -54.48 127.81 27.55 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.01 1.807 . . . . 0.44 112.318 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.15 -38.78 8.63 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.723 2.282 . . . . 0.44 112.652 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.84 -9.76 53.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.44 111.528 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -104.71 18.59 21.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.0 -0.546 . . . . 0.44 110.969 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.556 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -66.66 -31.88 4.58 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 113.97 1.1 . . . . 0.44 113.97 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 84.6 Cg_exo -44.32 -36.61 9.51 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.831 1.687 . . . . 0.44 113.504 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.457 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 93.0 t -77.89 -51.41 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.44 111.038 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.488 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 7.3 mm -68.68 -29.88 45.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 115.98 -0.554 . . . . 0.44 111.489 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.72 -27.0 37.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.979 0.419 . . . . 0.44 110.232 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -80.1 -51.85 8.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.876 -0.602 . . . . 0.44 111.684 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.03 -34.09 50.73 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.49 -0.323 . . . . 0.44 111.627 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 13.7 tttm -52.98 -42.72 65.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.192 -0.458 . . . . 0.44 111.002 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -69.29 -7.76 39.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.771 -0.65 . . . . 0.44 109.945 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-N 115.931 -0.577 . . . . 0.44 111.278 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 tptp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.808 0.337 . . . . 0.44 110.998 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -140.01 132.27 28.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.44 110.823 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pp -146.18 126.18 13.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.44 111.134 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -102.53 154.17 19.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.254 0.55 . . . . 0.44 111.87 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 4.5 mp -146.27 125.28 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.256 -0.884 . . . . 0.44 110.581 179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.605 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.82 125.7 44.43 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.31 -0.626 . . . . 0.44 109.31 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.2 m -140.1 162.64 24.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.202 0.525 . . . . 0.44 111.858 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.84 123.42 2.99 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.243 -0.889 . . . . 0.44 111.649 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.543 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -70.91 105.02 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.608 -0.516 . . . . 0.44 109.608 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.572 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -70.68 126.25 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.138 0.494 . . . . 0.44 111.941 -178.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -101.65 124.99 48.21 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.142 -0.935 . . . . 0.44 111.097 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.609 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.4 p-10 -79.15 -172.59 3.21 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 123.77 0.669 . . . . 0.44 111.382 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.3 tm-20 -76.14 9.22 2.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.204 -0.907 . . . . 0.44 113.337 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -132.89 46.91 2.56 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.958 -0.464 . . . . 0.44 112.098 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.54 24.53 0.52 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.055 0.455 . . . . 0.44 111.495 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 105' ' ' MET . 22.5 mt-10 -115.95 161.24 19.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.971 -0.751 . . . . 0.44 108.971 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -113.68 134.02 57.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 112.352 0.501 . . . . 0.44 112.352 -178.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 11' ' ' ILE . 40.7 t80 -91.84 95.18 9.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.376 -0.829 . . . . 0.44 110.433 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.465 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -111.25 162.42 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.44 110.733 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.8 p -70.63 132.68 45.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.44 110.563 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.391 . . . . 0.44 110.962 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.657 0.265 . . . . 0.44 111.087 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 26.1 10.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.941 0.401 . . . . 0.44 111.708 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 14.7 tp -69.01 69.51 0.18 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.956 -0.565 . . . . 0.44 110.555 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -110.48 -172.65 2.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.539 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.514 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.39 168.7 9.48 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.62 . . . . 0.44 111.374 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.603 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 84.1 Cg_endo -81.28 166.96 17.96 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.528 2.818 . . . . 0.44 113.586 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.12 -5.63 53.07 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.429 -0.805 . . . . 0.44 114.002 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -58.94 162.99 10.79 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.183 -0.532 . . . . 0.44 112.942 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 81.93 2.13 1.4 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.474 0.546 . . . . 0.44 112.474 179.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.605 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.2 pt -50.34 -28.92 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.616 0.722 . . . . 0.44 110.262 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.579 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -40.89 -57.44 1.96 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.219 -1.355 . . . . 0.44 110.961 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER 2.93 -78.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.931 0.77 . . . . 0.44 112.522 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 176.27 35.04 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.44 112.937 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -89.9 -172.72 3.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.677 0.275 . . . . 0.44 111.057 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.51 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.6 152.29 38.08 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.455 -0.339 . . . . 0.44 110.203 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.51 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.77 -25.09 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.751 2.301 . . . . 0.44 112.501 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.06 -39.59 6.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.457 -0.338 . . . . 0.44 111.378 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 2.9 mt-30 -80.37 -9.55 59.75 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.708 0.262 . . . . 0.44 111.708 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -58.64 -54.76 43.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.866 0.365 . . . . 0.44 110.811 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.503 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -78.64 -46.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.976 -0.556 . . . . 0.44 111.47 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 40.4 t -56.53 -44.74 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.44 111.852 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 7.7 mtp180 -72.81 -46.12 54.81 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.674 -0.41 . . . . 0.44 110.912 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' CG ' ' OE1' ' A' ' 57' ' ' GLU . 0.9 OUTLIER -69.43 -19.88 63.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.114 -0.494 . . . . 0.44 110.79 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.485 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -57.91 -44.6 86.92 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.822 0.344 . . . . 0.44 110.714 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.43 -30.69 71.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.105 0.478 . . . . 0.44 109.807 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.42 -34.39 54.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.601 -0.727 . . . . 0.44 111.414 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.581 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.6 mp0 -108.36 6.43 26.39 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 112.95 0.722 . . . . 0.44 112.95 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.588 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 34.3 t -133.8 -44.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.391 . . . . 0.44 110.45 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.538 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.01 -36.43 0.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.837 -0.62 . . . . 0.44 114.467 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.736 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 19.6 tt -77.37 163.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.58 0.228 . . . . 0.44 110.684 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.405 ' N ' HG12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -103.62 88.76 1.9 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 108.582 -0.896 . . . . 0.44 108.582 178.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.736 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.3 Cg_endo -115.12 152.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 123.558 2.839 . . . . 0.44 114.847 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.95 79.74 2.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.382 -2.081 . . . . 0.44 105.382 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.555 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.93 128.3 47.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.633 -1.167 . . . . 0.44 110.83 -176.146 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.3 t80 -176.85 -140.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.17 -0.468 . . . . 0.44 110.909 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.405 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 2.7 m 50.78 175.98 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.142 0.496 . . . . 0.44 112.008 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.833 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -142.99 121.17 12.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.44 111.006 179.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.92 -44.0 33.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.44 110.057 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.3 mt-10 -171.65 131.82 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.756 -0.656 . . . . 0.44 110.468 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.46 111.15 18.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.542 -0.299 . . . . 0.44 110.373 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.443 ' CD2' ' CD1' ' A' ' 73' ' ' TYR . 0.8 OUTLIER -96.94 141.97 29.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.44 111.132 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -137.87 109.9 7.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.44 110.53 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.443 ' CD1' ' CD2' ' A' ' 71' ' ' LEU . 2.0 p90 -137.71 149.97 46.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.44 110.694 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -118.82 139.67 51.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.223 0.535 . . . . 0.44 111.525 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.485 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.6 m-85 -103.02 162.67 19.4 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.402 -0.817 . . . . 0.44 110.192 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.5 Cg_endo -53.65 81.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.934 2.423 . . . . 0.44 112.131 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.0 t0 93.76 8.6 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.458 -0.792 . . . . 0.44 111.509 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -137.32 93.67 2.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.699 0.285 . . . . 0.44 110.758 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.27 110.94 19.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.806 0.336 . . . . 0.44 110.69 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.429 HG21 HD13 ' A' ' 80' ' ' ILE . 3.6 tt -108.09 146.64 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.22 0.533 . . . . 0.44 111.204 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.18 118.53 17.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.651 -0.704 . . . . 0.44 109.529 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 tp -119.15 114.01 21.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.923 0.392 . . . . 0.44 111.254 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 9.5 m0 -111.06 122.15 47.16 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.44 110.084 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.5 m-85 -106.12 113.3 26.75 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.868 -0.605 . . . . 0.44 109.977 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.833 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.7 m95 -94.72 148.35 22.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.44 111.671 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.9 tm? -94.3 102.59 14.6 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 121.395 0.617 . . . . 0.44 110.592 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 14.9 t -89.85 145.37 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 115.148 -0.933 . . . . 0.44 111.813 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -99.94 -59.68 1.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.178 1.177 . . . . 0.44 114.178 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 10.5 ptm180 -163.34 166.0 23.46 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.205 0.457 . . . . 0.44 112.22 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.648 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 41.9 p90 -125.79 164.7 20.12 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.152 -0.476 . . . . 0.44 111.634 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.439 ' N ' HD12 ' A' ' 60' ' ' ILE . 32.2 tt0 -104.13 95.83 6.24 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 116.173 -0.467 . . . . 0.44 110.919 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.01 -112.08 4.05 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.724 -0.75 . . . . 0.44 112.168 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -134.33 130.2 20.04 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.528 0.204 . . . . 0.44 111.17 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.428 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 4.8 Cg_exo -76.63 128.82 10.47 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.766 2.31 . . . . 0.44 111.372 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.538 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 6.9 p-90 -123.07 -65.7 1.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.191 0.52 . . . . 0.44 111.337 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.588 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 50.41 -117.33 4.96 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.468 -0.787 . . . . 0.44 113.288 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 177.57 35.96 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.72 0.295 . . . . 0.44 111.258 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -49.75 -30.33 9.25 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.512 -0.313 . . . . 0.44 110.942 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.4 -25.13 7.86 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.461 -0.876 . . . . 0.44 113.797 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -138.86 112.31 8.22 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 117.197 0.499 . . . . 0.44 111.754 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -43.57 145.39 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.935 2.423 . . . . 0.44 112.551 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.416 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.19 177.51 19.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 0.44 112.855 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -144.66 157.1 44.34 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.233 -0.284 . . . . 0.44 110.233 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.47 106.53 0.94 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.754 -0.379 . . . . 0.44 110.11 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -120.2 156.13 31.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.44 111.039 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.38 116.05 17.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.853 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -61.65 -18.74 60.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.44 111.386 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.37 -3.99 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.467 -0.333 . . . . 0.44 111.639 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.69 48.39 0.97 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.872 -0.68 . . . . 0.44 111.995 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.4 ' CD2' HD22 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -61.56 128.24 35.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.983 -0.377 . . . . 0.44 109.983 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -111.02 114.13 27.2 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.676 0.621 . . . . 0.44 112.676 -178.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.559 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -19.29 61.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.58 -0.736 . . . . 0.44 109.857 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -78.83 -47.69 16.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.843 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.75 -14.18 62.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.08 -0.509 . . . . 0.44 111.46 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -113.56 171.27 4.51 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.668 -0.493 . . . . 0.44 109.668 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.473 ' HD2' ' CD2' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.07 127.85 27.42 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.187 1.925 . . . . 0.44 112.373 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.99 -39.14 8.43 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.759 2.306 . . . . 0.44 112.866 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.71 -9.74 52.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.988 0.423 . . . . 0.44 111.538 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.445 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 21.7 m-20 -104.14 14.49 30.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.897 -0.592 . . . . 0.44 111.057 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.532 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -61.78 -32.25 9.75 Favored Pre-proline 0 N--CA 1.467 0.4 0 N-CA-C 114.403 1.26 . . . . 0.44 114.403 -178.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.9 Cg_exo -44.24 -41.5 13.19 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.712 1.608 . . . . 0.44 113.458 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 84' ' ' PHE . 35.8 t -77.69 -51.04 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.831 0.348 . . . . 0.44 111.059 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.528 HG13 ' CE2' ' A' ' 115' ' ' PHE . 38.2 mm -62.9 -33.77 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.44 111.403 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -29.6 54.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.955 0.407 . . . . 0.44 110.487 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -79.95 -45.21 18.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.44 111.339 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 22.9 tp -78.28 -50.08 12.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.379 . . . . 0.44 111.216 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 123' ' ' ILE . 6.5 ttpt -53.21 -34.9 59.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.44 110.995 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -63.6 -10.16 17.15 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.434 -0.58 . . . . 0.44 109.434 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 129' ' ' LEU . 10.5 mp . . . . . 0 CA--C 1.528 0.118 0 CA-C-N 115.762 -0.654 . . . . 0.44 111.251 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.814 0.34 . . . . 0.44 110.903 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -140.05 130.48 25.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.44 110.848 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.414 HD12 ' CD1' ' A' ' 6' ' ' ILE . 3.4 pp -146.19 128.36 15.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.44 111.162 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -102.85 150.52 23.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 0.44 112.025 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.414 ' CD1' HD12 ' A' ' 4' ' ' LEU . 4.2 mp -146.55 121.83 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.353 -0.839 . . . . 0.44 110.204 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -125.12 125.35 43.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.276 -0.639 . . . . 0.44 109.276 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.3 m -139.67 162.21 26.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.318 -0.553 . . . . 0.44 111.576 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -136.39 139.3 10.55 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.385 -0.825 . . . . 0.44 111.933 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.583 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -83.47 112.66 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.42 -0.585 . . . . 0.44 109.42 179.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -70.81 123.66 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 121.051 0.453 . . . . 0.44 111.493 -178.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.16 124.65 35.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.691 . . . . 0.44 111.858 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.486 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 13.2 t30 -81.75 -172.09 3.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.24 -0.891 . . . . 0.44 111.805 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -81.52 3.99 22.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.317 -1.311 . . . . 0.44 112.453 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -139.5 52.01 1.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.882 -0.327 . . . . 0.44 111.35 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 45.76 24.64 0.22 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.213 -0.449 . . . . 0.44 111.475 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 16.0 pt-20 -117.01 138.57 51.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.887 -0.783 . . . . 0.44 108.887 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 7.5 mt -105.97 139.7 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.26 0.552 . . . . 0.44 112.038 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 18.4 t80 -80.93 91.3 6.0 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.238 -0.892 . . . . 0.44 110.393 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.5 156.81 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.194 -0.457 . . . . 0.44 109.919 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 p -70.77 129.46 39.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.843 0.354 . . . . 0.44 110.709 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.44 110.712 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.714 0.292 . . . . 0.44 111.176 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.34 26.09 10.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.919 0.39 . . . . 0.44 111.515 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -67.25 70.33 0.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 0.44 110.967 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.36 -172.66 2.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.44 110.684 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.68 166.01 11.58 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.863 0.363 . . . . 0.44 110.956 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.436 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 36.4 Cg_endo -65.47 166.69 18.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.415 2.743 . . . . 0.44 114.174 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 101.85 -5.96 54.11 Favored Glycine 0 C--O 1.225 -0.469 0 CA-C-N 114.877 -1.056 . . . . 0.44 114.027 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -57.15 155.67 16.29 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 117.337 0.569 . . . . 0.44 112.528 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.82 7.07 0.5 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.076 0.399 . . . . 0.44 112.076 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.61 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -51.62 -28.43 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.715 0.769 . . . . 0.44 110.156 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.552 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -39.75 -60.64 0.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.218 -1.355 . . . . 0.44 110.731 179.337 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.528 ' C ' ' O ' ' A' ' 41' ' ' GLU . 8.7 mmt 5.8 -81.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.363 -0.835 . . . . 0.44 112.537 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.27 28.75 0.08 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.725 -0.75 . . . . 0.44 112.943 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -94.41 -174.71 3.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.773 0.321 . . . . 0.44 111.06 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.545 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.45 156.51 39.39 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.787 -0.449 . . . . 0.44 109.787 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.65 -24.66 0.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.799 2.333 . . . . 0.44 112.708 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.25 -57.73 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.035 0.383 . . . . 0.44 112.035 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -80.52 -4.26 53.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.91 0.337 . . . . 0.44 111.91 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -59.28 -57.73 11.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.44 110.97 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.2 m -79.01 -45.65 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.475 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.471 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 38.6 t -52.21 -38.84 25.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.44 111.099 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mmm-85 -78.15 -41.54 34.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.263 -0.426 . . . . 0.44 110.531 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.31 -19.89 62.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.44 110.76 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -58.59 -44.76 89.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.883 0.373 . . . . 0.44 110.402 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -32.13 70.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.052 0.453 . . . . 0.44 110.344 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.17 -31.92 55.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.766 -0.652 . . . . 0.44 111.499 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.05 3.96 24.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.522 0.564 . . . . 0.44 112.522 -178.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.629 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 11.3 t -134.69 -44.11 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.206 0.527 . . . . 0.44 109.934 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.16 -32.88 0.25 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.388 -0.824 . . . . 0.44 114.046 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.51 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -77.89 179.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 120.617 0.246 . . . . 0.44 110.6 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.97 88.4 10.02 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 109.576 -0.527 . . . . 0.44 109.576 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.645 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -110.78 144.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.527 2.818 . . . . 0.44 113.968 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 18.3 mt-30 -74.68 79.62 2.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.144 -2.169 . . . . 0.44 105.144 175.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.62 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.85 134.16 54.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.092 -1.413 . . . . 0.44 110.982 -175.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 179.97 -140.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.869 -0.605 . . . . 0.44 110.352 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.404 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 0.9 OUTLIER 50.33 176.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.138 0.494 . . . . 0.44 111.932 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.78 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.9 OUTLIER -143.88 123.31 13.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.566 . . . . 0.44 111.043 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.6 -43.77 37.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.186 0.517 . . . . 0.44 109.658 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.1 mt-10 -171.83 131.8 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.472 -0.786 . . . . 0.44 110.224 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.06 109.38 17.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.782 0.325 . . . . 0.44 110.408 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.418 HD23 ' CD1' ' A' ' 73' ' ' TYR . 3.9 tp -96.99 131.09 44.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.44 111.126 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -133.68 109.67 9.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.368 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.418 ' CD1' HD23 ' A' ' 71' ' ' LEU . 2.2 p90 -141.29 131.77 25.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.941 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 2.9 pm0 -102.76 138.92 39.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.115 0.483 . . . . 0.44 111.228 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -106.53 163.4 17.07 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.52 -0.764 . . . . 0.44 110.215 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.3 Cg_endo -51.87 82.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.87 2.38 . . . . 0.44 112.176 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 75' ' ' PHE . 12.5 m-20 89.56 11.16 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.289 -0.869 . . . . 0.44 111.518 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.4 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.49 93.73 2.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.263 . . . . 0.44 110.733 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 13.0 t-160 -89.72 98.98 12.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.346 . . . . 0.44 110.857 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -104.27 111.91 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.44 110.774 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 118.68 37.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.876 -0.602 . . . . 0.44 109.686 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tp -116.47 113.91 23.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.915 0.388 . . . . 0.44 111.722 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -110.31 122.55 47.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.005 -0.543 . . . . 0.44 110.398 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.6 m-85 -108.09 113.06 25.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.134 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.78 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.4 m95 -94.67 148.6 22.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.147 -0.479 . . . . 0.44 111.801 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.0 tm? -99.1 102.86 14.7 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.334 0.588 . . . . 0.44 111.355 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 64' ' ' HIS . 14.6 t -84.18 146.03 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 115.351 -0.84 . . . . 0.44 111.097 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -113.63 -24.97 8.93 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.119 1.155 . . . . 0.44 114.119 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.515 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -162.68 162.83 27.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.63 0.65 . . . . 0.44 111.777 -178.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.645 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -155.2 141.81 18.84 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.286 -0.416 . . . . 0.44 111.3 178.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.2 mt-10 -77.88 136.2 38.01 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-O 120.793 0.33 . . . . 0.44 111.383 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.94 -108.44 0.2 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.963 -0.637 . . . . 0.44 112.695 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 23.5 tt0 -131.25 135.78 27.68 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.473 0.178 . . . . 0.44 110.826 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.8 Cg_exo -76.04 128.85 10.97 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.801 2.334 . . . . 0.44 111.197 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 14.6 p-90 -114.15 -64.91 1.24 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.127 0.418 . . . . 0.44 112.127 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.629 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.31 -103.43 0.03 OUTLIER Glycine 0 CA--C 1.52 0.386 0 CA-C-N 115.635 -0.711 . . . . 0.44 113.251 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 tptp 174.08 40.19 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.697 0.284 . . . . 0.44 111.261 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.44 ' HA ' ' CG ' ' A' ' 57' ' ' GLU . 21.7 pt-20 -61.86 -47.06 86.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.575 -0.284 . . . . 0.44 110.868 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.86 -120.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.423 -0.894 . . . . 0.44 113.101 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -75.82 123.88 88.43 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.17 0.509 . . . . 0.44 111.788 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -43.7 146.32 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.257 2.638 . . . . 0.44 112.701 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.88 177.38 18.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.831 -0.699 . . . . 0.44 112.989 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -126.9 157.26 39.87 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.366 -0.235 . . . . 0.44 110.366 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CG ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -68.47 106.11 2.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.881 0.372 . . . . 0.44 110.252 -179.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.6 ptm -120.58 163.3 18.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.017 -0.538 . . . . 0.44 111.015 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.21 114.94 17.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.825 0.345 . . . . 0.44 110.549 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.84 -18.84 61.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.44 111.238 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.6 p -61.92 -9.3 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.645 -0.252 . . . . 0.44 111.563 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.25 49.18 0.94 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.818 -0.706 . . . . 0.44 111.96 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.15 150.2 39.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.253 -0.277 . . . . 0.44 110.253 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.44 121.27 39.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.133 0.79 . . . . 0.44 113.133 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.611 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.49 -21.65 61.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.374 -0.83 . . . . 0.44 110.269 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.7 -43.77 25.15 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.064 -0.516 . . . . 0.44 111.318 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.59 -37.52 85.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.402 . . . . 0.44 110.783 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.611 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.22 172.95 6.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.458 -0.571 . . . . 0.44 109.458 179.205 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HD2' ' CD2' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.27 127.82 27.43 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.012 1.808 . . . . 0.44 112.036 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.15 -39.0 8.3 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.666 2.244 . . . . 0.44 112.871 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.57 -9.8 51.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.933 0.397 . . . . 0.44 111.524 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.459 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 26.0 m-20 -104.95 20.47 18.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.892 -0.595 . . . . 0.44 110.741 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -62.03 -31.74 8.45 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 114.177 1.177 . . . . 0.44 114.177 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 79.8 Cg_exo -44.29 -43.89 13.17 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.771 1.647 . . . . 0.44 113.61 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.485 HG12 ' CD1' ' A' ' 84' ' ' PHE . 95.7 t -77.75 -51.52 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.775 0.321 . . . . 0.44 111.563 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.526 HG13 ' CE2' ' A' ' 115' ' ' PHE . 37.4 mm -64.74 -29.98 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.44 111.484 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.56 -32.14 66.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.985 0.421 . . . . 0.44 110.437 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -80.11 -45.58 17.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.862 -0.608 . . . . 0.44 111.323 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . 3.3 tm? -78.26 -19.79 52.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.603 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 123' ' ' ILE . 6.2 ttpm? -79.14 -42.64 25.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 0.44 110.681 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -67.75 -7.85 30.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.691 . . . . 0.44 109.962 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 CA-C-N 116.239 -0.437 . . . . 0.44 110.743 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 120.844 0.354 . . . . 0.44 110.825 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.1 133.91 30.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.766 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -146.12 124.66 12.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.089 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -102.66 147.9 26.24 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.273 0.559 . . . . 0.44 111.565 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 33.7 mm -146.4 124.83 4.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.267 -0.879 . . . . 0.44 110.687 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.612 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.82 125.19 43.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.698 -0.482 . . . . 0.44 109.698 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m -133.51 162.2 40.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.66 -0.416 . . . . 0.44 111.062 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.53 126.15 2.83 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.79 -0.719 . . . . 0.44 112.117 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.555 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.81 108.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.519 -0.549 . . . . 0.44 109.519 179.374 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -71.03 123.73 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.038 0.447 . . . . 0.44 111.151 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.43 124.02 34.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.637 -0.711 . . . . 0.44 111.653 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.463 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 13.9 t30 -81.61 -172.16 3.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.117 -0.947 . . . . 0.44 112.051 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.83 2.94 24.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.182 -1.372 . . . . 0.44 112.507 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -140.19 52.34 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.346 . . . . 0.44 111.441 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.6 p30 45.96 24.35 0.23 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.397 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 16.8 pt-20 -114.68 142.58 46.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.985 -0.746 . . . . 0.44 108.985 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 7.3 mt -115.58 136.79 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.141 0.496 . . . . 0.44 111.623 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.43 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -83.84 111.14 18.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.573 -0.74 . . . . 0.44 110.593 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.518 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -115.97 149.1 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.44 110.212 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.9 p -70.84 132.4 45.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.471 -0.331 . . . . 0.44 110.553 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.386 . . . . 0.44 110.968 -179.783 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.742 0.306 . . . . 0.44 111.075 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.28 25.94 11.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.103 0.478 . . . . 0.44 111.338 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.6 tp -62.77 84.38 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.728 -0.669 . . . . 0.44 110.769 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.13 -165.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.345 -0.389 . . . . 0.44 111.153 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.518 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -118.86 168.31 10.01 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.44 111.334 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.554 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 84.8 Cg_endo -79.4 167.37 21.29 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.416 2.744 . . . . 0.44 113.025 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.533 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.86 -5.65 50.88 Favored Glycine 0 C--O 1.224 -0.489 0 CA-C-N 115.719 -0.673 . . . . 0.44 114.462 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.09 152.44 46.7 Favored Glycine 0 C--N 1.318 -0.436 0 C-N-CA 120.896 -0.669 . . . . 0.44 112.585 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.493 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 91.76 3.53 0.1 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 122.827 0.451 . . . . 0.44 112.151 179.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.612 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 pt -52.46 -27.32 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.444 0.64 . . . . 0.44 110.379 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.507 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.78 -64.01 0.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.574 -1.194 . . . . 0.44 110.832 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.483 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 17.94 -83.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.509 -0.769 . . . . 0.44 112.448 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 178.68 35.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.724 -0.751 . . . . 0.44 112.867 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -92.17 -170.68 2.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.654 0.264 . . . . 0.44 111.076 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.506 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.67 153.08 38.42 Favored Pre-proline 0 N--CA 1.456 -0.131 0 N-CA-C 110.234 -0.284 . . . . 0.44 110.234 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.506 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.74 -24.9 0.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.786 2.324 . . . . 0.44 112.454 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -102.49 -43.86 5.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.366 -0.379 . . . . 0.44 111.592 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.5 -4.83 55.35 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 111.783 0.29 . . . . 0.44 111.783 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -61.91 -57.3 12.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.706 0.289 . . . . 0.44 110.738 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -78.78 -46.22 24.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.274 -0.421 . . . . 0.44 111.267 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 37.6 t -55.71 -40.53 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.44 112.14 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -78.11 -51.76 9.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.78 0.324 . . . . 0.44 111.221 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 1.4 mm-40 -68.54 -20.87 64.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.305 -0.407 . . . . 0.44 110.937 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.654 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 4.5 tp -51.18 -44.78 61.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.471 -0.566 . . . . 0.44 109.471 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -32.95 69.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.44 109.457 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -77.35 -29.84 53.58 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.525 -0.761 . . . . 0.44 110.941 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.496 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 6.0 mp0 -104.9 5.54 32.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.418 0.525 . . . . 0.44 112.418 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.543 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 1.6 t -134.38 -44.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.12 0.486 . . . . 0.44 110.005 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.519 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.34 -39.98 0.28 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.643 -0.708 . . . . 0.44 114.336 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.483 HG21 ' O ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -77.92 -174.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.088 0.471 . . . . 0.44 111.896 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.54 87.79 26.9 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 115.608 -0.724 . . . . 0.44 109.639 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.525 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 11.7 Cg_endo -112.06 146.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 123.733 2.955 . . . . 0.44 113.968 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -74.88 79.72 2.13 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 106.134 -1.802 . . . . 0.44 106.134 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.562 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -121.01 130.14 53.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.821 -1.536 . . . . 0.44 110.227 -176.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 86' ' ' LEU . 6.1 t80 178.52 160.88 0.62 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.458 0.54 . . . . 0.44 112.458 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 88.62 -165.64 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.735 -0.666 . . . . 0.44 111.209 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.5 pp -152.37 131.76 12.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.538 -0.301 . . . . 0.44 111.27 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 2.1 p90 -76.75 -41.81 43.44 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.501 -0.48 . . . . 0.44 109.773 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.553 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 13.0 mt-10 -171.12 131.46 0.79 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.707 -0.679 . . . . 0.44 109.583 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 132.06 55.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.754 0.312 . . . . 0.44 110.852 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.417 HD21 ' CD1' ' A' ' 73' ' ' TYR . 1.3 tp -110.66 139.14 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.392 -0.367 . . . . 0.44 110.99 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -138.42 109.6 6.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.44 110.504 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.417 ' CD1' HD21 ' A' ' 71' ' ' LEU . 2.1 p90 -141.52 137.25 31.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.44 110.87 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 2.3 pt-20 -121.17 132.07 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.202 0.525 . . . . 0.44 111.194 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 1.1 m-85 -83.21 163.9 48.3 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 115.514 -0.766 . . . . 0.44 110.2 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.416 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -38.68 -28.62 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.626 2.884 . . . . 0.44 113.261 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -139.77 -38.04 0.48 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.69 -0.686 . . . . 0.44 111.163 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.485 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 25.0 ttp180 -86.32 102.78 14.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.44 111.421 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.403 ' ND1' ' HB3' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -92.67 99.91 12.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.46 -0.337 . . . . 0.44 110.286 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.412 HG21 ' CZ ' ' A' ' 73' ' ' TYR . 3.7 tt -101.23 147.95 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.066 0.46 . . . . 0.44 111.088 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 118.48 17.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.811 -0.631 . . . . 0.44 109.63 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.423 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.2 mp -114.58 113.51 24.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.44 111.31 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -110.97 122.45 47.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 0.44 109.734 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.59 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 2.7 m-85 -113.19 112.72 24.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.037 0.446 . . . . 0.44 110.858 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.745 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 25.5 m95 -95.58 148.49 22.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.662 -0.699 . . . . 0.44 111.648 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 65' ' ' PHE . 35.5 tp -90.23 138.84 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.705 -0.68 . . . . 0.44 110.745 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 64' ' ' HIS . 17.9 t -123.23 144.67 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-N 116.405 -0.361 . . . . 0.44 110.711 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.11 -27.78 8.24 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 114.012 1.116 . . . . 0.44 114.012 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.518 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.07 160.08 24.0 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 119.922 -0.711 . . . . 0.44 111.875 -178.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.525 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -152.92 123.24 7.13 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.995 -0.548 . . . . 0.44 110.962 178.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.86 150.11 32.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.067 -0.515 . . . . 0.44 111.324 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.59 -144.37 30.12 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.971 -0.633 . . . . 0.44 112.77 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.483 ' O ' HG21 ' A' ' 60' ' ' ILE . 44.7 tt0 -105.59 134.92 19.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 110.334 -0.247 . . . . 0.44 110.334 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.43 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.3 Cg_exo -76.12 128.8 10.86 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.686 2.257 . . . . 0.44 111.61 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.519 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 34.2 p-90 -124.91 -61.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.518 -0.473 . . . . 0.44 111.735 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.543 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 48.74 -110.53 0.73 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.453 -0.88 . . . . 0.44 112.88 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.29 50.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.44 111.075 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -35.53 64.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.44 110.498 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.26 -5.55 45.4 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.626 -0.797 . . . . 0.44 113.348 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -140.12 96.02 8.24 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.981 0.419 . . . . 0.44 111.445 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -43.6 144.0 2.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.913 2.408 . . . . 0.44 112.35 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.1 177.13 19.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.525 -0.845 . . . . 0.44 113.124 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -139.26 157.44 45.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.127 -0.323 . . . . 0.44 110.127 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.03 106.41 0.5 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.702 -0.399 . . . . 0.44 110.065 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.444 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.4 mtp -120.11 163.47 17.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.44 111.252 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 81.7 p -90.79 114.8 27.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.231 -0.441 . . . . 0.44 110.559 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -18.53 65.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 0.44 111.207 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.9 p -53.67 -16.36 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.323 -0.398 . . . . 0.44 111.77 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.71 55.0 0.68 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.893 -0.67 . . . . 0.44 111.93 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.43 HD21 ' CE2' ' A' ' 35' ' ' PHE . 11.1 tp -62.07 150.49 38.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.878 0.371 . . . . 0.44 110.889 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -98.31 95.75 7.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.775 0.657 . . . . 0.44 112.775 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.6 -21.55 61.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.18 -0.464 . . . . 0.44 110.084 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -79.05 -44.67 21.71 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.022 -0.536 . . . . 0.44 111.199 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -41.2 88.37 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.28 -0.418 . . . . 0.44 111.227 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.523 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.45 174.29 6.27 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.181 -0.674 . . . . 0.44 109.181 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.6 Cg_endo -54.05 127.82 27.26 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 121.742 1.628 . . . . 0.44 112.255 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.5 -38.97 10.18 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.759 2.306 . . . . 0.44 112.575 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.73 -9.59 55.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.023 0.44 . . . . 0.44 111.344 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -103.15 16.19 27.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.805 -0.634 . . . . 0.44 111.029 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -68.28 -32.67 4.08 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 113.44 0.904 . . . . 0.44 113.44 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 91.2 Cg_exo -44.44 -33.54 6.53 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 121.778 1.652 . . . . 0.44 112.718 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.483 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 12.9 t -77.8 -51.51 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.44 111.003 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.499 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 17.3 mm -68.16 -33.61 61.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 0.44 111.67 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.67 -27.35 39.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.874 0.369 . . . . 0.44 110.775 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -80.54 -53.19 6.79 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.096 -0.502 . . . . 0.44 111.885 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.417 HD11 ' CG ' ' A' ' 68' ' ' PHE . 2.4 tp -78.23 -33.52 49.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.76 0.314 . . . . 0.44 111.628 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 28.3 ttpp -54.05 -42.64 69.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.026 0.441 . . . . 0.44 110.963 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -66.3 -10.09 39.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.789 -0.641 . . . . 0.44 109.694 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.975 -0.557 . . . . 0.44 110.94 179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.969 0.414 . . . . 0.44 110.963 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 138.67 38.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.44 110.368 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 pp -146.24 138.02 24.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 0.44 111.713 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 29.2 mt-30 -104.11 152.83 21.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.031 -0.532 . . . . 0.44 110.987 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.452 ' CD1' HD11 ' A' ' 80' ' ' ILE . 47.8 mt -146.35 119.53 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.805 -0.634 . . . . 0.44 111.274 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.625 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.86 125.68 44.36 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.113 -0.699 . . . . 0.44 109.113 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.665 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.8 m -132.79 162.45 39.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.478 0.656 . . . . 0.44 111.945 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.36 118.66 0.97 Allowed Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.055 -0.975 . . . . 0.44 111.92 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.663 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.27 109.76 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.956 -0.757 . . . . 0.44 108.956 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -70.6 119.14 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.062 0.458 . . . . 0.44 111.61 -178.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.65 118.57 23.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.567 -0.742 . . . . 0.44 111.75 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.535 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.1 t-20 -78.21 -172.46 2.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.045 -0.98 . . . . 0.44 111.589 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.525 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 10.9 tt0 -83.44 4.86 25.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.571 -1.195 . . . . 0.44 112.368 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -140.58 52.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.44 111.444 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.3 p30 46.26 23.23 0.19 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.138 -0.483 . . . . 0.44 111.683 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -116.42 146.89 42.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.653 -0.869 . . . . 0.44 108.653 178.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.5 mp -112.49 144.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.298 0.571 . . . . 0.44 112.299 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.471 ' N ' HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -88.37 114.24 24.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.216 -0.902 . . . . 0.44 110.127 179.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.71 137.7 51.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.341 -0.39 . . . . 0.44 110.236 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 p -70.84 123.01 20.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.44 111.033 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.473 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 5.0 ptt85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.44 111.099 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.695 0.283 . . . . 0.44 111.41 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.25 26.14 10.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.018 0.437 . . . . 0.44 111.316 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 27.2 tp -73.55 64.67 0.89 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.755 -0.657 . . . . 0.44 111.103 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -114.99 -173.09 2.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.789 0.328 . . . . 0.44 111.213 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.504 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 53.8 m-85 -90.42 159.95 40.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.514 0.561 . . . . 0.44 112.514 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.665 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 97.8 Cg_endo -84.02 167.13 12.71 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.809 3.006 . . . . 0.44 111.852 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.534 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.12 -5.12 52.6 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.716 -0.754 . . . . 0.44 114.136 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.62 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -64.18 129.82 37.93 Favored Glycine 0 C--N 1.316 -0.582 0 C-N-CA 121.154 -0.546 . . . . 0.44 112.848 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 108.97 2.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.1 0.56 . . . . 0.44 111.848 179.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.625 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.7 pt -49.05 -29.66 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.518 0.675 . . . . 0.44 110.747 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.581 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -38.16 -77.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.541 -1.209 . . . . 0.44 110.952 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.2 mmt 33.8 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.623 0.577 . . . . 0.44 111.885 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.0 32.93 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.822 -0.704 . . . . 0.44 112.663 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.477 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -89.09 -172.9 3.84 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.731 0.301 . . . . 0.44 111.132 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.528 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.64 154.04 37.66 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.382 -0.372 . . . . 0.44 110.288 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.76 -24.99 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.803 2.335 . . . . 0.44 112.491 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.47 -43.59 5.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.508 -0.314 . . . . 0.44 111.55 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 52.8 mm-40 -80.46 -4.84 55.33 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.821 0.304 . . . . 0.44 111.821 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.477 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -61.15 -55.47 31.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.682 0.277 . . . . 0.44 111.035 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -78.52 -45.65 25.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.372 -0.377 . . . . 0.44 110.968 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.461 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 39.4 t -60.13 -44.89 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.857 -0.61 . . . . 0.44 112.003 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 9.2 tpp180 -78.07 -37.14 47.31 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.771 -0.372 . . . . 0.44 111.393 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.445 ' CG ' ' OE2' ' A' ' 57' ' ' GLU . 6.2 tp10 -78.04 -23.54 48.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.444 -0.344 . . . . 0.44 110.716 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -51.67 -44.42 63.07 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 120.982 0.42 . . . . 0.44 109.988 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -28.85 62.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.599 . . . . 0.44 109.468 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -77.24 -30.67 54.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.489 -0.778 . . . . 0.44 111.314 179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.445 ' OE2' ' CG ' ' A' ' 53' ' ' GLU . 16.3 mp0 -108.22 5.85 26.13 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.218 0.451 . . . . 0.44 112.218 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.549 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 4.0 t -134.07 -44.88 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.024 0.44 . . . . 0.44 110.101 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.11 -38.32 0.15 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.56 -0.745 . . . . 0.44 114.577 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.464 HG13 ' CG1' ' A' ' 58' ' ' VAL . 21.3 pt -77.79 -176.03 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.99 0.424 . . . . 0.44 111.575 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.25 88.28 17.98 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.871 -0.604 . . . . 0.44 110.348 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.653 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.8 Cg_endo -112.44 146.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.568 2.845 . . . . 0.44 113.9 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 13.1 mt-30 -74.82 80.2 2.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.743 -1.947 . . . . 0.44 105.743 175.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.616 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.36 136.78 54.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.134 -1.394 . . . . 0.44 111.578 -175.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.0 t80 178.71 -135.52 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.663 -0.698 . . . . 0.44 110.199 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 55.94 166.49 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.147 0.498 . . . . 0.44 111.809 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.7 tt -129.14 114.95 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.589 -0.732 . . . . 0.44 110.683 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -76.53 -52.91 8.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.647 -0.501 . . . . 0.44 109.647 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.8 tt0 -171.91 153.03 3.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.436 -0.802 . . . . 0.44 109.927 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.55 129.28 19.31 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.095 -0.335 . . . . 0.44 110.095 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pp -130.91 159.13 38.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.014 0.435 . . . . 0.44 111.235 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -133.6 120.17 20.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.44 111.042 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.435 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 1.7 p90 -141.17 147.59 38.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.44 110.595 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.13 112.32 18.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.44 111.34 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.4 m-85 -69.96 162.86 65.74 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.692 -0.685 . . . . 0.44 110.355 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.7 Cg_endo -50.3 81.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.058 2.505 . . . . 0.44 112.342 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 75' ' ' PHE . 7.0 m-20 91.15 13.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.397 -0.819 . . . . 0.44 111.814 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 75' ' ' PHE . 21.3 ttp180 -137.45 102.01 4.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.613 0.244 . . . . 0.44 110.935 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -86.98 113.06 22.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.44 110.904 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.459 HD13 HG23 ' A' ' 80' ' ' ILE . 2.3 tt -120.22 118.83 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.44 111.091 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -97.58 118.77 34.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.047 -0.723 . . . . 0.44 109.047 178.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -113.83 114.61 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.343 0.497 . . . . 0.44 112.343 -178.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.413 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 8.8 m0 -113.35 122.38 47.21 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.793 -0.64 . . . . 0.44 109.965 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.583 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.1 m-30 -106.89 133.22 51.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.151 -0.477 . . . . 0.44 111.034 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 16.9 m95 -118.65 149.14 41.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.964 -0.562 . . . . 0.44 111.445 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 66' ' ' SER . 0.0 OUTLIER -102.07 103.79 14.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.48 0.657 . . . . 0.44 112.306 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.663 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 13.3 t -79.77 146.26 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-N 114.976 -1.011 . . . . 0.44 110.995 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -114.34 -23.99 9.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.299 1.222 . . . . 0.44 114.299 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -162.43 161.01 27.05 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.623 0.647 . . . . 0.44 111.371 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.653 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -157.07 125.98 5.86 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.231 -0.44 . . . . 0.44 111.404 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -74.5 140.31 44.44 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.338 -0.392 . . . . 0.44 111.242 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.77 -130.03 47.94 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.875 -0.678 . . . . 0.44 112.763 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.9 tt0 -121.01 137.4 26.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.462 -0.199 . . . . 0.44 110.462 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.477 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.8 Cg_exo -76.18 128.9 10.89 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.702 2.268 . . . . 0.44 111.562 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.592 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -119.5 -60.04 1.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.68 -0.408 . . . . 0.44 111.975 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.549 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.0 -103.93 0.06 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.774 -0.727 . . . . 0.44 112.973 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 172.28 37.36 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.722 0.296 . . . . 0.44 111.097 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -59.25 -48.98 79.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.44 110.762 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.86 -76.9 0.14 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.563 -0.827 . . . . 0.44 112.83 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -118.79 124.14 28.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.071 0.462 . . . . 0.44 111.318 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -43.29 145.95 1.28 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.994 2.463 . . . . 0.44 112.647 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.39 177.36 16.8 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.87 -0.681 . . . . 0.44 112.926 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -125.14 157.23 36.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.417 -0.216 . . . . 0.44 110.417 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -69.18 106.51 2.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.867 0.365 . . . . 0.44 110.322 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.0 ptp -120.19 163.24 18.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.02 -0.536 . . . . 0.44 111.106 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.7 p -81.64 114.94 20.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.472 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -18.69 64.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.44 111.456 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.01 -19.26 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.602 -0.272 . . . . 0.44 111.513 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.51 55.5 0.57 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.805 -0.712 . . . . 0.44 112.227 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.504 ' CD1' ' CZ ' ' A' ' 35' ' ' PHE . 2.0 tt -62.37 151.02 38.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.908 0.385 . . . . 0.44 110.967 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.43 ' C ' HD22 ' A' ' 110' ' ' LEU . 1.6 t-20 -92.44 92.87 8.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.092 -0.504 . . . . 0.44 112.048 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.501 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -71.36 -18.89 62.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.153 0.501 . . . . 0.44 110.142 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.89 -44.39 22.87 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.951 -0.568 . . . . 0.44 110.513 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.84 -41.36 87.56 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.945 -0.57 . . . . 0.44 110.816 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.575 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.78 170.06 17.89 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.433 -0.58 . . . . 0.44 109.433 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 34' ' ' GLU . 9.3 Cg_endo -54.14 127.63 26.53 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.131 1.887 . . . . 0.44 112.791 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.13 -34.85 15.71 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.73 2.287 . . . . 0.44 111.995 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.33 -9.96 57.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.44 110.877 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . 17.0 m-20 -109.53 14.09 23.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.726 -0.67 . . . . 0.44 110.183 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -76.1 -30.99 0.94 Allowed Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 113.849 1.055 . . . . 0.44 113.849 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 65.7 Cg_exo -43.61 -39.99 10.31 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.062 1.841 . . . . 0.44 113.831 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.478 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 1.5 t -77.91 -51.58 17.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.99 0.424 . . . . 0.44 111.598 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.473 ' CD1' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.13 -29.45 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.891 -0.595 . . . . 0.44 111.623 -179.059 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.45 -31.34 55.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.009 0.433 . . . . 0.44 110.086 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -66.74 -47.02 73.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.44 110.155 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 2.3 tm? -78.49 -20.03 51.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.935 -0.575 . . . . 0.44 111.032 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.407 ' CD ' ' CB ' ' A' ' 112' ' ' ALA . 23.0 tttm -74.48 -42.53 58.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.095 0.474 . . . . 0.44 110.445 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -64.65 -11.03 31.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.608 -0.724 . . . . 0.44 109.904 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.104 0 CA-C-N 116.305 -0.407 . . . . 0.44 110.58 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.82 0.343 . . . . 0.44 110.894 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.05 133.95 30.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.44 110.876 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.447 HD11 ' CD1' ' A' ' 6' ' ' ILE . 3.4 pp -146.15 121.95 10.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.44 111.099 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -102.89 151.32 22.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.241 0.543 . . . . 0.44 112.059 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.447 ' CD1' HD11 ' A' ' 4' ' ' LEU . 3.2 mp -146.48 128.93 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.251 -0.886 . . . . 0.44 110.279 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.611 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -125.13 125.58 43.96 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.913 -0.403 . . . . 0.44 109.913 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -137.13 162.16 34.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.313 -0.555 . . . . 0.44 111.381 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.04 127.86 2.45 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.733 -0.746 . . . . 0.44 112.045 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.622 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -70.76 110.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.649 -0.5 . . . . 0.44 109.649 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -70.93 119.72 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.44 110.891 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.92 121.01 26.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.675 -0.693 . . . . 0.44 111.744 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.526 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 2.5 t-20 -81.31 -172.56 3.86 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.27 -0.877 . . . . 0.44 111.52 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.526 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 22.2 tt0 -81.98 3.65 25.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.743 -1.117 . . . . 0.44 112.398 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -139.74 51.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.44 111.385 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.34 24.58 0.3 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.304 -0.407 . . . . 0.44 111.195 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 17.0 pt-20 -116.96 144.52 44.46 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.212 -0.662 . . . . 0.44 109.212 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 5.6 mt -116.03 145.18 22.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.172 0.511 . . . . 0.44 111.841 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -89.83 111.08 21.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.541 -0.754 . . . . 0.44 110.367 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.49 142.86 24.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 0.44 110.182 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.4 p -70.84 114.42 8.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.231 -0.285 . . . . 0.44 110.231 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.44 110.522 -179.69 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.695 0.283 . . . . 0.44 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.1 25.98 10.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.44 111.403 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.2 tt -67.48 76.05 0.17 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.718 -0.673 . . . . 0.44 110.792 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.88 -169.0 1.65 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.933 0.397 . . . . 0.44 111.464 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.28 168.46 9.93 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.002 -0.545 . . . . 0.44 111.461 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.546 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 74.0 Cg_endo -77.72 167.06 24.58 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.372 2.714 . . . . 0.44 112.953 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.573 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.11 -5.45 52.94 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.644 -0.707 . . . . 0.44 113.71 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.44 145.28 48.76 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 121.184 -0.532 . . . . 0.44 113.302 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 89.62 9.91 0.08 Allowed 'General case' 0 C--N 1.342 0.257 0 N-CA-C 113.18 0.807 . . . . 0.44 113.18 178.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.611 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.1 pt -57.84 -27.27 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.567 0.699 . . . . 0.44 110.051 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -37.04 -77.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.416 -1.266 . . . . 0.44 111.31 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 36.05 -87.85 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.997 -0.547 . . . . 0.44 111.938 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.07 33.58 0.07 OUTLIER Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.608 -0.806 . . . . 0.44 112.989 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -92.47 -166.23 1.5 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.54 0.21 . . . . 0.44 110.897 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.527 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.89 154.35 37.41 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 110.247 -0.279 . . . . 0.44 110.247 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.527 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.93 -24.81 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.704 2.269 . . . . 0.44 112.362 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.34 -49.83 4.54 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.046 0.388 . . . . 0.44 112.046 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -80.71 -8.89 59.8 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.812 0.301 . . . . 0.44 111.812 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.47 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -61.62 -57.24 12.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.843 0.354 . . . . 0.44 110.484 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 1.2 p -78.61 -46.61 24.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.44 111.716 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.3 t -50.69 -38.81 17.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.754 0.312 . . . . 0.44 111.387 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -78.89 -52.2 8.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.365 -0.379 . . . . 0.44 111.799 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -19.8 63.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.415 -0.357 . . . . 0.44 111.19 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 23.0 tp -58.74 -45.81 88.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.44 110.521 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -66.46 -26.69 67.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.004 0.43 . . . . 0.44 110.095 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.63 -24.57 67.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.44 110.602 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.492 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.54 5.64 25.3 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.838 0.681 . . . . 0.44 112.838 -178.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.571 ' CG2' ' O ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -133.49 -44.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.312 -0.625 . . . . 0.44 109.312 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.547 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 68.85 -35.24 0.28 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 115.251 0.86 . . . . 0.44 115.251 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 93' ' ' GLU . 0.5 OUTLIER -77.95 -172.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.893 0.377 . . . . 0.44 110.909 -179.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.02 88.82 12.65 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 115.889 -0.596 . . . . 0.44 110.412 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.652 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.3 Cg_endo -108.36 149.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 123.28 2.653 . . . . 0.44 113.787 -177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.531 ' HG2' ' HB3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.88 81.16 4.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 104.563 -2.384 . . . . 0.44 104.563 175.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.595 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.61 134.98 51.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.27 -1.332 . . . . 0.44 111.087 -175.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.506 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.6 t80 179.83 -142.83 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.02 -0.536 . . . . 0.44 110.657 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t 50.82 175.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.975 0.51 . . . . 0.44 111.95 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -141.88 124.9 16.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.862 -0.608 . . . . 0.44 111.02 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.97 -51.14 11.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.52 . . . . 0.44 109.985 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 mt-10 -171.73 131.64 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.825 -0.625 . . . . 0.44 110.35 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.26 119.46 39.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.791 0.329 . . . . 0.44 110.64 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.458 ' CD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -99.64 123.67 44.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.44 110.863 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -122.52 109.56 14.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.44 110.793 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.458 ' CD1' ' CD2' ' A' ' 71' ' ' LEU . 1.8 p90 -141.43 137.59 32.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.44 110.486 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 2.5 pt-20 -121.24 125.21 46.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.156 0.503 . . . . 0.44 111.462 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 2.6 m-85 -71.92 163.4 67.06 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.485 -0.78 . . . . 0.44 109.895 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.8 Cg_endo -39.28 -27.76 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.434 2.756 . . . . 0.44 112.97 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -139.78 -37.08 0.49 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.718 -0.674 . . . . 0.44 111.209 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 33.2 ttp180 -85.91 103.42 14.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.44 111.489 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.451 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 9.4 t-160 -91.15 100.27 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.44 110.425 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.446 HG23 ' CZ ' ' A' ' 73' ' ' TYR . 6.2 tt -101.88 146.2 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.091 0.472 . . . . 0.44 111.252 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -134.15 118.74 18.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.824 -0.626 . . . . 0.44 109.696 179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.5 mt -121.17 114.2 21.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.992 0.425 . . . . 0.44 111.763 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -109.44 122.06 46.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.44 109.774 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.543 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 7.7 m-30 -107.21 114.72 28.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.41 -0.359 . . . . 0.44 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.811 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 23.8 m95 -94.35 148.24 22.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.189 -0.46 . . . . 0.44 111.044 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.5 tm? -98.48 102.91 14.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.454 0.645 . . . . 0.44 111.463 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.622 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 13.3 t -82.36 145.74 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-N 115.186 -0.916 . . . . 0.44 111.03 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -114.79 -23.56 9.11 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.913 1.079 . . . . 0.44 113.913 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.531 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 8.6 ttt180 -162.59 164.54 26.68 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.369 -0.532 . . . . 0.44 111.507 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.652 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -157.14 124.42 5.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.44 111.248 178.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -75.19 146.25 41.4 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.29 -0.414 . . . . 0.44 111.116 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.65 -130.44 48.32 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.887 -0.673 . . . . 0.44 112.574 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.484 ' O ' HG12 ' A' ' 60' ' ' ILE . 44.3 mt-10 -121.52 141.43 33.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 110.62 -0.141 . . . . 0.44 110.62 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -75.63 131.52 13.67 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.827 2.351 . . . . 0.44 111.143 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.547 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 41.0 p-90 -133.49 -65.76 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.963 0.727 . . . . 0.44 112.963 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.562 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.23 -96.8 0.01 OUTLIER Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.843 -0.694 . . . . 0.44 112.876 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.404 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER 173.36 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.645 0.26 . . . . 0.44 111.341 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' CG ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -56.06 -43.99 78.46 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.804 0.335 . . . . 0.44 110.866 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.49 -82.88 0.25 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.67 -0.776 . . . . 0.44 112.717 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 111.54 48.7 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.917 0.389 . . . . 0.44 111.389 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -43.42 146.21 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.003 2.469 . . . . 0.44 112.625 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.21 177.19 16.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.697 -0.763 . . . . 0.44 112.808 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -139.21 157.28 46.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.438 -0.208 . . . . 0.44 110.438 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -60.33 106.57 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.92 0.39 . . . . 0.44 110.086 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.3 mtm -120.09 163.37 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.44 111.159 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.97 114.87 23.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 0.44 110.409 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -18.71 63.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.44 111.529 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.42 -14.82 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.548 -0.296 . . . . 0.44 111.673 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.98 53.52 0.7 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.84 -0.695 . . . . 0.44 112.154 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.439 HD13 ' CZ ' ' A' ' 35' ' ' PHE . 4.7 tt -62.4 150.59 39.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.008 0.432 . . . . 0.44 110.948 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -95.35 93.47 7.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.018 -0.537 . . . . 0.44 112.439 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.29 -20.71 61.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.167 -0.47 . . . . 0.44 110.014 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -45.22 20.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.955 -0.566 . . . . 0.44 111.128 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.79 -39.98 87.96 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.08 -0.509 . . . . 0.44 111.369 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.543 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.44 173.99 6.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.565 -0.531 . . . . 0.44 109.565 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.08 127.8 27.19 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.918 1.745 . . . . 0.44 112.607 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 52.1 Cg_endo -69.15 -35.16 15.0 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.752 2.301 . . . . 0.44 112.353 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.9 -9.63 58.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.074 0.464 . . . . 0.44 111.168 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -105.76 17.62 23.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.695 -0.684 . . . . 0.44 110.949 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.0 -31.05 0.96 Allowed Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 113.472 0.916 . . . . 0.44 113.472 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 80.0 Cg_exo -43.55 -34.28 5.13 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.877 1.718 . . . . 0.44 113.064 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.456 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 16.0 t -77.96 -47.28 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.275 0.56 . . . . 0.44 110.253 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.431 HG22 ' HB2' ' A' ' 127' ' ' LYS . 35.6 mm -68.9 -31.28 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.244 -0.889 . . . . 0.44 111.413 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.05 -26.88 40.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.936 0.398 . . . . 0.44 110.344 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -47.71 14.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.898 -0.592 . . . . 0.44 111.345 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.467 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 2.4 tm? -78.18 -45.95 21.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.44 111.329 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.8 tttm -52.68 -42.27 64.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.44 111.127 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -63.93 -8.07 10.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.44 109.971 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-N 116.093 -0.503 . . . . 0.44 111.337 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.849 0.357 . . . . 0.44 110.93 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.05 132.04 27.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.44 110.856 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.14 127.14 14.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.44 111.376 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -102.65 154.48 19.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.062 0.458 . . . . 0.44 111.46 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 1.8 mp -146.42 119.12 2.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.545 -0.752 . . . . 0.44 110.835 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.631 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.93 125.69 44.33 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.213 -0.662 . . . . 0.44 109.213 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.1 m -134.76 162.44 38.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.312 0.577 . . . . 0.44 112.041 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.7 111.12 0.9 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.043 -0.981 . . . . 0.44 111.277 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -70.47 103.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.765 -0.457 . . . . 0.44 109.765 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.477 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -71.41 125.76 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.086 -0.506 . . . . 0.44 112.23 -178.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -100.47 139.32 36.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.596 -0.729 . . . . 0.44 111.123 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.659 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.9 p-10 -98.74 -173.37 2.51 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.523 0.678 . . . . 0.44 112.234 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.49 -3.96 13.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.779 -1.101 . . . . 0.44 113.869 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 58.1 t30 -120.11 37.54 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.112 0.412 . . . . 0.44 112.112 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.97 15.94 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 0.44 111.579 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 15' ' ' ASN . 1.2 mm-40 -102.02 161.2 13.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.891 -0.781 . . . . 0.44 108.891 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -120.47 131.26 73.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.164 0.506 . . . . 0.44 111.801 -178.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -83.09 116.51 22.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.44 110.717 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.437 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -129.27 147.22 33.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.44 110.556 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.2 p -70.78 111.91 6.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.465 -0.334 . . . . 0.44 110.263 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.44 110.841 -179.658 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.5 t-20 . . . . . 0 CA--C 1.529 0.173 0 N-CA-C 111.746 0.276 . . . . 0.44 111.746 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 26.09 10.53 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.757 0.313 . . . . 0.44 111.777 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.6 tt -67.19 66.17 0.07 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.132 -0.486 . . . . 0.44 111.044 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.86 -170.17 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.408 . . . . 0.44 111.223 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.47 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.21 168.33 10.15 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.02 -0.536 . . . . 0.44 111.541 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.555 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 97.0 Cg_endo -84.12 166.55 12.74 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.433 2.755 . . . . 0.44 113.001 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.01 -6.08 53.75 Favored Glycine 0 C--O 1.225 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.44 114.096 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.79 167.45 15.45 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.038 -0.601 . . . . 0.44 112.509 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.468 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.67 1.5 1.21 Allowed 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.448 0.299 . . . . 0.44 111.795 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.631 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.2 pt -52.8 -27.06 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.495 0.665 . . . . 0.44 110.433 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -40.21 -61.44 0.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.596 -1.184 . . . . 0.44 111.025 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.509 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 11.07 -81.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.907 0.754 . . . . 0.44 112.467 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.0 32.33 0.09 OUTLIER Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.7 -0.762 . . . . 0.44 112.862 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.459 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.1 mp0 -93.48 -172.94 3.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.653 0.263 . . . . 0.44 111.191 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.519 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -101.59 153.64 37.76 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.391 -0.368 . . . . 0.44 110.323 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.98 -24.82 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.809 2.339 . . . . 0.44 112.615 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.93 -43.68 5.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.996 0.369 . . . . 0.44 111.996 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -80.09 -20.84 44.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.714 0.292 . . . . 0.44 111.644 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.459 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -56.38 -48.48 76.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.814 0.34 . . . . 0.44 111.036 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.521 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -78.29 -47.87 23.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.168 -0.469 . . . . 0.44 110.964 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.521 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 40.3 t -59.66 -44.11 92.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.759 -0.655 . . . . 0.44 111.59 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 mtp-105 -73.25 -41.15 64.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.44 110.821 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 57' ' ' GLU . 4.6 tp10 -73.5 -19.73 60.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.952 -0.567 . . . . 0.44 110.819 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 5.9 tp -60.04 -44.65 94.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.733 0.301 . . . . 0.44 110.962 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.69 -36.19 82.92 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.416 -0.587 . . . . 0.44 109.416 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.38 -24.66 50.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.44 110.911 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 12.0 mm-40 -108.26 5.75 25.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.649 -0.421 . . . . 0.44 112.03 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.614 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 60.1 t -134.16 -44.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.497 -0.557 . . . . 0.44 109.497 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.543 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.48 -40.04 0.28 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.332 -0.849 . . . . 0.44 114.091 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.517 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.74 -177.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.132 0.492 . . . . 0.44 111.217 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.82 88.71 14.57 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.44 109.914 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.621 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.1 Cg_endo -111.49 145.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.415 2.744 . . . . 0.44 114.207 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.6 mt-30 -74.92 79.93 2.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.693 -1.965 . . . . 0.44 105.693 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.564 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.34 129.56 53.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.094 -1.412 . . . . 0.44 110.389 -176.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 66' ' ' SER . 2.0 t80 179.91 166.02 1.21 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.102 0.408 . . . . 0.44 112.102 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.531 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 50.9 m 82.92 152.18 0.1 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.488 -0.778 . . . . 0.44 110.407 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.3 pp -107.66 134.68 50.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 0.44 111.973 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -81.94 -44.89 16.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.214 -0.662 . . . . 0.44 109.214 178.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -171.93 131.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.458 -0.792 . . . . 0.44 110.098 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.425 ' HE3' ' CZ3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -135.79 103.88 5.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.691 0.281 . . . . 0.44 110.733 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.414 HD11 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.66 169.37 8.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.104 0.478 . . . . 0.44 111.467 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -137.84 124.89 21.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.925 -0.58 . . . . 0.44 110.443 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -138.11 120.06 15.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 0.44 110.796 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.7 139.35 31.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.44 111.423 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 2.2 m-85 -103.94 162.47 19.82 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.44 110.218 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.9 Cg_endo -54.18 82.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.95 2.433 . . . . 0.44 112.117 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.7 t70 94.84 7.07 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.482 -0.781 . . . . 0.44 111.543 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -137.26 93.72 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.44 110.592 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 11.5 t-160 -85.69 99.36 11.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.762 0.315 . . . . 0.44 110.871 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 4.2 tt -103.04 135.5 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.981 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 118.78 31.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.841 -0.618 . . . . 0.44 109.356 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.406 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.1 mp -113.08 114.06 26.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.897 0.379 . . . . 0.44 111.727 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 9.7 m0 -111.6 122.04 46.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.032 -0.531 . . . . 0.44 109.743 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.524 ' CD1' HG11 ' A' ' 122' ' ' VAL . 1.7 m-85 -109.68 109.94 20.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.179 -0.464 . . . . 0.44 110.469 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.665 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 19.8 m95 -95.91 148.79 22.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.808 -0.633 . . . . 0.44 111.76 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.4 pp -95.69 138.77 32.89 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.162 0.506 . . . . 0.44 111.709 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 64' ' ' HIS . 38.4 t -123.33 145.66 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.44 110.368 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -113.82 -21.63 10.58 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.396 1.258 . . . . 0.44 114.396 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.536 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.92 160.16 24.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.707 0.685 . . . . 0.44 111.473 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.659 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -157.06 122.61 4.69 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.153 -0.476 . . . . 0.44 111.254 179.022 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -75.82 150.69 37.64 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.176 -0.465 . . . . 0.44 111.138 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.48 -129.92 47.21 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.873 -0.68 . . . . 0.44 112.526 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -125.21 145.8 51.86 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.507 0.194 . . . . 0.44 110.653 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.472 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.48 128.74 10.53 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.761 2.307 . . . . 0.44 111.573 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.543 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -132.34 -59.91 0.91 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.511 -0.476 . . . . 0.44 111.838 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 36.77 -97.89 0.01 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.093 -0.575 . . . . 0.44 113.195 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tttp 178.43 38.8 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.7 0.285 . . . . 0.44 111.153 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -60.51 -49.05 79.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.44 111.263 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 143.28 -49.83 0.71 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.262 -0.97 . . . . 0.44 113.345 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.77 118.98 16.86 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.124 0.488 . . . . 0.44 111.966 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -43.79 146.37 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.211 2.608 . . . . 0.44 112.807 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.97 177.23 17.45 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.723 -0.751 . . . . 0.44 113.092 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 105' ' ' MET . 1.6 mt-10 -137.43 157.79 45.82 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.306 0.242 . . . . 0.44 110.383 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -65.0 106.39 1.24 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.75 0.31 . . . . 0.44 110.259 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -120.0 157.14 29.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.298 -0.41 . . . . 0.44 110.796 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -75.63 114.93 14.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.369 -0.378 . . . . 0.44 110.666 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 2.5 tm? -75.38 -18.77 59.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.357 -0.383 . . . . 0.44 111.503 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.9 p -59.16 -12.58 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.44 111.737 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.79 54.3 0.62 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.71 -0.757 . . . . 0.44 112.367 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.0 150.36 38.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.595 0.236 . . . . 0.44 110.554 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 115.88 30.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.929 0.715 . . . . 0.44 112.929 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.535 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -18.9 61.73 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.571 -0.74 . . . . 0.44 110.012 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -79.09 -47.83 15.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.514 . . . . 0.44 110.881 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -66.86 -17.39 64.87 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.005 -0.543 . . . . 0.44 111.645 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.535 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.45 173.67 3.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.44 109.417 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.17 127.92 27.78 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 121.938 1.759 . . . . 0.44 112.405 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.0 Cg_endo -69.04 -38.32 9.56 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.756 2.304 . . . . 0.44 112.664 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.94 -9.72 56.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.977 0.418 . . . . 0.44 111.308 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . 0.448 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 29.2 m-20 -104.42 15.3 28.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.79 -0.641 . . . . 0.44 110.922 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -63.32 -31.59 7.01 Favored Pre-proline 0 N--CA 1.467 0.381 0 N-CA-C 114.121 1.156 . . . . 0.44 114.121 -178.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 71.3 Cg_exo -43.78 -40.38 11.13 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.793 1.662 . . . . 0.44 113.54 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.524 HG11 ' CD1' ' A' ' 84' ' ' PHE . 74.6 t -78.0 -51.55 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.44 111.379 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.509 HG13 ' CE2' ' A' ' 115' ' ' PHE . 38.7 mm -66.13 -31.88 55.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.035 -0.53 . . . . 0.44 111.595 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.86 -32.33 60.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.862 0.363 . . . . 0.44 110.676 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -80.44 -46.16 16.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.096 -0.502 . . . . 0.44 111.52 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.461 ' CD1' ' CE2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -78.34 -19.77 52.78 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.44 111.399 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 123' ' ' ILE . 22.2 tttm -74.31 -42.45 59.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.128 0.489 . . . . 0.44 110.593 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -68.29 -8.95 44.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.746 . . . . 0.44 109.936 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.15 0 CA-C-N 116.228 -0.442 . . . . 0.44 110.621 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.873 0.368 . . . . 0.44 110.977 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.35 131.23 26.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.91 -0.586 . . . . 0.44 110.489 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.4 pp -146.15 140.55 26.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.908 0.385 . . . . 0.44 111.661 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -104.67 152.86 21.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.213 0.53 . . . . 0.44 111.255 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.423 ' N ' ' O ' ' A' ' 81' ' ' THR . 4.4 mp -146.18 116.36 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.534 -0.757 . . . . 0.44 110.51 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.63 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -125.33 133.07 52.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.826 -0.435 . . . . 0.44 109.826 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.622 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.3 m -144.61 162.73 14.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.013 0.435 . . . . 0.44 111.773 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.22 115.15 1.08 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.613 -0.721 . . . . 0.44 111.855 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.458 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.28 107.25 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 110.027 -0.36 . . . . 0.44 110.027 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.476 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -71.16 127.29 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.93 0.395 . . . . 0.44 111.132 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.08 123.45 33.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.763 -0.653 . . . . 0.44 111.622 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 12.3 t-20 -78.28 -172.16 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.795 -1.093 . . . . 0.44 112.117 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.428 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 14.9 tt0 -82.18 -3.1 54.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.106 -1.406 . . . . 0.44 112.271 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -129.96 36.37 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.901 0.334 . . . . 0.44 111.901 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.64 7.59 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.526 -0.307 . . . . 0.44 111.743 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' ASN . 17.8 pt-20 -100.85 153.05 19.81 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 108.931 -0.766 . . . . 0.44 108.931 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 4.8 mt -115.89 140.56 37.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.17 0.509 . . . . 0.44 111.994 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' C ' ' CD1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -89.26 102.14 14.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.437 -0.801 . . . . 0.44 110.436 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.438 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -115.29 162.13 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.44 110.263 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 p -71.07 121.2 17.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.786 0.327 . . . . 0.44 110.759 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.44 110.807 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.574 0.226 . . . . 0.44 111.28 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.43 25.98 10.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 0.44 111.799 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.455 ' CB ' ' HB3' ' A' ' 114' ' ' ASP . 22.1 tp -76.36 78.79 3.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.272 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.52 -166.63 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.44 111.52 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.52 168.36 10.26 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.808 -0.633 . . . . 0.44 111.157 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.622 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 71.7 Cg_endo -77.5 166.9 25.19 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.238 2.625 . . . . 0.44 112.903 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.506 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.31 -5.58 52.46 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.71 -0.677 . . . . 0.44 114.242 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.51 156.44 42.64 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 117.176 0.488 . . . . 0.44 112.844 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.75 -1.06 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.034 0.534 . . . . 0.44 111.875 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.63 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.2 pt -53.37 -26.01 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.375 0.607 . . . . 0.44 110.929 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -40.99 -62.85 0.75 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.931 -1.031 . . . . 0.44 110.913 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.495 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.2 mtm 12.24 -83.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.527 -0.761 . . . . 0.44 112.562 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.59 31.68 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.44 112.816 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.13 -169.4 2.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.671 0.272 . . . . 0.44 111.043 -179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.62 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -113.62 164.69 15.21 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.477 -0.329 . . . . 0.44 110.451 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.62 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 6.7 Cg_endo -47.63 -24.62 4.71 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.017 2.478 . . . . 0.44 112.72 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.99 -55.24 3.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.519 0.562 . . . . 0.44 112.519 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -80.55 -4.61 54.62 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.428 0.529 . . . . 0.44 112.428 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -62.73 -58.02 8.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.734 -0.386 . . . . 0.44 110.811 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -79.5 -45.53 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.44 111.332 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.469 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 48.0 t -53.46 -39.75 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.44 111.724 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -78.13 -42.92 30.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.848 0.356 . . . . 0.44 111.231 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.416 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.3 mm-40 -74.22 -19.84 60.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.12 -0.491 . . . . 0.44 111.049 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.538 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.0 OUTLIER -60.57 -44.83 95.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.594 -0.276 . . . . 0.44 110.48 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -35.81 78.28 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.252 -0.647 . . . . 0.44 109.252 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.76 -28.03 50.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.492 -0.776 . . . . 0.44 111.124 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 33.4 mm-40 -105.34 5.01 31.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.42 0.526 . . . . 0.44 112.42 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 54' ' ' LEU . 4.1 t -134.87 -44.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.537 -0.542 . . . . 0.44 109.537 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.29 -38.94 0.21 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.36 -0.836 . . . . 0.44 114.049 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.487 ' H ' ' C ' ' A' ' 58' ' ' VAL . 22.8 pt -82.02 -176.18 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 120.985 0.422 . . . . 0.44 111.582 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.87 88.41 21.09 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 115.773 -0.649 . . . . 0.44 110.321 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.526 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 12.3 Cg_endo -109.92 153.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.459 2.773 . . . . 0.44 113.833 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ARG . 89.8 mt-30 -74.85 79.93 2.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.209 -1.774 . . . . 0.44 106.209 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.556 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -126.2 127.45 45.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.431 -1.259 . . . . 0.44 110.283 -176.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.9 t80 -177.86 158.85 1.32 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.518 0.562 . . . . 0.44 112.518 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.432 ' HB3' ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 78.01 -168.39 0.05 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.829 -0.623 . . . . 0.44 111.291 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.807 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -144.49 137.57 27.0 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.42 -0.355 . . . . 0.44 111.852 -179.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.673 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 2.5 p90 -76.75 -41.58 44.36 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.348 -0.612 . . . . 0.44 109.348 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . 5.5 mt-10 -171.76 131.45 0.69 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.678 -0.692 . . . . 0.44 109.696 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.49 120.81 42.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.44 111.201 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.486 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -104.68 122.22 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.44 111.026 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -130.68 113.64 14.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 0.44 110.971 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.486 ' CE2' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -141.24 153.38 45.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.44 110.955 179.378 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.1 pt-20 -121.17 127.06 51.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.343 0.592 . . . . 0.44 111.187 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 77' ' ' ASP . 1.0 OUTLIER -96.51 163.43 20.53 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.194 -0.912 . . . . 0.44 110.554 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.0 Cg_endo -53.18 81.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.032 2.488 . . . . 0.44 112.255 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.2 t70 93.4 8.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.534 -0.757 . . . . 0.44 111.532 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.44 93.86 2.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.633 0.254 . . . . 0.44 110.758 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 5.2 t-160 -93.27 95.7 9.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.797 0.332 . . . . 0.44 111.103 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.407 HG21 ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -100.35 111.99 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.44 111.132 179.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -97.26 118.1 32.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.799 -0.815 . . . . 0.44 108.799 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -110.09 113.82 26.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.094 0.473 . . . . 0.44 111.179 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 8.5 m0 -112.5 122.27 47.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.77 -0.65 . . . . 0.44 109.324 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.673 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 3.2 m-85 -116.58 113.16 22.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.013 0.435 . . . . 0.44 110.591 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.807 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.8 m95 -94.58 148.3 22.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.743 -0.662 . . . . 0.44 111.566 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.3 pp -93.97 138.25 32.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.671 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 64' ' ' HIS . 48.8 t -123.26 145.33 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-N 116.329 -0.396 . . . . 0.44 110.546 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -109.51 -28.2 9.03 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.135 1.161 . . . . 0.44 114.135 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.79 165.57 22.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.968 0.804 . . . . 0.44 111.789 -178.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 1.0 OUTLIER -152.93 126.02 8.52 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.317 -0.401 . . . . 0.44 111.145 178.357 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -76.88 146.4 37.69 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.072 -0.513 . . . . 0.44 111.409 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.57 -126.64 32.24 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.996 -0.621 . . . . 0.44 112.811 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.0 tt0 -124.4 126.59 25.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.427 0.156 . . . . 0.44 110.582 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 93' ' ' GLU . 13.7 Cg_exo -72.09 128.62 14.14 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.754 2.303 . . . . 0.44 111.2 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.569 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 17.1 p-90 -114.78 -61.43 1.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.016 0.436 . . . . 0.44 111.415 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.505 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.82 -114.02 1.39 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.745 -0.741 . . . . 0.44 112.904 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.61 74.61 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.927 0.394 . . . . 0.44 110.857 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.44 -29.22 14.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.013 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.2 -103.06 0.45 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.519 -0.848 . . . . 0.44 113.115 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.86 115.53 47.21 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.44 111.612 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -43.66 146.12 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.986 2.457 . . . . 0.44 112.718 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.88 177.69 18.69 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.987 -0.625 . . . . 0.44 112.36 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -133.16 157.26 45.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.607 0.242 . . . . 0.44 110.652 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -63.56 106.72 0.99 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 110.025 -0.361 . . . . 0.44 110.025 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.417 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtm -119.83 163.05 18.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.474 . . . . 0.44 111.032 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.7 p -81.2 114.92 20.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.44 110.855 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.86 -18.66 63.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.208 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.45 -14.29 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.433 -0.349 . . . . 0.44 111.402 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.53 56.76 0.6 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.361 -0.696 . . . . 0.44 111.361 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 tp -61.73 150.25 37.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.854 0.359 . . . . 0.44 110.861 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 2.3 t-20 -97.22 106.9 19.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.828 0.677 . . . . 0.44 112.828 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.518 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -24.16 61.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.823 -0.626 . . . . 0.44 109.957 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -79.17 -47.18 16.5 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.898 -0.592 . . . . 0.44 111.271 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.455 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.79 -14.21 62.37 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.126 -0.488 . . . . 0.44 111.869 -179.125 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -113.64 173.43 2.87 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.134 -0.691 . . . . 0.44 109.134 178.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.46 127.86 27.72 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 121.837 1.691 . . . . 0.44 111.974 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.97 -38.89 8.85 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.681 2.254 . . . . 0.44 112.613 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.41 -9.6 54.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.945 0.402 . . . . 0.44 111.572 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -103.54 19.96 18.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.44 110.871 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.59 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -70.45 -32.03 2.49 Favored Pre-proline 0 N--CA 1.466 0.349 0 N-CA-C 113.233 0.827 . . . . 0.44 113.233 -179.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.2 Cg_exo -44.31 -34.27 7.01 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 121.971 1.781 . . . . 0.44 112.899 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 24.5 t -77.59 -51.48 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.066 0.46 . . . . 0.44 110.977 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.518 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 12.9 mm -61.67 -38.98 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.649 . . . . 0.44 111.885 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.56 -29.6 51.65 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.587 -0.445 . . . . 0.44 110.684 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -80.69 -52.22 7.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.44 111.631 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.434 HD22 ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -74.82 -43.06 56.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.44 111.405 -179.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 40.9 tttt -52.05 -42.61 63.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 0.44 111.128 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -64.49 -9.48 19.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.737 -0.665 . . . . 0.44 109.963 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-N 116.082 -0.508 . . . . 0.44 110.815 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.784 0.326 . . . . 0.44 110.886 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.43 144.12 32.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.44 110.901 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.407 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.0 pp -146.07 137.72 24.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.44 111.075 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -106.2 152.86 22.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.229 0.537 . . . . 0.44 111.852 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.407 ' CD1' ' CD1' ' A' ' 4' ' ' LEU . 5.3 mp -146.75 129.79 8.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.414 -0.812 . . . . 0.44 110.866 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.536 ' HB3' ' CG1' ' A' ' 40' ' ' ILE . . . -125.04 125.18 43.43 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.082 -0.71 . . . . 0.44 109.082 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -144.52 162.03 14.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.812 -0.755 . . . . 0.44 111.91 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.422 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.03 143.06 10.11 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.435 -0.802 . . . . 0.44 111.741 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.597 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -92.7 111.57 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.819 -0.437 . . . . 0.44 109.819 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.584 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -71.1 113.45 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-O 121.283 0.563 . . . . 0.44 110.64 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.729 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.19 126.9 32.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.187 -0.915 . . . . 0.44 111.422 -178.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.538 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -83.91 -172.51 4.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.992 -1.004 . . . . 0.44 111.951 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.48 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 16.8 tp10 -78.89 -4.78 51.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.317 -1.31 . . . . 0.44 112.603 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -127.91 44.47 2.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.787 0.327 . . . . 0.44 111.613 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.03 19.58 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.358 -0.383 . . . . 0.44 111.539 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 10.0 pt-20 -114.77 142.76 46.09 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.497 -0.557 . . . . 0.44 109.497 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 19' ' ' PHE . 11.3 mt -109.92 144.1 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.298 0.571 . . . . 0.44 112.213 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.508 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 11.2 t80 -88.86 93.69 9.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.316 -0.856 . . . . 0.44 109.897 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.446 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.47 149.39 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.373 . . . . 0.44 110.536 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 3.1 p -70.93 111.87 6.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.378 -0.374 . . . . 0.44 110.506 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 21.9 ptt-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.429 -0.351 . . . . 0.44 110.818 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 111.665 0.246 . . . . 0.44 111.665 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.08 26.09 10.59 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.881 0.372 . . . . 0.44 111.55 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 21' ' ' THR . 5.1 tt -61.64 79.26 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.895 -0.593 . . . . 0.44 110.647 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -123.43 -173.23 2.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.112 0.482 . . . . 0.44 111.973 -179.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.45 168.21 10.54 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.635 -0.711 . . . . 0.44 111.634 -179.08 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 68.7 Cg_endo -74.87 167.09 27.85 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.465 2.777 . . . . 0.44 113.043 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.583 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 101.85 -5.51 53.76 Favored Glycine 0 C--O 1.222 -0.656 0 CA-C-N 115.87 -0.605 . . . . 0.44 114.155 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -62.21 145.65 49.4 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.989 -0.624 . . . . 0.44 112.941 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 92.06 2.01 0.11 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.065 0.765 . . . . 0.44 113.065 178.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.583 ' CG2' ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -51.41 -28.86 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.44 110.572 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.576 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.55 -60.8 1.6 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.47 -1.241 . . . . 0.44 111.143 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.513 ' C ' ' O ' ' A' ' 41' ' ' GLU . 8.9 mmm 10.28 -81.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.848 0.718 . . . . 0.44 112.633 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.43 27.98 0.13 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.551 -0.833 . . . . 0.44 113.083 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -103.97 -173.45 2.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.695 0.283 . . . . 0.44 110.999 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.535 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -108.85 155.91 39.92 Favored Pre-proline 0 N--CA 1.456 -0.159 0 N-CA-C 110.037 -0.356 . . . . 0.44 110.037 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.49 -24.5 0.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.674 2.249 . . . . 0.44 112.406 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -86.83 -60.27 2.03 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.276 0.472 . . . . 0.44 112.276 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -80.67 -21.62 41.2 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.198 0.444 . . . . 0.44 112.198 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -56.81 -48.77 77.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.675 0.274 . . . . 0.44 110.97 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.447 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.35 -50.72 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.424 -0.353 . . . . 0.44 110.754 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.9 t -51.14 -35.66 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.44 110.773 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -48.71 15.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.019 -0.537 . . . . 0.44 110.537 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.7 mm-40 -65.77 -19.77 66.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.2 -0.455 . . . . 0.44 110.669 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.463 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -58.43 -44.8 89.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.939 0.4 . . . . 0.44 110.774 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -30.96 67.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.13 0.491 . . . . 0.44 109.989 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -77.36 -32.61 55.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.588 -0.733 . . . . 0.44 111.523 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.495 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.16 5.9 26.3 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.786 0.661 . . . . 0.44 112.786 -178.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.684 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 12.5 t -133.91 -43.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.44 110.48 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.537 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 65.78 -33.12 0.14 Allowed Glycine 0 C--N 1.33 0.244 0 N-CA-C 114.655 0.622 . . . . 0.44 114.655 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.706 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 20.0 tt -77.6 165.62 2.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.584 0.231 . . . . 0.44 110.776 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.425 ' N ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -105.19 88.26 2.41 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 108.58 -0.896 . . . . 0.44 108.58 178.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 12.0 Cg_endo -114.36 150.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 123.568 2.846 . . . . 0.44 114.39 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -74.69 79.93 2.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.19 -2.152 . . . . 0.44 105.19 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.591 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.52 129.4 49.66 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.601 -1.181 . . . . 0.44 111.724 -175.539 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.546 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -177.85 -138.57 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.852 -0.613 . . . . 0.44 110.779 -179.148 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 85' ' ' TRP . 0.5 OUTLIER 51.01 173.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.823 0.449 . . . . 0.44 111.719 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.773 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -131.88 125.82 32.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.115 0.484 . . . . 0.44 111.101 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -78.59 -55.87 4.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.787 -0.642 . . . . 0.44 110.022 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.688 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -172.27 131.7 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.44 110.328 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HE3' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -114.19 118.71 34.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.712 0.291 . . . . 0.44 110.688 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.451 ' CD2' ' CD1' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -107.7 129.68 55.0 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.967 0.413 . . . . 0.44 111.047 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -115.92 110.05 18.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.035 -0.529 . . . . 0.44 110.176 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.451 ' CD1' ' CD2' ' A' ' 71' ' ' LEU . 2.8 p90 -136.33 143.64 44.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.44 111.052 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -121.27 118.18 28.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.808 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 2.6 m-85 -69.91 163.01 64.5 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.44 110.633 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.69 83.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.187 2.591 . . . . 0.44 112.239 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 17.4 t0 97.14 14.39 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.358 -0.837 . . . . 0.44 111.108 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.482 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -137.39 149.18 46.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.308 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -131.49 112.84 13.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.767 0.318 . . . . 0.44 110.658 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.1 tt -120.65 112.0 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.329 -0.396 . . . . 0.44 111.352 -179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.51 118.89 32.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.408 -0.59 . . . . 0.44 109.408 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -119.86 114.55 22.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.978 0.418 . . . . 0.44 111.913 -178.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.421 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.4 m0 -108.84 122.33 46.96 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.851 -0.613 . . . . 0.44 110.119 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.688 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.9 m-85 -106.91 118.18 36.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.44 110.755 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.773 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 68.1 m95 -94.75 148.27 22.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.44 111.223 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.546 ' O ' ' O ' ' A' ' 65' ' ' PHE . 44.0 tp -99.03 102.98 14.88 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 121.449 0.642 . . . . 0.44 110.854 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 7.4 t -86.13 145.68 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-N 114.892 -1.049 . . . . 0.44 112.277 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -100.7 -52.25 3.38 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.123 1.157 . . . . 0.44 114.123 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.729 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.21 165.65 24.15 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.479 0.582 . . . . 0.44 112.463 -178.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.66 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 33.0 p90 -129.73 160.14 34.31 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.988 -0.551 . . . . 0.44 111.319 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.402 ' O ' ' CD1' ' A' ' 60' ' ' ILE . 0.5 OUTLIER -100.83 93.35 5.49 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.868 0.366 . . . . 0.44 111.422 -179.146 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' ' NE1' ' A' ' 90' ' ' TRP . . . 100.31 -110.24 3.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.559 -0.829 . . . . 0.44 112.011 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.9 tt0 -135.3 127.03 17.71 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.447 0.165 . . . . 0.44 111.075 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.7 Cg_exo -75.4 153.13 39.67 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.704 2.269 . . . . 0.44 110.888 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.537 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 19.0 p-90 -150.27 -62.81 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.672 0.619 . . . . 0.44 112.672 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.684 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.39 -99.91 0.02 OUTLIER Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.602 -0.726 . . . . 0.44 112.948 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.7 32.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.807 0.337 . . . . 0.44 111.164 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HA ' ' CG ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -63.52 -21.99 66.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.314 -0.403 . . . . 0.44 111.187 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.45 -123.1 2.81 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.484 -0.865 . . . . 0.44 113.098 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.9 132.52 74.23 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.159 0.504 . . . . 0.44 111.702 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -43.39 146.26 1.26 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.105 2.536 . . . . 0.44 112.646 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.12 177.65 16.43 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.895 -0.669 . . . . 0.44 112.828 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.09 157.03 46.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.25 -0.278 . . . . 0.44 110.25 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.6 OUTLIER -66.21 106.29 1.63 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.878 -0.415 . . . . 0.44 109.878 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -120.31 163.19 18.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.929 -0.578 . . . . 0.44 111.22 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.7 p -82.37 114.83 21.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.481 -0.327 . . . . 0.44 110.473 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -18.68 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.44 111.43 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.22 -10.8 2.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.804 0.335 . . . . 0.44 111.438 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.76 55.1 0.72 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.126 -0.79 . . . . 0.44 111.126 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.5 tp -61.43 150.2 36.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.407 -0.397 . . . . 0.44 110.828 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.18 95.61 6.09 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.025 0.75 . . . . 0.44 113.025 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.494 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.51 -18.76 61.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.942 -0.572 . . . . 0.44 109.874 177.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -79.06 -47.11 16.76 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.9 -0.591 . . . . 0.44 111.365 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -39.25 87.99 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.244 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.39 174.43 6.04 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.524 -0.546 . . . . 0.44 109.524 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.4 Cg_endo -53.89 127.69 26.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.859 1.706 . . . . 0.44 112.497 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.8 Cg_endo -69.11 -34.93 15.59 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.753 2.302 . . . . 0.44 112.465 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.37 -9.57 58.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.008 0.433 . . . . 0.44 111.125 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -106.79 18.64 21.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.772 -0.649 . . . . 0.44 110.852 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 tt0 -70.38 -31.37 2.22 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 113.864 1.061 . . . . 0.44 113.864 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.5 Cg_exo -43.7 -36.08 7.14 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.83 1.687 . . . . 0.44 113.395 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.434 HG12 ' CE1' ' A' ' 84' ' ' PHE . 59.3 t -78.04 -51.31 18.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.44 111.903 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 3.9 mm -77.08 -39.78 29.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 112.936 0.717 . . . . 0.44 112.936 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.8 -26.88 26.08 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.821 0.304 . . . . 0.44 111.821 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.48 -53.9 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.954 0.353 . . . . 0.44 111.954 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.477 ' HG ' ' CE2' ' A' ' 68' ' ' PHE . 1.4 mm? -79.26 -30.3 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.665 0.269 . . . . 0.44 111.564 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 9.7 ttpt -54.03 -42.13 68.8 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.135 0.493 . . . . 0.44 110.338 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -67.46 -6.11 17.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 0.44 109.815 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-N 115.94 -0.573 . . . . 0.44 111.03 179.774 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 tttm . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.825 0.345 . . . . 0.44 110.956 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.17 128.27 22.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.44 110.777 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.0 pp -146.33 142.64 28.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.44 111.544 -179.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -102.88 153.58 20.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.139 -0.482 . . . . 0.44 111.34 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.499 ' CD1' HD13 ' A' ' 80' ' ' ILE . 40.5 mt -146.33 116.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.72 -0.673 . . . . 0.44 110.959 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -125.55 144.25 50.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.721 -0.474 . . . . 0.44 109.721 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -145.76 162.44 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.041 -0.664 . . . . 0.44 111.931 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.68 108.04 0.51 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.383 -0.826 . . . . 0.44 111.698 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.568 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.73 108.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.639 -0.504 . . . . 0.44 109.639 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.481 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -71.72 121.96 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.92 0.391 . . . . 0.44 111.443 -179.004 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -84.86 121.93 28.43 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.03 -0.532 . . . . 0.44 111.093 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.562 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -79.63 -171.67 2.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.731 0.777 . . . . 0.44 111.68 179.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.438 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 1.6 tm-20 -82.0 15.53 2.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.343 -1.299 . . . . 0.44 113.105 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -144.76 43.97 1.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.189 0.44 . . . . 0.44 112.189 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 54.13 17.82 1.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.016 0.376 . . . . 0.44 112.016 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 105' ' ' MET . 2.3 mt-10 -116.81 160.68 20.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.069 -0.715 . . . . 0.44 109.069 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.421 HG21 ' CB ' ' A' ' 10' ' ' ILE . 5.9 mt -121.33 139.7 47.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.201 0.524 . . . . 0.44 111.458 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PHE . . . . . 0.564 ' C ' ' CD1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -88.49 98.57 11.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.598 -0.728 . . . . 0.44 110.87 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.79 162.46 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.334 -0.848 . . . . 0.44 108.741 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.0 p -70.58 145.72 50.57 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.615 -0.434 . . . . 0.44 110.669 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.6 ttt-85 . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 0.44 111.068 -179.684 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 10.9 t-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.706 0.288 . . . . 0.44 111.403 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 26.26 10.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.908 0.385 . . . . 0.44 111.934 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.1 tt -68.97 67.22 0.15 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 0.44 110.67 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.53 -167.77 1.3 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.211 -0.45 . . . . 0.44 111.343 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.434 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.36 168.06 10.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.001 -0.545 . . . . 0.44 111.44 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.456 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 84.2 Cg_endo -84.19 166.76 12.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.398 2.732 . . . . 0.44 113.224 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 7' ' ' ALA . . . 101.28 -5.7 55.58 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.509 -0.769 . . . . 0.44 113.751 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -67.59 166.93 41.87 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.564 -0.351 . . . . 0.44 113.254 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.445 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.74 1.58 1.19 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.661 0.384 . . . . 0.44 111.871 179.575 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.599 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 3.4 pt -50.84 -28.6 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.516 0.674 . . . . 0.44 110.562 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.521 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -40.07 -63.43 0.61 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.496 -1.229 . . . . 0.44 110.878 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.521 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 11.15 -84.0 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.895 0.747 . . . . 0.44 112.625 179.368 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.74 29.26 0.08 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.659 -0.782 . . . . 0.44 112.913 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -168.23 1.98 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.734 0.302 . . . . 0.44 110.971 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.514 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -101.49 153.1 38.07 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.315 -0.402 . . . . 0.44 110.28 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.86 -25.17 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.852 2.368 . . . . 0.44 112.49 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -103.99 -41.27 5.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.392 -0.367 . . . . 0.44 111.482 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 20.3 mt-30 -80.27 -5.71 56.68 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.755 0.28 . . . . 0.44 111.755 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . . . -60.1 -55.25 36.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.329 . . . . 0.44 110.836 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 2.0 m -78.33 -46.7 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.466 . . . . 0.44 111.305 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 27.8 t -55.13 -36.91 41.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.959 -0.564 . . . . 0.44 111.342 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 4.3 mmp_? -78.19 -52.03 9.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.874 0.368 . . . . 0.44 110.616 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.28 -21.88 62.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.44 110.672 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.461 HD23 ' CG ' ' A' ' 64' ' ' HIS . 1.4 tp -60.29 -45.05 94.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.44 111.024 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -30.58 71.42 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.535 -0.543 . . . . 0.44 109.535 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.5 -27.85 51.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.324 -0.853 . . . . 0.44 111.419 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.546 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.64 6.97 26.34 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 113.028 0.751 . . . . 0.44 113.028 -178.447 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.466 ' CG1' HG13 ' A' ' 60' ' ' ILE . 12.4 t -133.38 -44.3 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.049 0.452 . . . . 0.44 110.545 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . 0.604 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 54.52 13.89 4.47 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 114.781 0.673 . . . . 0.44 114.781 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -127.08 -167.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 118.002 0.901 . . . . 0.44 110.796 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . 0.455 HG21 ' CB ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -111.13 88.65 8.77 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.44 110.535 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 25.2 Cg_endo -113.69 137.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 123.733 2.956 . . . . 0.44 114.413 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 33.6 mt-30 -74.83 79.23 2.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 104.788 -2.301 . . . . 0.44 104.788 175.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.531 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -117.9 130.61 56.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.587 -1.642 . . . . 0.44 109.873 -176.285 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 66' ' ' SER . 2.3 t80 -176.43 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 113.18 0.807 . . . . 0.44 113.18 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 86' ' ' LEU . 65.8 m -33.57 157.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.092 -0.958 . . . . 0.44 112.035 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tt -117.54 123.21 45.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.38 . . . . 0.44 110.95 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -82.36 -56.31 3.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.272 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.3 tt0 -171.66 159.22 5.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.779 -0.646 . . . . 0.44 110.429 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.1 108.44 5.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.756 0.312 . . . . 0.44 110.691 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.419 HD23 ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -96.81 146.23 25.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.393 -0.367 . . . . 0.44 110.674 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -138.96 109.89 6.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.44 110.763 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.419 ' CD1' HD23 ' A' ' 71' ' ' LEU . 2.4 p90 -141.17 153.01 45.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.44 110.677 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 4.2 pt-20 -121.25 133.81 55.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.158 0.504 . . . . 0.44 111.251 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.452 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -97.12 163.15 20.58 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 0.44 110.27 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.4 Cg_endo -54.99 81.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.82 2.346 . . . . 0.44 112.181 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.3 t70 96.25 6.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.373 -0.831 . . . . 0.44 111.647 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -137.38 93.95 2.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.677 0.275 . . . . 0.44 110.908 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -88.84 104.7 17.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.834 0.349 . . . . 0.44 110.487 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.499 HD13 ' CD1' ' A' ' 6' ' ' ILE . 2.2 tt -110.25 130.87 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.44 111.292 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.14 118.59 37.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.194 -0.669 . . . . 0.44 109.194 178.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.474 ' CD1' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -108.62 114.19 27.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.033 0.444 . . . . 0.44 111.862 -178.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TRP . . . . . 0.412 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 9.2 m0 -114.32 122.42 46.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.759 -0.655 . . . . 0.44 109.906 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.475 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 8.9 m-30 -114.05 116.94 29.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.87 -0.605 . . . . 0.44 110.762 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.405 ' NE1' HG11 ' A' ' 50' ' ' VAL . 20.0 m95 -106.64 148.34 28.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.952 -0.567 . . . . 0.44 111.83 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 66' ' ' SER . 48.1 tp -93.03 138.55 31.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.543 -0.753 . . . . 0.44 111.441 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 36.5 t -121.4 145.7 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 CA-C-N 115.119 -0.946 . . . . 0.44 110.248 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.77 -15.71 11.86 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.9 1.445 . . . . 0.44 114.9 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -163.33 162.3 25.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.594 1.088 . . . . 0.44 112.353 -179.053 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.6 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -157.66 123.45 4.66 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.143 -0.48 . . . . 0.44 110.882 178.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.455 ' CB ' HG21 ' A' ' 61' ' ' THR . 0.0 OUTLIER -79.55 146.52 32.57 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 120.481 -0.488 . . . . 0.44 110.551 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.0 -120.79 24.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.548 -0.834 . . . . 0.44 112.21 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -135.06 135.06 22.2 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.4 0.143 . . . . 0.44 110.931 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PRO . . . . . 0.534 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.9 Cg_exo -76.41 128.96 10.74 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.017 2.478 . . . . 0.44 111.224 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . 0.604 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 11.6 p-90 -129.72 -61.35 1.01 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.118 0.485 . . . . 0.44 111.733 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.546 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 40.68 -95.52 0.01 OUTLIER Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.093 -0.958 . . . . 0.44 113.101 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 168.24 69.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.909 0.385 . . . . 0.44 110.71 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -95.06 -38.65 10.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.696 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.18 -125.55 1.46 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.769 . . . . 0.44 112.732 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -78.59 126.51 82.67 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.44 111.414 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -43.43 144.08 2.14 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.006 2.47 . . . . 0.44 112.797 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.09 177.53 19.06 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.078 -0.582 . . . . 0.44 112.295 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -124.12 157.46 34.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.499 0.19 . . . . 0.44 110.823 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -59.38 106.86 0.49 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.784 0.326 . . . . 0.44 110.189 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.425 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -120.46 159.12 25.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.227 -0.442 . . . . 0.44 111.084 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -75.13 118.19 17.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.44 110.498 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -18.59 62.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 0.44 111.429 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.8 p -61.29 -12.08 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.641 -0.254 . . . . 0.44 111.653 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.47 50.81 0.85 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.894 -0.669 . . . . 0.44 112.192 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.94 150.61 37.22 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.739 0.304 . . . . 0.44 111.054 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -108.94 108.98 19.94 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.622 0.601 . . . . 0.44 112.622 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.465 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.45 -18.03 61.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.883 -0.598 . . . . 0.44 110.161 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.98 -47.97 15.32 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.081 -0.509 . . . . 0.44 110.9 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -66.97 -29.26 69.07 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.99 -0.55 . . . . 0.44 111.46 -179.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.565 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -89.87 173.47 5.8 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.646 -0.502 . . . . 0.44 109.646 179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.52 127.85 27.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 121.84 1.693 . . . . 0.44 112.283 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.0 Cg_endo -69.14 -35.96 13.43 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.657 2.238 . . . . 0.44 112.636 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.01 -9.75 58.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.982 0.42 . . . . 0.44 111.41 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -106.63 23.0 14.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.947 -0.57 . . . . 0.44 110.701 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.13 -30.66 0.9 Allowed Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 113.904 1.076 . . . . 0.44 113.904 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.3 Cg_exo -43.19 -35.13 4.82 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.971 1.78 . . . . 0.44 113.466 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.475 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 37.6 t -77.86 -51.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.266 0.555 . . . . 0.44 110.381 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.436 HG13 ' CE2' ' A' ' 115' ' ' PHE . 33.4 mm -64.93 -32.3 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.276 -0.874 . . . . 0.44 111.321 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -27.17 39.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.885 0.374 . . . . 0.44 110.77 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.22 -50.83 9.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.44 111.623 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.08 -27.04 48.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 0.44 111.399 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.433 ' HB2' HG23 ' A' ' 123' ' ' ILE . 53.1 tttp -54.94 -42.38 72.21 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.158 0.504 . . . . 0.44 110.464 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 -63.74 -12.96 39.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.48 -0.782 . . . . 0.44 109.593 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--O 1.231 0.085 0 CA-C-N 115.94 -0.573 . . . . 0.44 111.042 179.618 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mmm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.786 0.327 . . . . 0.44 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.41 106.44 16.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.44 110.91 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -139.97 142.85 36.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.44 110.884 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -146.04 134.48 21.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 0.44 110.986 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 15.6 mt-30 -102.63 152.86 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.35 0.595 . . . . 0.44 111.937 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.416 HG12 H5'' ' A' ' 131' ' ' 8OG . 4.7 mp -146.5 126.82 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.289 -0.869 . . . . 0.44 110.643 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.603 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.9 125.56 44.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.166 -0.679 . . . . 0.44 109.166 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.61 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.6 m -133.78 162.58 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.169 -0.612 . . . . 0.44 112.131 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.69 116.04 0.99 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.342 -0.844 . . . . 0.44 111.818 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.459 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.91 109.05 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.565 -0.531 . . . . 0.44 109.565 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.525 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -71.15 126.67 31.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.44 111.613 -178.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.479 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -91.18 123.0 34.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.75 -0.659 . . . . 0.44 111.474 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.0 t-20 -79.91 -172.45 3.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.44 111.622 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.478 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.1 tm-20 -81.8 4.29 22.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.463 -1.244 . . . . 0.44 112.418 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -139.5 51.83 1.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.44 111.324 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.2 p30 45.78 24.32 0.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.153 -0.476 . . . . 0.44 111.439 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.4 pt-20 -115.86 137.45 52.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.763 -0.828 . . . . 0.44 108.763 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.525 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 7.3 mt -105.88 139.59 26.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.324 0.583 . . . . 0.44 112.146 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.488 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 1.1 t80 -85.31 112.43 20.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.136 -0.938 . . . . 0.44 110.331 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.443 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -128.73 149.93 33.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.16 -0.473 . . . . 0.44 109.921 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.53 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 31.2 p -70.63 111.5 6.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.034 -0.358 . . . . 0.44 110.034 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -134.04 119.74 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.289 -0.414 . . . . 0.44 111.224 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 47.71 26.15 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.44 111.526 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 46.6 -168.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.823 0.344 . . . . 0.44 111.445 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.12 -29.77 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.44 111.061 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -162.33 33.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.44 110.824 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -96.21 -167.63 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.44 111.114 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.99 -36.22 6.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.44 110.908 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.34 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.44 110.917 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.72 -19.35 49.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.44 111.456 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.37 31.17 2.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.44 110.995 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 34' ' ' GLU . 3.1 tmtm? -106.29 26.3 9.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.336 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.53 ' HA ' ' O ' ' A' ' 21' ' ' THR . 2.7 tt -63.11 74.67 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.729 -0.669 . . . . 0.44 110.775 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.432 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -117.32 -173.27 2.38 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.014 0.435 . . . . 0.44 111.844 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.484 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -119.33 168.49 9.9 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.776 -0.647 . . . . 0.44 111.632 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.61 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 95.3 Cg_endo -81.92 166.74 16.8 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.437 2.758 . . . . 0.44 113.306 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.545 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 101.73 -5.77 54.32 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.607 -0.724 . . . . 0.44 114.384 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -59.25 159.8 18.59 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 117.23 0.515 . . . . 0.44 113.332 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.671 ' HD2' ' H1 ' ' A' 5013 ' ' HOH . 0.0 OUTLIER 86.11 -2.19 0.73 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.876 0.695 . . . . 0.44 112.876 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.603 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.1 pt -49.97 -27.91 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.544 0.688 . . . . 0.44 110.823 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.542 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -43.53 -61.49 1.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.678 -1.146 . . . . 0.44 111.253 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 41' ' ' GLU . 7.4 mmt 9.64 -81.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.826 0.703 . . . . 0.44 112.582 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.34 32.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.604 -0.808 . . . . 0.44 112.985 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -92.51 -170.67 2.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.713 0.292 . . . . 0.44 111.06 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.52 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -101.22 152.95 38.04 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.387 -0.369 . . . . 0.44 110.284 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.52 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.89 -24.78 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.782 2.321 . . . . 0.44 112.618 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -102.18 -42.21 6.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.899 0.333 . . . . 0.44 111.899 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -80.3 -18.39 49.4 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.674 0.25 . . . . 0.44 111.674 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -57.41 -49.93 74.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.792 0.33 . . . . 0.44 111.06 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.7 OUTLIER -78.45 -47.87 23.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.302 -0.408 . . . . 0.44 110.719 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 41.6 t -56.7 -36.02 47.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.934 -0.576 . . . . 0.44 111.247 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -52.01 9.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.352 -0.385 . . . . 0.44 110.649 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.418 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.0 mm-40 -63.43 -22.1 66.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.689 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.459 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 1.3 tp -58.38 -44.99 89.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.442 -0.345 . . . . 0.44 110.755 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -31.33 71.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.187 0.518 . . . . 0.44 109.681 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -77.4 -25.77 51.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.44 111.243 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.515 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.27 5.84 26.02 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.778 0.659 . . . . 0.44 112.778 -178.501 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.619 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 3.2 t -134.29 -45.1 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.987 0.423 . . . . 0.44 110.111 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.572 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 62.4 -20.4 0.06 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.768 -0.651 . . . . 0.44 114.664 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.557 HG22 ' CD1' ' A' ' 95' ' ' TRP . 0.1 OUTLIER -88.73 -176.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 120.961 0.41 . . . . 0.44 111.629 -179.068 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.462 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -115.49 87.9 18.16 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 115.761 -0.654 . . . . 0.44 110.162 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.654 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.6 Cg_endo -113.28 145.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 123.611 2.874 . . . . 0.44 113.789 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.445 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 36.3 mt-30 -74.9 79.89 2.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.496 -2.038 . . . . 0.44 105.496 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.58 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.05 126.98 49.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.172 -1.377 . . . . 0.44 111.072 -176.054 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.489 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.1 t80 179.77 166.91 1.2 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.44 111.77 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.7 m 87.31 155.39 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.853 -0.612 . . . . 0.44 110.644 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.4 pp -110.85 137.41 48.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.953 0.406 . . . . 0.44 111.308 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -91.21 -37.55 13.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.44 110.019 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.53 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.2 tt0 -171.77 144.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.626 -0.716 . . . . 0.44 110.45 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.2 132.12 22.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.483 -0.326 . . . . 0.44 110.345 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pp -141.0 151.09 43.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.426 . . . . 0.44 111.336 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -129.93 109.94 11.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.44 110.467 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.417 ' CE2' HG23 ' A' ' 80' ' ' ILE . 55.1 p90 -128.22 149.75 50.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.44 110.739 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -121.15 129.48 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.18 0.514 . . . . 0.44 111.22 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.46 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.7 m-85 -78.81 163.21 61.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.503 -0.771 . . . . 0.44 110.546 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.3 Cg_endo -50.72 83.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.227 2.618 . . . . 0.44 112.238 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 21.1 m-20 93.98 15.45 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.282 -0.872 . . . . 0.44 111.339 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.505 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 10.5 ttp180 -137.43 150.21 47.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.329 -0.396 . . . . 0.44 110.365 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -126.95 113.47 16.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.44 111.006 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.575 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 2.0 tt -124.22 119.44 56.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.44 110.977 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -106.35 118.82 37.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.529 . . . . 0.44 109.82 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.5 mt -118.39 114.36 22.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.964 0.412 . . . . 0.44 111.798 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -107.64 122.31 46.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.896 -0.593 . . . . 0.44 110.009 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.491 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 3.2 m-30 -104.54 120.16 40.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.033 0.444 . . . . 0.44 110.513 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.658 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 16.6 m95 -106.23 149.09 27.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.44 112.049 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.489 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.5 tm? -95.52 138.6 32.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.674 -0.694 . . . . 0.44 111.551 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.58 HG13 ' HA ' ' A' ' 64' ' ' HIS . 39.1 t -123.4 145.85 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-N 115.484 -0.78 . . . . 0.44 110.117 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -110.57 -26.71 9.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.282 1.216 . . . . 0.44 114.282 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.466 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -162.51 161.71 27.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.491 0.587 . . . . 0.44 111.41 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.654 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.3 OUTLIER -156.91 124.74 5.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.347 -0.388 . . . . 0.44 111.266 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -73.14 142.69 47.45 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.228 -0.442 . . . . 0.44 111.254 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.15 -143.38 26.11 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.0 -0.619 . . . . 0.44 112.704 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.471 ' O ' HG23 ' A' ' 60' ' ' ILE . 2.2 tt0 -107.52 138.01 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 110.402 -0.221 . . . . 0.44 110.402 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.491 ' HA ' HG21 ' A' ' 60' ' ' ILE . 6.6 Cg_exo -74.89 128.97 12.0 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.82 2.347 . . . . 0.44 111.598 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.572 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 52.0 p-90 -121.23 -62.62 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.429 0.529 . . . . 0.44 112.429 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.619 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.93 -97.68 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.096 -0.573 . . . . 0.44 113.21 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 tttt 173.59 39.43 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.724 0.297 . . . . 0.44 111.096 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -57.87 -49.39 76.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.428 -0.351 . . . . 0.44 110.798 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 148.86 -68.08 0.36 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.466 -0.874 . . . . 0.44 113.118 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -117.72 113.27 38.26 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.033 0.444 . . . . 0.44 111.746 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.6 146.15 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.077 2.518 . . . . 0.44 112.686 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.17 177.39 17.69 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.851 -0.69 . . . . 0.44 112.811 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -124.4 157.18 35.72 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.481 -0.192 . . . . 0.44 110.481 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.467 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.8 OUTLIER -67.65 106.44 2.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.91 0.386 . . . . 0.44 110.17 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.23 163.22 18.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.44 111.211 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.5 t -83.43 114.84 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.44 110.444 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.66 -18.77 55.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.44 111.458 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.2 t -62.89 -8.85 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.589 -0.278 . . . . 0.44 111.656 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.64 51.68 0.84 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.989 -0.624 . . . . 0.44 111.738 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 tp -62.18 150.16 39.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.652 0.263 . . . . 0.44 110.688 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.407 ' CB ' ' CD1' ' A' ' 33' ' ' LEU . 1.3 t-20 -107.26 97.31 7.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.692 0.627 . . . . 0.44 112.692 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.492 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.48 -22.58 61.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.44 110.211 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -78.98 -44.91 21.38 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.043 -0.526 . . . . 0.44 111.401 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.62 -42.74 86.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.287 -0.415 . . . . 0.44 111.199 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.506 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.55 174.32 6.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.438 -0.578 . . . . 0.44 109.438 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.5 Cg_endo -54.07 127.74 26.97 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.889 1.726 . . . . 0.44 112.233 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.03 -36.28 13.06 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.679 2.252 . . . . 0.44 112.503 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.468 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -71.13 -9.67 58.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.42 . . . . 0.44 111.339 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -104.37 21.61 16.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.44 110.798 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.22 -31.29 1.4 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 113.489 0.922 . . . . 0.44 113.489 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.8 Cg_exo -43.83 -32.97 4.68 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.833 1.689 . . . . 0.44 113.003 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.452 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 50.0 t -78.02 -51.1 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.121 0.486 . . . . 0.44 110.504 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 23.4 mm -69.17 -30.73 47.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.616 -0.72 . . . . 0.44 111.623 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.78 -27.61 42.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.906 0.384 . . . . 0.44 110.628 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -80.43 -53.11 6.89 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.029 -0.532 . . . . 0.44 111.941 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.19 -33.19 50.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.542 -0.299 . . . . 0.44 111.771 -179.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 31.0 ttpt -53.41 -42.84 67.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.133 0.492 . . . . 0.44 110.837 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -7.36 29.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.62 -0.718 . . . . 0.44 109.83 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.528 0.1 0 CA-C-N 115.861 -0.609 . . . . 0.44 111.32 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.71 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 5011 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 5012 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 5013 ' ' HOH . . . . . 0.671 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A 5014 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tmm? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.842 0.353 . . . . 0.44 111.209 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -91.23 146.15 24.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.44 110.89 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.99 126.76 20.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.44 110.932 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.437 HD12 ' CD1' ' A' ' 6' ' ' ILE . 3.1 pp -146.1 122.49 10.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.939 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 14.2 mt-30 -102.85 155.37 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.41 0.624 . . . . 0.44 112.391 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.437 ' CD1' HD12 ' A' ' 4' ' ' LEU . 3.6 mp -146.99 129.72 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.222 -0.899 . . . . 0.44 110.536 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.576 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.67 125.38 44.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.244 -0.65 . . . . 0.44 109.244 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.497 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.9 m -144.28 162.27 14.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.254 -0.578 . . . . 0.44 111.718 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.419 ' N ' HG21 ' A' ' 8' ' ' VAL . . . -149.65 132.14 3.92 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.626 -0.716 . . . . 0.44 112.006 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.54 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.85 114.49 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.523 -0.547 . . . . 0.44 109.523 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.5 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.1 mt -71.38 123.24 25.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.96 0.409 . . . . 0.44 111.513 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.95 122.86 29.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 0.44 111.684 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.465 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 14.7 t30 -82.34 -172.21 3.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.027 -0.988 . . . . 0.44 112.087 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.411 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.3 tt0 -81.61 0.99 35.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.085 -1.416 . . . . 0.44 112.431 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -139.74 52.16 1.71 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.798 0.332 . . . . 0.44 111.432 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 47.56 21.17 0.22 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.154 -0.475 . . . . 0.44 111.588 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 13' ' ' ASN . 17.2 pt-20 -111.79 153.28 26.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.582 -0.896 . . . . 0.44 108.582 178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.464 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 4.9 mt -123.61 141.87 42.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.351 0.596 . . . . 0.44 112.438 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.475 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -87.13 117.86 26.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.112 -0.949 . . . . 0.44 109.917 179.268 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.446 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -129.04 145.2 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.29 -0.414 . . . . 0.44 110.567 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.4 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 68.4 p -70.78 111.84 6.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.412 -0.358 . . . . 0.44 110.23 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 21.4 ttp180 -142.37 144.93 33.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.416 -0.357 . . . . 0.44 111.046 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 47.71 -109.75 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.44 111.033 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 168.4 -170.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.36 . . . . 0.44 111.007 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.89 -30.42 9.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.44 110.848 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -132.8 -45.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.035 -0.53 . . . . 0.44 110.733 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.75 -166.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.44 111.032 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.451 ' CE1' ' CB ' ' A' ' 30' ' ' ALA . 83.8 t60 -95.62 -86.54 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.344 -0.389 . . . . 0.44 110.894 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 46.47 29.09 0.83 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.837 0.351 . . . . 0.44 111.382 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' CB ' ' CE1' ' A' ' 28' ' ' HIS . . . -58.22 -23.21 54.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.44 111.5 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -106.29 30.32 6.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.44 111.318 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.22 26.04 10.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.371 -0.377 . . . . 0.44 111.409 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.402 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 7.2 tt -64.01 74.76 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.743 -0.662 . . . . 0.44 110.88 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.407 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -123.59 -171.22 2.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.896 0.379 . . . . 0.44 111.5 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.494 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.3 168.58 9.68 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.055 -0.52 . . . . 0.44 111.619 -179.524 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.497 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 92.0 Cg_endo -82.66 167.37 14.95 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.689 2.926 . . . . 0.44 113.307 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.14 -5.24 52.65 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.719 -0.673 . . . . 0.44 114.067 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.82 166.51 17.4 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.274 -0.488 . . . . 0.44 113.263 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.586 ' HD2' ' H2 ' ' A' 5026 ' ' HOH . 0.0 OUTLIER 82.29 0.25 1.38 Allowed 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.42 0.526 . . . . 0.44 112.42 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.576 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.2 pt -49.9 -29.07 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.682 0.753 . . . . 0.44 110.542 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.574 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.07 -60.37 1.9 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.481 -1.236 . . . . 0.44 110.964 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 8.05 -80.27 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.928 0.767 . . . . 0.44 112.511 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -178.66 32.71 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.844 -0.694 . . . . 0.44 112.725 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.435 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.6 mp0 -88.58 -174.11 4.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.796 0.331 . . . . 0.44 111.078 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.528 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.8 153.79 38.55 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.44 110.239 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.86 -25.18 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.805 2.337 . . . . 0.44 112.496 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -104.02 -40.31 6.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.413 -0.358 . . . . 0.44 111.398 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -80.25 -6.79 58.46 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.741 0.275 . . . . 0.44 111.741 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.435 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -61.52 -56.01 24.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.44 110.812 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.453 ' CG1' ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.28 -48.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.166 -0.47 . . . . 0.44 110.872 179.506 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.4 t -51.44 -35.8 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.364 -0.38 . . . . 0.44 111.016 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -52.26 8.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.44 111.255 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.3 mm-40 -66.27 -22.69 66.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.367 -0.379 . . . . 0.44 110.707 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.461 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 10.9 tp -58.01 -44.3 87.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.44 110.697 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -28.41 61.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.055 0.455 . . . . 0.44 109.885 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -77.1 -28.07 54.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.674 -0.694 . . . . 0.44 110.972 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.477 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.7 mp0 -108.39 6.94 26.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.351 0.5 . . . . 0.44 112.351 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.549 ' CG1' HG13 ' A' ' 60' ' ' ILE . 60.9 t -133.18 -44.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.495 -0.557 . . . . 0.44 109.495 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.594 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.85 -39.12 0.24 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.573 -0.74 . . . . 0.44 114.264 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.549 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.34 -176.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.959 0.409 . . . . 0.44 110.847 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.31 88.77 13.32 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-N 115.77 -0.65 . . . . 0.44 110.694 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.684 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.8 Cg_endo -110.46 143.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 123.402 2.735 . . . . 0.44 113.679 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.465 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 33.3 mt-30 -74.67 79.9 2.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.434 -2.061 . . . . 0.44 105.434 175.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.663 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.37 132.08 54.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.089 -1.414 . . . . 0.44 111.165 -175.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -179.82 -133.55 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.838 -0.619 . . . . 0.44 110.294 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.443 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.23 167.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.017 0.437 . . . . 0.44 111.754 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.7 tt -131.7 108.73 9.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.882 -0.599 . . . . 0.44 110.897 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.85 -44.29 32.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.037 0.446 . . . . 0.44 110.253 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.8 tt0 -171.6 156.89 4.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.738 -0.664 . . . . 0.44 110.316 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.09 106.24 4.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.52 -0.309 . . . . 0.44 110.644 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.425 HD23 ' CE1' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -96.77 124.88 40.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.916 0.389 . . . . 0.44 111.284 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -123.42 109.96 14.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.44 110.413 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.452 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 1.8 p90 -138.55 149.55 45.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 0.44 110.828 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.447 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 3.7 pt-20 -121.11 122.15 39.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.089 0.471 . . . . 0.44 111.248 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 77' ' ' ASP . 4.5 m-85 -84.99 162.86 48.23 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 0.44 110.482 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -50.81 81.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.011 2.474 . . . . 0.44 112.224 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 75' ' ' PHE . 12.3 m-20 89.58 12.88 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.401 -0.818 . . . . 0.44 111.475 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.554 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 24.3 ttp180 -137.35 93.7 2.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.705 0.288 . . . . 0.44 110.786 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.447 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.8 t-80 -81.49 110.74 17.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.436 -0.347 . . . . 0.44 110.957 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.571 ' CG2' ' N2 ' ' A' ' 131' ' ' 8OG . 1.8 tp -114.0 118.52 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.44 110.913 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.2 OUTLIER -111.72 118.77 36.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.913 -0.585 . . . . 0.44 109.763 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 11.8 mt -122.25 114.29 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.929 0.395 . . . . 0.44 111.873 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -106.99 122.32 46.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.44 110.057 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.453 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 3.5 m-30 -103.98 112.99 26.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.018 -0.537 . . . . 0.44 110.776 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.453 ' CZ2' ' CG1' ' A' ' 50' ' ' VAL . 44.4 m95 -94.68 148.68 22.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.109 -0.496 . . . . 0.44 111.212 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.8 tp -99.85 103.05 14.63 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.453 0.644 . . . . 0.44 111.324 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 64' ' ' HIS . 11.6 t -80.84 146.08 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 115.186 -0.915 . . . . 0.44 111.303 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.77 -26.23 8.3 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.976 1.102 . . . . 0.44 113.976 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.1 tpt180 -162.64 162.05 26.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.416 0.553 . . . . 0.44 111.44 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.684 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -155.85 124.32 5.9 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.44 111.449 178.779 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -73.07 140.34 47.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.132 -0.485 . . . . 0.44 110.914 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.34 -121.68 26.35 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.44 112.55 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.1 tt0 -132.84 142.13 43.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.506 0.193 . . . . 0.44 110.783 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.475 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 3.5 Cg_exo -75.8 128.84 11.16 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.824 2.349 . . . . 0.44 111.178 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.594 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 18.4 p-90 -126.24 -64.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.489 -0.484 . . . . 0.44 112.262 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.489 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.57 -94.9 0.01 OUTLIER Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.817 -0.629 . . . . 0.44 113.062 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 170.99 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.674 0.273 . . . . 0.44 111.35 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.417 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -50.33 -29.96 11.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.638 0.256 . . . . 0.44 110.794 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.09 -28.77 7.44 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.533 -0.841 . . . . 0.44 113.741 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -140.03 106.04 6.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 117.206 0.503 . . . . 0.44 112.003 -179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -43.56 146.28 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.112 2.541 . . . . 0.44 112.66 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.81 177.29 19.19 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.664 -0.779 . . . . 0.44 113.1 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.27 157.42 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.255 -0.276 . . . . 0.44 110.255 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.441 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -68.68 105.98 2.47 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.706 -0.398 . . . . 0.44 110.183 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.7 ptp -120.52 163.29 18.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 0.44 111.012 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.33 114.98 16.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.444 -0.344 . . . . 0.44 110.474 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -71.42 -18.74 62.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.44 111.407 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.8 p -58.0 -13.63 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.528 -0.305 . . . . 0.44 111.619 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.48 55.16 0.63 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.824 -0.703 . . . . 0.44 111.967 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.403 ' CD2' HG22 ' A' ' 123' ' ' ILE . 4.8 tt -61.95 150.54 37.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.896 0.379 . . . . 0.44 110.742 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -95.22 100.07 11.92 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.794 0.664 . . . . 0.44 112.794 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.468 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -20.93 61.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.14 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.98 -45.15 20.88 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.997 -0.547 . . . . 0.44 111.087 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.78 -41.0 88.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.241 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.478 ' CB ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -78.37 174.2 6.4 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.419 -0.585 . . . . 0.44 109.419 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.08 127.56 26.2 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.82 1.68 . . . . 0.44 112.301 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.27 -34.66 15.7 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.762 2.308 . . . . 0.44 112.415 -179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.488 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -72.49 -9.56 58.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.44 111.377 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -103.38 20.54 17.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.954 -0.566 . . . . 0.44 110.955 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.549 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -70.29 -31.16 2.15 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.872 1.064 . . . . 0.44 113.872 -178.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 90.2 Cg_exo -43.99 -37.81 9.67 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 121.704 1.603 . . . . 0.44 113.429 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.453 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 52.2 t -77.81 -51.02 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.517 . . . . 0.44 110.6 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.437 HG21 ' HB2' ' A' ' 127' ' ' LYS . 43.1 mm -66.19 -30.03 48.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.44 111.563 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -29.99 57.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.967 0.413 . . . . 0.44 110.254 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -50.79 11.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.44 111.509 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.498 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 3.4 tm? -78.41 -19.93 52.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.375 . . . . 0.44 111.831 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.437 ' HB2' HG21 ' A' ' 123' ' ' ILE . 8.5 tttt -74.45 -42.61 58.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.235 0.54 . . . . 0.44 110.522 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.74 -9.97 42.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.464 -0.789 . . . . 0.44 110.01 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.498 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.138 0 CA-C-N 116.35 -0.386 . . . . 0.44 110.639 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.695 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A 5023 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 5024 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 5025 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A 5026 ' ' HOH . . . . . 0.586 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ptm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.783 0.325 . . . . 0.44 111.178 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -103.63 147.11 27.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.881 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.81 129.04 23.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.44 110.721 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.428 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.3 pp -146.2 136.93 24.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.44 111.329 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -106.64 153.63 22.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.126 0.489 . . . . 0.44 111.648 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.562 HG12 H5'' ' A' ' 131' ' ' 8OG . 4.3 mp -146.32 118.84 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.513 -0.767 . . . . 0.44 110.695 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.595 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.94 125.83 44.53 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.426 -0.583 . . . . 0.44 109.426 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -140.08 162.6 24.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.449 -0.5 . . . . 0.44 111.559 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.58 125.69 2.7 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.46 -0.791 . . . . 0.44 112.134 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.81 107.26 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.577 -0.527 . . . . 0.44 109.577 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.455 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -71.23 125.33 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.898 0.38 . . . . 0.44 111.496 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.05 124.44 34.29 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.87 -0.605 . . . . 0.44 111.581 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.472 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 13.5 t30 -79.32 -172.22 3.09 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.261 -0.881 . . . . 0.44 111.834 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -82.57 -1.54 51.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.353 -1.294 . . . . 0.44 112.411 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -129.1 36.15 4.21 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.844 0.312 . . . . 0.44 111.844 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.99 7.29 3.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.452 -0.34 . . . . 0.44 111.601 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 19.2 pt-20 -100.95 146.11 27.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.045 -0.724 . . . . 0.44 109.045 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 6.4 mt -110.61 138.7 37.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.44 111.833 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -86.14 122.52 30.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.357 -0.838 . . . . 0.44 110.686 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.494 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -126.42 162.2 30.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.44 109.804 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 11.7 p -70.52 154.86 41.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.701 0.286 . . . . 0.44 110.392 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -148.04 104.71 3.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.44 111.197 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 50.33 -103.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.509 . . . . 0.44 111.225 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.71 -67.62 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.839 0.352 . . . . 0.44 111.038 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -175.64 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.44 111.132 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.5 p30 -140.02 -175.4 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.925 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 63.67 158.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.44 111.159 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -79.83 87.86 5.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.44 110.978 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mmt -142.75 41.09 1.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.828 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.64 -8.91 57.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.44 111.68 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.8 OUTLIER -94.91 27.92 2.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.632 0.253 . . . . 0.44 111.273 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -114.16 25.96 10.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.045 0.45 . . . . 0.44 111.66 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.2 tt -70.72 72.42 0.53 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.861 -0.608 . . . . 0.44 110.582 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -106.73 -167.71 1.32 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.995 0.426 . . . . 0.44 111.913 -179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.532 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.37 168.51 9.88 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.808 -0.633 . . . . 0.44 111.488 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.603 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 91.4 Cg_endo -80.39 167.34 19.39 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.524 2.816 . . . . 0.44 113.327 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.528 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.45 -5.79 52.24 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.594 -0.73 . . . . 0.44 114.006 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.48 163.22 18.35 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.207 -0.52 . . . . 0.44 112.852 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' HD2' ' H2 ' ' A' 5037 ' ' HOH . 0.0 OUTLIER 84.53 -0.18 0.91 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.803 0.441 . . . . 0.44 112.1 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.595 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.2 pt -50.83 -28.83 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.728 . . . . 0.44 110.424 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.588 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -42.38 -54.65 3.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.266 -1.334 . . . . 0.44 110.934 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.536 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 0.9 -75.33 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.966 0.791 . . . . 0.44 112.546 179.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 173.04 35.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 0.44 112.806 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.425 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.13 -172.47 3.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.777 0.323 . . . . 0.44 111.08 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.509 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -96.44 153.03 39.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.44 110.309 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.509 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.84 -25.03 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.781 2.32 . . . . 0.44 112.52 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -104.04 -39.38 6.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.426 -0.352 . . . . 0.44 111.569 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -80.11 -12.87 59.63 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.685 0.254 . . . . 0.44 111.685 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.425 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -58.45 -52.75 64.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.44 110.806 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.526 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -78.37 -48.34 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.44 111.21 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.526 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 36.3 t -57.1 -38.47 60.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.79 -0.641 . . . . 0.44 111.675 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -74.79 -52.06 12.46 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.844 -0.342 . . . . 0.44 110.786 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -63.08 -20.06 65.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.44 110.722 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.456 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 1.3 tp -60.46 -44.68 95.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.905 0.383 . . . . 0.44 110.926 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -68.54 -30.08 68.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.144 -0.48 . . . . 0.44 110.064 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -77.3 -25.63 51.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.44 111.678 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.85 6.65 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.956 0.725 . . . . 0.44 112.956 -178.388 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.485 ' CG1' HG13 ' A' ' 60' ' ' ILE . 10.0 t -133.81 -44.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.029 0.442 . . . . 0.44 110.721 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 56.67 6.33 1.63 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 114.846 0.699 . . . . 0.44 114.846 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.485 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.37 -166.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 118.087 0.943 . . . . 0.44 110.406 179.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.496 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -113.86 88.64 14.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.44 110.302 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.606 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 20.4 Cg_endo -111.92 137.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 123.529 2.819 . . . . 0.44 114.686 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -74.8 79.15 2.09 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 104.788 -2.301 . . . . 0.44 104.788 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.568 ' HA ' HG11 ' A' ' 87' ' ' VAL . 1.5 t-160 -117.09 124.05 48.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.901 -1.5 . . . . 0.44 110.358 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.5 t80 179.78 163.61 1.03 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.616 -0.434 . . . . 0.44 111.901 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 85.64 154.57 0.08 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.737 -0.665 . . . . 0.44 110.447 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.707 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.2 pp -107.68 121.06 43.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.44 111.616 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.81 -39.0 52.85 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.388 -0.597 . . . . 0.44 109.388 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.87 138.26 1.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.199 -0.91 . . . . 0.44 109.799 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.29 103.99 4.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.583 0.23 . . . . 0.44 110.746 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp -105.81 152.54 23.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.44 111.062 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -135.38 117.39 15.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.44 110.723 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -136.33 152.06 50.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.44 110.509 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.422 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.02 139.96 52.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.198 0.523 . . . . 0.44 111.397 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.436 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.4 OUTLIER -105.63 163.18 17.63 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 115.375 -0.83 . . . . 0.44 110.278 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.9 Cg_endo -55.63 81.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.819 2.346 . . . . 0.44 112.15 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 4.9 t70 97.08 6.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.482 -0.781 . . . . 0.44 111.676 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.574 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 12.1 ttp180 -137.32 94.84 2.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.702 0.287 . . . . 0.44 110.796 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.422 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -91.96 101.66 14.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 0.44 110.744 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.591 HG22 ' N2 ' ' A' ' 131' ' ' 8OG . 1.9 tt -103.52 142.77 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.134 0.493 . . . . 0.44 111.283 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -123.01 118.24 27.33 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.939 -0.764 . . . . 0.44 108.939 178.337 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.425 HD13 ' CG2' ' A' ' 6' ' ' ILE . 6.4 tp -114.49 114.03 25.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.085 0.469 . . . . 0.44 111.542 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.41 ' CD1' ' N ' ' A' ' 83' ' ' TRP . 8.7 m0 -114.15 121.8 44.87 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.71 -0.677 . . . . 0.44 109.83 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.502 ' HB3' ' CD1' ' A' ' 68' ' ' PHE . 3.5 m-30 -110.27 117.41 33.57 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.782 -0.644 . . . . 0.44 110.236 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.707 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 16.2 m95 -105.4 148.54 27.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.223 0.535 . . . . 0.44 112.343 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.5 tp -86.14 138.42 31.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.565 -0.743 . . . . 0.44 111.386 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 64' ' ' HIS . 20.7 t -124.11 145.49 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 115.87 -0.605 . . . . 0.44 110.712 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.88 -24.2 10.12 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.598 1.333 . . . . 0.44 114.598 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.548 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.76 163.18 26.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.344 0.974 . . . . 0.44 112.306 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -157.81 123.26 4.53 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.075 -0.511 . . . . 0.44 110.749 178.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.496 ' CB ' HG23 ' A' ' 61' ' ' THR . 6.8 tt0 -74.5 149.39 40.3 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 120.447 -0.501 . . . . 0.44 111.165 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.62 -116.83 6.35 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.852 -0.69 . . . . 0.44 112.593 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -135.33 143.39 45.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.431 0.158 . . . . 0.44 110.697 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.489 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -76.43 128.76 10.59 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.816 2.344 . . . . 0.44 111.079 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 38.0 p-90 -132.25 -59.75 0.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.202 0.445 . . . . 0.44 112.202 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.499 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.79 -94.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.804 -0.634 . . . . 0.44 112.786 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 95' ' ' TRP . 0.0 OUTLIER 174.77 39.63 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.786 0.327 . . . . 0.44 110.714 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' CA ' ' HG3' ' A' ' 57' ' ' GLU . 26.4 pt-20 -57.64 -45.67 85.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.358 -0.383 . . . . 0.44 110.767 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 131.92 -43.06 1.32 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.53 -0.843 . . . . 0.44 113.248 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.37 108.2 23.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.042 0.449 . . . . 0.44 111.769 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -43.75 146.31 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.004 2.469 . . . . 0.44 112.51 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.64 177.27 17.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.658 -0.782 . . . . 0.44 113.048 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.78 157.38 43.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.383 -0.228 . . . . 0.44 110.383 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.459 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -74.49 106.33 6.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.902 0.382 . . . . 0.44 110.295 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.1 ptp -120.42 163.24 18.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.44 111.13 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.4 p -79.28 114.98 18.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.44 110.509 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.21 -18.7 63.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.44 111.449 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -63.08 -8.57 3.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.55 -0.295 . . . . 0.44 111.6 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.97 50.46 0.88 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.892 -0.67 . . . . 0.44 112.096 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.1 tp -62.17 150.17 39.46 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.388 -0.227 . . . . 0.44 110.388 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.46 115.84 22.93 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.944 0.72 . . . . 0.44 112.944 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.558 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.59 -17.97 61.65 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.554 -0.748 . . . . 0.44 110.162 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -78.85 -49.06 13.55 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.062 -0.517 . . . . 0.44 111.075 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -66.93 -18.74 65.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.214 -0.448 . . . . 0.44 111.447 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.558 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.82 170.72 5.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.737 -0.468 . . . . 0.44 109.737 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.443 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.54 127.69 27.07 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.05 1.833 . . . . 0.44 112.326 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.16 -36.86 11.56 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.619 2.212 . . . . 0.44 112.528 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.484 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.57 -9.58 57.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.44 111.487 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -105.8 19.11 21.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.906 -0.588 . . . . 0.44 110.776 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.555 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -66.61 -31.88 4.63 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.796 1.036 . . . . 0.44 113.796 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.0 Cg_exo -44.2 -34.74 7.21 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 121.825 1.683 . . . . 0.44 113.154 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.458 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 39.4 t -77.96 -51.3 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.021 0.439 . . . . 0.44 110.785 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.475 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 26.2 mm -67.49 -31.94 54.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 CA-C-N 115.9 -0.591 . . . . 0.44 111.42 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.49 -26.86 33.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.891 0.377 . . . . 0.44 110.657 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.12 -53.09 7.02 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.44 111.791 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.25 -31.8 49.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.761 0.315 . . . . 0.44 111.744 -179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 4.7 ttpt -53.95 -42.56 69.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.97 0.414 . . . . 0.44 110.864 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -67.77 -9.22 42.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.786 -0.643 . . . . 0.44 109.825 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-N 115.959 -0.564 . . . . 0.44 111.264 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.731 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 5035 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 5036 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A 5037 ' ' HOH . . . . . 0.612 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A 5038 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.84 0.352 . . . . 0.44 111.219 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -109.49 102.98 11.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.44 110.871 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 145.4 55.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.44 110.943 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.443 ' CD1' " O4'" ' A' ' 131' ' ' 8OG . 2.8 pp -146.1 127.84 15.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.44 111.236 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -102.58 146.95 27.4 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.281 0.562 . . . . 0.44 111.696 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.442 ' CD1' " H4'" ' A' ' 131' ' ' 8OG . 0.8 OUTLIER -146.71 132.91 13.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.226 -0.897 . . . . 0.44 110.771 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.589 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.64 124.55 42.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.63 -0.507 . . . . 0.44 109.63 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 m -119.38 162.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.391 0.615 . . . . 0.44 112.089 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.51 106.23 0.32 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.132 -0.94 . . . . 0.44 111.904 179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.72 109.88 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.444 -0.576 . . . . 0.44 109.444 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.473 ' CG2' ' HB3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.34 123.06 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 0.44 111.805 -178.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.72 124.32 32.85 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.773 -0.649 . . . . 0.44 111.591 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.503 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 2.2 t-20 -81.41 -172.34 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.778 -1.101 . . . . 0.44 111.644 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.503 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 26.2 tt0 -83.34 9.18 11.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.602 -1.181 . . . . 0.44 112.487 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -141.36 52.24 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.156 -0.34 . . . . 0.44 111.503 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.9 p30 44.71 25.79 0.16 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.997 0.427 . . . . 0.44 111.368 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -117.93 160.16 21.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.12 -0.696 . . . . 0.44 109.12 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.406 ' CG2' ' CG2' ' A' ' 10' ' ' ILE . 9.0 mt -130.26 138.04 54.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.048 0.452 . . . . 0.44 111.435 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.464 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -79.02 112.5 16.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.44 110.305 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.28 139.61 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.136 -0.484 . . . . 0.44 110.156 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -70.8 111.88 6.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.824 0.345 . . . . 0.44 110.606 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -124.4 119.13 28.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.44 110.776 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.2 ttm180 50.77 -106.76 0.25 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.212 -0.449 . . . . 0.44 110.769 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 173.45 37.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.44 111.179 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.1 25.1 3.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.351 -0.386 . . . . 0.44 111.498 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 p30 176.62 162.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.41 -0.359 . . . . 0.44 110.884 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.49 -166.26 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.44 111.118 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -118.12 113.53 21.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.44 110.869 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.23 34.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.44 110.846 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.2 -8.93 57.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.44 111.587 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.69 -1.68 35.6 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.556 -0.293 . . . . 0.44 111.604 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 26.2 10.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.046 0.451 . . . . 0.44 111.3 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.1 tp -58.07 86.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.764 -0.653 . . . . 0.44 110.841 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.91 -175.94 3.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.44 111.112 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.457 ' CE1' HG21 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.63 161.58 36.94 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.44 111.177 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.7 166.7 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.069 2.513 . . . . 0.44 111.525 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.543 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 100.97 58.92 0.82 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 119.857 -1.164 . . . . 0.44 113.176 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.603 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.66 122.96 3.55 Favored Glycine 0 C--N 1.312 -0.802 0 CA-C-N 114.941 -0.63 . . . . 0.44 112.339 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.603 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 107.92 2.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.103 0.561 . . . . 0.44 112.296 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.589 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.6 pt -48.83 -28.95 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.541 0.686 . . . . 0.44 110.515 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.56 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.92 -69.72 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.608 -1.178 . . . . 0.44 110.779 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.462 ' C ' ' O ' ' A' ' 41' ' ' GLU . 13.7 mmt 22.43 -86.18 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.868 0.73 . . . . 0.44 112.19 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.88 27.86 0.17 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.991 -0.623 . . . . 0.44 112.502 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.41 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 5.9 mt-10 -93.83 -177.32 4.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.827 0.346 . . . . 0.44 111.108 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.56 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.86 158.44 35.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.44 109.982 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.93 -24.69 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.809 2.339 . . . . 0.44 112.409 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -88.85 -60.23 2.01 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.11 0.411 . . . . 0.44 112.11 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.48 -6.83 58.75 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.289 0.477 . . . . 0.44 112.289 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.443 ' N ' ' O ' ' A' ' 45' ' ' THR . . . -61.74 -54.47 42.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.76 0.314 . . . . 0.44 110.826 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.497 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -78.31 -46.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.44 110.977 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.497 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 32.6 t -55.55 -37.62 46.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.113 -0.494 . . . . 0.44 111.223 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.3 -52.02 9.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.336 -0.393 . . . . 0.44 110.998 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.87 -23.55 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.44 111.002 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.481 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -53.79 -44.63 70.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.44 110.532 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -33.93 75.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.069 -0.715 . . . . 0.44 109.069 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.68 -26.12 50.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.251 -0.886 . . . . 0.44 111.188 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.447 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 54.2 mm-40 -108.36 4.27 24.28 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.262 0.467 . . . . 0.44 112.262 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.573 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 26.0 t -134.85 -44.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.229 0.538 . . . . 0.44 110.117 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.549 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.14 -41.77 0.36 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.292 -0.867 . . . . 0.44 113.723 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.52 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.1 OUTLIER -77.79 -176.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.133 0.492 . . . . 0.44 111.251 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.79 88.79 14.64 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 115.573 -0.739 . . . . 0.44 110.17 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.546 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.2 Cg_endo -110.15 149.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.322 2.681 . . . . 0.44 113.887 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.466 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 77.7 mt-30 -74.74 79.78 2.06 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.053 -1.832 . . . . 0.44 106.053 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.561 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.56 129.27 50.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.305 -1.316 . . . . 0.44 110.206 -176.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -176.59 -39.34 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.887 0.699 . . . . 0.44 112.887 -178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.449 ' CB ' ' HB3' ' A' ' 86' ' ' LEU . 51.8 m -40.74 160.87 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.526 -0.761 . . . . 0.44 111.805 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -115.69 119.32 35.68 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.083 -0.508 . . . . 0.44 110.575 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -86.83 -56.34 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.262 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -172.03 144.08 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.982 -0.554 . . . . 0.44 110.309 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.443 ' NZ ' ' CZ3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -142.21 112.46 7.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.698 0.285 . . . . 0.44 110.768 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.7 pp -125.18 159.39 31.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.968 0.413 . . . . 0.44 111.028 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -135.35 109.93 8.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.592 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.456 ' CE1' ' CG2' ' A' ' 80' ' ' ILE . 30.1 p90 -125.59 151.12 46.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.31 -0.405 . . . . 0.44 110.746 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.12 131.29 54.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.44 111.114 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.455 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-85 -79.89 162.85 60.87 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.695 -0.684 . . . . 0.44 110.622 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.9 Cg_endo -53.6 82.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.203 2.602 . . . . 0.44 112.321 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER 100.43 11.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.895 0.878 . . . . 0.44 111.232 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 17.5 ttp180 -137.3 150.15 47.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.44 110.585 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -127.06 110.87 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.44 110.672 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.557 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 1.9 tt -120.3 120.69 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.44 111.369 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.02 118.65 37.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.32 -0.622 . . . . 0.44 109.32 178.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.405 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.1 mp -119.75 114.05 21.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.44 111.768 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.443 ' CZ3' ' NZ ' ' A' ' 70' ' ' LYS . 10.5 m0 -110.1 122.55 47.86 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.068 -0.515 . . . . 0.44 110.348 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.459 ' CD1' HG13 ' A' ' 122' ' ' VAL . 2.2 m-85 -109.98 109.79 20.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.063 -0.517 . . . . 0.44 110.919 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.408 ' NE1' HG13 ' A' ' 50' ' ' VAL . 34.2 m95 -98.02 148.95 22.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.801 -0.636 . . . . 0.44 111.592 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.449 ' HB3' ' CB ' ' A' ' 66' ' ' SER . 3.4 tt -97.83 138.5 35.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.461 0.648 . . . . 0.44 111.664 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.566 ' O ' ' HB2' ' A' ' 12' ' ' ARG . 61.5 t -114.78 146.38 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-N 115.104 -0.953 . . . . 0.44 110.436 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.41 -25.69 10.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 114.024 1.12 . . . . 0.44 114.024 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.4 165.36 24.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.72 0.691 . . . . 0.44 111.505 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.546 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -156.57 123.36 5.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.365 -0.38 . . . . 0.44 111.387 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -79.1 153.69 29.95 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.061 -0.518 . . . . 0.44 111.064 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.56 -131.95 49.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.829 -0.7 . . . . 0.44 112.566 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.4 mt-10 -123.33 144.24 43.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.51 0.195 . . . . 0.44 110.725 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.54 128.76 10.51 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.788 2.325 . . . . 0.44 111.628 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.549 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.9 p-90 -133.4 -58.91 0.88 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.559 -0.457 . . . . 0.44 111.604 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.573 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.07 -98.02 0.01 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.847 -0.692 . . . . 0.44 113.025 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 176.8 36.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.44 111.022 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -44.52 96.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.44 110.882 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.38 -68.5 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.57 -0.824 . . . . 0.44 113.111 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -110.86 106.37 57.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.44 111.554 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -43.58 146.27 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.016 2.477 . . . . 0.44 112.647 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.34 177.04 17.11 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.651 -0.785 . . . . 0.44 112.809 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.82 157.38 37.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.578 0.228 . . . . 0.44 110.568 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -60.14 106.68 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.44 110.258 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.03 163.29 17.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.44 110.93 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.3 p -80.36 114.75 19.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.461 -0.336 . . . . 0.44 110.47 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.25 -18.68 48.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.352 -0.385 . . . . 0.44 111.433 -179.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.13 -14.34 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.468 -0.333 . . . . 0.44 111.801 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.06 53.79 0.67 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.698 -0.763 . . . . 0.44 112.27 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.415 ' CD2' HG21 ' A' ' 123' ' ' ILE . 8.5 tt -62.24 150.37 39.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.371 -0.233 . . . . 0.44 110.371 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -106.36 115.02 29.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.043 0.757 . . . . 0.44 113.043 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.554 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.5 -17.91 61.71 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.585 -0.734 . . . . 0.44 110.049 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.03 -46.29 18.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.086 -0.506 . . . . 0.44 111.029 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -40.13 88.61 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.191 -0.458 . . . . 0.44 111.158 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.554 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.49 174.38 6.13 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.416 -0.587 . . . . 0.44 109.416 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.0 127.76 26.97 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 121.835 1.69 . . . . 0.44 112.435 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.17 -36.94 11.35 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.796 2.331 . . . . 0.44 112.557 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.448 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -69.33 -9.66 54.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.392 . . . . 0.44 111.361 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.428 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 13.2 m-20 -107.38 18.45 21.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.916 -0.584 . . . . 0.44 110.93 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 tt0 -64.78 -31.89 6.14 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 113.791 1.034 . . . . 0.44 113.791 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.3 Cg_exo -44.09 -38.77 10.94 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 121.746 1.631 . . . . 0.44 113.206 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.459 HG13 ' CD1' ' A' ' 84' ' ' PHE . 76.8 t -77.66 -51.2 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.829 0.347 . . . . 0.44 111.828 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.517 HG13 ' CE2' ' A' ' 115' ' ' PHE . 32.6 mm -73.04 -43.79 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.953 0.723 . . . . 0.44 112.953 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.19 -26.81 30.16 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.191 0.441 . . . . 0.44 112.191 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -80.32 -53.45 6.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.804 0.298 . . . . 0.44 111.804 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.489 ' HG ' ' CZ ' ' A' ' 68' ' ' PHE . 3.5 mm? -78.47 -28.46 46.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.671 0.248 . . . . 0.44 111.671 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.458 ' HB2' HG23 ' A' ' 123' ' ' ILE . 9.9 ttpp -55.74 -42.19 75.03 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.059 0.457 . . . . 0.44 110.696 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -71.45 -5.79 35.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.662 -0.699 . . . . 0.44 109.99 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 115.978 -0.556 . . . . 0.44 111.112 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.712 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 5047 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 5048 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A 5049 ' ' HOH . . . . . 0.542 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A 5050 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mtm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.791 0.329 . . . . 0.44 111.193 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.99 135.0 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.44 110.904 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.424 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.37 129.26 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.969 -0.559 . . . . 0.44 110.608 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.52 HD22 ' N3 ' ' A' ' 131' ' ' 8OG . 4.1 pp -146.48 139.37 25.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.913 0.387 . . . . 0.44 111.78 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' HB2' ' HA ' ' A' ' 41' ' ' GLU . 39.5 mt-30 -106.01 156.0 18.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.44 111.404 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.523 HD13 " O4'" ' A' ' 131' ' ' 8OG . 15.0 mt -146.74 126.51 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.44 111.357 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.496 ' HB2' ' CG1' ' A' ' 40' ' ' ILE . . . -125.17 125.2 43.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.513 -0.551 . . . . 0.44 109.513 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.464 HG21 ' CD1' ' A' ' 35' ' ' PHE . 1.1 m -144.7 156.49 14.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.994 -0.682 . . . . 0.44 111.999 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.406 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -146.8 124.45 1.99 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.337 -0.847 . . . . 0.44 111.864 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.606 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.57 112.45 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.232 -0.655 . . . . 0.44 109.232 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.44 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -70.81 119.94 17.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.215 0.531 . . . . 0.44 111.381 -178.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.426 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -84.3 124.39 31.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 0.44 111.625 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 23.0 t30 -80.91 -172.25 3.61 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.304 -0.862 . . . . 0.44 111.733 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.432 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.1 tt0 -82.91 5.4 22.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.45 -1.25 . . . . 0.44 112.212 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -139.44 51.23 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.875 0.369 . . . . 0.44 111.503 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 45.88 25.19 0.28 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.309 -0.405 . . . . 0.44 111.277 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.3 pt-20 -119.45 141.63 48.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.288 -0.634 . . . . 0.44 109.288 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 19' ' ' PHE . 10.3 mt -112.51 143.52 22.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.199 0.523 . . . . 0.44 111.749 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.474 ' N ' HG22 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -90.38 121.65 32.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.57 -0.741 . . . . 0.44 110.352 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.454 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -121.22 134.72 63.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.26 -0.427 . . . . 0.44 110.058 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -70.79 111.97 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.381 . . . . 0.44 110.889 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 34.9 ptt85 -136.68 131.35 33.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.44 110.768 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.0 tpp180 53.4 -111.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.44 110.748 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 173.13 -167.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.44 111.002 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.39 26.56 10.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.44 111.081 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -179.64 -41.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.338 -0.392 . . . . 0.44 110.811 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.93 -169.05 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.44 111.087 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -139.55 98.91 3.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.957 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.0 mmt -155.35 60.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.44 110.799 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -65.14 -13.75 58.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.44 111.555 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.9 t-20 -84.17 6.92 20.68 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.598 -0.273 . . . . 0.44 111.688 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.32 26.41 10.28 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.877 0.325 . . . . 0.44 111.877 -179.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.4 OUTLIER -67.93 63.2 0.08 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.183 -0.462 . . . . 0.44 110.67 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -109.42 -166.93 1.15 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.44 111.445 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.51 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.42 168.23 10.47 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.075 -0.511 . . . . 0.44 111.487 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 59.9 Cg_endo -72.62 167.21 27.72 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.34 2.693 . . . . 0.44 113.162 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.571 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 101.61 -5.49 54.48 Favored Glycine 0 C--O 1.223 -0.545 0 CA-C-N 115.603 -0.726 . . . . 0.44 113.971 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.37 149.3 50.16 Favored Glycine 0 C--N 1.315 -0.602 0 C-N-CA 120.945 -0.645 . . . . 0.44 112.798 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.509 ' HG2' ' H1 ' ' A' 5062 ' ' HOH . 0.0 OUTLIER 91.6 -0.98 0.17 Allowed 'General case' 0 C--N 1.342 0.247 0 N-CA-C 112.886 0.698 . . . . 0.44 112.886 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.595 HG13 ' N ' ' A' ' 41' ' ' GLU . 1.1 pt -49.41 -29.81 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.717 0.77 . . . . 0.44 110.584 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.595 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -43.12 -52.71 5.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.28 -1.327 . . . . 0.44 111.04 179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.531 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 0.4 -75.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.928 0.768 . . . . 0.44 112.564 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 176.12 35.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.509 -0.853 . . . . 0.44 112.979 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -93.56 -171.49 2.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.596 0.236 . . . . 0.44 111.022 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.503 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.04 152.58 38.4 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.464 -0.335 . . . . 0.44 110.294 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.503 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.82 -24.97 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.774 2.316 . . . . 0.44 112.491 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -104.08 -40.45 6.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.4 -0.364 . . . . 0.44 111.709 -179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -80.33 -14.18 58.58 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.749 0.278 . . . . 0.44 111.749 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.476 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -58.95 -52.33 66.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.818 0.342 . . . . 0.44 111.089 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.466 HG13 ' CE2' ' A' ' 85' ' ' TRP . 2.0 m -78.74 -49.03 21.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.44 110.632 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.443 ' N ' HG22 ' A' ' 50' ' ' VAL . 39.6 t -54.85 -36.02 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.44 111.392 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -51.99 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.44 110.597 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.41 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.1 mm-40 -61.59 -22.04 64.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.123 -0.49 . . . . 0.44 110.694 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.459 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -58.48 -44.48 89.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.344 -0.389 . . . . 0.44 110.867 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -33.87 75.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.44 110.116 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.6 tt0 -77.13 -26.93 53.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.697 -0.683 . . . . 0.44 111.075 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.08 6.33 26.86 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.179 0.437 . . . . 0.44 112.179 -178.634 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.564 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 48.2 t -133.41 -44.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.57 -0.529 . . . . 0.44 109.57 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.76 -40.66 0.31 Allowed Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.574 -0.739 . . . . 0.44 113.969 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.532 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.47 -177.55 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.084 0.469 . . . . 0.44 111.087 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.22 88.86 13.24 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.575 -0.739 . . . . 0.44 110.058 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.638 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -110.09 145.63 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 123.287 2.658 . . . . 0.44 114.159 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.421 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 84.2 mt-30 -74.69 79.96 2.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.485 -2.043 . . . . 0.44 105.485 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.585 ' HA ' HG11 ' A' ' 87' ' ' VAL . 1.7 t-160 -121.53 131.04 53.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.292 -1.322 . . . . 0.44 111.436 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -177.08 -133.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.771 -0.65 . . . . 0.44 110.345 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 54.51 171.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.039 0.447 . . . . 0.44 111.937 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 7.1 tt -136.85 108.07 6.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.44 110.714 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.74 -44.58 32.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.44 109.99 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.533 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.0 tt0 -171.79 142.72 1.57 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.782 -0.645 . . . . 0.44 110.429 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.24 103.86 4.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.376 -0.374 . . . . 0.44 110.213 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.4 pp -110.33 151.75 27.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.955 0.407 . . . . 0.44 111.479 -179.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -131.43 109.94 10.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.575 . . . . 0.44 110.393 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.425 ' CZ ' ' HG2' ' A' ' 121' ' ' PRO . 8.1 p90 -127.7 152.99 47.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.44 110.747 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.23 128.83 52.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.213 0.53 . . . . 0.44 111.306 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -94.19 163.38 23.55 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.432 -0.804 . . . . 0.44 110.416 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.468 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -52.74 82.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.0 2.467 . . . . 0.44 112.142 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.4 m-20 91.32 9.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.327 -0.852 . . . . 0.44 111.616 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.666 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.1 OUTLIER -137.42 93.85 2.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.616 0.246 . . . . 0.44 110.67 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 10.1 t-160 -89.8 98.78 11.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.44 110.673 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.566 HG23 ' N2 ' ' A' ' 131' ' ' 8OG . 2.0 tt -106.04 134.46 47.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.44 111.221 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -111.24 118.57 36.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.263 -0.643 . . . . 0.44 109.263 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.437 ' CD2' ' CG2' ' A' ' 122' ' ' VAL . 4.1 tp -111.7 113.91 26.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.017 0.437 . . . . 0.44 111.393 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -111.3 121.98 46.66 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.854 -0.612 . . . . 0.44 109.76 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.476 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 4.0 m-30 -112.73 111.24 21.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.066 -0.516 . . . . 0.44 111.011 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.528 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 14.6 m95 -96.14 149.12 21.98 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.44 111.056 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' PHE . 9.2 tp -97.63 103.31 15.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.515 0.674 . . . . 0.44 112.328 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.606 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 12.1 t -81.16 145.78 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 114.96 -1.018 . . . . 0.44 110.626 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.63 -26.16 8.0 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.448 1.277 . . . . 0.44 114.448 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 90' ' ' TRP . 15.4 ttm-85 -161.98 165.06 27.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.676 0.671 . . . . 0.44 111.782 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.638 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -156.26 126.16 6.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 0.44 111.419 179.035 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.7 147.98 37.07 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.12 -0.491 . . . . 0.44 110.94 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.2 -119.7 17.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.796 -0.716 . . . . 0.44 112.476 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -134.88 144.94 52.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.516 0.198 . . . . 0.44 110.856 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.461 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.39 128.83 10.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.983 2.455 . . . . 0.44 111.282 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 49.9 p-90 -135.06 -62.8 0.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.284 -0.566 . . . . 0.44 112.328 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.564 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.98 -100.08 0.02 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.869 -0.681 . . . . 0.44 113.02 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER 172.31 38.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.767 0.318 . . . . 0.44 111.103 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -58.53 -48.44 80.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.486 -0.325 . . . . 0.44 110.83 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.34 -60.84 0.21 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.494 -0.86 . . . . 0.44 112.834 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -139.02 126.34 13.1 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.44 111.384 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -43.31 146.2 1.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.164 2.576 . . . . 0.44 112.752 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.1 177.09 17.56 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.751 -0.738 . . . . 0.44 112.733 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -121.17 157.32 30.46 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.404 -0.221 . . . . 0.44 110.404 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -76.44 105.76 7.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.44 110.218 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 17.2 ptm -120.93 163.3 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.947 -0.57 . . . . 0.44 111.019 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -75.54 114.88 14.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.452 -0.34 . . . . 0.44 110.312 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.3 -18.81 64.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.374 -0.376 . . . . 0.44 111.569 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.1 p -54.91 -15.91 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.473 -0.33 . . . . 0.44 111.729 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.55 48.74 0.95 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.645 -0.788 . . . . 0.44 112.433 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.42 HD12 ' CZ ' ' A' ' 35' ' ' PHE . 6.5 tt -62.28 150.42 39.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.676 0.274 . . . . 0.44 110.452 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -111.13 114.88 28.45 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.955 0.724 . . . . 0.44 112.955 -178.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.532 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.35 -18.7 61.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.632 -0.713 . . . . 0.44 110.113 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.93 -45.58 20.2 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.96 -0.564 . . . . 0.44 110.949 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.453 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -66.78 -41.56 87.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.44 110.997 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.588 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -79.01 173.49 7.64 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.537 -0.542 . . . . 0.44 109.537 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.54 127.68 27.03 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 121.857 1.704 . . . . 0.44 112.027 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.02 -37.51 10.84 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.657 2.238 . . . . 0.44 112.667 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.504 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.64 -9.83 57.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.326 -0.397 . . . . 0.44 111.526 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -106.31 27.45 8.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.534 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.588 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.04 -30.99 0.95 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 113.957 1.095 . . . . 0.44 113.957 -178.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.2 Cg_exo -43.68 -35.01 6.06 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.966 1.777 . . . . 0.44 113.357 -178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.476 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 95.3 t -77.7 -51.1 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.087 0.47 . . . . 0.44 110.426 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.422 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 39.9 mm -64.61 -32.16 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.725 -0.67 . . . . 0.44 111.205 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.69 -27.37 39.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.9 0.381 . . . . 0.44 110.626 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -80.25 -51.26 9.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.004 -0.544 . . . . 0.44 111.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 23.2 tp -78.06 -28.23 48.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.722 0.296 . . . . 0.44 111.602 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 123' ' ' ILE . 49.6 tttm -55.27 -42.44 73.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.03 0.443 . . . . 0.44 110.599 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 -67.22 -10.08 46.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.73 -0.668 . . . . 0.44 109.693 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-N 115.85 -0.614 . . . . 0.44 111.294 179.746 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.802 ' P ' " H3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A 5059 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 5060 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 5061 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A 5062 ' ' HOH . . . . . 0.509 ' H1 ' ' HG2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.882 0.372 . . . . 0.44 111.217 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -78.43 138.57 38.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.44 110.883 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -140.08 128.72 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.44 110.861 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.405 HD13 ' CD1' ' A' ' 6' ' ' ILE . 3.1 pp -146.06 128.72 16.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.44 111.116 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.422 ' O ' ' HB3' ' A' ' 41' ' ' GLU . 13.8 mt-30 -102.69 154.91 18.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.284 0.564 . . . . 0.44 112.204 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.448 HD11 " O4'" ' A' ' 131' ' ' 8OG . 3.2 mp -146.89 130.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.424 -0.807 . . . . 0.44 110.68 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.541 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -125.07 125.69 44.2 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.554 -0.536 . . . . 0.44 109.554 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.598 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m -140.28 162.24 24.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 120.497 -0.481 . . . . 0.44 111.394 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.4 ' N ' HG21 ' A' ' 8' ' ' VAL . . . -147.58 129.88 3.35 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.645 -0.707 . . . . 0.44 112.057 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.589 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.7 110.54 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.521 -0.548 . . . . 0.44 109.521 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.492 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -70.94 121.99 21.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.996 0.427 . . . . 0.44 111.57 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.418 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.98 124.49 30.44 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.644 -0.707 . . . . 0.44 111.515 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.566 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 23.2 t-20 -70.88 178.26 3.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.924 -1.034 . . . . 0.44 112.006 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.566 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 31.6 tt0 -56.88 -17.24 8.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.345 -1.298 . . . . 0.44 112.76 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -122.49 -82.64 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.023 -0.271 . . . . 0.44 111.598 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.58 13.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.861 0.319 . . . . 0.44 111.861 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -100.81 160.3 14.48 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.868 -0.79 . . . . 0.44 108.868 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.426 HG22 ' HB ' ' A' ' 10' ' ' ILE . 5.2 mt -132.36 137.32 54.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.123 0.487 . . . . 0.44 111.624 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -83.48 118.29 23.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.44 110.573 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.49 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -121.28 141.42 41.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.44 110.092 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 5.2 p -70.75 111.74 6.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.686 0.279 . . . . 0.44 110.392 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -137.68 129.4 28.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.04 0.448 . . . . 0.44 111.407 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 50.07 24.0 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.44 111.484 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' O ' ' CB ' ' A' ' 25' ' ' ALA . . . 46.23 28.69 0.71 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.668 0.27 . . . . 0.44 111.512 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 24' ' ' ALA . . . 81.89 -47.09 0.2 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.229 -0.441 . . . . 0.44 111.192 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.32 82.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.37 . . . . 0.44 110.82 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.22 -79.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.44 111.222 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -166.21 -55.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.44 110.932 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.37 81.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.44 110.887 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.96 -8.93 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.44 111.672 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.0 31.13 2.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.771 0.32 . . . . 0.44 111.124 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -111.83 26.28 10.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.44 111.253 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 21' ' ' THR . 6.7 tt -65.67 69.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.675 -0.693 . . . . 0.44 111.057 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.402 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.2 OUTLIER -119.82 -166.97 1.35 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.386 . . . . 0.44 111.233 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.531 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.24 168.53 9.76 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.184 -0.462 . . . . 0.44 111.552 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.598 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 82.8 Cg_endo -78.68 167.68 22.15 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.564 2.842 . . . . 0.44 113.456 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.495 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.92 -3.67 48.84 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.407 -0.815 . . . . 0.44 114.534 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.41 158.13 31.94 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.225 -0.512 . . . . 0.44 113.632 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.602 ' HD2' ' H1 ' ' A' 5074 ' ' HOH . 0.0 OUTLIER 88.17 0.34 0.41 Allowed 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.213 0.605 . . . . 0.44 112.429 179.145 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.606 HG13 ' N ' ' A' ' 41' ' ' GLU . 1.1 pt -49.84 -29.14 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.607 0.718 . . . . 0.44 110.526 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.606 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.62 -57.44 2.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.52 -1.218 . . . . 0.44 110.914 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.536 ' C ' ' O ' ' A' ' 41' ' ' GLU . 9.4 mmt 4.23 -78.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.911 0.757 . . . . 0.44 112.567 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.48 34.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.69 -0.766 . . . . 0.44 112.789 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.436 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -89.39 -174.16 4.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.717 0.294 . . . . 0.44 111.049 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.517 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.03 153.45 38.51 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.44 110.248 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.517 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.83 -25.28 0.97 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.828 2.352 . . . . 0.44 112.455 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.04 -40.33 6.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.443 -0.344 . . . . 0.44 111.431 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -80.32 -4.89 55.19 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.792 0.293 . . . . 0.44 111.792 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.436 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -62.03 -57.01 13.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.44 110.869 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.455 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.6 OUTLIER -78.52 -45.66 25.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.217 -0.447 . . . . 0.44 110.949 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.455 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 44.6 t -53.24 -39.75 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.44 111.237 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -78.02 -48.67 15.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.333 -0.394 . . . . 0.44 110.462 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.5 mm-40 -64.77 -20.05 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.44 110.596 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.453 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 1.2 tp -59.77 -44.39 93.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.44 110.427 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -65.0 -34.75 79.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.372 -0.603 . . . . 0.44 109.372 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.1 tm-20 -77.43 -27.35 52.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.291 -0.868 . . . . 0.44 111.087 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 53' ' ' GLU . 0.5 OUTLIER -108.53 5.39 25.1 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.511 0.56 . . . . 0.44 112.511 -178.391 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.543 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 35.1 t -134.61 -44.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.185 0.517 . . . . 0.44 110.042 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.02 -42.39 0.48 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.538 -0.756 . . . . 0.44 113.472 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.527 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.56 -176.48 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.016 0.436 . . . . 0.44 111.12 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -113.08 89.13 13.34 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.694 -0.685 . . . . 0.44 110.531 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.663 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.3 Cg_endo -107.82 143.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 123.272 2.648 . . . . 0.44 113.936 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.484 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.9 mt-30 -74.62 80.1 2.0 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.497 -2.038 . . . . 0.44 105.497 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.579 ' HA ' HG11 ' A' ' 87' ' ' VAL . 2.7 t-160 -122.64 133.32 54.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.041 -1.436 . . . . 0.44 111.474 -175.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.579 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -175.65 -145.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.754 -0.657 . . . . 0.44 110.617 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m 51.96 172.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.009 0.523 . . . . 0.44 112.138 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.821 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -140.26 122.18 15.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.44 110.62 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.55 -44.24 35.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.44 109.966 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.546 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -171.68 131.9 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.44 110.395 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -115.65 109.95 18.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.76 0.314 . . . . 0.44 110.552 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.429 HD21 ' CE1' ' A' ' 73' ' ' TYR . 2.8 tp -96.88 121.56 38.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.865 0.365 . . . . 0.44 110.964 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -123.14 109.69 14.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.44 110.442 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.429 ' CE1' HD21 ' A' ' 71' ' ' LEU . 2.0 p90 -141.26 149.84 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.44 110.882 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.435 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 2.6 pt-20 -121.23 129.05 52.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.213 0.53 . . . . 0.44 111.062 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 77' ' ' ASP . 1.0 OUTLIER -95.69 163.27 21.73 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.421 -0.809 . . . . 0.44 110.52 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.1 Cg_endo -53.18 82.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.964 2.443 . . . . 0.44 112.337 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER 92.5 8.69 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.419 -0.81 . . . . 0.44 111.618 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.566 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 4.1 ttp180 -137.25 93.87 2.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.675 0.274 . . . . 0.44 110.896 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.435 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 3.2 t-160 -86.84 93.98 9.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.453 -0.34 . . . . 0.44 110.778 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.559 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 1.7 tp -101.24 111.93 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.049 0.452 . . . . 0.44 110.889 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.82 118.81 37.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.792 -0.64 . . . . 0.44 109.751 179.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.35 114.19 23.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.933 0.397 . . . . 0.44 112.023 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.9 m0 -108.53 122.48 47.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.878 -0.601 . . . . 0.44 110.147 178.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.546 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.7 m-85 -108.91 111.6 23.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.876 0.369 . . . . 0.44 110.078 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.821 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.5 m95 -94.54 148.91 21.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.087 -0.506 . . . . 0.44 111.704 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.579 ' O ' ' O ' ' A' ' 65' ' ' PHE . 38.0 tp -97.94 102.44 14.19 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 121.342 0.592 . . . . 0.44 111.262 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.589 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 12.2 t -85.5 145.77 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 115.274 -0.875 . . . . 0.44 110.928 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -114.67 -24.12 8.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 114.422 1.267 . . . . 0.44 114.422 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.484 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 7.5 tpt180 -162.61 160.76 26.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.787 0.721 . . . . 0.44 111.677 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.663 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.8 OUTLIER -152.06 125.33 8.73 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.184 -0.462 . . . . 0.44 111.244 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -72.83 141.82 48.0 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.171 -0.468 . . . . 0.44 110.996 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.91 -118.92 11.98 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.759 -0.734 . . . . 0.44 112.53 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -131.92 142.86 46.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.552 0.215 . . . . 0.44 110.773 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HG2' ' CD1' ' A' ' 19' ' ' PHE . 3.2 Cg_exo -76.29 128.79 10.72 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.862 2.375 . . . . 0.44 111.412 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.583 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 47.6 p-90 -132.06 -62.08 0.86 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.46 -0.496 . . . . 0.44 112.097 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.543 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.92 -102.42 0.04 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.812 -0.708 . . . . 0.44 112.784 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 56' ' ' GLU . 6.7 tptp 179.33 35.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.778 0.323 . . . . 0.44 111.097 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -50.85 -37.37 42.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.408 -0.36 . . . . 0.44 110.791 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.4 -31.93 5.78 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.777 -0.725 . . . . 0.44 112.848 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -128.76 97.17 27.87 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.44 111.449 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -43.57 146.11 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.953 2.435 . . . . 0.44 112.475 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.08 177.15 19.35 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.606 -0.807 . . . . 0.44 112.958 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.83 157.42 42.27 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.268 -0.271 . . . . 0.44 110.268 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.75 105.91 3.37 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.622 -0.431 . . . . 0.44 110.19 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.72 163.31 18.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.962 -0.563 . . . . 0.44 110.908 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 t -73.82 114.94 12.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 0.44 110.412 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.53 -18.68 62.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.364 -0.38 . . . . 0.44 111.517 -179.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.94 -12.28 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.506 -0.315 . . . . 0.44 111.732 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.51 53.15 0.74 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.792 -0.718 . . . . 0.44 112.032 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.454 ' CD1' ' CE2' ' A' ' 35' ' ' PHE . 6.0 tt -62.21 150.45 38.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.922 0.392 . . . . 0.44 110.771 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -97.03 97.75 9.49 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.823 0.675 . . . . 0.44 112.823 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.451 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.42 -20.32 61.44 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.056 -0.52 . . . . 0.44 109.965 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.14 -45.46 19.94 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.948 -0.569 . . . . 0.44 111.203 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.72 -40.61 88.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.221 -0.445 . . . . 0.44 111.274 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.527 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.4 174.24 6.34 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.442 -0.577 . . . . 0.44 109.442 179.641 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.06 127.79 27.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 121.844 1.696 . . . . 0.44 112.301 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 50.1 Cg_endo -69.01 -35.28 15.16 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.662 2.241 . . . . 0.44 112.505 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.485 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -72.7 -9.51 58.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 0.44 111.218 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -104.1 19.77 19.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.776 -0.647 . . . . 0.44 110.796 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.567 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -74.96 -30.57 1.02 Allowed Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 113.684 0.994 . . . . 0.44 113.684 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.6 Cg_exo -43.19 -36.46 6.02 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 121.887 1.725 . . . . 0.44 113.196 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.448 HG13 ' CD1' ' A' ' 84' ' ' PHE . 23.7 t -77.82 -50.26 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.308 0.575 . . . . 0.44 110.264 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.457 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 48.6 mm -64.17 -33.9 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.279 -0.873 . . . . 0.44 111.701 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.58 44.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.001 0.429 . . . . 0.44 110.616 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -80.13 -50.71 9.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.894 -0.594 . . . . 0.44 111.739 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.47 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 2.0 tm? -78.12 -40.06 39.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.439 -0.346 . . . . 0.44 111.741 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.436 ' HB2' HG23 ' A' ' 123' ' ' ILE . 18.0 tttm -53.19 -42.7 66.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.256 -0.429 . . . . 0.44 111.12 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -66.98 -7.34 21.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.44 109.884 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 C--O 1.231 0.119 0 CA-C-N 116.07 -0.514 . . . . 0.44 111.185 179.821 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.663 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A 5071 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 5072 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 5073 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A 5074 ' ' HOH . . . . . 0.602 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.755 0.312 . . . . 0.44 111.204 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.64 147.18 27.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.44 110.944 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.99 126.59 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.44 110.606 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.468 HD12 " H1'" ' A' ' 131' ' ' 8OG . 4.0 pp -146.09 127.05 14.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.44 111.194 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -104.6 152.41 22.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.301 0.572 . . . . 0.44 112.006 -179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.444 ' N ' ' O ' ' A' ' 81' ' ' THR . 5.2 mp -146.44 123.14 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.235 -0.893 . . . . 0.44 110.421 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.62 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -125.09 125.68 44.15 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.466 -0.568 . . . . 0.44 109.466 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.606 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.3 m -131.21 162.49 39.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.38 0.61 . . . . 0.44 112.051 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -137.43 111.53 0.84 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.077 -0.965 . . . . 0.44 111.677 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.444 ' HB ' ' CD1' ' A' ' 18' ' ' ILE . 8.5 pt -70.41 105.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-O 120.724 0.297 . . . . 0.44 110.412 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.466 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.7 OUTLIER -71.63 125.75 30.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.21 -0.45 . . . . 0.44 111.778 -178.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -98.75 136.02 39.39 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.842 -0.617 . . . . 0.44 111.412 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.731 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.6 p-10 -96.48 -173.3 2.72 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.511 0.672 . . . . 0.44 112.018 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.46 -0.99 9.45 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.885 -1.052 . . . . 0.44 113.642 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.448 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 15.0 t-20 -120.69 33.28 5.63 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.625 -0.43 . . . . 0.44 112.135 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.56 13.78 2.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.44 111.351 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' HG3' ' HB3' ' A' ' 15' ' ' ASN . 4.9 mt-10 -102.08 161.16 13.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.129 -0.693 . . . . 0.44 109.129 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.455 HG13 ' HG2' ' A' ' 12' ' ' ARG . 0.1 OUTLIER -120.7 124.58 72.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.184 0.516 . . . . 0.44 112.012 -178.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -74.2 120.18 19.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.74 . . . . 0.44 110.652 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.411 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -129.08 150.4 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.496 . . . . 0.44 110.287 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 69.2 p -70.83 111.75 6.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.768 0.318 . . . . 0.44 110.593 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 38.9 ttp180 -126.57 126.3 43.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.44 110.957 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 48.87 -102.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.44 111.162 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 177.73 -177.42 0.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.754 0.312 . . . . 0.44 111.045 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.74 29.69 5.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.44 111.123 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -170.02 -54.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.44 111.031 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -178.86 132.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.323 -0.398 . . . . 0.44 111.147 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.6 -169.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 0.44 110.81 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.5 mmm -71.17 106.47 3.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.44 110.835 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -64.98 -18.85 65.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.44 111.354 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.01 30.59 2.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.508 -0.314 . . . . 0.44 111.113 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.431 ' O ' ' N ' ' A' ' 34' ' ' GLU . 10.7 mttt -114.11 26.14 10.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.938 0.399 . . . . 0.44 111.219 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 21' ' ' THR . 21.7 tp -61.24 77.33 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.697 -0.683 . . . . 0.44 111.033 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' N ' ' O ' ' A' ' 32' ' ' LYS . 2.7 mt-10 -115.75 -170.44 1.78 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.295 -0.411 . . . . 0.44 111.116 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.479 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.26 168.15 10.55 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.44 111.625 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.606 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 94.6 Cg_endo -84.28 166.64 12.44 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.585 2.857 . . . . 0.44 113.307 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.522 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.05 -5.93 53.52 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-N 115.73 -0.668 . . . . 0.44 114.254 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.13 161.99 18.74 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 121.02 -0.61 . . . . 0.44 112.891 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.724 ' CG ' ' H2 ' ' A' 5086 ' ' HOH . 0.0 OUTLIER 84.84 1.62 0.78 Allowed 'General case' 0 C--N 1.341 0.228 0 N-CA-C 112.285 0.476 . . . . 0.44 112.285 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.62 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.2 pt -51.82 -27.69 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.54 0.686 . . . . 0.44 110.294 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.54 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -41.1 -57.78 1.95 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.487 -1.233 . . . . 0.44 110.804 179.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.528 ' C ' ' O ' ' A' ' 41' ' ' GLU . 25.0 mmm 5.86 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.459 -0.791 . . . . 0.44 112.457 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 178.28 33.51 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.733 -0.746 . . . . 0.44 112.755 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -87.94 -174.13 4.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.761 0.315 . . . . 0.44 111.069 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.516 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.08 153.1 38.27 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.427 . . . . 0.44 110.267 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.516 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.76 -25.41 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.873 2.382 . . . . 0.44 112.487 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -104.02 -39.68 6.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.404 -0.362 . . . . 0.44 111.448 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -80.25 -8.48 59.48 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.753 0.279 . . . . 0.44 111.753 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.443 ' O ' ' HB2' ' A' ' 53' ' ' GLU . . . -60.68 -54.62 43.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.7 0.286 . . . . 0.44 110.744 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.506 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.4 m -78.09 -47.46 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.44 111.167 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.506 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 38.8 t -54.1 -37.95 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.44 111.176 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -78.38 -51.97 9.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.158 -0.474 . . . . 0.44 111.257 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' GLU . 1.2 mm-40 -65.14 -19.85 66.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.44 111.331 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.459 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -61.2 -44.66 96.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.683 0.277 . . . . 0.44 111.054 -179.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -35.79 82.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.119 -0.697 . . . . 0.44 109.119 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -77.68 -26.34 50.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.353 -0.84 . . . . 0.44 111.209 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 53' ' ' GLU . 7.3 mm-40 -108.32 5.34 25.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.273 0.472 . . . . 0.44 112.273 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.602 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 44.7 t -134.45 -44.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.234 0.54 . . . . 0.44 109.68 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.554 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.29 -41.47 0.37 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.308 -0.86 . . . . 0.44 113.817 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.51 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.84 -177.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.137 0.494 . . . . 0.44 111.42 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.41 89.0 13.97 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 115.432 -0.804 . . . . 0.44 109.896 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.534 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 6.1 Cg_endo -109.98 150.86 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.339 2.693 . . . . 0.44 114.475 -177.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -74.73 79.82 2.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.972 -1.862 . . . . 0.44 105.972 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.536 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.77 128.0 47.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.329 -1.305 . . . . 0.44 110.155 -176.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -176.31 -40.67 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 112.555 0.576 . . . . 0.44 112.555 -178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 86' ' ' LEU . 58.4 m -41.4 163.57 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.279 -0.873 . . . . 0.44 111.894 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.404 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.59 120.57 39.1 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.983 -0.553 . . . . 0.44 110.071 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.3 OUTLIER -88.56 -56.65 3.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.347 -0.388 . . . . 0.44 110.807 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -172.27 162.48 5.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.735 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 132.02 22.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.726 0.298 . . . . 0.44 110.774 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.415 HD22 ' CD1' ' A' ' 73' ' ' TYR . 3.4 tp -121.62 133.37 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.423 -0.353 . . . . 0.44 110.812 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -130.85 109.66 10.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.44 110.608 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.415 ' CD1' HD22 ' A' ' 71' ' ' LEU . 2.2 p90 -141.24 144.75 34.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.44 110.625 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.08 136.03 55.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.135 0.493 . . . . 0.44 111.373 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -99.58 163.04 19.28 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 0.44 110.32 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 12.8 Cg_endo -56.41 81.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.754 2.303 . . . . 0.44 112.217 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 9.0 t70 99.45 3.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.479 -0.782 . . . . 0.44 111.754 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.563 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 21.6 ttp180 -137.25 94.76 2.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.685 0.279 . . . . 0.44 110.953 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.5 t-160 -91.3 105.04 17.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.44 110.98 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.569 ' CG2' ' N2 ' ' A' ' 131' ' ' 8OG . 3.8 tt -106.11 132.6 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.233 -0.439 . . . . 0.44 110.91 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.51 118.73 31.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.968 -0.56 . . . . 0.44 109.541 178.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.03 114.25 23.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.96 0.409 . . . . 0.44 111.431 -179.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -107.52 122.59 46.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.002 -0.545 . . . . 0.44 110.191 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.468 ' CE1' HG12 ' A' ' 122' ' ' VAL . 2.4 m-85 -108.08 109.64 21.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.039 0.447 . . . . 0.44 110.627 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 39.0 m95 -98.15 148.4 23.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.44 111.705 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' N ' ' O ' ' A' ' 66' ' ' SER . 56.0 tp -94.02 138.41 32.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.78 -0.646 . . . . 0.44 111.384 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 64' ' ' HIS . 58.1 t -120.54 145.87 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-N 115.131 -0.94 . . . . 0.44 110.364 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -107.01 -28.5 9.99 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 114.27 1.211 . . . . 0.44 114.27 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.517 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.45 165.49 23.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.894 0.77 . . . . 0.44 111.64 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.731 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -155.31 123.63 5.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.354 -0.384 . . . . 0.44 111.356 178.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.63 147.18 44.01 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.046 -0.525 . . . . 0.44 111.048 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.08 -121.97 25.74 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.845 -0.693 . . . . 0.44 112.586 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -131.88 146.29 61.13 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.579 0.228 . . . . 0.44 110.781 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.5 128.74 10.53 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.793 2.329 . . . . 0.44 111.475 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.554 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 51.4 p-90 -130.42 -61.26 0.97 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.412 -0.515 . . . . 0.44 111.869 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.602 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 36.87 -97.69 0.01 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.08 -0.581 . . . . 0.44 113.214 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.58 40.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.651 0.263 . . . . 0.44 110.948 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.98 -25.44 64.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.456 -0.338 . . . . 0.44 111.075 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.42 -86.58 0.27 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.366 -0.921 . . . . 0.44 113.3 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -108.24 115.98 57.41 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.44 111.847 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.63 146.19 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.04 2.493 . . . . 0.44 112.81 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -122.94 177.31 16.56 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.903 -0.665 . . . . 0.44 113.006 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.31 157.52 36.47 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.462 -0.199 . . . . 0.44 110.462 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -64.53 105.99 1.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.915 0.388 . . . . 0.44 110.09 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.5 ptp -120.7 152.2 38.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.069 -0.514 . . . . 0.44 110.865 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.8 p -74.23 118.55 17.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.44 110.55 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.403 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -73.04 -18.62 61.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.47 -0.332 . . . . 0.44 111.41 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.64 -11.54 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.694 0.283 . . . . 0.44 111.547 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.13 54.45 0.73 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.465 -0.654 . . . . 0.44 111.465 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 tp -61.74 150.27 37.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.765 0.317 . . . . 0.44 110.787 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -109.95 103.73 12.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.866 0.691 . . . . 0.44 112.866 -178.367 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.535 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.54 -18.86 61.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.873 -0.603 . . . . 0.44 110.153 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -79.0 -47.07 16.93 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.963 -0.562 . . . . 0.44 111.45 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.451 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.63 -40.52 88.77 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.414 -0.357 . . . . 0.44 111.229 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.535 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.4 174.2 6.4 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.58 -0.526 . . . . 0.44 109.58 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.481 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.09 127.73 26.91 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.911 1.74 . . . . 0.44 112.489 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.29 -35.48 13.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.726 2.284 . . . . 0.44 112.465 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.453 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.05 -9.75 56.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.44 111.316 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.402 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 14.6 m-20 -107.73 19.73 19.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 0.44 110.997 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -66.67 -31.75 4.45 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 113.761 1.023 . . . . 0.44 113.761 -179.079 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.8 Cg_exo -43.85 -36.57 8.06 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.797 1.665 . . . . 0.44 113.276 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.468 HG12 ' CE1' ' A' ' 84' ' ' PHE . 55.1 t -77.88 -51.14 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.44 111.738 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.506 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 9.5 mm -74.84 -42.0 46.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 112.997 0.74 . . . . 0.44 112.997 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.82 -28.27 34.51 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.922 0.342 . . . . 0.44 111.922 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -80.8 -53.78 6.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.006 0.373 . . . . 0.44 112.006 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.494 ' HG ' ' CZ ' ' A' ' 68' ' ' PHE . 3.5 mm? -78.86 -31.12 45.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.98 0.363 . . . . 0.44 111.98 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.506 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 15.9 tttm -54.09 -42.1 68.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.044 0.449 . . . . 0.44 110.684 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 60.3 ttm-85 -70.41 -6.48 35.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.672 -0.695 . . . . 0.44 109.978 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 115.914 -0.584 . . . . 0.44 111.148 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.709 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A 5083 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 5084 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 5085 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A 5086 ' ' HOH . . . . . 0.724 ' H2 ' ' CG ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 ptm . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.768 0.318 . . . . 0.44 111.143 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -107.9 134.6 50.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 0.44 110.869 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 139.1 35.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.44 110.812 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.426 ' CD1' " H1'" ' A' ' 131' ' ' 8OG . 2.8 pp -146.23 123.64 11.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.44 111.155 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 39.8 mt-30 -102.69 149.01 24.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.136 0.493 . . . . 0.44 111.612 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.642 HG22 ' HA ' ' A' ' 82' ' ' LEU . 2.2 tp -146.59 125.61 4.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.49 -0.777 . . . . 0.44 110.912 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.614 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.98 125.5 43.98 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.223 -0.658 . . . . 0.44 109.223 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.633 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -131.14 162.13 39.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.102 -0.639 . . . . 0.44 112.293 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -141.13 111.28 0.7 Allowed Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.083 -0.962 . . . . 0.44 111.664 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.64 109.42 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.531 -0.544 . . . . 0.44 109.531 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.464 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -71.18 124.92 28.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.232 0.539 . . . . 0.44 111.785 -178.496 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.541 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.29 121.13 31.27 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.376 -0.829 . . . . 0.44 111.442 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.697 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.8 p30 -81.35 -172.96 4.08 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 123.704 0.628 . . . . 0.44 111.007 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tt0 -79.31 11.02 3.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.969 0.729 . . . . 0.44 112.969 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -136.4 48.22 2.15 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.988 -0.445 . . . . 0.44 112.128 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 44.85 27.36 0.26 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.319 0.58 . . . . 0.44 111.071 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.515 ' HB3' ' O ' ' A' ' 105' ' ' MET . 25.9 mt-10 -122.49 161.89 22.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.424 -0.807 . . . . 0.44 109.005 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.474 HG21 ' N ' ' A' ' 19' ' ' PHE . 6.6 mt -128.85 143.62 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.241 0.543 . . . . 0.44 111.83 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.474 ' N ' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.62 118.42 28.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.412 -0.813 . . . . 0.44 110.728 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.474 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -118.29 145.89 23.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.861 -0.422 . . . . 0.44 109.861 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.7 p -70.72 111.95 6.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.71 0.29 . . . . 0.44 110.528 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -123.02 123.15 40.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.44 110.95 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.2 ttp180 53.08 -102.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.44 110.915 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 174.45 -68.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.839 0.352 . . . . 0.44 110.968 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -170.59 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.44 111.09 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -160.79 38.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.44 110.947 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.0 132.44 41.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.44 111.048 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.22 87.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.44 111.036 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.0 mmt -155.08 28.42 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.827 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.11 -13.01 60.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.44 111.535 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -84.35 4.41 31.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.583 -0.281 . . . . 0.44 111.493 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 34' ' ' GLU . 2.7 mptp? -114.07 26.08 10.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.967 0.413 . . . . 0.44 111.196 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 21' ' ' THR . 22.4 tp -55.71 86.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.707 -0.679 . . . . 0.44 110.943 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -119.11 -170.86 2.0 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.084 0.469 . . . . 0.44 111.872 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.474 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.5 168.33 10.3 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.708 -0.678 . . . . 0.44 111.607 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.633 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 57.8 Cg_endo -72.06 166.93 28.17 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.377 2.718 . . . . 0.44 112.983 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.577 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 101.82 -5.76 54.03 Favored Glycine 0 C--O 1.222 -0.601 0 CA-C-N 115.914 -0.585 . . . . 0.44 113.876 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -61.96 140.97 47.11 Favored Glycine 0 C--N 1.316 -0.571 0 C-N-CA 121.161 -0.543 . . . . 0.44 113.262 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.565 ' HB2' ' H1 ' ' A' 5097 ' ' HOH . 0.0 OUTLIER 96.27 3.41 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.776 0.658 . . . . 0.44 112.776 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.614 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.2 pt -51.86 -27.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.489 0.661 . . . . 0.44 110.638 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.539 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.09 -76.53 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.663 -1.153 . . . . 0.44 111.173 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 41' ' ' GLU . 44.2 mmm 24.77 -85.48 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.708 0.63 . . . . 0.44 112.316 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.66 31.85 0.11 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.714 -0.755 . . . . 0.44 112.809 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.452 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.3 mp0 -89.96 -172.83 3.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.662 0.268 . . . . 0.44 111.195 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.52 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.88 153.06 37.95 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.422 -0.354 . . . . 0.44 110.376 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.52 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -44.06 -24.81 0.96 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.704 2.27 . . . . 0.44 112.643 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -103.39 -41.21 6.08 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.936 0.347 . . . . 0.44 111.936 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.409 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 12.9 mm-40 -80.2 -18.12 50.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.589 0.233 . . . . 0.44 111.618 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.452 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -58.04 -48.59 79.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.472 -0.331 . . . . 0.44 111.266 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.504 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.9 OUTLIER -78.15 -46.95 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.44 110.79 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.504 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 45.2 t -54.12 -37.5 35.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.785 -0.643 . . . . 0.44 111.441 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -78.07 -52.06 9.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.44 110.548 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -61.14 -19.99 62.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.12 -0.491 . . . . 0.44 110.605 179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.482 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -61.4 -44.86 96.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.299 -0.41 . . . . 0.44 111.047 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -69.23 -30.0 68.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.204 0.526 . . . . 0.44 109.762 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.7 tt0 -77.33 -29.57 53.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.44 111.062 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.447 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -109.08 6.67 25.19 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.835 0.679 . . . . 0.44 112.835 -178.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.577 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 46.0 t -133.41 -44.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.44 109.939 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.55 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.84 -39.17 0.18 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.7 -0.682 . . . . 0.44 114.237 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.508 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.69 -177.53 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.092 0.472 . . . . 0.44 111.33 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.43 88.99 13.99 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.514 -0.766 . . . . 0.44 109.953 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.542 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.5 Cg_endo -110.24 148.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.399 2.733 . . . . 0.44 114.312 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 40.3 mt-30 -74.93 79.81 2.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.962 -1.866 . . . . 0.44 105.962 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.554 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -124.82 128.8 49.27 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.052 -1.431 . . . . 0.44 109.664 -176.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.44 ' N ' ' HD1' ' A' ' 64' ' ' HIS . 1.6 t80 -173.98 -49.77 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.695 0.998 . . . . 0.44 113.695 -178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 86' ' ' LEU . 2.2 p -38.16 159.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.63 -0.713 . . . . 0.44 111.947 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 tt -119.32 116.63 26.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.44 110.888 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.96 -54.74 6.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.44 110.178 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.549 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.74 142.19 1.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.44 110.447 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.419 ' HE2' ' CZ3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -139.92 103.87 4.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.525 -0.307 . . . . 0.44 110.432 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.9 pp -111.46 160.79 16.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 0.44 111.174 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 -135.14 109.89 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.44 110.653 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -129.36 123.45 31.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.44 110.336 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.411 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 11.2 pt-20 -110.07 133.87 52.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.179 0.514 . . . . 0.44 111.616 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.512 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 2.8 m-85 -74.68 163.67 66.65 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.44 109.885 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.458 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.7 Cg_endo -37.38 -29.1 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.642 2.894 . . . . 0.44 113.214 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -139.62 -39.66 0.46 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.657 -0.701 . . . . 0.44 111.076 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -84.75 104.38 14.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.44 111.25 -179.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.411 ' ND1' ' HB3' ' A' ' 74' ' ' GLU . 0.5 OUTLIER -89.37 112.38 23.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.765 0.317 . . . . 0.44 110.572 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.547 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 3.2 tt -118.48 128.99 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.44 111.228 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.72 118.56 34.67 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.26 -0.644 . . . . 0.44 109.26 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.642 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -114.28 114.17 25.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.115 0.483 . . . . 0.44 112.031 -178.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.419 ' CZ3' ' HE2' ' A' ' 70' ' ' LYS . 10.5 m0 -110.22 122.08 46.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.58 -0.737 . . . . 0.44 110.201 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.453 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 6.1 m-30 -112.43 111.94 23.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.987 -0.551 . . . . 0.44 110.7 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 21.1 m95 -100.56 148.98 24.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.912 -0.586 . . . . 0.44 111.718 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 66' ' ' SER . 45.9 tp -93.97 138.69 31.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.768 -0.651 . . . . 0.44 111.514 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.554 ' CG1' ' HB2' ' A' ' 64' ' ' HIS . 44.8 t -120.09 145.7 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-N 115.195 -0.912 . . . . 0.44 110.095 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.99 -24.55 10.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.512 1.301 . . . . 0.44 114.512 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -163.66 164.96 23.78 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.958 0.799 . . . . 0.44 111.508 -178.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.697 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -157.24 123.54 4.89 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.94 0.4 . . . . 0.44 111.326 178.499 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -76.13 151.7 36.93 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.016 -0.538 . . . . 0.44 111.077 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.97 -122.66 28.17 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 0.44 112.558 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 13.6 mt-10 -132.17 147.87 67.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.516 0.198 . . . . 0.44 110.77 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.48 128.81 10.58 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.845 2.363 . . . . 0.44 111.202 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.55 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 52.5 p-90 -134.43 -64.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.139 -0.624 . . . . 0.44 112.539 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.577 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.85 -96.56 0.01 OUTLIER Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.934 -0.65 . . . . 0.44 113.143 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 173.44 38.83 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.678 0.275 . . . . 0.44 110.93 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -58.45 -49.42 77.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.4 -0.364 . . . . 0.44 110.855 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.44 -63.56 0.36 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.456 -0.878 . . . . 0.44 112.967 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.92 120.21 25.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.004 0.431 . . . . 0.44 111.637 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -43.48 146.28 1.33 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.101 2.534 . . . . 0.44 112.658 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.7 177.11 17.18 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.752 -0.737 . . . . 0.44 112.874 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -130.29 157.43 42.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.533 0.206 . . . . 0.44 110.472 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.466 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 1.0 OUTLIER -65.28 106.08 1.27 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.926 0.393 . . . . 0.44 110.272 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.515 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -120.83 163.21 18.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.22 -0.445 . . . . 0.44 111.224 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.414 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -77.32 115.96 17.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.44 110.791 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.4 ' HG ' HG22 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -80.05 -18.82 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.449 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.46 -12.62 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.494 -0.321 . . . . 0.44 111.601 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.87 54.88 0.63 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.845 -0.693 . . . . 0.44 111.979 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 tt -61.84 150.52 37.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.44 110.544 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.02 108.89 20.72 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.942 0.719 . . . . 0.44 112.942 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.545 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -16.96 61.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.686 -0.688 . . . . 0.44 110.062 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.01 -46.82 17.4 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.024 -0.534 . . . . 0.44 111.184 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.79 -40.51 88.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.976 -179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.545 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.61 174.02 6.72 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.082 -0.508 . . . . 0.44 109.642 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.43 127.71 27.08 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 121.893 1.728 . . . . 0.44 112.321 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.88 -37.49 11.41 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.643 2.229 . . . . 0.44 112.628 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.474 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.5 -9.58 56.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.44 111.481 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -104.69 21.78 16.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.861 -0.609 . . . . 0.44 110.829 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -71.87 -31.51 1.8 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.727 1.01 . . . . 0.44 113.727 -178.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 90.9 Cg_exo -44.07 -37.33 9.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.86 1.707 . . . . 0.44 113.188 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.453 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 58.8 t -77.67 -51.0 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.12 0.486 . . . . 0.44 110.63 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.461 ' O ' ' N ' ' A' ' 127' ' ' LYS . 43.1 mm -65.48 -30.61 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.677 -0.692 . . . . 0.44 111.33 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.86 -29.43 55.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.121 0.486 . . . . 0.44 110.493 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -78.27 -51.3 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.773 -0.648 . . . . 0.44 111.622 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.474 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 3.2 tm? -78.22 -19.91 52.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.369 -0.378 . . . . 0.44 111.814 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.461 ' N ' ' O ' ' A' ' 123' ' ' ILE . 4.9 ttpm? -75.18 -42.57 55.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.095 0.474 . . . . 0.44 110.51 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.0 ttm105 -67.77 -9.14 41.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.632 -0.713 . . . . 0.44 110.027 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 116.351 -0.386 . . . . 0.44 110.582 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.7 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 5095 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 5096 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A 5097 ' ' HOH . . . . . 0.565 ' H1 ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A 5098 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tpp . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.776 0.322 . . . . 0.44 111.235 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -98.97 141.19 32.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.44 110.948 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -140.26 138.11 34.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.44 110.594 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.461 HD13 " H1'" ' A' ' 131' ' ' 8OG . 3.9 pp -146.29 131.26 18.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.44 111.345 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -103.09 153.05 20.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.217 0.532 . . . . 0.44 111.965 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.446 ' CD1' ' CD1' ' A' ' 4' ' ' LEU . 5.0 mp -146.53 134.66 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.455 -0.793 . . . . 0.44 110.854 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.575 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.51 124.29 41.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.1 -0.704 . . . . 0.44 109.1 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.491 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.6 m -125.48 162.53 28.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.233 0.539 . . . . 0.44 112.005 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -145.95 113.5 0.69 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.303 -0.862 . . . . 0.44 112.146 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.585 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -70.69 101.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.205 -0.665 . . . . 0.44 109.205 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.461 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -71.04 123.35 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 121.306 0.574 . . . . 0.44 111.937 -178.374 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.81 123.62 34.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.347 -0.842 . . . . 0.44 111.482 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.492 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 12.5 t-20 -76.73 -172.31 2.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.08 -0.963 . . . . 0.44 111.865 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.427 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.7 tm-20 -83.15 4.05 28.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.316 -1.311 . . . . 0.44 112.093 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -138.41 50.85 1.87 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.346 . . . . 0.44 111.551 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.71 24.42 0.33 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.305 -0.407 . . . . 0.44 111.384 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' O ' ' N ' ' A' ' 13' ' ' ASN . 23.5 pt-20 -117.74 144.4 45.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.918 -0.771 . . . . 0.44 108.918 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.459 HG21 ' N ' ' A' ' 19' ' ' PHE . 6.1 mt -113.1 138.84 41.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.228 0.537 . . . . 0.44 111.754 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.459 ' N ' HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -91.27 108.29 19.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.366 -0.834 . . . . 0.44 110.275 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.532 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -107.86 155.89 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.083 -0.508 . . . . 0.44 110.141 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 p -71.04 111.81 6.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.686 0.279 . . . . 0.44 110.253 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.87 129.67 50.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.44 110.955 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.6 ttm180 48.01 -104.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.44 110.885 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 175.07 -166.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.794 0.331 . . . . 0.44 110.97 179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.52 -30.85 42.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.44 111.091 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -166.17 81.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.44 110.92 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.73 -171.17 3.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.44 111.118 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -123.07 31.26 6.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.93 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.96 50.23 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.44 110.855 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.72 -22.51 5.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.44 111.607 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.61 31.25 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.44 111.348 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -113.71 25.99 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.44 111.259 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 22' ' ' ARG . 1.8 tt -70.59 65.83 0.32 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.742 -0.663 . . . . 0.44 110.605 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.86 -169.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.44 111.444 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.532 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 3.0 m-85 -119.13 143.75 34.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.969 -0.559 . . . . 0.44 111.709 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.491 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 17.8 Cg_endo -58.23 165.98 6.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.741 2.294 . . . . 0.44 111.067 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 100.36 58.66 0.85 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 119.72 -1.228 . . . . 0.44 113.359 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -124.84 134.02 8.8 Favored Glycine 0 C--N 1.31 -0.879 0 CA-C-N 114.857 -0.672 . . . . 0.44 112.25 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 101.58 -2.47 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.394 0.516 . . . . 0.44 112.394 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.575 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -50.19 -26.27 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.219 0.533 . . . . 0.44 111.017 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.492 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.59 -68.67 0.16 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.045 -0.98 . . . . 0.44 110.973 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.455 ' C ' ' O ' ' A' ' 41' ' ' GLU . 76.6 mmm 23.54 -86.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.831 0.707 . . . . 0.44 112.318 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.97 29.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.44 112.832 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.438 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.5 mp0 -93.66 -173.7 3.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.792 0.329 . . . . 0.44 111.068 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.542 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.0 155.44 37.61 Favored Pre-proline 0 N--CA 1.456 -0.157 0 CA-C-N 116.435 -0.348 . . . . 0.44 110.327 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 4.1 Cg_endo -45.24 -24.6 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.651 2.234 . . . . 0.44 112.461 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.23 -50.17 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.218 0.451 . . . . 0.44 112.218 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -80.17 -29.55 38.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.721 0.296 . . . . 0.44 111.604 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.438 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -52.42 -45.86 66.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.91 0.386 . . . . 0.44 110.845 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.629 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -78.46 -50.55 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.044 -0.526 . . . . 0.44 110.898 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.525 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 55.5 t -54.45 -36.78 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.44 111.875 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -52.02 9.44 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.875 -0.33 . . . . 0.44 110.927 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.476 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.9 mm-40 -66.93 -25.0 66.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.334 -0.394 . . . . 0.44 110.722 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.629 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 12.4 tp -52.75 -45.76 67.19 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.874 0.369 . . . . 0.44 110.39 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -62.64 -26.68 68.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.058 -0.519 . . . . 0.44 109.84 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -71.43 -23.65 61.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.44 110.891 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.479 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.0 mm-40 -108.19 5.09 25.49 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.17 0.433 . . . . 0.44 112.17 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.517 ' CG2' ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -134.61 -44.7 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.424 0.63 . . . . 0.44 109.497 178.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.565 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 70.01 -36.6 0.4 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.276 -0.874 . . . . 0.44 114.597 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.555 HG12 ' O ' ' A' ' 93' ' ' GLU . 0.3 OUTLIER -84.4 -168.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 120.945 0.403 . . . . 0.44 110.882 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -111.73 89.29 10.87 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 115.831 -0.622 . . . . 0.44 110.603 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.61 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.3 Cg_endo -107.36 147.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.018 2.478 . . . . 0.44 113.997 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -74.83 80.05 2.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.07 -1.826 . . . . 0.44 106.07 176.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.6 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -123.87 129.05 50.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.307 -1.315 . . . . 0.44 110.481 -176.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.6 t80 179.6 163.5 0.98 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.932 0.396 . . . . 0.44 112.034 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 84.64 163.62 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.772 -0.649 . . . . 0.44 110.882 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.7 pp -121.8 127.55 50.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.286 -0.415 . . . . 0.44 111.071 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.64 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 1.5 p90 -76.81 -44.37 32.84 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.526 -0.469 . . . . 0.44 109.9 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.562 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 12.4 mt-10 -171.43 131.78 0.75 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.845 -0.616 . . . . 0.44 109.859 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.407 ' HD2' ' CD2' ' A' ' 83' ' ' TRP . 0.9 OUTLIER -132.53 132.0 42.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.592 -0.277 . . . . 0.44 110.635 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.436 ' N ' ' CD1' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -127.34 154.61 44.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.003 0.43 . . . . 0.44 111.23 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -131.8 109.78 10.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.44 110.377 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.451 ' CE2' ' CG2' ' A' ' 80' ' ' ILE . 55.4 p90 -125.97 151.87 46.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.44 110.604 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 5.6 pt-20 -120.16 140.12 51.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.361 0.6 . . . . 0.44 111.493 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.2 m-85 -103.44 162.73 19.15 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 115.355 -0.839 . . . . 0.44 110.085 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.5 Cg_endo -52.61 81.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.919 2.413 . . . . 0.44 112.174 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.2 t70 93.14 10.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.491 -0.777 . . . . 0.44 111.556 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.602 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.5 OUTLIER -137.37 93.82 2.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.735 -0.211 . . . . 0.44 110.679 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.423 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.7 t-80 -85.42 93.94 8.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.745 0.307 . . . . 0.44 110.69 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.557 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 2.7 tt -96.7 111.99 27.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.982 0.42 . . . . 0.44 111.397 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.61 118.54 36.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.857 -0.794 . . . . 0.44 108.857 178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 9.9 mt -120.71 114.12 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.631 -0.428 . . . . 0.44 111.936 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.422 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.4 m0 -110.42 122.11 46.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.814 -0.63 . . . . 0.44 109.838 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.64 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 3.2 m-85 -106.45 133.7 50.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.968 -0.56 . . . . 0.44 110.045 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 11.0 m95 -117.01 148.45 41.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.578 0.585 . . . . 0.44 112.578 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 65' ' ' PHE . 35.4 tp -85.9 138.24 32.17 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.57 -0.741 . . . . 0.44 111.319 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 64' ' ' HIS . 20.5 t -124.2 145.9 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-N 116.053 -0.522 . . . . 0.44 110.427 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -110.44 -32.07 7.06 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 114.268 1.21 . . . . 0.44 114.268 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.1 164.28 25.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.777 0.717 . . . . 0.44 111.843 -178.795 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.61 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 1.8 p90 -148.63 126.38 11.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.045 -0.525 . . . . 0.44 111.235 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.95 150.6 35.91 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.223 -0.444 . . . . 0.44 111.292 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.24 -129.98 48.8 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.852 -0.69 . . . . 0.44 112.707 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.555 ' O ' HG12 ' A' ' 60' ' ' ILE . 16.3 mt-10 -120.65 136.57 25.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.421 -0.214 . . . . 0.44 110.421 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.499 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.2 Cg_exo -74.46 128.85 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.573 2.182 . . . . 0.44 111.375 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.565 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 39.1 p-90 -130.22 -63.47 0.9 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.315 -0.554 . . . . 0.44 112.48 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 51.25 -109.51 0.79 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.479 -0.867 . . . . 0.44 112.603 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 168.55 41.95 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.769 0.318 . . . . 0.44 111.007 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.32 -46.31 79.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.44 110.861 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.11 -23.56 4.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.67 -0.776 . . . . 0.44 112.89 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.44 100.7 13.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.911 0.386 . . . . 0.44 111.306 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -43.5 143.3 2.58 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.912 2.408 . . . . 0.44 112.581 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.1 177.12 19.38 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.708 -0.758 . . . . 0.44 112.666 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -131.84 157.17 44.62 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.432 -0.21 . . . . 0.44 110.432 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -72.43 106.38 4.51 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.819 -0.353 . . . . 0.44 110.196 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.421 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.5 ptm -120.43 163.16 18.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.44 111.224 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.84 117.94 21.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.44 110.592 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.77 -18.84 46.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.392 . . . . 0.44 111.4 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.9 p -58.37 -14.65 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.583 -0.281 . . . . 0.44 111.611 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.33 49.95 0.91 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.953 -0.642 . . . . 0.44 111.785 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 10.0 tp -62.31 150.51 39.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.74 0.305 . . . . 0.44 111.098 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -111.0 92.92 4.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.635 0.605 . . . . 0.44 112.635 -178.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.51 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.5 -19.93 61.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.108 -0.496 . . . . 0.44 110.117 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -79.06 -45.31 20.38 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.927 -0.579 . . . . 0.44 111.394 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -42.16 87.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.268 -0.424 . . . . 0.44 111.112 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.538 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.34 174.37 6.13 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.626 -0.509 . . . . 0.44 109.626 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.09 127.87 27.51 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 121.99 1.793 . . . . 0.44 112.173 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.82 -39.13 11.99 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.727 2.284 . . . . 0.44 112.76 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.462 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.63 -9.63 57.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.083 0.468 . . . . 0.44 111.533 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -101.83 20.46 16.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.768 -0.651 . . . . 0.44 110.754 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -72.84 -31.08 1.42 Allowed Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 113.845 1.054 . . . . 0.44 113.845 -178.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.4 Cg_exo -43.71 -36.57 7.64 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.831 1.687 . . . . 0.44 113.011 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.517 HG13 ' CG ' ' A' ' 84' ' ' PHE . 69.9 t -77.91 -51.33 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.092 0.472 . . . . 0.44 110.958 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.493 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 17.8 mm -65.24 -34.63 71.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 115.608 -0.723 . . . . 0.44 111.75 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.23 -27.74 36.56 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.672 -0.411 . . . . 0.44 110.472 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -80.58 -53.04 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.44 111.934 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.417 HD22 ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -78.14 -32.97 50.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.528 -0.305 . . . . 0.44 111.75 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.456 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 8.3 ttpt -53.35 -42.21 66.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.978 0.418 . . . . 0.44 110.984 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 15.2 ttt-85 -71.02 -6.17 36.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.77 -0.65 . . . . 0.44 110.003 178.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 127' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 115.997 -0.547 . . . . 0.44 111.061 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.703 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A 5107 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 5108 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 5109 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A 5110 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 mtp . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.756 0.312 . . . . 0.44 111.265 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.85 146.62 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.44 110.85 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.06 139.57 35.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.44 110.837 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.411 ' CD1' " H1'" ' A' ' 131' ' ' 8OG . 2.8 pp -146.25 122.98 11.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.44 111.194 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -102.57 151.31 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.13 0.491 . . . . 0.44 111.378 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.52 HD12 " H4'" ' A' ' 131' ' ' 8OG . 2.0 tp -146.61 130.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.44 111.332 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.538 ' HB3' ' CG1' ' A' ' 40' ' ' ILE . . . -125.02 125.48 43.93 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.802 -0.814 . . . . 0.44 108.802 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m -139.93 154.8 23.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 119.831 -0.747 . . . . 0.44 112.269 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.05 120.92 2.34 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.856 -1.066 . . . . 0.44 111.461 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.529 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -70.35 108.43 2.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.148 -0.686 . . . . 0.44 109.148 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.542 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.05 124.98 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.155 0.502 . . . . 0.44 111.688 -178.146 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.633 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -100.7 129.25 46.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.242 -0.89 . . . . 0.44 111.3 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.69 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.8 p-10 -84.44 -172.87 4.41 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.43 0.634 . . . . 0.44 111.786 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.3 tm-20 -73.63 4.89 4.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.026 -0.988 . . . . 0.44 113.452 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -128.63 44.39 2.97 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.014 -0.429 . . . . 0.44 112.092 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 48.96 23.13 0.66 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.973 0.416 . . . . 0.44 111.473 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.409 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 33.6 mt-10 -114.0 161.61 17.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.156 -0.683 . . . . 0.44 109.156 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.485 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.0 OUTLIER -115.03 139.83 39.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.435 0.532 . . . . 0.44 112.435 -178.497 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.467 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 1.8 t80 -93.41 97.56 10.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.608 -0.724 . . . . 0.44 110.569 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.464 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -110.01 162.22 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.636 -0.505 . . . . 0.44 109.636 179.253 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.437 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 71.3 p -70.59 134.95 48.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.18 -0.304 . . . . 0.44 110.18 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.48 100.51 5.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.44 111.133 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 48.82 -95.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 0.44 111.24 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.57 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.272 -0.422 . . . . 0.44 111.047 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -169.49 -52.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.44 111.059 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -169.24 -49.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.44 110.905 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.4 90.3 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.44 111.03 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -169.09 -164.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.44 110.798 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.0 mtt -65.15 77.83 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.4 -0.364 . . . . 0.44 110.843 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.42 -13.04 61.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.44 111.687 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -95.65 23.14 6.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.591 -0.277 . . . . 0.44 111.276 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.34 26.39 10.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.44 111.577 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.437 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.2 tt -64.77 73.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.929 -0.578 . . . . 0.44 110.768 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.406 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -113.66 -172.06 2.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.063 0.459 . . . . 0.44 111.675 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.503 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.45 168.27 10.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.715 -0.675 . . . . 0.44 111.609 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.513 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 60.2 Cg_endo -72.63 166.88 28.63 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.42 2.746 . . . . 0.44 113.162 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 101.68 -5.33 54.15 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 116.011 -0.541 . . . . 0.44 113.99 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.582 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -65.34 132.56 35.76 Favored Glycine 0 C--N 1.315 -0.598 0 C-N-CA 121.094 -0.574 . . . . 0.44 112.727 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 106.36 1.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.273 0.629 . . . . 0.44 112.081 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.612 HG13 ' N ' ' A' ' 41' ' ' GLU . 0.9 OUTLIER -49.16 -29.8 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.672 0.748 . . . . 0.44 110.588 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.612 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -41.45 -58.65 1.82 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.338 -1.301 . . . . 0.44 111.105 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.538 ' C ' ' O ' ' A' ' 41' ' ' GLU . 12.6 mmt 2.68 -78.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.591 -0.731 . . . . 0.44 112.656 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.42 33.27 0.07 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.595 -0.812 . . . . 0.44 113.031 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.439 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 13.1 mp0 -101.55 -174.96 2.72 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.617 0.246 . . . . 0.44 111.037 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.508 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -105.42 152.39 39.91 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-N 116.554 -0.294 . . . . 0.44 110.283 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.508 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.68 -24.57 0.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.73 2.287 . . . . 0.44 112.463 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -94.39 -50.38 5.26 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.283 0.475 . . . . 0.44 112.283 -179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -80.42 -29.22 37.67 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.954 0.353 . . . . 0.44 111.954 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.451 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -55.6 -43.88 76.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.522 -0.308 . . . . 0.44 111.184 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.549 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 m -78.27 -48.75 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.89 0.376 . . . . 0.44 110.233 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.459 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 48.7 t -57.16 -35.91 49.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.871 -0.604 . . . . 0.44 110.75 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.4 mmt-85 -77.94 -50.14 12.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.44 110.497 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.71 -21.99 66.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.44 110.626 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -56.88 -44.75 82.6 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.931 0.396 . . . . 0.44 110.289 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -68.36 -28.05 66.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.44 110.348 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.33 -38.65 49.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.44 111.48 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.679 ' CG ' ' H1 ' ' A' 5121 ' ' HOH . 1.3 mp0 -104.66 5.16 33.35 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.322 0.49 . . . . 0.44 112.322 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.647 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 11.1 t -134.42 -43.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.048 0.451 . . . . 0.44 109.997 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.544 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.0 -35.06 0.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.706 -0.679 . . . . 0.44 114.418 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.772 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 5.4 tp -77.53 166.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.56 0.219 . . . . 0.44 110.773 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.73 89.05 1.36 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 108.86 -0.792 . . . . 0.44 108.86 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.772 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.0 Cg_endo -114.38 150.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 123.552 2.835 . . . . 0.44 114.525 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -74.94 79.42 2.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.43 -2.063 . . . . 0.44 105.43 175.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.552 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -123.39 127.61 48.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.565 -1.198 . . . . 0.44 110.492 -176.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -179.1 -134.12 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.44 110.634 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.432 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 55.77 166.34 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.918 0.39 . . . . 0.44 111.849 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 6.9 tt -127.87 110.79 12.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.969 -0.56 . . . . 0.44 111.047 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.79 -45.25 29.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.122 0.486 . . . . 0.44 109.821 179.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.52 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.3 tt0 -171.6 156.72 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.44 110.364 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.28 104.32 4.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.501 -0.318 . . . . 0.44 110.453 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.417 HD23 ' CD1' ' A' ' 73' ' ' TYR . 4.7 tp -96.84 135.79 38.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.889 0.376 . . . . 0.44 111.097 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -126.98 109.48 11.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.44 110.615 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.417 ' CD1' HD23 ' A' ' 71' ' ' LEU . 4.2 p90 -141.41 128.64 21.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.44 110.449 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.442 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 7.9 pt-20 -116.02 130.73 56.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 0.44 111.56 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 2.7 m-85 -71.11 163.33 66.44 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 115.595 -0.729 . . . . 0.44 110.026 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.466 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.4 Cg_endo -38.06 -29.14 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.598 2.865 . . . . 0.44 113.036 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -139.63 -38.43 0.48 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.633 -0.712 . . . . 0.44 111.009 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.496 ' HG2' ' N2 ' ' A' ' 131' ' ' 8OG . 0.9 OUTLIER -83.86 99.85 10.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.44 111.284 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.442 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 4.1 t60 -87.01 110.33 19.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.785 0.326 . . . . 0.44 110.673 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.566 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 2.5 tt -115.27 137.38 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.961 0.41 . . . . 0.44 110.935 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.74 118.43 30.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.045 -0.525 . . . . 0.44 109.656 178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.48 HD13 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -107.18 113.87 27.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.44 111.384 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.453 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 8.7 m0 -114.99 122.43 46.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.176 0.512 . . . . 0.44 110.32 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.48 ' CE1' HD13 ' A' ' 82' ' ' LEU . 3.9 m-85 -110.68 124.08 51.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.654 -0.703 . . . . 0.44 111.572 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.549 ' CE2' HG11 ' A' ' 50' ' ' VAL . 66.4 m95 -108.58 148.64 30.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.025 -0.534 . . . . 0.44 110.76 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.525 ' O ' ' O ' ' A' ' 65' ' ' PHE . 37.6 tp -99.53 103.21 14.93 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.448 0.642 . . . . 0.44 111.746 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.552 HG13 ' HA ' ' A' ' 64' ' ' HIS . 19.0 t -83.23 145.58 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.155 -0.93 . . . . 0.44 111.515 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -104.27 -50.74 3.27 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.15 1.167 . . . . 0.44 114.15 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.15 165.76 24.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.488 0.586 . . . . 0.44 112.508 -178.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.69 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 24.1 p90 -133.81 159.57 40.22 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.134 -0.485 . . . . 0.44 111.506 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.19 102.15 14.17 Favored 'General case' 0 N--CA 1.46 0.039 0 CA-C-N 116.325 -0.398 . . . . 0.44 111.237 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.4 -112.09 4.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.57 -0.824 . . . . 0.44 112.384 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.1 tt0 -131.53 135.4 26.88 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.212 . . . . 0.44 111.224 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.482 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 5.2 Cg_exo -76.5 139.6 20.68 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.856 2.371 . . . . 0.44 111.211 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.544 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 33.4 p-90 -134.59 -63.45 0.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.486 -0.485 . . . . 0.44 112.19 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.647 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.77 -104.68 0.04 OUTLIER Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.614 -0.721 . . . . 0.44 113.308 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt 168.22 40.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.75 0.31 . . . . 0.44 110.897 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -23.68 62.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.472 -0.331 . . . . 0.44 111.081 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 145.3 -86.85 0.17 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.349 -0.929 . . . . 0.44 113.078 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.07 118.78 47.28 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.06 0.457 . . . . 0.44 111.649 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.55 146.19 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.192 2.595 . . . . 0.44 112.802 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.09 177.42 19.14 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.81 -0.709 . . . . 0.44 112.846 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -122.69 157.23 32.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.566 0.222 . . . . 0.44 110.436 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.444 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -68.38 106.37 2.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.976 0.417 . . . . 0.44 110.24 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.9 ptm -120.54 152.02 38.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.44 111.105 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.25 114.9 8.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.44 110.637 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 1.0 OUTLIER -59.17 -18.5 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.44 111.66 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.7 p -52.75 -14.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 111.758 0.281 . . . . 0.44 111.758 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.83 54.37 0.72 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.97 -0.633 . . . . 0.44 111.635 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.422 HD23 ' CG2' ' A' ' 123' ' ' ILE . 3.8 tt -61.77 150.53 36.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.886 0.374 . . . . 0.44 110.918 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.415 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -100.61 93.2 5.48 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.991 0.737 . . . . 0.44 112.991 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.421 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.48 -21.42 61.21 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.704 -0.48 . . . . 0.44 109.704 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -79.22 -44.91 20.89 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.941 -0.572 . . . . 0.44 111.07 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -66.72 -40.11 88.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.138 -0.483 . . . . 0.44 111.372 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.53 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.37 174.39 6.09 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.323 -0.621 . . . . 0.44 109.323 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.475 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.8 Cg_endo -53.79 127.78 26.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.899 1.733 . . . . 0.44 112.603 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.416 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 49.6 Cg_endo -68.41 -36.11 16.44 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.885 2.39 . . . . 0.44 112.366 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.47 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -71.4 -9.54 58.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.07 0.462 . . . . 0.44 111.071 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -106.02 16.66 24.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.44 111.055 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.576 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -73.44 -30.97 1.29 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 113.5 0.926 . . . . 0.44 113.5 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.1 Cg_exo -43.57 -36.37 7.04 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.847 1.698 . . . . 0.44 113.51 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.462 ' CG1' ' CE1' ' A' ' 84' ' ' PHE . 17.6 t -77.88 -51.27 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.145 0.498 . . . . 0.44 110.534 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.44 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 20.4 mm -65.48 -30.99 51.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.46 -0.791 . . . . 0.44 111.25 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.89 47.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.44 110.614 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -49.83 11.52 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.922 -0.581 . . . . 0.44 111.653 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -78.3 -28.84 47.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.494 -0.321 . . . . 0.44 111.405 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.41 ' HB2' HG22 ' A' ' 123' ' ' ILE . 7.9 ttpt -55.01 -42.54 72.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.109 0.48 . . . . 0.44 110.654 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -64.05 -12.61 40.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.698 -0.683 . . . . 0.44 109.521 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 5.0 mp . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.887 -0.597 . . . . 0.44 110.947 179.681 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.709 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 5119 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 5120 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A 5121 ' ' HOH . . . . . 0.679 ' H1 ' ' CG ' ' A' ' 57' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A 5122 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.738 0.304 . . . . 0.44 111.117 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -109.97 144.45 38.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.44 110.962 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -140.11 130.17 24.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.44 110.68 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.413 HD13 ' CD1' ' A' ' 6' ' ' ILE . 3.2 pp -146.19 124.72 12.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.393 . . . . 0.44 111.369 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.418 ' HB2' ' HA ' ' A' ' 41' ' ' GLU . 30.4 mt-30 -102.81 151.7 22.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.44 111.419 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.466 ' CD1' " O4'" ' A' ' 131' ' ' 8OG . 2.1 mp -146.53 127.09 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.652 -0.703 . . . . 0.44 110.904 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.531 ' HB1' ' CG1' ' A' ' 40' ' ' ILE . . . -124.77 125.63 44.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.381 -0.6 . . . . 0.44 109.381 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.519 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -144.36 162.16 14.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.207 -0.597 . . . . 0.44 111.833 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.401 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -147.76 125.62 2.17 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.321 -0.854 . . . . 0.44 111.692 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.475 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.84 110.92 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.455 -0.572 . . . . 0.44 109.455 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.603 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.53 125.31 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-O 121.178 0.513 . . . . 0.44 111.537 -178.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.604 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.92 118.93 30.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.542 -0.754 . . . . 0.44 111.194 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.707 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 2.9 p-10 -79.64 -172.22 3.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.331 0.586 . . . . 0.44 111.389 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.6 tm-20 -77.08 13.46 1.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.582 0.956 . . . . 0.44 113.582 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -143.25 51.89 1.37 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.393 -0.523 . . . . 0.44 112.214 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.17 27.62 0.22 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.023 0.439 . . . . 0.44 111.571 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' C ' ' OD1' ' A' ' 13' ' ' ASN . 23.2 mt-10 -122.94 161.75 23.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.052 -0.721 . . . . 0.44 109.052 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.491 HG23 ' N ' ' A' ' 19' ' ' PHE . 8.1 mt -128.22 144.11 38.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.189 0.519 . . . . 0.44 112.186 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.491 ' N ' HG23 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -88.68 115.21 26.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.57 -0.741 . . . . 0.44 110.446 179.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.43 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.46 133.34 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.39 -0.368 . . . . 0.44 110.404 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.4 p -70.97 114.44 9.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.39 . . . . 0.44 111.042 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 1.5 ptm180 -121.78 131.58 54.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.44 110.691 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 47.22 -103.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.486 . . . . 0.44 110.813 -179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 170.54 -166.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 0.44 110.915 179.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.21 -29.94 34.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.44 111.165 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.18 33.4 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 0.44 111.109 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.58 167.73 9.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.44 111.062 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -117.29 37.63 3.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.44 110.999 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.1 mtt -116.03 68.46 0.72 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.912 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.58 -19.03 56.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 0.44 111.458 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.29 31.09 2.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.523 -0.308 . . . . 0.44 111.267 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.22 25.94 10.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.983 0.421 . . . . 0.44 111.574 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.469 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 38.6 tp -68.68 71.72 0.21 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.902 -0.59 . . . . 0.44 110.449 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -109.43 -167.21 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.44 111.175 -179.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.517 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -119.12 168.29 10.18 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.44 111.566 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.519 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 85.1 Cg_endo -84.08 167.51 12.45 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.695 2.93 . . . . 0.44 113.695 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.484 ' CA ' ' HG2' ' A' ' 57' ' ' GLU . . . 102.92 -3.23 48.49 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.241 -0.89 . . . . 0.44 114.525 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -64.2 165.04 31.77 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 117.264 0.532 . . . . 0.44 113.793 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.611 ' HD2' ' H1 ' ' A' 5134 ' ' HOH . 0.0 OUTLIER 86.0 0.51 0.66 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.188 0.595 . . . . 0.44 112.046 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.619 ' HA ' ' HG3' ' A' ' 53' ' ' GLU . 1.0 OUTLIER -50.92 -28.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.675 0.75 . . . . 0.44 110.552 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.582 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.9 -58.23 2.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.427 -1.261 . . . . 0.44 111.161 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.0 mmt 6.96 -79.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.887 0.742 . . . . 0.44 112.579 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 179.56 34.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.541 -0.837 . . . . 0.44 113.03 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -93.76 -170.45 2.34 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.653 0.263 . . . . 0.44 111.045 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.519 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.68 153.19 38.03 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.509 -0.314 . . . . 0.44 110.314 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.9 -25.0 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.796 2.331 . . . . 0.44 112.396 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.57 -42.99 5.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.5 -0.318 . . . . 0.44 111.818 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -11.16 59.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.787 0.292 . . . . 0.44 111.787 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -60.03 -53.97 51.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.86 0.362 . . . . 0.44 110.81 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.577 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 0.2 OUTLIER -78.27 -50.14 19.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.184 -0.462 . . . . 0.44 110.914 179.401 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.2 t -51.75 -37.76 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.44 111.407 -178.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -78.49 -52.19 8.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.333 -0.394 . . . . 0.44 111.291 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.619 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.1 mm-40 -66.0 -20.02 66.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.358 -0.383 . . . . 0.44 110.586 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.603 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 9.4 tp -55.53 -45.01 77.24 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.405 -0.361 . . . . 0.44 110.282 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -35.89 82.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.174 0.512 . . . . 0.44 109.713 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.1 -25.45 62.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.44 109.968 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.679 ' HG3' ' H2 ' ' A' 5133 ' ' HOH . 0.6 OUTLIER -108.36 6.73 26.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.782 -0.644 . . . . 0.44 112.185 -178.724 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -133.39 -44.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.064 0.459 . . . . 0.44 109.952 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.513 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.54 -37.79 0.22 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.648 -0.705 . . . . 0.44 114.456 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.463 ' H ' ' C ' ' A' ' 58' ' ' VAL . 0.6 OUTLIER -86.76 -174.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 120.853 0.358 . . . . 0.44 110.919 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.78 88.64 14.36 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.902 -0.59 . . . . 0.44 110.498 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.522 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.9 Cg_endo -110.84 146.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.514 2.809 . . . . 0.44 113.811 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.414 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 37.6 mt-30 -74.79 79.83 2.09 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.623 -1.991 . . . . 0.44 105.623 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.535 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -119.3 132.44 55.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.268 -1.333 . . . . 0.44 110.867 -176.446 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.94 -136.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.183 -0.462 . . . . 0.44 110.651 -179.466 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 54.08 165.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.079 0.466 . . . . 0.44 111.885 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 7.2 tt -128.02 108.84 11.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.865 -0.607 . . . . 0.44 110.798 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.86 -43.36 36.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.44 110.302 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 11.8 tt0 -171.27 156.11 4.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 0.44 110.553 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.453 ' HD3' ' CE2' ' A' ' 83' ' ' TRP . 1.4 ttmm -143.27 105.73 4.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.165 -0.471 . . . . 0.44 110.657 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.407 HD21 ' CE1' ' A' ' 73' ' ' TYR . 1.1 tp -97.09 136.29 37.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.44 111.054 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -140.02 109.64 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.44 110.409 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.416 ' CZ ' HG22 ' A' ' 80' ' ' ILE . 2.3 p90 -141.18 152.22 44.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.44 110.829 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.429 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.1 pt-20 -121.13 135.81 55.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.168 0.509 . . . . 0.44 111.29 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -101.12 163.21 18.39 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.491 -0.777 . . . . 0.44 110.183 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.3 Cg_endo -53.86 82.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.779 2.319 . . . . 0.44 112.068 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.0 m-20 92.96 8.81 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.277 -0.874 . . . . 0.44 111.659 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.546 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 20.6 ttp180 -137.3 93.83 2.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.601 0.239 . . . . 0.44 110.86 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.429 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 20.2 t-80 -90.38 107.45 19.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.44 110.962 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.599 ' CG2' ' N2 ' ' A' ' 131' ' ' 8OG . 3.3 tt -107.53 146.42 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.44 110.762 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.07 118.82 18.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.44 110.02 179.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.409 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.0 OUTLIER -117.21 114.22 23.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.798 0.332 . . . . 0.44 111.169 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.453 ' CE2' ' HD3' ' A' ' 70' ' ' LYS . 8.5 m0 -106.93 122.23 46.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.64 -0.504 . . . . 0.44 109.64 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.457 ' CE2' ' CG1' ' A' ' 122' ' ' VAL . 2.2 m-85 -111.49 109.9 20.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.084 0.468 . . . . 0.44 111.665 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 58.8 m95 -94.81 148.71 22.01 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.834 -0.621 . . . . 0.44 110.82 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.5 tp -97.84 102.79 14.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.549 0.69 . . . . 0.44 111.367 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.603 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 18.0 t -83.53 146.29 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 114.937 -1.029 . . . . 0.44 111.441 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -108.56 -40.15 5.19 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.731 1.382 . . . . 0.44 114.731 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.604 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 2.3 ptp180 -163.34 165.72 23.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.064 0.847 . . . . 0.44 112.527 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.707 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 3.3 p90 -145.44 133.35 21.27 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.926 -0.579 . . . . 0.44 111.453 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -81.25 121.18 25.84 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.153 -0.476 . . . . 0.44 110.875 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.98 -128.16 8.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 0.44 112.426 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.1 tt0 -123.43 139.29 31.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 O-C-N 122.886 -0.185 . . . . 0.44 110.818 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.49 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 2.6 Cg_exo -76.2 128.72 10.75 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.885 2.39 . . . . 0.44 111.514 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.513 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 61.4 p-90 -132.86 -61.08 0.85 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.34 -0.544 . . . . 0.44 112.06 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.588 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.83 -104.37 0.05 OUTLIER Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.834 -0.698 . . . . 0.44 113.256 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.24 37.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.684 0.278 . . . . 0.44 111.049 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -26.84 63.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.479 -0.328 . . . . 0.44 111.026 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.32 -67.6 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.553 -0.832 . . . . 0.44 112.939 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.89 110.84 32.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.989 0.423 . . . . 0.44 111.545 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -43.64 146.16 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.973 2.449 . . . . 0.44 112.517 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.42 177.01 18.58 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.653 -0.784 . . . . 0.44 112.856 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -116.49 157.29 25.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.664 0.269 . . . . 0.44 110.56 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.496 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.25 106.57 5.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.91 0.386 . . . . 0.44 110.476 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.8 ptm -120.18 160.71 22.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.44 110.877 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.427 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 22.3 p -73.07 115.25 12.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 0.44 110.928 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.18 -18.92 65.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.44 111.214 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.12 -12.4 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.475 -0.33 . . . . 0.44 111.446 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.97 47.63 1.01 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.954 -0.641 . . . . 0.44 111.892 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 tp -62.01 150.12 38.96 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.333 -0.247 . . . . 0.44 110.333 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -122.57 118.57 28.54 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.816 0.672 . . . . 0.44 112.816 -178.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.575 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.37 -19.61 61.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.445 -0.798 . . . . 0.44 110.125 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -78.96 -47.27 16.64 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.067 -0.515 . . . . 0.44 110.996 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.84 -20.17 65.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.119 -0.491 . . . . 0.44 111.362 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.575 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.47 172.04 4.24 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.675 -0.491 . . . . 0.44 109.675 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -54.48 127.81 27.55 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.01 1.807 . . . . 0.44 112.318 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.15 -38.78 8.63 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.723 2.282 . . . . 0.44 112.652 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.455 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -68.84 -9.76 53.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.44 111.528 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 14.4 m-20 -104.71 18.59 21.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.0 -0.546 . . . . 0.44 110.969 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.556 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -66.66 -31.88 4.58 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 113.97 1.1 . . . . 0.44 113.97 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 84.6 Cg_exo -44.32 -36.61 9.51 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.831 1.687 . . . . 0.44 113.504 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.457 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 93.0 t -77.89 -51.41 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.44 111.038 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.488 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 7.3 mm -68.68 -29.88 45.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 115.98 -0.554 . . . . 0.44 111.489 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.72 -27.0 37.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.979 0.419 . . . . 0.44 110.232 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -80.1 -51.85 8.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.876 -0.602 . . . . 0.44 111.684 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -78.03 -34.09 50.73 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.49 -0.323 . . . . 0.44 111.627 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.406 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 13.7 tttm -52.98 -42.72 65.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.192 -0.458 . . . . 0.44 111.002 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -69.29 -7.76 39.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.771 -0.65 . . . . 0.44 109.945 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-N 115.931 -0.577 . . . . 0.44 111.278 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.682 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 5131 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 5132 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A 5133 ' ' HOH . . . . . 0.679 ' H2 ' ' HG3' ' A' ' 57' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A 5134 ' ' HOH . . . . . 0.611 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.867 0.365 . . . . 0.44 111.187 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -99.7 145.27 27.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.44 110.998 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -140.01 132.27 28.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.44 110.823 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pp -146.18 126.18 13.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.44 111.134 -179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -102.53 154.17 19.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.254 0.55 . . . . 0.44 111.87 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.421 HG12 " C4'" ' A' ' 131' ' ' 8OG . 4.5 mp -146.27 125.28 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.256 -0.884 . . . . 0.44 110.581 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.605 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.82 125.7 44.43 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.31 -0.626 . . . . 0.44 109.31 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.603 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.2 m -140.1 162.64 24.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.202 0.525 . . . . 0.44 111.858 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -135.84 123.42 2.99 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.243 -0.889 . . . . 0.44 111.649 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.543 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.8 OUTLIER -70.91 105.02 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.608 -0.516 . . . . 0.44 109.608 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.572 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -70.68 126.25 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.138 0.494 . . . . 0.44 111.941 -178.053 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -101.65 124.99 48.21 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.142 -0.935 . . . . 0.44 111.097 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.609 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.4 p-10 -79.15 -172.59 3.21 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 123.77 0.669 . . . . 0.44 111.382 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.3 tm-20 -76.14 9.22 2.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.204 -0.907 . . . . 0.44 113.337 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -132.89 46.91 2.56 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.958 -0.464 . . . . 0.44 112.098 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.54 24.53 0.52 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.055 0.455 . . . . 0.44 111.495 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 105' ' ' MET . 22.5 mt-10 -115.95 161.24 19.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.971 -0.751 . . . . 0.44 108.971 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -113.68 134.02 57.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 112.352 0.501 . . . . 0.44 112.352 -178.655 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 11' ' ' ILE . 40.7 t80 -91.84 95.18 9.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.376 -0.829 . . . . 0.44 110.433 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.465 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -111.25 162.42 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.44 110.733 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.8 p -70.63 132.68 45.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.44 110.563 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -119.75 105.25 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.391 . . . . 0.44 110.962 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 ttp85 56.15 -100.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.44 110.971 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -179.21 -167.73 0.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.828 0.347 . . . . 0.44 111.019 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.27 -41.79 6.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.44 111.111 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -112.58 -36.07 5.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.44 110.917 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.96 -179.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 0.44 111.09 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -138.73 31.45 2.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.44 110.936 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.6 tpt -96.09 86.81 4.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.44 110.919 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.62 -11.79 60.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 0.44 111.557 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -94.52 29.36 2.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.657 0.265 . . . . 0.44 111.087 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 26.1 10.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.941 0.401 . . . . 0.44 111.708 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.435 ' HB2' ' HB3' ' A' ' 114' ' ' ASP . 14.7 tp -69.01 69.51 0.18 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.956 -0.565 . . . . 0.44 110.555 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -110.48 -172.65 2.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.539 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.514 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.39 168.7 9.48 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.62 . . . . 0.44 111.374 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.603 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 84.1 Cg_endo -81.28 166.96 17.96 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.528 2.818 . . . . 0.44 113.586 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.12 -5.63 53.07 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.429 -0.805 . . . . 0.44 114.002 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -58.94 162.99 10.79 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.183 -0.532 . . . . 0.44 112.942 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' HD2' ' H2 ' ' A' 5146 ' ' HOH . 0.0 OUTLIER 81.93 2.13 1.4 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.474 0.546 . . . . 0.44 112.474 179.108 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.605 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.2 pt -50.34 -28.92 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.616 0.722 . . . . 0.44 110.262 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.579 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -40.89 -57.44 1.96 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.219 -1.355 . . . . 0.44 110.961 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER 2.93 -78.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.931 0.77 . . . . 0.44 112.522 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 176.27 35.04 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.44 112.937 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -89.9 -172.72 3.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.677 0.275 . . . . 0.44 111.057 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.51 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.6 152.29 38.08 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.455 -0.339 . . . . 0.44 110.203 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.51 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.77 -25.09 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.751 2.301 . . . . 0.44 112.501 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -104.06 -39.59 6.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.457 -0.338 . . . . 0.44 111.378 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.419 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 2.9 mt-30 -80.37 -9.55 59.75 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.708 0.262 . . . . 0.44 111.708 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.427 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -58.64 -54.76 43.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.866 0.365 . . . . 0.44 110.811 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.503 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -78.64 -46.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.976 -0.556 . . . . 0.44 111.47 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 40.4 t -56.53 -44.74 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.44 111.852 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 7.7 mtp180 -72.81 -46.12 54.81 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.674 -0.41 . . . . 0.44 110.912 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' CG ' ' OE1' ' A' ' 57' ' ' GLU . 0.9 OUTLIER -69.43 -19.88 63.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.114 -0.494 . . . . 0.44 110.79 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.485 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -57.91 -44.6 86.92 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.822 0.344 . . . . 0.44 110.714 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.43 -30.69 71.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.105 0.478 . . . . 0.44 109.807 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.42 -34.39 54.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.601 -0.727 . . . . 0.44 111.414 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.581 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.6 mp0 -108.36 6.43 26.39 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 112.95 0.722 . . . . 0.44 112.95 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.588 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 34.3 t -133.8 -44.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.391 . . . . 0.44 110.45 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.538 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.01 -36.43 0.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.837 -0.62 . . . . 0.44 114.467 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.736 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 19.6 tt -77.37 163.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.58 0.228 . . . . 0.44 110.684 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.405 ' N ' HG12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -103.62 88.76 1.9 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 108.582 -0.896 . . . . 0.44 108.582 178.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.736 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.3 Cg_endo -115.12 152.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 123.558 2.839 . . . . 0.44 114.847 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.95 79.74 2.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.382 -2.081 . . . . 0.44 105.382 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.555 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.93 128.3 47.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.633 -1.167 . . . . 0.44 110.83 -176.146 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.3 t80 -176.85 -140.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.17 -0.468 . . . . 0.44 110.909 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.405 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 2.7 m 50.78 175.98 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.142 0.496 . . . . 0.44 112.008 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.833 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -142.99 121.17 12.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.44 111.006 179.481 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.92 -44.0 33.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.44 110.057 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.3 mt-10 -171.65 131.82 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.756 -0.656 . . . . 0.44 110.468 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.46 111.15 18.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.542 -0.299 . . . . 0.44 110.373 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.443 ' CD2' ' CD1' ' A' ' 73' ' ' TYR . 0.8 OUTLIER -96.94 141.97 29.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.44 111.132 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -137.87 109.9 7.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.44 110.53 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.443 ' CD1' ' CD2' ' A' ' 71' ' ' LEU . 2.0 p90 -137.71 149.97 46.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.44 110.694 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -118.82 139.67 51.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.223 0.535 . . . . 0.44 111.525 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.485 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.6 m-85 -103.02 162.67 19.4 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.402 -0.817 . . . . 0.44 110.192 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.5 Cg_endo -53.65 81.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.934 2.423 . . . . 0.44 112.131 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.0 t0 93.76 8.6 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.458 -0.792 . . . . 0.44 111.509 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 33.9 ttp180 -137.32 93.67 2.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.699 0.285 . . . . 0.44 110.758 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.27 110.94 19.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.806 0.336 . . . . 0.44 110.69 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.548 ' CG2' ' N2 ' ' A' ' 131' ' ' 8OG . 3.6 tt -108.09 146.64 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.22 0.533 . . . . 0.44 111.204 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.18 118.53 17.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.651 -0.704 . . . . 0.44 109.529 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.9 tp -119.15 114.01 21.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.923 0.392 . . . . 0.44 111.254 -179.191 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.417 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 9.5 m0 -111.06 122.15 47.16 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.44 110.084 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 2.5 m-85 -106.12 113.3 26.75 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.868 -0.605 . . . . 0.44 109.977 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.833 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.7 m95 -94.72 148.35 22.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.44 111.671 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.9 tm? -94.3 102.59 14.6 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 121.395 0.617 . . . . 0.44 110.592 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.572 ' HB ' ' HA ' ' A' ' 11' ' ' ILE . 14.9 t -89.85 145.37 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 115.148 -0.933 . . . . 0.44 111.813 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -99.94 -59.68 1.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.178 1.177 . . . . 0.44 114.178 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 10.5 ptm180 -163.34 166.0 23.46 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.205 0.457 . . . . 0.44 112.22 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.648 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 41.9 p90 -125.79 164.7 20.12 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.152 -0.476 . . . . 0.44 111.634 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.439 ' N ' HD12 ' A' ' 60' ' ' ILE . 32.2 tt0 -104.13 95.83 6.24 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 116.173 -0.467 . . . . 0.44 110.919 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.01 -112.08 4.05 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.724 -0.75 . . . . 0.44 112.168 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -134.33 130.2 20.04 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.528 0.204 . . . . 0.44 111.17 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.428 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 4.8 Cg_exo -76.63 128.82 10.47 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.766 2.31 . . . . 0.44 111.372 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.538 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 6.9 p-90 -123.07 -65.7 1.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.191 0.52 . . . . 0.44 111.337 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.588 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 50.41 -117.33 4.96 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.468 -0.787 . . . . 0.44 113.288 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 177.57 35.96 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.72 0.295 . . . . 0.44 111.258 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.419 ' HB3' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -49.75 -30.33 9.25 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.512 -0.313 . . . . 0.44 110.942 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.4 -25.13 7.86 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.461 -0.876 . . . . 0.44 113.797 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -138.86 112.31 8.22 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 117.197 0.499 . . . . 0.44 111.754 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -43.57 145.39 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.935 2.423 . . . . 0.44 112.551 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.416 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.19 177.51 19.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 0.44 112.855 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -144.66 157.1 44.34 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.233 -0.284 . . . . 0.44 110.233 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.47 106.53 0.94 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.754 -0.379 . . . . 0.44 110.11 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.462 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -120.2 156.13 31.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.44 111.039 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.38 116.05 17.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.25 -0.432 . . . . 0.44 110.853 179.633 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.406 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -61.65 -18.74 60.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.44 111.386 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.37 -3.99 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.467 -0.333 . . . . 0.44 111.639 179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.69 48.39 0.97 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.872 -0.68 . . . . 0.44 111.995 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.4 ' CD2' HD22 ' A' ' 107' ' ' LEU . 0.1 OUTLIER -61.56 128.24 35.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.983 -0.377 . . . . 0.44 109.983 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.417 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -111.02 114.13 27.2 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.676 0.621 . . . . 0.44 112.676 -178.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.559 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -19.29 61.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.58 -0.736 . . . . 0.44 109.857 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -78.83 -47.69 16.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.01 -0.541 . . . . 0.44 110.843 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.75 -14.18 62.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.08 -0.509 . . . . 0.44 111.46 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.559 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -113.56 171.27 4.51 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.668 -0.493 . . . . 0.44 109.668 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.473 ' HD2' ' CD2' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.07 127.85 27.42 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.187 1.925 . . . . 0.44 112.373 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.99 -39.14 8.43 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.759 2.306 . . . . 0.44 112.866 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.452 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -68.71 -9.74 52.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.988 0.423 . . . . 0.44 111.538 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.445 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 21.7 m-20 -104.14 14.49 30.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.897 -0.592 . . . . 0.44 111.057 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.532 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -61.78 -32.25 9.75 Favored Pre-proline 0 N--CA 1.467 0.4 0 N-CA-C 114.403 1.26 . . . . 0.44 114.403 -178.503 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.9 Cg_exo -44.24 -41.5 13.19 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.712 1.608 . . . . 0.44 113.458 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.5 HG11 ' CE2' ' A' ' 84' ' ' PHE . 35.8 t -77.69 -51.04 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.831 0.348 . . . . 0.44 111.059 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.528 HG13 ' CE2' ' A' ' 115' ' ' PHE . 38.2 mm -62.9 -33.77 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.44 111.403 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -29.6 54.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.955 0.407 . . . . 0.44 110.487 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -79.95 -45.21 18.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.44 111.339 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.454 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 22.9 tp -78.28 -50.08 12.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.379 . . . . 0.44 111.216 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.435 ' N ' ' O ' ' A' ' 123' ' ' ILE . 6.5 ttpt -53.21 -34.9 59.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.44 110.995 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -63.6 -10.16 17.15 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.434 -0.58 . . . . 0.44 109.434 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.406 ' N ' HD12 ' A' ' 129' ' ' LEU . 10.5 mp . . . . . 0 CA--C 1.528 0.118 0 CA-C-N 115.762 -0.654 . . . . 0.44 111.251 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.688 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A 5143 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5144 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5145 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A 5146 ' ' HOH . . . . . 0.615 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.811 0.338 . . . . 0.44 111.18 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -75.89 138.31 40.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.44 110.903 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -140.05 130.48 25.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.44 110.848 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.414 HD12 ' CD1' ' A' ' 6' ' ' ILE . 3.4 pp -146.19 128.36 15.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.44 111.162 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -102.85 150.52 23.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 0.44 112.025 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.441 ' CD1' " H4'" ' A' ' 131' ' ' 8OG . 4.2 mp -146.55 121.83 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.353 -0.839 . . . . 0.44 110.204 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.61 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -125.12 125.35 43.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.276 -0.639 . . . . 0.44 109.276 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 35' ' ' PHE . 1.3 m -139.67 162.21 26.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.318 -0.553 . . . . 0.44 111.576 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -136.39 139.3 10.55 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.385 -0.825 . . . . 0.44 111.933 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.583 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -83.47 112.66 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.42 -0.585 . . . . 0.44 109.42 179.262 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.8 OUTLIER -70.81 123.66 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 121.051 0.453 . . . . 0.44 111.493 -178.61 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.16 124.65 35.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.691 . . . . 0.44 111.858 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.486 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 13.2 t30 -81.75 -172.09 3.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.24 -0.891 . . . . 0.44 111.805 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -81.52 3.99 22.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.317 -1.311 . . . . 0.44 112.453 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -139.5 52.01 1.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.882 -0.327 . . . . 0.44 111.35 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 45.76 24.64 0.22 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.213 -0.449 . . . . 0.44 111.475 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.445 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 16.0 pt-20 -117.01 138.57 51.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.887 -0.783 . . . . 0.44 108.887 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.538 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 7.5 mt -105.97 139.7 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.26 0.552 . . . . 0.44 112.038 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 18.4 t80 -80.93 91.3 6.0 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.238 -0.892 . . . . 0.44 110.393 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.5 156.81 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.194 -0.457 . . . . 0.44 109.919 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 25.7 p -70.77 129.46 39.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.843 0.354 . . . . 0.44 110.709 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.48 102.26 6.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.44 110.712 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.8 ttm105 61.3 -112.49 0.49 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.445 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 171.67 -166.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.44 110.938 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.27 28.46 4.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.44 111.062 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.52 -80.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.44 110.883 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -179.41 -65.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.45 -0.341 . . . . 0.44 111.179 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -57.5 176.88 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.44 111.128 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mmt 61.69 35.32 17.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.44 110.874 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.12 -8.92 56.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.44 111.749 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.55 24.72 5.67 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.714 0.292 . . . . 0.44 111.176 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.34 26.09 10.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.919 0.39 . . . . 0.44 111.515 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 0.6 OUTLIER -67.25 70.33 0.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 0.44 110.967 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.36 -172.66 2.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.44 110.684 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.57 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -110.68 166.01 11.58 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.863 0.363 . . . . 0.44 110.956 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 36.4 Cg_endo -65.47 166.69 18.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.415 2.743 . . . . 0.44 114.174 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.521 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 101.85 -5.96 54.11 Favored Glycine 0 C--O 1.225 -0.469 0 CA-C-N 114.877 -1.056 . . . . 0.44 114.027 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -57.15 155.67 16.29 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 117.337 0.569 . . . . 0.44 112.528 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.512 ' HD2' ' H1 ' ' A' 5157 ' ' HOH . 0.0 OUTLIER 84.82 7.07 0.5 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.076 0.399 . . . . 0.44 112.076 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.61 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -51.62 -28.43 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.715 0.769 . . . . 0.44 110.156 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.552 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -39.75 -60.64 0.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.218 -1.355 . . . . 0.44 110.731 179.337 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.528 ' C ' ' O ' ' A' ' 41' ' ' GLU . 8.7 mmt 5.8 -81.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.363 -0.835 . . . . 0.44 112.537 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.27 28.75 0.08 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.725 -0.75 . . . . 0.44 112.943 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -94.41 -174.71 3.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.773 0.321 . . . . 0.44 111.06 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.545 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.45 156.51 39.39 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.787 -0.449 . . . . 0.44 109.787 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.545 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.65 -24.66 0.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.799 2.333 . . . . 0.44 112.708 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.25 -57.73 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.035 0.383 . . . . 0.44 112.035 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -80.52 -4.26 53.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.91 0.337 . . . . 0.44 111.91 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.463 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -59.28 -57.73 11.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.44 110.97 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.471 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.2 m -79.01 -45.65 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.896 -0.593 . . . . 0.44 111.475 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.471 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 38.6 t -52.21 -38.84 25.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.44 111.099 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mmm-85 -78.15 -41.54 34.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.263 -0.426 . . . . 0.44 110.531 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.31 -19.89 62.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.44 110.76 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.436 HD11 ' CD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -58.59 -44.76 89.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.883 0.373 . . . . 0.44 110.402 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -32.13 70.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.052 0.453 . . . . 0.44 110.344 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.17 -31.92 55.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.766 -0.652 . . . . 0.44 111.499 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.05 3.96 24.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.522 0.564 . . . . 0.44 112.522 -178.479 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.629 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 11.3 t -134.69 -44.11 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.206 0.527 . . . . 0.44 109.934 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.16 -32.88 0.25 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.388 -0.824 . . . . 0.44 114.046 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.51 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -77.89 179.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 120.617 0.246 . . . . 0.44 110.6 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.97 88.4 10.02 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 109.576 -0.527 . . . . 0.44 109.576 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.645 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -110.78 144.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.527 2.818 . . . . 0.44 113.968 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 18.3 mt-30 -74.68 79.62 2.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.144 -2.169 . . . . 0.44 105.144 175.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.62 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.85 134.16 54.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.092 -1.413 . . . . 0.44 110.982 -175.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 179.97 -140.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.869 -0.605 . . . . 0.44 110.352 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.404 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 0.9 OUTLIER 50.33 176.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.138 0.494 . . . . 0.44 111.932 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.78 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.9 OUTLIER -143.88 123.31 13.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.566 . . . . 0.44 111.043 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.6 -43.77 37.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.186 0.517 . . . . 0.44 109.658 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.1 mt-10 -171.83 131.8 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.472 -0.786 . . . . 0.44 110.224 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.06 109.38 17.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.782 0.325 . . . . 0.44 110.408 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.418 HD23 ' CD1' ' A' ' 73' ' ' TYR . 3.9 tp -96.99 131.09 44.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.44 111.126 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -133.68 109.67 9.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.368 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.418 ' CD1' HD23 ' A' ' 71' ' ' LEU . 2.2 p90 -141.29 131.77 25.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.941 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.423 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 2.9 pm0 -102.76 138.92 39.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.115 0.483 . . . . 0.44 111.228 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -106.53 163.4 17.07 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.52 -0.764 . . . . 0.44 110.215 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.449 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.3 Cg_endo -51.87 82.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.87 2.38 . . . . 0.44 112.176 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 75' ' ' PHE . 12.5 m-20 89.56 11.16 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.289 -0.869 . . . . 0.44 111.518 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.617 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -137.49 93.73 2.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.263 . . . . 0.44 110.733 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.423 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 13.0 t-160 -89.72 98.98 12.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.346 . . . . 0.44 110.857 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.584 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 0.6 OUTLIER -104.27 111.91 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.44 110.774 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 118.68 37.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.876 -0.602 . . . . 0.44 109.686 179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.4 tp -116.47 113.91 23.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.915 0.388 . . . . 0.44 111.722 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.8 m0 -110.31 122.55 47.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.005 -0.543 . . . . 0.44 110.398 179.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.519 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.6 m-85 -108.09 113.06 25.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.175 -0.466 . . . . 0.44 110.134 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.78 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.4 m95 -94.67 148.6 22.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.147 -0.479 . . . . 0.44 111.801 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.0 tm? -99.1 102.86 14.7 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.334 0.588 . . . . 0.44 111.355 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 64' ' ' HIS . 14.6 t -84.18 146.03 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 115.351 -0.84 . . . . 0.44 111.097 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -113.63 -24.97 8.93 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.119 1.155 . . . . 0.44 114.119 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.515 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -162.68 162.83 27.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.63 0.65 . . . . 0.44 111.777 -178.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.645 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -155.2 141.81 18.84 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.286 -0.416 . . . . 0.44 111.3 178.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.2 mt-10 -77.88 136.2 38.01 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-O 120.793 0.33 . . . . 0.44 111.383 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.94 -108.44 0.2 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.963 -0.637 . . . . 0.44 112.695 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 23.5 tt0 -131.25 135.78 27.68 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.473 0.178 . . . . 0.44 110.826 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.504 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.8 Cg_exo -76.04 128.85 10.97 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.801 2.334 . . . . 0.44 111.197 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 14.6 p-90 -114.15 -64.91 1.24 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.127 0.418 . . . . 0.44 112.127 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.629 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.31 -103.43 0.03 OUTLIER Glycine 0 CA--C 1.52 0.386 0 CA-C-N 115.635 -0.711 . . . . 0.44 113.251 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 tptp 174.08 40.19 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.697 0.284 . . . . 0.44 111.261 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.44 ' HA ' ' CG ' ' A' ' 57' ' ' GLU . 21.7 pt-20 -61.86 -47.06 86.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.575 -0.284 . . . . 0.44 110.868 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 160.86 -120.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.423 -0.894 . . . . 0.44 113.101 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -75.82 123.88 88.43 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.17 0.509 . . . . 0.44 111.788 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -43.7 146.32 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.257 2.638 . . . . 0.44 112.701 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.88 177.38 18.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.831 -0.699 . . . . 0.44 112.989 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -126.9 157.26 39.87 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.366 -0.235 . . . . 0.44 110.366 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CG ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -68.47 106.11 2.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.881 0.372 . . . . 0.44 110.252 -179.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.6 ptm -120.58 163.3 18.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.017 -0.538 . . . . 0.44 111.015 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.21 114.94 17.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.825 0.345 . . . . 0.44 110.549 179.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.84 -18.84 61.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.44 111.238 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.6 p -61.92 -9.3 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.645 -0.252 . . . . 0.44 111.563 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.25 49.18 0.94 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.818 -0.706 . . . . 0.44 111.96 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.4 tp -62.15 150.2 39.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.253 -0.277 . . . . 0.44 110.253 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.44 121.27 39.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.133 0.79 . . . . 0.44 113.133 -178.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.611 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.49 -21.65 61.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.374 -0.83 . . . . 0.44 110.269 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.7 -43.77 25.15 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.064 -0.516 . . . . 0.44 111.318 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.59 -37.52 85.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.402 . . . . 0.44 110.783 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.611 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.22 172.95 6.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.458 -0.571 . . . . 0.44 109.458 179.205 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HD2' ' CD2' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.27 127.82 27.43 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.012 1.808 . . . . 0.44 112.036 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.15 -39.0 8.3 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.666 2.244 . . . . 0.44 112.871 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.43 ' HB2' ' O6 ' ' A' ' 131' ' ' 8OG . . . -68.57 -9.8 51.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.933 0.397 . . . . 0.44 111.524 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.459 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 26.0 m-20 -104.95 20.47 18.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.892 -0.595 . . . . 0.44 110.741 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -62.03 -31.74 8.45 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 114.177 1.177 . . . . 0.44 114.177 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 79.8 Cg_exo -44.29 -43.89 13.17 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.771 1.647 . . . . 0.44 113.61 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.485 HG12 ' CD1' ' A' ' 84' ' ' PHE . 95.7 t -77.75 -51.52 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.775 0.321 . . . . 0.44 111.563 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.526 HG13 ' CE2' ' A' ' 115' ' ' PHE . 37.4 mm -64.74 -29.98 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.44 111.484 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.56 -32.14 66.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.985 0.421 . . . . 0.44 110.437 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -80.11 -45.58 17.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.862 -0.608 . . . . 0.44 111.323 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.455 ' HB2' ' CZ ' ' A' ' 68' ' ' PHE . 3.3 tm? -78.26 -19.79 52.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.603 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 123' ' ' ILE . 6.2 ttpm? -79.14 -42.64 25.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 0.44 110.681 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -67.75 -7.85 30.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.691 . . . . 0.44 109.962 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 CA-C-N 116.239 -0.437 . . . . 0.44 110.743 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.688 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 5155 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 5156 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A 5157 ' ' HOH . . . . . 0.512 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A 5158 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttp . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.901 0.381 . . . . 0.44 111.134 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -109.97 126.42 53.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.44 110.825 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.1 133.91 30.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.44 110.766 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -146.12 124.66 12.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.44 111.089 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -102.66 147.9 26.24 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.273 0.559 . . . . 0.44 111.565 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.444 HG13 " C4'" ' A' ' 131' ' ' 8OG . 33.7 mm -146.4 124.83 4.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.267 -0.879 . . . . 0.44 110.687 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.612 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.82 125.19 43.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.698 -0.482 . . . . 0.44 109.698 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.554 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m -133.51 162.2 40.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.66 -0.416 . . . . 0.44 111.062 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.53 126.15 2.83 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.79 -0.719 . . . . 0.44 112.117 179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.555 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -74.81 108.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.519 -0.549 . . . . 0.44 109.519 179.374 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -71.03 123.73 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.038 0.447 . . . . 0.44 111.151 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.43 124.02 34.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.637 -0.711 . . . . 0.44 111.653 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.463 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 13.9 t30 -81.61 -172.16 3.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.117 -0.947 . . . . 0.44 112.051 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.83 2.94 24.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.182 -1.372 . . . . 0.44 112.507 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -140.19 52.34 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.346 . . . . 0.44 111.441 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.6 p30 45.96 24.35 0.23 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.44 111.397 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 16.8 pt-20 -114.68 142.58 46.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.985 -0.746 . . . . 0.44 108.985 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 7.3 mt -115.58 136.79 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.141 0.496 . . . . 0.44 111.623 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.43 ' O ' ' CG ' ' A' ' 19' ' ' PHE . 0.0 OUTLIER -83.84 111.14 18.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.573 -0.74 . . . . 0.44 110.593 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.518 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -115.97 149.1 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.44 110.212 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 13.9 p -70.84 132.4 45.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.471 -0.331 . . . . 0.44 110.553 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 30.1 ttt180 -137.76 110.49 7.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.386 . . . . 0.44 110.968 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 ttm105 56.52 -113.61 0.78 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.19 -0.459 . . . . 0.44 110.81 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -177.55 36.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.349 . . . . 0.44 111.172 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.07 27.65 13.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.44 111.244 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -178.44 159.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.44 110.829 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.36 90.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.44 111.215 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -167.76 90.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.44 110.867 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 61.19 70.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.44 110.978 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.72 -14.53 60.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.44 111.432 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.35 31.06 2.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.514 -0.312 . . . . 0.44 111.075 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.28 25.94 11.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.103 0.478 . . . . 0.44 111.338 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.6 tp -62.77 84.38 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.728 -0.669 . . . . 0.44 110.769 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -126.13 -165.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.345 -0.389 . . . . 0.44 111.153 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.518 ' CD2' ' CG2' ' A' ' 20' ' ' ILE . 0.0 OUTLIER -118.86 168.31 10.01 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.44 111.334 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.554 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 84.8 Cg_endo -79.4 167.37 21.29 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.416 2.744 . . . . 0.44 113.025 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.533 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.86 -5.65 50.88 Favored Glycine 0 C--O 1.224 -0.489 0 CA-C-N 115.719 -0.673 . . . . 0.44 114.462 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.493 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.09 152.44 46.7 Favored Glycine 0 C--N 1.318 -0.436 0 C-N-CA 120.896 -0.669 . . . . 0.44 112.585 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.587 ' HD2' ' H1 ' ' A' 5169 ' ' HOH . 0.0 OUTLIER 91.76 3.53 0.1 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 122.827 0.451 . . . . 0.44 112.151 179.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.612 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.3 pt -52.46 -27.32 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.444 0.64 . . . . 0.44 110.379 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.507 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.78 -64.01 0.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.574 -1.194 . . . . 0.44 110.832 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.483 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 17.94 -83.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.509 -0.769 . . . . 0.44 112.448 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 178.68 35.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.724 -0.751 . . . . 0.44 112.867 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.46 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -92.17 -170.68 2.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.654 0.264 . . . . 0.44 111.076 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.506 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.67 153.08 38.42 Favored Pre-proline 0 N--CA 1.456 -0.131 0 N-CA-C 110.234 -0.284 . . . . 0.44 110.234 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.506 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.74 -24.9 0.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.786 2.324 . . . . 0.44 112.454 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -102.49 -43.86 5.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.366 -0.379 . . . . 0.44 111.592 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.5 -4.83 55.35 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 111.783 0.29 . . . . 0.44 111.783 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.46 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -61.91 -57.3 12.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.706 0.289 . . . . 0.44 110.738 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -78.78 -46.22 24.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.274 -0.421 . . . . 0.44 111.267 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 37.6 t -55.71 -40.53 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.44 112.14 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -78.11 -51.76 9.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.78 0.324 . . . . 0.44 111.221 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 1.4 mm-40 -68.54 -20.87 64.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.305 -0.407 . . . . 0.44 110.937 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.654 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 4.5 tp -51.18 -44.78 61.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.471 -0.566 . . . . 0.44 109.471 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -32.95 69.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.44 109.457 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -77.35 -29.84 53.58 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.525 -0.761 . . . . 0.44 110.941 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.496 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 6.0 mp0 -104.9 5.54 32.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.418 0.525 . . . . 0.44 112.418 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.543 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 1.6 t -134.38 -44.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.12 0.486 . . . . 0.44 110.005 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.519 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.34 -39.98 0.28 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.643 -0.708 . . . . 0.44 114.336 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.483 HG21 ' O ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -77.92 -174.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.088 0.471 . . . . 0.44 111.896 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.54 87.79 26.9 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 115.608 -0.724 . . . . 0.44 109.639 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.525 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 11.7 Cg_endo -112.06 146.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 123.733 2.955 . . . . 0.44 113.968 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -74.88 79.72 2.13 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 106.134 -1.802 . . . . 0.44 106.134 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.562 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -121.01 130.14 53.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.821 -1.536 . . . . 0.44 110.227 -176.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 86' ' ' LEU . 6.1 t80 178.52 160.88 0.62 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.458 0.54 . . . . 0.44 112.458 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 88.62 -165.64 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.735 -0.666 . . . . 0.44 111.209 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.745 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.5 pp -152.37 131.76 12.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.538 -0.301 . . . . 0.44 111.27 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 2.1 p90 -76.75 -41.81 43.44 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.501 -0.48 . . . . 0.44 109.773 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.553 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 13.0 mt-10 -171.12 131.46 0.79 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.707 -0.679 . . . . 0.44 109.583 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 132.06 55.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.754 0.312 . . . . 0.44 110.852 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.417 HD21 ' CD1' ' A' ' 73' ' ' TYR . 1.3 tp -110.66 139.14 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.392 -0.367 . . . . 0.44 110.99 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -138.42 109.6 6.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.44 110.504 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.417 ' CD1' HD21 ' A' ' 71' ' ' LEU . 2.1 p90 -141.52 137.25 31.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.44 110.87 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 2.3 pt-20 -121.17 132.07 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.202 0.525 . . . . 0.44 111.194 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.485 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 1.1 m-85 -83.21 163.9 48.3 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 115.514 -0.766 . . . . 0.44 110.2 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.416 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -38.68 -28.62 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.626 2.884 . . . . 0.44 113.261 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -139.77 -38.04 0.48 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.69 -0.686 . . . . 0.44 111.163 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.538 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 25.0 ttp180 -86.32 102.78 14.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.44 111.421 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.403 ' ND1' ' HB3' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -92.67 99.91 12.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.46 -0.337 . . . . 0.44 110.286 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.556 ' CG2' ' N2 ' ' A' ' 131' ' ' 8OG . 3.7 tt -101.23 147.95 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.066 0.46 . . . . 0.44 111.088 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -134.19 118.48 17.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.811 -0.631 . . . . 0.44 109.63 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.423 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.2 mp -114.58 113.51 24.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.44 111.31 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 11.0 m0 -110.97 122.45 47.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 0.44 109.734 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.59 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 2.7 m-85 -113.19 112.72 24.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.037 0.446 . . . . 0.44 110.858 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.745 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 25.5 m95 -95.58 148.49 22.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.662 -0.699 . . . . 0.44 111.648 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 65' ' ' PHE . 35.5 tp -90.23 138.84 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.705 -0.68 . . . . 0.44 110.745 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.562 HG12 ' HA ' ' A' ' 64' ' ' HIS . 17.9 t -123.23 144.67 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-N 116.405 -0.361 . . . . 0.44 110.711 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.11 -27.78 8.24 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 114.012 1.116 . . . . 0.44 114.012 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.518 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.07 160.08 24.0 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 119.922 -0.711 . . . . 0.44 111.875 -178.938 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.525 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.6 OUTLIER -152.92 123.24 7.13 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.995 -0.548 . . . . 0.44 110.962 178.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.86 150.11 32.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.067 -0.515 . . . . 0.44 111.324 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.59 -144.37 30.12 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.971 -0.633 . . . . 0.44 112.77 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.483 ' O ' HG21 ' A' ' 60' ' ' ILE . 44.7 tt0 -105.59 134.92 19.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 110.334 -0.247 . . . . 0.44 110.334 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.43 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.3 Cg_exo -76.12 128.8 10.86 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.686 2.257 . . . . 0.44 111.61 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.519 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 34.2 p-90 -124.91 -61.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.518 -0.473 . . . . 0.44 111.735 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.543 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 48.74 -110.53 0.73 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.453 -0.88 . . . . 0.44 112.88 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.29 50.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.44 111.075 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -35.53 64.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.44 110.498 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.26 -5.55 45.4 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.626 -0.797 . . . . 0.44 113.348 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -140.12 96.02 8.24 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.981 0.419 . . . . 0.44 111.445 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -43.6 144.0 2.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.913 2.408 . . . . 0.44 112.35 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.1 177.13 19.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.525 -0.845 . . . . 0.44 113.124 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -139.26 157.44 45.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.127 -0.323 . . . . 0.44 110.127 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.03 106.41 0.5 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.702 -0.399 . . . . 0.44 110.065 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.444 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.4 mtp -120.11 163.47 17.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.44 111.252 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 81.7 p -90.79 114.8 27.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.231 -0.441 . . . . 0.44 110.559 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -18.53 65.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 0.44 111.207 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.9 p -53.67 -16.36 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.323 -0.398 . . . . 0.44 111.77 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.71 55.0 0.68 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.893 -0.67 . . . . 0.44 111.93 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.43 HD21 ' CE2' ' A' ' 35' ' ' PHE . 11.1 tp -62.07 150.49 38.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.878 0.371 . . . . 0.44 110.889 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -98.31 95.75 7.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.775 0.657 . . . . 0.44 112.775 -178.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.452 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.6 -21.55 61.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.18 -0.464 . . . . 0.44 110.084 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -79.05 -44.67 21.71 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.022 -0.536 . . . . 0.44 111.199 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -41.2 88.37 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.28 -0.418 . . . . 0.44 111.227 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.523 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.45 174.29 6.27 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.181 -0.674 . . . . 0.44 109.181 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.48 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.6 Cg_endo -54.05 127.82 27.26 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 121.742 1.628 . . . . 0.44 112.255 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.5 -38.97 10.18 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.759 2.306 . . . . 0.44 112.575 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.457 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -69.73 -9.59 55.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.023 0.44 . . . . 0.44 111.344 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -103.15 16.19 27.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.805 -0.634 . . . . 0.44 111.029 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -68.28 -32.67 4.08 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 113.44 0.904 . . . . 0.44 113.44 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 91.2 Cg_exo -44.44 -33.54 6.53 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 121.778 1.652 . . . . 0.44 112.718 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.483 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 12.9 t -77.8 -51.51 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.44 111.003 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.499 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 17.3 mm -68.16 -33.61 61.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 0.44 111.67 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.67 -27.35 39.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.874 0.369 . . . . 0.44 110.775 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -80.54 -53.19 6.79 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.096 -0.502 . . . . 0.44 111.885 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.417 HD11 ' CG ' ' A' ' 68' ' ' PHE . 2.4 tp -78.23 -33.52 49.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.76 0.314 . . . . 0.44 111.628 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.466 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 28.3 ttpp -54.05 -42.64 69.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.026 0.441 . . . . 0.44 110.963 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -66.3 -10.09 39.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.789 -0.641 . . . . 0.44 109.694 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.975 -0.557 . . . . 0.44 110.94 179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.669 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 5167 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 5168 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A 5169 ' ' HOH . . . . . 0.587 ' H1 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A 5170 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.794 0.33 . . . . 0.44 111.173 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -74.0 147.39 42.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.44 110.963 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 138.67 38.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.44 110.368 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.538 HD23 ' N3 ' ' A' ' 131' ' ' 8OG . 3.7 pp -146.24 138.02 24.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 0.44 111.713 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.428 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 29.2 mt-30 -104.11 152.83 21.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.031 -0.532 . . . . 0.44 110.987 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.52 HD11 " O4'" ' A' ' 131' ' ' 8OG . 47.8 mt -146.35 119.53 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.805 -0.634 . . . . 0.44 111.274 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.625 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -124.86 125.68 44.36 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.113 -0.699 . . . . 0.44 109.113 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.665 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.8 m -132.79 162.45 39.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.478 0.656 . . . . 0.44 111.945 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.36 118.66 0.97 Allowed Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.055 -0.975 . . . . 0.44 111.92 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.663 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -70.27 109.76 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.956 -0.757 . . . . 0.44 108.956 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.7 OUTLIER -70.6 119.14 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.062 0.458 . . . . 0.44 111.61 -178.478 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.442 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.65 118.57 23.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.567 -0.742 . . . . 0.44 111.75 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.535 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.1 t-20 -78.21 -172.46 2.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.045 -0.98 . . . . 0.44 111.589 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.525 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 10.9 tt0 -83.44 4.86 25.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.571 -1.195 . . . . 0.44 112.368 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -140.58 52.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.44 111.444 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.3 p30 46.26 23.23 0.19 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.138 -0.483 . . . . 0.44 111.683 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.429 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -116.42 146.89 42.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.653 -0.869 . . . . 0.44 108.653 178.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.539 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 1.5 mp -112.49 144.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.298 0.571 . . . . 0.44 112.299 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.471 ' N ' HG21 ' A' ' 18' ' ' ILE . 0.6 OUTLIER -88.37 114.24 24.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.216 -0.902 . . . . 0.44 110.127 179.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.71 137.7 51.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.341 -0.39 . . . . 0.44 110.236 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.3 p -70.84 123.01 20.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.44 111.033 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' HB3' ' CD1' ' A' ' 33' ' ' LEU . 5.0 ptt85 -148.2 154.13 39.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.44 111.099 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 1.4 ttm180 45.24 -107.42 0.13 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.066 -0.515 . . . . 0.44 111.22 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 172.86 -52.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.88 0.372 . . . . 0.44 110.892 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -175.98 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.44 111.066 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -172.77 100.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.44 110.852 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.99 110.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.44 111.126 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -177.37 -70.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.479 . . . . 0.44 110.902 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.4 67.1 0.95 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.44 110.816 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.89 -17.88 53.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.44 111.544 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -93.92 24.65 4.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.695 0.283 . . . . 0.44 111.41 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.25 26.14 10.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.018 0.437 . . . . 0.44 111.316 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.52 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 27.2 tp -73.55 64.67 0.89 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.755 -0.657 . . . . 0.44 111.103 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.462 ' HB3' ' HD2' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -114.99 -173.09 2.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.789 0.328 . . . . 0.44 111.213 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.504 ' CZ ' ' CD1' ' A' ' 110' ' ' LEU . 53.8 m-85 -90.42 159.95 40.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.514 0.561 . . . . 0.44 112.514 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.665 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 97.8 Cg_endo -84.02 167.13 12.71 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.809 3.006 . . . . 0.44 111.852 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.534 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.12 -5.12 52.6 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.716 -0.754 . . . . 0.44 114.136 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.62 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -64.18 129.82 37.93 Favored Glycine 0 C--N 1.316 -0.582 0 C-N-CA 121.154 -0.546 . . . . 0.44 112.848 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 108.97 2.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.1 0.56 . . . . 0.44 111.848 179.514 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.625 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.7 pt -49.05 -29.66 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.518 0.675 . . . . 0.44 110.747 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.581 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -38.16 -77.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.541 -1.209 . . . . 0.44 110.952 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.2 mmt 33.8 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.623 0.577 . . . . 0.44 111.885 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.0 32.93 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.822 -0.704 . . . . 0.44 112.663 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.477 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -89.09 -172.9 3.84 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.731 0.301 . . . . 0.44 111.132 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.528 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.64 154.04 37.66 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.382 -0.372 . . . . 0.44 110.288 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.528 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.76 -24.99 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.803 2.335 . . . . 0.44 112.491 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.47 -43.59 5.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.508 -0.314 . . . . 0.44 111.55 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 52.8 mm-40 -80.46 -4.84 55.33 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.821 0.304 . . . . 0.44 111.821 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.477 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -61.15 -55.47 31.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.682 0.277 . . . . 0.44 111.035 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -78.52 -45.65 25.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.372 -0.377 . . . . 0.44 110.968 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.461 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 39.4 t -60.13 -44.89 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.857 -0.61 . . . . 0.44 112.003 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 9.2 tpp180 -78.07 -37.14 47.31 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.771 -0.372 . . . . 0.44 111.393 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.445 ' CG ' ' OE2' ' A' ' 57' ' ' GLU . 6.2 tp10 -78.04 -23.54 48.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.444 -0.344 . . . . 0.44 110.716 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -51.67 -44.42 63.07 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 120.982 0.42 . . . . 0.44 109.988 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -28.85 62.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.599 . . . . 0.44 109.468 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -77.24 -30.67 54.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.489 -0.778 . . . . 0.44 111.314 179.447 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.445 ' OE2' ' CG ' ' A' ' 53' ' ' GLU . 16.3 mp0 -108.22 5.85 26.13 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.218 0.451 . . . . 0.44 112.218 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.549 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 4.0 t -134.07 -44.88 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.024 0.44 . . . . 0.44 110.101 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.11 -38.32 0.15 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.56 -0.745 . . . . 0.44 114.577 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.464 HG13 ' CG1' ' A' ' 58' ' ' VAL . 21.3 pt -77.79 -176.03 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.99 0.424 . . . . 0.44 111.575 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.25 88.28 17.98 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.871 -0.604 . . . . 0.44 110.348 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.653 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.8 Cg_endo -112.44 146.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.568 2.845 . . . . 0.44 113.9 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.502 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 13.1 mt-30 -74.82 80.2 2.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.743 -1.947 . . . . 0.44 105.743 175.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.616 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.36 136.78 54.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.134 -1.394 . . . . 0.44 111.578 -175.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.0 t80 178.71 -135.52 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.663 -0.698 . . . . 0.44 110.199 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 55.94 166.49 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.147 0.498 . . . . 0.44 111.809 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.7 tt -129.14 114.95 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.589 -0.732 . . . . 0.44 110.683 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -76.53 -52.91 8.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.647 -0.501 . . . . 0.44 109.647 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.8 tt0 -171.91 153.03 3.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.436 -0.802 . . . . 0.44 109.927 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.55 129.28 19.31 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.095 -0.335 . . . . 0.44 110.095 179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.1 pp -130.91 159.13 38.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.014 0.435 . . . . 0.44 111.235 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -133.6 120.17 20.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.44 111.042 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.435 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 1.7 p90 -141.17 147.59 38.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.44 110.595 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.13 112.32 18.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.44 111.34 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.4 m-85 -69.96 162.86 65.74 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.692 -0.685 . . . . 0.44 110.355 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.7 Cg_endo -50.3 81.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.058 2.505 . . . . 0.44 112.342 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 75' ' ' PHE . 7.0 m-20 91.15 13.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.397 -0.819 . . . . 0.44 111.814 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.606 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 21.3 ttp180 -137.45 102.01 4.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.613 0.244 . . . . 0.44 110.935 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -86.98 113.06 22.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.44 110.904 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.571 HG22 ' N2 ' ' A' ' 131' ' ' 8OG . 2.3 tt -120.22 118.83 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.44 111.091 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -97.58 118.77 34.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.047 -0.723 . . . . 0.44 109.047 178.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.429 HD13 ' CD1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -113.83 114.61 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.343 0.497 . . . . 0.44 112.343 -178.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.413 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 8.8 m0 -113.35 122.38 47.21 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.793 -0.64 . . . . 0.44 109.965 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.583 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.1 m-30 -106.89 133.22 51.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.151 -0.477 . . . . 0.44 111.034 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.544 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 16.9 m95 -118.65 149.14 41.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.964 -0.562 . . . . 0.44 111.445 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 66' ' ' SER . 0.0 OUTLIER -102.07 103.79 14.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.48 0.657 . . . . 0.44 112.306 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.663 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 13.3 t -79.77 146.26 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-N 114.976 -1.011 . . . . 0.44 110.995 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -114.34 -23.99 9.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.299 1.222 . . . . 0.44 114.299 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.502 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -162.43 161.01 27.05 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.623 0.647 . . . . 0.44 111.371 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.653 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.2 OUTLIER -157.07 125.98 5.86 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.231 -0.44 . . . . 0.44 111.404 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -74.5 140.31 44.44 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.338 -0.392 . . . . 0.44 111.242 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.77 -130.03 47.94 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.875 -0.678 . . . . 0.44 112.763 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.465 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.9 tt0 -121.01 137.4 26.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.462 -0.199 . . . . 0.44 110.462 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.477 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.8 Cg_exo -76.18 128.9 10.89 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.702 2.268 . . . . 0.44 111.562 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.592 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 50.0 p-90 -119.5 -60.04 1.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.68 -0.408 . . . . 0.44 111.975 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.549 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.0 -103.93 0.06 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.774 -0.727 . . . . 0.44 112.973 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 172.28 37.36 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.722 0.296 . . . . 0.44 111.097 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -59.25 -48.98 79.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.44 110.762 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.86 -76.9 0.14 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.563 -0.827 . . . . 0.44 112.83 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 pm0 -118.79 124.14 28.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.071 0.462 . . . . 0.44 111.318 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -43.29 145.95 1.28 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.994 2.463 . . . . 0.44 112.647 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.39 177.36 16.8 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.87 -0.681 . . . . 0.44 112.926 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -125.14 157.23 36.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.417 -0.216 . . . . 0.44 110.417 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -69.18 106.51 2.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.867 0.365 . . . . 0.44 110.322 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.0 ptp -120.19 163.24 18.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.02 -0.536 . . . . 0.44 111.106 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.7 p -81.64 114.94 20.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.44 110.472 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.05 -18.69 64.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.44 111.456 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.01 -19.26 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.602 -0.272 . . . . 0.44 111.513 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.51 55.5 0.57 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.805 -0.712 . . . . 0.44 112.227 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.504 ' CD1' ' CZ ' ' A' ' 35' ' ' PHE . 2.0 tt -62.37 151.02 38.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.908 0.385 . . . . 0.44 110.967 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.43 ' C ' HD22 ' A' ' 110' ' ' LEU . 1.6 t-20 -92.44 92.87 8.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.092 -0.504 . . . . 0.44 112.048 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.501 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -71.36 -18.89 62.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.153 0.501 . . . . 0.44 110.142 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.89 -44.39 22.87 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.951 -0.568 . . . . 0.44 110.513 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.84 -41.36 87.56 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.945 -0.57 . . . . 0.44 110.816 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.575 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.78 170.06 17.89 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.433 -0.58 . . . . 0.44 109.433 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 34' ' ' GLU . 9.3 Cg_endo -54.14 127.63 26.53 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.131 1.887 . . . . 0.44 112.791 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.13 -34.85 15.71 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.73 2.287 . . . . 0.44 111.995 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.519 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.33 -9.96 57.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.44 110.877 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . 17.0 m-20 -109.53 14.09 23.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.726 -0.67 . . . . 0.44 110.183 179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -76.1 -30.99 0.94 Allowed Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 113.849 1.055 . . . . 0.44 113.849 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 65.7 Cg_exo -43.61 -39.99 10.31 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.062 1.841 . . . . 0.44 113.831 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.478 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 1.5 t -77.91 -51.58 17.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.99 0.424 . . . . 0.44 111.598 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.473 ' CD1' HD23 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.13 -29.45 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.891 -0.595 . . . . 0.44 111.623 -179.059 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.45 -31.34 55.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.009 0.433 . . . . 0.44 110.086 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -66.74 -47.02 73.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.44 110.155 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 2.3 tm? -78.49 -20.03 51.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.935 -0.575 . . . . 0.44 111.032 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.407 ' CD ' ' CB ' ' A' ' 112' ' ' ALA . 23.0 tttm -74.48 -42.53 58.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.095 0.474 . . . . 0.44 110.445 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -64.65 -11.03 31.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.608 -0.724 . . . . 0.44 109.904 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.104 0 CA-C-N 116.305 -0.407 . . . . 0.44 110.58 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.754 ' P ' " H3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A 5179 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 5180 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 5181 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A 5182 ' ' HOH . . . . . 0.486 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.842 0.353 . . . . 0.44 111.193 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.13 119.87 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.44 110.894 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.05 133.95 30.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.44 110.876 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.447 HD11 ' CD1' ' A' ' 6' ' ' ILE . 3.4 pp -146.15 121.95 10.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.44 111.099 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -102.89 151.32 22.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.241 0.543 . . . . 0.44 112.059 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.447 ' CD1' HD11 ' A' ' 4' ' ' LEU . 3.2 mp -146.48 128.93 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.251 -0.886 . . . . 0.44 110.279 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.611 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -125.13 125.58 43.96 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.913 -0.403 . . . . 0.44 109.913 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -137.13 162.16 34.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.313 -0.555 . . . . 0.44 111.381 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.04 127.86 2.45 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.733 -0.746 . . . . 0.44 112.045 179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.622 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.1 OUTLIER -70.76 110.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.649 -0.5 . . . . 0.44 109.649 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 18' ' ' ILE . 0.9 OUTLIER -70.93 119.72 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.44 110.891 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.92 121.01 26.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.675 -0.693 . . . . 0.44 111.744 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.526 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 2.5 t-20 -81.31 -172.56 3.86 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.27 -0.877 . . . . 0.44 111.52 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.526 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 22.2 tt0 -81.98 3.65 25.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.743 -1.117 . . . . 0.44 112.398 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -139.74 51.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.44 111.385 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.34 24.58 0.3 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.304 -0.407 . . . . 0.44 111.195 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 17.0 pt-20 -116.96 144.52 44.46 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.212 -0.662 . . . . 0.44 109.212 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.486 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 5.6 mt -116.03 145.18 22.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.172 0.511 . . . . 0.44 111.841 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD2' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -89.83 111.08 21.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.541 -0.754 . . . . 0.44 110.367 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.49 142.86 24.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 0.44 110.182 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.409 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 1.4 p -70.84 114.42 8.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.231 -0.285 . . . . 0.44 110.231 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 6.0 ttt85 -130.33 136.27 48.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.44 110.522 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.414 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 29.4 mtp180 51.74 -113.26 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.387 . . . . 0.44 110.086 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 23' ' ' ARG . . . 166.27 -176.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.841 0.353 . . . . 0.44 110.875 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.31 -31.52 62.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.72 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -139.63 -176.22 4.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.906 -0.588 . . . . 0.44 110.549 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.88 -159.66 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.444 -0.344 . . . . 0.44 110.918 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.52 -84.2 0.49 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.664 -0.244 . . . . 0.44 110.917 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 47.6 29.29 1.41 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.802 0.334 . . . . 0.44 111.129 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.62 -23.27 58.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.44 111.577 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -97.66 29.78 3.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.473 -0.33 . . . . 0.44 111.142 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.1 25.98 10.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.44 111.403 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 21' ' ' THR . 1.2 tt -67.48 76.05 0.17 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.718 -0.673 . . . . 0.44 110.792 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.88 -169.0 1.65 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.933 0.397 . . . . 0.44 111.464 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.471 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.28 168.46 9.93 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.002 -0.545 . . . . 0.44 111.461 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.546 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 74.0 Cg_endo -77.72 167.06 24.58 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.372 2.714 . . . . 0.44 112.953 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.573 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.11 -5.45 52.94 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.644 -0.707 . . . . 0.44 113.71 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.44 145.28 48.76 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 121.184 -0.532 . . . . 0.44 113.302 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.654 ' HD2' ' H2 ' ' A' 5194 ' ' HOH . 0.1 OUTLIER 89.62 9.91 0.08 Allowed 'General case' 0 C--N 1.342 0.257 0 N-CA-C 113.18 0.807 . . . . 0.44 113.18 178.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.611 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.1 pt -57.84 -27.27 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.567 0.699 . . . . 0.44 110.051 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.503 ' O ' ' N ' ' A' ' 43' ' ' GLY . 0.0 OUTLIER -37.04 -77.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.416 -1.266 . . . . 0.44 111.31 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 36.05 -87.85 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.997 -0.547 . . . . 0.44 111.938 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.07 33.58 0.07 OUTLIER Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.608 -0.806 . . . . 0.44 112.989 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.47 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -92.47 -166.23 1.5 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.54 0.21 . . . . 0.44 110.897 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.527 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.89 154.35 37.41 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 110.247 -0.279 . . . . 0.44 110.247 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.527 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.93 -24.81 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.704 2.269 . . . . 0.44 112.362 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.34 -49.83 4.54 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.046 0.388 . . . . 0.44 112.046 -179.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -80.71 -8.89 59.8 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.812 0.301 . . . . 0.44 111.812 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.47 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -61.62 -57.24 12.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.843 0.354 . . . . 0.44 110.484 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.594 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 1.2 p -78.61 -46.61 24.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.44 111.716 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 55.3 t -50.69 -38.81 17.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.754 0.312 . . . . 0.44 111.387 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -78.89 -52.2 8.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.365 -0.379 . . . . 0.44 111.799 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.59 -19.8 63.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.415 -0.357 . . . . 0.44 111.19 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.594 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 23.0 tp -58.74 -45.81 88.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.44 110.521 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -66.46 -26.69 67.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.004 0.43 . . . . 0.44 110.095 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.63 -24.57 67.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.44 110.602 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.492 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.54 5.64 25.3 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.838 0.681 . . . . 0.44 112.838 -178.915 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.571 ' CG2' ' O ' ' A' ' 54' ' ' LEU . 0.0 OUTLIER -133.49 -44.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.312 -0.625 . . . . 0.44 109.312 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.547 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 68.85 -35.24 0.28 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 115.251 0.86 . . . . 0.44 115.251 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 93' ' ' GLU . 0.5 OUTLIER -77.95 -172.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.893 0.377 . . . . 0.44 110.909 -179.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.02 88.82 12.65 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 115.889 -0.596 . . . . 0.44 110.412 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.652 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.3 Cg_endo -108.36 149.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 123.28 2.653 . . . . 0.44 113.787 -177.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.531 ' HG2' ' HB3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.88 81.16 4.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 104.563 -2.384 . . . . 0.44 104.563 175.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.595 ' HA ' HG11 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.61 134.98 51.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.27 -1.332 . . . . 0.44 111.087 -175.449 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.506 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.6 t80 179.83 -142.83 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.02 -0.536 . . . . 0.44 110.657 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t 50.82 175.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.975 0.51 . . . . 0.44 111.95 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -141.88 124.9 16.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.862 -0.608 . . . . 0.44 111.02 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.97 -51.14 11.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.52 . . . . 0.44 109.985 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.543 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 mt-10 -171.73 131.64 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.825 -0.625 . . . . 0.44 110.35 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.26 119.46 39.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.791 0.329 . . . . 0.44 110.64 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.458 ' CD2' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -99.64 123.67 44.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.44 110.863 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -122.52 109.56 14.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.44 110.793 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.458 ' CD1' ' CD2' ' A' ' 71' ' ' LEU . 1.8 p90 -141.43 137.59 32.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.44 110.486 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.451 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 2.5 pt-20 -121.24 125.21 46.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.156 0.503 . . . . 0.44 111.462 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 2.6 m-85 -71.92 163.4 67.06 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.485 -0.78 . . . . 0.44 109.895 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.8 Cg_endo -39.28 -27.76 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.434 2.756 . . . . 0.44 112.97 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -139.78 -37.08 0.49 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.718 -0.674 . . . . 0.44 111.209 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.552 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 33.2 ttp180 -85.91 103.42 14.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.44 111.489 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.451 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 9.4 t-160 -91.15 100.27 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.44 110.425 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.578 ' CG2' ' N2 ' ' A' ' 131' ' ' 8OG . 6.2 tt -101.88 146.2 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.091 0.472 . . . . 0.44 111.252 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.415 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.3 OUTLIER -134.15 118.74 18.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.824 -0.626 . . . . 0.44 109.696 179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 13.5 mt -121.17 114.2 21.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.992 0.425 . . . . 0.44 111.763 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -109.44 122.06 46.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.44 109.774 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.543 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 7.7 m-30 -107.21 114.72 28.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.41 -0.359 . . . . 0.44 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.811 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 23.8 m95 -94.35 148.24 22.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.189 -0.46 . . . . 0.44 111.044 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.506 ' O ' ' O ' ' A' ' 65' ' ' PHE . 3.5 tm? -98.48 102.91 14.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.454 0.645 . . . . 0.44 111.463 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.622 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 13.3 t -82.36 145.74 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-N 115.186 -0.916 . . . . 0.44 111.03 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -114.79 -23.56 9.11 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.913 1.079 . . . . 0.44 113.913 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.531 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 8.6 ttt180 -162.59 164.54 26.68 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.369 -0.532 . . . . 0.44 111.507 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.652 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 0.4 OUTLIER -157.14 124.42 5.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.44 111.248 178.631 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -75.19 146.25 41.4 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.29 -0.414 . . . . 0.44 111.116 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.65 -130.44 48.32 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.887 -0.673 . . . . 0.44 112.574 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.484 ' O ' HG12 ' A' ' 60' ' ' ILE . 44.3 mt-10 -121.52 141.43 33.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 110.62 -0.141 . . . . 0.44 110.62 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.45 ' HG2' ' CD2' ' A' ' 19' ' ' PHE . 2.7 Cg_exo -75.63 131.52 13.67 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.827 2.351 . . . . 0.44 111.143 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.547 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 41.0 p-90 -133.49 -65.76 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.963 0.727 . . . . 0.44 112.963 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.562 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.23 -96.8 0.01 OUTLIER Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.843 -0.694 . . . . 0.44 112.876 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER 173.36 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.645 0.26 . . . . 0.44 111.341 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.401 ' HA ' ' CG ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -56.06 -43.99 78.46 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.804 0.335 . . . . 0.44 110.866 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.49 -82.88 0.25 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.67 -0.776 . . . . 0.44 112.717 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 111.54 48.7 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.917 0.389 . . . . 0.44 111.389 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -43.42 146.21 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.003 2.469 . . . . 0.44 112.625 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.21 177.19 16.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.697 -0.763 . . . . 0.44 112.808 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -139.21 157.28 46.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.438 -0.208 . . . . 0.44 110.438 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -60.33 106.57 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.92 0.39 . . . . 0.44 110.086 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.3 mtm -120.09 163.37 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.44 111.159 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.97 114.87 23.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 0.44 110.409 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.62 -18.71 63.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.44 111.529 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.42 -14.82 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.548 -0.296 . . . . 0.44 111.673 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.98 53.52 0.7 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.84 -0.695 . . . . 0.44 112.154 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.439 HD13 ' CZ ' ' A' ' 35' ' ' PHE . 4.7 tt -62.4 150.59 39.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.008 0.432 . . . . 0.44 110.948 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -95.35 93.47 7.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.018 -0.537 . . . . 0.44 112.439 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.29 -20.71 61.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.167 -0.47 . . . . 0.44 110.014 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -45.22 20.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.955 -0.566 . . . . 0.44 111.128 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.79 -39.98 87.96 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.08 -0.509 . . . . 0.44 111.369 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.543 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.44 173.99 6.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.565 -0.531 . . . . 0.44 109.565 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.08 127.8 27.19 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.918 1.745 . . . . 0.44 112.607 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 52.1 Cg_endo -69.15 -35.16 15.0 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.752 2.301 . . . . 0.44 112.353 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.461 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -71.9 -9.63 58.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.074 0.464 . . . . 0.44 111.168 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -105.76 17.62 23.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.695 -0.684 . . . . 0.44 110.949 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.0 -31.05 0.96 Allowed Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 113.472 0.916 . . . . 0.44 113.472 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 80.0 Cg_exo -43.55 -34.28 5.13 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.877 1.718 . . . . 0.44 113.064 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.456 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 16.0 t -77.96 -47.28 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.275 0.56 . . . . 0.44 110.253 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.431 HG22 ' HB2' ' A' ' 127' ' ' LYS . 35.6 mm -68.9 -31.28 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.244 -0.889 . . . . 0.44 111.413 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.05 -26.88 40.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.936 0.398 . . . . 0.44 110.344 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -47.71 14.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.898 -0.592 . . . . 0.44 111.345 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.467 ' HB2' ' CE2' ' A' ' 68' ' ' PHE . 2.4 tm? -78.18 -45.95 21.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.44 111.329 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.431 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.8 tttm -52.68 -42.27 64.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.44 111.127 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -63.93 -8.07 10.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.44 109.971 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-N 116.093 -0.503 . . . . 0.44 111.337 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.685 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A 5191 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 5192 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 5193 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A 5194 ' ' HOH . . . . . 0.654 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ttp . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.862 0.363 . . . . 0.44 111.179 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.81 146.95 34.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.44 110.93 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.05 132.04 27.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.44 110.856 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.14 127.14 14.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.44 111.376 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -102.65 154.48 19.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.062 0.458 . . . . 0.44 111.46 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.458 ' CD1' " O4'" ' A' ' 131' ' ' 8OG . 1.8 mp -146.42 119.12 2.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.545 -0.752 . . . . 0.44 110.835 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.631 ' HB1' ' CG2' ' A' ' 40' ' ' ILE . . . -124.93 125.69 44.33 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.213 -0.662 . . . . 0.44 109.213 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.1 m -134.76 162.44 38.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.312 0.577 . . . . 0.44 112.041 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.7 111.12 0.9 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.043 -0.981 . . . . 0.44 111.277 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.531 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.4 OUTLIER -70.47 103.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.765 -0.457 . . . . 0.44 109.765 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.477 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 0.9 OUTLIER -71.41 125.76 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.086 -0.506 . . . . 0.44 112.23 -178.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -100.47 139.32 36.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.596 -0.729 . . . . 0.44 111.123 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.659 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.9 p-10 -98.74 -173.37 2.51 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.523 0.678 . . . . 0.44 112.234 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.49 -3.96 13.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.779 -1.101 . . . . 0.44 113.869 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 58.1 t30 -120.11 37.54 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.112 0.412 . . . . 0.44 112.112 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.97 15.94 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 0.44 111.579 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 15' ' ' ASN . 1.2 mm-40 -102.02 161.2 13.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.891 -0.781 . . . . 0.44 108.891 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 107' ' ' LEU . 0.1 OUTLIER -120.47 131.26 73.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.164 0.506 . . . . 0.44 111.801 -178.64 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -83.09 116.51 22.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.44 110.717 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.437 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -129.27 147.22 33.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.44 110.556 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 29.2 p -70.78 111.91 6.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.465 -0.334 . . . . 0.44 110.263 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -122.97 126.65 47.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.44 110.841 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.97 -106.74 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.44 110.641 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 168.44 -167.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 0.44 110.742 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.19 24.79 6.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.44 111.08 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 p30 179.55 164.09 1.0 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.244 -0.435 . . . . 0.44 110.821 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.54 -168.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.44 111.057 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -96.75 -99.79 0.18 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.362 -0.381 . . . . 0.44 110.817 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.1 mtp 47.05 41.53 11.32 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.899 0.38 . . . . 0.44 111.137 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.14 -8.76 56.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.44 111.774 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.5 t-20 -91.26 25.25 2.6 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.746 0.276 . . . . 0.44 111.746 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.37 26.09 10.53 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.757 0.313 . . . . 0.44 111.777 -179.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.6 tt -67.19 66.17 0.07 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.132 -0.486 . . . . 0.44 111.044 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.86 -170.17 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.408 . . . . 0.44 111.223 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.47 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.21 168.33 10.15 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.02 -0.536 . . . . 0.44 111.541 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.555 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 97.0 Cg_endo -84.12 166.55 12.74 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.433 2.755 . . . . 0.44 113.001 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.516 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.01 -6.08 53.75 Favored Glycine 0 C--O 1.225 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.44 114.096 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.79 167.45 15.45 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.038 -0.601 . . . . 0.44 112.509 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.595 ' HB2' ' H1 ' ' A' 5206 ' ' HOH . 0.0 OUTLIER 82.67 1.5 1.21 Allowed 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.448 0.299 . . . . 0.44 111.795 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.631 ' CG2' ' HB1' ' A' ' 7' ' ' ALA . 1.2 pt -52.8 -27.06 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.495 0.665 . . . . 0.44 110.433 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.536 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -40.21 -61.44 0.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.596 -1.184 . . . . 0.44 111.025 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.509 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 11.07 -81.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.907 0.754 . . . . 0.44 112.467 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.0 32.33 0.09 OUTLIER Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.7 -0.762 . . . . 0.44 112.862 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.459 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.1 mp0 -93.48 -172.94 3.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.653 0.263 . . . . 0.44 111.191 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.519 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -101.59 153.64 37.76 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.391 -0.368 . . . . 0.44 110.323 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.98 -24.82 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.809 2.339 . . . . 0.44 112.615 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -100.93 -43.68 5.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.996 0.369 . . . . 0.44 111.996 -179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -80.09 -20.84 44.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.714 0.292 . . . . 0.44 111.644 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.459 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -56.38 -48.48 76.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.814 0.34 . . . . 0.44 111.036 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.521 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 1.0 OUTLIER -78.29 -47.87 23.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.168 -0.469 . . . . 0.44 110.964 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.521 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 40.3 t -59.66 -44.11 92.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.759 -0.655 . . . . 0.44 111.59 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 mtp-105 -73.25 -41.15 64.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.44 110.821 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 57' ' ' GLU . 4.6 tp10 -73.5 -19.73 60.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.952 -0.567 . . . . 0.44 110.819 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 5.9 tp -60.04 -44.65 94.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.733 0.301 . . . . 0.44 110.962 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.69 -36.19 82.92 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.416 -0.587 . . . . 0.44 109.416 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.38 -24.66 50.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.44 110.911 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 12.0 mm-40 -108.26 5.75 25.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.649 -0.421 . . . . 0.44 112.03 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.614 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 60.1 t -134.16 -44.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.497 -0.557 . . . . 0.44 109.497 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.543 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.48 -40.04 0.28 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.332 -0.849 . . . . 0.44 114.091 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.517 HG13 ' CG1' ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.74 -177.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.132 0.492 . . . . 0.44 111.217 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.82 88.71 14.57 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.44 109.914 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.621 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 3.1 Cg_endo -111.49 145.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.415 2.744 . . . . 0.44 114.207 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.536 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.6 mt-30 -74.92 79.93 2.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.693 -1.965 . . . . 0.44 105.693 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.564 ' HA ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.34 129.56 53.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.094 -1.412 . . . . 0.44 110.389 -176.501 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.531 ' O ' ' HB2' ' A' ' 66' ' ' SER . 2.0 t80 179.91 166.02 1.21 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.102 0.408 . . . . 0.44 112.102 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.531 ' HB2' ' O ' ' A' ' 65' ' ' PHE . 50.9 m 82.92 152.18 0.1 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.488 -0.778 . . . . 0.44 110.407 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.665 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.3 pp -107.66 134.68 50.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 0.44 111.973 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -81.94 -44.89 16.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.214 -0.662 . . . . 0.44 109.214 178.973 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -171.93 131.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.458 -0.792 . . . . 0.44 110.098 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.425 ' HE3' ' CZ3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -135.79 103.88 5.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.691 0.281 . . . . 0.44 110.733 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.414 HD11 ' O ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -111.66 169.37 8.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.104 0.478 . . . . 0.44 111.467 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -137.84 124.89 21.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.925 -0.58 . . . . 0.44 110.443 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -138.11 120.06 15.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 0.44 110.796 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.7 139.35 31.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.44 111.423 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 2.2 m-85 -103.94 162.47 19.82 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.44 110.218 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.9 Cg_endo -54.18 82.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.95 2.433 . . . . 0.44 112.117 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.7 t70 94.84 7.07 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.482 -0.781 . . . . 0.44 111.543 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.4 OUTLIER -137.26 93.72 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.44 110.592 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.437 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 11.5 t-160 -85.69 99.36 11.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.762 0.315 . . . . 0.44 110.871 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.514 HG23 ' N2 ' ' A' ' 131' ' ' 8OG . 4.2 tt -103.04 135.5 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 116.211 -0.45 . . . . 0.44 110.981 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 118.78 31.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.841 -0.618 . . . . 0.44 109.356 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.406 HD22 ' CE1' ' A' ' 84' ' ' PHE . 1.1 mp -113.08 114.06 26.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.897 0.379 . . . . 0.44 111.727 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.466 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 9.7 m0 -111.6 122.04 46.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.032 -0.531 . . . . 0.44 109.743 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.524 ' CD1' HG11 ' A' ' 122' ' ' VAL . 1.7 m-85 -109.68 109.94 20.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.179 -0.464 . . . . 0.44 110.469 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.665 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 19.8 m95 -95.91 148.79 22.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.808 -0.633 . . . . 0.44 111.76 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 65' ' ' PHE . 1.4 pp -95.69 138.77 32.89 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.162 0.506 . . . . 0.44 111.709 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.564 HG13 ' HA ' ' A' ' 64' ' ' HIS . 38.4 t -123.33 145.66 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.44 110.368 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -113.82 -21.63 10.58 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.396 1.258 . . . . 0.44 114.396 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.536 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.92 160.16 24.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.707 0.685 . . . . 0.44 111.473 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.659 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.1 OUTLIER -157.06 122.61 4.69 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.153 -0.476 . . . . 0.44 111.254 179.022 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -75.82 150.69 37.64 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.176 -0.465 . . . . 0.44 111.138 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.48 -129.92 47.21 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.873 -0.68 . . . . 0.44 112.526 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -125.21 145.8 51.86 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.507 0.194 . . . . 0.44 110.653 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.472 ' HA ' ' CD1' ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.48 128.74 10.53 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.761 2.307 . . . . 0.44 111.573 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.543 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -132.34 -59.91 0.91 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.511 -0.476 . . . . 0.44 111.838 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 36.77 -97.89 0.01 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.093 -0.575 . . . . 0.44 113.195 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tttp 178.43 38.8 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.7 0.285 . . . . 0.44 111.153 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.551 ' H ' ' CD ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -60.51 -49.05 79.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.44 111.263 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 143.28 -49.83 0.71 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.262 -0.97 . . . . 0.44 113.345 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.77 118.98 16.86 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.124 0.488 . . . . 0.44 111.966 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -43.79 146.37 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.211 2.608 . . . . 0.44 112.807 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.97 177.23 17.45 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.723 -0.751 . . . . 0.44 113.092 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 105' ' ' MET . 1.6 mt-10 -137.43 157.79 45.82 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.306 0.242 . . . . 0.44 110.383 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -65.0 106.39 1.24 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.75 0.31 . . . . 0.44 110.259 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -120.0 157.14 29.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.298 -0.41 . . . . 0.44 110.796 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.4 p -75.63 114.93 14.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.369 -0.378 . . . . 0.44 110.666 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . 0.563 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 2.5 tm? -75.38 -18.77 59.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.357 -0.383 . . . . 0.44 111.503 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.9 p -59.16 -12.58 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.44 111.737 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.79 54.3 0.62 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.71 -0.757 . . . . 0.44 112.367 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.0 150.36 38.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.595 0.236 . . . . 0.44 110.554 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.19 115.88 30.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.929 0.715 . . . . 0.44 112.929 -178.581 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.535 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -18.9 61.73 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.571 -0.74 . . . . 0.44 110.012 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -79.09 -47.83 15.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.514 . . . . 0.44 110.881 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.433 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -66.86 -17.39 64.87 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.005 -0.543 . . . . 0.44 111.645 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.535 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.45 173.67 3.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.44 109.417 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.17 127.92 27.78 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 121.938 1.759 . . . . 0.44 112.405 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.413 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.0 Cg_endo -69.04 -38.32 9.56 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.756 2.304 . . . . 0.44 112.664 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.453 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -69.94 -9.72 56.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.977 0.418 . . . . 0.44 111.308 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . 0.448 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 29.2 m-20 -104.42 15.3 28.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.79 -0.641 . . . . 0.44 110.922 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -63.32 -31.59 7.01 Favored Pre-proline 0 N--CA 1.467 0.381 0 N-CA-C 114.121 1.156 . . . . 0.44 114.121 -178.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 71.3 Cg_exo -43.78 -40.38 11.13 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.793 1.662 . . . . 0.44 113.54 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.524 HG11 ' CD1' ' A' ' 84' ' ' PHE . 74.6 t -78.0 -51.55 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.44 111.379 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.509 HG13 ' CE2' ' A' ' 115' ' ' PHE . 38.7 mm -66.13 -31.88 55.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.035 -0.53 . . . . 0.44 111.595 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.86 -32.33 60.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.862 0.363 . . . . 0.44 110.676 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -80.44 -46.16 16.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.096 -0.502 . . . . 0.44 111.52 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.461 ' CD1' ' CE2' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -78.34 -19.77 52.78 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.44 111.399 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 123' ' ' ILE . 22.2 tttm -74.31 -42.45 59.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.128 0.489 . . . . 0.44 110.593 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -68.29 -8.95 44.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.746 . . . . 0.44 109.936 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.453 ' HB3' ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.15 0 CA-C-N 116.228 -0.442 . . . . 0.44 110.621 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.729 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A 5203 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5204 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5205 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A 5206 ' ' HOH . . . . . 0.595 ' H1 ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttm . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.795 0.331 . . . . 0.44 111.08 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 140.17 31.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.44 110.977 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.35 131.23 26.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.91 -0.586 . . . . 0.44 110.489 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.477 HD13 " O4'" ' A' ' 131' ' ' 8OG . 1.4 pp -146.15 140.55 26.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.908 0.385 . . . . 0.44 111.661 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -104.67 152.86 21.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.213 0.53 . . . . 0.44 111.255 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.535 HG12 H5'' ' A' ' 131' ' ' 8OG . 4.4 mp -146.18 116.36 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.534 -0.757 . . . . 0.44 110.51 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.63 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -125.33 133.07 52.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.826 -0.435 . . . . 0.44 109.826 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.622 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.3 m -144.61 162.73 14.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.013 0.435 . . . . 0.44 111.773 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -139.22 115.15 1.08 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.613 -0.721 . . . . 0.44 111.855 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.458 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -71.28 107.25 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 110.027 -0.36 . . . . 0.44 110.027 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.476 ' HA ' ' CB ' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -71.16 127.29 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.93 0.395 . . . . 0.44 111.132 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.08 123.45 33.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.763 -0.653 . . . . 0.44 111.622 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 12.3 t-20 -78.28 -172.16 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.795 -1.093 . . . . 0.44 112.117 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.428 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 14.9 tt0 -82.18 -3.1 54.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.106 -1.406 . . . . 0.44 112.271 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -129.96 36.37 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.901 0.334 . . . . 0.44 111.901 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.64 7.59 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.526 -0.307 . . . . 0.44 111.743 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' ASN . 17.8 pt-20 -100.85 153.05 19.81 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 108.931 -0.766 . . . . 0.44 108.931 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.446 ' HA ' ' O ' ' A' ' 11' ' ' ILE . 4.8 mt -115.89 140.56 37.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.17 0.509 . . . . 0.44 111.994 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' C ' ' CD1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -89.26 102.14 14.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.437 -0.801 . . . . 0.44 110.436 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.438 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -115.29 162.13 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.44 110.263 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.8 p -71.07 121.2 17.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.786 0.327 . . . . 0.44 110.759 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.38 172.31 7.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.44 110.807 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.441 ' O ' ' CB ' ' A' ' 24' ' ' ALA . 0.1 OUTLIER -62.41 -10.16 10.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.451 . . . . 0.44 111.449 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.441 ' CB ' ' O ' ' A' ' 23' ' ' ARG . . . 80.42 3.0 1.86 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.602 -0.272 . . . . 0.44 111.709 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.46 29.92 4.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.739 0.304 . . . . 0.44 111.321 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -107.49 13.87 26.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.44 111.397 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 53.34 30.15 9.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.77 0.319 . . . . 0.44 111.33 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -97.71 -68.85 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.44 110.926 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -124.09 92.69 3.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.44 110.923 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -78.44 -8.91 59.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.44 111.608 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -113.07 25.38 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.574 0.226 . . . . 0.44 111.28 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.43 25.98 10.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 0.44 111.799 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.455 ' CB ' ' HB3' ' A' ' 114' ' ' ASP . 22.1 tp -76.36 78.79 3.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.016 -0.538 . . . . 0.44 110.272 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.52 -166.63 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.44 111.52 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.503 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.52 168.36 10.26 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.808 -0.633 . . . . 0.44 111.157 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.622 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 71.7 Cg_endo -77.5 166.9 25.19 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.238 2.625 . . . . 0.44 112.903 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.506 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 102.31 -5.58 52.46 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.71 -0.677 . . . . 0.44 114.242 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.51 156.44 42.64 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 117.176 0.488 . . . . 0.44 112.844 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.545 ' CD ' ' H1 ' ' A' 5217 ' ' HOH . 0.0 OUTLIER 93.75 -1.06 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.034 0.534 . . . . 0.44 111.875 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.63 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 1.2 pt -53.37 -26.01 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.375 0.607 . . . . 0.44 110.929 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.495 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -40.99 -62.85 0.75 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.931 -1.031 . . . . 0.44 110.913 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.495 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.2 mtm 12.24 -83.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.527 -0.761 . . . . 0.44 112.562 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.59 31.68 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.44 112.816 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.13 -169.4 2.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.671 0.272 . . . . 0.44 111.043 -179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.62 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -113.62 164.69 15.21 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.477 -0.329 . . . . 0.44 110.451 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.62 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 6.7 Cg_endo -47.63 -24.62 4.71 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.017 2.478 . . . . 0.44 112.72 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.99 -55.24 3.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.519 0.562 . . . . 0.44 112.519 -179.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -80.55 -4.61 54.62 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.428 0.529 . . . . 0.44 112.428 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' HA ' ' CB ' ' A' ' 44' ' ' GLU . . . -62.73 -58.02 8.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.734 -0.386 . . . . 0.44 110.811 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.469 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 0.8 OUTLIER -79.5 -45.53 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.44 111.332 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.469 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 48.0 t -53.46 -39.75 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.44 111.724 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -78.13 -42.92 30.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.848 0.356 . . . . 0.44 111.231 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.416 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.3 mm-40 -74.22 -19.84 60.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.12 -0.491 . . . . 0.44 111.049 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.538 ' O ' ' HB ' ' A' ' 58' ' ' VAL . 1.0 OUTLIER -60.57 -44.83 95.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.594 -0.276 . . . . 0.44 110.48 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -35.81 78.28 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.252 -0.647 . . . . 0.44 109.252 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.76 -28.03 50.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.492 -0.776 . . . . 0.44 111.124 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 33.4 mm-40 -105.34 5.01 31.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.42 0.526 . . . . 0.44 112.42 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 54' ' ' LEU . 4.1 t -134.87 -44.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.537 -0.542 . . . . 0.44 109.537 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.29 -38.94 0.21 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.36 -0.836 . . . . 0.44 114.049 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.487 ' H ' ' C ' ' A' ' 58' ' ' VAL . 22.8 pt -82.02 -176.18 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 120.985 0.422 . . . . 0.44 111.582 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.87 88.41 21.09 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 115.773 -0.649 . . . . 0.44 110.321 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.526 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 12.3 Cg_endo -109.92 153.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.459 2.773 . . . . 0.44 113.833 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 89' ' ' ARG . 89.8 mt-30 -74.85 79.93 2.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.209 -1.774 . . . . 0.44 106.209 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.556 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -126.2 127.45 45.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.431 -1.259 . . . . 0.44 110.283 -176.944 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.9 t80 -177.86 158.85 1.32 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.518 0.562 . . . . 0.44 112.518 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.432 ' HB3' ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 78.01 -168.39 0.05 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.829 -0.623 . . . . 0.44 111.291 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.807 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -144.49 137.57 27.0 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.42 -0.355 . . . . 0.44 111.852 -179.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.673 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 2.5 p90 -76.75 -41.58 44.36 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.348 -0.612 . . . . 0.44 109.348 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . 5.5 mt-10 -171.76 131.45 0.69 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.678 -0.692 . . . . 0.44 109.696 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.49 120.81 42.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.44 111.201 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.486 ' CD2' ' CE2' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -104.68 122.22 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.44 111.026 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -130.68 113.64 14.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 0.44 110.971 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.486 ' CE2' ' CD2' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -141.24 153.38 45.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.44 110.955 179.378 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.1 pt-20 -121.17 127.06 51.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.343 0.592 . . . . 0.44 111.187 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 77' ' ' ASP . 1.0 OUTLIER -96.51 163.43 20.53 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.194 -0.912 . . . . 0.44 110.554 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.0 Cg_endo -53.18 81.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.032 2.488 . . . . 0.44 112.255 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.2 t70 93.4 8.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.534 -0.757 . . . . 0.44 111.532 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.63 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.1 OUTLIER -137.44 93.86 2.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.633 0.254 . . . . 0.44 110.758 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.47 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 5.2 t-160 -93.27 95.7 9.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.797 0.332 . . . . 0.44 111.103 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.569 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 0.5 OUTLIER -100.35 111.99 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.44 111.132 179.835 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -97.26 118.1 32.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.799 -0.815 . . . . 0.44 108.799 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.7 mp -110.09 113.82 26.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.094 0.473 . . . . 0.44 111.179 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 8.5 m0 -112.5 122.27 47.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.77 -0.65 . . . . 0.44 109.324 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.673 ' HB3' ' CE2' ' A' ' 68' ' ' PHE . 3.2 m-85 -116.58 113.16 22.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.013 0.435 . . . . 0.44 110.591 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.807 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.8 m95 -94.58 148.3 22.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.743 -0.662 . . . . 0.44 111.566 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.507 ' O ' ' O ' ' A' ' 65' ' ' PHE . 2.3 pp -93.97 138.25 32.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.44 110.671 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 64' ' ' HIS . 48.8 t -123.26 145.33 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-N 116.329 -0.396 . . . . 0.44 110.546 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -109.51 -28.2 9.03 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.135 1.161 . . . . 0.44 114.135 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.526 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.79 165.57 22.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.968 0.804 . . . . 0.44 111.789 -178.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.497 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 1.0 OUTLIER -152.93 126.02 8.52 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.317 -0.401 . . . . 0.44 111.145 178.357 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -76.88 146.4 37.69 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.072 -0.513 . . . . 0.44 111.409 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.57 -126.64 32.24 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.996 -0.621 . . . . 0.44 112.811 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.0 tt0 -124.4 126.59 25.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.427 0.156 . . . . 0.44 110.582 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 93' ' ' GLU . 13.7 Cg_exo -72.09 128.62 14.14 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.754 2.303 . . . . 0.44 111.2 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.569 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 17.1 p-90 -114.78 -61.43 1.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.016 0.436 . . . . 0.44 111.415 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.505 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.82 -114.02 1.39 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.745 -0.741 . . . . 0.44 112.904 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.61 74.61 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.927 0.394 . . . . 0.44 110.857 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.44 -29.22 14.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.44 111.013 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.2 -103.06 0.45 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.519 -0.848 . . . . 0.44 113.115 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.86 115.53 47.21 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.44 111.612 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -43.66 146.12 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.986 2.457 . . . . 0.44 112.718 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.88 177.69 18.69 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.987 -0.625 . . . . 0.44 112.36 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -133.16 157.26 45.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.607 0.242 . . . . 0.44 110.652 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -63.56 106.72 0.99 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 110.025 -0.361 . . . . 0.44 110.025 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.417 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtm -119.83 163.05 18.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.474 . . . . 0.44 111.032 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 7.7 p -81.2 114.92 20.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.44 110.855 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.86 -18.66 63.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.44 111.208 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.6 p -56.45 -14.29 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.433 -0.349 . . . . 0.44 111.402 179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.53 56.76 0.6 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.361 -0.696 . . . . 0.44 111.361 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.9 tp -61.73 150.25 37.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.854 0.359 . . . . 0.44 110.861 -179.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 2.3 t-20 -97.22 106.9 19.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.828 0.677 . . . . 0.44 112.828 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.518 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -24.16 61.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.823 -0.626 . . . . 0.44 109.957 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -79.17 -47.18 16.5 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.898 -0.592 . . . . 0.44 111.271 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.455 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.79 -14.21 62.37 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.126 -0.488 . . . . 0.44 111.869 -179.125 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.518 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -113.64 173.43 2.87 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.134 -0.691 . . . . 0.44 109.134 178.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.477 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.46 127.86 27.72 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 121.837 1.691 . . . . 0.44 111.974 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.97 -38.89 8.85 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.681 2.254 . . . . 0.44 112.613 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.47 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -69.41 -9.6 54.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.945 0.402 . . . . 0.44 111.572 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -103.54 19.96 18.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.44 110.871 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.59 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -70.45 -32.03 2.49 Favored Pre-proline 0 N--CA 1.466 0.349 0 N-CA-C 113.233 0.827 . . . . 0.44 113.233 -179.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.2 Cg_exo -44.31 -34.27 7.01 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 121.971 1.781 . . . . 0.44 112.899 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.494 ' CG1' ' CE2' ' A' ' 84' ' ' PHE . 24.5 t -77.59 -51.48 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.066 0.46 . . . . 0.44 110.977 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.518 HG13 ' CZ ' ' A' ' 115' ' ' PHE . 12.9 mm -61.67 -38.98 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.649 . . . . 0.44 111.885 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.56 -29.6 51.65 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.587 -0.445 . . . . 0.44 110.684 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -80.69 -52.22 7.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.44 111.631 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.434 HD22 ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -74.82 -43.06 56.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.44 111.405 -179.261 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 40.9 tttt -52.05 -42.61 63.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 0.44 111.128 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -64.49 -9.48 19.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.737 -0.665 . . . . 0.44 109.963 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-N 116.082 -0.508 . . . . 0.44 110.815 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.63 ' N1 ' ' NH2' ' A' ' 78' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 5215 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 5216 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A 5217 ' ' HOH . . . . . 0.545 ' H1 ' ' CD ' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A 5218 ' ' HOH . . . . . 0.516 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 mmm . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.812 0.339 . . . . 0.44 111.126 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.55 103.1 13.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.44 110.886 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.43 144.12 32.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.44 110.901 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.407 ' CD1' ' CD1' ' A' ' 6' ' ' ILE . 3.0 pp -146.07 137.72 24.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.44 111.075 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -106.2 152.86 22.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.229 0.537 . . . . 0.44 111.852 -179.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.423 HG12 H5'' ' A' ' 131' ' ' 8OG . 5.3 mp -146.75 129.79 8.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.414 -0.812 . . . . 0.44 110.866 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.536 ' HB3' ' CG1' ' A' ' 40' ' ' ILE . . . -125.04 125.18 43.43 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.082 -0.71 . . . . 0.44 109.082 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.538 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -144.52 162.03 14.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.812 -0.755 . . . . 0.44 111.91 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.422 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.03 143.06 10.11 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.435 -0.802 . . . . 0.44 111.741 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.597 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -92.7 111.57 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.819 -0.437 . . . . 0.44 109.819 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.584 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.3 OUTLIER -71.1 113.45 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-O 121.283 0.563 . . . . 0.44 110.64 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.729 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.19 126.9 32.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.187 -0.915 . . . . 0.44 111.422 -178.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.538 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -83.91 -172.51 4.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.992 -1.004 . . . . 0.44 111.951 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.48 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 16.8 tp10 -78.89 -4.78 51.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.317 -1.31 . . . . 0.44 112.603 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -127.91 44.47 2.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.787 0.327 . . . . 0.44 111.613 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.03 19.58 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.358 -0.383 . . . . 0.44 111.539 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 10.0 pt-20 -114.77 142.76 46.09 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.497 -0.557 . . . . 0.44 109.497 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.472 HG23 ' N ' ' A' ' 19' ' ' PHE . 11.3 mt -109.92 144.1 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.298 0.571 . . . . 0.44 112.213 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.508 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 11.2 t80 -88.86 93.69 9.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.316 -0.856 . . . . 0.44 109.897 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.446 HG23 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -112.47 149.39 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.373 . . . . 0.44 110.536 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.452 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 3.1 p -70.93 111.87 6.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.378 -0.374 . . . . 0.44 110.506 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.405 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 21.9 ptt-85 -139.42 137.11 35.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.429 -0.351 . . . . 0.44 110.818 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 52.44 -110.41 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.44 110.746 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 173.4 -170.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.841 0.353 . . . . 0.44 110.98 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.25 -30.58 34.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.44 110.971 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -171.41 35.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.44 110.831 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.97 -175.37 3.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.44 111.128 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -113.46 83.93 1.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.44 110.914 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.3 tpp -142.12 29.99 1.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.44 110.795 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.5 -18.81 54.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.44 111.421 -179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.24 8.36 16.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.53 -0.304 . . . . 0.44 111.665 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.08 26.09 10.59 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.881 0.372 . . . . 0.44 111.55 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.452 ' HA ' ' O ' ' A' ' 21' ' ' THR . 5.1 tt -61.64 79.26 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.895 -0.593 . . . . 0.44 110.647 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -123.43 -173.23 2.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.112 0.482 . . . . 0.44 111.973 -179.364 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.471 ' N ' ' CD1' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -119.45 168.21 10.54 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.635 -0.711 . . . . 0.44 111.634 -179.08 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.538 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 68.7 Cg_endo -74.87 167.09 27.85 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.465 2.777 . . . . 0.44 113.043 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.583 ' O ' ' CG2' ' A' ' 40' ' ' ILE . . . 101.85 -5.51 53.76 Favored Glycine 0 C--O 1.222 -0.656 0 CA-C-N 115.87 -0.605 . . . . 0.44 114.155 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -62.21 145.65 49.4 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.989 -0.624 . . . . 0.44 112.941 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.686 ' HD2' ' H2 ' ' A' 5229 ' ' HOH . 0.1 OUTLIER 92.06 2.01 0.11 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.065 0.765 . . . . 0.44 113.065 178.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.583 ' CG2' ' O ' ' A' ' 37' ' ' GLY . 0.9 OUTLIER -51.41 -28.86 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.44 110.572 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.576 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.55 -60.8 1.6 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.47 -1.241 . . . . 0.44 111.143 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.513 ' C ' ' O ' ' A' ' 41' ' ' GLU . 8.9 mmm 10.28 -81.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.848 0.718 . . . . 0.44 112.633 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.43 27.98 0.13 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.551 -0.833 . . . . 0.44 113.083 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -103.97 -173.45 2.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.695 0.283 . . . . 0.44 110.999 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.535 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -108.85 155.91 39.92 Favored Pre-proline 0 N--CA 1.456 -0.159 0 N-CA-C 110.037 -0.356 . . . . 0.44 110.037 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.49 -24.5 0.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.674 2.249 . . . . 0.44 112.406 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -86.83 -60.27 2.03 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.276 0.472 . . . . 0.44 112.276 -179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -80.67 -21.62 41.2 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.198 0.444 . . . . 0.44 112.198 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.45 ' HB2' ' HB ' ' A' ' 40' ' ' ILE . . . -56.81 -48.77 77.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.675 0.274 . . . . 0.44 110.97 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.447 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.35 -50.72 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.424 -0.353 . . . . 0.44 110.754 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 49.9 t -51.14 -35.66 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.44 110.773 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -48.71 15.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.019 -0.537 . . . . 0.44 110.537 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.7 mm-40 -65.77 -19.77 66.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.2 -0.455 . . . . 0.44 110.669 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.463 ' CD2' ' CD2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -58.43 -44.8 89.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.939 0.4 . . . . 0.44 110.774 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -30.96 67.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.13 0.491 . . . . 0.44 109.989 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -77.36 -32.61 55.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.588 -0.733 . . . . 0.44 111.523 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.495 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.16 5.9 26.3 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.786 0.661 . . . . 0.44 112.786 -178.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.684 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 12.5 t -133.91 -43.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.44 110.48 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.537 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 65.78 -33.12 0.14 Allowed Glycine 0 C--N 1.33 0.244 0 N-CA-C 114.655 0.622 . . . . 0.44 114.655 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.706 ' O ' ' HD3' ' A' ' 62' ' ' PRO . 20.0 tt -77.6 165.62 2.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.584 0.231 . . . . 0.44 110.776 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.425 ' N ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -105.19 88.26 2.41 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 108.58 -0.896 . . . . 0.44 108.58 178.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.706 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 12.0 Cg_endo -114.36 150.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 123.568 2.846 . . . . 0.44 114.39 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -74.69 79.93 2.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.19 -2.152 . . . . 0.44 105.19 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.591 ' HA ' HG12 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.52 129.4 49.66 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.601 -1.181 . . . . 0.44 111.724 -175.539 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.546 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -177.85 -138.57 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.852 -0.613 . . . . 0.44 110.779 -179.148 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 85' ' ' TRP . 0.5 OUTLIER 51.01 173.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.823 0.449 . . . . 0.44 111.719 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.773 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -131.88 125.82 32.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.115 0.484 . . . . 0.44 111.101 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -78.59 -55.87 4.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.787 -0.642 . . . . 0.44 110.022 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.688 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -172.27 131.7 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.44 110.328 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.415 ' HE3' ' CE3' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -114.19 118.71 34.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.712 0.291 . . . . 0.44 110.688 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.451 ' CD2' ' CD1' ' A' ' 73' ' ' TYR . 1.0 OUTLIER -107.7 129.68 55.0 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.967 0.413 . . . . 0.44 111.047 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -115.92 110.05 18.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.035 -0.529 . . . . 0.44 110.176 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.451 ' CD1' ' CD2' ' A' ' 71' ' ' LEU . 2.8 p90 -136.33 143.64 44.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.44 111.052 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -121.27 118.18 28.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.44 110.808 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.482 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 2.6 m-85 -69.91 163.01 64.5 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.44 110.633 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.69 83.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.187 2.591 . . . . 0.44 112.239 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 17.4 t0 97.14 14.39 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.358 -0.837 . . . . 0.44 111.108 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.55 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.2 OUTLIER -137.39 149.18 46.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.44 110.308 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -131.49 112.84 13.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.767 0.318 . . . . 0.44 110.658 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.563 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 3.1 tt -120.65 112.0 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.329 -0.396 . . . . 0.44 111.352 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.51 118.89 32.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.408 -0.59 . . . . 0.44 109.408 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.415 HD11 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -119.86 114.55 22.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.978 0.418 . . . . 0.44 111.913 -178.822 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.421 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.4 m0 -108.84 122.33 46.96 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.851 -0.613 . . . . 0.44 110.119 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.688 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 1.9 m-85 -106.91 118.18 36.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.44 110.755 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.773 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 68.1 m95 -94.75 148.27 22.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.44 111.223 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.546 ' O ' ' O ' ' A' ' 65' ' ' PHE . 44.0 tp -99.03 102.98 14.88 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 121.449 0.642 . . . . 0.44 110.854 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.597 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 7.4 t -86.13 145.68 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-N 114.892 -1.049 . . . . 0.44 112.277 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -100.7 -52.25 3.38 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.123 1.157 . . . . 0.44 114.123 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.729 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.21 165.65 24.15 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.479 0.582 . . . . 0.44 112.463 -178.335 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.66 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 33.0 p90 -129.73 160.14 34.31 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.988 -0.551 . . . . 0.44 111.319 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.402 ' O ' ' CD1' ' A' ' 60' ' ' ILE . 0.5 OUTLIER -100.83 93.35 5.49 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.868 0.366 . . . . 0.44 111.422 -179.146 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' ' NE1' ' A' ' 90' ' ' TRP . . . 100.31 -110.24 3.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.559 -0.829 . . . . 0.44 112.011 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 19.9 tt0 -135.3 127.03 17.71 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.447 0.165 . . . . 0.44 111.075 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.514 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.7 Cg_exo -75.4 153.13 39.67 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.704 2.269 . . . . 0.44 110.888 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.537 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 19.0 p-90 -150.27 -62.81 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.672 0.619 . . . . 0.44 112.672 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.684 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.39 -99.91 0.02 OUTLIER Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.602 -0.726 . . . . 0.44 112.948 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.7 32.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.807 0.337 . . . . 0.44 111.164 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.405 ' HA ' ' CG ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -63.52 -21.99 66.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.314 -0.403 . . . . 0.44 111.187 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.45 -123.1 2.81 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.484 -0.865 . . . . 0.44 113.098 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -75.9 132.52 74.23 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.159 0.504 . . . . 0.44 111.702 -179.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -43.39 146.26 1.26 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.105 2.536 . . . . 0.44 112.646 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.12 177.65 16.43 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.895 -0.669 . . . . 0.44 112.828 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.09 157.03 46.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.25 -0.278 . . . . 0.44 110.25 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.6 OUTLIER -66.21 106.29 1.63 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.878 -0.415 . . . . 0.44 109.878 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.433 ' O ' ' N ' ' A' ' 18' ' ' ILE . 0.6 OUTLIER -120.31 163.19 18.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.929 -0.578 . . . . 0.44 111.22 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.7 p -82.37 114.83 21.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.481 -0.327 . . . . 0.44 110.473 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.47 -18.68 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.44 111.43 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.22 -10.8 2.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.804 0.335 . . . . 0.44 111.438 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.76 55.1 0.72 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.126 -0.79 . . . . 0.44 111.126 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.5 tp -61.43 150.2 36.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.407 -0.397 . . . . 0.44 110.828 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -104.18 95.61 6.09 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.025 0.75 . . . . 0.44 113.025 -178.34 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.494 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.51 -18.76 61.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.942 -0.572 . . . . 0.44 109.874 177.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -79.06 -47.11 16.76 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.9 -0.591 . . . . 0.44 111.365 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -66.7 -39.25 87.99 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.243 -0.435 . . . . 0.44 111.244 -179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.1 OUTLIER -78.39 174.43 6.04 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.524 -0.546 . . . . 0.44 109.524 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.4 Cg_endo -53.89 127.69 26.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.859 1.706 . . . . 0.44 112.497 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.8 Cg_endo -69.11 -34.93 15.59 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.753 2.302 . . . . 0.44 112.465 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.453 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -71.37 -9.57 58.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.008 0.433 . . . . 0.44 111.125 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -106.79 18.64 21.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.772 -0.649 . . . . 0.44 110.852 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 tt0 -70.38 -31.37 2.22 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 113.864 1.061 . . . . 0.44 113.864 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.5 Cg_exo -43.7 -36.08 7.14 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.83 1.687 . . . . 0.44 113.395 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.434 HG12 ' CE1' ' A' ' 84' ' ' PHE . 59.3 t -78.04 -51.31 18.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.44 111.903 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.477 ' O ' ' CB ' ' A' ' 127' ' ' LYS . 3.9 mm -77.08 -39.78 29.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 112.936 0.717 . . . . 0.44 112.936 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.8 -26.88 26.08 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.821 0.304 . . . . 0.44 111.821 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.48 -53.9 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.954 0.353 . . . . 0.44 111.954 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.477 ' HG ' ' CE2' ' A' ' 68' ' ' PHE . 1.4 mm? -79.26 -30.3 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.665 0.269 . . . . 0.44 111.564 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.477 ' CB ' ' O ' ' A' ' 123' ' ' ILE . 9.7 ttpt -54.03 -42.13 68.8 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.135 0.493 . . . . 0.44 110.338 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -67.46 -6.11 17.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 0.44 109.815 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-N 115.94 -0.573 . . . . 0.44 111.03 179.774 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.743 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 5227 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 5228 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A 5229 ' ' HOH . . . . . 0.686 ' H2 ' ' HD2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A 5230 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ttm . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.8 0.333 . . . . 0.44 111.196 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -109.96 141.05 43.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.44 110.956 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.453 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.17 128.27 22.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.44 110.777 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.466 ' CD1' " O4'" ' A' ' 131' ' ' 8OG . 4.0 pp -146.33 142.64 28.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.44 111.544 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -102.88 153.58 20.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.139 -0.482 . . . . 0.44 111.34 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.528 HG12 " H5'" ' A' ' 131' ' ' 8OG . 40.5 mt -146.33 116.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.72 -0.673 . . . . 0.44 110.959 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.599 ' HB2' ' CG2' ' A' ' 40' ' ' ILE . . . -125.55 144.25 50.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.721 -0.474 . . . . 0.44 109.721 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -145.76 162.44 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.041 -0.664 . . . . 0.44 111.931 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -142.68 108.04 0.51 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.383 -0.826 . . . . 0.44 111.698 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.568 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -70.73 108.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.639 -0.504 . . . . 0.44 109.639 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.481 ' HA ' ' HB ' ' A' ' 87' ' ' VAL . 0.2 OUTLIER -71.72 121.96 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.92 0.391 . . . . 0.44 111.443 -179.004 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -84.86 121.93 28.43 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.03 -0.532 . . . . 0.44 111.093 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.562 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -79.63 -171.67 2.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.731 0.777 . . . . 0.44 111.68 179.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.438 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 1.6 tm-20 -82.0 15.53 2.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.343 -1.299 . . . . 0.44 113.105 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -144.76 43.97 1.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.189 0.44 . . . . 0.44 112.189 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 54.13 17.82 1.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.016 0.376 . . . . 0.44 112.016 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.425 ' HB3' ' O ' ' A' ' 105' ' ' MET . 2.3 mt-10 -116.81 160.68 20.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.069 -0.715 . . . . 0.44 109.069 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.421 HG21 ' CB ' ' A' ' 10' ' ' ILE . 5.9 mt -121.33 139.7 47.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.201 0.524 . . . . 0.44 111.458 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.564 ' C ' ' CD1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -88.49 98.57 11.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.598 -0.728 . . . . 0.44 110.87 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -113.79 162.46 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.334 -0.848 . . . . 0.44 108.741 178.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.0 p -70.58 145.72 50.57 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.615 -0.434 . . . . 0.44 110.669 -179.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.6 ttt-85 -148.14 96.24 2.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 0.44 111.068 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 55.21 -92.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.44 111.226 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 173.71 -32.35 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.155 -0.475 . . . . 0.44 111.239 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 72.86 20.21 3.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.222 -0.445 . . . . 0.44 111.224 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 p30 178.93 37.24 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.289 -0.414 . . . . 0.44 110.807 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 179.6 -166.58 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.44 111.021 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.03 -164.42 1.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.44 110.782 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.0 mtt 64.3 61.14 0.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.331 -0.395 . . . . 0.44 110.857 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.91 -8.92 56.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.44 111.65 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 10.9 t-20 -99.1 28.71 4.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.706 0.288 . . . . 0.44 111.403 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 26.26 10.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.908 0.385 . . . . 0.44 111.934 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.1 tt -68.97 67.22 0.15 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 0.44 110.67 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.53 -167.77 1.3 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.211 -0.45 . . . . 0.44 111.343 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.434 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.36 168.06 10.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.001 -0.545 . . . . 0.44 111.44 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 84.2 Cg_endo -84.19 166.76 12.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.398 2.732 . . . . 0.44 113.224 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.534 ' C ' ' O ' ' A' ' 7' ' ' ALA . . . 101.28 -5.7 55.58 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.509 -0.769 . . . . 0.44 113.751 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -67.59 166.93 41.87 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.564 -0.351 . . . . 0.44 113.254 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HB2' ' H1 ' ' A' 5241 ' ' HOH . 0.0 OUTLIER 82.74 1.58 1.19 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.661 0.384 . . . . 0.44 111.871 179.575 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.599 ' CG2' ' HB2' ' A' ' 7' ' ' ALA . 3.4 pt -50.84 -28.6 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.516 0.674 . . . . 0.44 110.562 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.521 ' O ' ' C ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -40.07 -63.43 0.61 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.496 -1.229 . . . . 0.44 110.878 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.521 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 11.15 -84.0 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.895 0.747 . . . . 0.44 112.625 179.368 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.74 29.26 0.08 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.659 -0.782 . . . . 0.44 112.913 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -168.23 1.98 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.734 0.302 . . . . 0.44 110.971 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.514 ' CG2' ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -101.49 153.1 38.07 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.315 -0.402 . . . . 0.44 110.28 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.514 ' HD2' ' CG2' ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.86 -25.17 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.852 2.368 . . . . 0.44 112.49 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -103.99 -41.27 5.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.392 -0.367 . . . . 0.44 111.482 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.4 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 20.3 mt-30 -80.27 -5.71 56.68 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.755 0.28 . . . . 0.44 111.755 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 40' ' ' ILE . . . -60.1 -55.25 36.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.329 . . . . 0.44 110.836 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.49 ' CG2' ' N ' ' A' ' 51' ' ' VAL . 2.0 m -78.33 -46.7 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.466 . . . . 0.44 111.305 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 27.8 t -55.13 -36.91 41.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.959 -0.564 . . . . 0.44 111.342 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.4 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 4.3 mmp_? -78.19 -52.03 9.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.874 0.368 . . . . 0.44 110.616 179.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -60.28 -21.88 62.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.44 110.672 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.461 HD23 ' CG ' ' A' ' 64' ' ' HIS . 1.4 tp -60.29 -45.05 94.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.44 111.024 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -30.58 71.42 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.535 -0.543 . . . . 0.44 109.535 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.5 -27.85 51.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.324 -0.853 . . . . 0.44 111.419 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.546 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.64 6.97 26.34 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 113.028 0.751 . . . . 0.44 113.028 -178.447 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.466 ' CG1' HG13 ' A' ' 60' ' ' ILE . 12.4 t -133.38 -44.3 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.049 0.452 . . . . 0.44 110.545 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . 0.604 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 54.52 13.89 4.47 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 114.781 0.673 . . . . 0.44 114.781 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -127.08 -167.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 118.002 0.901 . . . . 0.44 110.796 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . 0.455 HG21 ' CB ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -111.13 88.65 8.77 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.44 110.535 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.6 ' HA ' ' HA ' ' A' ' 90' ' ' TRP . 25.2 Cg_endo -113.69 137.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 123.733 2.956 . . . . 0.44 114.413 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.483 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 33.6 mt-30 -74.83 79.23 2.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 104.788 -2.301 . . . . 0.44 104.788 175.235 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.531 ' HB2' ' CG1' ' A' ' 87' ' ' VAL . 1.0 OUTLIER -117.9 130.61 56.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.587 -1.642 . . . . 0.44 109.873 -176.285 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 66' ' ' SER . 2.3 t80 -176.43 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 113.18 0.807 . . . . 0.44 113.18 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 86' ' ' LEU . 65.8 m -33.57 157.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.092 -0.958 . . . . 0.44 112.035 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tt -117.54 123.21 45.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.38 . . . . 0.44 110.95 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -82.36 -56.31 3.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.44 110.272 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.3 tt0 -171.66 159.22 5.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.779 -0.646 . . . . 0.44 110.429 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.1 108.44 5.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.756 0.312 . . . . 0.44 110.691 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.419 HD23 ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -96.81 146.23 25.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.393 -0.367 . . . . 0.44 110.674 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -138.96 109.89 6.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.44 110.763 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.419 ' CD1' HD23 ' A' ' 71' ' ' LEU . 2.4 p90 -141.17 153.01 45.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.44 110.677 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 4.2 pt-20 -121.25 133.81 55.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.158 0.504 . . . . 0.44 111.251 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.452 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -97.12 163.15 20.58 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 0.44 110.27 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.4 Cg_endo -54.99 81.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.82 2.346 . . . . 0.44 112.181 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.3 t70 96.25 6.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.373 -0.831 . . . . 0.44 111.647 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.633 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 9.5 ttp180 -137.38 93.95 2.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.677 0.275 . . . . 0.44 110.908 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.453 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -88.84 104.7 17.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.834 0.349 . . . . 0.44 110.487 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.58 HG22 ' N2 ' ' A' ' 131' ' ' 8OG . 2.2 tt -110.25 130.87 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.44 111.292 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.14 118.59 37.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.194 -0.669 . . . . 0.44 109.194 178.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.474 ' CD1' ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -108.62 114.19 27.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.033 0.444 . . . . 0.44 111.862 -178.756 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TRP . . . . . 0.412 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 9.2 m0 -114.32 122.42 46.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.759 -0.655 . . . . 0.44 109.906 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.475 ' CD2' ' CG1' ' A' ' 122' ' ' VAL . 8.9 m-30 -114.05 116.94 29.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.87 -0.605 . . . . 0.44 110.762 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.405 ' NE1' HG11 ' A' ' 50' ' ' VAL . 20.0 m95 -106.64 148.34 28.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.952 -0.567 . . . . 0.44 111.83 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 66' ' ' SER . 48.1 tp -93.03 138.55 31.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.543 -0.753 . . . . 0.44 111.441 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.568 ' HB ' ' O ' ' A' ' 10' ' ' ILE . 36.5 t -121.4 145.7 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 CA-C-N 115.119 -0.946 . . . . 0.44 110.248 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.77 -15.71 11.86 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.9 1.445 . . . . 0.44 114.9 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -163.33 162.3 25.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.594 1.088 . . . . 0.44 112.353 -179.053 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.6 ' HA ' ' HA ' ' A' ' 62' ' ' PRO . 0.5 OUTLIER -157.66 123.45 4.66 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.143 -0.48 . . . . 0.44 110.882 178.289 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.455 ' CB ' HG21 ' A' ' 61' ' ' THR . 0.0 OUTLIER -79.55 146.52 32.57 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 120.481 -0.488 . . . . 0.44 110.551 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.0 -120.79 24.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.548 -0.834 . . . . 0.44 112.21 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -135.06 135.06 22.2 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.4 0.143 . . . . 0.44 110.931 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . 0.534 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.9 Cg_exo -76.41 128.96 10.74 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.017 2.478 . . . . 0.44 111.224 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . 0.604 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 11.6 p-90 -129.72 -61.35 1.01 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.118 0.485 . . . . 0.44 111.733 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.546 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 40.68 -95.52 0.01 OUTLIER Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.093 -0.958 . . . . 0.44 113.101 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 168.24 69.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.909 0.385 . . . . 0.44 110.71 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.434 ' HB3' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -95.06 -38.65 10.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.44 110.696 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.18 -125.55 1.46 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.769 . . . . 0.44 112.732 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -78.59 126.51 82.67 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.44 111.414 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -43.43 144.08 2.14 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.006 2.47 . . . . 0.44 112.797 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.09 177.53 19.06 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.078 -0.582 . . . . 0.44 112.295 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -124.12 157.46 34.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.499 0.19 . . . . 0.44 110.823 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -59.38 106.86 0.49 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.784 0.326 . . . . 0.44 110.189 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.425 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -120.46 159.12 25.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.227 -0.442 . . . . 0.44 111.084 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.4 p -75.13 118.19 17.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.44 110.498 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.42 -18.59 62.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 0.44 111.429 -179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.8 p -61.29 -12.08 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.641 -0.254 . . . . 0.44 111.653 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.47 50.81 0.85 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.894 -0.669 . . . . 0.44 112.192 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.94 150.61 37.22 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.739 0.304 . . . . 0.44 111.054 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -108.94 108.98 19.94 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.622 0.601 . . . . 0.44 112.622 -178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.465 ' O ' ' HD1' ' A' ' 115' ' ' PHE . . . -72.45 -18.03 61.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.883 -0.598 . . . . 0.44 110.161 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.98 -47.97 15.32 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.081 -0.509 . . . . 0.44 110.9 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -66.97 -29.26 69.07 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.99 -0.55 . . . . 0.44 111.46 -179.465 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.565 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -89.87 173.47 5.8 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.646 -0.502 . . . . 0.44 109.646 179.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.52 127.85 27.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 121.84 1.693 . . . . 0.44 112.283 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.407 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.0 Cg_endo -69.14 -35.96 13.43 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.657 2.238 . . . . 0.44 112.636 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . 0.479 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -72.01 -9.75 58.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.982 0.42 . . . . 0.44 111.41 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -106.63 23.0 14.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.947 -0.57 . . . . 0.44 110.701 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.58 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.13 -30.66 0.9 Allowed Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 113.904 1.076 . . . . 0.44 113.904 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.3 Cg_exo -43.19 -35.13 4.82 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.971 1.78 . . . . 0.44 113.466 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.475 ' CG1' ' CD2' ' A' ' 84' ' ' PHE . 37.6 t -77.86 -51.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.266 0.555 . . . . 0.44 110.381 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.436 HG13 ' CE2' ' A' ' 115' ' ' PHE . 33.4 mm -64.93 -32.3 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.276 -0.874 . . . . 0.44 111.321 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -27.17 39.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.885 0.374 . . . . 0.44 110.77 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.22 -50.83 9.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.44 111.623 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -78.08 -27.04 48.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 0.44 111.399 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.433 ' HB2' HG23 ' A' ' 123' ' ' ILE . 53.1 tttp -54.94 -42.38 72.21 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.158 0.504 . . . . 0.44 110.464 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 -63.74 -12.96 39.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.48 -0.782 . . . . 0.44 109.593 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.6 mp . . . . . 0 C--O 1.231 0.085 0 CA-C-N 115.94 -0.573 . . . . 0.44 111.042 179.618 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' 8OG . . . . . 0.754 ' P ' " H3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 5239 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 5240 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A 5241 ' ' HOH . . . . . 0.463 ' H1 ' ' HB2' ' A' ' 39' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A 5242 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.813 0.34 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -139.97 142.85 36.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 1.067 HD12 HD11 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -146.04 134.48 21.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.986 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.466 ' C ' HD12 ' A' ' 6' ' ' ILE . 15.6 mt-30 -102.63 152.86 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.35 0.595 . . . . 0.0 111.937 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.067 HD11 HD12 ' A' ' 4' ' ' LEU . 4.7 mp -146.5 126.82 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.643 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.048 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.9 125.56 44.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.6 m -133.78 162.58 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.131 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.451 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.69 116.04 0.99 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.818 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.021 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.91 109.05 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -71.15 126.67 31.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.613 -178.641 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -91.18 123.0 34.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.474 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.467 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 42.6 t30 -79.91 -172.45 3.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.622 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.45 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.1 tm-20 -81.8 4.29 22.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.418 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -139.5 51.83 1.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 111.324 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.2 p30 45.78 24.32 0.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.439 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.4 pt-20 -115.86 137.45 52.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.021 HG21 HG22 ' A' ' 10' ' ' ILE . 7.3 mt -105.88 139.59 26.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.324 0.583 . . . . 0.0 112.146 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 1.1 t80 -85.31 112.43 20.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.331 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.534 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -128.73 149.93 33.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.921 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.699 HG22 ' OE2' ' A' ' 98' ' ' GLU . 31.2 p -70.63 111.5 6.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.224 -179.528 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.83 0.348 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 34' ' ' GLU . 3.1 tmtm? -106.29 26.3 9.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.336 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.611 HD13 ' HB3' ' A' ' 111' ' ' ASN . 2.7 tt -63.11 74.67 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.775 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -117.32 -173.27 2.38 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.014 0.435 . . . . 0.0 111.844 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.657 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -119.33 168.49 9.9 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.632 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.623 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 95.3 Cg_endo -81.92 166.74 16.8 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.437 2.758 . . . . 0.0 113.306 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.629 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.73 -5.77 54.32 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.384 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -59.25 159.8 18.59 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 117.23 0.515 . . . . 0.0 113.332 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.11 -2.19 0.73 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.048 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -49.97 -27.91 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.544 0.688 . . . . 0.0 110.823 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -43.53 -61.49 1.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.253 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 41' ' ' GLU . 7.4 mmt 9.64 -81.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.826 0.703 . . . . 0.0 112.582 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.34 32.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.985 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.424 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -92.51 -170.67 2.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.713 0.292 . . . . 0.0 111.06 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.844 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -101.22 152.95 38.04 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.284 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.844 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.89 -24.78 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.782 2.321 . . . . 0.0 112.618 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.632 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.0 mp0 -102.18 -42.21 6.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -80.3 -18.39 49.4 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.802 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -57.41 -49.93 74.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.792 0.33 . . . . 0.0 111.06 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.793 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.45 -47.87 23.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.719 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.6 t -56.7 -36.02 47.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.247 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -52.01 9.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.649 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.0 mm-40 -63.43 -22.1 66.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.689 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.782 HD21 ' CD2' ' A' ' 64' ' ' HIS . 1.3 tp -58.38 -44.99 89.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.755 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -31.33 71.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 109.681 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -77.4 -25.77 51.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.243 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.27 5.84 26.02 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.501 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.752 ' O ' HG23 ' A' ' 60' ' ' ILE . 3.2 t -134.29 -45.1 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.987 0.423 . . . . 0.0 110.111 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.587 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 62.4 -20.4 0.06 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.768 -0.651 . . . . 0.0 114.664 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.752 HG23 ' O ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -88.73 -176.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 120.961 0.41 . . . . 0.0 111.629 -179.068 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.485 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -115.49 87.9 18.16 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.162 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.674 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.6 Cg_endo -113.28 145.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 123.611 2.874 . . . . 0.0 113.789 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 36.3 mt-30 -74.9 79.89 2.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.989 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.05 126.98 49.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.172 -1.377 . . . . 0.0 111.072 -176.054 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.489 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.1 t80 179.77 166.91 1.2 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.77 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.7 m 87.31 155.39 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.644 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.738 HD13 ' HD3' ' A' ' 70' ' ' LYS . 1.4 pp -110.85 137.41 48.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -91.21 -37.55 13.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.019 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.53 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.2 tt0 -171.77 144.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.45 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.738 ' HD3' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.2 132.12 22.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.345 179.535 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.79 HD21 HG22 ' A' ' 122' ' ' VAL . 2.4 pp -141.0 151.09 43.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.426 . . . . 0.0 111.336 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HB2' HG23 ' A' ' 81' ' ' THR . 16.4 tt0 -129.93 109.94 11.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.467 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -128.22 149.75 50.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.739 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -121.15 129.48 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.18 0.514 . . . . 0.0 111.22 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.7 m-85 -78.81 163.21 61.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.546 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.3 Cg_endo -50.72 83.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.227 2.618 . . . . 0.0 112.238 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 21.1 m-20 93.98 15.45 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.339 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 10.5 ttp180 -137.43 150.21 47.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.365 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -126.95 113.47 16.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.006 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 tt -124.22 119.44 56.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.46 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -106.35 118.82 37.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.82 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.741 HD23 ' HB ' ' A' ' 6' ' ' ILE . 11.5 mt -118.39 114.36 22.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.964 0.412 . . . . 0.0 111.798 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.46 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.5 m0 -107.64 122.31 46.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.009 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.631 ' CE2' HG11 ' A' ' 122' ' ' VAL . 3.2 m-30 -104.54 120.16 40.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.033 0.444 . . . . 0.0 110.513 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.707 ' CE2' HG11 ' A' ' 50' ' ' VAL . 16.6 m95 -106.23 149.09 27.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.049 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 87' ' ' VAL . 3.5 tm? -95.52 138.6 32.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.551 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.989 HG22 ' ND1' ' A' ' 64' ' ' HIS . 39.1 t -123.4 145.85 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.117 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -110.57 -26.71 9.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -162.51 161.71 27.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.491 0.587 . . . . 0.0 111.41 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.702 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -156.91 124.74 5.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.266 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.537 ' O ' HD12 ' A' ' 60' ' ' ILE . 75.3 mt-10 -73.14 142.69 47.45 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.254 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.15 -143.38 26.11 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.704 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.2 tt0 -107.52 138.01 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.598 ' HA ' HG21 ' A' ' 60' ' ' ILE . 6.6 Cg_exo -74.89 128.97 12.0 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.82 2.347 . . . . 0.0 111.598 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.674 ' CD1' HG22 ' A' ' 60' ' ' ILE . 52.0 p-90 -121.23 -62.62 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.642 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.93 -97.68 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.21 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 tttt 173.59 39.43 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.724 0.297 . . . . 0.0 111.096 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.699 ' OE2' HG22 ' A' ' 21' ' ' THR . 15.7 pt-20 -57.87 -49.39 76.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.798 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 148.86 -68.08 0.36 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.466 -0.874 . . . . 0.0 113.118 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -117.72 113.27 38.26 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.033 0.444 . . . . 0.0 111.746 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.6 146.15 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.077 2.518 . . . . 0.0 112.686 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.17 177.39 17.69 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.811 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -124.4 157.18 35.72 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.467 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.8 OUTLIER -67.65 106.44 2.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.91 0.386 . . . . 0.0 110.17 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.23 163.22 18.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.211 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.5 t -83.43 114.84 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.444 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.602 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -60.66 -18.77 55.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.458 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 108' ' ' VAL . 21.2 t -62.89 -8.85 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.656 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.64 51.68 0.84 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.738 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD23 HD12 ' A' ' 123' ' ' ILE . 6.9 tp -62.18 150.16 39.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.652 0.263 . . . . 0.0 110.688 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.611 ' HB3' HD13 ' A' ' 33' ' ' LEU . 1.3 t-20 -107.26 97.31 7.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.48 -22.58 61.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.211 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -78.98 -44.91 21.38 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.401 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.62 -42.74 86.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.199 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.529 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.55 174.32 6.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.5 Cg_endo -54.07 127.74 26.97 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.889 1.726 . . . . 0.0 112.233 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.03 -36.28 13.06 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.679 2.252 . . . . 0.0 112.503 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.13 -9.67 58.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.42 . . . . 0.0 111.339 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -104.37 21.61 16.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.798 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.22 -31.29 1.4 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.8 Cg_exo -43.83 -32.97 4.68 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.833 1.689 . . . . 0.0 113.003 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.79 HG22 HD21 ' A' ' 71' ' ' LEU . 50.0 t -78.02 -51.1 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.121 0.486 . . . . 0.0 110.504 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.895 HG22 ' HB2' ' A' ' 127' ' ' LYS . 23.4 mm -69.17 -30.73 47.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.623 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.78 -27.61 42.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.906 0.384 . . . . 0.0 110.628 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -80.43 -53.11 6.89 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.941 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.717 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.5 tm? -78.19 -33.19 50.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.771 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.895 ' HB2' HG22 ' A' ' 123' ' ' ILE . 31.0 ttpt -53.41 -42.84 67.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.133 0.492 . . . . 0.0 110.837 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -7.36 29.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.83 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.528 0.1 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.32 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.0 tttm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.99 126.76 20.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.411 HD11 HD13 ' A' ' 80' ' ' ILE . 3.1 pp -146.1 122.49 10.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.5 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 14.2 mt-30 -102.85 155.37 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.41 0.624 . . . . 0.0 112.391 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 80' ' ' ILE . 3.6 mp -146.99 129.72 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.536 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.994 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 125.38 44.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.9 m -144.28 162.27 14.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.718 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.446 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -149.65 132.14 3.92 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.006 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.059 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.85 114.49 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.736 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.1 mt -71.38 123.24 25.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.96 0.409 . . . . 0.0 111.513 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.405 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -84.95 122.86 29.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.684 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.465 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 14.7 t30 -82.34 -172.21 3.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.087 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tt0 -81.61 0.99 35.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.431 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -139.74 52.16 1.71 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.432 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 47.56 21.17 0.22 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.588 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -111.79 153.28 26.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.059 HG21 HG22 ' A' ' 10' ' ' ILE . 4.9 mt -123.61 141.87 42.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.351 0.596 . . . . 0.0 112.438 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -87.13 117.86 26.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.917 179.268 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -129.04 145.2 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.567 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 100' ' ' GLN . 68.4 p -70.78 111.84 6.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.23 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HG3' HD12 ' A' ' 33' ' ' LEU . 21.4 ttp180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.046 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.4 t30 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.779 0.323 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.22 26.04 10.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.409 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.893 HD13 ' HB3' ' A' ' 111' ' ' ASN . 7.2 tt -64.01 74.76 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.88 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -123.59 -171.22 2.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.896 0.379 . . . . 0.0 111.5 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.721 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.3 168.58 9.68 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.619 -179.524 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.515 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 92.0 Cg_endo -82.66 167.37 14.95 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.689 2.926 . . . . 0.0 113.307 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.14 -5.24 52.65 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.067 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.82 166.51 17.4 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.274 -0.488 . . . . 0.0 113.263 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.29 0.25 1.38 Allowed 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.994 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -49.9 -29.07 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.682 0.753 . . . . 0.0 110.542 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.596 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.07 -60.37 1.9 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.964 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 8.05 -80.27 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.928 0.767 . . . . 0.0 112.511 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -178.66 32.71 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.725 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.6 mp0 -88.58 -174.11 4.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.796 0.331 . . . . 0.0 111.078 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.843 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.8 153.79 38.55 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.239 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.843 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.86 -25.18 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.805 2.337 . . . . 0.0 112.496 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.539 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mt-10 -104.02 -40.31 6.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.398 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -80.25 -6.79 58.46 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.859 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.52 -56.01 24.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.812 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.784 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.28 -48.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.506 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.4 t -51.44 -35.8 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.016 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -52.26 8.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.255 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.3 mm-40 -66.27 -22.69 66.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.707 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.556 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 10.9 tp -58.01 -44.3 87.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -28.41 61.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.055 0.455 . . . . 0.0 109.885 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -77.1 -28.07 54.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.972 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.7 mp0 -108.39 6.94 26.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.936 HG12 HG13 ' A' ' 60' ' ' ILE . 60.9 t -133.18 -44.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.609 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.85 -39.12 0.24 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.573 -0.74 . . . . 0.0 114.264 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.936 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.34 -176.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.959 0.409 . . . . 0.0 110.847 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.31 88.77 13.32 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.694 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.744 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.8 Cg_endo -110.46 143.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 123.402 2.735 . . . . 0.0 113.679 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 33.3 mt-30 -74.67 79.9 2.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.817 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.37 132.08 54.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.165 -175.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -179.82 -133.55 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.294 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.23 167.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.017 0.437 . . . . 0.0 111.754 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 67' ' ' LEU . 6.7 tt -131.7 108.73 9.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.897 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.85 -44.29 32.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.037 0.446 . . . . 0.0 110.253 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.8 tt0 -171.6 156.89 4.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.316 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.09 106.24 4.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.644 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.823 ' HB2' HG22 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -96.77 124.88 40.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -123.42 109.96 14.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.413 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.602 ' CD1' HD23 ' A' ' 71' ' ' LEU . 1.8 p90 -138.55 149.55 45.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.828 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 3.7 pt-20 -121.11 122.15 39.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.089 0.471 . . . . 0.0 111.248 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 77' ' ' ASP . 4.5 m-85 -84.99 162.86 48.23 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.482 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -50.81 81.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.011 2.474 . . . . 0.0 112.224 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 75' ' ' PHE . 12.3 m-20 89.58 12.88 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 24.3 ttp180 -137.35 93.7 2.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.705 0.288 . . . . 0.0 110.786 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.463 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.8 t-80 -81.49 110.74 17.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.957 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.511 ' CD1' HD13 ' A' ' 6' ' ' ILE . 1.8 tp -114.0 118.52 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.519 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -111.72 118.77 36.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.763 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.44 HD23 ' HB ' ' A' ' 6' ' ' ILE . 11.8 mt -122.25 114.29 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.929 0.395 . . . . 0.0 111.873 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.519 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.3 m0 -106.99 122.32 46.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.057 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.596 ' CD2' HG11 ' A' ' 122' ' ' VAL . 3.5 m-30 -103.98 112.99 26.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.776 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.784 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 44.4 m95 -94.68 148.68 22.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.212 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.8 tp -99.85 103.05 14.63 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.453 0.644 . . . . 0.0 111.324 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.817 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.6 t -80.84 146.08 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.303 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.77 -26.23 8.3 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.1 tpt180 -162.64 162.05 26.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.416 0.553 . . . . 0.0 111.44 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.722 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -155.85 124.32 5.9 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.449 178.779 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -73.07 140.34 47.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.914 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.34 -121.68 26.35 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.1 tt0 -132.84 142.13 43.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.506 0.193 . . . . 0.0 110.783 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.494 ' CA ' HD11 ' A' ' 60' ' ' ILE . 3.5 Cg_exo -75.8 128.84 11.16 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.824 2.349 . . . . 0.0 111.178 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.662 ' HE1' HG23 ' A' ' 60' ' ' ILE . 18.4 p-90 -126.24 -64.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.489 -0.484 . . . . 0.0 112.262 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.506 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.57 -94.9 0.01 OUTLIER Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.062 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.419 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.5 OUTLIER 170.99 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.674 0.273 . . . . 0.0 111.35 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -50.33 -29.96 11.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.638 0.256 . . . . 0.0 110.794 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.09 -28.77 7.44 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.741 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.458 ' O ' HG22 ' A' ' 21' ' ' THR . 1.0 OUTLIER -140.03 106.04 6.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 117.206 0.503 . . . . 0.0 112.003 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -43.56 146.28 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.112 2.541 . . . . 0.0 112.66 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.81 177.29 19.19 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.1 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.27 157.42 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.441 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -68.68 105.98 2.47 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.183 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.7 ptp -120.52 163.29 18.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.012 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.33 114.98 16.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.474 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.4 tm? -71.42 -18.74 62.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.407 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.41 ' O ' HG22 ' A' ' 108' ' ' VAL . 10.8 p -58.0 -13.63 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.619 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.48 55.16 0.63 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.967 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.724 HD22 HD12 ' A' ' 123' ' ' ILE . 4.8 tt -61.95 150.54 37.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.896 0.379 . . . . 0.0 110.742 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.893 ' HB3' HD13 ' A' ' 33' ' ' LEU . 2.8 t-20 -95.22 100.07 11.92 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.48 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -20.93 61.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.14 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.98 -45.15 20.88 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.087 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.78 -41.0 88.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.241 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.487 ' CB ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -78.37 174.2 6.4 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.08 127.56 26.2 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.82 1.68 . . . . 0.0 112.301 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 120' ' ' GLU . 52.6 Cg_endo -69.27 -34.66 15.7 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.762 2.308 . . . . 0.0 112.415 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.56 58.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.377 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -103.38 20.54 17.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.955 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.549 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -70.29 -31.16 2.15 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 90.2 Cg_exo -43.99 -37.81 9.67 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 121.704 1.603 . . . . 0.0 113.429 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.823 HG22 ' HB2' ' A' ' 71' ' ' LEU . 52.2 t -77.81 -51.02 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.517 . . . . 0.0 110.6 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.724 HD12 HD22 ' A' ' 110' ' ' LEU . 43.1 mm -66.19 -30.03 48.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.563 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -29.99 57.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.967 0.413 . . . . 0.0 110.254 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -50.79 11.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.509 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.858 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.4 tm? -78.41 -19.93 52.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.831 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.646 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.5 tttt -74.45 -42.61 58.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.235 0.54 . . . . 0.0 110.522 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.74 -9.97 42.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.01 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.696 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.639 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 tptm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.932 0.396 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -139.81 129.04 23.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.721 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.808 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.3 pp -146.2 136.93 24.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.329 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.749 ' C ' HD12 ' A' ' 6' ' ' ILE . 22.1 mt-30 -106.64 153.63 22.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.126 0.489 . . . . 0.0 111.648 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.808 HD11 ' CD1' ' A' ' 4' ' ' LEU . 4.3 mp -146.32 118.84 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.695 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.074 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.94 125.83 44.53 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -140.08 162.6 24.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.559 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.58 125.69 2.7 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.134 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.818 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.81 107.26 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.723 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.23 125.33 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.898 0.38 . . . . 0.0 111.496 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.05 124.44 34.29 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.581 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.472 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 13.5 t30 -79.32 -172.22 3.09 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.834 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -82.57 -1.54 51.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.411 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -129.1 36.15 4.21 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.99 7.29 3.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.601 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 19.2 pt-20 -100.95 146.11 27.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.818 HG21 HG22 ' A' ' 10' ' ' ILE . 6.4 mt -110.61 138.7 37.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 111.833 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.493 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -86.14 122.52 30.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.686 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -126.42 162.2 30.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.804 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.593 HG22 ' OE1' ' A' ' 98' ' ' GLU . 11.7 p -70.52 154.86 41.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.701 0.286 . . . . 0.0 110.392 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.197 -179.683 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.632 0.253 . . . . 0.0 111.273 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -114.16 25.96 10.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.045 0.45 . . . . 0.0 111.66 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.2 tt -70.72 72.42 0.53 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.582 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.681 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -106.73 -167.71 1.32 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.995 0.426 . . . . 0.0 111.913 -179.355 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.541 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.37 168.51 9.88 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.488 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.615 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 91.4 Cg_endo -80.39 167.34 19.39 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.524 2.816 . . . . 0.0 113.327 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.639 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.45 -5.79 52.24 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.006 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.48 163.22 18.35 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.852 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.53 -0.18 0.91 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.803 0.441 . . . . 0.0 112.1 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.074 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -50.83 -28.83 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.728 . . . . 0.0 110.424 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.602 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -42.38 -54.65 3.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.934 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.536 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 0.9 -75.33 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.966 0.791 . . . . 0.0 112.546 179.459 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 173.04 35.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.806 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.13 -172.47 3.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.777 0.323 . . . . 0.0 111.08 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.838 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -96.44 153.03 39.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.309 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.838 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.84 -25.03 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.781 2.32 . . . . 0.0 112.52 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.3 mt-10 -104.04 -39.38 6.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.569 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -80.11 -12.87 59.63 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.843 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.45 -52.75 64.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.806 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.949 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.37 -48.34 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 47' ' ' GLU . 36.3 t -57.1 -38.47 60.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.675 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -74.79 -52.06 12.46 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.786 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' A' ' 40' ' ' ILE . 2.9 mm-40 -63.08 -20.06 65.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.722 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.88 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.3 tp -60.46 -44.68 95.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.905 0.383 . . . . 0.0 110.926 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -68.54 -30.08 68.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.064 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -77.3 -25.63 51.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.678 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.85 6.65 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.388 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.979 HG12 HG13 ' A' ' 60' ' ' ILE . 10.0 t -133.81 -44.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 110.721 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.575 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 56.67 6.33 1.63 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 114.846 0.699 . . . . 0.0 114.846 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.979 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.37 -166.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 118.087 0.943 . . . . 0.0 110.406 179.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.628 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -113.86 88.64 14.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.302 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 20.4 Cg_endo -111.92 137.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 123.529 2.819 . . . . 0.0 114.686 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -74.8 79.15 2.09 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.88 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -117.09 124.05 48.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.358 -176.307 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.5 t80 179.78 163.61 1.03 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.901 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 85.64 154.57 0.08 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.447 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.732 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.2 pp -107.68 121.06 43.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 111.616 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -76.81 -39.0 52.85 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.87 138.26 1.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.799 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.29 103.99 4.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.583 0.23 . . . . 0.0 110.746 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 71' ' ' LEU . 4.4 pp -105.81 152.54 23.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 111.062 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -135.38 117.39 15.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.723 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -136.33 152.06 50.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.509 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.02 139.96 52.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.198 0.523 . . . . 0.0 111.397 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.467 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -105.63 163.18 17.63 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.278 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.9 Cg_endo -55.63 81.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.819 2.346 . . . . 0.0 112.15 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 4.9 t70 97.08 6.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.676 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -137.32 94.84 2.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.702 0.287 . . . . 0.0 110.796 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.436 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -91.96 101.66 14.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.755 HG13 HD13 ' A' ' 6' ' ' ILE . 1.9 tt -103.52 142.77 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.134 0.493 . . . . 0.0 111.283 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -123.01 118.24 27.33 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 178.337 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.868 HD23 ' CG2' ' A' ' 122' ' ' VAL . 6.4 tp -114.49 114.03 25.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.085 0.469 . . . . 0.0 111.542 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.417 ' HE1' HG22 ' A' ' 81' ' ' THR . 8.7 m0 -114.15 121.8 44.87 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.83 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.658 ' CE2' HG11 ' A' ' 122' ' ' VAL . 3.5 m-30 -110.27 117.41 33.57 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.236 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.732 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 16.2 m95 -105.4 148.54 27.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.223 0.535 . . . . 0.0 112.343 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.5 tp -86.14 138.42 31.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.386 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.823 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.7 t -124.11 145.49 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.712 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.88 -24.2 10.12 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.76 163.18 26.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.344 0.974 . . . . 0.0 112.306 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.723 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -157.81 123.26 4.53 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.749 178.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.63 ' O ' HG21 ' A' ' 60' ' ' ILE . 6.8 tt0 -74.5 149.39 40.3 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.165 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.62 -116.83 6.35 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.593 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 11.8 mt-10 -135.33 143.39 45.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.431 0.158 . . . . 0.0 110.697 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.642 ' CA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.43 128.76 10.59 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.816 2.344 . . . . 0.0 111.079 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.575 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 38.0 p-90 -132.25 -59.75 0.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.499 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.79 -94.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.786 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 174.77 39.63 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.786 0.327 . . . . 0.0 110.714 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.593 ' OE1' HG22 ' A' ' 21' ' ' THR . 26.4 pt-20 -57.64 -45.67 85.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.767 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 131.92 -43.06 1.32 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.248 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.37 108.2 23.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.042 0.449 . . . . 0.0 111.769 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -43.75 146.31 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.004 2.469 . . . . 0.0 112.51 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.64 177.27 17.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.048 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.78 157.38 43.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.459 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -74.49 106.33 6.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.295 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.1 ptp -120.42 163.24 18.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.13 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.4 p -79.28 114.98 18.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.509 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.771 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -63.21 -18.7 63.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.449 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 108' ' ' VAL . 21.3 t -63.08 -8.57 3.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.6 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.97 50.46 0.88 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.096 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.523 ' CD2' HD12 ' A' ' 123' ' ' ILE . 8.1 tp -62.17 150.17 39.46 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.46 115.84 22.93 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.59 -17.97 61.65 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.162 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -78.85 -49.06 13.55 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.075 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -66.93 -18.74 65.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.447 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.573 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.82 170.72 5.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.54 127.69 27.07 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.05 1.833 . . . . 0.0 112.326 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.16 -36.86 11.56 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.619 2.212 . . . . 0.0 112.528 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.57 -9.58 57.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.487 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.418 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 15.4 m-20 -105.8 19.11 21.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.776 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.555 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -66.61 -31.88 4.63 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.0 Cg_exo -44.2 -34.74 7.21 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 121.825 1.683 . . . . 0.0 113.154 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.868 ' CG2' HD23 ' A' ' 82' ' ' LEU . 39.4 t -77.96 -51.3 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.021 0.439 . . . . 0.0 110.785 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.829 HG22 ' HB2' ' A' ' 127' ' ' LYS . 26.2 mm -67.49 -31.94 54.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.42 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.49 -26.86 33.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.891 0.377 . . . . 0.0 110.657 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.12 -53.09 7.02 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.791 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.692 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.5 tm? -78.25 -31.8 49.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.761 0.315 . . . . 0.0 111.744 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.829 ' HB2' HG22 ' A' ' 123' ' ' ILE . 4.7 ttpt -53.95 -42.56 69.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.97 0.414 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -67.77 -9.22 42.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.825 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.264 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.828 0.346 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 145.4 55.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 pp -146.1 127.84 15.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.236 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.527 ' O ' HD12 ' A' ' 6' ' ' ILE . 25.7 mt-30 -102.58 146.95 27.4 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.281 0.562 . . . . 0.0 111.696 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -146.71 132.91 13.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.771 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.136 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.64 124.55 42.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.58 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 m -119.38 162.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.391 0.615 . . . . 0.0 112.089 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -149.51 106.23 0.32 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.904 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.035 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.72 109.88 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.713 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.34 123.06 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.805 -178.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.72 124.32 32.85 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.591 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.477 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 51.6 t30 -81.41 -172.34 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.644 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 26.2 tt0 -83.34 9.18 11.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.487 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -141.36 52.24 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.156 -0.34 . . . . 0.0 111.503 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.71 25.79 0.16 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 111.368 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -117.93 160.16 21.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.035 HG21 HG22 ' A' ' 10' ' ' ILE . 9.0 mt -130.26 138.04 54.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.048 0.452 . . . . 0.0 111.435 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -79.02 112.5 16.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.305 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.28 139.61 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.156 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -70.8 111.88 6.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.824 0.345 . . . . 0.0 110.606 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.803 ' HD2' HD22 ' A' ' 33' ' ' LEU . 9.3 ttp180 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 26.2 10.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.046 0.451 . . . . 0.0 111.3 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.803 HD22 ' HD2' ' A' ' 22' ' ' ARG . 28.1 tp -58.07 86.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.841 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.91 -175.94 3.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.112 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.753 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.63 161.58 36.94 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.177 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.7 166.7 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.069 2.513 . . . . 0.0 111.525 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 100.97 58.92 0.82 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 119.857 -1.164 . . . . 0.0 113.176 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.603 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.66 122.96 3.55 Favored Glycine 0 C--N 1.312 -0.802 0 CA-C-N 114.941 -0.63 . . . . 0.0 112.339 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.603 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 107.92 2.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.103 0.561 . . . . 0.0 112.296 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.136 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -48.83 -28.95 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.541 0.686 . . . . 0.0 110.515 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.583 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.92 -69.72 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.779 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.462 ' C ' ' O ' ' A' ' 41' ' ' GLU . 13.7 mmt 22.43 -86.18 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.868 0.73 . . . . 0.0 112.19 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.88 27.86 0.17 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.502 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.407 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 5.9 mt-10 -93.83 -177.32 4.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.827 0.346 . . . . 0.0 111.108 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.925 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.86 158.44 35.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.982 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.925 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.93 -24.69 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.809 2.339 . . . . 0.0 112.409 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -88.85 -60.23 2.01 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.558 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.48 -6.83 58.75 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.799 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.74 -54.47 42.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.76 0.314 . . . . 0.0 110.826 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.797 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.31 -46.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.977 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 47' ' ' GLU . 32.6 t -55.55 -37.62 46.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.223 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.3 -52.02 9.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.998 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.87 -23.55 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.002 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.737 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -53.79 -44.63 70.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.532 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -33.93 75.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.68 -26.12 50.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.188 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 54.2 mm-40 -108.36 4.27 24.28 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.938 HG12 HG13 ' A' ' 60' ' ' ILE . 26.0 t -134.85 -44.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.229 0.538 . . . . 0.0 110.117 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.14 -41.77 0.36 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.723 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.938 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.79 -176.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.133 0.492 . . . . 0.0 111.251 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.79 88.79 14.64 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.17 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.82 ' HG3' HG11 ' A' ' 58' ' ' VAL . 7.2 Cg_endo -110.15 149.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.322 2.681 . . . . 0.0 113.887 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 77.7 mt-30 -74.74 79.78 2.06 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.962 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.56 129.27 50.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.206 -176.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' HD1' ' A' ' 64' ' ' HIS . 3.4 t80 -176.59 -39.34 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.456 ' CB ' ' HB3' ' A' ' 86' ' ' LEU . 51.8 m -40.74 160.87 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.805 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -115.69 119.32 35.68 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.575 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -86.83 -56.34 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.262 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.539 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -172.03 144.08 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.309 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.443 ' NZ ' ' CZ3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -142.21 112.46 7.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.698 0.285 . . . . 0.0 110.768 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.792 HD21 ' HA ' ' A' ' 122' ' ' VAL . 3.7 pp -125.18 159.39 31.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.968 0.413 . . . . 0.0 111.028 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -135.35 109.93 8.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.592 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.51 ' HD2' HD13 ' A' ' 71' ' ' LEU . 30.1 p90 -125.59 151.12 46.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.746 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.12 131.29 54.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 111.114 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.468 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-85 -79.89 162.85 60.87 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.622 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.9 Cg_endo -53.6 82.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.203 2.602 . . . . 0.0 112.321 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER 100.43 11.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.895 0.878 . . . . 0.0 111.232 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 17.5 ttp180 -137.3 150.15 47.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.585 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -127.06 110.87 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.672 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.595 HD11 HD13 ' A' ' 82' ' ' LEU . 1.9 tt -120.3 120.69 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.369 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.552 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -103.02 118.65 37.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.595 HD13 HD11 ' A' ' 80' ' ' ILE . 1.1 mp -119.75 114.05 21.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.768 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.552 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.5 m0 -110.1 122.55 47.86 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.348 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.698 ' CE1' HG11 ' A' ' 122' ' ' VAL . 2.2 m-85 -109.98 109.79 20.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.919 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.707 ' NE1' HG11 ' A' ' 50' ' ' VAL . 34.2 m95 -98.02 148.95 22.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.592 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.832 HD23 ' N ' ' A' ' 87' ' ' VAL . 3.4 tt -97.83 138.5 35.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.461 0.648 . . . . 0.0 111.664 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.962 HG22 ' ND1' ' A' ' 64' ' ' HIS . 61.5 t -114.78 146.38 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.436 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.41 -25.69 10.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.477 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.4 165.36 24.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.72 0.691 . . . . 0.0 111.505 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.713 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -156.57 123.36 5.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.387 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -79.1 153.69 29.95 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.064 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.56 -131.95 49.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.566 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.4 mt-10 -123.33 144.24 43.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.51 0.195 . . . . 0.0 110.725 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.54 128.76 10.51 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.788 2.325 . . . . 0.0 111.628 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.561 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.9 p-90 -133.4 -58.91 0.88 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.604 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.07 -98.02 0.01 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.025 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 176.8 36.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 111.022 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -44.52 96.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.38 -68.5 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.111 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -110.86 106.37 57.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 111.554 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -43.58 146.27 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.016 2.477 . . . . 0.0 112.647 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.34 177.04 17.11 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.809 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.82 157.38 37.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.578 0.228 . . . . 0.0 110.568 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -60.14 106.68 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.258 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.03 163.29 17.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.3 p -80.36 114.75 19.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.47 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -80.25 -18.68 48.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.433 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.13 -14.34 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.801 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.06 53.79 0.67 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.27 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.626 HD22 HG23 ' A' ' 123' ' ' ILE . 8.5 tt -62.24 150.37 39.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -106.36 115.02 29.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.5 -17.91 61.71 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.049 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.03 -46.29 18.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.029 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -40.13 88.61 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.158 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.49 174.38 6.13 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.0 127.76 26.97 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 121.835 1.69 . . . . 0.0 112.435 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.17 -36.94 11.35 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.796 2.331 . . . . 0.0 112.557 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.33 -9.66 54.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.392 . . . . 0.0 111.361 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.452 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 13.2 m-20 -107.38 18.45 21.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.93 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 tt0 -64.78 -31.89 6.14 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.3 Cg_exo -44.09 -38.77 10.94 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 121.746 1.631 . . . . 0.0 113.206 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.792 ' HA ' HD21 ' A' ' 71' ' ' LEU . 76.8 t -77.66 -51.2 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.829 0.347 . . . . 0.0 111.828 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.626 HG23 HD22 ' A' ' 110' ' ' LEU . 32.6 mm -73.04 -43.79 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.19 -26.81 30.16 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -80.32 -53.45 6.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.505 ' HG ' ' CZ ' ' A' ' 68' ' ' PHE . 3.5 mm? -78.47 -28.46 46.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.549 ' HD3' ' HB2' ' A' ' 112' ' ' ALA . 9.9 ttpp -55.74 -42.19 75.03 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.059 0.457 . . . . 0.0 110.696 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.817 ' O ' HD12 ' A' ' 129' ' ' LEU . 62.9 ttt180 -71.45 -5.79 35.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.99 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.112 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.904 0.383 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.37 129.26 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.608 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.495 HD11 ' HB ' ' A' ' 80' ' ' ILE . 4.1 pp -146.48 139.37 25.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.913 0.387 . . . . 0.0 111.78 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.502 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 39.5 mt-30 -106.01 156.0 18.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.404 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.714 HD12 HD13 ' A' ' 82' ' ' LEU . 15.0 mt -146.74 126.51 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.357 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.905 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.17 125.2 43.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.1 m -144.7 156.49 14.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.999 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.8 124.45 1.99 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.864 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.084 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.57 112.45 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.749 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.8 OUTLIER -70.81 119.94 17.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.215 0.531 . . . . 0.0 111.381 -178.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -84.3 124.39 31.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.625 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.454 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 23.0 t30 -80.91 -172.25 3.61 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.733 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.1 tt0 -82.91 5.4 22.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.212 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -139.44 51.23 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.875 0.369 . . . . 0.0 111.503 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 45.88 25.19 0.28 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.277 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 21.3 pt-20 -119.45 141.63 48.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.084 HG21 HG22 ' A' ' 10' ' ' ILE . 10.3 mt -112.51 143.52 22.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.199 0.523 . . . . 0.0 111.749 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -90.38 121.65 32.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.352 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -121.22 134.72 63.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.058 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -70.79 111.97 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.381 . . . . 0.0 110.889 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.824 ' HB3' HD12 ' A' ' 33' ' ' LEU . 34.9 ptt85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.768 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.9 t-20 . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.32 26.41 10.28 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -67.93 63.2 0.08 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.67 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -109.42 -166.93 1.15 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.445 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.788 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.42 168.23 10.47 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.487 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 59.9 Cg_endo -72.62 167.21 27.72 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.34 2.693 . . . . 0.0 113.162 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.8 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.61 -5.49 54.48 Favored Glycine 0 C--O 1.223 -0.545 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.971 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.37 149.3 50.16 Favored Glycine 0 C--N 1.315 -0.602 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.798 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 91.6 -0.98 0.17 Allowed 'General case' 0 C--N 1.342 0.247 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.905 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -49.41 -29.81 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.717 0.77 . . . . 0.0 110.584 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -43.12 -52.71 5.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.04 179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.531 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 0.4 -75.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.928 0.768 . . . . 0.0 112.564 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 176.12 35.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.979 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -93.56 -171.49 2.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.596 0.236 . . . . 0.0 111.022 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.04 152.58 38.4 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.294 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.813 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.82 -24.97 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.774 2.316 . . . . 0.0 112.491 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -104.08 -40.45 6.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.709 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -80.33 -14.18 58.58 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.763 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.95 -52.33 66.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.818 0.342 . . . . 0.0 111.089 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.704 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.0 m -78.74 -49.03 21.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 47' ' ' GLU . 39.6 t -54.85 -36.02 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.392 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -51.99 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 110.597 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.1 mm-40 -61.59 -22.04 64.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.694 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.905 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -58.48 -44.48 89.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.867 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -33.87 75.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.116 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.6 tt0 -77.13 -26.93 53.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.075 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.08 6.33 26.86 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.634 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 60' ' ' ILE . 48.2 t -133.41 -44.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.76 -40.66 0.31 Allowed Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.969 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.943 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.47 -177.55 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.084 0.469 . . . . 0.0 111.087 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.22 88.86 13.24 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.058 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.749 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.6 Cg_endo -110.09 145.63 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 123.287 2.658 . . . . 0.0 114.159 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 84.2 mt-30 -74.69 79.96 2.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.905 ' CD2' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -121.53 131.04 53.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.436 -175.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -177.08 -133.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.345 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 54.51 171.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.039 0.447 . . . . 0.0 111.937 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.892 HD11 ' HG2' ' A' ' 70' ' ' LYS . 7.1 tt -136.85 108.07 6.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.714 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.886 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.74 -44.58 32.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.99 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.533 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.0 tt0 -171.79 142.72 1.57 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.429 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.892 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.24 103.86 4.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.213 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 71' ' ' LEU . 4.4 pp -110.33 151.75 27.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.955 0.407 . . . . 0.0 111.479 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -131.43 109.94 10.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.393 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.431 ' CZ ' ' HG2' ' A' ' 121' ' ' PRO . 8.1 p90 -127.7 152.99 47.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.747 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.23 128.83 52.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.213 0.53 . . . . 0.0 111.306 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -94.19 163.38 23.55 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.416 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 9.7 Cg_endo -52.74 82.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.0 2.467 . . . . 0.0 112.142 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.4 m-20 91.32 9.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.616 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.42 93.85 2.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.616 0.246 . . . . 0.0 110.67 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 10.1 t-160 -89.8 98.78 11.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 110.673 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.584 HD11 HD12 ' A' ' 6' ' ' ILE . 2.0 tt -106.04 134.46 47.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.221 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -111.24 118.57 36.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.907 HD23 ' CG2' ' A' ' 122' ' ' VAL . 4.1 tp -111.7 113.91 26.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.017 0.437 . . . . 0.0 111.393 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -111.3 121.98 46.66 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.76 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.695 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.0 m-30 -112.73 111.24 21.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.011 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.704 ' CE2' HG11 ' A' ' 50' ' ' VAL . 14.6 m95 -96.14 149.12 21.98 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.056 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' PHE . 9.2 tp -97.63 103.31 15.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.515 0.674 . . . . 0.0 112.328 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.864 HG22 ' ND1' ' A' ' 64' ' ' HIS . 12.1 t -81.16 145.78 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.626 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.63 -26.16 8.0 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 90' ' ' TRP . 15.4 ttm-85 -161.98 165.06 27.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.676 0.671 . . . . 0.0 111.782 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.749 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -156.26 126.16 6.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.419 179.035 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.7 147.98 37.07 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.94 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.2 -119.7 17.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.476 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 35.3 tt0 -134.88 144.94 52.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.516 0.198 . . . . 0.0 110.856 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.509 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.39 128.83 10.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.983 2.455 . . . . 0.0 111.282 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.576 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 49.9 p-90 -135.06 -62.8 0.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.328 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.585 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.98 -100.08 0.02 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.02 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER 172.31 38.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 111.103 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -58.53 -48.44 80.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.83 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.34 -60.84 0.21 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.834 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -139.02 126.34 13.1 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.384 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -43.31 146.2 1.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.164 2.576 . . . . 0.0 112.752 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.1 177.09 17.56 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.733 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -121.17 157.32 30.46 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -76.44 105.76 7.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 110.218 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 17.2 ptm -120.93 163.3 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.019 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.499 ' HB3' HG12 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -75.54 114.88 14.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.312 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -68.3 -18.81 64.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.569 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 106' ' ' SER . 12.1 p -54.91 -15.91 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.729 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.55 48.74 0.95 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.433 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.622 HD22 HD12 ' A' ' 123' ' ' ILE . 6.5 tt -62.28 150.42 39.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -111.13 114.88 28.45 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.712 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.546 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.35 -18.7 61.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.113 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.93 -45.58 20.2 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.949 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -66.78 -41.56 87.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.997 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.624 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -79.01 173.49 7.64 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.54 127.68 27.03 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 121.857 1.704 . . . . 0.0 112.027 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.02 -37.51 10.84 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.657 2.238 . . . . 0.0 112.667 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.64 -9.83 57.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.526 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -106.31 27.45 8.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.534 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.624 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.04 -30.99 0.95 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.2 Cg_exo -43.68 -35.01 6.06 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.966 1.777 . . . . 0.0 113.357 -178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.907 ' CG2' HD23 ' A' ' 82' ' ' LEU . 95.3 t -77.7 -51.1 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.087 0.47 . . . . 0.0 110.426 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.622 HD12 HD22 ' A' ' 110' ' ' LEU . 39.9 mm -64.61 -32.16 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.205 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.69 -27.37 39.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.9 0.381 . . . . 0.0 110.626 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -80.25 -51.26 9.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.886 HD22 ' CE2' ' A' ' 68' ' ' PHE . 23.2 tp -78.06 -28.23 48.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.609 ' HB2' HG22 ' A' ' 123' ' ' ILE . 49.6 tttm -55.27 -42.44 73.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.03 0.443 . . . . 0.0 110.599 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 -67.22 -10.08 46.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.693 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.294 179.746 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.845 0.355 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -140.08 128.72 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.06 128.72 16.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 13.8 mt-30 -102.69 154.91 18.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.284 0.564 . . . . 0.0 112.204 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.524 HD13 ' CD1' ' A' ' 80' ' ' ILE . 3.2 mp -146.89 130.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.68 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.945 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.07 125.69 44.2 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.612 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m -140.28 162.24 24.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.394 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.439 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -147.58 129.88 3.35 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.057 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.594 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.7 110.54 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.731 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -70.94 121.99 21.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.996 0.427 . . . . 0.0 111.57 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.98 124.49 30.44 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.515 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.539 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 23.2 t-20 -70.88 178.26 3.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.006 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.539 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 31.6 tt0 -56.88 -17.24 8.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.76 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -122.49 -82.64 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.598 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.58 13.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -100.81 160.3 14.48 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 11' ' ' ILE . 5.2 mt -132.36 137.32 54.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.123 0.487 . . . . 0.0 111.624 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.466 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -83.48 118.29 23.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.573 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -121.28 141.42 41.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.092 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.517 HG22 ' CD ' ' A' ' 98' ' ' GLU . 5.2 p -70.75 111.74 6.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.686 0.279 . . . . 0.0 110.392 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 121.04 0.448 . . . . 0.0 111.407 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.771 0.32 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -111.83 26.28 10.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.253 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 33' ' ' LEU . 6.7 tt -65.67 69.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.057 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.615 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -119.82 -166.97 1.35 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.233 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.56 ' CZ ' HD11 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -119.24 168.53 9.76 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.552 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.612 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 82.8 Cg_endo -78.68 167.68 22.15 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.564 2.842 . . . . 0.0 113.456 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.92 -3.67 48.84 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.407 -0.815 . . . . 0.0 114.534 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.41 158.13 31.94 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.632 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 88.17 0.34 0.41 Allowed 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.213 0.605 . . . . 0.0 112.429 179.145 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.945 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -49.84 -29.14 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.607 0.718 . . . . 0.0 110.526 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.617 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.62 -57.44 2.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.914 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.536 ' C ' ' O ' ' A' ' 41' ' ' GLU . 9.4 mmt 4.23 -78.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.911 0.757 . . . . 0.0 112.567 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.48 34.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.789 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -89.39 -174.16 4.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.717 0.294 . . . . 0.0 111.049 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.03 153.45 38.51 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.825 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.83 -25.28 0.97 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.828 2.352 . . . . 0.0 112.455 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.5 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -104.04 -40.33 6.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.431 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -80.32 -4.89 55.19 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.74 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.03 -57.01 13.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.869 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.846 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -78.52 -45.66 25.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.6 t -53.24 -39.75 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.237 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -78.02 -48.67 15.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.462 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.5 mm-40 -64.77 -20.05 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.596 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.693 HD11 ' NE2' ' A' ' 64' ' ' HIS . 1.2 tp -59.77 -44.39 93.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -65.0 -34.75 79.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.1 tm-20 -77.43 -27.35 52.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.087 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -108.53 5.39 25.1 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.391 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.964 HG12 HG13 ' A' ' 60' ' ' ILE . 35.1 t -134.61 -44.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.185 0.517 . . . . 0.0 110.042 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.02 -42.39 0.48 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.472 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.964 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.56 -176.48 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.016 0.436 . . . . 0.0 111.12 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -113.08 89.13 13.34 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.531 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.831 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.3 Cg_endo -107.82 143.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 123.272 2.648 . . . . 0.0 113.936 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.9 mt-30 -74.62 80.1 2.0 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.878 ' CE1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.64 133.32 54.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.474 -175.657 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.579 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -175.65 -145.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.617 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m 51.96 172.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.009 0.523 . . . . 0.0 112.138 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.863 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -140.26 122.18 15.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.62 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE2' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.55 -44.24 35.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.966 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -171.68 131.9 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.395 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -115.65 109.95 18.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.76 0.314 . . . . 0.0 110.552 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 tp -96.88 121.56 38.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.865 0.365 . . . . 0.0 110.964 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -123.14 109.69 14.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.442 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.41 ' CZ ' HG23 ' A' ' 80' ' ' ILE . 2.0 p90 -141.26 149.84 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 2.6 pt-20 -121.23 129.05 52.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.213 0.53 . . . . 0.0 111.062 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.455 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -95.69 163.27 21.73 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.52 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.1 Cg_endo -53.18 82.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.964 2.443 . . . . 0.0 112.337 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER 92.5 8.69 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.618 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -137.25 93.87 2.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.675 0.274 . . . . 0.0 110.896 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 3.2 t-160 -86.84 93.98 9.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.778 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.524 ' CD1' HD13 ' A' ' 6' ' ' ILE . 1.7 tp -101.24 111.93 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.049 0.452 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.477 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -103.82 118.81 37.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.751 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.517 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -116.35 114.19 23.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 112.023 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.477 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.9 m0 -108.53 122.48 47.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.147 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.677 ' CD1' HG11 ' A' ' 122' ' ' VAL . 1.7 m-85 -108.91 111.6 23.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.876 0.369 . . . . 0.0 110.078 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.863 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.5 m95 -94.54 148.91 21.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.704 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.579 ' O ' ' O ' ' A' ' 65' ' ' PHE . 38.0 tp -97.94 102.44 14.19 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 121.342 0.592 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.878 HG22 ' CE1' ' A' ' 64' ' ' HIS . 12.2 t -85.5 145.77 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.928 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.406 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 7.5 pt-20 -114.67 -24.12 8.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 7.5 tpt180 -162.61 160.76 26.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.787 0.721 . . . . 0.0 111.677 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.731 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -152.06 125.33 8.73 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.244 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -72.83 141.82 48.0 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.91 -118.92 11.98 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.53 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -131.92 142.86 46.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.552 0.215 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.2 Cg_exo -76.29 128.79 10.72 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.862 2.375 . . . . 0.0 111.412 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.613 ' HE1' HG23 ' A' ' 60' ' ' ILE . 47.6 p-90 -132.06 -62.08 0.86 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.097 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.564 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.92 -102.42 0.04 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.784 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 56' ' ' GLU . 6.7 tptp 179.33 35.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.778 0.323 . . . . 0.0 111.097 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.517 ' CD ' HG22 ' A' ' 21' ' ' THR . 16.0 pt-20 -50.85 -37.37 42.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.791 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.4 -31.93 5.78 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.848 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -128.76 97.17 27.87 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 111.449 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -43.57 146.11 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.953 2.435 . . . . 0.0 112.475 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.08 177.15 19.35 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.958 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.83 157.42 42.27 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.75 105.91 3.37 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.19 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.525 ' HE2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.72 163.31 18.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.908 179.589 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 t -73.82 114.94 12.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.412 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.576 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.53 -18.68 62.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.517 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.531 ' CG1' HD21 ' A' ' 129' ' ' LEU . 21.4 t -58.94 -12.28 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.732 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.51 53.15 0.74 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.032 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.56 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 6.0 tt -62.21 150.45 38.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.922 0.392 . . . . 0.0 110.771 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.516 ' HB3' HD13 ' A' ' 33' ' ' LEU . 3.9 t-20 -97.03 97.75 9.49 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.461 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.42 -20.32 61.44 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.965 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.14 -45.46 19.94 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.203 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.72 -40.61 88.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.551 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.4 174.24 6.34 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.641 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.06 127.79 27.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 121.844 1.696 . . . . 0.0 112.301 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 50.1 Cg_endo -69.01 -35.28 15.16 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.662 2.241 . . . . 0.0 112.505 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.7 -9.51 58.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 0.0 111.218 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -104.1 19.77 19.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.567 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -74.96 -30.57 1.02 Allowed Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.6 Cg_exo -43.19 -36.46 6.02 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 121.887 1.725 . . . . 0.0 113.196 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.677 HG11 ' CD1' ' A' ' 84' ' ' PHE . 23.7 t -77.82 -50.26 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.308 0.575 . . . . 0.0 110.264 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.684 HG22 ' HB2' ' A' ' 127' ' ' LYS . 48.6 mm -64.17 -33.9 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.701 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.58 44.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.001 0.429 . . . . 0.0 110.616 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -80.13 -50.71 9.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.739 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.0 tm? -78.12 -40.06 39.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.741 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.684 ' HB2' HG22 ' A' ' 123' ' ' ILE . 18.0 tttm -53.19 -42.7 66.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.12 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -66.98 -7.34 21.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.884 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.762 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.4 mp . . . . . 0 C--O 1.231 0.119 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.185 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.924 0.393 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -139.99 126.59 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.606 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.752 ' CD1' HD11 ' A' ' 6' ' ' ILE . 4.0 pp -146.09 127.05 14.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.194 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 43.4 mt-30 -104.6 152.41 22.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.301 0.572 . . . . 0.0 112.006 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.2 mp -146.44 123.14 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.421 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.022 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.09 125.68 44.15 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.3 m -131.21 162.49 39.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.38 0.61 . . . . 0.0 112.051 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -137.43 111.53 0.84 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.677 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.909 HD12 HD13 ' A' ' 18' ' ' ILE . 8.5 pt -70.41 105.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-O 120.724 0.297 . . . . 0.0 110.412 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.686 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.63 125.75 30.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.778 -178.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -98.75 136.02 39.39 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.412 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.741 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.6 p-10 -96.48 -173.3 2.72 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.511 0.672 . . . . 0.0 112.018 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.46 -0.99 9.45 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.642 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.44 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 15.0 t-20 -120.69 33.28 5.63 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.625 -0.43 . . . . 0.0 112.135 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.56 13.78 2.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 111.351 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HG3' ' HB3' ' A' ' 15' ' ' ASN . 4.9 mt-10 -102.08 161.16 13.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.909 HD13 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.7 124.58 72.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.184 0.516 . . . . 0.0 112.012 -178.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -74.2 120.18 19.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.652 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -129.08 150.4 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.287 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 69.2 p -70.83 111.75 6.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.768 0.318 . . . . 0.0 110.593 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HB2' HD13 ' A' ' 33' ' ' LEU . 38.9 ttp180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.957 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.758 0.313 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 34' ' ' GLU . 10.7 mttt -114.11 26.14 10.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.938 0.399 . . . . 0.0 111.219 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.486 HD13 ' HB2' ' A' ' 22' ' ' ARG . 21.7 tp -61.24 77.33 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.033 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.617 ' O ' HG22 ' A' ' 20' ' ' ILE . 2.7 mt-10 -115.75 -170.44 1.78 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.116 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.572 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.26 168.15 10.55 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.625 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.616 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 94.6 Cg_endo -84.28 166.64 12.44 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.585 2.857 . . . . 0.0 113.307 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.05 -5.93 53.52 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-N 115.73 -0.668 . . . . 0.0 114.254 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.13 161.99 18.74 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.891 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.84 1.62 0.78 Allowed 'General case' 0 C--N 1.341 0.228 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.022 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -51.82 -27.69 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.54 0.686 . . . . 0.0 110.294 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.554 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -41.1 -57.78 1.95 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.804 179.526 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.528 ' C ' ' O ' ' A' ' 41' ' ' GLU . 25.0 mmm 5.86 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.457 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 178.28 33.51 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.755 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -87.94 -174.13 4.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.761 0.315 . . . . 0.0 111.069 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.08 153.1 38.27 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.267 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.825 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.76 -25.41 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.873 2.382 . . . . 0.0 112.487 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.5 mp0 -104.02 -39.68 6.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.448 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -80.25 -8.48 59.48 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.803 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.68 -54.62 43.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.7 0.286 . . . . 0.0 110.744 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.79 HG12 ' HB1' ' A' ' 7' ' ' ALA . 1.4 m -78.09 -47.46 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.167 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.8 t -54.1 -37.95 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.176 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -78.38 -51.97 9.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.257 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' GLU . 1.2 mm-40 -65.14 -19.85 66.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.331 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.767 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -61.2 -44.66 96.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.683 0.277 . . . . 0.0 111.054 -179.586 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -35.79 82.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -77.68 -26.34 50.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.209 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 53' ' ' GLU . 7.3 mm-40 -108.32 5.34 25.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.929 HG12 HG13 ' A' ' 60' ' ' ILE . 44.7 t -134.45 -44.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.234 0.54 . . . . 0.0 109.68 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.29 -41.47 0.37 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.817 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.929 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.84 -177.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.137 0.494 . . . . 0.0 111.42 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.41 89.0 13.97 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.896 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.752 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.1 Cg_endo -109.98 150.86 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.339 2.693 . . . . 0.0 114.475 -177.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.415 ' CG ' ' HG2' ' A' ' 89' ' ' ARG . 33.7 mt-30 -74.73 79.82 2.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.952 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.77 128.0 47.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.155 -176.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.432 ' N ' ' HD1' ' A' ' 64' ' ' HIS . 1.8 t80 -176.31 -40.67 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.639 ' HB3' HD23 ' A' ' 86' ' ' LEU . 58.4 m -41.4 163.57 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.894 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.404 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.59 120.57 39.1 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.071 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.3 OUTLIER -88.56 -56.65 3.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.807 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -172.27 162.48 5.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.735 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 132.02 22.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.726 0.298 . . . . 0.0 110.774 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.684 HD22 HG23 ' A' ' 122' ' ' VAL . 3.4 tp -121.62 133.37 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.812 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -130.85 109.66 10.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.608 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.694 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.2 p90 -141.24 144.75 34.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.625 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.08 136.03 55.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.135 0.493 . . . . 0.0 111.373 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.467 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -99.58 163.04 19.28 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.32 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 12.8 Cg_endo -56.41 81.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.754 2.303 . . . . 0.0 112.217 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 9.0 t70 99.45 3.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.754 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -137.25 94.76 2.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.685 0.279 . . . . 0.0 110.953 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.5 t-160 -91.3 105.04 17.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 110.98 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.694 HD13 ' OH ' ' A' ' 73' ' ' TYR . 3.8 tt -106.11 132.6 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.51 118.73 31.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.541 178.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -117.03 114.25 23.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.96 0.409 . . . . 0.0 111.431 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 11.2 m0 -107.52 122.59 46.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.191 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.893 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 2.4 m-85 -108.08 109.64 21.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.039 0.447 . . . . 0.0 110.627 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.742 ' NE1' HG11 ' A' ' 50' ' ' VAL . 39.0 m95 -98.15 148.4 23.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.705 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.639 HD23 ' HB3' ' A' ' 66' ' ' SER . 56.0 tp -94.02 138.41 32.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.384 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.952 HG22 ' ND1' ' A' ' 64' ' ' HIS . 58.1 t -120.54 145.87 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.364 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -107.01 -28.5 9.99 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.45 165.49 23.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.894 0.77 . . . . 0.0 111.64 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.741 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -155.31 123.63 5.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.356 178.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.63 147.18 44.01 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.048 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.08 -121.97 25.74 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.586 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -131.88 146.29 61.13 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.579 0.228 . . . . 0.0 110.781 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.5 128.74 10.53 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.793 2.329 . . . . 0.0 111.475 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.568 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 51.4 p-90 -130.42 -61.26 0.97 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.869 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.622 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 36.87 -97.69 0.01 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.214 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.58 40.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.651 0.263 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -68.98 -25.44 64.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.075 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.42 -86.58 0.27 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.3 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 21' ' ' THR . 1.2 pt20 -108.24 115.98 57.41 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 111.847 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.63 146.19 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.04 2.493 . . . . 0.0 112.81 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -122.94 177.31 16.56 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.006 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.525 ' HG3' ' HE3' ' A' ' 105' ' ' MET . 0.4 OUTLIER -125.31 157.52 36.47 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -64.53 105.99 1.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.915 0.388 . . . . 0.0 110.09 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.525 ' HE3' ' HG3' ' A' ' 103' ' ' GLU . 5.5 ptp -120.7 152.2 38.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.8 p -74.23 118.55 17.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.55 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.79 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -73.04 -18.62 61.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.41 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 108' ' ' VAL . 21.3 t -59.64 -11.54 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.694 0.283 . . . . 0.0 111.547 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.13 54.45 0.73 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.661 HD13 HD22 ' A' ' 107' ' ' LEU . 7.0 tp -61.74 150.27 37.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 110.787 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -109.95 103.73 12.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.367 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.54 -18.86 61.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.153 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -79.0 -47.07 16.93 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.45 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.63 -40.52 88.77 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.229 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.4 174.2 6.4 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.09 127.73 26.91 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.911 1.74 . . . . 0.0 112.489 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.29 -35.48 13.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.726 2.284 . . . . 0.0 112.465 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.05 -9.75 56.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.316 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.425 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 14.6 m-20 -107.73 19.73 19.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.997 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -66.67 -31.75 4.45 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -179.079 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.8 Cg_exo -43.85 -36.57 8.06 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.797 1.665 . . . . 0.0 113.276 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.893 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 55.1 t -77.88 -51.14 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 111.738 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.833 HG22 ' HB2' ' A' ' 127' ' ' LYS . 9.5 mm -74.84 -42.0 46.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.82 -28.27 34.51 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -80.8 -53.78 6.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.51 ' HG ' ' CZ ' ' A' ' 68' ' ' PHE . 3.5 mm? -78.86 -31.12 45.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.833 ' HB2' HG22 ' A' ' 123' ' ' ILE . 15.9 tttm -54.09 -42.1 68.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.044 0.449 . . . . 0.0 110.684 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.818 ' O ' HD12 ' A' ' 129' ' ' LEU . 60.3 ttm-85 -70.41 -6.48 35.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.978 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.148 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tttt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.83 0.347 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 139.1 35.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.812 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 pp -146.23 123.64 11.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 39.8 mt-30 -102.69 149.01 24.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.136 0.493 . . . . 0.0 111.612 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.697 HG22 ' HA ' ' A' ' 82' ' ' LEU . 2.2 tp -146.59 125.61 4.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.912 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.037 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.98 125.5 43.98 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.648 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -131.14 162.13 39.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.293 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -141.13 111.28 0.7 Allowed Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.664 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.977 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.64 109.42 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -71.18 124.92 28.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.232 0.539 . . . . 0.0 111.785 -178.496 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.29 121.13 31.27 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.442 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.709 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.8 p30 -81.35 -172.96 4.08 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 123.704 0.628 . . . . 0.0 111.007 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tt0 -79.31 11.02 3.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -136.4 48.22 2.15 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.988 -0.445 . . . . 0.0 112.128 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 44.85 27.36 0.26 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.319 0.58 . . . . 0.0 111.071 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 105' ' ' MET . 25.9 mt-10 -122.49 161.89 22.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.005 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.977 HG21 HG22 ' A' ' 10' ' ' ILE . 6.6 mt -128.85 143.62 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.241 0.543 . . . . 0.0 111.83 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -88.62 118.42 28.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.728 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.474 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -118.29 145.89 23.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.642 HG22 ' OE2' ' A' ' 98' ' ' GLU . 1.7 p -70.72 111.95 6.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.71 0.29 . . . . 0.0 110.528 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.631 ' CB ' HD13 ' A' ' 33' ' ' LEU . 10.6 ttp180 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.1 t30 . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.506 0.193 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 34' ' ' GLU . 2.7 mptp? -114.07 26.08 10.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 111.196 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.631 HD13 ' CB ' ' A' ' 22' ' ' ARG . 22.4 tp -55.71 86.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.943 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -119.11 -170.86 2.0 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.084 0.469 . . . . 0.0 111.872 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.5 168.33 10.3 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.607 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.648 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 57.8 Cg_endo -72.06 166.93 28.17 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.377 2.718 . . . . 0.0 112.983 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.785 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.82 -5.76 54.03 Favored Glycine 0 C--O 1.222 -0.601 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.876 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -61.96 140.97 47.11 Favored Glycine 0 C--N 1.316 -0.571 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.262 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 96.27 3.41 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.037 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -51.86 -27.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.489 0.661 . . . . 0.0 110.638 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.09 -76.53 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.173 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 41' ' ' GLU . 44.2 mmm 24.77 -85.48 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.708 0.63 . . . . 0.0 112.316 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.66 31.85 0.11 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.809 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.3 mp0 -89.96 -172.83 3.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.662 0.268 . . . . 0.0 111.195 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.852 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.88 153.06 37.95 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.376 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.852 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -44.06 -24.81 0.96 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.704 2.27 . . . . 0.0 112.643 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.674 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.8 mt-10 -103.39 -41.21 6.08 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 12.9 mm-40 -80.2 -18.12 50.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.618 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.829 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.04 -48.59 79.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.266 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.762 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.15 -46.95 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 110.79 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.2 t -54.12 -37.5 35.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.441 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -78.07 -52.06 9.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.548 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.439 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.7 tp10 -61.14 -19.99 62.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.605 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.855 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -61.4 -44.86 96.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.047 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -69.23 -30.0 68.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.204 0.526 . . . . 0.0 109.762 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.7 tt0 -77.33 -29.57 53.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.062 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.46 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -109.08 6.67 25.19 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -178.665 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.902 HG12 HG13 ' A' ' 60' ' ' ILE . 46.0 t -133.41 -44.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 109.939 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.84 -39.17 0.18 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.237 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.902 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.69 -177.53 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.092 0.472 . . . . 0.0 111.33 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.43 88.99 13.99 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.953 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.695 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.5 Cg_endo -110.24 148.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.399 2.733 . . . . 0.0 114.312 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 40.3 mt-30 -74.93 79.81 2.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.997 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -124.82 128.8 49.27 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.052 -1.431 . . . . 0.0 109.664 -176.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -173.98 -49.77 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 86' ' ' LEU . 2.2 p -38.16 159.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.947 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.762 HD11 ' HG2' ' A' ' 70' ' ' LYS . 6.8 tt -119.32 116.63 26.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.96 -54.74 6.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.178 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.549 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.74 142.19 1.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.447 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.762 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -139.92 103.87 4.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.432 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.645 HD21 HG22 ' A' ' 122' ' ' VAL . 1.9 pp -111.46 160.79 16.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.548 ' HB2' HG22 ' A' ' 81' ' ' THR . 16.1 tt0 -135.14 109.89 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.653 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -129.36 123.45 31.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.336 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 11.2 pt-20 -110.07 133.87 52.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.179 0.514 . . . . 0.0 111.616 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 2.8 m-85 -74.68 163.67 66.65 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.885 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.7 Cg_endo -37.38 -29.1 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.642 2.894 . . . . 0.0 113.214 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -139.62 -39.66 0.46 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.076 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -84.75 104.38 14.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.25 -179.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.427 ' HE1' HG23 ' A' ' 81' ' ' THR . 0.5 OUTLIER -89.37 112.38 23.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.765 0.317 . . . . 0.0 110.572 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.2 tt -118.48 128.99 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.228 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.548 HG22 ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -113.72 118.56 34.67 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.57 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.697 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -114.28 114.17 25.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.115 0.483 . . . . 0.0 112.031 -178.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.422 ' CZ3' ' HE2' ' A' ' 70' ' ' LYS . 10.5 m0 -110.22 122.08 46.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.201 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' A' ' 122' ' ' VAL . 6.1 m-30 -112.43 111.94 23.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.7 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.617 ' CE2' HG11 ' A' ' 50' ' ' VAL . 21.1 m95 -100.56 148.98 24.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.718 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 66' ' ' SER . 45.9 tp -93.97 138.69 31.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.514 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.997 HG22 ' ND1' ' A' ' 64' ' ' HIS . 44.8 t -120.09 145.7 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.095 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.99 -24.55 10.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -163.66 164.96 23.78 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.958 0.799 . . . . 0.0 111.508 -178.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.709 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -157.24 123.54 4.89 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.94 0.4 . . . . 0.0 111.326 178.499 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -76.13 151.7 36.93 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.077 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.97 -122.66 28.17 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.558 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 13.6 mt-10 -132.17 147.87 67.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.516 0.198 . . . . 0.0 110.77 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.557 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.48 128.81 10.58 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.845 2.363 . . . . 0.0 111.202 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.561 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 52.5 p-90 -134.43 -64.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.539 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.596 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.85 -96.56 0.01 OUTLIER Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.143 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 173.44 38.83 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.678 0.275 . . . . 0.0 110.93 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.642 ' OE2' HG22 ' A' ' 21' ' ' THR . 15.2 pt-20 -58.45 -49.42 77.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.855 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.44 -63.56 0.36 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.967 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.92 120.21 25.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.004 0.431 . . . . 0.0 111.637 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -43.48 146.28 1.33 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.101 2.534 . . . . 0.0 112.658 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.7 177.11 17.18 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.874 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -130.29 157.43 42.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.533 0.206 . . . . 0.0 110.472 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.475 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -65.28 106.08 1.27 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.926 0.393 . . . . 0.0 110.272 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.518 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -120.83 163.21 18.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.224 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.408 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -77.32 115.96 17.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.791 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.541 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -80.05 -18.82 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.449 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.46 -12.62 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.601 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.87 54.88 0.63 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.979 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.74 HD22 HD12 ' A' ' 123' ' ' ILE . 4.6 tt -61.84 150.52 37.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -101.02 108.89 20.72 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -16.96 61.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.062 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.01 -46.82 17.4 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.184 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -66.79 -40.51 88.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.61 174.02 6.72 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.642 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.43 127.71 27.08 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 121.893 1.728 . . . . 0.0 112.321 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.88 -37.49 11.41 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.643 2.229 . . . . 0.0 112.628 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.5 -9.58 56.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 111.481 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -104.69 21.78 16.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.829 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -71.87 -31.51 1.8 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 90.9 Cg_exo -44.07 -37.33 9.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.86 1.707 . . . . 0.0 113.188 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.666 HG11 ' CD2' ' A' ' 84' ' ' PHE . 58.8 t -77.67 -51.0 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.63 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.74 HD12 HD22 ' A' ' 110' ' ' LEU . 43.1 mm -65.48 -30.61 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.33 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.86 -29.43 55.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.121 0.486 . . . . 0.0 110.493 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -78.27 -51.3 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.622 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.839 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.2 tm? -78.22 -19.91 52.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.814 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.605 ' HB2' HG22 ' A' ' 123' ' ' ILE . 4.9 ttpm? -75.18 -42.57 55.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.095 0.474 . . . . 0.0 110.51 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.0 ttm105 -67.77 -9.14 41.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.027 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.582 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 tptm . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.824 0.345 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -140.26 138.11 34.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.594 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.848 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.9 pp -146.29 131.26 18.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.345 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.444 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 28.0 mt-30 -103.09 153.05 20.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.217 0.532 . . . . 0.0 111.965 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.848 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.0 mp -146.53 134.66 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.854 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.061 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.51 124.29 41.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.602 HG11 ' CE1' ' A' ' 84' ' ' PHE . 1.6 m -125.48 162.53 28.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.233 0.539 . . . . 0.0 112.005 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -145.95 113.5 0.69 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.146 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.946 ' CG2' HG21 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -70.69 101.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.828 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -71.04 123.35 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 121.306 0.574 . . . . 0.0 111.937 -178.374 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.81 123.62 34.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.482 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.492 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 12.5 t-20 -76.73 -172.31 2.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.865 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.7 tm-20 -83.15 4.05 28.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.093 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -138.41 50.85 1.87 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.346 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.71 24.42 0.33 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.384 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 23.5 pt-20 -117.74 144.4 45.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.946 HG21 ' CG2' ' A' ' 10' ' ' ILE . 6.1 mt -113.1 138.84 41.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.228 0.537 . . . . 0.0 111.754 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.27 108.29 19.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.275 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.884 HD12 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -107.86 155.89 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.141 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.714 HG23 ' HD3' ' A' ' 36' ' ' PRO . 5.8 p -71.04 111.81 6.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.686 0.279 . . . . 0.0 110.253 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.955 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.689 0.28 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -113.71 25.99 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 111.259 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.884 HD21 HD12 ' A' ' 20' ' ' ILE . 1.8 tt -70.59 65.83 0.32 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.605 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.86 -169.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.444 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.811 ' CD2' HD12 ' A' ' 10' ' ' ILE . 3.0 m-85 -119.13 143.75 34.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.709 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.714 ' HD3' HG23 ' A' ' 21' ' ' THR . 17.8 Cg_endo -58.23 165.98 6.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.741 2.294 . . . . 0.0 111.067 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 100.36 58.66 0.85 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 119.72 -1.228 . . . . 0.0 113.359 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -124.84 134.02 8.8 Favored Glycine 0 C--N 1.31 -0.879 0 CA-C-N 114.857 -0.672 . . . . 0.0 112.25 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 101.58 -2.47 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.061 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -50.19 -26.27 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.219 0.533 . . . . 0.0 111.017 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.513 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.59 -68.67 0.16 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.973 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.455 ' C ' ' O ' ' A' ' 41' ' ' GLU . 76.6 mmm 23.54 -86.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.831 0.707 . . . . 0.0 112.318 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.97 29.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.832 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.5 mp0 -93.66 -173.7 3.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.792 0.329 . . . . 0.0 111.068 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.905 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.0 155.44 37.61 Favored Pre-proline 0 N--CA 1.456 -0.157 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.327 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.905 ' HD2' HG22 ' A' ' 45' ' ' THR . 4.1 Cg_endo -45.24 -24.6 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.651 2.234 . . . . 0.0 112.461 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.743 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -94.23 -50.17 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -80.17 -29.55 38.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.721 0.296 . . . . 0.0 111.604 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.984 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -52.42 -45.86 66.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.91 0.386 . . . . 0.0 110.845 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.791 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -78.46 -50.55 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.898 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 47' ' ' GLU . 55.5 t -54.45 -36.78 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.875 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -52.02 9.44 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.927 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.586 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.9 mm-40 -66.93 -25.0 66.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.722 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.985 ' O ' HG23 ' A' ' 58' ' ' VAL . 12.4 tp -52.75 -45.76 67.19 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.874 0.369 . . . . 0.0 110.39 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -62.64 -26.68 68.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.84 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -71.43 -23.65 61.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.891 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.496 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.0 mm-40 -108.19 5.09 25.49 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -134.61 -44.7 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.424 0.63 . . . . 0.0 109.497 178.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.58 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 70.01 -36.6 0.4 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.276 -0.874 . . . . 0.0 114.597 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.927 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -84.4 -168.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 120.945 0.403 . . . . 0.0 110.882 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -111.73 89.29 10.87 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.603 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.633 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.3 Cg_endo -107.36 147.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.018 2.478 . . . . 0.0 113.997 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 53.8 mt-30 -74.83 80.05 2.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.917 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.87 129.05 50.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.481 -176.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.6 t80 179.6 163.5 0.98 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.932 0.396 . . . . 0.0 112.034 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 84.64 163.62 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.882 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.7 pp -121.8 127.55 50.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.071 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 1.5 p90 -76.81 -44.37 32.84 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.9 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.571 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 12.4 mt-10 -171.43 131.78 0.75 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.859 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -132.53 132.0 42.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.635 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 1.038 HD11 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.34 154.61 44.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.003 0.43 . . . . 0.0 111.23 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.552 ' CG ' HG23 ' A' ' 81' ' ' THR . 19.5 tt0 -131.8 109.78 10.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.377 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.511 ' OH ' HD13 ' A' ' 80' ' ' ILE . 55.4 p90 -125.97 151.87 46.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 5.6 pt-20 -120.16 140.12 51.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.361 0.6 . . . . 0.0 111.493 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.2 m-85 -103.44 162.73 19.15 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.085 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.5 Cg_endo -52.61 81.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.919 2.413 . . . . 0.0 112.174 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.2 t70 93.14 10.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.556 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.37 93.82 2.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.679 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.441 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.7 t-80 -85.42 93.94 8.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.745 0.307 . . . . 0.0 110.69 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.511 HD13 ' OH ' ' A' ' 73' ' ' TYR . 2.7 tt -96.7 111.99 27.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 111.397 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.578 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -99.61 118.54 36.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.208 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.676 HD23 ' HB ' ' A' ' 6' ' ' ILE . 9.9 mt -120.71 114.12 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.936 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.578 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.4 m0 -110.42 122.11 46.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.838 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.843 ' CD2' HG11 ' A' ' 122' ' ' VAL . 3.2 m-85 -106.45 133.7 50.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.045 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.791 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 11.0 m95 -117.01 148.45 41.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 65' ' ' PHE . 35.4 tp -85.9 138.24 32.17 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.319 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.803 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.5 t -124.2 145.9 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.427 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -110.44 -32.07 7.06 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.1 164.28 25.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.777 0.717 . . . . 0.0 111.843 -178.795 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.739 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.8 p90 -148.63 126.38 11.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.235 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.95 150.6 35.91 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.292 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.24 -129.98 48.8 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.707 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.587 ' O ' HG12 ' A' ' 60' ' ' ILE . 16.3 mt-10 -120.65 136.57 25.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.886 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.2 Cg_exo -74.46 128.85 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.573 2.182 . . . . 0.0 111.375 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.58 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 39.1 p-90 -130.22 -63.47 0.9 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.48 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.496 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 51.25 -109.51 0.79 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.603 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 168.55 41.95 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.769 0.318 . . . . 0.0 111.007 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.32 -46.31 79.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.861 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.11 -23.56 4.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.89 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.44 100.7 13.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.911 0.386 . . . . 0.0 111.306 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -43.5 143.3 2.58 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.912 2.408 . . . . 0.0 112.581 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.1 177.12 19.38 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.666 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -131.84 157.17 44.62 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -72.43 106.38 4.51 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.196 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.421 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.5 ptm -120.43 163.16 18.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.224 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.84 117.94 21.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.592 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.665 HD11 HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.77 -18.84 46.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.4 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.647 HG23 HD22 ' A' ' 129' ' ' LEU . 11.9 p -58.37 -14.65 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.611 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.33 49.95 0.91 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.785 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.896 HD23 HG23 ' A' ' 123' ' ' ILE . 10.0 tp -62.31 150.51 39.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.74 0.305 . . . . 0.0 111.098 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.69 ' CB ' HD13 ' A' ' 33' ' ' LEU . 1.9 t-20 -111.0 92.92 4.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.5 -19.93 61.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.117 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -79.06 -45.31 20.38 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -42.16 87.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.568 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.34 174.37 6.13 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.09 127.87 27.51 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 121.99 1.793 . . . . 0.0 112.173 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.82 -39.13 11.99 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.727 2.284 . . . . 0.0 112.76 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.63 -9.63 57.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.083 0.468 . . . . 0.0 111.533 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -101.83 20.46 16.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.754 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -72.84 -31.08 1.42 Allowed Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.4 Cg_exo -43.71 -36.57 7.64 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.831 1.687 . . . . 0.0 113.011 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 1.038 HG22 HD11 ' A' ' 71' ' ' LEU . 69.9 t -77.91 -51.33 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.092 0.472 . . . . 0.0 110.958 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.896 HG23 HD23 ' A' ' 110' ' ' LEU . 17.8 mm -65.24 -34.63 71.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.75 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.23 -27.74 36.56 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.472 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -80.58 -53.04 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.934 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.524 HD23 ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -78.14 -32.97 50.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.75 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.892 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.3 ttpt -53.35 -42.21 66.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.818 ' O ' HD12 ' A' ' 129' ' ' LEU . 15.2 ttt-85 -71.02 -6.17 36.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.003 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.061 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.842 0.353 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.06 139.57 35.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.837 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.409 ' O ' HD12 ' A' ' 4' ' ' LEU . 2.8 pp -146.25 122.98 11.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -102.57 151.31 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.13 0.491 . . . . 0.0 111.378 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.632 ' CG2' HD13 ' A' ' 82' ' ' LEU . 2.0 tp -146.61 130.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.332 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.906 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.02 125.48 43.93 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m -139.93 154.8 23.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.269 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.05 120.92 2.34 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.461 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.757 HG22 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -70.35 108.43 2.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.772 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.05 124.98 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.155 0.502 . . . . 0.0 111.688 -178.146 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -100.7 129.25 46.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.3 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.707 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.8 p-10 -84.44 -172.87 4.41 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.43 0.634 . . . . 0.0 111.786 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.3 tm-20 -73.63 4.89 4.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.452 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -128.63 44.39 2.97 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.014 -0.429 . . . . 0.0 112.092 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 48.96 23.13 0.66 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 111.473 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 33.6 mt-10 -114.0 161.61 17.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.757 HG12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -115.03 139.83 39.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.497 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.577 ' CD2' HD12 ' A' ' 11' ' ' ILE . 1.8 t80 -93.41 97.56 10.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.569 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.668 HD12 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -110.01 162.22 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.253 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 71.3 p -70.59 134.95 48.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 111.133 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.654 0.264 . . . . 0.0 111.276 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.34 26.39 10.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 111.577 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 20' ' ' ILE . 1.2 tt -64.77 73.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.768 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -113.66 -172.06 2.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.063 0.459 . . . . 0.0 111.675 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.554 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.45 168.27 10.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.609 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.705 ' HG3' HD11 ' A' ' 11' ' ' ILE . 60.2 Cg_endo -72.63 166.88 28.63 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.42 2.746 . . . . 0.0 113.162 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.788 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.68 -5.33 54.15 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 116.011 -0.541 . . . . 0.0 113.99 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.582 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -65.34 132.56 35.76 Favored Glycine 0 C--N 1.315 -0.598 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.727 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 106.36 1.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.273 0.629 . . . . 0.0 112.081 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.906 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -49.16 -29.8 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.672 0.748 . . . . 0.0 110.588 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.627 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -41.45 -58.65 1.82 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.105 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.538 ' C ' ' O ' ' A' ' 41' ' ' GLU . 12.6 mmt 2.68 -78.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.656 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.42 33.27 0.07 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.031 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 13.1 mp0 -101.55 -174.96 2.72 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.617 0.246 . . . . 0.0 111.037 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.819 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -105.42 152.39 39.91 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.283 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.819 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.68 -24.57 0.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.73 2.287 . . . . 0.0 112.463 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.76 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -94.39 -50.38 5.26 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -80.42 -29.22 37.67 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.831 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -55.6 -43.88 76.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.184 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.517 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 m -78.27 -48.75 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.89 0.376 . . . . 0.0 110.233 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.7 t -57.16 -35.91 49.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.75 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.4 mmt-85 -77.94 -50.14 12.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.497 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.71 -21.99 66.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.626 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.135 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -56.88 -44.75 82.6 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.931 0.396 . . . . 0.0 110.289 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -68.36 -28.05 66.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.348 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.33 -38.65 49.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.48 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 1.3 mp0 -104.66 5.16 33.35 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.086 HG12 HG22 ' A' ' 60' ' ' ILE . 11.1 t -134.42 -43.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.048 0.451 . . . . 0.0 109.997 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.0 -35.06 0.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.706 -0.679 . . . . 0.0 114.418 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.086 HG22 HG12 ' A' ' 58' ' ' VAL . 5.4 tp -77.53 166.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.56 0.219 . . . . 0.0 110.773 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.73 89.05 1.36 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.0 Cg_endo -114.38 150.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 123.552 2.835 . . . . 0.0 114.525 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.408 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 35.0 mt-30 -74.94 79.42 2.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.135 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -123.39 127.61 48.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.492 -176.595 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -179.1 -134.12 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.634 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 55.77 166.34 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.918 0.39 . . . . 0.0 111.849 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 67' ' ' LEU . 6.9 tt -127.87 110.79 12.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.047 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.79 -45.25 29.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.122 0.486 . . . . 0.0 109.821 179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.52 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.3 tt0 -171.6 156.72 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.364 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.28 104.32 4.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.453 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.542 HD23 ' CE1' ' A' ' 73' ' ' TYR . 4.7 tp -96.84 135.79 38.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.889 0.376 . . . . 0.0 111.097 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -126.98 109.48 11.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.615 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.542 ' CE1' HD23 ' A' ' 71' ' ' LEU . 4.2 p90 -141.41 128.64 21.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.449 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 7.9 pt-20 -116.02 130.73 56.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 111.56 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 2.7 m-85 -71.11 163.33 66.44 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.026 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.472 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.4 Cg_endo -38.06 -29.14 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.598 2.865 . . . . 0.0 113.036 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -139.63 -38.43 0.48 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.009 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -83.86 99.85 10.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.284 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.457 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 4.1 t60 -87.01 110.33 19.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.785 0.326 . . . . 0.0 110.673 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.58 HD11 ' CD2' ' A' ' 82' ' ' LEU . 2.5 tt -115.27 137.38 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.961 0.41 . . . . 0.0 110.935 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.74 118.43 30.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.656 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.884 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -107.18 113.87 27.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.0 111.384 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 8.7 m0 -114.99 122.43 46.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.176 0.512 . . . . 0.0 110.32 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.887 ' CD1' HG11 ' A' ' 122' ' ' VAL . 3.9 m-85 -110.68 124.08 51.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.572 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.728 ' HE1' ' HB1' ' A' ' 7' ' ' ALA . 66.4 m95 -108.58 148.64 30.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.76 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.525 ' O ' ' O ' ' A' ' 65' ' ' PHE . 37.6 tp -99.53 103.21 14.93 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.448 0.642 . . . . 0.0 111.746 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.843 HG13 ' CB ' ' A' ' 64' ' ' HIS . 19.0 t -83.23 145.58 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.515 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -104.27 -50.74 3.27 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.15 165.76 24.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.488 0.586 . . . . 0.0 112.508 -178.096 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.707 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 24.1 p90 -133.81 159.57 40.22 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.506 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.19 102.15 14.17 Favored 'General case' 0 N--CA 1.46 0.039 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.237 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.4 -112.09 4.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.384 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.1 tt0 -131.53 135.4 26.88 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.212 . . . . 0.0 111.224 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.478 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 5.2 Cg_exo -76.5 139.6 20.68 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 111.211 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.556 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 33.4 p-90 -134.59 -63.45 0.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.19 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.667 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.77 -104.68 0.04 OUTLIER Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.308 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt 168.22 40.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.75 0.31 . . . . 0.0 110.897 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -23.68 62.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.081 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 145.3 -86.85 0.17 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.078 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.07 118.78 47.28 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.06 0.457 . . . . 0.0 111.649 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.55 146.19 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.192 2.595 . . . . 0.0 112.802 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.09 177.42 19.14 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.846 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -122.69 157.23 32.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.566 0.222 . . . . 0.0 110.436 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.444 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -68.38 106.37 2.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.976 0.417 . . . . 0.0 110.24 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.9 ptm -120.54 152.02 38.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.105 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.58 ' HB3' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -70.25 114.9 8.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.637 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.987 HD21 HD12 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -59.17 -18.5 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.66 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 106' ' ' SER . 13.7 p -52.75 -14.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.83 54.37 0.72 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.635 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.987 HD12 HD21 ' A' ' 107' ' ' LEU . 3.8 tt -61.77 150.53 36.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.886 0.374 . . . . 0.0 110.918 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -100.61 93.2 5.48 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.428 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.48 -21.42 61.21 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -79.22 -44.91 20.89 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.07 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -66.72 -40.11 88.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.372 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.569 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.37 174.39 6.09 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.8 Cg_endo -53.79 127.78 26.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.899 1.733 . . . . 0.0 112.603 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 49.6 Cg_endo -68.41 -36.11 16.44 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.885 2.39 . . . . 0.0 112.366 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.4 -9.54 58.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.07 0.462 . . . . 0.0 111.071 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -106.02 16.66 24.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.055 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.576 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -73.44 -30.97 1.29 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.1 Cg_exo -43.57 -36.37 7.04 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.847 1.698 . . . . 0.0 113.51 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.887 HG11 ' CD1' ' A' ' 84' ' ' PHE . 17.6 t -77.88 -51.27 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.145 0.498 . . . . 0.0 110.534 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 127' ' ' LYS . 20.4 mm -65.48 -30.99 51.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.25 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.89 47.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.614 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -49.83 11.52 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.653 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.815 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.3 tm? -78.3 -28.84 47.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.405 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 123' ' ' ILE . 7.9 ttpt -55.01 -42.54 72.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.109 0.48 . . . . 0.0 110.654 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -64.05 -12.61 40.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.521 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.0 mp . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.947 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.732 ' CE ' HD23 ' A' ' 4' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.852 0.358 . . . . 0.0 110.962 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -140.11 130.17 24.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.68 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.732 HD23 ' CE ' ' A' ' 2' ' ' LYS . 3.2 pp -146.19 124.72 12.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.369 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.421 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 30.4 mt-30 -102.81 151.7 22.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.419 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.618 ' HB ' HD12 ' A' ' 82' ' ' LEU . 2.1 mp -146.53 127.09 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.904 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.894 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.77 125.63 44.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -144.36 162.16 14.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.833 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -147.76 125.62 2.17 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.692 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.091 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.84 110.92 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.764 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.53 125.31 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-O 121.178 0.513 . . . . 0.0 111.537 -178.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.92 118.93 30.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.194 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.731 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 2.9 p-10 -79.64 -172.22 3.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.331 0.586 . . . . 0.0 111.389 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.6 tm-20 -77.08 13.46 1.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.426 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 10.7 t-20 -143.25 51.89 1.37 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.214 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.17 27.62 0.22 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.023 0.439 . . . . 0.0 111.571 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' C ' ' OD1' ' A' ' 13' ' ' ASN . 23.2 mt-10 -122.94 161.75 23.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.091 HG21 HG22 ' A' ' 10' ' ' ILE . 8.1 mt -128.22 144.11 38.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.189 0.519 . . . . 0.0 112.186 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.68 115.21 26.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.446 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -112.46 133.34 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.404 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 100' ' ' GLN . 23.4 p -70.97 114.44 9.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.042 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HB3' HD13 ' A' ' 33' ' ' LEU . 1.5 ptm180 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.691 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.679 0.276 . . . . 0.0 111.267 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.22 25.94 10.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.983 0.421 . . . . 0.0 111.574 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 38.6 tp -68.68 71.72 0.21 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.449 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.704 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -109.43 -167.21 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.79 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -119.12 168.29 10.18 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.566 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.533 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 85.1 Cg_endo -84.08 167.51 12.45 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.695 2.93 . . . . 0.0 113.695 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.501 ' H ' ' CG ' ' A' ' 57' ' ' GLU . . . 102.92 -3.23 48.49 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.241 -0.89 . . . . 0.0 114.525 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -64.2 165.04 31.77 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 117.264 0.532 . . . . 0.0 113.793 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.0 0.51 0.66 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.188 0.595 . . . . 0.0 112.046 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.894 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -50.92 -28.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.675 0.75 . . . . 0.0 110.552 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.602 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.9 -58.23 2.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.161 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.0 mmt 6.96 -79.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.887 0.742 . . . . 0.0 112.579 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 179.56 34.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.03 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.466 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -93.76 -170.45 2.34 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.653 0.263 . . . . 0.0 111.045 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.834 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.68 153.19 38.03 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.314 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.834 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.9 -25.0 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.796 2.331 . . . . 0.0 112.396 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -102.57 -42.99 5.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.818 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -11.16 59.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.835 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.03 -53.97 51.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.86 0.362 . . . . 0.0 110.81 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.812 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.27 -50.14 19.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.401 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.2 t -51.75 -37.76 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.407 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -78.49 -52.19 8.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.291 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.668 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.1 mm-40 -66.0 -20.02 66.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.586 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.911 HD11 ' CE1' ' A' ' 64' ' ' HIS . 9.4 tp -55.53 -45.01 77.24 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -35.89 82.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.174 0.512 . . . . 0.0 109.713 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.1 -25.45 62.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.968 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.501 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -108.36 6.73 26.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.185 -178.724 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.973 HG13 HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -133.39 -44.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.064 0.459 . . . . 0.0 109.952 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.54 -37.79 0.22 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.648 -0.705 . . . . 0.0 114.456 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.973 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -86.76 -174.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 120.853 0.358 . . . . 0.0 110.919 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.78 88.64 14.36 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.498 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.539 ' HB3' ' HB2' ' A' ' 90' ' ' TRP . 5.9 Cg_endo -110.84 146.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.514 2.809 . . . . 0.0 113.811 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 15.3 mt-30 -74.79 79.83 2.09 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.911 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.3 132.44 55.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.867 -176.446 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.94 -136.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.651 -179.466 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 54.08 165.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.079 0.466 . . . . 0.0 111.885 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.653 HD23 ' O ' ' A' ' 67' ' ' LEU . 7.2 tt -128.02 108.84 11.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.798 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.86 -43.36 36.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.302 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 11.8 tt0 -171.27 156.11 4.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.553 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HD3' ' CE2' ' A' ' 83' ' ' TRP . 1.4 ttmm -143.27 105.73 4.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.657 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.522 HD22 HG23 ' A' ' 122' ' ' VAL . 1.1 tp -97.09 136.29 37.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.054 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -140.02 109.64 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.409 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.412 ' CE1' HD21 ' A' ' 71' ' ' LEU . 2.3 p90 -141.18 152.22 44.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.1 pt-20 -121.13 135.81 55.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.168 0.509 . . . . 0.0 111.29 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.483 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -101.12 163.21 18.39 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.183 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 10.3 Cg_endo -53.86 82.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.779 2.319 . . . . 0.0 112.068 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.0 m-20 92.96 8.81 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.659 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -137.3 93.83 2.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.601 0.239 . . . . 0.0 110.86 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 20.2 t-80 -90.38 107.45 19.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.67 HD11 HD13 ' A' ' 82' ' ' LEU . 3.3 tt -107.53 146.42 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.762 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.07 118.82 18.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.02 179.314 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.67 HD13 HD11 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -117.21 114.22 23.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.798 0.332 . . . . 0.0 111.169 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.457 ' CE2' ' HD3' ' A' ' 70' ' ' LYS . 8.5 m0 -106.93 122.23 46.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.787 ' CE2' HG11 ' A' ' 122' ' ' VAL . 2.2 m-85 -111.49 109.9 20.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.084 0.468 . . . . 0.0 111.665 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.812 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 58.8 m95 -94.81 148.71 22.01 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.82 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.5 tp -97.84 102.79 14.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.549 0.69 . . . . 0.0 111.367 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.775 HG13 ' CB ' ' A' ' 64' ' ' HIS . 18.0 t -83.53 146.29 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.441 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -108.56 -40.15 5.19 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 2.3 ptp180 -163.34 165.72 23.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.064 0.847 . . . . 0.0 112.527 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.731 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 3.3 p90 -145.44 133.35 21.27 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.453 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -81.25 121.18 25.84 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.98 -128.16 8.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.426 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.1 tt0 -123.43 139.29 31.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 O-C-N 122.886 -0.185 . . . . 0.0 110.818 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.512 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 2.6 Cg_exo -76.2 128.72 10.75 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.885 2.39 . . . . 0.0 111.514 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.523 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 61.4 p-90 -132.86 -61.08 0.85 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.06 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.83 -104.37 0.05 OUTLIER Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.256 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.24 37.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.684 0.278 . . . . 0.0 111.049 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -26.84 63.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.026 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.32 -67.6 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.939 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -121.89 110.84 32.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.989 0.423 . . . . 0.0 111.545 -179.423 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -43.64 146.16 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.973 2.449 . . . . 0.0 112.517 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.42 177.01 18.58 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.856 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -116.49 157.29 25.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.496 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.25 106.57 5.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.91 0.386 . . . . 0.0 110.476 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.8 ptm -120.18 160.71 22.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.877 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 22.3 p -73.07 115.25 12.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.928 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.765 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -66.18 -18.92 65.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.12 -12.4 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.446 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.97 47.63 1.01 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.892 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.548 HD13 HD22 ' A' ' 107' ' ' LEU . 9.2 tp -62.01 150.12 38.96 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -122.57 118.57 28.54 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -178.657 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.37 -19.61 61.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.125 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -78.96 -47.27 16.64 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.996 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.84 -20.17 65.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.362 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.47 172.04 4.24 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -54.48 127.81 27.55 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.01 1.807 . . . . 0.0 112.318 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.15 -38.78 8.63 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.723 2.282 . . . . 0.0 112.652 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.84 -9.76 53.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 111.528 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.41 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 14.4 m-20 -104.71 18.59 21.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.969 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.556 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -66.66 -31.88 4.58 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 84.6 Cg_exo -44.32 -36.61 9.51 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.831 1.687 . . . . 0.0 113.504 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.787 HG11 ' CE2' ' A' ' 84' ' ' PHE . 93.0 t -77.89 -51.41 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 111.038 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.876 HG22 ' HB2' ' A' ' 127' ' ' LYS . 7.3 mm -68.68 -29.88 45.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.489 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.72 -27.0 37.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.979 0.419 . . . . 0.0 110.232 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -80.1 -51.85 8.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.684 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.5 tm? -78.03 -34.09 50.73 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.627 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.876 ' HB2' HG22 ' A' ' 123' ' ' ILE . 13.7 tttm -52.98 -42.72 65.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.002 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -69.29 -7.76 39.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.945 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.278 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 tptp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.808 0.337 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -140.01 132.27 28.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 1.035 HD12 HD11 ' A' ' 6' ' ' ILE . 1.7 pp -146.18 126.18 13.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.134 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.476 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 30.1 mt-30 -102.53 154.17 19.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.254 0.55 . . . . 0.0 111.87 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 1.035 HD11 HD12 ' A' ' 4' ' ' LEU . 4.5 mp -146.27 125.28 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.581 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.051 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.82 125.7 44.43 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.2 m -140.1 162.64 24.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.202 0.525 . . . . 0.0 111.858 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -135.84 123.42 2.99 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.649 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.777 HG22 HG12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -70.91 105.02 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.75 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -70.68 126.25 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.138 0.494 . . . . 0.0 111.941 -178.053 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.664 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -101.65 124.99 48.21 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.097 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.624 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.4 p-10 -79.15 -172.59 3.21 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 123.77 0.669 . . . . 0.0 111.382 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.3 tm-20 -76.14 9.22 2.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.337 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -132.89 46.91 2.56 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.958 -0.464 . . . . 0.0 112.098 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.54 24.53 0.52 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 111.495 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 105' ' ' MET . 22.5 mt-10 -115.95 161.24 19.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.777 HG12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -113.68 134.02 57.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.655 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 11' ' ' ILE . 40.7 t80 -91.84 95.18 9.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.433 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -111.25 162.42 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.733 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.787 ' O ' HD12 ' A' ' 33' ' ' LEU . 70.8 p -70.63 132.68 45.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.563 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.962 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.657 0.265 . . . . 0.0 111.087 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 26.1 10.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.941 0.401 . . . . 0.0 111.708 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 21' ' ' THR . 14.7 tp -69.01 69.51 0.18 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.555 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -110.48 -172.65 2.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.539 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.39 168.7 9.48 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.374 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.749 ' HG3' HD11 ' A' ' 11' ' ' ILE . 84.1 Cg_endo -81.28 166.96 17.96 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.528 2.818 . . . . 0.0 113.586 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.12 -5.63 53.07 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.002 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -58.94 162.99 10.79 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.942 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 81.93 2.13 1.4 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 179.108 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.051 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -50.34 -28.92 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.616 0.722 . . . . 0.0 110.262 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.595 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -40.89 -57.44 1.96 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.961 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER 2.93 -78.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.931 0.77 . . . . 0.0 112.522 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 176.27 35.04 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.937 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -89.9 -172.72 3.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.677 0.275 . . . . 0.0 111.057 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.817 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.6 152.29 38.08 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.203 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.817 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.77 -25.09 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.751 2.301 . . . . 0.0 112.501 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mm-40 -104.06 -39.59 6.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.378 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 2.9 mt-30 -80.37 -9.55 59.75 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.835 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -58.64 -54.76 43.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.866 0.365 . . . . 0.0 110.811 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.713 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -78.64 -46.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.47 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 40.4 t -56.53 -44.74 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.852 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 7.7 mtp180 -72.81 -46.12 54.81 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.912 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' CG ' ' OE1' ' A' ' 57' ' ' GLU . 0.9 OUTLIER -69.43 -19.88 63.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.79 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.937 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -57.91 -44.6 86.92 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.822 0.344 . . . . 0.0 110.714 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.43 -30.69 71.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.105 0.478 . . . . 0.0 109.807 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.42 -34.39 54.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.414 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.606 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.6 mp0 -108.36 6.43 26.39 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.046 HG12 HG22 ' A' ' 60' ' ' ILE . 34.3 t -133.8 -44.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.391 . . . . 0.0 110.45 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.01 -36.43 0.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.837 -0.62 . . . . 0.0 114.467 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.046 HG22 HG12 ' A' ' 58' ' ' VAL . 19.6 tt -77.37 163.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.58 0.228 . . . . 0.0 110.684 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.433 ' N ' HG12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -103.62 88.76 1.9 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.759 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.3 Cg_endo -115.12 152.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 123.558 2.839 . . . . 0.0 114.847 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.95 79.74 2.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.937 ' CD2' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -125.93 128.3 47.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.83 -176.146 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.3 t80 -176.85 -140.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.405 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 2.7 m 50.78 175.98 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.142 0.496 . . . . 0.0 112.008 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.87 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -142.99 121.17 12.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.006 179.481 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.92 -44.0 33.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.057 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.3 mt-10 -171.65 131.82 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.468 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.46 111.15 18.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.373 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.558 ' HB3' HG22 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -96.94 141.97 29.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.132 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.401 ' N ' ' HG ' ' A' ' 71' ' ' LEU . 6.1 tt0 -137.87 109.9 7.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.53 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.803 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.0 p90 -137.71 149.97 46.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.694 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -118.82 139.67 51.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.223 0.535 . . . . 0.0 111.525 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.504 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.6 m-85 -103.02 162.67 19.4 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.192 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.5 Cg_endo -53.65 81.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.934 2.423 . . . . 0.0 112.131 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.0 t0 93.76 8.6 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -137.32 93.67 2.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.699 0.285 . . . . 0.0 110.758 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.27 110.94 19.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.806 0.336 . . . . 0.0 110.69 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.803 HD13 ' OH ' ' A' ' 73' ' ' TYR . 3.6 tt -108.09 146.64 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.22 0.533 . . . . 0.0 111.204 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.498 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -134.18 118.53 17.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.529 178.815 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' A' ' 6' ' ' ILE . 2.9 tp -119.15 114.01 21.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.923 0.392 . . . . 0.0 111.254 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.498 ' HE1' HG22 ' A' ' 81' ' ' THR . 9.5 m0 -111.06 122.15 47.16 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.084 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.96 ' CD1' HG11 ' A' ' 122' ' ' VAL . 2.5 m-85 -106.12 113.3 26.75 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.977 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.87 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.7 m95 -94.72 148.35 22.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.671 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.582 ' C ' HD13 ' A' ' 86' ' ' LEU . 2.9 tm? -94.3 102.59 14.6 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 121.395 0.617 . . . . 0.0 110.592 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.895 HG22 ' CE1' ' A' ' 64' ' ' HIS . 14.9 t -89.85 145.37 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.813 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -99.94 -59.68 1.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 10.5 ptm180 -163.34 166.0 23.46 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.205 0.457 . . . . 0.0 112.22 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.815 ' HB2' HD13 ' A' ' 60' ' ' ILE . 41.9 p90 -125.79 164.7 20.12 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.634 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.779 ' C ' HD11 ' A' ' 60' ' ' ILE . 32.2 tt0 -104.13 95.83 6.24 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.01 -112.08 4.05 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.168 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.428 ' C ' HD12 ' A' ' 60' ' ' ILE . 21.0 tt0 -134.33 130.2 20.04 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.528 0.204 . . . . 0.0 111.17 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 4.8 Cg_exo -76.63 128.82 10.47 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.766 2.31 . . . . 0.0 111.372 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 6.9 p-90 -123.07 -65.7 1.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.191 0.52 . . . . 0.0 111.337 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.621 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 50.41 -117.33 4.96 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.288 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 177.57 35.96 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.72 0.295 . . . . 0.0 111.258 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -49.75 -30.33 9.25 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.942 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.4 -25.13 7.86 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.797 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.449 ' O ' HG22 ' A' ' 21' ' ' THR . 1.3 pm0 -138.86 112.31 8.22 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 117.197 0.499 . . . . 0.0 111.754 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -43.57 145.39 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.935 2.423 . . . . 0.0 112.551 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.416 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.19 177.51 19.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.855 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -144.66 157.1 44.34 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.47 106.53 0.94 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.11 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -120.2 156.13 31.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.039 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.713 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -77.38 116.05 17.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -61.65 -18.74 60.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.386 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.713 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.2 p -62.37 -3.99 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.639 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.69 48.39 0.97 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.995 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.44 HD11 HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -61.56 128.24 35.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -111.02 114.13 27.2 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.575 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.574 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -19.29 61.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.857 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -78.83 -47.69 16.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.843 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.75 -14.18 62.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.46 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.574 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -113.56 171.27 4.51 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.07 127.85 27.42 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.187 1.925 . . . . 0.0 112.373 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.99 -39.14 8.43 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.759 2.306 . . . . 0.0 112.866 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.71 -9.74 52.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.988 0.423 . . . . 0.0 111.538 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.468 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 21.7 m-20 -104.14 14.49 30.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.057 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.532 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -61.78 -32.25 9.75 Favored Pre-proline 0 N--CA 1.467 0.4 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -178.503 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.9 Cg_exo -44.24 -41.5 13.19 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.712 1.608 . . . . 0.0 113.458 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.96 HG11 ' CD1' ' A' ' 84' ' ' PHE . 35.8 t -77.69 -51.04 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.831 0.348 . . . . 0.0 111.059 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.562 HG13 ' CE2' ' A' ' 115' ' ' PHE . 38.2 mm -62.9 -33.77 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.403 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -29.6 54.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.955 0.407 . . . . 0.0 110.487 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -79.95 -45.21 18.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.339 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.608 HD21 HD11 ' A' ' 107' ' ' LEU . 22.9 tp -78.28 -50.08 12.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.379 . . . . 0.0 111.216 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.586 ' O ' HD13 ' A' ' 129' ' ' LEU . 6.5 ttpt -53.21 -34.9 59.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.995 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -63.6 -10.16 17.15 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 127' ' ' LYS . 10.5 mp . . . . . 0 CA--C 1.528 0.118 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.251 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 4.3 mttt -140.05 130.48 25.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.4 pp -146.19 128.36 15.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 111.162 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.449 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 46.2 mt-30 -102.85 150.52 23.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.025 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' HB ' HD12 ' A' ' 82' ' ' LEU . 4.2 mp -146.55 121.83 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.204 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.033 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.12 125.35 43.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 35' ' ' PHE . 1.3 m -139.67 162.21 26.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.576 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.39 139.3 10.55 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.933 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.992 HG22 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -83.47 112.66 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.262 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.824 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -70.81 123.66 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 121.051 0.453 . . . . 0.0 111.493 -178.61 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.16 124.65 35.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.858 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.477 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 13.2 t30 -81.75 -172.09 3.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.805 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -81.52 3.99 22.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.453 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -139.5 52.01 1.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.35 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 45.76 24.64 0.22 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.475 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 16.0 pt-20 -117.01 138.57 51.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.992 HG21 HG22 ' A' ' 10' ' ' ILE . 7.5 mt -105.97 139.7 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.26 0.552 . . . . 0.0 112.038 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 18.4 t80 -80.93 91.3 6.0 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.393 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.5 156.81 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.919 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.484 ' O ' HD12 ' A' ' 33' ' ' LEU . 25.7 p -70.77 129.46 39.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.843 0.354 . . . . 0.0 110.709 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.811 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.712 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.714 0.292 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.34 26.09 10.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.919 0.39 . . . . 0.0 111.515 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -67.25 70.33 0.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.36 -172.66 2.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.684 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.669 ' CD1' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -110.68 166.01 11.58 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.863 0.363 . . . . 0.0 110.956 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.824 ' HG3' HD11 ' A' ' 11' ' ' ILE . 36.4 Cg_endo -65.47 166.69 18.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.415 2.743 . . . . 0.0 114.174 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.643 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.85 -5.96 54.11 Favored Glycine 0 C--O 1.225 -0.469 0 CA-C-N 114.877 -1.056 . . . . 0.0 114.027 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -57.15 155.67 16.29 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 117.337 0.569 . . . . 0.0 112.528 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.82 7.07 0.5 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.033 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -51.62 -28.43 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.715 0.769 . . . . 0.0 110.156 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.569 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -39.75 -60.64 0.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.731 179.337 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.528 ' C ' ' O ' ' A' ' 41' ' ' GLU . 8.7 mmt 5.8 -81.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.537 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.27 28.75 0.08 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.943 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -94.41 -174.71 3.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.773 0.321 . . . . 0.0 111.06 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.867 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.45 156.51 39.39 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.867 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.65 -24.66 0.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.799 2.333 . . . . 0.0 112.708 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -90.25 -57.73 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -80.52 -4.26 53.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.932 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.28 -57.73 11.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.97 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.79 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.2 m -79.01 -45.65 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.475 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.6 t -52.21 -38.84 25.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mmm-85 -78.15 -41.54 34.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.531 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.31 -19.89 62.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.76 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.869 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -58.59 -44.76 89.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.883 0.373 . . . . 0.0 110.402 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -32.13 70.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.052 0.453 . . . . 0.0 110.344 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.17 -31.92 55.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.499 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.519 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.05 3.96 24.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.479 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.934 HG12 HG22 ' A' ' 60' ' ' ILE . 11.3 t -134.69 -44.11 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.206 0.527 . . . . 0.0 109.934 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.16 -32.88 0.25 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.046 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.934 HG22 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.89 179.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 120.617 0.246 . . . . 0.0 110.6 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.97 88.4 10.02 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.668 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -110.78 144.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.527 2.818 . . . . 0.0 113.968 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 18.3 mt-30 -74.68 79.62 2.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 175.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.869 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.85 134.16 54.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.982 -175.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 179.97 -140.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.352 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.404 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 0.9 OUTLIER 50.33 176.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.138 0.494 . . . . 0.0 111.932 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.9 OUTLIER -143.88 123.31 13.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.043 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.6 -43.77 37.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.186 0.517 . . . . 0.0 109.658 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.1 mt-10 -171.83 131.8 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.224 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.06 109.38 17.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.782 0.325 . . . . 0.0 110.408 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.64 HD22 HG23 ' A' ' 122' ' ' VAL . 3.9 tp -96.99 131.09 44.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.126 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -133.68 109.67 9.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.368 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -141.29 131.77 25.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.9 pm0 -102.76 138.92 39.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.115 0.483 . . . . 0.0 111.228 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -106.53 163.4 17.07 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.215 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 10.3 Cg_endo -51.87 82.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.87 2.38 . . . . 0.0 112.176 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 75' ' ' PHE . 12.5 m-20 89.56 11.16 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.518 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.49 93.73 2.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.263 . . . . 0.0 110.733 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 13.0 t-160 -89.72 98.98 12.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.579 HD11 HD13 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -104.27 111.91 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.532 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -103.79 118.68 37.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.686 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.579 HD13 HD11 ' A' ' 80' ' ' ILE . 1.4 tp -116.47 113.91 23.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.915 0.388 . . . . 0.0 111.722 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.532 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.8 m0 -110.31 122.55 47.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.398 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.736 ' CE1' HG11 ' A' ' 122' ' ' VAL . 1.6 m-85 -108.09 113.06 25.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.134 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.814 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.4 m95 -94.67 148.6 22.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.801 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.531 ' C ' HD13 ' A' ' 86' ' ' LEU . 3.0 tm? -99.1 102.86 14.7 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.334 0.588 . . . . 0.0 111.355 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.843 HG13 ' CB ' ' A' ' 64' ' ' HIS . 14.6 t -84.18 146.03 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.097 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -113.63 -24.97 8.93 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.511 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -162.68 162.83 27.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.63 0.65 . . . . 0.0 111.777 -178.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.712 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -155.2 141.81 18.84 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.3 178.64 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.2 mt-10 -77.88 136.2 38.01 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-O 120.793 0.33 . . . . 0.0 111.383 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.94 -108.44 0.2 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.695 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 23.5 tt0 -131.25 135.78 27.68 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.473 0.178 . . . . 0.0 110.826 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.801 ' HB3' HG13 ' A' ' 58' ' ' VAL . 2.8 Cg_exo -76.04 128.85 10.97 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.801 2.334 . . . . 0.0 111.197 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.573 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 14.6 p-90 -114.15 -64.91 1.24 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.65 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.31 -103.43 0.03 OUTLIER Glycine 0 CA--C 1.52 0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.251 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 tptp 174.08 40.19 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.697 0.284 . . . . 0.0 111.261 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.44 ' HA ' ' CG ' ' A' ' 57' ' ' GLU . 21.7 pt-20 -61.86 -47.06 86.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.868 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 160.86 -120.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.101 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -75.82 123.88 88.43 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.17 0.509 . . . . 0.0 111.788 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -43.7 146.32 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.257 2.638 . . . . 0.0 112.701 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.88 177.38 18.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.989 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -126.9 157.26 39.87 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CG ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -68.47 106.11 2.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.881 0.372 . . . . 0.0 110.252 -179.703 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 18' ' ' ILE . 6.6 ptm -120.58 163.3 18.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.015 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.776 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -78.21 114.94 17.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.825 0.345 . . . . 0.0 110.549 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -61.84 -18.84 61.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.238 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.6 p -61.92 -9.3 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.563 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.25 49.18 0.94 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.96 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 126' ' ' LEU . 7.4 tp -62.15 150.2 39.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -118.44 121.27 39.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.383 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.63 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.49 -21.65 61.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.269 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.7 -43.77 25.15 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.318 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.582 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.59 -37.52 85.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.402 . . . . 0.0 110.783 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.63 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.22 172.95 6.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.205 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.27 127.82 27.43 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.012 1.808 . . . . 0.0 112.036 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.15 -39.0 8.3 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.666 2.244 . . . . 0.0 112.871 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.57 -9.8 51.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.933 0.397 . . . . 0.0 111.524 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.48 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 26.0 m-20 -104.95 20.47 18.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.741 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -62.03 -31.74 8.45 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 79.8 Cg_exo -44.29 -43.89 13.17 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.771 1.647 . . . . 0.0 113.61 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.736 HG11 ' CE1' ' A' ' 84' ' ' PHE . 95.7 t -77.75 -51.52 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.775 0.321 . . . . 0.0 111.563 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.561 HG13 ' CE2' ' A' ' 115' ' ' PHE . 37.4 mm -64.74 -29.98 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.484 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.56 -32.14 66.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.985 0.421 . . . . 0.0 110.437 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -80.11 -45.58 17.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.323 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.819 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.3 tm? -78.26 -19.79 52.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.603 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 123' ' ' ILE . 6.2 ttpm? -79.14 -42.64 25.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 0.0 110.681 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -67.75 -7.85 30.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.962 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.743 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 120.844 0.354 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.9 OUTLIER -140.1 133.91 30.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -146.12 124.66 12.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.573 ' O ' HD13 ' A' ' 6' ' ' ILE . 48.8 mt-30 -102.66 147.9 26.24 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.273 0.559 . . . . 0.0 111.565 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 5' ' ' GLN . 33.7 mm -146.4 124.83 4.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.687 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.026 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.82 125.19 43.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m -133.51 162.2 40.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.062 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.53 126.15 2.83 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.117 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.061 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.81 108.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.374 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.719 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.03 123.73 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.038 0.447 . . . . 0.0 111.151 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.43 124.02 34.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.653 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.463 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 13.9 t30 -81.61 -172.16 3.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.051 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.83 2.94 24.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.507 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -140.19 52.34 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.346 . . . . 0.0 111.441 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.6 p30 45.96 24.35 0.23 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.397 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 16.8 pt-20 -114.68 142.58 46.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.061 HG21 HG22 ' A' ' 10' ' ' ILE . 7.3 mt -115.58 136.79 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.141 0.496 . . . . 0.0 111.623 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -83.84 111.14 18.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.593 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 105' ' ' MET . 0.2 OUTLIER -115.97 149.1 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.212 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.719 ' O ' HD12 ' A' ' 33' ' ' LEU . 13.9 p -70.84 132.4 45.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.54 ' CG ' HD13 ' A' ' 33' ' ' LEU . 30.1 ttt180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.968 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.742 0.306 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.28 25.94 11.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.103 0.478 . . . . 0.0 111.338 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 21' ' ' THR . 28.6 tp -62.77 84.38 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.769 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -126.13 -165.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.153 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.709 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -118.86 168.31 10.01 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.334 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.566 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 84.8 Cg_endo -79.4 167.37 21.29 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.416 2.744 . . . . 0.0 113.025 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.86 -5.65 50.88 Favored Glycine 0 C--O 1.224 -0.489 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.462 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -63.09 152.44 46.7 Favored Glycine 0 C--N 1.318 -0.436 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.585 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 91.76 3.53 0.1 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 122.827 0.451 . . . . 0.0 112.151 179.579 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.026 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.3 pt -52.46 -27.32 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.444 0.64 . . . . 0.0 110.379 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.528 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.78 -64.01 0.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.832 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.483 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 17.94 -83.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.448 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 178.68 35.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.867 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -92.17 -170.68 2.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.654 0.264 . . . . 0.0 111.076 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.824 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.67 153.08 38.42 Favored Pre-proline 0 N--CA 1.456 -0.131 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.824 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.74 -24.9 0.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.786 2.324 . . . . 0.0 112.454 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 51' ' ' VAL . 24.1 mt-10 -102.49 -43.86 5.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.5 -4.83 55.35 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.995 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.91 -57.3 12.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.706 0.289 . . . . 0.0 110.738 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.843 HG11 ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER -78.78 -46.22 24.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.267 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 37.6 t -55.71 -40.53 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.14 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -78.11 -51.76 9.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 1.4 mm-40 -68.54 -20.87 64.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.937 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 4.5 tp -51.18 -44.78 61.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -32.95 69.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.457 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -77.35 -29.84 53.58 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.941 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 6.0 mp0 -104.9 5.54 32.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.574 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 1.6 t -134.38 -44.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.12 0.486 . . . . 0.0 110.005 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.34 -39.98 0.28 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.336 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -77.92 -174.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.088 0.471 . . . . 0.0 111.896 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.54 87.79 26.9 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.639 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.545 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 11.7 Cg_endo -112.06 146.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 123.733 2.955 . . . . 0.0 113.968 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -74.88 79.72 2.13 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.832 ' HB2' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.01 130.14 53.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.227 -176.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 86' ' ' LEU . 6.1 t80 178.52 160.88 0.62 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 88.62 -165.64 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.209 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.778 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.5 pp -152.37 131.76 12.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.27 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.743 ' CE2' HD11 ' A' ' 10' ' ' ILE . 2.1 p90 -76.75 -41.81 43.44 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.773 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 13.0 mt-10 -171.12 131.46 0.79 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.583 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 132.06 55.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.754 0.312 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 122' ' ' VAL . 1.3 tp -110.66 139.14 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.99 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -138.42 109.6 6.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.504 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.705 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.1 p90 -141.52 137.25 31.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 2.3 pt-20 -121.17 132.07 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.202 0.525 . . . . 0.0 111.194 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 1.1 m-85 -83.21 163.9 48.3 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.2 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.443 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -38.68 -28.62 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.626 2.884 . . . . 0.0 113.261 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -139.77 -38.04 0.48 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.163 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 25.0 ttp180 -86.32 102.78 14.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.421 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.415 ' ND1' ' HB3' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -92.67 99.91 12.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.286 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 82' ' ' LEU . 3.7 tt -101.23 147.95 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.066 0.46 . . . . 0.0 111.088 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.406 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -134.19 118.48 17.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.63 178.915 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.754 HD13 HD11 ' A' ' 80' ' ' ILE . 1.2 mp -114.58 113.51 24.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 111.31 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.0 m0 -110.97 122.45 47.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.734 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.887 ' CE2' HG11 ' A' ' 122' ' ' VAL . 2.7 m-85 -113.19 112.72 24.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.037 0.446 . . . . 0.0 110.858 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.843 ' NE1' HG11 ' A' ' 50' ' ' VAL . 25.5 m95 -95.58 148.49 22.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.648 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 65' ' ' PHE . 35.5 tp -90.23 138.84 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.745 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.832 HG13 ' HB2' ' A' ' 64' ' ' HIS . 17.9 t -123.23 144.67 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.711 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.11 -27.78 8.24 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.07 160.08 24.0 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.875 -178.938 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.719 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -152.92 123.24 7.13 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.962 178.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.86 150.11 32.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.324 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.59 -144.37 30.12 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.77 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.481 ' O ' HG21 ' A' ' 60' ' ' ILE . 44.7 tt0 -105.59 134.92 19.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.3 Cg_exo -76.12 128.8 10.86 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.686 2.257 . . . . 0.0 111.61 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.528 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 34.2 p-90 -124.91 -61.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.735 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 48.74 -110.53 0.73 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.88 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.29 50.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 111.075 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -35.53 64.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.498 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.26 -5.55 45.4 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.348 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -140.12 96.02 8.24 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.981 0.419 . . . . 0.0 111.445 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -43.6 144.0 2.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.913 2.408 . . . . 0.0 112.35 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.1 177.13 19.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.124 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -139.26 157.44 45.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.03 106.41 0.5 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.065 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.598 ' HB2' HD11 ' A' ' 20' ' ' ILE . 2.4 mtp -120.11 163.47 17.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.252 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.535 ' HB2' HG12 ' A' ' 108' ' ' VAL . 81.7 p -90.79 114.8 27.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.559 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -67.03 -18.53 65.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.207 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.626 HG23 HD21 ' A' ' 129' ' ' LEU . 11.9 p -53.67 -16.36 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.77 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.71 55.0 0.68 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.93 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 107' ' ' LEU . 11.1 tp -62.07 150.49 38.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.878 0.371 . . . . 0.0 110.889 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.582 ' HB3' HD23 ' A' ' 33' ' ' LEU . 1.1 t-20 -98.31 95.75 7.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.462 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.6 -21.55 61.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.084 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -79.05 -44.67 21.71 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.199 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -41.2 88.37 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.227 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.553 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.45 174.29 6.27 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.6 Cg_endo -54.05 127.82 27.26 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 121.742 1.628 . . . . 0.0 112.255 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.5 -38.97 10.18 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.759 2.306 . . . . 0.0 112.575 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.73 -9.59 55.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.023 0.44 . . . . 0.0 111.344 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -103.15 16.19 27.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -68.28 -32.67 4.08 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 91.2 Cg_exo -44.44 -33.54 6.53 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 121.778 1.652 . . . . 0.0 112.718 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.887 HG11 ' CE2' ' A' ' 84' ' ' PHE . 12.9 t -77.8 -51.51 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.003 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.882 HG22 ' HB2' ' A' ' 127' ' ' LYS . 17.3 mm -68.16 -33.61 61.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.67 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.67 -27.35 39.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.874 0.369 . . . . 0.0 110.775 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -80.54 -53.19 6.79 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.885 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.618 HD13 ' CD1' ' A' ' 68' ' ' PHE . 2.4 tp -78.23 -33.52 49.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.76 0.314 . . . . 0.0 111.628 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.882 ' HB2' HG22 ' A' ' 123' ' ' ILE . 28.3 ttpp -54.05 -42.64 69.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.026 0.441 . . . . 0.0 110.963 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -66.3 -10.09 39.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.626 HD21 HG23 ' A' ' 108' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.94 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.969 0.414 . . . . 0.0 110.963 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 138.67 38.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.368 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.563 HD11 HG13 ' A' ' 80' ' ' ILE . 3.7 pp -146.24 138.02 24.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 0.0 111.713 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.455 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 29.2 mt-30 -104.11 152.83 21.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.987 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.619 HD12 HD11 ' A' ' 80' ' ' ILE . 47.8 mt -146.35 119.53 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.274 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.047 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.86 125.68 44.36 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.677 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.8 m -132.79 162.45 39.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.478 0.656 . . . . 0.0 111.945 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.462 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -149.36 118.66 0.97 Allowed Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.92 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.063 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.27 109.76 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.716 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -70.6 119.14 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.062 0.458 . . . . 0.0 111.61 -178.478 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.706 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.65 118.57 23.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.75 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.492 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 54.5 t30 -78.21 -172.46 2.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.589 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 10.9 tt0 -83.44 4.86 25.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.368 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -140.58 52.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 111.444 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.3 p30 46.26 23.23 0.19 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.683 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.684 ' C ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -116.42 146.89 42.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.581 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.063 HG21 HG22 ' A' ' 10' ' ' ILE . 1.5 mp -112.49 144.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.298 0.571 . . . . 0.0 112.299 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.6 OUTLIER -88.37 114.24 24.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.127 179.199 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.862 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -118.71 137.7 51.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 100' ' ' GLN . 6.3 p -70.84 123.01 20.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 111.033 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HB3' HD13 ' A' ' 33' ' ' LEU . 5.0 ptt85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.695 0.283 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.25 26.14 10.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.018 0.437 . . . . 0.0 111.316 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 111' ' ' ASN . 27.2 tp -73.55 64.67 0.89 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.103 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.862 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -114.99 -173.09 2.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.789 0.328 . . . . 0.0 111.213 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.688 ' CD1' HG23 ' A' ' 10' ' ' ILE . 53.8 m-85 -90.42 159.95 40.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.677 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 97.8 Cg_endo -84.02 167.13 12.71 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.809 3.006 . . . . 0.0 111.852 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.757 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.12 -5.12 52.6 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.716 -0.754 . . . . 0.0 114.136 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.62 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -64.18 129.82 37.93 Favored Glycine 0 C--N 1.316 -0.582 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.848 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 108.97 2.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.1 0.56 . . . . 0.0 111.848 179.514 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.047 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.7 pt -49.05 -29.66 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.518 0.675 . . . . 0.0 110.747 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.597 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -38.16 -77.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.952 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.2 mmt 33.8 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.623 0.577 . . . . 0.0 111.885 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.0 32.93 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.663 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.479 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -89.09 -172.9 3.84 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.731 0.301 . . . . 0.0 111.132 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.833 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.64 154.04 37.66 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.288 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.833 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.76 -24.99 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.803 2.335 . . . . 0.0 112.491 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.47 -43.59 5.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.55 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 52.8 mm-40 -80.46 -4.84 55.33 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 1.039 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.15 -55.47 31.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.682 0.277 . . . . 0.0 111.035 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.713 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -78.52 -45.65 25.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.968 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.461 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 39.4 t -60.13 -44.89 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.003 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 9.2 tpp180 -78.07 -37.14 47.31 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.393 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.445 ' CG ' ' OE2' ' A' ' 57' ' ' GLU . 6.2 tp10 -78.04 -23.54 48.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.716 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.068 HD21 ' CE1' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -51.67 -44.42 63.07 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 120.982 0.42 . . . . 0.0 109.988 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -28.85 62.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.468 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -77.24 -30.67 54.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.314 179.447 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.448 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 16.3 mp0 -108.22 5.85 26.13 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.581 HG11 ' HG3' ' A' ' 62' ' ' PRO . 4.0 t -134.07 -44.88 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.024 0.44 . . . . 0.0 110.101 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.607 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.11 -38.32 0.15 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.56 -0.745 . . . . 0.0 114.577 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.747 HG23 ' CD1' ' A' ' 95' ' ' TRP . 21.3 pt -77.79 -176.03 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.99 0.424 . . . . 0.0 111.575 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.25 88.28 17.98 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.348 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.67 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.8 Cg_endo -112.44 146.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.568 2.845 . . . . 0.0 113.9 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 13.1 mt-30 -74.82 80.2 2.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 175.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 1.068 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -121.36 136.78 54.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.578 -175.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.0 t80 178.71 -135.52 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.199 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 55.94 166.49 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.147 0.498 . . . . 0.0 111.809 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.7 tt -129.14 114.95 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.683 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -76.53 -52.91 8.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.8 tt0 -171.91 153.03 3.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.927 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.564 ' CD ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.55 129.28 19.31 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.896 HD11 HG22 ' A' ' 122' ' ' VAL . 1.1 pp -130.91 159.13 38.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.014 0.435 . . . . 0.0 111.235 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.752 ' HG3' HG22 ' A' ' 81' ' ' THR . 1.8 mp0 -133.6 120.17 20.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.042 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.435 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 1.7 p90 -141.17 147.59 38.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.595 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.13 112.32 18.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 111.34 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.4 m-85 -69.96 162.86 65.74 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.355 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.7 Cg_endo -50.3 81.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.058 2.505 . . . . 0.0 112.342 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 75' ' ' PHE . 7.0 m-20 91.15 13.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.814 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 75' ' ' PHE . 21.3 ttp180 -137.45 102.01 4.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.613 0.244 . . . . 0.0 110.935 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -86.98 113.06 22.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.619 HD11 HD12 ' A' ' 6' ' ' ILE . 2.3 tt -120.22 118.83 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.091 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.752 HG22 ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -97.58 118.77 34.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.856 ' HG ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -113.83 114.61 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.719 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.413 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 8.8 m0 -113.35 122.38 47.21 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.965 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.1 m-30 -106.89 133.22 51.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.034 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.713 ' CE2' HG11 ' A' ' 50' ' ' VAL . 16.9 m95 -118.65 149.14 41.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.445 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 66' ' ' SER . 0.0 OUTLIER -102.07 103.79 14.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.48 0.657 . . . . 0.0 112.306 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.83 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.3 t -79.77 146.26 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.995 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -114.34 -23.99 9.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -162.43 161.01 27.05 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.623 0.647 . . . . 0.0 111.371 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.716 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -157.07 125.98 5.86 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.404 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -74.5 140.31 44.44 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.242 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.77 -130.03 47.94 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.763 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.694 ' O ' HG21 ' A' ' 60' ' ' ILE . 4.9 tt0 -121.01 137.4 26.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 93' ' ' GLU . 2.8 Cg_exo -76.18 128.9 10.89 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.702 2.268 . . . . 0.0 111.562 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.747 ' CD1' HG23 ' A' ' 60' ' ' ILE . 50.0 p-90 -119.5 -60.04 1.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.975 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.573 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.0 -103.93 0.06 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.973 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 172.28 37.36 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.097 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.416 ' HB2' HG21 ' A' ' 21' ' ' THR . 1.3 mp0 -59.25 -48.98 79.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.762 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.86 -76.9 0.14 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.83 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.43 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -118.79 124.14 28.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.071 0.462 . . . . 0.0 111.318 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -43.29 145.95 1.28 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.994 2.463 . . . . 0.0 112.647 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.39 177.36 16.8 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.926 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -125.14 157.23 36.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -69.18 106.51 2.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.867 0.365 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.408 ' SD ' HD11 ' A' ' 33' ' ' LEU . 2.0 ptp -120.19 163.24 18.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.106 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.7 p -81.64 114.94 20.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.472 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.607 ' HG ' HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -68.05 -18.69 64.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.456 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.01 -19.26 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.513 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.51 55.5 0.57 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.227 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.707 HD22 ' CD1' ' A' ' 123' ' ' ILE . 2.0 tt -62.37 151.02 38.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.908 0.385 . . . . 0.0 110.967 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.587 ' HB3' HD23 ' A' ' 33' ' ' LEU . 1.6 t-20 -92.44 92.87 8.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.048 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.516 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -71.36 -18.89 62.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.153 0.501 . . . . 0.0 110.142 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.89 -44.39 22.87 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.513 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.84 -41.36 87.56 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.816 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.615 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.78 170.06 17.89 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 34' ' ' GLU . 9.3 Cg_endo -54.14 127.63 26.53 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.131 1.887 . . . . 0.0 112.791 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.13 -34.85 15.71 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.73 2.287 . . . . 0.0 111.995 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.33 -9.96 57.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.877 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -109.53 14.09 23.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.615 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -76.1 -30.99 0.94 Allowed Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 65.7 Cg_exo -43.61 -39.99 10.31 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.062 1.841 . . . . 0.0 113.831 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.896 HG22 HD11 ' A' ' 71' ' ' LEU . 1.5 t -77.91 -51.58 17.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.99 0.424 . . . . 0.0 111.598 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.707 ' CD1' HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.13 -29.45 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.623 -179.059 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.45 -31.34 55.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.009 0.433 . . . . 0.0 110.086 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -66.74 -47.02 73.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.155 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.848 ' O ' HD13 ' A' ' 126' ' ' LEU . 2.3 tm? -78.49 -20.03 51.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.032 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.425 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 23.0 tttm -74.48 -42.53 58.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.095 0.474 . . . . 0.0 110.445 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -64.65 -11.03 31.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.904 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.744 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.104 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.58 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.82 0.343 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.05 133.95 30.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.4 pp -146.15 121.95 10.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.401 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 32.6 mt-30 -102.89 151.32 22.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.241 0.543 . . . . 0.0 112.059 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.527 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.2 mp -146.48 128.93 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.279 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.108 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.13 125.58 43.96 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -137.13 162.16 34.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.381 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.462 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.04 127.86 2.45 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.045 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.714 HG22 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -70.76 110.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.714 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -70.93 119.72 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.891 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.92 121.01 26.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.744 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 58.3 t30 -81.31 -172.56 3.86 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.52 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.506 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 22.2 tt0 -81.98 3.65 25.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.398 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -139.74 51.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 111.385 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.34 24.58 0.3 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.195 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 17.0 pt-20 -116.96 144.52 44.46 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.714 HG21 HG22 ' A' ' 10' ' ' ILE . 5.6 mt -116.03 145.18 22.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.172 0.511 . . . . 0.0 111.841 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.459 ' CD2' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -89.83 111.08 21.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.367 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.49 142.86 24.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.182 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.49 HG22 ' OE2' ' A' ' 98' ' ' GLU . 1.4 p -70.84 114.42 8.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 6.0 ttt85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.522 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.695 0.283 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.1 25.98 10.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 111.403 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.543 HD13 ' CB ' ' A' ' 111' ' ' ASN . 1.2 tt -67.48 76.05 0.17 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.792 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.88 -169.0 1.65 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.933 0.397 . . . . 0.0 111.464 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.678 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.28 168.46 9.93 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.461 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.559 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 74.0 Cg_endo -77.72 167.06 24.58 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.372 2.714 . . . . 0.0 112.953 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.11 -5.45 52.94 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.71 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.44 145.28 48.76 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.302 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 89.62 9.91 0.08 Allowed 'General case' 0 C--N 1.342 0.257 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.108 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -57.84 -27.27 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.567 0.699 . . . . 0.0 110.051 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.506 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.04 -77.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.416 -1.266 . . . . 0.0 111.31 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 36.05 -87.85 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.938 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.07 33.58 0.07 OUTLIER Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.989 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.474 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -92.47 -166.23 1.5 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.54 0.21 . . . . 0.0 110.897 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.856 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.89 154.35 37.41 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.856 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.93 -24.81 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.704 2.269 . . . . 0.0 112.362 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.613 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -98.34 -49.83 4.54 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.511 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -80.71 -8.89 59.8 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.774 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -61.62 -57.24 12.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.843 0.354 . . . . 0.0 110.484 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.613 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 1.2 p -78.61 -46.61 24.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.716 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 47' ' ' GLU . 55.3 t -50.69 -38.81 17.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.754 0.312 . . . . 0.0 111.387 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -78.89 -52.2 8.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.799 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -69.59 -19.8 63.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.19 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.873 ' O ' HG23 ' A' ' 58' ' ' VAL . 23.0 tp -58.74 -45.81 88.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.521 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -66.46 -26.69 67.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.004 0.43 . . . . 0.0 110.095 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.63 -24.57 67.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.602 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.508 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.54 5.64 25.3 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.915 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.036 HG12 HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -133.49 -44.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 68.85 -35.24 0.28 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.036 HD11 HG12 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -77.95 -172.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.893 0.377 . . . . 0.0 110.909 -179.546 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.02 88.82 12.65 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.412 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.675 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.3 Cg_endo -108.36 149.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 123.28 2.653 . . . . 0.0 113.787 -177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.552 ' HG2' ' HB3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.88 81.16 4.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 175.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.82 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.61 134.98 51.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.087 -175.449 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.506 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.6 t80 179.83 -142.83 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.657 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t 50.82 175.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.975 0.51 . . . . 0.0 111.95 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.843 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -141.88 124.9 16.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.02 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.97 -51.14 11.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.985 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 mt-10 -171.73 131.64 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.35 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.26 119.46 39.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.791 0.329 . . . . 0.0 110.64 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.691 ' CB ' HG22 ' A' ' 122' ' ' VAL . 0.5 OUTLIER -99.64 123.67 44.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.863 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -122.52 109.56 14.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.793 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.548 ' OH ' HD13 ' A' ' 80' ' ' ILE . 1.8 p90 -141.43 137.59 32.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.486 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -121.24 125.21 46.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.156 0.503 . . . . 0.0 111.462 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 2.6 m-85 -71.92 163.4 67.06 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.895 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.471 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.8 Cg_endo -39.28 -27.76 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.434 2.756 . . . . 0.0 112.97 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -139.78 -37.08 0.49 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.209 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 33.2 ttp180 -85.91 103.42 14.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.489 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -91.15 100.27 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 110.425 179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.548 HD13 ' OH ' ' A' ' 73' ' ' TYR . 6.2 tt -101.88 146.2 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.091 0.472 . . . . 0.0 111.252 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.523 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -134.15 118.74 18.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.696 179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.527 HD23 ' HB ' ' A' ' 6' ' ' ILE . 13.5 mt -121.17 114.2 21.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.992 0.425 . . . . 0.0 111.763 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.523 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.7 m0 -109.44 122.06 46.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.774 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' A' ' 122' ' ' VAL . 7.7 m-30 -107.21 114.72 28.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.843 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 23.8 m95 -94.35 148.24 22.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.044 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 86' ' ' LEU . 3.5 tm? -98.48 102.91 14.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.454 0.645 . . . . 0.0 111.463 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.82 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.3 t -82.36 145.74 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.03 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -114.79 -23.56 9.11 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.552 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 8.6 ttt180 -162.59 164.54 26.68 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.507 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.714 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -157.14 124.42 5.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.248 178.631 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -75.19 146.25 41.4 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.116 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.65 -130.44 48.32 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.574 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 60' ' ' ILE . 44.3 mt-10 -121.52 141.43 33.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -75.63 131.52 13.67 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.827 2.351 . . . . 0.0 111.143 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 41.0 p-90 -133.49 -65.76 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.58 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.23 -96.8 0.01 OUTLIER Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.876 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER 173.36 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.645 0.26 . . . . 0.0 111.341 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.49 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -56.06 -43.99 78.46 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.804 0.335 . . . . 0.0 110.866 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.49 -82.88 0.25 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.717 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 111.54 48.7 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.917 0.389 . . . . 0.0 111.389 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -43.42 146.21 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.003 2.469 . . . . 0.0 112.625 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.21 177.19 16.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.808 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -139.21 157.28 46.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -60.33 106.57 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.92 0.39 . . . . 0.0 110.086 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.3 mtm -120.09 163.37 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.159 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.97 114.87 23.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.409 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -69.62 -18.71 63.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.529 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.42 -14.82 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.673 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.98 53.52 0.7 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.154 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.437 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 4.7 tt -62.4 150.59 39.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.008 0.432 . . . . 0.0 110.948 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.543 ' CB ' HD13 ' A' ' 33' ' ' LEU . 1.1 t-20 -95.35 93.47 7.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.439 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 123' ' ' ILE . . . -72.29 -20.71 61.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.014 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -45.22 20.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.128 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.79 -39.98 87.96 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.369 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.564 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.44 173.99 6.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.08 127.8 27.19 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.918 1.745 . . . . 0.0 112.607 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 52.1 Cg_endo -69.15 -35.16 15.0 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.752 2.301 . . . . 0.0 112.353 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.9 -9.63 58.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.074 0.464 . . . . 0.0 111.168 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -105.76 17.62 23.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.949 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.0 -31.05 0.96 Allowed Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 80.0 Cg_exo -43.55 -34.28 5.13 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.877 1.718 . . . . 0.0 113.064 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.691 HG22 ' CB ' ' A' ' 71' ' ' LEU . 16.0 t -77.96 -47.28 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.275 0.56 . . . . 0.0 110.253 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.678 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 35.6 mm -68.9 -31.28 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.413 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.05 -26.88 40.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.936 0.398 . . . . 0.0 110.344 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -47.71 14.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.345 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.575 ' O ' HD13 ' A' ' 126' ' ' LEU . 2.4 tm? -78.18 -45.95 21.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 111.329 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.589 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.8 tttm -52.68 -42.27 64.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.127 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -63.93 -8.07 10.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.971 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.337 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LYS . . . . . 0.527 ' HE3' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.849 0.357 . . . . 0.0 110.93 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.05 132.04 27.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.527 HD23 ' HE3' ' A' ' 2' ' ' LYS . 3.1 pp -146.14 127.14 14.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.376 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.406 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 14.9 mt-30 -102.65 154.48 19.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.062 0.458 . . . . 0.0 111.46 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.601 ' HB ' HD12 ' A' ' 82' ' ' LEU . 1.8 mp -146.42 119.12 2.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.835 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.04 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.93 125.69 44.33 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.1 m -134.76 162.44 38.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.312 0.577 . . . . 0.0 112.041 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.7 111.12 0.9 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.277 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -70.47 103.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.689 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.41 125.76 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.23 -178.361 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -100.47 139.32 36.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.123 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.669 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.9 p-10 -98.74 -173.37 2.51 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.523 0.678 . . . . 0.0 112.234 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.49 -3.96 13.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.869 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.473 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 58.1 t30 -120.11 37.54 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.97 15.94 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 0.0 111.579 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 15' ' ' ASN . 1.2 mm-40 -102.02 161.2 13.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.838 HG12 HG22 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.47 131.26 73.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.164 0.506 . . . . 0.0 111.801 -178.64 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -83.09 116.51 22.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.717 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.671 HD12 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.27 147.22 33.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.556 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 29.2 p -70.78 111.91 6.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.263 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.841 -179.658 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.5 t-20 . . . . . 0 CA--C 1.529 0.173 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.37 26.09 10.53 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 111.777 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.671 HD21 HD12 ' A' ' 20' ' ' ILE . 2.6 tt -67.19 66.17 0.07 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.044 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -106.86 -170.17 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.223 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.665 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.21 168.33 10.15 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.541 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.567 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 97.0 Cg_endo -84.12 166.55 12.74 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.433 2.755 . . . . 0.0 113.001 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.572 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.01 -6.08 53.75 Favored Glycine 0 C--O 1.225 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 114.096 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.79 167.45 15.45 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.509 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.67 1.5 1.21 Allowed 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.448 0.299 . . . . 0.0 111.795 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.04 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -52.8 -27.06 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.495 0.665 . . . . 0.0 110.433 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.55 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -40.21 -61.44 0.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.025 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.509 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 11.07 -81.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.907 0.754 . . . . 0.0 112.467 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.0 32.33 0.09 OUTLIER Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.862 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.1 mp0 -93.48 -172.94 3.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.653 0.263 . . . . 0.0 111.191 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.853 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -101.59 153.64 37.76 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.323 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.853 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.98 -24.82 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.809 2.339 . . . . 0.0 112.615 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.622 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -100.93 -43.68 5.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -80.09 -20.84 44.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.714 0.292 . . . . 0.0 111.644 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.835 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.38 -48.48 76.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.814 0.34 . . . . 0.0 111.036 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.798 HG12 ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.29 -47.87 23.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.3 t -59.66 -44.11 92.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.59 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 17.9 mtp-105 -73.25 -41.15 64.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 110.821 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 57' ' ' GLU . 4.6 tp10 -73.5 -19.73 60.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.819 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.644 HD21 ' CE1' ' A' ' 64' ' ' HIS . 5.9 tp -60.04 -44.65 94.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.733 0.301 . . . . 0.0 110.962 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.69 -36.19 82.92 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.38 -24.66 50.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.911 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 12.0 mm-40 -108.26 5.75 25.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.649 -0.421 . . . . 0.0 112.03 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.886 HG12 HG13 ' A' ' 60' ' ' ILE . 60.1 t -134.16 -44.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.48 -40.04 0.28 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.091 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.886 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.74 -177.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.132 0.492 . . . . 0.0 111.217 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.82 88.71 14.57 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.914 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.703 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.1 Cg_endo -111.49 145.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.415 2.744 . . . . 0.0 114.207 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.6 mt-30 -74.92 79.93 2.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.752 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.34 129.56 53.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.389 -176.501 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 66' ' ' SER . 2.0 t80 179.91 166.02 1.21 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.709 ' HB3' HD21 ' A' ' 86' ' ' LEU . 50.9 m 82.92 152.18 0.1 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.407 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.3 pp -107.66 134.68 50.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 111.973 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.684 ' CE2' HD12 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -81.94 -44.89 16.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.973 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -171.93 131.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.098 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.614 ' HE2' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -135.79 103.88 5.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.691 0.281 . . . . 0.0 110.733 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -111.66 169.37 8.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.104 0.478 . . . . 0.0 111.467 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.772 ' N ' HD22 ' A' ' 71' ' ' LEU . 8.2 tt0 -137.84 124.89 21.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.674 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.1 p90 -138.11 120.06 15.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.796 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -94.7 139.35 31.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 111.423 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.488 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 2.2 m-85 -103.94 162.47 19.82 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.218 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.9 Cg_endo -54.18 82.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.95 2.433 . . . . 0.0 112.117 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.7 t70 94.84 7.07 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.543 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -137.26 93.72 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 110.592 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 11.5 t-160 -85.69 99.36 11.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.762 0.315 . . . . 0.0 110.871 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.674 HD13 ' OH ' ' A' ' 73' ' ' TYR . 4.2 tt -103.04 135.5 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 118.78 31.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.356 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.66 HD13 HD11 ' A' ' 80' ' ' ILE . 1.1 mp -113.08 114.06 26.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.897 0.379 . . . . 0.0 111.727 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 9.7 m0 -111.6 122.04 46.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.743 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.654 ' CE1' HG11 ' A' ' 122' ' ' VAL . 1.7 m-85 -109.68 109.94 20.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.469 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.843 ' O ' HD12 ' A' ' 10' ' ' ILE . 19.8 m95 -95.91 148.79 22.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.76 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 66' ' ' SER . 1.4 pp -95.69 138.77 32.89 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.162 0.506 . . . . 0.0 111.709 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.752 HG13 ' CB ' ' A' ' 64' ' ' HIS . 38.4 t -123.33 145.66 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.368 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -113.82 -21.63 10.58 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.92 160.16 24.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.707 0.685 . . . . 0.0 111.473 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.689 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.06 122.61 4.69 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.254 179.022 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -75.82 150.69 37.64 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.138 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.48 -129.92 47.21 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.526 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -125.21 145.8 51.86 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.507 0.194 . . . . 0.0 110.653 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.461 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.48 128.74 10.53 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.761 2.307 . . . . 0.0 111.573 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.556 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -132.34 -59.91 0.91 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.838 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.634 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 36.77 -97.89 0.01 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.195 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tttp 178.43 38.8 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.7 0.285 . . . . 0.0 111.153 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.614 ' CD ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -60.51 -49.05 79.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.263 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 143.28 -49.83 0.71 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.262 -0.97 . . . . 0.0 113.345 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.77 118.98 16.86 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.124 0.488 . . . . 0.0 111.966 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -43.79 146.37 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.211 2.608 . . . . 0.0 112.807 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.97 177.23 17.45 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.092 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 105' ' ' MET . 1.6 mt-10 -137.43 157.79 45.82 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.306 0.242 . . . . 0.0 110.383 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -65.0 106.39 1.24 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.75 0.31 . . . . 0.0 110.259 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -120.0 157.14 29.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.796 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.439 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.4 p -75.63 114.93 14.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.666 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.86 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.5 tm? -75.38 -18.77 59.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.503 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.9 p -59.16 -12.58 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.737 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.79 54.3 0.62 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.367 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.598 HD22 HD12 ' A' ' 123' ' ' ILE . 9.2 tt -62.0 150.36 38.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.595 0.236 . . . . 0.0 110.554 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.59 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -108.19 115.88 30.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.581 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -18.9 61.73 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.012 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -79.09 -47.83 15.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.881 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.507 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -66.86 -17.39 64.87 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.645 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.45 173.67 3.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.17 127.92 27.78 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 121.938 1.759 . . . . 0.0 112.405 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.0 Cg_endo -69.04 -38.32 9.56 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.756 2.304 . . . . 0.0 112.664 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.94 -9.72 56.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.977 0.418 . . . . 0.0 111.308 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . 0.474 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 29.2 m-20 -104.42 15.3 28.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.922 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -63.32 -31.59 7.01 Favored Pre-proline 0 N--CA 1.467 0.381 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 71.3 Cg_exo -43.78 -40.38 11.13 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.793 1.662 . . . . 0.0 113.54 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.715 HG22 ' CD1' ' A' ' 71' ' ' LEU . 74.6 t -78.0 -51.55 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.379 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.665 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 38.7 mm -66.13 -31.88 55.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.595 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.86 -32.33 60.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.862 0.363 . . . . 0.0 110.676 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -80.44 -46.16 16.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.52 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 107' ' ' LEU . 0.4 OUTLIER -78.34 -19.77 52.78 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.399 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.566 ' HB2' HG22 ' A' ' 123' ' ' ILE . 22.2 tttm -74.31 -42.45 59.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.128 0.489 . . . . 0.0 110.593 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -68.29 -8.95 44.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.936 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.786 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.15 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.621 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.873 0.368 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.35 131.23 26.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.489 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.4 pp -146.15 140.55 26.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.908 0.385 . . . . 0.0 111.661 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.717 ' C ' HD12 ' A' ' 6' ' ' ILE . 30.9 mt-30 -104.67 152.86 21.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.213 0.53 . . . . 0.0 111.255 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.738 ' HB ' HD12 ' A' ' 82' ' ' LEU . 4.4 mp -146.18 116.36 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.51 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 1.012 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.33 133.07 52.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.3 m -144.61 162.73 14.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.013 0.435 . . . . 0.0 111.773 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -139.22 115.15 1.08 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.855 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.02 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -71.28 107.25 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.715 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.16 127.29 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.93 0.395 . . . . 0.0 111.132 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.08 123.45 33.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.622 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 12.3 t-20 -78.28 -172.16 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.117 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -82.18 -3.1 54.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.106 -1.406 . . . . 0.0 112.271 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -129.96 36.37 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.64 7.59 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.743 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 17.8 pt-20 -100.85 153.05 19.81 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.02 HG21 HG22 ' A' ' 10' ' ' ILE . 4.8 mt -115.89 140.56 37.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.17 0.509 . . . . 0.0 111.994 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' C ' ' CD1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -89.26 102.14 14.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.436 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -115.29 162.13 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.263 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.581 HG22 ' OE2' ' A' ' 98' ' ' GLU . 5.8 p -71.07 121.2 17.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.786 0.327 . . . . 0.0 110.759 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.807 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.574 0.226 . . . . 0.0 111.28 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.43 25.98 10.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 0.0 111.799 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 21' ' ' THR . 22.1 tp -76.36 78.79 3.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.272 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.52 -166.63 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.52 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.619 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.52 168.36 10.26 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.157 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.631 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 71.7 Cg_endo -77.5 166.9 25.19 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.238 2.625 . . . . 0.0 112.903 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.579 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.31 -5.58 52.46 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.71 -0.677 . . . . 0.0 114.242 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.51 156.44 42.64 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 117.176 0.488 . . . . 0.0 112.844 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.75 -1.06 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.034 0.534 . . . . 0.0 111.875 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 1.012 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -53.37 -26.01 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.375 0.607 . . . . 0.0 110.929 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.99 -62.85 0.75 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.913 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.495 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.2 mtm 12.24 -83.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.562 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.59 31.68 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.816 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.13 -169.4 2.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.671 0.272 . . . . 0.0 111.043 -179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.904 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -113.62 164.69 15.21 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.451 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.904 ' HD2' HG22 ' A' ' 45' ' ' THR . 6.7 Cg_endo -47.63 -24.62 4.71 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.017 2.478 . . . . 0.0 112.72 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -95.99 -55.24 3.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.016 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -80.55 -4.61 54.62 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.73 -58.02 8.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.811 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.812 HG11 ' NE1' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -79.5 -45.53 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.332 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.0 t -53.46 -39.75 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.724 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -78.13 -42.92 30.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.848 0.356 . . . . 0.0 111.231 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.3 mm-40 -74.22 -19.84 60.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.049 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.804 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -60.57 -44.83 95.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.48 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -35.81 78.28 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.76 -28.03 50.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.124 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 33.4 mm-40 -105.34 5.01 31.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 54' ' ' LEU . 4.1 t -134.87 -44.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.29 -38.94 0.21 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.049 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.643 HG23 ' CD1' ' A' ' 95' ' ' TRP . 22.8 pt -82.02 -176.18 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 120.985 0.422 . . . . 0.0 111.582 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.87 88.41 21.09 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.321 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HB3' ' HB2' ' A' ' 90' ' ' TRP . 12.3 Cg_endo -109.92 153.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.459 2.773 . . . . 0.0 113.833 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 89' ' ' ARG . 89.8 mt-30 -74.85 79.93 2.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.928 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -126.2 127.45 45.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.283 -176.944 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.9 t80 -177.86 158.85 1.32 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 78.01 -168.39 0.05 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.291 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.84 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -144.49 137.57 27.0 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.852 -179.477 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.886 ' CD1' HD23 ' A' ' 126' ' ' LEU . 2.5 p90 -76.75 -41.58 44.36 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . 5.5 mt-10 -171.76 131.45 0.69 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.696 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.49 120.81 42.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.0 111.201 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.734 HD22 ' CE2' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -104.68 122.22 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.026 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -130.68 113.64 14.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.971 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.734 ' CE2' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -141.24 153.38 45.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.378 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.1 pt-20 -121.17 127.06 51.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.343 0.592 . . . . 0.0 111.187 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 77' ' ' ASP . 1.0 OUTLIER -96.51 163.43 20.53 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.554 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.0 Cg_endo -53.18 81.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.032 2.488 . . . . 0.0 112.255 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.2 t70 93.4 8.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.532 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.44 93.86 2.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.633 0.254 . . . . 0.0 110.758 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.2 t-80 -93.27 95.7 9.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 111.103 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.641 ' HA ' HD12 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -100.35 111.99 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.132 179.835 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -97.26 118.1 32.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.738 HD12 ' HB ' ' A' ' 6' ' ' ILE . 1.7 mp -110.09 113.82 26.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.094 0.473 . . . . 0.0 111.179 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 8.5 m0 -112.5 122.27 47.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.324 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.927 ' CE2' HG11 ' A' ' 122' ' ' VAL . 3.2 m-85 -116.58 113.16 22.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.013 0.435 . . . . 0.0 110.591 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.84 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.8 m95 -94.58 148.3 22.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.566 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 86' ' ' LEU . 2.3 pp -93.97 138.25 32.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.928 HG22 ' ND1' ' A' ' 64' ' ' HIS . 48.8 t -123.26 145.33 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.546 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -109.51 -28.2 9.03 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.79 165.57 22.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.968 0.804 . . . . 0.0 111.789 -178.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.715 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -152.93 126.02 8.52 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.145 178.357 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -76.88 146.4 37.69 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.409 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.57 -126.64 32.24 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.811 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.606 ' O ' HG21 ' A' ' 60' ' ' ILE . 4.0 tt0 -124.4 126.59 25.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.427 0.156 . . . . 0.0 110.582 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.496 ' CA ' HD13 ' A' ' 60' ' ' ILE . 13.7 Cg_exo -72.09 128.62 14.14 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.754 2.303 . . . . 0.0 111.2 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.643 ' CD1' HG23 ' A' ' 60' ' ' ILE . 17.1 p-90 -114.78 -61.43 1.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.016 0.436 . . . . 0.0 111.415 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.82 -114.02 1.39 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.904 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.61 74.61 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.927 0.394 . . . . 0.0 110.857 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.581 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -96.44 -29.22 14.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.013 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.2 -103.06 0.45 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.115 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.86 115.53 47.21 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.0 111.612 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -43.66 146.12 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.986 2.457 . . . . 0.0 112.718 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.88 177.69 18.69 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.36 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -133.16 157.26 45.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.607 0.242 . . . . 0.0 110.652 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -63.56 106.72 0.99 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.417 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtm -119.83 163.05 18.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.666 ' HB2' HG12 ' A' ' 108' ' ' VAL . 7.7 p -81.2 114.92 20.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.817 HD11 HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -69.86 -18.66 63.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.208 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.6 p -56.45 -14.29 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.402 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.53 56.76 0.6 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.843 HD23 HD12 ' A' ' 123' ' ' ILE . 9.9 tp -61.73 150.25 37.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.854 0.359 . . . . 0.0 110.861 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 2.3 t-20 -97.22 106.9 19.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.531 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -24.16 61.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -79.17 -47.18 16.5 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.271 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.466 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.79 -14.21 62.37 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.869 -179.125 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.549 ' CZ ' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -113.64 173.43 2.87 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.46 127.86 27.72 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 121.837 1.691 . . . . 0.0 111.974 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.97 -38.89 8.85 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.681 2.254 . . . . 0.0 112.613 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.41 -9.6 54.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.945 0.402 . . . . 0.0 111.572 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -103.54 19.96 18.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.871 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.59 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -70.45 -32.03 2.49 Favored Pre-proline 0 N--CA 1.466 0.349 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.292 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.2 Cg_exo -44.31 -34.27 7.01 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 121.971 1.781 . . . . 0.0 112.899 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.927 HG11 ' CE2' ' A' ' 84' ' ' PHE . 24.5 t -77.59 -51.48 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.066 0.46 . . . . 0.0 110.977 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.873 HG22 ' HB2' ' A' ' 127' ' ' LYS . 12.9 mm -61.67 -38.98 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.885 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.56 -29.6 51.65 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.684 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -80.69 -52.22 7.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.631 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.886 HD23 ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -74.82 -43.06 56.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.405 -179.261 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.873 ' HB2' HG22 ' A' ' 123' ' ' ILE . 40.9 tttt -52.05 -42.61 63.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.128 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -64.49 -9.48 19.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.963 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.815 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.784 0.326 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.43 144.12 32.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.776 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.0 pp -146.07 137.72 24.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.075 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLN . . . . . 0.586 ' C ' HD12 ' A' ' 6' ' ' ILE . 14.6 mt-30 -106.2 152.86 22.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.229 0.537 . . . . 0.0 111.852 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.776 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.3 mp -146.75 129.79 8.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.866 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.916 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.04 125.18 43.43 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -144.52 162.03 14.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.91 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.03 143.06 10.11 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.741 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.983 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -92.7 111.57 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.926 HG23 HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -71.1 113.45 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-O 121.283 0.563 . . . . 0.0 110.64 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.19 126.9 32.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.422 -178.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.464 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 45.5 t30 -83.91 -172.51 4.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.951 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 16.8 tp10 -78.89 -4.78 51.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.317 -1.31 . . . . 0.0 112.603 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -127.91 44.47 2.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.787 0.327 . . . . 0.0 111.613 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.03 19.58 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.539 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 10.0 pt-20 -114.77 142.76 46.09 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.983 HG21 HG22 ' A' ' 10' ' ' ILE . 11.3 mt -109.92 144.1 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.298 0.571 . . . . 0.0 112.213 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.508 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 11.2 t80 -88.86 93.69 9.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.897 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.619 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -112.47 149.39 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.536 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 3.1 p -70.93 111.87 6.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.506 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 21.9 ptt-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.818 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.08 26.09 10.59 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.881 0.372 . . . . 0.0 111.55 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 111' ' ' ASN . 5.1 tt -61.64 79.26 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.647 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -123.43 -173.23 2.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.112 0.482 . . . . 0.0 111.973 -179.364 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.739 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.45 168.21 10.54 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.634 -179.08 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.553 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 68.7 Cg_endo -74.87 167.09 27.85 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.465 2.777 . . . . 0.0 113.043 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.784 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.85 -5.51 53.76 Favored Glycine 0 C--O 1.222 -0.656 0 CA-C-N 115.87 -0.605 . . . . 0.0 114.155 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -62.21 145.65 49.4 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.941 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 92.06 2.01 0.11 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.916 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -51.41 -28.86 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.572 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.59 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.55 -60.8 1.6 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.143 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.513 ' C ' ' O ' ' A' ' 41' ' ' GLU . 8.9 mmm 10.28 -81.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.848 0.718 . . . . 0.0 112.633 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.43 27.98 0.13 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.083 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -103.97 -173.45 2.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.695 0.283 . . . . 0.0 110.999 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.886 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -108.85 155.91 39.92 Favored Pre-proline 0 N--CA 1.456 -0.159 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.886 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.49 -24.5 0.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.674 2.249 . . . . 0.0 112.406 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.9 tt0 -86.83 -60.27 2.03 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -80.67 -21.62 41.2 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.733 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -56.81 -48.77 77.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.675 0.274 . . . . 0.0 110.97 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.558 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.35 -50.72 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.754 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 47' ' ' GLU . 49.9 t -51.14 -35.66 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.773 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -48.71 15.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.537 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.7 mm-40 -65.77 -19.77 66.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.669 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.902 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -58.43 -44.8 89.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.939 0.4 . . . . 0.0 110.774 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -30.96 67.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.13 0.491 . . . . 0.0 109.989 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -77.36 -32.61 55.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.523 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.16 5.9 26.3 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.24 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.091 HG12 HG22 ' A' ' 60' ' ' ILE . 12.5 t -133.91 -43.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.48 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 65.78 -33.12 0.14 Allowed Glycine 0 C--N 1.33 0.244 0 N-CA-C 114.655 0.622 . . . . 0.0 114.655 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 1.091 HG22 HG12 ' A' ' 58' ' ' VAL . 20.0 tt -77.6 165.62 2.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.584 0.231 . . . . 0.0 110.776 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.452 ' N ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -105.19 88.26 2.41 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.465 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 12.0 Cg_endo -114.36 150.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 123.568 2.846 . . . . 0.0 114.39 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -74.69 79.93 2.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.927 ' CE1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.52 129.4 49.66 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.724 -175.539 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.546 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -177.85 -138.57 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.779 -179.148 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 85' ' ' TRP . 0.5 OUTLIER 51.01 173.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.823 0.449 . . . . 0.0 111.719 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.813 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -131.88 125.82 32.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.115 0.484 . . . . 0.0 111.101 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -78.59 -55.87 4.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.022 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.691 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -172.27 131.7 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.328 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.623 ' CD ' HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -114.19 118.71 34.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.712 0.291 . . . . 0.0 110.688 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.712 ' HB3' HG22 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -107.7 129.68 55.0 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.967 0.413 . . . . 0.0 111.047 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -115.92 110.05 18.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.176 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.666 ' CD1' HD23 ' A' ' 71' ' ' LEU . 2.8 p90 -136.33 143.64 44.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.052 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -121.27 118.18 28.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.808 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 2.6 m-85 -69.91 163.01 64.5 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.633 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.69 83.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.187 2.591 . . . . 0.0 112.239 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 17.4 t0 97.14 14.39 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.108 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -137.39 149.18 46.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.308 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -131.49 112.84 13.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.767 0.318 . . . . 0.0 110.658 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.554 HD11 HD23 ' A' ' 82' ' ' LEU . 3.1 tt -120.65 112.0 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.352 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.51 118.89 32.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.735 HD22 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.86 114.55 22.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.978 0.418 . . . . 0.0 111.913 -178.822 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.4 m0 -108.84 122.33 46.96 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.119 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.781 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 1.9 m-85 -106.91 118.18 36.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.755 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.813 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 68.1 m95 -94.75 148.27 22.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.223 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.546 ' O ' ' O ' ' A' ' 65' ' ' PHE . 44.0 tp -99.03 102.98 14.88 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 121.449 0.642 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.927 HG22 ' CE1' ' A' ' 64' ' ' HIS . 7.4 t -86.13 145.68 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.277 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -100.7 -52.25 3.38 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.21 165.65 24.15 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.479 0.582 . . . . 0.0 112.463 -178.335 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.679 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 33.0 p90 -129.73 160.14 34.31 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.319 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.832 ' O ' HD11 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -100.83 93.35 5.49 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.868 0.366 . . . . 0.0 111.422 -179.146 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' ' NE1' ' A' ' 90' ' ' TRP . . . 100.31 -110.24 3.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.011 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.531 ' C ' HD12 ' A' ' 60' ' ' ILE . 19.9 tt0 -135.3 127.03 17.71 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.447 0.165 . . . . 0.0 111.075 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.7 Cg_exo -75.4 153.13 39.67 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.704 2.269 . . . . 0.0 110.888 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.548 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 19.0 p-90 -150.27 -62.81 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.707 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.39 -99.91 0.02 OUTLIER Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.948 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.7 32.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.441 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -63.52 -21.99 66.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.187 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.45 -123.1 2.81 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.098 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.409 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -75.9 132.52 74.23 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.159 0.504 . . . . 0.0 111.702 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -43.39 146.26 1.26 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.105 2.536 . . . . 0.0 112.646 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.12 177.65 16.43 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.828 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.09 157.03 46.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.6 OUTLIER -66.21 106.29 1.63 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.619 ' SD ' HD11 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -120.31 163.19 18.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.22 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.7 p -82.37 114.83 21.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.473 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.765 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -68.47 -18.68 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.43 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.22 -10.8 2.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.804 0.335 . . . . 0.0 111.438 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.76 55.1 0.72 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.677 HD22 HD11 ' A' ' 107' ' ' LEU . 7.5 tp -61.43 150.2 36.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.407 -0.397 . . . . 0.0 110.828 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.486 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -104.18 95.61 6.09 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.34 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.597 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . . . -72.51 -18.76 61.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.874 177.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -79.06 -47.11 16.76 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.365 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.7 OUTLIER -66.7 -39.25 87.99 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.244 -179.163 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.525 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.39 174.43 6.04 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.4 Cg_endo -53.89 127.69 26.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.859 1.706 . . . . 0.0 112.497 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.8 Cg_endo -69.11 -34.93 15.59 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.753 2.302 . . . . 0.0 112.465 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.37 -9.57 58.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.008 0.433 . . . . 0.0 111.125 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -106.79 18.64 21.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.852 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 tt0 -70.38 -31.37 2.22 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.5 Cg_exo -43.7 -36.08 7.14 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.83 1.687 . . . . 0.0 113.395 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.781 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 59.3 t -78.04 -51.31 18.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 111.903 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.83 HG22 ' HB2' ' A' ' 127' ' ' LYS . 3.9 mm -77.08 -39.78 29.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.8 -26.88 26.08 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.48 -53.9 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.49 ' HG ' ' CE2' ' A' ' 68' ' ' PHE . 1.4 mm? -79.26 -30.3 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.665 0.269 . . . . 0.0 111.564 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.83 ' HB2' HG22 ' A' ' 123' ' ' ILE . 9.7 ttpt -54.03 -42.13 68.8 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.135 0.493 . . . . 0.0 110.338 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -67.46 -6.11 17.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.815 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.03 179.774 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 tttm . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.825 0.345 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.17 128.27 22.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.777 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 4' ' ' LEU . 4.0 pp -146.33 142.64 28.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.544 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -102.88 153.58 20.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.34 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 80' ' ' ILE . 40.5 mt -146.33 116.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.959 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.954 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.55 144.25 50.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -145.76 162.44 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.931 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.68 108.04 0.51 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.698 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 1.077 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.73 108.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.774 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -71.72 121.96 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.92 0.391 . . . . 0.0 111.443 -179.004 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -84.86 121.93 28.43 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.093 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.562 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -79.63 -171.67 2.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.731 0.777 . . . . 0.0 111.68 179.423 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.522 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 1.6 tm-20 -82.0 15.53 2.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.343 -1.299 . . . . 0.0 113.105 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 54.8 t30 -144.76 43.97 1.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 54.13 17.82 1.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 105' ' ' MET . 2.3 mt-10 -116.81 160.68 20.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.077 HG21 HG22 ' A' ' 10' ' ' ILE . 5.9 mt -121.33 139.7 47.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.201 0.524 . . . . 0.0 111.458 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PHE . . . . . 0.564 ' C ' ' CD1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -88.49 98.57 11.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.87 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.777 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -113.79 162.46 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.741 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.736 HG22 ' OE2' ' A' ' 98' ' ' GLU . 8.0 p -70.58 145.72 50.57 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.669 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.6 ttt-85 . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.068 -179.684 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 10.9 t-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.706 0.288 . . . . 0.0 111.403 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 26.26 10.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.908 0.385 . . . . 0.0 111.934 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.1 tt -68.97 67.22 0.15 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.67 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.53 -167.77 1.3 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.343 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.777 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.36 168.06 10.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.44 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.774 ' HG3' HD11 ' A' ' 11' ' ' ILE . 84.2 Cg_endo -84.19 166.76 12.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.398 2.732 . . . . 0.0 113.224 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.28 -5.7 55.58 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.751 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -67.59 166.93 41.87 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.254 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.74 1.58 1.19 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.661 0.384 . . . . 0.0 111.871 179.575 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.954 HG21 ' HB3' ' A' ' 7' ' ' ALA . 3.4 pt -50.84 -28.6 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.516 0.674 . . . . 0.0 110.562 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.07 -63.43 0.61 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.878 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.521 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 11.15 -84.0 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.895 0.747 . . . . 0.0 112.625 179.368 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.74 29.26 0.08 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.913 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -168.23 1.98 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.734 0.302 . . . . 0.0 110.971 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.824 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -101.49 153.1 38.07 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.28 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.824 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.86 -25.17 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.852 2.368 . . . . 0.0 112.49 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mm-40 -103.99 -41.27 5.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.482 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -80.27 -5.71 56.68 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.93 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.1 -55.25 36.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.329 . . . . 0.0 110.836 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.725 HG12 ' HB1' ' A' ' 7' ' ' ALA . 2.0 m -78.33 -46.7 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.305 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 27.8 t -55.13 -36.91 41.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.342 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -78.19 -52.03 9.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.874 0.368 . . . . 0.0 110.616 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HB2' HG22 ' A' ' 40' ' ' ILE . 1.8 mm-40 -60.28 -21.88 62.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.672 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.786 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.4 tp -60.29 -45.05 94.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.024 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -30.58 71.42 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.5 -27.85 51.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.419 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.56 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.64 6.97 26.34 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.447 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.945 HG12 HG13 ' A' ' 60' ' ' ILE . 12.4 t -133.38 -44.3 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.049 0.452 . . . . 0.0 110.545 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.619 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 54.52 13.89 4.47 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 114.781 0.673 . . . . 0.0 114.781 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.945 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.08 -167.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 118.002 0.901 . . . . 0.0 110.796 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . 0.469 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -111.13 88.65 8.77 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.535 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.655 ' HG3' HG11 ' A' ' 58' ' ' VAL . 25.2 Cg_endo -113.69 137.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 123.733 2.956 . . . . 0.0 114.413 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 33.6 mt-30 -74.83 79.23 2.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.235 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.822 ' HB2' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -117.9 130.61 56.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.873 -176.285 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 66' ' ' SER . 2.3 t80 -176.43 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 86' ' ' LEU . 65.8 m -33.57 157.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.035 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tt -117.54 123.21 45.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.38 . . . . 0.0 110.95 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -82.36 -56.31 3.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.272 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.3 tt0 -171.66 159.22 5.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.429 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.1 108.44 5.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.756 0.312 . . . . 0.0 110.691 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.832 HD21 ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -96.81 146.23 25.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.674 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -138.96 109.89 6.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.763 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.832 ' CD1' HD21 ' A' ' 71' ' ' LEU . 2.4 p90 -141.17 153.01 45.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.677 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 4.2 pt-20 -121.25 133.81 55.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.158 0.504 . . . . 0.0 111.251 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.488 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -97.12 163.15 20.58 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.27 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.4 Cg_endo -54.99 81.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.82 2.346 . . . . 0.0 112.181 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.3 t70 96.25 6.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.647 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -137.38 93.95 2.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.677 0.275 . . . . 0.0 110.908 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -88.84 104.7 17.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.834 0.349 . . . . 0.0 110.487 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.65 HD11 HD12 ' A' ' 6' ' ' ILE . 2.2 tt -110.25 130.87 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.292 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.14 118.59 37.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.532 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.509 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -108.62 114.19 27.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.033 0.444 . . . . 0.0 111.862 -178.756 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TRP . . . . . 0.412 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 9.2 m0 -114.32 122.42 46.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.906 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.777 ' CD2' HG11 ' A' ' 122' ' ' VAL . 8.9 m-30 -114.05 116.94 29.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.762 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.725 ' NE1' HG11 ' A' ' 50' ' ' VAL . 20.0 m95 -106.64 148.34 28.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.83 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 66' ' ' SER . 48.1 tp -93.03 138.55 31.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.441 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.822 HG13 ' HB2' ' A' ' 64' ' ' HIS . 36.5 t -121.4 145.7 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.248 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.77 -15.71 11.86 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -163.33 162.3 25.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.594 1.088 . . . . 0.0 112.353 -179.053 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.562 ' CH2' ' CB ' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -157.66 123.45 4.66 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 178.289 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.562 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.55 146.52 32.57 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.551 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.0 -120.79 24.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.21 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 41.1 mt-10 -135.06 135.06 22.2 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.4 0.143 . . . . 0.0 110.931 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PRO . . . . . 0.7 ' CA ' HD11 ' A' ' 60' ' ' ILE . 2.9 Cg_exo -76.41 128.96 10.74 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.017 2.478 . . . . 0.0 111.224 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . 0.619 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 11.6 p-90 -129.72 -61.35 1.01 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.118 0.485 . . . . 0.0 111.733 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 40.68 -95.52 0.01 OUTLIER Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.101 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 168.24 69.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.909 0.385 . . . . 0.0 110.71 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.736 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -95.06 -38.65 10.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.696 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.18 -125.55 1.46 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.732 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.417 ' O ' ' HB ' ' A' ' 21' ' ' THR . 12.0 mp0 -78.59 126.51 82.67 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 111.414 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -43.43 144.08 2.14 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.006 2.47 . . . . 0.0 112.797 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.4 ' CA ' ' HE1' ' A' ' 19' ' ' PHE . . . -134.09 177.53 19.06 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.295 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -124.12 157.46 34.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.499 0.19 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -59.38 106.86 0.49 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.784 0.326 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -120.46 159.12 25.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.606 ' HB2' HG12 ' A' ' 108' ' ' VAL . 2.4 p -75.13 118.19 17.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.498 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . 0.763 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -71.42 -18.59 62.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.429 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 106' ' ' SER . 10.8 p -61.29 -12.08 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.653 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.47 50.81 0.85 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.192 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.883 HD11 ' CG2' ' A' ' 123' ' ' ILE . 1.0 OUTLIER -61.94 150.61 37.22 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.739 0.304 . . . . 0.0 111.054 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 1.2 t-20 -108.94 108.98 19.94 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.475 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.45 -18.03 61.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.161 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.98 -47.97 15.32 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -66.97 -29.26 69.07 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.46 -179.465 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.6 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -89.87 173.47 5.8 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.52 127.85 27.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 121.84 1.693 . . . . 0.0 112.283 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.0 Cg_endo -69.14 -35.96 13.43 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.657 2.238 . . . . 0.0 112.636 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.01 -9.75 58.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.982 0.42 . . . . 0.0 111.41 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -106.63 23.0 14.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLU . . . . . 0.6 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.13 -30.66 0.9 Allowed Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.3 Cg_exo -43.19 -35.13 4.82 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.971 1.78 . . . . 0.0 113.466 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.777 HG11 ' CD2' ' A' ' 84' ' ' PHE . 37.6 t -77.86 -51.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.266 0.555 . . . . 0.0 110.381 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.883 ' CG2' HD11 ' A' ' 110' ' ' LEU . 33.4 mm -64.93 -32.3 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.321 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -27.17 39.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.885 0.374 . . . . 0.0 110.77 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.22 -50.83 9.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.623 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.681 HD12 ' CD2' ' A' ' 110' ' ' LEU . 2.8 tm? -78.08 -27.04 48.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.399 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HB2' HG22 ' A' ' 123' ' ' ILE . 53.1 tttp -54.94 -42.38 72.21 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.158 0.504 . . . . 0.0 110.464 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 -63.74 -12.96 39.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.593 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 126' ' ' LEU . 2.6 mp . . . . . 0 C--O 1.231 0.085 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.042 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mmm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.41 106.44 16.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -139.97 142.85 36.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 1.067 HD12 HD11 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -146.04 134.48 21.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.986 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.466 ' C ' HD12 ' A' ' 6' ' ' ILE . 15.6 mt-30 -102.63 152.86 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.35 0.595 . . . . 0.0 111.937 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.067 HD11 HD12 ' A' ' 4' ' ' LEU . 4.7 mp -146.5 126.82 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.643 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.048 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.9 125.56 44.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.6 m -133.78 162.58 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.131 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.451 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.69 116.04 0.99 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.818 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.021 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.91 109.05 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -71.15 126.67 31.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.613 -178.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -91.18 123.0 34.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.474 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.467 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 42.6 t30 -79.91 -172.45 3.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.622 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.1 tm-20 -81.8 4.29 22.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.418 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -139.5 51.83 1.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 111.324 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.2 p30 45.78 24.32 0.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.439 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.4 pt-20 -115.86 137.45 52.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.021 HG21 HG22 ' A' ' 10' ' ' ILE . 7.3 mt -105.88 139.59 26.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.324 0.583 . . . . 0.0 112.146 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 1.1 t80 -85.31 112.43 20.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.331 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.534 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -128.73 149.93 33.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.921 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.699 HG22 ' OE2' ' A' ' 98' ' ' GLU . 31.2 p -70.63 111.5 6.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -134.04 119.74 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.224 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 47.71 26.15 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.526 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.745 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . 46.6 -168.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.823 0.344 . . . . 0.0 111.445 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.41 ' HB2' ' HB2' ' A' ' 101' ' ' PRO . . . -91.12 -29.77 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -162.33 33.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.824 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.605 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . . . -96.21 -167.63 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.99 -36.22 6.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.34 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.72 -19.35 49.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.456 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.37 31.17 2.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 110.995 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 34' ' ' GLU . 3.1 tmtm? -106.29 26.3 9.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.336 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.611 HD13 ' HB3' ' A' ' 111' ' ' ASN . 2.7 tt -63.11 74.67 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.775 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -117.32 -173.27 2.38 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.014 0.435 . . . . 0.0 111.844 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.657 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -119.33 168.49 9.9 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.632 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.623 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 95.3 Cg_endo -81.92 166.74 16.8 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.437 2.758 . . . . 0.0 113.306 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.629 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.73 -5.77 54.32 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.384 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -59.25 159.8 18.59 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 117.23 0.515 . . . . 0.0 113.332 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.11 -2.19 0.73 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.048 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -49.97 -27.91 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.544 0.688 . . . . 0.0 110.823 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -43.53 -61.49 1.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.253 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 41' ' ' GLU . 7.4 mmt 9.64 -81.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.826 0.703 . . . . 0.0 112.582 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.34 32.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.985 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.424 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -92.51 -170.67 2.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.713 0.292 . . . . 0.0 111.06 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.844 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -101.22 152.95 38.04 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.284 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.844 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.89 -24.78 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.782 2.321 . . . . 0.0 112.618 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.632 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.0 mp0 -102.18 -42.21 6.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -80.3 -18.39 49.4 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.802 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -57.41 -49.93 74.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.792 0.33 . . . . 0.0 111.06 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.793 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.45 -47.87 23.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.719 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.6 t -56.7 -36.02 47.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.247 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -52.01 9.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.649 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.0 mm-40 -63.43 -22.1 66.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.689 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.782 HD21 ' CD2' ' A' ' 64' ' ' HIS . 1.3 tp -58.38 -44.99 89.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.755 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -31.33 71.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 109.681 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -77.4 -25.77 51.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.243 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.27 5.84 26.02 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.501 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.752 ' O ' HG23 ' A' ' 60' ' ' ILE . 3.2 t -134.29 -45.1 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.987 0.423 . . . . 0.0 110.111 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.587 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 62.4 -20.4 0.06 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.768 -0.651 . . . . 0.0 114.664 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.752 HG23 ' O ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -88.73 -176.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 120.961 0.41 . . . . 0.0 111.629 -179.068 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.485 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -115.49 87.9 18.16 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.162 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.674 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.6 Cg_endo -113.28 145.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 123.611 2.874 . . . . 0.0 113.789 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 36.3 mt-30 -74.9 79.89 2.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.989 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.05 126.98 49.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.172 -1.377 . . . . 0.0 111.072 -176.054 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.489 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.1 t80 179.77 166.91 1.2 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.77 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.7 m 87.31 155.39 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.644 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.738 HD13 ' HD3' ' A' ' 70' ' ' LYS . 1.4 pp -110.85 137.41 48.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -91.21 -37.55 13.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.019 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.53 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.2 tt0 -171.77 144.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.45 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.738 ' HD3' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.2 132.12 22.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.345 179.535 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.79 HD21 HG22 ' A' ' 122' ' ' VAL . 2.4 pp -141.0 151.09 43.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.426 . . . . 0.0 111.336 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HB2' HG23 ' A' ' 81' ' ' THR . 16.4 tt0 -129.93 109.94 11.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.467 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -128.22 149.75 50.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.739 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -121.15 129.48 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.18 0.514 . . . . 0.0 111.22 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.7 m-85 -78.81 163.21 61.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.546 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.3 Cg_endo -50.72 83.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.227 2.618 . . . . 0.0 112.238 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 21.1 m-20 93.98 15.45 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.339 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.505 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 10.5 ttp180 -137.43 150.21 47.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.365 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -126.95 113.47 16.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.006 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.909 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 2.0 tt -124.22 119.44 56.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.46 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -106.35 118.82 37.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.82 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.741 HD23 ' HB ' ' A' ' 6' ' ' ILE . 11.5 mt -118.39 114.36 22.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.964 0.412 . . . . 0.0 111.798 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.46 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.5 m0 -107.64 122.31 46.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.009 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.631 ' CE2' HG11 ' A' ' 122' ' ' VAL . 3.2 m-30 -104.54 120.16 40.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.033 0.444 . . . . 0.0 110.513 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.707 ' CE2' HG11 ' A' ' 50' ' ' VAL . 16.6 m95 -106.23 149.09 27.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.049 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 87' ' ' VAL . 3.5 tm? -95.52 138.6 32.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.551 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.989 HG22 ' ND1' ' A' ' 64' ' ' HIS . 39.1 t -123.4 145.85 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.117 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -110.57 -26.71 9.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -162.51 161.71 27.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.491 0.587 . . . . 0.0 111.41 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.702 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -156.91 124.74 5.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.266 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.537 ' O ' HD12 ' A' ' 60' ' ' ILE . 75.3 mt-10 -73.14 142.69 47.45 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.254 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.15 -143.38 26.11 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.704 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.2 tt0 -107.52 138.01 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.598 ' HA ' HG21 ' A' ' 60' ' ' ILE . 6.6 Cg_exo -74.89 128.97 12.0 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.82 2.347 . . . . 0.0 111.598 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.674 ' CD1' HG22 ' A' ' 60' ' ' ILE . 52.0 p-90 -121.23 -62.62 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.642 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.93 -97.68 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.21 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 tttt 173.59 39.43 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.724 0.297 . . . . 0.0 111.096 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.699 ' OE2' HG22 ' A' ' 21' ' ' THR . 15.7 pt-20 -57.87 -49.39 76.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.798 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 148.86 -68.08 0.36 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.466 -0.874 . . . . 0.0 113.118 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.745 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 1.4 mt-30 -117.72 113.27 38.26 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.033 0.444 . . . . 0.0 111.746 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 53.6 Cg_exo -43.6 146.15 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.077 2.518 . . . . 0.0 112.686 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.17 177.39 17.69 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.811 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -124.4 157.18 35.72 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.467 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.8 OUTLIER -67.65 106.44 2.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.91 0.386 . . . . 0.0 110.17 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.23 163.22 18.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.211 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.5 t -83.43 114.84 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.444 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.602 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -60.66 -18.77 55.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.458 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 108' ' ' VAL . 21.2 t -62.89 -8.85 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.656 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.64 51.68 0.84 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.738 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD23 HD12 ' A' ' 123' ' ' ILE . 6.9 tp -62.18 150.16 39.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.652 0.263 . . . . 0.0 110.688 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.611 ' HB3' HD13 ' A' ' 33' ' ' LEU . 1.3 t-20 -107.26 97.31 7.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.48 -22.58 61.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.211 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -78.98 -44.91 21.38 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.401 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.62 -42.74 86.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.199 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.529 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.55 174.32 6.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.5 Cg_endo -54.07 127.74 26.97 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.889 1.726 . . . . 0.0 112.233 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.03 -36.28 13.06 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.679 2.252 . . . . 0.0 112.503 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.617 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -71.13 -9.67 58.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.42 . . . . 0.0 111.339 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -104.37 21.61 16.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.798 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.22 -31.29 1.4 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.8 Cg_exo -43.83 -32.97 4.68 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.833 1.689 . . . . 0.0 113.003 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.79 HG22 HD21 ' A' ' 71' ' ' LEU . 50.0 t -78.02 -51.1 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.121 0.486 . . . . 0.0 110.504 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.895 HG22 ' HB2' ' A' ' 127' ' ' LYS . 23.4 mm -69.17 -30.73 47.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.623 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.78 -27.61 42.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.906 0.384 . . . . 0.0 110.628 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -80.43 -53.11 6.89 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.941 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.717 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.5 tm? -78.19 -33.19 50.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.771 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.895 ' HB2' HG22 ' A' ' 123' ' ' ILE . 31.0 ttpt -53.41 -42.84 67.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.133 0.492 . . . . 0.0 110.837 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -7.36 29.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.83 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.528 0.1 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.32 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.909 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A 5011 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 5012 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tmm? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.842 0.353 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -91.23 146.15 24.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.99 126.76 20.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.439 HD11 " H1'" ' A' ' 131' ' ' 8OG . 3.1 pp -146.1 122.49 10.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.5 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 14.2 mt-30 -102.85 155.37 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.41 0.624 . . . . 0.0 112.391 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.606 HD11 " H4'" ' A' ' 131' ' ' 8OG . 3.6 mp -146.99 129.72 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.536 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.994 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 125.38 44.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.9 m -144.28 162.27 14.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.718 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.446 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -149.65 132.14 3.92 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.006 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.059 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.85 114.49 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.736 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.1 mt -71.38 123.24 25.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.96 0.409 . . . . 0.0 111.513 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.405 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -84.95 122.86 29.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.684 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.465 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 14.7 t30 -82.34 -172.21 3.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.087 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tt0 -81.61 0.99 35.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.431 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -139.74 52.16 1.71 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.432 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 47.56 21.17 0.22 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.588 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -111.79 153.28 26.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.059 HG21 HG22 ' A' ' 10' ' ' ILE . 4.9 mt -123.61 141.87 42.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.351 0.596 . . . . 0.0 112.438 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -87.13 117.86 26.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.917 179.268 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -129.04 145.2 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.567 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 100' ' ' GLN . 68.4 p -70.78 111.84 6.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.23 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HG3' HD12 ' A' ' 33' ' ' LEU . 21.4 ttp180 -142.37 144.93 33.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.046 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER 47.71 -109.75 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.033 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 168.4 -170.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.36 . . . . 0.0 111.007 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.89 -30.42 9.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.848 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -132.8 -45.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.733 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.75 -166.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.032 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.513 ' CE1' ' HB3' ' A' ' 30' ' ' ALA . 35.6 t-80 -95.62 -86.54 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.894 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 46.47 29.09 0.83 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.837 0.351 . . . . 0.0 111.382 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.513 ' HB3' ' CE1' ' A' ' 28' ' ' HIS . . . -58.22 -23.21 54.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.5 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -106.29 30.32 6.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 111.318 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.22 26.04 10.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.409 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.893 HD13 ' HB3' ' A' ' 111' ' ' ASN . 7.2 tt -64.01 74.76 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.88 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -123.59 -171.22 2.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.896 0.379 . . . . 0.0 111.5 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.721 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.3 168.58 9.68 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.619 -179.524 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.515 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 92.0 Cg_endo -82.66 167.37 14.95 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.689 2.926 . . . . 0.0 113.307 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.14 -5.24 52.65 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.067 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.82 166.51 17.4 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.274 -0.488 . . . . 0.0 113.263 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.29 0.25 1.38 Allowed 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.994 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -49.9 -29.07 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.682 0.753 . . . . 0.0 110.542 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.596 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.07 -60.37 1.9 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.964 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 8.05 -80.27 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.928 0.767 . . . . 0.0 112.511 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -178.66 32.71 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.725 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.6 mp0 -88.58 -174.11 4.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.796 0.331 . . . . 0.0 111.078 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.843 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.8 153.79 38.55 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.239 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.843 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.86 -25.18 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.805 2.337 . . . . 0.0 112.496 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.539 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mt-10 -104.02 -40.31 6.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.398 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -80.25 -6.79 58.46 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.859 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.52 -56.01 24.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.812 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.784 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.28 -48.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.506 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.4 t -51.44 -35.8 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.016 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -52.26 8.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.255 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.3 mm-40 -66.27 -22.69 66.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.707 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.556 ' CD1' ' CE1' ' A' ' 64' ' ' HIS . 10.9 tp -58.01 -44.3 87.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -28.41 61.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.055 0.455 . . . . 0.0 109.885 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -77.1 -28.07 54.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.972 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.7 mp0 -108.39 6.94 26.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.936 HG12 HG13 ' A' ' 60' ' ' ILE . 60.9 t -133.18 -44.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.609 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.85 -39.12 0.24 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.573 -0.74 . . . . 0.0 114.264 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.936 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.34 -176.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.959 0.409 . . . . 0.0 110.847 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.31 88.77 13.32 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.694 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.744 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.8 Cg_endo -110.46 143.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 123.402 2.735 . . . . 0.0 113.679 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 33.3 mt-30 -74.67 79.9 2.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.817 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.37 132.08 54.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.165 -175.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -179.82 -133.55 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.294 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.23 167.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.017 0.437 . . . . 0.0 111.754 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.682 HD23 ' O ' ' A' ' 67' ' ' LEU . 6.7 tt -131.7 108.73 9.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.897 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.85 -44.29 32.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.037 0.446 . . . . 0.0 110.253 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.8 tt0 -171.6 156.89 4.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.316 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.09 106.24 4.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.644 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.823 ' HB2' HG22 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -96.77 124.88 40.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -123.42 109.96 14.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.413 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.602 ' CD1' HD23 ' A' ' 71' ' ' LEU . 1.8 p90 -138.55 149.55 45.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.828 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 3.7 pt-20 -121.11 122.15 39.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.089 0.471 . . . . 0.0 111.248 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 77' ' ' ASP . 4.5 m-85 -84.99 162.86 48.23 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.482 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -50.81 81.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.011 2.474 . . . . 0.0 112.224 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 75' ' ' PHE . 12.3 m-20 89.58 12.88 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.554 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 24.3 ttp180 -137.35 93.7 2.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.705 0.288 . . . . 0.0 110.786 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.463 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.8 t-80 -81.49 110.74 17.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.957 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.571 ' CG2' ' N2 ' ' A' ' 131' ' ' 8OG . 1.8 tp -114.0 118.52 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.519 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -111.72 118.77 36.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.763 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.44 HD23 ' HB ' ' A' ' 6' ' ' ILE . 11.8 mt -122.25 114.29 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.929 0.395 . . . . 0.0 111.873 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.519 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.3 m0 -106.99 122.32 46.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.057 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.596 ' CD2' HG11 ' A' ' 122' ' ' VAL . 3.5 m-30 -103.98 112.99 26.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.776 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.784 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 44.4 m95 -94.68 148.68 22.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.212 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.8 tp -99.85 103.05 14.63 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.453 0.644 . . . . 0.0 111.324 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.817 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.6 t -80.84 146.08 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.303 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.77 -26.23 8.3 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.1 tpt180 -162.64 162.05 26.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.416 0.553 . . . . 0.0 111.44 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.722 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -155.85 124.32 5.9 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.449 178.779 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -73.07 140.34 47.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.914 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.34 -121.68 26.35 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.1 tt0 -132.84 142.13 43.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.506 0.193 . . . . 0.0 110.783 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.494 ' CA ' HD11 ' A' ' 60' ' ' ILE . 3.5 Cg_exo -75.8 128.84 11.16 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.824 2.349 . . . . 0.0 111.178 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.662 ' HE1' HG23 ' A' ' 60' ' ' ILE . 18.4 p-90 -126.24 -64.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.489 -0.484 . . . . 0.0 112.262 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.506 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.57 -94.9 0.01 OUTLIER Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.062 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.419 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.5 OUTLIER 170.99 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.674 0.273 . . . . 0.0 111.35 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -50.33 -29.96 11.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.638 0.256 . . . . 0.0 110.794 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.09 -28.77 7.44 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.741 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.458 ' O ' HG22 ' A' ' 21' ' ' THR . 1.0 OUTLIER -140.03 106.04 6.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 117.206 0.503 . . . . 0.0 112.003 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -43.56 146.28 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.112 2.541 . . . . 0.0 112.66 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.81 177.29 19.19 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.1 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.27 157.42 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.441 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -68.68 105.98 2.47 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.183 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.7 ptp -120.52 163.29 18.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.012 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.33 114.98 16.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.474 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.4 tm? -71.42 -18.74 62.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.407 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.41 ' O ' HG22 ' A' ' 108' ' ' VAL . 10.8 p -58.0 -13.63 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.619 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.48 55.16 0.63 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.967 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.724 HD22 HD12 ' A' ' 123' ' ' ILE . 4.8 tt -61.95 150.54 37.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.896 0.379 . . . . 0.0 110.742 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.893 ' HB3' HD13 ' A' ' 33' ' ' LEU . 2.8 t-20 -95.22 100.07 11.92 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.48 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -20.93 61.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.14 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.98 -45.15 20.88 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.087 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.78 -41.0 88.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.241 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.487 ' CB ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -78.37 174.2 6.4 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.08 127.56 26.2 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.82 1.68 . . . . 0.0 112.301 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 120' ' ' GLU . 52.6 Cg_endo -69.27 -34.66 15.7 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.762 2.308 . . . . 0.0 112.415 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.766 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -72.49 -9.56 58.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.377 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -103.38 20.54 17.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.955 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.549 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -70.29 -31.16 2.15 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 90.2 Cg_exo -43.99 -37.81 9.67 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 121.704 1.603 . . . . 0.0 113.429 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.823 HG22 ' HB2' ' A' ' 71' ' ' LEU . 52.2 t -77.81 -51.02 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.517 . . . . 0.0 110.6 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.724 HD12 HD22 ' A' ' 110' ' ' LEU . 43.1 mm -66.19 -30.03 48.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.563 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -29.99 57.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.967 0.413 . . . . 0.0 110.254 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -50.79 11.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.509 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.858 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.4 tm? -78.41 -19.93 52.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.831 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.646 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.5 tttt -74.45 -42.61 58.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.235 0.54 . . . . 0.0 110.522 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.74 -9.97 42.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.01 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.696 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.639 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.766 ' O6 ' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A 5023 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A 5024 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ptm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.783 0.325 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -103.63 147.11 27.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -139.81 129.04 23.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.721 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.808 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.3 pp -146.2 136.93 24.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.329 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.749 ' C ' HD12 ' A' ' 6' ' ' ILE . 22.1 mt-30 -106.64 153.63 22.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.126 0.489 . . . . 0.0 111.648 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.808 HD11 ' CD1' ' A' ' 4' ' ' LEU . 4.3 mp -146.32 118.84 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.695 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.074 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.94 125.83 44.53 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -140.08 162.6 24.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.559 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.58 125.69 2.7 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.134 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.818 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.81 107.26 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.723 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.23 125.33 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.898 0.38 . . . . 0.0 111.496 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.05 124.44 34.29 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.581 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.472 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 13.5 t30 -79.32 -172.22 3.09 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.834 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -82.57 -1.54 51.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.411 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -129.1 36.15 4.21 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.99 7.29 3.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.601 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 19.2 pt-20 -100.95 146.11 27.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.818 HG21 HG22 ' A' ' 10' ' ' ILE . 6.4 mt -110.61 138.7 37.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 111.833 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.493 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -86.14 122.52 30.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.686 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -126.42 162.2 30.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.804 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.593 HG22 ' OE1' ' A' ' 98' ' ' GLU . 11.7 p -70.52 154.86 41.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.701 0.286 . . . . 0.0 110.392 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -148.04 104.71 3.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.197 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 50.33 -103.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.225 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.71 -67.62 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.839 0.352 . . . . 0.0 111.038 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -175.64 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.5 p30 -140.02 -175.4 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 63.67 158.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -79.83 87.86 5.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.978 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mmt -142.75 41.09 1.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.828 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.64 -8.91 57.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.68 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.8 OUTLIER -94.91 27.92 2.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.632 0.253 . . . . 0.0 111.273 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -114.16 25.96 10.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.045 0.45 . . . . 0.0 111.66 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.2 tt -70.72 72.42 0.53 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.582 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.681 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -106.73 -167.71 1.32 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.995 0.426 . . . . 0.0 111.913 -179.355 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.541 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.37 168.51 9.88 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.488 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.615 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 91.4 Cg_endo -80.39 167.34 19.39 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.524 2.816 . . . . 0.0 113.327 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.639 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.45 -5.79 52.24 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.006 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.48 163.22 18.35 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.852 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.53 -0.18 0.91 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.803 0.441 . . . . 0.0 112.1 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.074 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -50.83 -28.83 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.728 . . . . 0.0 110.424 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.602 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -42.38 -54.65 3.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.934 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.536 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 0.9 -75.33 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.966 0.791 . . . . 0.0 112.546 179.459 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 173.04 35.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.806 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.13 -172.47 3.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.777 0.323 . . . . 0.0 111.08 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.838 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -96.44 153.03 39.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.309 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.838 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.84 -25.03 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.781 2.32 . . . . 0.0 112.52 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.3 mt-10 -104.04 -39.38 6.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.569 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -80.11 -12.87 59.63 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.843 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.45 -52.75 64.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.806 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.949 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.37 -48.34 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 47' ' ' GLU . 36.3 t -57.1 -38.47 60.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.675 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -74.79 -52.06 12.46 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.786 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' A' ' 40' ' ' ILE . 2.9 mm-40 -63.08 -20.06 65.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.722 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.88 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.3 tp -60.46 -44.68 95.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.905 0.383 . . . . 0.0 110.926 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -68.54 -30.08 68.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.064 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -77.3 -25.63 51.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.678 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.85 6.65 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.388 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.979 HG12 HG13 ' A' ' 60' ' ' ILE . 10.0 t -133.81 -44.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 110.721 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.575 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 56.67 6.33 1.63 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 114.846 0.699 . . . . 0.0 114.846 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.979 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.37 -166.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 118.087 0.943 . . . . 0.0 110.406 179.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.628 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -113.86 88.64 14.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.302 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 20.4 Cg_endo -111.92 137.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 123.529 2.819 . . . . 0.0 114.686 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -74.8 79.15 2.09 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.88 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -117.09 124.05 48.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.358 -176.307 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.5 t80 179.78 163.61 1.03 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.901 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 85.64 154.57 0.08 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.447 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.732 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.2 pp -107.68 121.06 43.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 111.616 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -76.81 -39.0 52.85 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.87 138.26 1.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.799 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.29 103.99 4.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.583 0.23 . . . . 0.0 110.746 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 71' ' ' LEU . 4.4 pp -105.81 152.54 23.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 111.062 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -135.38 117.39 15.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.723 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -136.33 152.06 50.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.509 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.02 139.96 52.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.198 0.523 . . . . 0.0 111.397 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.467 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -105.63 163.18 17.63 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.278 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.9 Cg_endo -55.63 81.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.819 2.346 . . . . 0.0 112.15 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 4.9 t70 97.08 6.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.676 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.574 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 12.1 ttp180 -137.32 94.84 2.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.702 0.287 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.436 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -91.96 101.66 14.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.755 HG13 HD13 ' A' ' 6' ' ' ILE . 1.9 tt -103.52 142.77 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.134 0.493 . . . . 0.0 111.283 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -123.01 118.24 27.33 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 178.337 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.868 HD23 ' CG2' ' A' ' 122' ' ' VAL . 6.4 tp -114.49 114.03 25.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.085 0.469 . . . . 0.0 111.542 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.417 ' HE1' HG22 ' A' ' 81' ' ' THR . 8.7 m0 -114.15 121.8 44.87 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.83 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.658 ' CE2' HG11 ' A' ' 122' ' ' VAL . 3.5 m-30 -110.27 117.41 33.57 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.236 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.732 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 16.2 m95 -105.4 148.54 27.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.223 0.535 . . . . 0.0 112.343 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.5 tp -86.14 138.42 31.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.386 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.823 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.7 t -124.11 145.49 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.712 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.88 -24.2 10.12 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.76 163.18 26.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.344 0.974 . . . . 0.0 112.306 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.723 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -157.81 123.26 4.53 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.749 178.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.63 ' O ' HG21 ' A' ' 60' ' ' ILE . 6.8 tt0 -74.5 149.39 40.3 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.165 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.62 -116.83 6.35 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.593 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 11.8 mt-10 -135.33 143.39 45.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.431 0.158 . . . . 0.0 110.697 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.642 ' CA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.43 128.76 10.59 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.816 2.344 . . . . 0.0 111.079 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.575 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 38.0 p-90 -132.25 -59.75 0.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.499 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.79 -94.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.786 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 174.77 39.63 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.786 0.327 . . . . 0.0 110.714 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.593 ' OE1' HG22 ' A' ' 21' ' ' THR . 26.4 pt-20 -57.64 -45.67 85.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.767 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 131.92 -43.06 1.32 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.248 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.37 108.2 23.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.042 0.449 . . . . 0.0 111.769 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -43.75 146.31 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.004 2.469 . . . . 0.0 112.51 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.64 177.27 17.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.048 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.78 157.38 43.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.459 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -74.49 106.33 6.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.295 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.1 ptp -120.42 163.24 18.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.13 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.4 p -79.28 114.98 18.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.509 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.771 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -63.21 -18.7 63.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.449 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 108' ' ' VAL . 21.3 t -63.08 -8.57 3.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.6 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.97 50.46 0.88 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.096 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.523 ' CD2' HD12 ' A' ' 123' ' ' ILE . 8.1 tp -62.17 150.17 39.46 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.46 115.84 22.93 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.59 -17.97 61.65 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.162 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -78.85 -49.06 13.55 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.075 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -66.93 -18.74 65.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.447 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.573 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.82 170.72 5.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.54 127.69 27.07 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.05 1.833 . . . . 0.0 112.326 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.16 -36.86 11.56 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.619 2.212 . . . . 0.0 112.528 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.682 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.57 -9.58 57.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.487 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.418 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 15.4 m-20 -105.8 19.11 21.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.776 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.555 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -66.61 -31.88 4.63 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.0 Cg_exo -44.2 -34.74 7.21 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 121.825 1.683 . . . . 0.0 113.154 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.868 ' CG2' HD23 ' A' ' 82' ' ' LEU . 39.4 t -77.96 -51.3 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.021 0.439 . . . . 0.0 110.785 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.829 HG22 ' HB2' ' A' ' 127' ' ' LYS . 26.2 mm -67.49 -31.94 54.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.42 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.49 -26.86 33.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.891 0.377 . . . . 0.0 110.657 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.12 -53.09 7.02 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.791 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.692 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.5 tm? -78.25 -31.8 49.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.761 0.315 . . . . 0.0 111.744 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.829 ' HB2' HG22 ' A' ' 123' ' ' ILE . 4.7 ttpt -53.95 -42.56 69.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.97 0.414 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -67.77 -9.22 42.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.825 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.264 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.682 ' O6 ' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A 5035 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A 5036 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.84 0.352 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -109.49 102.98 11.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 145.4 55.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.503 HD21 " H1'" ' A' ' 131' ' ' 8OG . 2.8 pp -146.1 127.84 15.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.236 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.527 ' O ' HD12 ' A' ' 6' ' ' ILE . 25.7 mt-30 -102.58 146.95 27.4 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.281 0.562 . . . . 0.0 111.696 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.929 HD13 " H4'" ' A' ' 131' ' ' 8OG . 0.8 OUTLIER -146.71 132.91 13.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.771 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.136 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.64 124.55 42.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.58 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 m -119.38 162.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.391 0.615 . . . . 0.0 112.089 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -149.51 106.23 0.32 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.904 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.035 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.72 109.88 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.713 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.34 123.06 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.805 -178.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.72 124.32 32.85 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.591 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.477 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 51.6 t30 -81.41 -172.34 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.644 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 26.2 tt0 -83.34 9.18 11.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.487 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -141.36 52.24 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.156 -0.34 . . . . 0.0 111.503 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.71 25.79 0.16 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 111.368 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -117.93 160.16 21.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.035 HG21 HG22 ' A' ' 10' ' ' ILE . 9.0 mt -130.26 138.04 54.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.048 0.452 . . . . 0.0 111.435 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -79.02 112.5 16.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.305 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.28 139.61 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.156 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -70.8 111.88 6.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.824 0.345 . . . . 0.0 110.606 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.803 ' HD2' HD22 ' A' ' 33' ' ' LEU . 9.3 ttp180 -124.4 119.13 28.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 19.2 ttm180 50.77 -106.76 0.25 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 173.45 37.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 111.179 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.1 25.1 3.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.498 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 p30 176.62 162.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.49 -166.26 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.118 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -118.12 113.53 21.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.23 34.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.2 -8.93 57.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.587 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.69 -1.68 35.6 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.604 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 26.2 10.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.046 0.451 . . . . 0.0 111.3 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.803 HD22 ' HD2' ' A' ' 22' ' ' ARG . 28.1 tp -58.07 86.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.841 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.91 -175.94 3.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.112 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.753 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.63 161.58 36.94 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.177 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.7 166.7 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.069 2.513 . . . . 0.0 111.525 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 100.97 58.92 0.82 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 119.857 -1.164 . . . . 0.0 113.176 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.603 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.66 122.96 3.55 Favored Glycine 0 C--N 1.312 -0.802 0 CA-C-N 114.941 -0.63 . . . . 0.0 112.339 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.603 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 107.92 2.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.103 0.561 . . . . 0.0 112.296 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.136 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -48.83 -28.95 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.541 0.686 . . . . 0.0 110.515 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.583 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.92 -69.72 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.779 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.462 ' C ' ' O ' ' A' ' 41' ' ' GLU . 13.7 mmt 22.43 -86.18 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.868 0.73 . . . . 0.0 112.19 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.88 27.86 0.17 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.502 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.407 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 5.9 mt-10 -93.83 -177.32 4.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.827 0.346 . . . . 0.0 111.108 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.925 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.86 158.44 35.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.982 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.925 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.93 -24.69 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.809 2.339 . . . . 0.0 112.409 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -88.85 -60.23 2.01 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.558 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.48 -6.83 58.75 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.799 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.74 -54.47 42.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.76 0.314 . . . . 0.0 110.826 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.797 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.31 -46.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.977 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 47' ' ' GLU . 32.6 t -55.55 -37.62 46.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.223 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.3 -52.02 9.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.998 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.87 -23.55 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.002 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.737 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -53.79 -44.63 70.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.532 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -33.93 75.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.68 -26.12 50.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.188 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 54.2 mm-40 -108.36 4.27 24.28 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.938 HG12 HG13 ' A' ' 60' ' ' ILE . 26.0 t -134.85 -44.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.229 0.538 . . . . 0.0 110.117 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.14 -41.77 0.36 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.723 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.938 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.79 -176.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.133 0.492 . . . . 0.0 111.251 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.79 88.79 14.64 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.17 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.82 ' HG3' HG11 ' A' ' 58' ' ' VAL . 7.2 Cg_endo -110.15 149.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.322 2.681 . . . . 0.0 113.887 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 77.7 mt-30 -74.74 79.78 2.06 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.962 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.56 129.27 50.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.206 -176.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' HD1' ' A' ' 64' ' ' HIS . 3.4 t80 -176.59 -39.34 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.456 ' CB ' ' HB3' ' A' ' 86' ' ' LEU . 51.8 m -40.74 160.87 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.805 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -115.69 119.32 35.68 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.575 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -86.83 -56.34 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.262 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -172.03 144.08 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.309 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.443 ' NZ ' ' CZ3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -142.21 112.46 7.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.698 0.285 . . . . 0.0 110.768 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.792 HD21 ' HA ' ' A' ' 122' ' ' VAL . 3.7 pp -125.18 159.39 31.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.968 0.413 . . . . 0.0 111.028 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -135.35 109.93 8.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.592 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.51 ' HD2' HD13 ' A' ' 71' ' ' LEU . 30.1 p90 -125.59 151.12 46.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.746 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.12 131.29 54.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 111.114 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.468 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-85 -79.89 162.85 60.87 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.622 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.9 Cg_endo -53.6 82.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.203 2.602 . . . . 0.0 112.321 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER 100.43 11.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.895 0.878 . . . . 0.0 111.232 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 17.5 ttp180 -137.3 150.15 47.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.585 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -127.06 110.87 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.672 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.96 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 1.9 tt -120.3 120.69 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.369 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.552 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -103.02 118.65 37.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.595 HD13 HD11 ' A' ' 80' ' ' ILE . 1.1 mp -119.75 114.05 21.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.768 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.552 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.5 m0 -110.1 122.55 47.86 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.348 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.698 ' CE1' HG11 ' A' ' 122' ' ' VAL . 2.2 m-85 -109.98 109.79 20.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.919 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.707 ' NE1' HG11 ' A' ' 50' ' ' VAL . 34.2 m95 -98.02 148.95 22.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.592 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.832 HD23 ' N ' ' A' ' 87' ' ' VAL . 3.4 tt -97.83 138.5 35.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.461 0.648 . . . . 0.0 111.664 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.962 HG22 ' ND1' ' A' ' 64' ' ' HIS . 61.5 t -114.78 146.38 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.436 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.41 -25.69 10.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.477 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.4 165.36 24.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.72 0.691 . . . . 0.0 111.505 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.713 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -156.57 123.36 5.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.387 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -79.1 153.69 29.95 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.064 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.56 -131.95 49.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.566 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.4 mt-10 -123.33 144.24 43.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.51 0.195 . . . . 0.0 110.725 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.54 128.76 10.51 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.788 2.325 . . . . 0.0 111.628 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.561 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.9 p-90 -133.4 -58.91 0.88 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.604 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.07 -98.02 0.01 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.025 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 176.8 36.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 111.022 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -44.52 96.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.38 -68.5 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.111 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -110.86 106.37 57.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 111.554 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -43.58 146.27 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.016 2.477 . . . . 0.0 112.647 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.34 177.04 17.11 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.809 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.82 157.38 37.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.578 0.228 . . . . 0.0 110.568 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -60.14 106.68 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.258 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.03 163.29 17.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.3 p -80.36 114.75 19.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.47 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -80.25 -18.68 48.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.433 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.13 -14.34 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.801 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.06 53.79 0.67 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.27 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.626 HD22 HG23 ' A' ' 123' ' ' ILE . 8.5 tt -62.24 150.37 39.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -106.36 115.02 29.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.5 -17.91 61.71 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.049 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.03 -46.29 18.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.029 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -40.13 88.61 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.158 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.49 174.38 6.13 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.0 127.76 26.97 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 121.835 1.69 . . . . 0.0 112.435 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.17 -36.94 11.35 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.796 2.331 . . . . 0.0 112.557 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.858 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -69.33 -9.66 54.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.392 . . . . 0.0 111.361 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.452 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 13.2 m-20 -107.38 18.45 21.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.93 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 tt0 -64.78 -31.89 6.14 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.3 Cg_exo -44.09 -38.77 10.94 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 121.746 1.631 . . . . 0.0 113.206 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.792 ' HA ' HD21 ' A' ' 71' ' ' LEU . 76.8 t -77.66 -51.2 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.829 0.347 . . . . 0.0 111.828 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.626 HG23 HD22 ' A' ' 110' ' ' LEU . 32.6 mm -73.04 -43.79 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.19 -26.81 30.16 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -80.32 -53.45 6.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.505 ' HG ' ' CZ ' ' A' ' 68' ' ' PHE . 3.5 mm? -78.47 -28.46 46.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.549 ' HD3' ' HB2' ' A' ' 112' ' ' ALA . 9.9 ttpp -55.74 -42.19 75.03 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.059 0.457 . . . . 0.0 110.696 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.817 ' O ' HD12 ' A' ' 129' ' ' LEU . 62.9 ttt180 -71.45 -5.79 35.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.99 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.112 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.96 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A 5047 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A 5048 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mtm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.791 0.329 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.99 135.0 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.37 129.26 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.608 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.847 HD13 " O4'" ' A' ' 131' ' ' 8OG . 4.1 pp -146.48 139.37 25.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.913 0.387 . . . . 0.0 111.78 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.502 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 39.5 mt-30 -106.01 156.0 18.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.404 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.714 HD12 HD13 ' A' ' 82' ' ' LEU . 15.0 mt -146.74 126.51 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.357 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.905 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.17 125.2 43.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.1 m -144.7 156.49 14.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.999 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.8 124.45 1.99 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.864 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.084 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.57 112.45 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.749 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.8 OUTLIER -70.81 119.94 17.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.215 0.531 . . . . 0.0 111.381 -178.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -84.3 124.39 31.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.625 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 23.0 t30 -80.91 -172.25 3.61 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.733 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.1 tt0 -82.91 5.4 22.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.212 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -139.44 51.23 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.875 0.369 . . . . 0.0 111.503 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 45.88 25.19 0.28 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.277 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 21.3 pt-20 -119.45 141.63 48.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.084 HG21 HG22 ' A' ' 10' ' ' ILE . 10.3 mt -112.51 143.52 22.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.199 0.523 . . . . 0.0 111.749 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -90.38 121.65 32.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.352 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -121.22 134.72 63.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.058 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -70.79 111.97 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.381 . . . . 0.0 110.889 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.824 ' HB3' HD12 ' A' ' 33' ' ' LEU . 34.9 ptt85 -136.68 131.35 33.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.768 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 30' ' ' ALA . 2.0 tpp180 53.4 -111.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.748 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 173.13 -167.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.0 111.002 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.39 26.56 10.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -179.64 -41.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.811 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.93 -169.05 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.087 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -139.55 98.91 3.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.957 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.0 mmt -155.35 60.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.799 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . . . -65.14 -13.75 58.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.555 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.9 t-20 -84.17 6.92 20.68 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.688 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.32 26.41 10.28 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -67.93 63.2 0.08 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.67 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -109.42 -166.93 1.15 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.445 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.788 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.42 168.23 10.47 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.487 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 59.9 Cg_endo -72.62 167.21 27.72 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.34 2.693 . . . . 0.0 113.162 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.8 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.61 -5.49 54.48 Favored Glycine 0 C--O 1.223 -0.545 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.971 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.37 149.3 50.16 Favored Glycine 0 C--N 1.315 -0.602 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.798 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 91.6 -0.98 0.17 Allowed 'General case' 0 C--N 1.342 0.247 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.905 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -49.41 -29.81 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.717 0.77 . . . . 0.0 110.584 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -43.12 -52.71 5.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.04 179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.531 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 0.4 -75.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.928 0.768 . . . . 0.0 112.564 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 176.12 35.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.979 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -93.56 -171.49 2.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.596 0.236 . . . . 0.0 111.022 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.04 152.58 38.4 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.294 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.813 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.82 -24.97 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.774 2.316 . . . . 0.0 112.491 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -104.08 -40.45 6.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.709 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -80.33 -14.18 58.58 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.763 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.95 -52.33 66.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.818 0.342 . . . . 0.0 111.089 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.704 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.0 m -78.74 -49.03 21.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 47' ' ' GLU . 39.6 t -54.85 -36.02 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.392 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -51.99 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 110.597 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.1 mm-40 -61.59 -22.04 64.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.694 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.905 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -58.48 -44.48 89.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.867 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -33.87 75.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.116 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.6 tt0 -77.13 -26.93 53.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.075 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.08 6.33 26.86 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.634 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 60' ' ' ILE . 48.2 t -133.41 -44.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.76 -40.66 0.31 Allowed Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.969 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.943 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.47 -177.55 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.084 0.469 . . . . 0.0 111.087 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.22 88.86 13.24 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.058 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.749 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.6 Cg_endo -110.09 145.63 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 123.287 2.658 . . . . 0.0 114.159 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 84.2 mt-30 -74.69 79.96 2.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.905 ' CD2' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -121.53 131.04 53.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.436 -175.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -177.08 -133.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.345 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 54.51 171.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.039 0.447 . . . . 0.0 111.937 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.892 HD11 ' HG2' ' A' ' 70' ' ' LYS . 7.1 tt -136.85 108.07 6.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.714 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.886 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.74 -44.58 32.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.99 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.533 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.0 tt0 -171.79 142.72 1.57 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.429 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.892 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.24 103.86 4.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.213 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.577 ' O ' HD12 ' A' ' 71' ' ' LEU . 4.4 pp -110.33 151.75 27.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.955 0.407 . . . . 0.0 111.479 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -131.43 109.94 10.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.393 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.431 ' CZ ' ' HG2' ' A' ' 121' ' ' PRO . 8.1 p90 -127.7 152.99 47.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.747 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.23 128.83 52.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.213 0.53 . . . . 0.0 111.306 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -94.19 163.38 23.55 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.416 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 9.7 Cg_endo -52.74 82.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.0 2.467 . . . . 0.0 112.142 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.4 m-20 91.32 9.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.616 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.666 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.1 OUTLIER -137.42 93.85 2.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.616 0.246 . . . . 0.0 110.67 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 10.1 t-160 -89.8 98.78 11.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 110.673 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.988 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 2.0 tt -106.04 134.46 47.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.221 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -111.24 118.57 36.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.907 HD23 ' CG2' ' A' ' 122' ' ' VAL . 4.1 tp -111.7 113.91 26.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.017 0.437 . . . . 0.0 111.393 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -111.3 121.98 46.66 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.76 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.695 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.0 m-30 -112.73 111.24 21.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.011 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.704 ' CE2' HG11 ' A' ' 50' ' ' VAL . 14.6 m95 -96.14 149.12 21.98 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.056 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' PHE . 9.2 tp -97.63 103.31 15.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.515 0.674 . . . . 0.0 112.328 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.864 HG22 ' ND1' ' A' ' 64' ' ' HIS . 12.1 t -81.16 145.78 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.626 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.63 -26.16 8.0 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 90' ' ' TRP . 15.4 ttm-85 -161.98 165.06 27.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.676 0.671 . . . . 0.0 111.782 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.749 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -156.26 126.16 6.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.419 179.035 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.7 147.98 37.07 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.94 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.2 -119.7 17.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.476 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 35.3 tt0 -134.88 144.94 52.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.516 0.198 . . . . 0.0 110.856 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.509 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.39 128.83 10.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.983 2.455 . . . . 0.0 111.282 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.576 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 49.9 p-90 -135.06 -62.8 0.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.328 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.585 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.98 -100.08 0.02 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.02 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER 172.31 38.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 111.103 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -58.53 -48.44 80.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.83 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.34 -60.84 0.21 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.834 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.413 ' NE2' ' O ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -139.02 126.34 13.1 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.384 -179.584 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -43.31 146.2 1.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.164 2.576 . . . . 0.0 112.752 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.1 177.09 17.56 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.733 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -121.17 157.32 30.46 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -76.44 105.76 7.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 110.218 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 17.2 ptm -120.93 163.3 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.019 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.499 ' HB3' HG12 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -75.54 114.88 14.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.312 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -68.3 -18.81 64.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.569 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 106' ' ' SER . 12.1 p -54.91 -15.91 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.729 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.55 48.74 0.95 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.433 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.622 HD22 HD12 ' A' ' 123' ' ' ILE . 6.5 tt -62.28 150.42 39.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -111.13 114.88 28.45 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.712 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.546 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.35 -18.7 61.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.113 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.93 -45.58 20.2 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.949 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -66.78 -41.56 87.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.997 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.624 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -79.01 173.49 7.64 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.54 127.68 27.03 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 121.857 1.704 . . . . 0.0 112.027 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.02 -37.51 10.84 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.657 2.238 . . . . 0.0 112.667 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.542 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.64 -9.83 57.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.526 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -106.31 27.45 8.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.534 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.624 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.04 -30.99 0.95 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.2 Cg_exo -43.68 -35.01 6.06 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.966 1.777 . . . . 0.0 113.357 -178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.907 ' CG2' HD23 ' A' ' 82' ' ' LEU . 95.3 t -77.7 -51.1 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.087 0.47 . . . . 0.0 110.426 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.622 HD12 HD22 ' A' ' 110' ' ' LEU . 39.9 mm -64.61 -32.16 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.205 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.69 -27.37 39.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.9 0.381 . . . . 0.0 110.626 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -80.25 -51.26 9.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.886 HD22 ' CE2' ' A' ' 68' ' ' PHE . 23.2 tp -78.06 -28.23 48.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.609 ' HB2' HG22 ' A' ' 123' ' ' ILE . 49.6 tttm -55.27 -42.44 73.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.03 0.443 . . . . 0.0 110.599 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 -67.22 -10.08 46.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.693 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.294 179.746 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.988 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A 5059 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A 5060 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.882 0.372 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -78.43 138.57 38.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -140.08 128.72 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.484 HD11 " H1'" ' A' ' 131' ' ' 8OG . 3.1 pp -146.06 128.72 16.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 13.8 mt-30 -102.69 154.91 18.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.284 0.564 . . . . 0.0 112.204 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.608 HD11 " H4'" ' A' ' 131' ' ' 8OG . 3.2 mp -146.89 130.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.68 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.945 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.07 125.69 44.2 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.612 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m -140.28 162.24 24.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.394 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.439 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -147.58 129.88 3.35 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.057 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.594 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.7 110.54 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.731 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -70.94 121.99 21.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.996 0.427 . . . . 0.0 111.57 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.98 124.49 30.44 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.515 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.539 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 23.2 t-20 -70.88 178.26 3.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.006 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.539 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 31.6 tt0 -56.88 -17.24 8.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.76 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -122.49 -82.64 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.598 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.58 13.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -100.81 160.3 14.48 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 11' ' ' ILE . 5.2 mt -132.36 137.32 54.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.123 0.487 . . . . 0.0 111.624 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.466 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -83.48 118.29 23.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.573 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -121.28 141.42 41.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.092 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.517 HG22 ' CD ' ' A' ' 98' ' ' GLU . 5.2 p -70.75 111.74 6.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.686 0.279 . . . . 0.0 110.392 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -137.68 129.4 28.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.04 0.448 . . . . 0.0 111.407 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 50.07 24.0 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.484 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 25' ' ' ALA . . . 46.23 28.69 0.71 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.668 0.27 . . . . 0.0 111.512 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 81.89 -47.09 0.2 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.192 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.32 82.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.37 . . . . 0.0 110.82 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.22 -79.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -166.21 -55.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.37 81.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.96 -8.93 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.672 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.0 31.13 2.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.771 0.32 . . . . 0.0 111.124 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -111.83 26.28 10.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.253 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 33' ' ' LEU . 6.7 tt -65.67 69.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.057 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.615 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -119.82 -166.97 1.35 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.233 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.56 ' CZ ' HD11 ' A' ' 110' ' ' LEU . 0.0 OUTLIER -119.24 168.53 9.76 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.552 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.612 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 82.8 Cg_endo -78.68 167.68 22.15 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.564 2.842 . . . . 0.0 113.456 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.92 -3.67 48.84 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.407 -0.815 . . . . 0.0 114.534 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.41 158.13 31.94 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.632 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 88.17 0.34 0.41 Allowed 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.213 0.605 . . . . 0.0 112.429 179.145 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.945 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -49.84 -29.14 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.607 0.718 . . . . 0.0 110.526 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.617 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.62 -57.44 2.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.914 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.536 ' C ' ' O ' ' A' ' 41' ' ' GLU . 9.4 mmt 4.23 -78.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.911 0.757 . . . . 0.0 112.567 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.48 34.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.789 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -89.39 -174.16 4.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.717 0.294 . . . . 0.0 111.049 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.03 153.45 38.51 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.825 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.83 -25.28 0.97 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.828 2.352 . . . . 0.0 112.455 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -104.04 -40.33 6.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.431 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -80.32 -4.89 55.19 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.74 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.03 -57.01 13.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.869 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.846 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -78.52 -45.66 25.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.6 t -53.24 -39.75 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.237 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -78.02 -48.67 15.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.462 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.5 mm-40 -64.77 -20.05 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.596 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.693 HD11 ' NE2' ' A' ' 64' ' ' HIS . 1.2 tp -59.77 -44.39 93.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -65.0 -34.75 79.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.1 tm-20 -77.43 -27.35 52.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.087 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -108.53 5.39 25.1 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.391 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.964 HG12 HG13 ' A' ' 60' ' ' ILE . 35.1 t -134.61 -44.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.185 0.517 . . . . 0.0 110.042 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.02 -42.39 0.48 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.472 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.964 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.56 -176.48 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.016 0.436 . . . . 0.0 111.12 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -113.08 89.13 13.34 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.531 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.831 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.3 Cg_endo -107.82 143.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 123.272 2.648 . . . . 0.0 113.936 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.9 mt-30 -74.62 80.1 2.0 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.878 ' CE1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.64 133.32 54.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.474 -175.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.579 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -175.65 -145.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.617 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m 51.96 172.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.009 0.523 . . . . 0.0 112.138 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.863 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -140.26 122.18 15.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.62 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE2' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.55 -44.24 35.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.966 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -171.68 131.9 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.395 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -115.65 109.95 18.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.76 0.314 . . . . 0.0 110.552 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 tp -96.88 121.56 38.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.865 0.365 . . . . 0.0 110.964 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -123.14 109.69 14.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.442 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.41 ' CZ ' HG23 ' A' ' 80' ' ' ILE . 2.0 p90 -141.26 149.84 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 2.6 pt-20 -121.23 129.05 52.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.213 0.53 . . . . 0.0 111.062 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.455 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -95.69 163.27 21.73 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.52 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.1 Cg_endo -53.18 82.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.964 2.443 . . . . 0.0 112.337 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER 92.5 8.69 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.618 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.566 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 4.1 ttp180 -137.25 93.87 2.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.675 0.274 . . . . 0.0 110.896 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 3.2 t-160 -86.84 93.98 9.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.778 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.561 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 1.7 tp -101.24 111.93 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.049 0.452 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.477 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -103.82 118.81 37.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.751 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.517 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -116.35 114.19 23.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 112.023 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.477 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.9 m0 -108.53 122.48 47.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.147 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.677 ' CD1' HG11 ' A' ' 122' ' ' VAL . 1.7 m-85 -108.91 111.6 23.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.876 0.369 . . . . 0.0 110.078 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.863 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.5 m95 -94.54 148.91 21.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.704 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.579 ' O ' ' O ' ' A' ' 65' ' ' PHE . 38.0 tp -97.94 102.44 14.19 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 121.342 0.592 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.878 HG22 ' CE1' ' A' ' 64' ' ' HIS . 12.2 t -85.5 145.77 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.928 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.406 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 7.5 pt-20 -114.67 -24.12 8.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 7.5 tpt180 -162.61 160.76 26.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.787 0.721 . . . . 0.0 111.677 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.731 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -152.06 125.33 8.73 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.244 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -72.83 141.82 48.0 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.91 -118.92 11.98 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.53 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -131.92 142.86 46.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.552 0.215 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.2 Cg_exo -76.29 128.79 10.72 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.862 2.375 . . . . 0.0 111.412 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.613 ' HE1' HG23 ' A' ' 60' ' ' ILE . 47.6 p-90 -132.06 -62.08 0.86 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.097 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.564 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.92 -102.42 0.04 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.784 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 56' ' ' GLU . 6.7 tptp 179.33 35.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.778 0.323 . . . . 0.0 111.097 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.517 ' CD ' HG22 ' A' ' 21' ' ' THR . 16.0 pt-20 -50.85 -37.37 42.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.791 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.4 -31.93 5.78 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.848 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -128.76 97.17 27.87 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 111.449 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -43.57 146.11 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.953 2.435 . . . . 0.0 112.475 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.08 177.15 19.35 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.958 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.83 157.42 42.27 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.75 105.91 3.37 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.19 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.525 ' HE2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.72 163.31 18.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.908 179.589 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 t -73.82 114.94 12.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.412 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.576 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.53 -18.68 62.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.517 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.531 ' CG1' HD21 ' A' ' 129' ' ' LEU . 21.4 t -58.94 -12.28 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.732 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.51 53.15 0.74 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.032 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.56 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 6.0 tt -62.21 150.45 38.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.922 0.392 . . . . 0.0 110.771 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.516 ' HB3' HD13 ' A' ' 33' ' ' LEU . 3.9 t-20 -97.03 97.75 9.49 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.461 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.42 -20.32 61.44 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.965 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.14 -45.46 19.94 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.203 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.72 -40.61 88.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.551 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.4 174.24 6.34 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.641 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.06 127.79 27.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 121.844 1.696 . . . . 0.0 112.301 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 50.1 Cg_endo -69.01 -35.28 15.16 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.662 2.241 . . . . 0.0 112.505 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.581 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -72.7 -9.51 58.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 0.0 111.218 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -104.1 19.77 19.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.567 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -74.96 -30.57 1.02 Allowed Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.6 Cg_exo -43.19 -36.46 6.02 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 121.887 1.725 . . . . 0.0 113.196 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.677 HG11 ' CD1' ' A' ' 84' ' ' PHE . 23.7 t -77.82 -50.26 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.308 0.575 . . . . 0.0 110.264 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.684 HG22 ' HB2' ' A' ' 127' ' ' LYS . 48.6 mm -64.17 -33.9 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.701 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.58 44.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.001 0.429 . . . . 0.0 110.616 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -80.13 -50.71 9.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.739 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.0 tm? -78.12 -40.06 39.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.741 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.684 ' HB2' HG22 ' A' ' 123' ' ' ILE . 18.0 tttm -53.19 -42.7 66.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.12 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -66.98 -7.34 21.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.884 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.762 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.4 mp . . . . . 0 C--O 1.231 0.119 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.185 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.652 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A 5071 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A 5072 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.755 0.312 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.64 147.18 27.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.944 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -139.99 126.59 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.606 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.752 ' CD1' HD11 ' A' ' 6' ' ' ILE . 4.0 pp -146.09 127.05 14.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.194 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 43.4 mt-30 -104.6 152.41 22.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.301 0.572 . . . . 0.0 112.006 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.2 mp -146.44 123.14 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.421 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.022 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.09 125.68 44.15 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.3 m -131.21 162.49 39.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.38 0.61 . . . . 0.0 112.051 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -137.43 111.53 0.84 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.677 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.909 HD12 HD13 ' A' ' 18' ' ' ILE . 8.5 pt -70.41 105.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-O 120.724 0.297 . . . . 0.0 110.412 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.686 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.63 125.75 30.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.778 -178.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -98.75 136.02 39.39 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.412 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.741 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.6 p-10 -96.48 -173.3 2.72 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.511 0.672 . . . . 0.0 112.018 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.46 -0.99 9.45 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.642 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.44 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 15.0 t-20 -120.69 33.28 5.63 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.625 -0.43 . . . . 0.0 112.135 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.56 13.78 2.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 111.351 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HG3' ' HB3' ' A' ' 15' ' ' ASN . 4.9 mt-10 -102.08 161.16 13.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.909 HD13 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.7 124.58 72.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.184 0.516 . . . . 0.0 112.012 -178.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -74.2 120.18 19.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.652 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -129.08 150.4 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.287 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 69.2 p -70.83 111.75 6.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.768 0.318 . . . . 0.0 110.593 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HB2' HD13 ' A' ' 33' ' ' LEU . 38.9 ttp180 -126.57 126.3 43.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.957 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.876 ' CZ ' ' HB2' ' A' ' 30' ' ' ALA . 2.3 ttm180 48.87 -102.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 177.73 -177.42 0.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.754 0.312 . . . . 0.0 111.045 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.74 29.69 5.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.123 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -170.02 -54.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.031 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -178.86 132.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.6 -169.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.81 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.5 mmm -71.17 106.47 3.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.876 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . . . -64.98 -18.85 65.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.354 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.01 30.59 2.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.113 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 34' ' ' GLU . 10.7 mttt -114.11 26.14 10.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.938 0.399 . . . . 0.0 111.219 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.486 HD13 ' HB2' ' A' ' 22' ' ' ARG . 21.7 tp -61.24 77.33 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.033 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.617 ' O ' HG22 ' A' ' 20' ' ' ILE . 2.7 mt-10 -115.75 -170.44 1.78 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.116 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.572 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.26 168.15 10.55 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.625 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.616 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 94.6 Cg_endo -84.28 166.64 12.44 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.585 2.857 . . . . 0.0 113.307 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.05 -5.93 53.52 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-N 115.73 -0.668 . . . . 0.0 114.254 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.13 161.99 18.74 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.891 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.84 1.62 0.78 Allowed 'General case' 0 C--N 1.341 0.228 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.022 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -51.82 -27.69 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.54 0.686 . . . . 0.0 110.294 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.554 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -41.1 -57.78 1.95 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.804 179.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.528 ' C ' ' O ' ' A' ' 41' ' ' GLU . 25.0 mmm 5.86 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.457 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 178.28 33.51 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.755 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -87.94 -174.13 4.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.761 0.315 . . . . 0.0 111.069 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.08 153.1 38.27 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.267 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.825 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.76 -25.41 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.873 2.382 . . . . 0.0 112.487 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.5 mp0 -104.02 -39.68 6.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.448 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -80.25 -8.48 59.48 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.803 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.68 -54.62 43.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.7 0.286 . . . . 0.0 110.744 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.79 HG12 ' HB1' ' A' ' 7' ' ' ALA . 1.4 m -78.09 -47.46 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.167 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.8 t -54.1 -37.95 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.176 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -78.38 -51.97 9.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.257 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' GLU . 1.2 mm-40 -65.14 -19.85 66.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.331 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.767 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -61.2 -44.66 96.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.683 0.277 . . . . 0.0 111.054 -179.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -35.79 82.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -77.68 -26.34 50.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.209 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 53' ' ' GLU . 7.3 mm-40 -108.32 5.34 25.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.929 HG12 HG13 ' A' ' 60' ' ' ILE . 44.7 t -134.45 -44.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.234 0.54 . . . . 0.0 109.68 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.29 -41.47 0.37 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.817 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.929 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.84 -177.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.137 0.494 . . . . 0.0 111.42 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.41 89.0 13.97 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.896 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.752 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.1 Cg_endo -109.98 150.86 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.339 2.693 . . . . 0.0 114.475 -177.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' CG ' ' HG2' ' A' ' 89' ' ' ARG . 33.7 mt-30 -74.73 79.82 2.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.952 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.77 128.0 47.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.155 -176.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.432 ' N ' ' HD1' ' A' ' 64' ' ' HIS . 1.8 t80 -176.31 -40.67 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.639 ' HB3' HD23 ' A' ' 86' ' ' LEU . 58.4 m -41.4 163.57 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.894 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.404 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.59 120.57 39.1 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.071 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.3 OUTLIER -88.56 -56.65 3.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.807 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -172.27 162.48 5.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.735 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 132.02 22.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.726 0.298 . . . . 0.0 110.774 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.684 HD22 HG23 ' A' ' 122' ' ' VAL . 3.4 tp -121.62 133.37 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.812 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -130.85 109.66 10.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.608 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.694 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.2 p90 -141.24 144.75 34.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.625 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.08 136.03 55.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.135 0.493 . . . . 0.0 111.373 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.467 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -99.58 163.04 19.28 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.32 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 12.8 Cg_endo -56.41 81.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.754 2.303 . . . . 0.0 112.217 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 9.0 t70 99.45 3.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.754 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.563 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 21.6 ttp180 -137.25 94.76 2.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.685 0.279 . . . . 0.0 110.953 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.5 t-160 -91.3 105.04 17.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 110.98 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.968 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 3.8 tt -106.11 132.6 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.51 118.73 31.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.541 178.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -117.03 114.25 23.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.96 0.409 . . . . 0.0 111.431 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 11.2 m0 -107.52 122.59 46.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.191 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.893 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 2.4 m-85 -108.08 109.64 21.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.039 0.447 . . . . 0.0 110.627 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.742 ' NE1' HG11 ' A' ' 50' ' ' VAL . 39.0 m95 -98.15 148.4 23.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.705 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.639 HD23 ' HB3' ' A' ' 66' ' ' SER . 56.0 tp -94.02 138.41 32.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.384 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.952 HG22 ' ND1' ' A' ' 64' ' ' HIS . 58.1 t -120.54 145.87 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.364 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -107.01 -28.5 9.99 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.45 165.49 23.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.894 0.77 . . . . 0.0 111.64 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.741 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -155.31 123.63 5.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.356 178.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.63 147.18 44.01 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.048 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.08 -121.97 25.74 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.586 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -131.88 146.29 61.13 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.579 0.228 . . . . 0.0 110.781 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.5 128.74 10.53 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.793 2.329 . . . . 0.0 111.475 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.568 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 51.4 p-90 -130.42 -61.26 0.97 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.869 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.622 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 36.87 -97.69 0.01 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.214 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.58 40.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.651 0.263 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -68.98 -25.44 64.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.075 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.42 -86.58 0.27 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.3 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 21' ' ' THR . 2.0 pt20 -108.24 115.98 57.41 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 111.847 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.63 146.19 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.04 2.493 . . . . 0.0 112.81 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -122.94 177.31 16.56 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.006 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.525 ' HG3' ' HE3' ' A' ' 105' ' ' MET . 0.4 OUTLIER -125.31 157.52 36.47 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -64.53 105.99 1.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.915 0.388 . . . . 0.0 110.09 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.525 ' HE3' ' HG3' ' A' ' 103' ' ' GLU . 5.5 ptp -120.7 152.2 38.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.8 p -74.23 118.55 17.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.55 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.79 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -73.04 -18.62 61.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.41 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 108' ' ' VAL . 21.3 t -59.64 -11.54 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.694 0.283 . . . . 0.0 111.547 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.13 54.45 0.73 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.661 HD13 HD22 ' A' ' 107' ' ' LEU . 7.0 tp -61.74 150.27 37.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 110.787 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -109.95 103.73 12.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.54 -18.86 61.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.153 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -79.0 -47.07 16.93 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.45 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.63 -40.52 88.77 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.229 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.4 174.2 6.4 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.09 127.73 26.91 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.911 1.74 . . . . 0.0 112.489 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.29 -35.48 13.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.726 2.284 . . . . 0.0 112.465 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.846 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.05 -9.75 56.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.316 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.425 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 14.6 m-20 -107.73 19.73 19.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.997 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -66.67 -31.75 4.45 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -179.079 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.8 Cg_exo -43.85 -36.57 8.06 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.797 1.665 . . . . 0.0 113.276 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.893 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 55.1 t -77.88 -51.14 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 111.738 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.833 HG22 ' HB2' ' A' ' 127' ' ' LYS . 9.5 mm -74.84 -42.0 46.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.82 -28.27 34.51 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -80.8 -53.78 6.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.51 ' HG ' ' CZ ' ' A' ' 68' ' ' PHE . 3.5 mm? -78.86 -31.12 45.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.833 ' HB2' HG22 ' A' ' 123' ' ' ILE . 15.9 tttm -54.09 -42.1 68.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.044 0.449 . . . . 0.0 110.684 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.818 ' O ' HD12 ' A' ' 129' ' ' LEU . 60.3 ttm-85 -70.41 -6.48 35.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.978 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.148 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.968 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A 5083 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A 5084 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 ptm . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.768 0.318 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -107.9 134.6 50.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 139.1 35.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.812 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.402 HD21 ' N3 ' ' A' ' 131' ' ' 8OG . 2.8 pp -146.23 123.64 11.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 39.8 mt-30 -102.69 149.01 24.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.136 0.493 . . . . 0.0 111.612 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.697 HG22 ' HA ' ' A' ' 82' ' ' LEU . 2.2 tp -146.59 125.61 4.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.912 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.037 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.98 125.5 43.98 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.648 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -131.14 162.13 39.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.293 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -141.13 111.28 0.7 Allowed Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.664 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.977 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.64 109.42 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -71.18 124.92 28.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.232 0.539 . . . . 0.0 111.785 -178.496 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.29 121.13 31.27 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.442 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.709 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.8 p30 -81.35 -172.96 4.08 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 123.704 0.628 . . . . 0.0 111.007 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tt0 -79.31 11.02 3.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -136.4 48.22 2.15 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.988 -0.445 . . . . 0.0 112.128 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 44.85 27.36 0.26 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.319 0.58 . . . . 0.0 111.071 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 105' ' ' MET . 25.9 mt-10 -122.49 161.89 22.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.005 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.977 HG21 HG22 ' A' ' 10' ' ' ILE . 6.6 mt -128.85 143.62 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.241 0.543 . . . . 0.0 111.83 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -88.62 118.42 28.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.728 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.474 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -118.29 145.89 23.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.642 HG22 ' OE2' ' A' ' 98' ' ' GLU . 1.7 p -70.72 111.95 6.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.71 0.29 . . . . 0.0 110.528 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.631 ' CB ' HD13 ' A' ' 33' ' ' LEU . 10.6 ttp180 -123.02 123.15 40.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 6.2 ttp180 53.08 -102.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.915 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 174.45 -68.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.839 0.352 . . . . 0.0 110.968 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -170.59 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -160.79 38.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.0 132.44 41.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.048 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.22 87.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.036 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.0 mmt -155.08 28.42 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.11 -13.01 60.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.535 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -84.35 4.41 31.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.493 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 34' ' ' GLU . 2.7 mptp? -114.07 26.08 10.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 111.196 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.631 HD13 ' CB ' ' A' ' 22' ' ' ARG . 22.4 tp -55.71 86.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.943 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -119.11 -170.86 2.0 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.084 0.469 . . . . 0.0 111.872 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.5 168.33 10.3 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.607 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.648 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 57.8 Cg_endo -72.06 166.93 28.17 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.377 2.718 . . . . 0.0 112.983 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.785 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.82 -5.76 54.03 Favored Glycine 0 C--O 1.222 -0.601 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.876 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -61.96 140.97 47.11 Favored Glycine 0 C--N 1.316 -0.571 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.262 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 96.27 3.41 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.037 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -51.86 -27.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.489 0.661 . . . . 0.0 110.638 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.09 -76.53 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.173 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 41' ' ' GLU . 44.2 mmm 24.77 -85.48 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.708 0.63 . . . . 0.0 112.316 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.66 31.85 0.11 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.809 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.3 mp0 -89.96 -172.83 3.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.662 0.268 . . . . 0.0 111.195 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.852 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.88 153.06 37.95 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.376 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.852 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -44.06 -24.81 0.96 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.704 2.27 . . . . 0.0 112.643 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.674 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.8 mt-10 -103.39 -41.21 6.08 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 12.9 mm-40 -80.2 -18.12 50.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.618 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.829 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.04 -48.59 79.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.266 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.762 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.15 -46.95 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 110.79 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.2 t -54.12 -37.5 35.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.441 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -78.07 -52.06 9.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.548 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.439 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.7 tp10 -61.14 -19.99 62.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.605 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.855 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -61.4 -44.86 96.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.047 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -69.23 -30.0 68.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.204 0.526 . . . . 0.0 109.762 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.7 tt0 -77.33 -29.57 53.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.062 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -109.08 6.67 25.19 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -178.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.902 HG12 HG13 ' A' ' 60' ' ' ILE . 46.0 t -133.41 -44.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 109.939 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.84 -39.17 0.18 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.237 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.902 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.69 -177.53 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.092 0.472 . . . . 0.0 111.33 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.43 88.99 13.99 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.953 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.695 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.5 Cg_endo -110.24 148.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.399 2.733 . . . . 0.0 114.312 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 40.3 mt-30 -74.93 79.81 2.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.997 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -124.82 128.8 49.27 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.052 -1.431 . . . . 0.0 109.664 -176.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -173.98 -49.77 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 86' ' ' LEU . 2.2 p -38.16 159.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.947 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.762 HD11 ' HG2' ' A' ' 70' ' ' LYS . 6.8 tt -119.32 116.63 26.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.96 -54.74 6.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.178 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.549 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.74 142.19 1.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.447 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.762 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -139.92 103.87 4.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.432 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.645 HD21 HG22 ' A' ' 122' ' ' VAL . 1.9 pp -111.46 160.79 16.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.548 ' HB2' HG22 ' A' ' 81' ' ' THR . 16.1 tt0 -135.14 109.89 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.653 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -129.36 123.45 31.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.336 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 11.2 pt-20 -110.07 133.87 52.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.179 0.514 . . . . 0.0 111.616 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 2.8 m-85 -74.68 163.67 66.65 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.885 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.7 Cg_endo -37.38 -29.1 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.642 2.894 . . . . 0.0 113.214 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -139.62 -39.66 0.46 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.076 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -84.75 104.38 14.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.25 -179.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.427 ' HE1' HG23 ' A' ' 81' ' ' THR . 0.5 OUTLIER -89.37 112.38 23.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.765 0.317 . . . . 0.0 110.572 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.951 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 3.2 tt -118.48 128.99 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.228 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.548 HG22 ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -113.72 118.56 34.67 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.57 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.697 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -114.28 114.17 25.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.115 0.483 . . . . 0.0 112.031 -178.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.422 ' CZ3' ' HE2' ' A' ' 70' ' ' LYS . 10.5 m0 -110.22 122.08 46.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.201 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' A' ' 122' ' ' VAL . 6.1 m-30 -112.43 111.94 23.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.7 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.617 ' CE2' HG11 ' A' ' 50' ' ' VAL . 21.1 m95 -100.56 148.98 24.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.718 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 66' ' ' SER . 45.9 tp -93.97 138.69 31.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.514 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.997 HG22 ' ND1' ' A' ' 64' ' ' HIS . 44.8 t -120.09 145.7 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.095 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.99 -24.55 10.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -163.66 164.96 23.78 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.958 0.799 . . . . 0.0 111.508 -178.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.709 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -157.24 123.54 4.89 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.94 0.4 . . . . 0.0 111.326 178.499 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -76.13 151.7 36.93 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.077 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.97 -122.66 28.17 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.558 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 13.6 mt-10 -132.17 147.87 67.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.516 0.198 . . . . 0.0 110.77 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.557 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.48 128.81 10.58 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.845 2.363 . . . . 0.0 111.202 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.561 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 52.5 p-90 -134.43 -64.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.539 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.596 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.85 -96.56 0.01 OUTLIER Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.143 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 173.44 38.83 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.678 0.275 . . . . 0.0 110.93 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.642 ' OE2' HG22 ' A' ' 21' ' ' THR . 15.2 pt-20 -58.45 -49.42 77.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.855 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.44 -63.56 0.36 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.967 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.92 120.21 25.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.004 0.431 . . . . 0.0 111.637 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -43.48 146.28 1.33 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.101 2.534 . . . . 0.0 112.658 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.7 177.11 17.18 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.874 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -130.29 157.43 42.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.533 0.206 . . . . 0.0 110.472 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.475 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -65.28 106.08 1.27 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.926 0.393 . . . . 0.0 110.272 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.518 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -120.83 163.21 18.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.224 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.408 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -77.32 115.96 17.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.791 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.541 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -80.05 -18.82 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.449 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.46 -12.62 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.601 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.87 54.88 0.63 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.979 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.74 HD22 HD12 ' A' ' 123' ' ' ILE . 4.6 tt -61.84 150.52 37.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -101.02 108.89 20.72 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -16.96 61.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.062 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.01 -46.82 17.4 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.184 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -66.79 -40.51 88.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.61 174.02 6.72 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.642 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.43 127.71 27.08 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 121.893 1.728 . . . . 0.0 112.321 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.88 -37.49 11.41 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.643 2.229 . . . . 0.0 112.628 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.778 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.5 -9.58 56.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 111.481 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -104.69 21.78 16.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.829 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -71.87 -31.51 1.8 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 90.9 Cg_exo -44.07 -37.33 9.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.86 1.707 . . . . 0.0 113.188 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.666 HG11 ' CD2' ' A' ' 84' ' ' PHE . 58.8 t -77.67 -51.0 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.63 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.74 HD12 HD22 ' A' ' 110' ' ' LEU . 43.1 mm -65.48 -30.61 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.33 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.86 -29.43 55.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.121 0.486 . . . . 0.0 110.493 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -78.27 -51.3 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.622 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.839 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.2 tm? -78.22 -19.91 52.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.814 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.605 ' HB2' HG22 ' A' ' 123' ' ' ILE . 4.9 ttpm? -75.18 -42.57 55.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.095 0.474 . . . . 0.0 110.51 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.0 ttm105 -67.77 -9.14 41.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.027 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.582 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.951 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A 5095 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A 5096 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tpp . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.776 0.322 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -98.97 141.19 32.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -140.26 138.11 34.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.594 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.848 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.9 pp -146.29 131.26 18.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.345 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.444 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 28.0 mt-30 -103.09 153.05 20.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.217 0.532 . . . . 0.0 111.965 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.848 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.0 mp -146.53 134.66 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.854 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.061 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.51 124.29 41.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.602 HG11 ' CE1' ' A' ' 84' ' ' PHE . 1.6 m -125.48 162.53 28.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.233 0.539 . . . . 0.0 112.005 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -145.95 113.5 0.69 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.146 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.946 ' CG2' HG21 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -70.69 101.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.828 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -71.04 123.35 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 121.306 0.574 . . . . 0.0 111.937 -178.374 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.81 123.62 34.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.482 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.492 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 12.5 t-20 -76.73 -172.31 2.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.865 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.7 tm-20 -83.15 4.05 28.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.093 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -138.41 50.85 1.87 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.346 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.71 24.42 0.33 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.384 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 23.5 pt-20 -117.74 144.4 45.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.946 HG21 ' CG2' ' A' ' 10' ' ' ILE . 6.1 mt -113.1 138.84 41.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.228 0.537 . . . . 0.0 111.754 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.27 108.29 19.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.275 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.884 HD12 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -107.86 155.89 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.141 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.714 HG23 ' HD3' ' A' ' 36' ' ' PRO . 5.8 p -71.04 111.81 6.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.686 0.279 . . . . 0.0 110.253 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.87 129.67 50.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.955 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 13.6 ttm180 48.01 -104.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 175.07 -166.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.794 0.331 . . . . 0.0 110.97 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.52 -30.85 42.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -166.17 81.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.73 -171.17 3.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.2 t-80 -123.07 31.26 6.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.96 50.23 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.72 -22.51 5.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.607 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.61 31.25 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.348 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -113.71 25.99 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 111.259 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.884 HD21 HD12 ' A' ' 20' ' ' ILE . 1.8 tt -70.59 65.83 0.32 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.605 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.86 -169.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.444 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.811 ' CD2' HD12 ' A' ' 10' ' ' ILE . 3.0 m-85 -119.13 143.75 34.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.709 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.714 ' HD3' HG23 ' A' ' 21' ' ' THR . 17.8 Cg_endo -58.23 165.98 6.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.741 2.294 . . . . 0.0 111.067 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 100.36 58.66 0.85 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 119.72 -1.228 . . . . 0.0 113.359 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -124.84 134.02 8.8 Favored Glycine 0 C--N 1.31 -0.879 0 CA-C-N 114.857 -0.672 . . . . 0.0 112.25 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 101.58 -2.47 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.061 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -50.19 -26.27 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.219 0.533 . . . . 0.0 111.017 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.513 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.59 -68.67 0.16 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.973 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.455 ' C ' ' O ' ' A' ' 41' ' ' GLU . 76.6 mmm 23.54 -86.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.831 0.707 . . . . 0.0 112.318 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.97 29.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.832 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.5 mp0 -93.66 -173.7 3.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.792 0.329 . . . . 0.0 111.068 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.905 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.0 155.44 37.61 Favored Pre-proline 0 N--CA 1.456 -0.157 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.327 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.905 ' HD2' HG22 ' A' ' 45' ' ' THR . 4.1 Cg_endo -45.24 -24.6 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.651 2.234 . . . . 0.0 112.461 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.743 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -94.23 -50.17 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -80.17 -29.55 38.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.721 0.296 . . . . 0.0 111.604 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.984 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -52.42 -45.86 66.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.91 0.386 . . . . 0.0 110.845 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.791 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -78.46 -50.55 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.898 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 47' ' ' GLU . 55.5 t -54.45 -36.78 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.875 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -52.02 9.44 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.927 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.586 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.9 mm-40 -66.93 -25.0 66.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.722 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.985 ' O ' HG23 ' A' ' 58' ' ' VAL . 12.4 tp -52.75 -45.76 67.19 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.874 0.369 . . . . 0.0 110.39 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -62.64 -26.68 68.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.84 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -71.43 -23.65 61.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.891 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.496 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.0 mm-40 -108.19 5.09 25.49 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -134.61 -44.7 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.424 0.63 . . . . 0.0 109.497 178.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.58 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 70.01 -36.6 0.4 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.276 -0.874 . . . . 0.0 114.597 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.927 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -84.4 -168.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 120.945 0.403 . . . . 0.0 110.882 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -111.73 89.29 10.87 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.603 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.633 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.3 Cg_endo -107.36 147.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.018 2.478 . . . . 0.0 113.997 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 53.8 mt-30 -74.83 80.05 2.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.917 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.87 129.05 50.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.481 -176.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.6 t80 179.6 163.5 0.98 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.932 0.396 . . . . 0.0 112.034 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 84.64 163.62 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.882 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.7 pp -121.8 127.55 50.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.071 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 1.5 p90 -76.81 -44.37 32.84 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.9 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.571 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 12.4 mt-10 -171.43 131.78 0.75 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.859 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -132.53 132.0 42.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.635 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 1.038 HD11 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.34 154.61 44.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.003 0.43 . . . . 0.0 111.23 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.552 ' CG ' HG23 ' A' ' 81' ' ' THR . 19.5 tt0 -131.8 109.78 10.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.377 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.511 ' OH ' HD13 ' A' ' 80' ' ' ILE . 55.4 p90 -125.97 151.87 46.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 5.6 pt-20 -120.16 140.12 51.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.361 0.6 . . . . 0.0 111.493 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.2 m-85 -103.44 162.73 19.15 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.085 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.5 Cg_endo -52.61 81.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.919 2.413 . . . . 0.0 112.174 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.2 t70 93.14 10.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.556 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.602 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.5 OUTLIER -137.37 93.82 2.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.679 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.441 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.7 t-80 -85.42 93.94 8.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.745 0.307 . . . . 0.0 110.69 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.991 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 2.7 tt -96.7 111.99 27.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 111.397 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.578 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -99.61 118.54 36.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.208 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.676 HD23 ' HB ' ' A' ' 6' ' ' ILE . 9.9 mt -120.71 114.12 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.936 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.578 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.4 m0 -110.42 122.11 46.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.838 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.843 ' CD2' HG11 ' A' ' 122' ' ' VAL . 3.2 m-85 -106.45 133.7 50.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.045 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.791 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 11.0 m95 -117.01 148.45 41.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 65' ' ' PHE . 35.4 tp -85.9 138.24 32.17 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.319 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.803 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.5 t -124.2 145.9 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.427 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -110.44 -32.07 7.06 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.1 164.28 25.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.777 0.717 . . . . 0.0 111.843 -178.795 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.739 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.8 p90 -148.63 126.38 11.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.235 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.95 150.6 35.91 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.292 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.24 -129.98 48.8 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.707 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.587 ' O ' HG12 ' A' ' 60' ' ' ILE . 16.3 mt-10 -120.65 136.57 25.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.886 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.2 Cg_exo -74.46 128.85 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.573 2.182 . . . . 0.0 111.375 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.58 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 39.1 p-90 -130.22 -63.47 0.9 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.48 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.496 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 51.25 -109.51 0.79 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.603 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 168.55 41.95 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.769 0.318 . . . . 0.0 111.007 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.32 -46.31 79.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.861 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.11 -23.56 4.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.89 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.44 100.7 13.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.911 0.386 . . . . 0.0 111.306 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -43.5 143.3 2.58 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.912 2.408 . . . . 0.0 112.581 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.1 177.12 19.38 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.666 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -131.84 157.17 44.62 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -72.43 106.38 4.51 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.196 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.421 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.5 ptm -120.43 163.16 18.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.224 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.84 117.94 21.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.592 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.665 HD11 HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.77 -18.84 46.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.4 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.647 HG23 HD22 ' A' ' 129' ' ' LEU . 11.9 p -58.37 -14.65 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.611 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.33 49.95 0.91 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.785 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.896 HD23 HG23 ' A' ' 123' ' ' ILE . 10.0 tp -62.31 150.51 39.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.74 0.305 . . . . 0.0 111.098 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.69 ' CB ' HD13 ' A' ' 33' ' ' LEU . 1.9 t-20 -111.0 92.92 4.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.5 -19.93 61.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.117 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -79.06 -45.31 20.38 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -42.16 87.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.568 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.34 174.37 6.13 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.09 127.87 27.51 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 121.99 1.793 . . . . 0.0 112.173 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.82 -39.13 11.99 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.727 2.284 . . . . 0.0 112.76 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.462 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.63 -9.63 57.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.083 0.468 . . . . 0.0 111.533 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -101.83 20.46 16.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.754 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -72.84 -31.08 1.42 Allowed Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.4 Cg_exo -43.71 -36.57 7.64 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.831 1.687 . . . . 0.0 113.011 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 1.038 HG22 HD11 ' A' ' 71' ' ' LEU . 69.9 t -77.91 -51.33 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.092 0.472 . . . . 0.0 110.958 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.896 HG23 HD23 ' A' ' 110' ' ' LEU . 17.8 mm -65.24 -34.63 71.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.75 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.23 -27.74 36.56 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.472 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -80.58 -53.04 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.934 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.524 HD23 ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -78.14 -32.97 50.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.75 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.892 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.3 ttpt -53.35 -42.21 66.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.818 ' O ' HD12 ' A' ' 129' ' ' LEU . 15.2 ttt-85 -71.02 -6.17 36.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.003 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.061 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.991 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A 5107 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A 5108 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 mtp . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.756 0.312 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.85 146.62 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.06 139.57 35.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.837 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.412 HD11 " H1'" ' A' ' 131' ' ' 8OG . 2.8 pp -146.25 122.98 11.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -102.57 151.31 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.13 0.491 . . . . 0.0 111.378 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.673 HD13 " H4'" ' A' ' 131' ' ' 8OG . 2.0 tp -146.61 130.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.332 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.906 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.02 125.48 43.93 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m -139.93 154.8 23.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.269 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.05 120.92 2.34 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.461 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.757 HG22 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -70.35 108.43 2.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.772 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.05 124.98 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.155 0.502 . . . . 0.0 111.688 -178.146 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -100.7 129.25 46.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.3 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.707 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.8 p-10 -84.44 -172.87 4.41 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.43 0.634 . . . . 0.0 111.786 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.3 tm-20 -73.63 4.89 4.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.452 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -128.63 44.39 2.97 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.014 -0.429 . . . . 0.0 112.092 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 48.96 23.13 0.66 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 111.473 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 33.6 mt-10 -114.0 161.61 17.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.757 HG12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -115.03 139.83 39.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.497 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.577 ' CD2' HD12 ' A' ' 11' ' ' ILE . 1.8 t80 -93.41 97.56 10.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.569 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.668 HD12 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -110.01 162.22 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.253 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 71.3 p -70.59 134.95 48.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.48 100.51 5.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 111.133 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.904 ' HD3' ' HB2' ' A' ' 30' ' ' ALA . 21.6 ttp180 48.82 -95.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.24 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.57 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.047 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -169.49 -52.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.059 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -169.24 -49.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.4 90.3 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -169.09 -164.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.798 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.0 mtt -65.15 77.83 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.843 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.904 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . . . -71.42 -13.04 61.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.687 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -95.65 23.14 6.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.276 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.34 26.39 10.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 111.577 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 20' ' ' ILE . 1.2 tt -64.77 73.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.768 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -113.66 -172.06 2.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.063 0.459 . . . . 0.0 111.675 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.554 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.45 168.27 10.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.609 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.705 ' HG3' HD11 ' A' ' 11' ' ' ILE . 60.2 Cg_endo -72.63 166.88 28.63 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.42 2.746 . . . . 0.0 113.162 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.788 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.68 -5.33 54.15 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 116.011 -0.541 . . . . 0.0 113.99 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.582 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -65.34 132.56 35.76 Favored Glycine 0 C--N 1.315 -0.598 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.727 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 106.36 1.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.273 0.629 . . . . 0.0 112.081 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.906 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -49.16 -29.8 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.672 0.748 . . . . 0.0 110.588 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.627 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -41.45 -58.65 1.82 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.105 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.538 ' C ' ' O ' ' A' ' 41' ' ' GLU . 12.6 mmt 2.68 -78.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.656 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.42 33.27 0.07 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.031 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 13.1 mp0 -101.55 -174.96 2.72 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.617 0.246 . . . . 0.0 111.037 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.819 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -105.42 152.39 39.91 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.283 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.819 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.68 -24.57 0.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.73 2.287 . . . . 0.0 112.463 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.76 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -94.39 -50.38 5.26 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -80.42 -29.22 37.67 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.831 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -55.6 -43.88 76.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.184 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.517 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 m -78.27 -48.75 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.89 0.376 . . . . 0.0 110.233 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.7 t -57.16 -35.91 49.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.75 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.4 mmt-85 -77.94 -50.14 12.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.497 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.71 -21.99 66.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.626 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.135 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -56.88 -44.75 82.6 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.931 0.396 . . . . 0.0 110.289 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -68.36 -28.05 66.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.348 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.33 -38.65 49.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.48 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 1.3 mp0 -104.66 5.16 33.35 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.086 HG12 HG22 ' A' ' 60' ' ' ILE . 11.1 t -134.42 -43.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.048 0.451 . . . . 0.0 109.997 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.0 -35.06 0.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.706 -0.679 . . . . 0.0 114.418 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.086 HG22 HG12 ' A' ' 58' ' ' VAL . 5.4 tp -77.53 166.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.56 0.219 . . . . 0.0 110.773 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.73 89.05 1.36 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.0 Cg_endo -114.38 150.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 123.552 2.835 . . . . 0.0 114.525 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.408 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 35.0 mt-30 -74.94 79.42 2.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.135 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.0 OUTLIER -123.39 127.61 48.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.492 -176.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -179.1 -134.12 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.634 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 55.77 166.34 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.918 0.39 . . . . 0.0 111.849 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.641 HD23 ' O ' ' A' ' 67' ' ' LEU . 6.9 tt -127.87 110.79 12.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.047 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.79 -45.25 29.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.122 0.486 . . . . 0.0 109.821 179.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.52 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.3 tt0 -171.6 156.72 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.364 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.28 104.32 4.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.453 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.542 HD23 ' CE1' ' A' ' 73' ' ' TYR . 4.7 tp -96.84 135.79 38.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.889 0.376 . . . . 0.0 111.097 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -126.98 109.48 11.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.615 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.542 ' CE1' HD23 ' A' ' 71' ' ' LEU . 4.2 p90 -141.41 128.64 21.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.449 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 7.9 pt-20 -116.02 130.73 56.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 111.56 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 2.7 m-85 -71.11 163.33 66.44 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.026 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.472 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.4 Cg_endo -38.06 -29.14 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.598 2.865 . . . . 0.0 113.036 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -139.63 -38.43 0.48 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.009 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -83.86 99.85 10.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.284 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.457 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 4.1 t60 -87.01 110.33 19.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.785 0.326 . . . . 0.0 110.673 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.987 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 2.5 tt -115.27 137.38 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.961 0.41 . . . . 0.0 110.935 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.74 118.43 30.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.656 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.884 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -107.18 113.87 27.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.0 111.384 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 8.7 m0 -114.99 122.43 46.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.176 0.512 . . . . 0.0 110.32 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.887 ' CD1' HG11 ' A' ' 122' ' ' VAL . 3.9 m-85 -110.68 124.08 51.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.572 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.728 ' HE1' ' HB1' ' A' ' 7' ' ' ALA . 66.4 m95 -108.58 148.64 30.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.76 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.525 ' O ' ' O ' ' A' ' 65' ' ' PHE . 37.6 tp -99.53 103.21 14.93 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.448 0.642 . . . . 0.0 111.746 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.843 HG13 ' CB ' ' A' ' 64' ' ' HIS . 19.0 t -83.23 145.58 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.515 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -104.27 -50.74 3.27 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.15 165.76 24.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.488 0.586 . . . . 0.0 112.508 -178.096 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.707 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 24.1 p90 -133.81 159.57 40.22 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.506 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.19 102.15 14.17 Favored 'General case' 0 N--CA 1.46 0.039 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.237 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.4 -112.09 4.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.384 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.1 tt0 -131.53 135.4 26.88 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.212 . . . . 0.0 111.224 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.478 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 5.2 Cg_exo -76.5 139.6 20.68 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 111.211 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.556 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 33.4 p-90 -134.59 -63.45 0.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.19 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.667 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.77 -104.68 0.04 OUTLIER Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.308 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt 168.22 40.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.75 0.31 . . . . 0.0 110.897 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -23.68 62.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.081 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 145.3 -86.85 0.17 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.078 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.451 ' NE2' ' O ' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -111.07 118.78 47.28 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.06 0.457 . . . . 0.0 111.649 -179.29 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.55 146.19 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.192 2.595 . . . . 0.0 112.802 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.09 177.42 19.14 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.846 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -122.69 157.23 32.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.566 0.222 . . . . 0.0 110.436 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.444 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -68.38 106.37 2.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.976 0.417 . . . . 0.0 110.24 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.9 ptm -120.54 152.02 38.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.105 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.58 ' HB3' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -70.25 114.9 8.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.637 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.987 HD21 HD12 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -59.17 -18.5 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.66 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 106' ' ' SER . 13.7 p -52.75 -14.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.83 54.37 0.72 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.635 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.987 HD12 HD21 ' A' ' 107' ' ' LEU . 3.8 tt -61.77 150.53 36.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.886 0.374 . . . . 0.0 110.918 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -100.61 93.2 5.48 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.428 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.48 -21.42 61.21 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -79.22 -44.91 20.89 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.07 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -66.72 -40.11 88.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.372 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.569 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.37 174.39 6.09 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.8 Cg_endo -53.79 127.78 26.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.899 1.733 . . . . 0.0 112.603 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 49.6 Cg_endo -68.41 -36.11 16.44 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.885 2.39 . . . . 0.0 112.366 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.802 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -71.4 -9.54 58.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.07 0.462 . . . . 0.0 111.071 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -106.02 16.66 24.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.055 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.576 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -73.44 -30.97 1.29 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.1 Cg_exo -43.57 -36.37 7.04 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.847 1.698 . . . . 0.0 113.51 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.887 HG11 ' CD1' ' A' ' 84' ' ' PHE . 17.6 t -77.88 -51.27 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.145 0.498 . . . . 0.0 110.534 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 127' ' ' LYS . 20.4 mm -65.48 -30.99 51.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.25 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.89 47.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.614 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -49.83 11.52 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.653 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.815 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.3 tm? -78.3 -28.84 47.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.405 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 123' ' ' ILE . 7.9 ttpt -55.01 -42.54 72.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.109 0.48 . . . . 0.0 110.654 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -64.05 -12.61 40.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.521 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.0 mp . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.947 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.987 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A 5119 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A 5120 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.738 0.304 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.732 ' CE ' HD23 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -109.97 144.45 38.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -140.11 130.17 24.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.68 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.732 HD23 ' CE ' ' A' ' 2' ' ' LYS . 3.2 pp -146.19 124.72 12.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.369 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.421 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 30.4 mt-30 -102.81 151.7 22.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.419 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.618 ' HB ' HD12 ' A' ' 82' ' ' LEU . 2.1 mp -146.53 127.09 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.904 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.894 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.77 125.63 44.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -144.36 162.16 14.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.833 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -147.76 125.62 2.17 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.692 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.091 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.84 110.92 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.764 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.53 125.31 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-O 121.178 0.513 . . . . 0.0 111.537 -178.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.92 118.93 30.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.194 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.731 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 2.9 p-10 -79.64 -172.22 3.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.331 0.586 . . . . 0.0 111.389 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.6 tm-20 -77.08 13.46 1.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.426 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 10.7 t-20 -143.25 51.89 1.37 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.214 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.17 27.62 0.22 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.023 0.439 . . . . 0.0 111.571 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' C ' ' OD1' ' A' ' 13' ' ' ASN . 23.2 mt-10 -122.94 161.75 23.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.091 HG21 HG22 ' A' ' 10' ' ' ILE . 8.1 mt -128.22 144.11 38.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.189 0.519 . . . . 0.0 112.186 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.68 115.21 26.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.446 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -112.46 133.34 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.404 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 100' ' ' GLN . 23.4 p -70.97 114.44 9.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.042 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HB3' HD13 ' A' ' 33' ' ' LEU . 1.5 ptm180 -121.78 131.58 54.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.691 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 6.9 ttm180 47.22 -103.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.813 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.552 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . . . 170.54 -166.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 0.0 110.915 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.21 -29.94 34.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.165 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.18 33.4 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.109 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.552 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . . . -103.58 167.73 9.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.062 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -117.29 37.63 3.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.999 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.1 mtt -116.03 68.46 0.72 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.58 -19.03 56.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.458 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.29 31.09 2.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.267 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.22 25.94 10.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.983 0.421 . . . . 0.0 111.574 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 38.6 tp -68.68 71.72 0.21 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.449 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.704 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -109.43 -167.21 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.79 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -119.12 168.29 10.18 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.566 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.533 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 85.1 Cg_endo -84.08 167.51 12.45 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.695 2.93 . . . . 0.0 113.695 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.501 ' H ' ' CG ' ' A' ' 57' ' ' GLU . . . 102.92 -3.23 48.49 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.241 -0.89 . . . . 0.0 114.525 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -64.2 165.04 31.77 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 117.264 0.532 . . . . 0.0 113.793 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.0 0.51 0.66 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.188 0.595 . . . . 0.0 112.046 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.894 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -50.92 -28.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.675 0.75 . . . . 0.0 110.552 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.602 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.9 -58.23 2.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.161 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.0 mmt 6.96 -79.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.887 0.742 . . . . 0.0 112.579 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 179.56 34.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.03 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.466 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -93.76 -170.45 2.34 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.653 0.263 . . . . 0.0 111.045 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.834 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.68 153.19 38.03 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.314 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.834 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.9 -25.0 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.796 2.331 . . . . 0.0 112.396 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -102.57 -42.99 5.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.818 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -11.16 59.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.835 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.03 -53.97 51.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.86 0.362 . . . . 0.0 110.81 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.812 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.27 -50.14 19.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.401 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.2 t -51.75 -37.76 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.407 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -78.49 -52.19 8.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.291 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.668 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.1 mm-40 -66.0 -20.02 66.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.586 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.911 HD11 ' CE1' ' A' ' 64' ' ' HIS . 9.4 tp -55.53 -45.01 77.24 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -35.89 82.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.174 0.512 . . . . 0.0 109.713 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.1 -25.45 62.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.968 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.501 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -108.36 6.73 26.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.185 -178.724 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.973 HG13 HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -133.39 -44.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.064 0.459 . . . . 0.0 109.952 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.54 -37.79 0.22 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.648 -0.705 . . . . 0.0 114.456 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.973 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -86.76 -174.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 120.853 0.358 . . . . 0.0 110.919 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.78 88.64 14.36 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.498 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.539 ' HB3' ' HB2' ' A' ' 90' ' ' TRP . 5.9 Cg_endo -110.84 146.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.514 2.809 . . . . 0.0 113.811 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 15.3 mt-30 -74.79 79.83 2.09 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.911 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.3 132.44 55.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.867 -176.446 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.94 -136.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.651 -179.466 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 54.08 165.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.079 0.466 . . . . 0.0 111.885 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.653 HD23 ' O ' ' A' ' 67' ' ' LEU . 7.2 tt -128.02 108.84 11.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.798 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.86 -43.36 36.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.302 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 11.8 tt0 -171.27 156.11 4.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.553 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HD3' ' CE2' ' A' ' 83' ' ' TRP . 1.4 ttmm -143.27 105.73 4.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.657 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.522 HD22 HG23 ' A' ' 122' ' ' VAL . 1.1 tp -97.09 136.29 37.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.054 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -140.02 109.64 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.409 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.412 ' CE1' HD21 ' A' ' 71' ' ' LEU . 2.3 p90 -141.18 152.22 44.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.1 pt-20 -121.13 135.81 55.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.168 0.509 . . . . 0.0 111.29 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.483 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -101.12 163.21 18.39 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.183 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 10.3 Cg_endo -53.86 82.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.779 2.319 . . . . 0.0 112.068 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.0 m-20 92.96 8.81 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.659 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.546 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 20.6 ttp180 -137.3 93.83 2.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.601 0.239 . . . . 0.0 110.86 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 20.2 t-80 -90.38 107.45 19.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.938 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 3.3 tt -107.53 146.42 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.762 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.07 118.82 18.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.02 179.314 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.67 HD13 HD11 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -117.21 114.22 23.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.798 0.332 . . . . 0.0 111.169 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.457 ' CE2' ' HD3' ' A' ' 70' ' ' LYS . 8.5 m0 -106.93 122.23 46.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.787 ' CE2' HG11 ' A' ' 122' ' ' VAL . 2.2 m-85 -111.49 109.9 20.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.084 0.468 . . . . 0.0 111.665 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.812 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 58.8 m95 -94.81 148.71 22.01 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.82 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.5 tp -97.84 102.79 14.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.549 0.69 . . . . 0.0 111.367 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.775 HG13 ' CB ' ' A' ' 64' ' ' HIS . 18.0 t -83.53 146.29 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.441 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -108.56 -40.15 5.19 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 2.3 ptp180 -163.34 165.72 23.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.064 0.847 . . . . 0.0 112.527 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.731 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 3.3 p90 -145.44 133.35 21.27 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.453 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -81.25 121.18 25.84 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.98 -128.16 8.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.426 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.1 tt0 -123.43 139.29 31.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 O-C-N 122.886 -0.185 . . . . 0.0 110.818 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.512 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 2.6 Cg_exo -76.2 128.72 10.75 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.885 2.39 . . . . 0.0 111.514 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.523 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 61.4 p-90 -132.86 -61.08 0.85 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.06 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.83 -104.37 0.05 OUTLIER Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.256 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.24 37.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.684 0.278 . . . . 0.0 111.049 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -26.84 63.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.026 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.32 -67.6 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.939 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -121.89 110.84 32.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.989 0.423 . . . . 0.0 111.545 -179.423 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -43.64 146.16 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.973 2.449 . . . . 0.0 112.517 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.42 177.01 18.58 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.856 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -116.49 157.29 25.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.496 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.25 106.57 5.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.91 0.386 . . . . 0.0 110.476 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.8 ptm -120.18 160.71 22.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.877 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 22.3 p -73.07 115.25 12.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.928 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.765 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -66.18 -18.92 65.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.12 -12.4 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.446 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.97 47.63 1.01 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.892 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.548 HD13 HD22 ' A' ' 107' ' ' LEU . 9.2 tp -62.01 150.12 38.96 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -122.57 118.57 28.54 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -178.657 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.37 -19.61 61.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.125 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -78.96 -47.27 16.64 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.996 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.84 -20.17 65.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.362 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.47 172.04 4.24 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -54.48 127.81 27.55 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.01 1.807 . . . . 0.0 112.318 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.15 -38.78 8.63 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.723 2.282 . . . . 0.0 112.652 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.847 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -68.84 -9.76 53.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 111.528 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.41 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 14.4 m-20 -104.71 18.59 21.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.969 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.556 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -66.66 -31.88 4.58 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 84.6 Cg_exo -44.32 -36.61 9.51 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.831 1.687 . . . . 0.0 113.504 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.787 HG11 ' CE2' ' A' ' 84' ' ' PHE . 93.0 t -77.89 -51.41 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 111.038 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.876 HG22 ' HB2' ' A' ' 127' ' ' LYS . 7.3 mm -68.68 -29.88 45.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.489 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.72 -27.0 37.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.979 0.419 . . . . 0.0 110.232 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -80.1 -51.85 8.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.684 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.5 tm? -78.03 -34.09 50.73 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.627 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.876 ' HB2' HG22 ' A' ' 123' ' ' ILE . 13.7 tttm -52.98 -42.72 65.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.002 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -69.29 -7.76 39.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.945 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.278 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.938 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A 5131 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A 5132 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.867 0.365 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -99.7 145.27 27.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.998 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -140.01 132.27 28.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 1.035 HD12 HD11 ' A' ' 6' ' ' ILE . 1.7 pp -146.18 126.18 13.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.134 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.476 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 30.1 mt-30 -102.53 154.17 19.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.254 0.55 . . . . 0.0 111.87 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 1.035 HD11 HD12 ' A' ' 4' ' ' LEU . 4.5 mp -146.27 125.28 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.581 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.051 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.82 125.7 44.43 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.2 m -140.1 162.64 24.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.202 0.525 . . . . 0.0 111.858 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -135.84 123.42 2.99 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.649 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.777 HG22 HG12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -70.91 105.02 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.75 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -70.68 126.25 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.138 0.494 . . . . 0.0 111.941 -178.053 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.664 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -101.65 124.99 48.21 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.097 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.624 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.4 p-10 -79.15 -172.59 3.21 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 123.77 0.669 . . . . 0.0 111.382 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.3 tm-20 -76.14 9.22 2.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.337 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -132.89 46.91 2.56 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.958 -0.464 . . . . 0.0 112.098 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.54 24.53 0.52 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 111.495 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 105' ' ' MET . 22.5 mt-10 -115.95 161.24 19.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.777 HG12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -113.68 134.02 57.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.655 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 11' ' ' ILE . 40.7 t80 -91.84 95.18 9.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.433 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -111.25 162.42 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.733 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.787 ' O ' HD12 ' A' ' 33' ' ' LEU . 70.8 p -70.63 132.68 45.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.563 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -119.75 105.25 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.962 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 ttp85 56.15 -100.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.971 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . . . -179.21 -167.73 0.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.27 -41.79 6.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -112.58 -36.07 5.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . . . -59.96 -179.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.09 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -138.73 31.45 2.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.6 tpt -96.09 86.81 4.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.62 -11.79 60.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.557 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -94.52 29.36 2.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.657 0.265 . . . . 0.0 111.087 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 26.1 10.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.941 0.401 . . . . 0.0 111.708 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 21' ' ' THR . 14.7 tp -69.01 69.51 0.18 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.555 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -110.48 -172.65 2.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.539 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.39 168.7 9.48 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.374 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.749 ' HG3' HD11 ' A' ' 11' ' ' ILE . 84.1 Cg_endo -81.28 166.96 17.96 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.528 2.818 . . . . 0.0 113.586 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.12 -5.63 53.07 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.002 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -58.94 162.99 10.79 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.942 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 81.93 2.13 1.4 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 179.108 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.051 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -50.34 -28.92 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.616 0.722 . . . . 0.0 110.262 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.595 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -40.89 -57.44 1.96 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.961 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER 2.93 -78.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.931 0.77 . . . . 0.0 112.522 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 176.27 35.04 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.937 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -89.9 -172.72 3.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.677 0.275 . . . . 0.0 111.057 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.817 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.6 152.29 38.08 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.203 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.817 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.77 -25.09 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.751 2.301 . . . . 0.0 112.501 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mm-40 -104.06 -39.59 6.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.378 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 2.9 mt-30 -80.37 -9.55 59.75 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.835 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -58.64 -54.76 43.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.866 0.365 . . . . 0.0 110.811 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.713 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -78.64 -46.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.47 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 40.4 t -56.53 -44.74 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.852 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 7.7 mtp180 -72.81 -46.12 54.81 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.912 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' CG ' ' OE1' ' A' ' 57' ' ' GLU . 0.9 OUTLIER -69.43 -19.88 63.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.79 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.937 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -57.91 -44.6 86.92 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.822 0.344 . . . . 0.0 110.714 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.43 -30.69 71.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.105 0.478 . . . . 0.0 109.807 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.42 -34.39 54.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.414 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.606 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.6 mp0 -108.36 6.43 26.39 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.046 HG12 HG22 ' A' ' 60' ' ' ILE . 34.3 t -133.8 -44.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.391 . . . . 0.0 110.45 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.01 -36.43 0.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.837 -0.62 . . . . 0.0 114.467 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.046 HG22 HG12 ' A' ' 58' ' ' VAL . 19.6 tt -77.37 163.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.58 0.228 . . . . 0.0 110.684 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.433 ' N ' HG12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -103.62 88.76 1.9 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.759 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.3 Cg_endo -115.12 152.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 123.558 2.839 . . . . 0.0 114.847 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.95 79.74 2.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.937 ' CD2' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -125.93 128.3 47.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.83 -176.146 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.3 t80 -176.85 -140.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.405 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 2.7 m 50.78 175.98 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.142 0.496 . . . . 0.0 112.008 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.87 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -142.99 121.17 12.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.006 179.481 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.92 -44.0 33.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.057 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.3 mt-10 -171.65 131.82 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.468 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.46 111.15 18.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.373 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.558 ' HB3' HG22 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -96.94 141.97 29.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.132 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.401 ' N ' ' HG ' ' A' ' 71' ' ' LEU . 6.1 tt0 -137.87 109.9 7.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.53 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.803 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.0 p90 -137.71 149.97 46.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.694 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -118.82 139.67 51.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.223 0.535 . . . . 0.0 111.525 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.504 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.6 m-85 -103.02 162.67 19.4 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.192 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.5 Cg_endo -53.65 81.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.934 2.423 . . . . 0.0 112.131 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.0 t0 93.76 8.6 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 33.9 ttp180 -137.32 93.67 2.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.699 0.285 . . . . 0.0 110.758 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.27 110.94 19.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.806 0.336 . . . . 0.0 110.69 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.979 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 3.6 tt -108.09 146.64 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.22 0.533 . . . . 0.0 111.204 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.498 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -134.18 118.53 17.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.529 178.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' A' ' 6' ' ' ILE . 2.9 tp -119.15 114.01 21.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.923 0.392 . . . . 0.0 111.254 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.498 ' HE1' HG22 ' A' ' 81' ' ' THR . 9.5 m0 -111.06 122.15 47.16 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.084 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.96 ' CD1' HG11 ' A' ' 122' ' ' VAL . 2.5 m-85 -106.12 113.3 26.75 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.977 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.87 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.7 m95 -94.72 148.35 22.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.671 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 86' ' ' LEU . 2.9 tm? -94.3 102.59 14.6 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 121.395 0.617 . . . . 0.0 110.592 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.895 HG22 ' CE1' ' A' ' 64' ' ' HIS . 14.9 t -89.85 145.37 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.813 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -99.94 -59.68 1.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 10.5 ptm180 -163.34 166.0 23.46 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.205 0.457 . . . . 0.0 112.22 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.815 ' HB2' HD13 ' A' ' 60' ' ' ILE . 41.9 p90 -125.79 164.7 20.12 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.634 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.779 ' C ' HD11 ' A' ' 60' ' ' ILE . 32.2 tt0 -104.13 95.83 6.24 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.01 -112.08 4.05 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.168 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' C ' HD12 ' A' ' 60' ' ' ILE . 21.0 tt0 -134.33 130.2 20.04 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.528 0.204 . . . . 0.0 111.17 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 4.8 Cg_exo -76.63 128.82 10.47 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.766 2.31 . . . . 0.0 111.372 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 6.9 p-90 -123.07 -65.7 1.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.191 0.52 . . . . 0.0 111.337 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.621 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 50.41 -117.33 4.96 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.288 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 177.57 35.96 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.72 0.295 . . . . 0.0 111.258 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -49.75 -30.33 9.25 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.942 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.4 -25.13 7.86 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.797 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.449 ' O ' HG22 ' A' ' 21' ' ' THR . 1.3 pm0 -138.86 112.31 8.22 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 117.197 0.499 . . . . 0.0 111.754 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -43.57 145.39 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.935 2.423 . . . . 0.0 112.551 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.416 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.19 177.51 19.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.855 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -144.66 157.1 44.34 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.47 106.53 0.94 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.11 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -120.2 156.13 31.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.039 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.713 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -77.38 116.05 17.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -61.65 -18.74 60.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.386 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.713 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.2 p -62.37 -3.99 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.639 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.69 48.39 0.97 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.995 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.44 HD11 HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -61.56 128.24 35.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -111.02 114.13 27.2 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.575 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.574 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -19.29 61.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.857 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -78.83 -47.69 16.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.843 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.75 -14.18 62.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.46 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.574 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -113.56 171.27 4.51 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.07 127.85 27.42 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.187 1.925 . . . . 0.0 112.373 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.99 -39.14 8.43 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.759 2.306 . . . . 0.0 112.866 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.832 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -68.71 -9.74 52.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.988 0.423 . . . . 0.0 111.538 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.468 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 21.7 m-20 -104.14 14.49 30.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.057 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.532 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -61.78 -32.25 9.75 Favored Pre-proline 0 N--CA 1.467 0.4 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -178.503 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.9 Cg_exo -44.24 -41.5 13.19 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.712 1.608 . . . . 0.0 113.458 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.96 HG11 ' CD1' ' A' ' 84' ' ' PHE . 35.8 t -77.69 -51.04 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.831 0.348 . . . . 0.0 111.059 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.562 HG13 ' CE2' ' A' ' 115' ' ' PHE . 38.2 mm -62.9 -33.77 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.403 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -29.6 54.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.955 0.407 . . . . 0.0 110.487 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -79.95 -45.21 18.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.339 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.608 HD21 HD11 ' A' ' 107' ' ' LEU . 22.9 tp -78.28 -50.08 12.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.379 . . . . 0.0 111.216 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.586 ' O ' HD13 ' A' ' 129' ' ' LEU . 6.5 ttpt -53.21 -34.9 59.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.995 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -63.6 -10.16 17.15 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 127' ' ' LYS . 10.5 mp . . . . . 0 CA--C 1.528 0.118 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.251 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.979 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A 5143 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A 5144 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.811 0.338 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -75.89 138.31 40.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 4.3 mttt -140.05 130.48 25.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.4 pp -146.19 128.36 15.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 111.162 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.449 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 46.2 mt-30 -102.85 150.52 23.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.025 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.552 ' HB ' HD12 ' A' ' 82' ' ' LEU . 4.2 mp -146.55 121.83 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.204 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.033 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.12 125.35 43.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 35' ' ' PHE . 1.3 m -139.67 162.21 26.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.576 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.39 139.3 10.55 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.933 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.992 HG22 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -83.47 112.66 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.262 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.824 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -70.81 123.66 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 121.051 0.453 . . . . 0.0 111.493 -178.61 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.16 124.65 35.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.858 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.477 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 13.2 t30 -81.75 -172.09 3.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.805 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -81.52 3.99 22.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.453 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -139.5 52.01 1.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.35 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 45.76 24.64 0.22 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.475 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 16.0 pt-20 -117.01 138.57 51.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.992 HG21 HG22 ' A' ' 10' ' ' ILE . 7.5 mt -105.97 139.7 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.26 0.552 . . . . 0.0 112.038 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 18.4 t80 -80.93 91.3 6.0 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.393 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.5 156.81 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.919 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.484 ' O ' HD12 ' A' ' 33' ' ' LEU . 25.7 p -70.77 129.46 39.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.843 0.354 . . . . 0.0 110.709 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.811 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.48 102.26 6.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.712 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.545 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 16.8 ttm105 61.3 -112.49 0.49 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.445 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 171.67 -166.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.938 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.27 28.46 4.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.062 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.52 -80.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -179.41 -65.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.179 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -57.5 176.88 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.128 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mmt 61.69 35.32 17.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.12 -8.92 56.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.749 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -96.55 24.72 5.67 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.714 0.292 . . . . 0.0 111.176 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.34 26.09 10.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.919 0.39 . . . . 0.0 111.515 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -67.25 70.33 0.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.36 -172.66 2.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.684 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.669 ' CD1' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -110.68 166.01 11.58 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.863 0.363 . . . . 0.0 110.956 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.824 ' HG3' HD11 ' A' ' 11' ' ' ILE . 36.4 Cg_endo -65.47 166.69 18.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.415 2.743 . . . . 0.0 114.174 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.643 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.85 -5.96 54.11 Favored Glycine 0 C--O 1.225 -0.469 0 CA-C-N 114.877 -1.056 . . . . 0.0 114.027 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -57.15 155.67 16.29 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 117.337 0.569 . . . . 0.0 112.528 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.82 7.07 0.5 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.033 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -51.62 -28.43 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.715 0.769 . . . . 0.0 110.156 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.569 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -39.75 -60.64 0.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.731 179.337 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.528 ' C ' ' O ' ' A' ' 41' ' ' GLU . 8.7 mmt 5.8 -81.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.537 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.27 28.75 0.08 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.943 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -94.41 -174.71 3.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.773 0.321 . . . . 0.0 111.06 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.867 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.45 156.51 39.39 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.867 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.65 -24.66 0.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.799 2.333 . . . . 0.0 112.708 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -90.25 -57.73 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -80.52 -4.26 53.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.932 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.28 -57.73 11.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.97 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.79 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.2 m -79.01 -45.65 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.475 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.6 t -52.21 -38.84 25.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mmm-85 -78.15 -41.54 34.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.531 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.31 -19.89 62.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.76 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.869 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -58.59 -44.76 89.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.883 0.373 . . . . 0.0 110.402 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -32.13 70.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.052 0.453 . . . . 0.0 110.344 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.17 -31.92 55.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.499 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.05 3.96 24.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.479 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.934 HG12 HG22 ' A' ' 60' ' ' ILE . 11.3 t -134.69 -44.11 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.206 0.527 . . . . 0.0 109.934 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.16 -32.88 0.25 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.046 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.934 HG22 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.89 179.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 120.617 0.246 . . . . 0.0 110.6 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.97 88.4 10.02 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.668 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -110.78 144.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.527 2.818 . . . . 0.0 113.968 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 18.3 mt-30 -74.68 79.62 2.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 175.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.869 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.85 134.16 54.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.982 -175.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 179.97 -140.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.352 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.404 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 0.9 OUTLIER 50.33 176.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.138 0.494 . . . . 0.0 111.932 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.9 OUTLIER -143.88 123.31 13.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.043 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.6 -43.77 37.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.186 0.517 . . . . 0.0 109.658 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.1 mt-10 -171.83 131.8 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.224 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.06 109.38 17.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.782 0.325 . . . . 0.0 110.408 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.64 HD22 HG23 ' A' ' 122' ' ' VAL . 3.9 tp -96.99 131.09 44.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.126 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -133.68 109.67 9.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.368 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -141.29 131.77 25.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.9 pm0 -102.76 138.92 39.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.115 0.483 . . . . 0.0 111.228 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -106.53 163.4 17.07 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.215 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 10.3 Cg_endo -51.87 82.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.87 2.38 . . . . 0.0 112.176 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 75' ' ' PHE . 12.5 m-20 89.56 11.16 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.518 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.617 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -137.49 93.73 2.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.263 . . . . 0.0 110.733 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 13.0 t-160 -89.72 98.98 12.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.585 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 0.6 OUTLIER -104.27 111.91 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.532 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -103.79 118.68 37.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.686 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.579 HD13 HD11 ' A' ' 80' ' ' ILE . 1.4 tp -116.47 113.91 23.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.915 0.388 . . . . 0.0 111.722 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.532 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.8 m0 -110.31 122.55 47.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.398 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.736 ' CE1' HG11 ' A' ' 122' ' ' VAL . 1.6 m-85 -108.09 113.06 25.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.134 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.814 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.4 m95 -94.67 148.6 22.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.801 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.531 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.0 tm? -99.1 102.86 14.7 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.334 0.588 . . . . 0.0 111.355 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.843 HG13 ' CB ' ' A' ' 64' ' ' HIS . 14.6 t -84.18 146.03 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.097 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -113.63 -24.97 8.93 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -162.68 162.83 27.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.63 0.65 . . . . 0.0 111.777 -178.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.712 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -155.2 141.81 18.84 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.3 178.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.2 mt-10 -77.88 136.2 38.01 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-O 120.793 0.33 . . . . 0.0 111.383 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.94 -108.44 0.2 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.695 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 23.5 tt0 -131.25 135.78 27.68 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.473 0.178 . . . . 0.0 110.826 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.801 ' HB3' HG13 ' A' ' 58' ' ' VAL . 2.8 Cg_exo -76.04 128.85 10.97 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.801 2.334 . . . . 0.0 111.197 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.573 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 14.6 p-90 -114.15 -64.91 1.24 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.65 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.31 -103.43 0.03 OUTLIER Glycine 0 CA--C 1.52 0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.251 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 tptp 174.08 40.19 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.697 0.284 . . . . 0.0 111.261 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.44 ' HA ' ' CG ' ' A' ' 57' ' ' GLU . 21.7 pt-20 -61.86 -47.06 86.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.868 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 160.86 -120.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.101 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -75.82 123.88 88.43 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.17 0.509 . . . . 0.0 111.788 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -43.7 146.32 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.257 2.638 . . . . 0.0 112.701 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.88 177.38 18.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.989 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -126.9 157.26 39.87 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CG ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -68.47 106.11 2.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.881 0.372 . . . . 0.0 110.252 -179.703 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 18' ' ' ILE . 6.6 ptm -120.58 163.3 18.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.015 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.776 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -78.21 114.94 17.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.825 0.345 . . . . 0.0 110.549 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -61.84 -18.84 61.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.238 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.6 p -61.92 -9.3 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.563 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.25 49.18 0.94 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.96 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 126' ' ' LEU . 7.4 tp -62.15 150.2 39.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -118.44 121.27 39.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.383 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.63 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.49 -21.65 61.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.269 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.7 -43.77 25.15 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.318 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.582 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.59 -37.52 85.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.402 . . . . 0.0 110.783 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.63 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.22 172.95 6.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.205 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.27 127.82 27.43 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.012 1.808 . . . . 0.0 112.036 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.15 -39.0 8.3 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.666 2.244 . . . . 0.0 112.871 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.435 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -68.57 -9.8 51.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.933 0.397 . . . . 0.0 111.524 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.48 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 26.0 m-20 -104.95 20.47 18.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.741 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -62.03 -31.74 8.45 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 79.8 Cg_exo -44.29 -43.89 13.17 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.771 1.647 . . . . 0.0 113.61 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.736 HG11 ' CE1' ' A' ' 84' ' ' PHE . 95.7 t -77.75 -51.52 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.775 0.321 . . . . 0.0 111.563 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.561 HG13 ' CE2' ' A' ' 115' ' ' PHE . 37.4 mm -64.74 -29.98 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.484 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.56 -32.14 66.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.985 0.421 . . . . 0.0 110.437 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -80.11 -45.58 17.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.323 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.819 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.3 tm? -78.26 -19.79 52.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.603 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 123' ' ' ILE . 6.2 ttpm? -79.14 -42.64 25.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 0.0 110.681 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -67.75 -7.85 30.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.962 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.743 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.678 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A 5155 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A 5156 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttp . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.901 0.381 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -109.97 126.42 53.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.825 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.9 OUTLIER -140.1 133.91 30.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -146.12 124.66 12.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.573 ' O ' HD13 ' A' ' 6' ' ' ILE . 48.8 mt-30 -102.66 147.9 26.24 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.273 0.559 . . . . 0.0 111.565 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 5' ' ' GLN . 33.7 mm -146.4 124.83 4.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.687 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.026 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.82 125.19 43.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m -133.51 162.2 40.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.062 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.53 126.15 2.83 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.117 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.061 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.81 108.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.374 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.719 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.03 123.73 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.038 0.447 . . . . 0.0 111.151 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.43 124.02 34.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.653 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.463 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 13.9 t30 -81.61 -172.16 3.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.051 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.83 2.94 24.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.507 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -140.19 52.34 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.346 . . . . 0.0 111.441 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.6 p30 45.96 24.35 0.23 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.397 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 16.8 pt-20 -114.68 142.58 46.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.061 HG21 HG22 ' A' ' 10' ' ' ILE . 7.3 mt -115.58 136.79 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.141 0.496 . . . . 0.0 111.623 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -83.84 111.14 18.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.593 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 105' ' ' MET . 0.2 OUTLIER -115.97 149.1 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.212 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.719 ' O ' HD12 ' A' ' 33' ' ' LEU . 13.9 p -70.84 132.4 45.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.54 ' CG ' HD13 ' A' ' 33' ' ' LEU . 30.1 ttt180 -137.76 110.49 7.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.968 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 ttm105 56.52 -113.61 0.78 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.81 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -177.55 36.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.349 . . . . 0.0 111.172 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.07 27.65 13.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.244 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -178.44 159.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.829 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.36 90.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.215 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -167.76 90.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 61.19 70.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.72 -14.53 60.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.432 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.35 31.06 2.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.075 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.28 25.94 11.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.103 0.478 . . . . 0.0 111.338 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 21' ' ' THR . 28.6 tp -62.77 84.38 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.769 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -126.13 -165.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.153 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.709 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -118.86 168.31 10.01 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.334 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.566 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 84.8 Cg_endo -79.4 167.37 21.29 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.416 2.744 . . . . 0.0 113.025 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.86 -5.65 50.88 Favored Glycine 0 C--O 1.224 -0.489 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.462 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -63.09 152.44 46.7 Favored Glycine 0 C--N 1.318 -0.436 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.585 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 91.76 3.53 0.1 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 122.827 0.451 . . . . 0.0 112.151 179.579 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.026 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.3 pt -52.46 -27.32 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.444 0.64 . . . . 0.0 110.379 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.528 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.78 -64.01 0.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.832 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.483 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 17.94 -83.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.448 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 178.68 35.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.867 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -92.17 -170.68 2.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.654 0.264 . . . . 0.0 111.076 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.824 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.67 153.08 38.42 Favored Pre-proline 0 N--CA 1.456 -0.131 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.824 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.74 -24.9 0.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.786 2.324 . . . . 0.0 112.454 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 51' ' ' VAL . 24.1 mt-10 -102.49 -43.86 5.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.5 -4.83 55.35 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.995 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.91 -57.3 12.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.706 0.289 . . . . 0.0 110.738 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.843 HG11 ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER -78.78 -46.22 24.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.267 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 37.6 t -55.71 -40.53 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.14 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -78.11 -51.76 9.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 1.4 mm-40 -68.54 -20.87 64.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.937 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 4.5 tp -51.18 -44.78 61.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -32.95 69.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.457 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -77.35 -29.84 53.58 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.941 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 6.0 mp0 -104.9 5.54 32.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.574 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 1.6 t -134.38 -44.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.12 0.486 . . . . 0.0 110.005 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.34 -39.98 0.28 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.336 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -77.92 -174.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.088 0.471 . . . . 0.0 111.896 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.54 87.79 26.9 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.639 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.545 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 11.7 Cg_endo -112.06 146.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 123.733 2.955 . . . . 0.0 113.968 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 69.5 mt-30 -74.88 79.72 2.13 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.832 ' HB2' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -121.01 130.14 53.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.227 -176.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 86' ' ' LEU . 6.1 t80 178.52 160.88 0.62 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 88.62 -165.64 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.209 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.778 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.5 pp -152.37 131.76 12.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.27 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.743 ' CE2' HD11 ' A' ' 10' ' ' ILE . 2.1 p90 -76.75 -41.81 43.44 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.773 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 13.0 mt-10 -171.12 131.46 0.79 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.583 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 132.06 55.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.754 0.312 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 122' ' ' VAL . 1.3 tp -110.66 139.14 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.99 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -138.42 109.6 6.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.504 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.705 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.1 p90 -141.52 137.25 31.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 2.3 pt-20 -121.17 132.07 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.202 0.525 . . . . 0.0 111.194 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 1.1 m-85 -83.21 163.9 48.3 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.2 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.443 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -38.68 -28.62 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.626 2.884 . . . . 0.0 113.261 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -139.77 -38.04 0.48 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.163 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.538 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 25.0 ttp180 -86.32 102.78 14.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.421 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.415 ' ND1' ' HB3' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -92.67 99.91 12.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.286 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 1.0 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 3.7 tt -101.23 147.95 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.066 0.46 . . . . 0.0 111.088 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.406 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -134.19 118.48 17.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.63 178.915 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.754 HD13 HD11 ' A' ' 80' ' ' ILE . 1.2 mp -114.58 113.51 24.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 111.31 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.0 m0 -110.97 122.45 47.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.734 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.887 ' CE2' HG11 ' A' ' 122' ' ' VAL . 2.7 m-85 -113.19 112.72 24.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.037 0.446 . . . . 0.0 110.858 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.843 ' NE1' HG11 ' A' ' 50' ' ' VAL . 25.5 m95 -95.58 148.49 22.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.648 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 65' ' ' PHE . 35.5 tp -90.23 138.84 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.745 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.832 HG13 ' HB2' ' A' ' 64' ' ' HIS . 17.9 t -123.23 144.67 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.711 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.11 -27.78 8.24 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.07 160.08 24.0 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.875 -178.938 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.719 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -152.92 123.24 7.13 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.962 178.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.86 150.11 32.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.324 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.59 -144.37 30.12 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.77 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.481 ' O ' HG21 ' A' ' 60' ' ' ILE . 44.7 tt0 -105.59 134.92 19.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.3 Cg_exo -76.12 128.8 10.86 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.686 2.257 . . . . 0.0 111.61 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.528 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 34.2 p-90 -124.91 -61.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.735 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 48.74 -110.53 0.73 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.88 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.29 50.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 111.075 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -35.53 64.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.498 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.26 -5.55 45.4 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.348 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -140.12 96.02 8.24 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.981 0.419 . . . . 0.0 111.445 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -43.6 144.0 2.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.913 2.408 . . . . 0.0 112.35 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.1 177.13 19.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.124 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -139.26 157.44 45.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.03 106.41 0.5 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.065 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.598 ' HB2' HD11 ' A' ' 20' ' ' ILE . 2.4 mtp -120.11 163.47 17.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.252 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.535 ' HB2' HG12 ' A' ' 108' ' ' VAL . 81.7 p -90.79 114.8 27.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.559 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -67.03 -18.53 65.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.207 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.626 HG23 HD21 ' A' ' 129' ' ' LEU . 11.9 p -53.67 -16.36 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.77 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.71 55.0 0.68 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.93 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 107' ' ' LEU . 11.1 tp -62.07 150.49 38.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.878 0.371 . . . . 0.0 110.889 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.582 ' HB3' HD23 ' A' ' 33' ' ' LEU . 1.1 t-20 -98.31 95.75 7.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.462 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.6 -21.55 61.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.084 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -79.05 -44.67 21.71 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.199 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -41.2 88.37 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.227 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.553 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.45 174.29 6.27 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.6 Cg_endo -54.05 127.82 27.26 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 121.742 1.628 . . . . 0.0 112.255 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.5 -38.97 10.18 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.759 2.306 . . . . 0.0 112.575 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.48 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -69.73 -9.59 55.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.023 0.44 . . . . 0.0 111.344 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -103.15 16.19 27.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -68.28 -32.67 4.08 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 91.2 Cg_exo -44.44 -33.54 6.53 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 121.778 1.652 . . . . 0.0 112.718 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.887 HG11 ' CE2' ' A' ' 84' ' ' PHE . 12.9 t -77.8 -51.51 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.003 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.882 HG22 ' HB2' ' A' ' 127' ' ' LYS . 17.3 mm -68.16 -33.61 61.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.67 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.67 -27.35 39.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.874 0.369 . . . . 0.0 110.775 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -80.54 -53.19 6.79 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.885 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.618 HD13 ' CD1' ' A' ' 68' ' ' PHE . 2.4 tp -78.23 -33.52 49.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.76 0.314 . . . . 0.0 111.628 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.882 ' HB2' HG22 ' A' ' 123' ' ' ILE . 28.3 ttpp -54.05 -42.64 69.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.026 0.441 . . . . 0.0 110.963 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -66.3 -10.09 39.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.626 HD21 HG23 ' A' ' 108' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.94 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 1.0 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A 5167 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A 5168 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.794 0.33 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -74.0 147.39 42.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.963 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 138.67 38.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.368 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.744 HD13 " O4'" ' A' ' 131' ' ' 8OG . 3.7 pp -146.24 138.02 24.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 0.0 111.713 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.455 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 29.2 mt-30 -104.11 152.83 21.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.987 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.704 HD11 " O4'" ' A' ' 131' ' ' 8OG . 47.8 mt -146.35 119.53 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.274 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.047 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.86 125.68 44.36 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.677 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.8 m -132.79 162.45 39.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.478 0.656 . . . . 0.0 111.945 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.462 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -149.36 118.66 0.97 Allowed Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.92 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.063 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.27 109.76 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.716 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -70.6 119.14 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.062 0.458 . . . . 0.0 111.61 -178.478 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.706 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.65 118.57 23.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.75 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.492 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 54.5 t30 -78.21 -172.46 2.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.589 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 10.9 tt0 -83.44 4.86 25.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.368 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -140.58 52.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 111.444 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.3 p30 46.26 23.23 0.19 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.683 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.684 ' C ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -116.42 146.89 42.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.581 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.063 HG21 HG22 ' A' ' 10' ' ' ILE . 1.5 mp -112.49 144.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.298 0.571 . . . . 0.0 112.299 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.6 OUTLIER -88.37 114.24 24.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.127 179.199 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.862 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -118.71 137.7 51.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 100' ' ' GLN . 6.3 p -70.84 123.01 20.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 111.033 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HB3' HD13 ' A' ' 33' ' ' LEU . 5.0 ptt85 -148.2 154.13 39.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.099 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.756 ' CZ ' ' HB2' ' A' ' 30' ' ' ALA . 1.4 ttm180 45.24 -107.42 0.13 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.22 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 172.86 -52.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.88 0.372 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -175.98 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.066 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -172.77 100.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.852 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.99 110.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -177.37 -70.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.4 67.1 0.95 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.816 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.756 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . . . -60.89 -17.88 53.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.544 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -93.92 24.65 4.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.695 0.283 . . . . 0.0 111.41 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.25 26.14 10.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.018 0.437 . . . . 0.0 111.316 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 111' ' ' ASN . 27.2 tp -73.55 64.67 0.89 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.103 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.862 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -114.99 -173.09 2.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.789 0.328 . . . . 0.0 111.213 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.688 ' CD1' HG23 ' A' ' 10' ' ' ILE . 53.8 m-85 -90.42 159.95 40.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.677 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 97.8 Cg_endo -84.02 167.13 12.71 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.809 3.006 . . . . 0.0 111.852 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.757 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.12 -5.12 52.6 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.716 -0.754 . . . . 0.0 114.136 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.62 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -64.18 129.82 37.93 Favored Glycine 0 C--N 1.316 -0.582 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.848 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 108.97 2.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.1 0.56 . . . . 0.0 111.848 179.514 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.047 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.7 pt -49.05 -29.66 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.518 0.675 . . . . 0.0 110.747 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.597 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -38.16 -77.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.952 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.2 mmt 33.8 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.623 0.577 . . . . 0.0 111.885 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.0 32.93 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.663 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.479 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -89.09 -172.9 3.84 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.731 0.301 . . . . 0.0 111.132 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.833 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.64 154.04 37.66 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.288 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.833 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.76 -24.99 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.803 2.335 . . . . 0.0 112.491 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.47 -43.59 5.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.55 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 52.8 mm-40 -80.46 -4.84 55.33 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 1.039 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.15 -55.47 31.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.682 0.277 . . . . 0.0 111.035 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.713 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -78.52 -45.65 25.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.968 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.461 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 39.4 t -60.13 -44.89 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.003 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 9.2 tpp180 -78.07 -37.14 47.31 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.393 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.445 ' CG ' ' OE2' ' A' ' 57' ' ' GLU . 6.2 tp10 -78.04 -23.54 48.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.716 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.068 HD21 ' CE1' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -51.67 -44.42 63.07 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 120.982 0.42 . . . . 0.0 109.988 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -28.85 62.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.468 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -77.24 -30.67 54.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.314 179.447 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 16.3 mp0 -108.22 5.85 26.13 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.581 HG11 ' HG3' ' A' ' 62' ' ' PRO . 4.0 t -134.07 -44.88 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.024 0.44 . . . . 0.0 110.101 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.607 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.11 -38.32 0.15 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.56 -0.745 . . . . 0.0 114.577 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.747 HG23 ' CD1' ' A' ' 95' ' ' TRP . 21.3 pt -77.79 -176.03 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.99 0.424 . . . . 0.0 111.575 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.25 88.28 17.98 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.348 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.67 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.8 Cg_endo -112.44 146.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.568 2.845 . . . . 0.0 113.9 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 13.1 mt-30 -74.82 80.2 2.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 175.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 1.068 ' CE1' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -121.36 136.78 54.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.578 -175.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.0 t80 178.71 -135.52 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.199 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 55.94 166.49 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.147 0.498 . . . . 0.0 111.809 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.7 tt -129.14 114.95 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.683 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -76.53 -52.91 8.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.8 tt0 -171.91 153.03 3.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.927 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.564 ' CD ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.55 129.28 19.31 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.896 HD11 HG22 ' A' ' 122' ' ' VAL . 1.1 pp -130.91 159.13 38.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.014 0.435 . . . . 0.0 111.235 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.752 ' HG3' HG22 ' A' ' 81' ' ' THR . 1.8 mp0 -133.6 120.17 20.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.042 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.435 ' CD1' ' N ' ' A' ' 73' ' ' TYR . 1.7 p90 -141.17 147.59 38.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.595 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.13 112.32 18.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 111.34 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.4 m-85 -69.96 162.86 65.74 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.355 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.7 Cg_endo -50.3 81.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.058 2.505 . . . . 0.0 112.342 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 75' ' ' PHE . 7.0 m-20 91.15 13.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.814 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.606 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 21.3 ttp180 -137.45 102.01 4.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.613 0.244 . . . . 0.0 110.935 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -86.98 113.06 22.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.995 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 2.3 tt -120.22 118.83 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.091 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.752 HG22 ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -97.58 118.77 34.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.856 ' HG ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -113.83 114.61 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.719 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.413 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 8.8 m0 -113.35 122.38 47.21 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.965 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.1 m-30 -106.89 133.22 51.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.034 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.713 ' CE2' HG11 ' A' ' 50' ' ' VAL . 16.9 m95 -118.65 149.14 41.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.445 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 66' ' ' SER . 0.0 OUTLIER -102.07 103.79 14.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.48 0.657 . . . . 0.0 112.306 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.83 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.3 t -79.77 146.26 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.995 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -114.34 -23.99 9.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -162.43 161.01 27.05 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.623 0.647 . . . . 0.0 111.371 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.716 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -157.07 125.98 5.86 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.404 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -74.5 140.31 44.44 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.242 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.77 -130.03 47.94 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.763 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.694 ' O ' HG21 ' A' ' 60' ' ' ILE . 4.9 tt0 -121.01 137.4 26.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 93' ' ' GLU . 2.8 Cg_exo -76.18 128.9 10.89 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.702 2.268 . . . . 0.0 111.562 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.747 ' CD1' HG23 ' A' ' 60' ' ' ILE . 50.0 p-90 -119.5 -60.04 1.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.975 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.573 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.0 -103.93 0.06 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.973 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 172.28 37.36 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.097 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' HB2' HG21 ' A' ' 21' ' ' THR . 1.3 mp0 -59.25 -48.98 79.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.762 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.86 -76.9 0.14 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.83 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.43 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.4 OUTLIER -118.79 124.14 28.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.071 0.462 . . . . 0.0 111.318 -179.485 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -43.29 145.95 1.28 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.994 2.463 . . . . 0.0 112.647 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.39 177.36 16.8 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.926 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -125.14 157.23 36.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -69.18 106.51 2.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.867 0.365 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.408 ' SD ' HD11 ' A' ' 33' ' ' LEU . 2.0 ptp -120.19 163.24 18.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.106 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.7 p -81.64 114.94 20.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.472 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.607 ' HG ' HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -68.05 -18.69 64.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.456 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.01 -19.26 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.513 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.51 55.5 0.57 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.227 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.707 HD22 ' CD1' ' A' ' 123' ' ' ILE . 2.0 tt -62.37 151.02 38.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.908 0.385 . . . . 0.0 110.967 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.587 ' HB3' HD23 ' A' ' 33' ' ' LEU . 1.6 t-20 -92.44 92.87 8.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.048 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.516 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -71.36 -18.89 62.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.153 0.501 . . . . 0.0 110.142 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.89 -44.39 22.87 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.513 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.84 -41.36 87.56 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.816 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.615 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.78 170.06 17.89 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 34' ' ' GLU . 9.3 Cg_endo -54.14 127.63 26.53 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.131 1.887 . . . . 0.0 112.791 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.13 -34.85 15.71 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.73 2.287 . . . . 0.0 111.995 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.678 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.33 -9.96 57.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.877 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -109.53 14.09 23.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.615 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -76.1 -30.99 0.94 Allowed Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 65.7 Cg_exo -43.61 -39.99 10.31 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.062 1.841 . . . . 0.0 113.831 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.896 HG22 HD11 ' A' ' 71' ' ' LEU . 1.5 t -77.91 -51.58 17.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.99 0.424 . . . . 0.0 111.598 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.707 ' CD1' HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.13 -29.45 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.623 -179.059 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.45 -31.34 55.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.009 0.433 . . . . 0.0 110.086 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -66.74 -47.02 73.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.155 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.848 ' O ' HD13 ' A' ' 126' ' ' LEU . 2.3 tm? -78.49 -20.03 51.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.032 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.425 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 23.0 tttm -74.48 -42.53 58.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.095 0.474 . . . . 0.0 110.445 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -64.65 -11.03 31.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.904 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.744 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.104 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.58 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.995 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A 5179 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A 5180 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.842 0.353 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.13 119.87 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.05 133.95 30.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.521 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.4 pp -146.15 121.95 10.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.401 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 32.6 mt-30 -102.89 151.32 22.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.241 0.543 . . . . 0.0 112.059 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.553 HD11 " H4'" ' A' ' 131' ' ' 8OG . 3.2 mp -146.48 128.93 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.279 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.108 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.13 125.58 43.96 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -137.13 162.16 34.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.381 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.462 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.04 127.86 2.45 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.045 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.714 HG22 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -70.76 110.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.714 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -70.93 119.72 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.891 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.92 121.01 26.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.744 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 58.3 t30 -81.31 -172.56 3.86 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.52 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.506 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 22.2 tt0 -81.98 3.65 25.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.398 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -139.74 51.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 111.385 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.34 24.58 0.3 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.195 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 17.0 pt-20 -116.96 144.52 44.46 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.714 HG21 HG22 ' A' ' 10' ' ' ILE . 5.6 mt -116.03 145.18 22.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.172 0.511 . . . . 0.0 111.841 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.459 ' CD2' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -89.83 111.08 21.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.367 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.49 142.86 24.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.182 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.49 HG22 ' OE2' ' A' ' 98' ' ' GLU . 1.4 p -70.84 114.42 8.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 6.0 ttt85 -130.33 136.27 48.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.522 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 29.4 mtp180 51.74 -113.26 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.086 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 166.27 -176.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.31 -31.52 62.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.72 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -139.63 -176.22 4.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.549 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.88 -159.66 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.52 -84.2 0.49 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.917 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 47.6 29.29 1.41 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.802 0.334 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.62 -23.27 58.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.577 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -97.66 29.78 3.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.142 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.1 25.98 10.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 111.403 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.543 HD13 ' CB ' ' A' ' 111' ' ' ASN . 1.2 tt -67.48 76.05 0.17 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.792 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.88 -169.0 1.65 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.933 0.397 . . . . 0.0 111.464 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.678 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.28 168.46 9.93 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.461 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.559 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 74.0 Cg_endo -77.72 167.06 24.58 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.372 2.714 . . . . 0.0 112.953 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.11 -5.45 52.94 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.71 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.44 145.28 48.76 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.302 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 89.62 9.91 0.08 Allowed 'General case' 0 C--N 1.342 0.257 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.108 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -57.84 -27.27 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.567 0.699 . . . . 0.0 110.051 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.506 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.04 -77.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.416 -1.266 . . . . 0.0 111.31 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 36.05 -87.85 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.938 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.07 33.58 0.07 OUTLIER Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.989 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.474 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -92.47 -166.23 1.5 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.54 0.21 . . . . 0.0 110.897 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.856 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.89 154.35 37.41 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.856 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.93 -24.81 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.704 2.269 . . . . 0.0 112.362 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.613 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -98.34 -49.83 4.54 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.511 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -80.71 -8.89 59.8 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.774 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -61.62 -57.24 12.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.843 0.354 . . . . 0.0 110.484 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.613 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 1.2 p -78.61 -46.61 24.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.716 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 47' ' ' GLU . 55.3 t -50.69 -38.81 17.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.754 0.312 . . . . 0.0 111.387 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -78.89 -52.2 8.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.799 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -69.59 -19.8 63.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.19 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.873 ' O ' HG23 ' A' ' 58' ' ' VAL . 23.0 tp -58.74 -45.81 88.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.521 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -66.46 -26.69 67.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.004 0.43 . . . . 0.0 110.095 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.63 -24.57 67.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.602 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.508 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.54 5.64 25.3 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.915 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.036 HG12 HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -133.49 -44.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 68.85 -35.24 0.28 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.036 HD11 HG12 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -77.95 -172.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.893 0.377 . . . . 0.0 110.909 -179.546 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.02 88.82 12.65 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.412 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.675 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.3 Cg_endo -108.36 149.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 123.28 2.653 . . . . 0.0 113.787 -177.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.552 ' HG2' ' HB3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.88 81.16 4.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 175.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.82 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.61 134.98 51.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.087 -175.449 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.506 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.6 t80 179.83 -142.83 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.657 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t 50.82 175.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.975 0.51 . . . . 0.0 111.95 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.843 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -141.88 124.9 16.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.02 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.97 -51.14 11.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.985 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 mt-10 -171.73 131.64 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.35 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.26 119.46 39.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.791 0.329 . . . . 0.0 110.64 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.691 ' CB ' HG22 ' A' ' 122' ' ' VAL . 0.5 OUTLIER -99.64 123.67 44.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.863 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -122.52 109.56 14.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.793 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.548 ' OH ' HD13 ' A' ' 80' ' ' ILE . 1.8 p90 -141.43 137.59 32.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.486 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -121.24 125.21 46.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.156 0.503 . . . . 0.0 111.462 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 2.6 m-85 -71.92 163.4 67.06 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.895 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.471 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.8 Cg_endo -39.28 -27.76 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.434 2.756 . . . . 0.0 112.97 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -139.78 -37.08 0.49 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.209 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.552 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 33.2 ttp180 -85.91 103.42 14.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.489 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.403 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 0.3 OUTLIER -91.15 100.27 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 110.425 179.484 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.893 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 6.2 tt -101.88 146.2 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.091 0.472 . . . . 0.0 111.252 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.523 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -134.15 118.74 18.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.696 179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.527 HD23 ' HB ' ' A' ' 6' ' ' ILE . 13.5 mt -121.17 114.2 21.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.992 0.425 . . . . 0.0 111.763 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.523 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.7 m0 -109.44 122.06 46.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.774 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' A' ' 122' ' ' VAL . 7.7 m-30 -107.21 114.72 28.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.843 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 23.8 m95 -94.35 148.24 22.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.044 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 86' ' ' LEU . 3.5 tm? -98.48 102.91 14.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.454 0.645 . . . . 0.0 111.463 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.82 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.3 t -82.36 145.74 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.03 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -114.79 -23.56 9.11 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.552 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 8.6 ttt180 -162.59 164.54 26.68 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.507 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.714 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -157.14 124.42 5.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.248 178.631 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -75.19 146.25 41.4 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.116 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.65 -130.44 48.32 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.574 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 60' ' ' ILE . 44.3 mt-10 -121.52 141.43 33.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -75.63 131.52 13.67 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.827 2.351 . . . . 0.0 111.143 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 41.0 p-90 -133.49 -65.76 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.58 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.23 -96.8 0.01 OUTLIER Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.876 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER 173.36 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.645 0.26 . . . . 0.0 111.341 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.49 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -56.06 -43.99 78.46 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.804 0.335 . . . . 0.0 110.866 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.49 -82.88 0.25 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.717 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 111.54 48.7 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.917 0.389 . . . . 0.0 111.389 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -43.42 146.21 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.003 2.469 . . . . 0.0 112.625 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.21 177.19 16.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.808 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -139.21 157.28 46.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -60.33 106.57 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.92 0.39 . . . . 0.0 110.086 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.3 mtm -120.09 163.37 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.159 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.97 114.87 23.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.409 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -69.62 -18.71 63.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.529 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.42 -14.82 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.673 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.98 53.52 0.7 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.154 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.437 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 4.7 tt -62.4 150.59 39.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.008 0.432 . . . . 0.0 110.948 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.543 ' CB ' HD13 ' A' ' 33' ' ' LEU . 1.1 t-20 -95.35 93.47 7.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.439 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 123' ' ' ILE . . . -72.29 -20.71 61.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.014 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -45.22 20.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.128 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.79 -39.98 87.96 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.369 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.564 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.44 173.99 6.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.08 127.8 27.19 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.918 1.745 . . . . 0.0 112.607 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 52.1 Cg_endo -69.15 -35.16 15.0 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.752 2.301 . . . . 0.0 112.353 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.787 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -71.9 -9.63 58.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.074 0.464 . . . . 0.0 111.168 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -105.76 17.62 23.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.949 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.0 -31.05 0.96 Allowed Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 80.0 Cg_exo -43.55 -34.28 5.13 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.877 1.718 . . . . 0.0 113.064 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.691 HG22 ' CB ' ' A' ' 71' ' ' LEU . 16.0 t -77.96 -47.28 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.275 0.56 . . . . 0.0 110.253 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.678 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 35.6 mm -68.9 -31.28 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.413 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.05 -26.88 40.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.936 0.398 . . . . 0.0 110.344 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -47.71 14.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.345 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.575 ' O ' HD13 ' A' ' 126' ' ' LEU . 2.4 tm? -78.18 -45.95 21.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 111.329 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.589 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.8 tttm -52.68 -42.27 64.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.127 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -63.93 -8.07 10.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.971 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.337 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.893 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A 5191 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A 5192 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ttp . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.862 0.363 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.527 ' HE3' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -109.81 146.95 34.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.05 132.04 27.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.527 HD23 ' HE3' ' A' ' 2' ' ' LYS . 3.1 pp -146.14 127.14 14.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.376 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.406 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 14.9 mt-30 -102.65 154.48 19.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.062 0.458 . . . . 0.0 111.46 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.601 ' HB ' HD12 ' A' ' 82' ' ' LEU . 1.8 mp -146.42 119.12 2.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.835 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.04 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.93 125.69 44.33 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.1 m -134.76 162.44 38.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.312 0.577 . . . . 0.0 112.041 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.7 111.12 0.9 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.277 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -70.47 103.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.689 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.41 125.76 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.23 -178.361 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -100.47 139.32 36.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.123 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.669 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.9 p-10 -98.74 -173.37 2.51 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.523 0.678 . . . . 0.0 112.234 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.49 -3.96 13.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.869 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.473 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 58.1 t30 -120.11 37.54 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.97 15.94 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 0.0 111.579 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 15' ' ' ASN . 1.2 mm-40 -102.02 161.2 13.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.838 HG12 HG22 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.47 131.26 73.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.164 0.506 . . . . 0.0 111.801 -178.64 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -83.09 116.51 22.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.717 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.671 HD12 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.27 147.22 33.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.556 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 29.2 p -70.78 111.91 6.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.263 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -122.97 126.65 47.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.841 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 48.97 -106.74 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.641 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 168.44 -167.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 0.0 110.742 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.19 24.79 6.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.08 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 p30 179.55 164.09 1.0 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.821 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.54 -168.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.057 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -96.75 -99.79 0.18 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.817 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.1 mtp 47.05 41.53 11.32 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.899 0.38 . . . . 0.0 111.137 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.14 -8.76 56.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.774 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.5 t-20 -91.26 25.25 2.6 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.37 26.09 10.53 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 111.777 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.671 HD21 HD12 ' A' ' 20' ' ' ILE . 2.6 tt -67.19 66.17 0.07 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.044 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -106.86 -170.17 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.223 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.665 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.21 168.33 10.15 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.541 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.567 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 97.0 Cg_endo -84.12 166.55 12.74 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.433 2.755 . . . . 0.0 113.001 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.572 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.01 -6.08 53.75 Favored Glycine 0 C--O 1.225 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 114.096 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.79 167.45 15.45 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.509 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.67 1.5 1.21 Allowed 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.448 0.299 . . . . 0.0 111.795 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.04 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -52.8 -27.06 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.495 0.665 . . . . 0.0 110.433 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.55 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -40.21 -61.44 0.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.025 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.509 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 11.07 -81.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.907 0.754 . . . . 0.0 112.467 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.0 32.33 0.09 OUTLIER Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.862 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.1 mp0 -93.48 -172.94 3.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.653 0.263 . . . . 0.0 111.191 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.853 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -101.59 153.64 37.76 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.323 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.853 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.98 -24.82 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.809 2.339 . . . . 0.0 112.615 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.622 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -100.93 -43.68 5.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -80.09 -20.84 44.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.714 0.292 . . . . 0.0 111.644 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.835 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.38 -48.48 76.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.814 0.34 . . . . 0.0 111.036 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.798 HG12 ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.29 -47.87 23.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.3 t -59.66 -44.11 92.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.59 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' HB3' ' NH1' ' A' ' 52' ' ' ARG . 17.9 mtp-105 -73.25 -41.15 64.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 110.821 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 57' ' ' GLU . 4.6 tp10 -73.5 -19.73 60.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.819 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.644 HD21 ' CE1' ' A' ' 64' ' ' HIS . 5.9 tp -60.04 -44.65 94.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.733 0.301 . . . . 0.0 110.962 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.69 -36.19 82.92 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.38 -24.66 50.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.911 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 12.0 mm-40 -108.26 5.75 25.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.649 -0.421 . . . . 0.0 112.03 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.886 HG12 HG13 ' A' ' 60' ' ' ILE . 60.1 t -134.16 -44.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.48 -40.04 0.28 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.091 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.886 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.74 -177.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.132 0.492 . . . . 0.0 111.217 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.82 88.71 14.57 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.914 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.703 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.1 Cg_endo -111.49 145.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.415 2.744 . . . . 0.0 114.207 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.6 mt-30 -74.92 79.93 2.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.752 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -121.34 129.56 53.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.389 -176.501 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 66' ' ' SER . 2.0 t80 179.91 166.02 1.21 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.709 ' HB3' HD21 ' A' ' 86' ' ' LEU . 50.9 m 82.92 152.18 0.1 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.407 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.3 pp -107.66 134.68 50.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 111.973 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.684 ' CE2' HD12 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -81.94 -44.89 16.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.973 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -171.93 131.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.098 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.614 ' HE2' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -135.79 103.88 5.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.691 0.281 . . . . 0.0 110.733 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -111.66 169.37 8.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.104 0.478 . . . . 0.0 111.467 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.772 ' N ' HD22 ' A' ' 71' ' ' LEU . 8.2 tt0 -137.84 124.89 21.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.674 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.1 p90 -138.11 120.06 15.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.796 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -94.7 139.35 31.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 111.423 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.488 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 2.2 m-85 -103.94 162.47 19.82 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.218 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.9 Cg_endo -54.18 82.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.95 2.433 . . . . 0.0 112.117 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.7 t70 94.84 7.07 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.543 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.4 OUTLIER -137.26 93.72 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 110.592 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 11.5 t-160 -85.69 99.36 11.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.762 0.315 . . . . 0.0 110.871 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.942 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 4.2 tt -103.04 135.5 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 118.78 31.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.356 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.66 HD13 HD11 ' A' ' 80' ' ' ILE . 1.1 mp -113.08 114.06 26.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.897 0.379 . . . . 0.0 111.727 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 9.7 m0 -111.6 122.04 46.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.743 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.654 ' CE1' HG11 ' A' ' 122' ' ' VAL . 1.7 m-85 -109.68 109.94 20.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.469 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.843 ' O ' HD12 ' A' ' 10' ' ' ILE . 19.8 m95 -95.91 148.79 22.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.76 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 66' ' ' SER . 1.4 pp -95.69 138.77 32.89 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.162 0.506 . . . . 0.0 111.709 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.752 HG13 ' CB ' ' A' ' 64' ' ' HIS . 38.4 t -123.33 145.66 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.368 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -113.82 -21.63 10.58 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.92 160.16 24.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.707 0.685 . . . . 0.0 111.473 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.689 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.06 122.61 4.69 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.254 179.022 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -75.82 150.69 37.64 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.138 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.48 -129.92 47.21 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.526 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -125.21 145.8 51.86 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.507 0.194 . . . . 0.0 110.653 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.461 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.48 128.74 10.53 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.761 2.307 . . . . 0.0 111.573 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.556 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -132.34 -59.91 0.91 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.838 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.634 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 36.77 -97.89 0.01 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.195 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tttp 178.43 38.8 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.7 0.285 . . . . 0.0 111.153 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.614 ' CD ' ' H ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -60.51 -49.05 79.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.263 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 143.28 -49.83 0.71 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.262 -0.97 . . . . 0.0 113.345 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.77 118.98 16.86 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.124 0.488 . . . . 0.0 111.966 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -43.79 146.37 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.211 2.608 . . . . 0.0 112.807 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.97 177.23 17.45 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.092 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 105' ' ' MET . 1.6 mt-10 -137.43 157.79 45.82 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.306 0.242 . . . . 0.0 110.383 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -65.0 106.39 1.24 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.75 0.31 . . . . 0.0 110.259 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -120.0 157.14 29.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.796 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.439 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.4 p -75.63 114.93 14.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.666 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.86 HD13 ' O ' ' A' ' 107' ' ' LEU . 2.5 tm? -75.38 -18.77 59.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.503 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.9 p -59.16 -12.58 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.737 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.79 54.3 0.62 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.367 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.598 HD22 HD12 ' A' ' 123' ' ' ILE . 9.2 tt -62.0 150.36 38.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.595 0.236 . . . . 0.0 110.554 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.59 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -108.19 115.88 30.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.581 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -18.9 61.73 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.012 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -79.09 -47.83 15.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.881 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.507 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -66.86 -17.39 64.87 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.645 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.45 173.67 3.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.17 127.92 27.78 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 121.938 1.759 . . . . 0.0 112.405 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.0 Cg_endo -69.04 -38.32 9.56 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.756 2.304 . . . . 0.0 112.664 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.836 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -69.94 -9.72 56.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.977 0.418 . . . . 0.0 111.308 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.474 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 29.2 m-20 -104.42 15.3 28.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.922 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -63.32 -31.59 7.01 Favored Pre-proline 0 N--CA 1.467 0.381 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 71.3 Cg_exo -43.78 -40.38 11.13 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.793 1.662 . . . . 0.0 113.54 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.715 HG22 ' CD1' ' A' ' 71' ' ' LEU . 74.6 t -78.0 -51.55 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.379 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.665 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 38.7 mm -66.13 -31.88 55.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.595 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.86 -32.33 60.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.862 0.363 . . . . 0.0 110.676 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -80.44 -46.16 16.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.52 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 107' ' ' LEU . 0.4 OUTLIER -78.34 -19.77 52.78 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.399 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.566 ' HB2' HG22 ' A' ' 123' ' ' ILE . 22.2 tttm -74.31 -42.45 59.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.128 0.489 . . . . 0.0 110.593 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -68.29 -8.95 44.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.936 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.786 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.15 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.621 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.942 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A 5203 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A 5204 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttm . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.795 0.331 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 140.17 31.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.35 131.23 26.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.489 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.4 pp -146.15 140.55 26.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.908 0.385 . . . . 0.0 111.661 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.717 ' C ' HD12 ' A' ' 6' ' ' ILE . 30.9 mt-30 -104.67 152.86 21.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.213 0.53 . . . . 0.0 111.255 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.738 ' HB ' HD12 ' A' ' 82' ' ' LEU . 4.4 mp -146.18 116.36 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.51 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 1.012 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.33 133.07 52.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.3 m -144.61 162.73 14.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.013 0.435 . . . . 0.0 111.773 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -139.22 115.15 1.08 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.855 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.02 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -71.28 107.25 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.715 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.16 127.29 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.93 0.395 . . . . 0.0 111.132 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.08 123.45 33.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.622 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 12.3 t-20 -78.28 -172.16 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.117 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -82.18 -3.1 54.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.106 -1.406 . . . . 0.0 112.271 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -129.96 36.37 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.64 7.59 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.743 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 17.8 pt-20 -100.85 153.05 19.81 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.02 HG21 HG22 ' A' ' 10' ' ' ILE . 4.8 mt -115.89 140.56 37.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.17 0.509 . . . . 0.0 111.994 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -89.26 102.14 14.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.436 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -115.29 162.13 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.263 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.581 HG22 ' OE2' ' A' ' 98' ' ' GLU . 5.8 p -71.07 121.2 17.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.786 0.327 . . . . 0.0 110.759 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.38 172.31 7.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.807 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.931 ' CZ ' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -62.41 -10.16 10.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.449 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 80.42 3.0 1.86 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.709 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.46 29.92 4.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.739 0.304 . . . . 0.0 111.321 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -107.49 13.87 26.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.397 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 53.34 30.15 9.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.77 0.319 . . . . 0.0 111.33 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -97.71 -68.85 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -124.09 92.69 3.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.923 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.931 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . . . -78.44 -8.91 59.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.608 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -113.07 25.38 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.574 0.226 . . . . 0.0 111.28 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.43 25.98 10.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 0.0 111.799 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 21' ' ' THR . 22.1 tp -76.36 78.79 3.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.272 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.52 -166.63 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.52 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.619 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.52 168.36 10.26 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.157 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.631 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 71.7 Cg_endo -77.5 166.9 25.19 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.238 2.625 . . . . 0.0 112.903 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.579 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.31 -5.58 52.46 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.71 -0.677 . . . . 0.0 114.242 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.51 156.44 42.64 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 117.176 0.488 . . . . 0.0 112.844 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.75 -1.06 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.034 0.534 . . . . 0.0 111.875 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 1.012 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -53.37 -26.01 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.375 0.607 . . . . 0.0 110.929 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.99 -62.85 0.75 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.913 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.495 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.2 mtm 12.24 -83.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.562 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.59 31.68 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.816 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.13 -169.4 2.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.671 0.272 . . . . 0.0 111.043 -179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.904 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -113.62 164.69 15.21 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.451 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.904 ' HD2' HG22 ' A' ' 45' ' ' THR . 6.7 Cg_endo -47.63 -24.62 4.71 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.017 2.478 . . . . 0.0 112.72 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -95.99 -55.24 3.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.016 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -80.55 -4.61 54.62 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.73 -58.02 8.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.811 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.812 HG11 ' NE1' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -79.5 -45.53 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.332 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.0 t -53.46 -39.75 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.724 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -78.13 -42.92 30.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.848 0.356 . . . . 0.0 111.231 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.3 mm-40 -74.22 -19.84 60.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.049 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.804 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -60.57 -44.83 95.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.48 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -35.81 78.28 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.76 -28.03 50.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.124 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 33.4 mm-40 -105.34 5.01 31.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 54' ' ' LEU . 4.1 t -134.87 -44.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.29 -38.94 0.21 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.049 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.643 HG23 ' CD1' ' A' ' 95' ' ' TRP . 22.8 pt -82.02 -176.18 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 120.985 0.422 . . . . 0.0 111.582 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.87 88.41 21.09 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.321 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HB3' ' HB2' ' A' ' 90' ' ' TRP . 12.3 Cg_endo -109.92 153.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.459 2.773 . . . . 0.0 113.833 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 89' ' ' ARG . 89.8 mt-30 -74.85 79.93 2.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.928 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -126.2 127.45 45.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.283 -176.944 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.9 t80 -177.86 158.85 1.32 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 78.01 -168.39 0.05 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.291 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.84 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -144.49 137.57 27.0 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.852 -179.477 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.886 ' CD1' HD23 ' A' ' 126' ' ' LEU . 2.5 p90 -76.75 -41.58 44.36 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . 5.5 mt-10 -171.76 131.45 0.69 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.696 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.49 120.81 42.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.0 111.201 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.734 HD22 ' CE2' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -104.68 122.22 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.026 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -130.68 113.64 14.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.971 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.734 ' CE2' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -141.24 153.38 45.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.378 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.1 pt-20 -121.17 127.06 51.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.343 0.592 . . . . 0.0 111.187 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 77' ' ' ASP . 1.0 OUTLIER -96.51 163.43 20.53 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.554 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.0 Cg_endo -53.18 81.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.032 2.488 . . . . 0.0 112.255 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.2 t70 93.4 8.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.532 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.63 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.1 OUTLIER -137.44 93.86 2.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.633 0.254 . . . . 0.0 110.758 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 1.2 t-80 -93.27 95.7 9.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 111.103 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.71 HD13 ' C4 ' ' A' ' 131' ' ' 8OG . 0.5 OUTLIER -100.35 111.99 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.132 179.835 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -97.26 118.1 32.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.738 HD12 ' HB ' ' A' ' 6' ' ' ILE . 1.7 mp -110.09 113.82 26.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.094 0.473 . . . . 0.0 111.179 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 8.5 m0 -112.5 122.27 47.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.324 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.927 ' CE2' HG11 ' A' ' 122' ' ' VAL . 3.2 m-85 -116.58 113.16 22.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.013 0.435 . . . . 0.0 110.591 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.84 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.8 m95 -94.58 148.3 22.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.566 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 86' ' ' LEU . 2.3 pp -93.97 138.25 32.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.928 HG22 ' ND1' ' A' ' 64' ' ' HIS . 48.8 t -123.26 145.33 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.546 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -109.51 -28.2 9.03 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.79 165.57 22.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.968 0.804 . . . . 0.0 111.789 -178.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.715 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -152.93 126.02 8.52 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.145 178.357 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -76.88 146.4 37.69 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.409 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.57 -126.64 32.24 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.811 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.606 ' O ' HG21 ' A' ' 60' ' ' ILE . 4.0 tt0 -124.4 126.59 25.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.427 0.156 . . . . 0.0 110.582 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' CA ' HD13 ' A' ' 60' ' ' ILE . 13.7 Cg_exo -72.09 128.62 14.14 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.754 2.303 . . . . 0.0 111.2 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.643 ' CD1' HG23 ' A' ' 60' ' ' ILE . 17.1 p-90 -114.78 -61.43 1.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.016 0.436 . . . . 0.0 111.415 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.82 -114.02 1.39 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.904 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.61 74.61 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.927 0.394 . . . . 0.0 110.857 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.581 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -96.44 -29.22 14.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.013 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.2 -103.06 0.45 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.115 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.86 115.53 47.21 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.0 111.612 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -43.66 146.12 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.986 2.457 . . . . 0.0 112.718 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.88 177.69 18.69 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.36 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -133.16 157.26 45.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.607 0.242 . . . . 0.0 110.652 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -63.56 106.72 0.99 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.417 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtm -119.83 163.05 18.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.666 ' HB2' HG12 ' A' ' 108' ' ' VAL . 7.7 p -81.2 114.92 20.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.817 HD11 HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -69.86 -18.66 63.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.208 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.6 p -56.45 -14.29 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.402 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.53 56.76 0.6 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.843 HD23 HD12 ' A' ' 123' ' ' ILE . 9.9 tp -61.73 150.25 37.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.854 0.359 . . . . 0.0 110.861 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 2.3 t-20 -97.22 106.9 19.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.531 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -24.16 61.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -79.17 -47.18 16.5 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.271 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.466 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.79 -14.21 62.37 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.869 -179.125 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.549 ' CZ ' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -113.64 173.43 2.87 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.46 127.86 27.72 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 121.837 1.691 . . . . 0.0 111.974 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.97 -38.89 8.85 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.681 2.254 . . . . 0.0 112.613 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.632 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -69.41 -9.6 54.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.945 0.402 . . . . 0.0 111.572 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -103.54 19.96 18.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.871 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.59 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -70.45 -32.03 2.49 Favored Pre-proline 0 N--CA 1.466 0.349 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.292 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.2 Cg_exo -44.31 -34.27 7.01 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 121.971 1.781 . . . . 0.0 112.899 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.927 HG11 ' CE2' ' A' ' 84' ' ' PHE . 24.5 t -77.59 -51.48 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.066 0.46 . . . . 0.0 110.977 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.873 HG22 ' HB2' ' A' ' 127' ' ' LYS . 12.9 mm -61.67 -38.98 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.885 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.56 -29.6 51.65 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.684 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -80.69 -52.22 7.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.631 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.886 HD23 ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -74.82 -43.06 56.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.405 -179.261 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.873 ' HB2' HG22 ' A' ' 123' ' ' ILE . 40.9 tttt -52.05 -42.61 63.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.128 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -64.49 -9.48 19.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.963 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.815 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.71 ' C4 ' HD13 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A 5215 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A 5216 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 mmm . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.812 0.339 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.55 103.1 13.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.43 144.12 32.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.776 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.0 pp -146.07 137.72 24.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.075 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.586 ' C ' HD12 ' A' ' 6' ' ' ILE . 14.6 mt-30 -106.2 152.86 22.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.229 0.537 . . . . 0.0 111.852 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.776 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.3 mp -146.75 129.79 8.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.866 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.916 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.04 125.18 43.43 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -144.52 162.03 14.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.91 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.03 143.06 10.11 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.741 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.983 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -92.7 111.57 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.926 HG23 HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -71.1 113.45 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-O 121.283 0.563 . . . . 0.0 110.64 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.19 126.9 32.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.422 -178.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.464 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 45.5 t30 -83.91 -172.51 4.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.951 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 16.8 tp10 -78.89 -4.78 51.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.317 -1.31 . . . . 0.0 112.603 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -127.91 44.47 2.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.787 0.327 . . . . 0.0 111.613 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.03 19.58 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.539 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 10.0 pt-20 -114.77 142.76 46.09 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.983 HG21 HG22 ' A' ' 10' ' ' ILE . 11.3 mt -109.92 144.1 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.298 0.571 . . . . 0.0 112.213 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.508 ' O ' ' CD1' ' A' ' 19' ' ' PHE . 11.2 t80 -88.86 93.69 9.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.897 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.619 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -112.47 149.39 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.536 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 3.1 p -70.93 111.87 6.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.506 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 21.9 ptt-85 -139.42 137.11 35.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.818 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.868 ' HD3' ' HB2' ' A' ' 30' ' ' ALA . 10.8 tpt180 52.44 -110.41 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.746 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 173.4 -170.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.841 0.353 . . . . 0.0 110.98 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.25 -30.58 34.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.971 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -171.41 35.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.97 -175.37 3.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -113.46 83.93 1.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.3 tpp -142.12 29.99 1.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.795 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.868 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . . . -60.5 -18.81 54.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.421 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -84.24 8.36 16.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.665 -179.767 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.08 26.09 10.59 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.881 0.372 . . . . 0.0 111.55 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 111' ' ' ASN . 5.1 tt -61.64 79.26 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.647 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -123.43 -173.23 2.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.112 0.482 . . . . 0.0 111.973 -179.364 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.739 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.45 168.21 10.54 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.634 -179.08 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.553 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 68.7 Cg_endo -74.87 167.09 27.85 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.465 2.777 . . . . 0.0 113.043 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.784 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.85 -5.51 53.76 Favored Glycine 0 C--O 1.222 -0.656 0 CA-C-N 115.87 -0.605 . . . . 0.0 114.155 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -62.21 145.65 49.4 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.941 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 92.06 2.01 0.11 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.916 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -51.41 -28.86 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.572 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.59 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.55 -60.8 1.6 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.143 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.513 ' C ' ' O ' ' A' ' 41' ' ' GLU . 8.9 mmm 10.28 -81.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.848 0.718 . . . . 0.0 112.633 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.43 27.98 0.13 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.083 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -103.97 -173.45 2.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.695 0.283 . . . . 0.0 110.999 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.886 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -108.85 155.91 39.92 Favored Pre-proline 0 N--CA 1.456 -0.159 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.886 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.49 -24.5 0.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.674 2.249 . . . . 0.0 112.406 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.9 tt0 -86.83 -60.27 2.03 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -80.67 -21.62 41.2 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.733 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -56.81 -48.77 77.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.675 0.274 . . . . 0.0 110.97 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.558 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.35 -50.72 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.754 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 47' ' ' GLU . 49.9 t -51.14 -35.66 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.773 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -48.71 15.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.537 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.7 mm-40 -65.77 -19.77 66.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.669 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.902 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -58.43 -44.8 89.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.939 0.4 . . . . 0.0 110.774 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -30.96 67.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.13 0.491 . . . . 0.0 109.989 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -77.36 -32.61 55.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.523 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.16 5.9 26.3 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.24 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.091 HG12 HG22 ' A' ' 60' ' ' ILE . 12.5 t -133.91 -43.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.48 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 65.78 -33.12 0.14 Allowed Glycine 0 C--N 1.33 0.244 0 N-CA-C 114.655 0.622 . . . . 0.0 114.655 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 1.091 HG22 HG12 ' A' ' 58' ' ' VAL . 20.0 tt -77.6 165.62 2.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.584 0.231 . . . . 0.0 110.776 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.452 ' N ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -105.19 88.26 2.41 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.465 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 12.0 Cg_endo -114.36 150.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 123.568 2.846 . . . . 0.0 114.39 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -74.69 79.93 2.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.927 ' CE1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.52 129.4 49.66 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.724 -175.539 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.546 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -177.85 -138.57 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.779 -179.148 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 85' ' ' TRP . 0.5 OUTLIER 51.01 173.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.823 0.449 . . . . 0.0 111.719 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.813 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -131.88 125.82 32.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.115 0.484 . . . . 0.0 111.101 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -78.59 -55.87 4.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.022 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.691 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -172.27 131.7 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.328 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.623 ' CD ' HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -114.19 118.71 34.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.712 0.291 . . . . 0.0 110.688 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.712 ' HB3' HG22 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -107.7 129.68 55.0 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.967 0.413 . . . . 0.0 111.047 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -115.92 110.05 18.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.176 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.666 ' CD1' HD23 ' A' ' 71' ' ' LEU . 2.8 p90 -136.33 143.64 44.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.052 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -121.27 118.18 28.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.808 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 2.6 m-85 -69.91 163.01 64.5 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.633 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.69 83.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.187 2.591 . . . . 0.0 112.239 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 17.4 t0 97.14 14.39 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.108 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.55 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.2 OUTLIER -137.39 149.18 46.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.308 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -131.49 112.84 13.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.767 0.318 . . . . 0.0 110.658 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.873 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 3.1 tt -120.65 112.0 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.352 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.51 118.89 32.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.735 HD22 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.86 114.55 22.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.978 0.418 . . . . 0.0 111.913 -178.822 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.4 m0 -108.84 122.33 46.96 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.119 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.781 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 1.9 m-85 -106.91 118.18 36.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.755 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.813 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 68.1 m95 -94.75 148.27 22.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.223 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.546 ' O ' ' O ' ' A' ' 65' ' ' PHE . 44.0 tp -99.03 102.98 14.88 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 121.449 0.642 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.927 HG22 ' CE1' ' A' ' 64' ' ' HIS . 7.4 t -86.13 145.68 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.277 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -100.7 -52.25 3.38 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.21 165.65 24.15 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.479 0.582 . . . . 0.0 112.463 -178.335 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.679 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 33.0 p90 -129.73 160.14 34.31 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.319 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.832 ' O ' HD11 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -100.83 93.35 5.49 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.868 0.366 . . . . 0.0 111.422 -179.146 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' ' NE1' ' A' ' 90' ' ' TRP . . . 100.31 -110.24 3.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.011 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.531 ' C ' HD12 ' A' ' 60' ' ' ILE . 19.9 tt0 -135.3 127.03 17.71 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.447 0.165 . . . . 0.0 111.075 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.7 Cg_exo -75.4 153.13 39.67 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.704 2.269 . . . . 0.0 110.888 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.548 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 19.0 p-90 -150.27 -62.81 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.707 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.39 -99.91 0.02 OUTLIER Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.948 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.7 32.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.441 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -63.52 -21.99 66.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.187 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.45 -123.1 2.81 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.098 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.409 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.7 OUTLIER -75.9 132.52 74.23 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.159 0.504 . . . . 0.0 111.702 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -43.39 146.26 1.26 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.105 2.536 . . . . 0.0 112.646 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.12 177.65 16.43 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.828 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.09 157.03 46.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.6 OUTLIER -66.21 106.29 1.63 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.619 ' SD ' HD11 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -120.31 163.19 18.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.22 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.7 p -82.37 114.83 21.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.473 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.765 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -68.47 -18.68 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.43 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.22 -10.8 2.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.804 0.335 . . . . 0.0 111.438 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.76 55.1 0.72 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.677 HD22 HD11 ' A' ' 107' ' ' LEU . 7.5 tp -61.43 150.2 36.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.407 -0.397 . . . . 0.0 110.828 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.486 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -104.18 95.61 6.09 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.34 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.597 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . . . -72.51 -18.76 61.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.874 177.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -79.06 -47.11 16.76 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.365 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.7 OUTLIER -66.7 -39.25 87.99 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.244 -179.163 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.525 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.39 174.43 6.04 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.4 Cg_endo -53.89 127.69 26.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.859 1.706 . . . . 0.0 112.497 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.8 Cg_endo -69.11 -34.93 15.59 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.753 2.302 . . . . 0.0 112.465 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.848 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -71.37 -9.57 58.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.008 0.433 . . . . 0.0 111.125 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -106.79 18.64 21.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.852 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 tt0 -70.38 -31.37 2.22 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.5 Cg_exo -43.7 -36.08 7.14 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.83 1.687 . . . . 0.0 113.395 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.781 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 59.3 t -78.04 -51.31 18.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 111.903 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.83 HG22 ' HB2' ' A' ' 127' ' ' LYS . 3.9 mm -77.08 -39.78 29.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.8 -26.88 26.08 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.48 -53.9 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.49 ' HG ' ' CE2' ' A' ' 68' ' ' PHE . 1.4 mm? -79.26 -30.3 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.665 0.269 . . . . 0.0 111.564 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.83 ' HB2' HG22 ' A' ' 123' ' ' ILE . 9.7 ttpt -54.03 -42.13 68.8 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.135 0.493 . . . . 0.0 110.338 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -67.46 -6.11 17.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.815 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.03 179.774 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.873 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A 5227 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A 5228 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ttm . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.8 0.333 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -109.96 141.05 43.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.17 128.27 22.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.777 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.668 HD13 " O4'" ' A' ' 131' ' ' 8OG . 4.0 pp -146.33 142.64 28.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.544 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -102.88 153.58 20.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.34 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.77 HD11 " O4'" ' A' ' 131' ' ' 8OG . 40.5 mt -146.33 116.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.959 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.954 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.55 144.25 50.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -145.76 162.44 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.931 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.68 108.04 0.51 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.698 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 1.077 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.73 108.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.774 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -71.72 121.96 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.92 0.391 . . . . 0.0 111.443 -179.004 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -84.86 121.93 28.43 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.093 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.562 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -79.63 -171.67 2.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.731 0.777 . . . . 0.0 111.68 179.423 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.522 ' N ' ' ND2' ' A' ' 13' ' ' ASN . 1.6 tm-20 -82.0 15.53 2.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.343 -1.299 . . . . 0.0 113.105 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 54.8 t30 -144.76 43.97 1.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 54.13 17.82 1.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 105' ' ' MET . 2.3 mt-10 -116.81 160.68 20.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.077 HG21 HG22 ' A' ' 10' ' ' ILE . 5.9 mt -121.33 139.7 47.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.201 0.524 . . . . 0.0 111.458 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.564 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -88.49 98.57 11.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.87 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.777 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -113.79 162.46 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.741 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.736 HG22 ' OE2' ' A' ' 98' ' ' GLU . 8.0 p -70.58 145.72 50.57 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.669 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.6 ttt-85 -148.14 96.24 2.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.068 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.505 ' HD2' ' HB2' ' A' ' 30' ' ' ALA . 11.6 ttp180 55.21 -92.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.226 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 173.71 -32.35 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.239 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 72.86 20.21 3.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.224 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 p30 178.93 37.24 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.807 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 179.6 -166.58 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.021 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.03 -164.42 1.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.782 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.0 mtt 64.3 61.14 0.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.857 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.505 ' HB2' ' HD2' ' A' ' 23' ' ' ARG . . . -86.91 -8.92 56.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.65 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 10.9 t-20 -99.1 28.71 4.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.706 0.288 . . . . 0.0 111.403 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 26.26 10.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.908 0.385 . . . . 0.0 111.934 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.1 tt -68.97 67.22 0.15 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.67 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.53 -167.77 1.3 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.343 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.777 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.36 168.06 10.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.44 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.774 ' HG3' HD11 ' A' ' 11' ' ' ILE . 84.2 Cg_endo -84.19 166.76 12.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.398 2.732 . . . . 0.0 113.224 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.28 -5.7 55.58 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.751 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -67.59 166.93 41.87 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.254 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.74 1.58 1.19 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.661 0.384 . . . . 0.0 111.871 179.575 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.954 HG21 ' HB3' ' A' ' 7' ' ' ALA . 3.4 pt -50.84 -28.6 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.516 0.674 . . . . 0.0 110.562 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.07 -63.43 0.61 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.878 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.521 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 11.15 -84.0 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.895 0.747 . . . . 0.0 112.625 179.368 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.74 29.26 0.08 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.913 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -168.23 1.98 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.734 0.302 . . . . 0.0 110.971 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.824 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -101.49 153.1 38.07 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.28 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.824 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.86 -25.17 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.852 2.368 . . . . 0.0 112.49 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mm-40 -103.99 -41.27 5.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.482 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -80.27 -5.71 56.68 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.93 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.1 -55.25 36.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.329 . . . . 0.0 110.836 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.725 HG12 ' HB1' ' A' ' 7' ' ' ALA . 2.0 m -78.33 -46.7 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.305 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 27.8 t -55.13 -36.91 41.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.342 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -78.19 -52.03 9.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.874 0.368 . . . . 0.0 110.616 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HB2' HG22 ' A' ' 40' ' ' ILE . 1.8 mm-40 -60.28 -21.88 62.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.672 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.786 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.4 tp -60.29 -45.05 94.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.024 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -30.58 71.42 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.5 -27.85 51.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.419 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.56 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.64 6.97 26.34 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.447 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.945 HG12 HG13 ' A' ' 60' ' ' ILE . 12.4 t -133.38 -44.3 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.049 0.452 . . . . 0.0 110.545 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.619 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 54.52 13.89 4.47 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 114.781 0.673 . . . . 0.0 114.781 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.945 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.08 -167.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 118.002 0.901 . . . . 0.0 110.796 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . 0.469 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -111.13 88.65 8.77 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.535 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.655 ' HG3' HG11 ' A' ' 58' ' ' VAL . 25.2 Cg_endo -113.69 137.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 123.733 2.956 . . . . 0.0 114.413 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 33.6 mt-30 -74.83 79.23 2.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.235 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.822 ' HB2' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -117.9 130.61 56.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.873 -176.285 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 66' ' ' SER . 2.3 t80 -176.43 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 86' ' ' LEU . 65.8 m -33.57 157.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.035 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tt -117.54 123.21 45.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.38 . . . . 0.0 110.95 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -82.36 -56.31 3.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.272 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.3 tt0 -171.66 159.22 5.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.429 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.1 108.44 5.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.756 0.312 . . . . 0.0 110.691 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.832 HD21 ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -96.81 146.23 25.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.674 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -138.96 109.89 6.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.763 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.832 ' CD1' HD21 ' A' ' 71' ' ' LEU . 2.4 p90 -141.17 153.01 45.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.677 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 4.2 pt-20 -121.25 133.81 55.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.158 0.504 . . . . 0.0 111.251 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.488 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -97.12 163.15 20.58 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.27 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.4 Cg_endo -54.99 81.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.82 2.346 . . . . 0.0 112.181 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.3 t70 96.25 6.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.647 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.633 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 9.5 ttp180 -137.38 93.95 2.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.677 0.275 . . . . 0.0 110.908 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -88.84 104.7 17.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.834 0.349 . . . . 0.0 110.487 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.991 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 2.2 tt -110.25 130.87 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.292 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.14 118.59 37.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.532 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.509 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -108.62 114.19 27.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.033 0.444 . . . . 0.0 111.862 -178.756 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TRP . . . . . 0.412 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 9.2 m0 -114.32 122.42 46.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.906 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.777 ' CD2' HG11 ' A' ' 122' ' ' VAL . 8.9 m-30 -114.05 116.94 29.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.762 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.725 ' NE1' HG11 ' A' ' 50' ' ' VAL . 20.0 m95 -106.64 148.34 28.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.83 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 66' ' ' SER . 48.1 tp -93.03 138.55 31.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.441 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.822 HG13 ' HB2' ' A' ' 64' ' ' HIS . 36.5 t -121.4 145.7 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.248 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.77 -15.71 11.86 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -163.33 162.3 25.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.594 1.088 . . . . 0.0 112.353 -179.053 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.562 ' CH2' ' CB ' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -157.66 123.45 4.66 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 178.289 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.562 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.55 146.52 32.57 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.551 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.0 -120.79 24.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.21 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 41.1 mt-10 -135.06 135.06 22.2 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.4 0.143 . . . . 0.0 110.931 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . 0.7 ' CA ' HD11 ' A' ' 60' ' ' ILE . 2.9 Cg_exo -76.41 128.96 10.74 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.017 2.478 . . . . 0.0 111.224 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . 0.619 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 11.6 p-90 -129.72 -61.35 1.01 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.118 0.485 . . . . 0.0 111.733 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 40.68 -95.52 0.01 OUTLIER Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.101 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 168.24 69.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.909 0.385 . . . . 0.0 110.71 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.736 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -95.06 -38.65 10.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.696 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.18 -125.55 1.46 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.732 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.417 ' O ' ' HB ' ' A' ' 21' ' ' THR . 12.0 mp0 -78.59 126.51 82.67 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 111.414 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -43.43 144.08 2.14 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.006 2.47 . . . . 0.0 112.797 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.4 ' CA ' ' HE1' ' A' ' 19' ' ' PHE . . . -134.09 177.53 19.06 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.295 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -124.12 157.46 34.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.499 0.19 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -59.38 106.86 0.49 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.784 0.326 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -120.46 159.12 25.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.606 ' HB2' HG12 ' A' ' 108' ' ' VAL . 2.4 p -75.13 118.19 17.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.498 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . 0.763 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -71.42 -18.59 62.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.429 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 106' ' ' SER . 10.8 p -61.29 -12.08 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.653 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.47 50.81 0.85 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.192 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.883 HD11 ' CG2' ' A' ' 123' ' ' ILE . 1.0 OUTLIER -61.94 150.61 37.22 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.739 0.304 . . . . 0.0 111.054 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 1.2 t-20 -108.94 108.98 19.94 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.475 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.45 -18.03 61.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.161 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.98 -47.97 15.32 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -66.97 -29.26 69.07 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.46 -179.465 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.6 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -89.87 173.47 5.8 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.52 127.85 27.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 121.84 1.693 . . . . 0.0 112.283 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.0 Cg_endo -69.14 -35.96 13.43 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.657 2.238 . . . . 0.0 112.636 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.559 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -72.01 -9.75 58.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.982 0.42 . . . . 0.0 111.41 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -106.63 23.0 14.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.6 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.13 -30.66 0.9 Allowed Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.3 Cg_exo -43.19 -35.13 4.82 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.971 1.78 . . . . 0.0 113.466 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.777 HG11 ' CD2' ' A' ' 84' ' ' PHE . 37.6 t -77.86 -51.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.266 0.555 . . . . 0.0 110.381 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.883 ' CG2' HD11 ' A' ' 110' ' ' LEU . 33.4 mm -64.93 -32.3 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.321 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -27.17 39.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.885 0.374 . . . . 0.0 110.77 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.22 -50.83 9.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.623 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.681 HD12 ' CD2' ' A' ' 110' ' ' LEU . 2.8 tm? -78.08 -27.04 48.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.399 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HB2' HG22 ' A' ' 123' ' ' ILE . 53.1 tttp -54.94 -42.38 72.21 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.158 0.504 . . . . 0.0 110.464 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 -63.74 -12.96 39.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.593 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 126' ' ' LEU . 2.6 mp . . . . . 0 C--O 1.231 0.085 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.042 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 131' ' ' 8OG . . . . . 0.991 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A 5239 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A 5240 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.813 0.34 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -139.97 142.85 36.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 1.067 HD12 HD11 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -146.04 134.48 21.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.986 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.466 ' C ' HD12 ' A' ' 6' ' ' ILE . 15.6 mt-30 -102.63 152.86 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.35 0.595 . . . . 0.0 111.937 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.067 HD11 HD12 ' A' ' 4' ' ' LEU . 4.7 mp -146.5 126.82 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.643 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.048 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.9 125.56 44.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.6 m -133.78 162.58 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.131 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.451 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.69 116.04 0.99 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.818 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.021 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.91 109.05 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -71.15 126.67 31.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.613 -178.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -91.18 123.0 34.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.474 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.5 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.0 t-20 -79.91 -172.45 3.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.622 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.45 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.1 tm-20 -81.8 4.29 22.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.418 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -139.5 51.83 1.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 111.324 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.2 p30 45.78 24.32 0.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.439 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.4 pt-20 -115.86 137.45 52.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.021 HG21 HG22 ' A' ' 10' ' ' ILE . 7.3 mt -105.88 139.59 26.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.324 0.583 . . . . 0.0 112.146 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 1.1 t80 -85.31 112.43 20.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.331 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.534 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -128.73 149.93 33.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.921 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.699 HG22 ' OE2' ' A' ' 98' ' ' GLU . 31.2 p -70.63 111.5 6.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.224 -179.528 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.528 0.113 0 CA-C-O 120.83 0.348 . . . . 0.0 110.995 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 34' ' ' GLU . 3.1 tmtm? -106.29 26.3 9.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.336 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.611 HD13 ' HB3' ' A' ' 111' ' ' ASN . 2.7 tt -63.11 74.67 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.775 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -117.32 -173.27 2.38 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.014 0.435 . . . . 0.0 111.844 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.657 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -119.33 168.49 9.9 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.632 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.623 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 95.3 Cg_endo -81.92 166.74 16.8 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.437 2.758 . . . . 0.0 113.306 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.629 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.73 -5.77 54.32 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.384 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -59.25 159.8 18.59 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 117.23 0.515 . . . . 0.0 113.332 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.11 -2.19 0.73 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.048 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -49.97 -27.91 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.544 0.688 . . . . 0.0 110.823 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -43.53 -61.49 1.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.253 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 41' ' ' GLU . 7.4 mmt 9.64 -81.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.826 0.703 . . . . 0.0 112.582 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.34 32.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.985 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.424 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -92.51 -170.67 2.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.713 0.292 . . . . 0.0 111.06 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.844 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -101.22 152.95 38.04 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.284 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.844 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.89 -24.78 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.782 2.321 . . . . 0.0 112.618 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.632 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.0 mp0 -102.18 -42.21 6.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -80.3 -18.39 49.4 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.802 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -57.41 -49.93 74.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.792 0.33 . . . . 0.0 111.06 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.793 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.45 -47.87 23.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.719 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.6 t -56.7 -36.02 47.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.247 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -52.01 9.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.649 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.0 mm-40 -63.43 -22.1 66.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.689 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.782 HD21 ' CD2' ' A' ' 64' ' ' HIS . 1.3 tp -58.38 -44.99 89.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.755 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -31.33 71.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 109.681 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -77.4 -25.77 51.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.243 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.27 5.84 26.02 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.752 ' O ' HG23 ' A' ' 60' ' ' ILE . 3.2 t -134.29 -45.1 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.987 0.423 . . . . 0.0 110.111 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.587 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 62.4 -20.4 0.06 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.768 -0.651 . . . . 0.0 114.664 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.752 HG23 ' O ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -88.73 -176.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 120.961 0.41 . . . . 0.0 111.629 -179.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.485 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -115.49 87.9 18.16 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.162 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.674 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.6 Cg_endo -113.28 145.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 123.611 2.874 . . . . 0.0 113.789 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 36.3 mt-30 -74.9 79.89 2.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.989 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.05 126.98 49.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.172 -1.377 . . . . 0.0 111.072 -176.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.489 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.1 t80 179.77 166.91 1.2 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.77 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.7 m 87.31 155.39 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.644 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.738 HD13 ' HD3' ' A' ' 70' ' ' LYS . 1.4 pp -110.85 137.41 48.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -91.21 -37.55 13.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.019 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.53 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.2 tt0 -171.77 144.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.45 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.738 ' HD3' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.2 132.12 22.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.345 179.535 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.79 HD21 HG22 ' A' ' 122' ' ' VAL . 2.4 pp -141.0 151.09 43.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.426 . . . . 0.0 111.336 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HB2' HG23 ' A' ' 81' ' ' THR . 16.4 tt0 -129.93 109.94 11.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.467 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -128.22 149.75 50.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.739 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -121.15 129.48 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.18 0.514 . . . . 0.0 111.22 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.7 m-85 -78.81 163.21 61.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.546 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.3 Cg_endo -50.72 83.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.227 2.618 . . . . 0.0 112.238 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 21.1 m-20 93.98 15.45 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.339 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 10.5 ttp180 -137.43 150.21 47.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.365 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -126.95 113.47 16.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.006 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 2.0 tt -124.22 119.44 56.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.46 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -106.35 118.82 37.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.82 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.741 HD23 ' HB ' ' A' ' 6' ' ' ILE . 11.5 mt -118.39 114.36 22.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.964 0.412 . . . . 0.0 111.798 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.46 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.5 m0 -107.64 122.31 46.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.009 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.631 ' CE2' HG11 ' A' ' 122' ' ' VAL . 3.2 m-30 -104.54 120.16 40.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.033 0.444 . . . . 0.0 110.513 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.707 ' CE2' HG11 ' A' ' 50' ' ' VAL . 16.6 m95 -106.23 149.09 27.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.049 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 87' ' ' VAL . 3.5 tm? -95.52 138.6 32.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.551 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.989 HG22 ' ND1' ' A' ' 64' ' ' HIS . 39.1 t -123.4 145.85 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.117 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -110.57 -26.71 9.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -162.51 161.71 27.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.491 0.587 . . . . 0.0 111.41 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.702 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -156.91 124.74 5.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.266 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.537 ' O ' HD12 ' A' ' 60' ' ' ILE . 75.3 mt-10 -73.14 142.69 47.45 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.254 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.15 -143.38 26.11 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.704 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.2 tt0 -107.52 138.01 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.598 ' HA ' HG21 ' A' ' 60' ' ' ILE . 6.6 Cg_exo -74.89 128.97 12.0 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.82 2.347 . . . . 0.0 111.598 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.674 ' CD1' HG22 ' A' ' 60' ' ' ILE . 52.0 p-90 -121.23 -62.62 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.642 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.93 -97.68 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.21 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 tttt 173.59 39.43 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.724 0.297 . . . . 0.0 111.096 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.699 ' OE2' HG22 ' A' ' 21' ' ' THR . 15.7 pt-20 -57.87 -49.39 76.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.798 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 148.86 -68.08 0.36 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.466 -0.874 . . . . 0.0 113.118 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -117.72 113.27 38.26 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.033 0.444 . . . . 0.0 111.746 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -43.6 146.15 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.077 2.518 . . . . 0.0 112.686 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.17 177.39 17.69 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.811 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -124.4 157.18 35.72 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.8 OUTLIER -67.65 106.44 2.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.91 0.386 . . . . 0.0 110.17 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.23 163.22 18.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.211 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.5 t -83.43 114.84 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.444 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.602 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -60.66 -18.77 55.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.458 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 108' ' ' VAL . 21.2 t -62.89 -8.85 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.656 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.64 51.68 0.84 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.738 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.671 HD23 HD12 ' A' ' 123' ' ' ILE . 6.9 tp -62.18 150.16 39.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.652 0.263 . . . . 0.0 110.688 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.611 ' HB3' HD13 ' A' ' 33' ' ' LEU . 1.3 t-20 -107.26 97.31 7.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.48 -22.58 61.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.211 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -78.98 -44.91 21.38 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.401 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.62 -42.74 86.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.199 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.529 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.55 174.32 6.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.5 Cg_endo -54.07 127.74 26.97 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.889 1.726 . . . . 0.0 112.233 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.03 -36.28 13.06 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.679 2.252 . . . . 0.0 112.503 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.13 -9.67 58.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.42 . . . . 0.0 111.339 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -104.37 21.61 16.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.798 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.22 -31.29 1.4 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.8 Cg_exo -43.83 -32.97 4.68 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.833 1.689 . . . . 0.0 113.003 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.79 HG22 HD21 ' A' ' 71' ' ' LEU . 50.0 t -78.02 -51.1 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.121 0.486 . . . . 0.0 110.504 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.895 HG22 ' HB2' ' A' ' 127' ' ' LYS . 23.4 mm -69.17 -30.73 47.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.623 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.78 -27.61 42.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.906 0.384 . . . . 0.0 110.628 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -80.43 -53.11 6.89 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.941 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.717 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.5 tm? -78.19 -33.19 50.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.771 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.895 ' HB2' HG22 ' A' ' 123' ' ' ILE . 31.0 ttpt -53.41 -42.84 67.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.133 0.492 . . . . 0.0 110.837 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -7.36 29.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.83 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.528 0.1 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.32 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.0 tttm . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.868 0.366 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.99 126.76 20.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.411 HD11 HD13 ' A' ' 80' ' ' ILE . 3.1 pp -146.1 122.49 10.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.5 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 14.2 mt-30 -102.85 155.37 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.41 0.624 . . . . 0.0 112.391 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.511 HD13 ' CD1' ' A' ' 80' ' ' ILE . 3.6 mp -146.99 129.72 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.536 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.994 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 125.38 44.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.9 m -144.28 162.27 14.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.718 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.446 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -149.65 132.14 3.92 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.006 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.059 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.85 114.49 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.736 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.1 mt -71.38 123.24 25.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.96 0.409 . . . . 0.0 111.513 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.405 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -84.95 122.86 29.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.684 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.465 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 14.7 t30 -82.34 -172.21 3.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.087 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tt0 -81.61 0.99 35.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.431 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -139.74 52.16 1.71 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.432 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 47.56 21.17 0.22 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.588 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -111.79 153.28 26.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.059 HG21 HG22 ' A' ' 10' ' ' ILE . 4.9 mt -123.61 141.87 42.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.351 0.596 . . . . 0.0 112.438 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -87.13 117.86 26.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.917 179.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -129.04 145.2 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.567 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 100' ' ' GLN . 68.4 p -70.78 111.84 6.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.23 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HG3' HD12 ' A' ' 33' ' ' LEU . 21.4 ttp180 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.046 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.4 t30 . . . . . 0 C--O 1.23 0.073 0 CA-C-O 120.779 0.323 . . . . 0.0 111.318 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.22 26.04 10.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.409 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.893 HD13 ' HB3' ' A' ' 111' ' ' ASN . 7.2 tt -64.01 74.76 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.88 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -123.59 -171.22 2.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.896 0.379 . . . . 0.0 111.5 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.721 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.3 168.58 9.68 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.619 -179.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.515 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 92.0 Cg_endo -82.66 167.37 14.95 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.689 2.926 . . . . 0.0 113.307 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.14 -5.24 52.65 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.067 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.82 166.51 17.4 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.274 -0.488 . . . . 0.0 113.263 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.29 0.25 1.38 Allowed 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.994 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -49.9 -29.07 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.682 0.753 . . . . 0.0 110.542 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.596 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.07 -60.37 1.9 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.964 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 8.05 -80.27 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.928 0.767 . . . . 0.0 112.511 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -178.66 32.71 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.725 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.6 mp0 -88.58 -174.11 4.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.796 0.331 . . . . 0.0 111.078 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.843 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.8 153.79 38.55 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.239 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.843 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.86 -25.18 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.805 2.337 . . . . 0.0 112.496 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.539 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mt-10 -104.02 -40.31 6.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.398 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -80.25 -6.79 58.46 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.859 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.52 -56.01 24.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.812 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.784 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.28 -48.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.4 t -51.44 -35.8 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.016 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -52.26 8.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.255 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.3 mm-40 -66.27 -22.69 66.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.707 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 58' ' ' VAL . 10.9 tp -58.01 -44.3 87.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -28.41 61.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.055 0.455 . . . . 0.0 109.885 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -77.1 -28.07 54.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.972 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.487 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.7 mp0 -108.39 6.94 26.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.936 HG12 HG13 ' A' ' 60' ' ' ILE . 60.9 t -133.18 -44.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.609 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.85 -39.12 0.24 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.573 -0.74 . . . . 0.0 114.264 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.936 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.34 -176.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.959 0.409 . . . . 0.0 110.847 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.31 88.77 13.32 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.694 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.744 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.8 Cg_endo -110.46 143.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 123.402 2.735 . . . . 0.0 113.679 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 33.3 mt-30 -74.67 79.9 2.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.817 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.37 132.08 54.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.165 -175.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -179.82 -133.55 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.294 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.23 167.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.017 0.437 . . . . 0.0 111.754 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 67' ' ' LEU . 6.7 tt -131.7 108.73 9.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.897 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.85 -44.29 32.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.037 0.446 . . . . 0.0 110.253 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.536 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.8 tt0 -171.6 156.89 4.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.316 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.09 106.24 4.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.644 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.823 ' HB2' HG22 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -96.77 124.88 40.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -123.42 109.96 14.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.413 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.602 ' CD1' HD23 ' A' ' 71' ' ' LEU . 1.8 p90 -138.55 149.55 45.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.828 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 3.7 pt-20 -121.11 122.15 39.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.089 0.471 . . . . 0.0 111.248 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 77' ' ' ASP . 4.5 m-85 -84.99 162.86 48.23 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.482 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.456 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -50.81 81.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.011 2.474 . . . . 0.0 112.224 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 75' ' ' PHE . 12.3 m-20 89.58 12.88 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.415 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 24.3 ttp180 -137.35 93.7 2.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.705 0.288 . . . . 0.0 110.786 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.463 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.8 t-80 -81.49 110.74 17.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.957 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.511 ' CD1' HD13 ' A' ' 6' ' ' ILE . 1.8 tp -114.0 118.52 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.519 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -111.72 118.77 36.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.763 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.44 HD23 ' HB ' ' A' ' 6' ' ' ILE . 11.8 mt -122.25 114.29 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.929 0.395 . . . . 0.0 111.873 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.519 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.3 m0 -106.99 122.32 46.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.057 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.596 ' CD2' HG11 ' A' ' 122' ' ' VAL . 3.5 m-30 -103.98 112.99 26.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.776 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.784 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 44.4 m95 -94.68 148.68 22.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.212 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.8 tp -99.85 103.05 14.63 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.453 0.644 . . . . 0.0 111.324 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.817 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.6 t -80.84 146.08 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.303 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.77 -26.23 8.3 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.1 tpt180 -162.64 162.05 26.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.416 0.553 . . . . 0.0 111.44 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.722 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -155.85 124.32 5.9 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.449 178.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -73.07 140.34 47.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.914 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.34 -121.68 26.35 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.1 tt0 -132.84 142.13 43.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.506 0.193 . . . . 0.0 110.783 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.494 ' CA ' HD11 ' A' ' 60' ' ' ILE . 3.5 Cg_exo -75.8 128.84 11.16 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.824 2.349 . . . . 0.0 111.178 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.662 ' HE1' HG23 ' A' ' 60' ' ' ILE . 18.4 p-90 -126.24 -64.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.489 -0.484 . . . . 0.0 112.262 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.506 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.57 -94.9 0.01 OUTLIER Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.062 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.419 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.5 OUTLIER 170.99 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.674 0.273 . . . . 0.0 111.35 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -50.33 -29.96 11.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.638 0.256 . . . . 0.0 110.794 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.09 -28.77 7.44 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.741 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.458 ' O ' HG22 ' A' ' 21' ' ' THR . 1.0 OUTLIER -140.03 106.04 6.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 117.206 0.503 . . . . 0.0 112.003 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -43.56 146.28 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.112 2.541 . . . . 0.0 112.66 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.81 177.29 19.19 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.1 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.27 157.42 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.441 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -68.68 105.98 2.47 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.183 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.7 ptp -120.52 163.29 18.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.012 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.33 114.98 16.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.474 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 107' ' ' LEU . 1.4 tm? -71.42 -18.74 62.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.407 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.41 ' O ' HG22 ' A' ' 108' ' ' VAL . 10.8 p -58.0 -13.63 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.619 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.48 55.16 0.63 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.967 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.724 HD22 HD12 ' A' ' 123' ' ' ILE . 4.8 tt -61.95 150.54 37.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.896 0.379 . . . . 0.0 110.742 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.893 ' HB3' HD13 ' A' ' 33' ' ' LEU . 2.8 t-20 -95.22 100.07 11.92 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.48 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -20.93 61.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.14 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.98 -45.15 20.88 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.087 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.78 -41.0 88.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.241 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.487 ' CB ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -78.37 174.2 6.4 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.08 127.56 26.2 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.82 1.68 . . . . 0.0 112.301 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 120' ' ' GLU . 52.6 Cg_endo -69.27 -34.66 15.7 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.762 2.308 . . . . 0.0 112.415 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.49 -9.56 58.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.377 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -103.38 20.54 17.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.955 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.549 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -70.29 -31.16 2.15 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 90.2 Cg_exo -43.99 -37.81 9.67 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 121.704 1.603 . . . . 0.0 113.429 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.823 HG22 ' HB2' ' A' ' 71' ' ' LEU . 52.2 t -77.81 -51.02 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.517 . . . . 0.0 110.6 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.724 HD12 HD22 ' A' ' 110' ' ' LEU . 43.1 mm -66.19 -30.03 48.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.563 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -29.99 57.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.967 0.413 . . . . 0.0 110.254 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -50.79 11.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.509 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.858 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.4 tm? -78.41 -19.93 52.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.831 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.646 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.5 tttt -74.45 -42.61 58.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.235 0.54 . . . . 0.0 110.522 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.74 -9.97 42.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.01 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.696 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.639 179.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 tptm . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.932 0.396 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -139.81 129.04 23.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.721 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.808 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.3 pp -146.2 136.93 24.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.329 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.749 ' C ' HD12 ' A' ' 6' ' ' ILE . 22.1 mt-30 -106.64 153.63 22.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.126 0.489 . . . . 0.0 111.648 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.808 HD11 ' CD1' ' A' ' 4' ' ' LEU . 4.3 mp -146.32 118.84 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.695 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.074 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.94 125.83 44.53 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -140.08 162.6 24.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.559 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.58 125.69 2.7 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.134 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.818 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.81 107.26 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.723 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.23 125.33 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.898 0.38 . . . . 0.0 111.496 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.05 124.44 34.29 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.581 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.472 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 13.5 t30 -79.32 -172.22 3.09 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.834 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -82.57 -1.54 51.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.411 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -129.1 36.15 4.21 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.99 7.29 3.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.601 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 19.2 pt-20 -100.95 146.11 27.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.818 HG21 HG22 ' A' ' 10' ' ' ILE . 6.4 mt -110.61 138.7 37.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 111.833 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.493 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -86.14 122.52 30.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.686 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -126.42 162.2 30.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.804 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.593 HG22 ' OE1' ' A' ' 98' ' ' GLU . 11.7 p -70.52 154.86 41.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.701 0.286 . . . . 0.0 110.392 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.197 -179.683 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.632 0.253 . . . . 0.0 111.273 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -114.16 25.96 10.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.045 0.45 . . . . 0.0 111.66 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.2 tt -70.72 72.42 0.53 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.582 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.681 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -106.73 -167.71 1.32 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.995 0.426 . . . . 0.0 111.913 -179.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.541 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.37 168.51 9.88 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.488 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.615 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 91.4 Cg_endo -80.39 167.34 19.39 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.524 2.816 . . . . 0.0 113.327 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.639 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.45 -5.79 52.24 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.006 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.48 163.22 18.35 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.852 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.53 -0.18 0.91 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.803 0.441 . . . . 0.0 112.1 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.074 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -50.83 -28.83 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.728 . . . . 0.0 110.424 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.602 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -42.38 -54.65 3.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.934 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.536 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 0.9 -75.33 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.966 0.791 . . . . 0.0 112.546 179.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 173.04 35.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.806 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.13 -172.47 3.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.777 0.323 . . . . 0.0 111.08 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.838 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -96.44 153.03 39.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.309 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.838 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.84 -25.03 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.781 2.32 . . . . 0.0 112.52 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.3 mt-10 -104.04 -39.38 6.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.569 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -80.11 -12.87 59.63 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.843 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.45 -52.75 64.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.806 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.949 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.37 -48.34 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 47' ' ' GLU . 36.3 t -57.1 -38.47 60.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.675 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -74.79 -52.06 12.46 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.786 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' A' ' 40' ' ' ILE . 2.9 mm-40 -63.08 -20.06 65.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.722 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.954 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.3 tp -60.46 -44.68 95.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.905 0.383 . . . . 0.0 110.926 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -68.54 -30.08 68.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.064 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -77.3 -25.63 51.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.678 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.47 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.85 6.65 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.979 HG12 HG13 ' A' ' 60' ' ' ILE . 10.0 t -133.81 -44.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 110.721 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.575 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 56.67 6.33 1.63 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 114.846 0.699 . . . . 0.0 114.846 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.979 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.37 -166.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 118.087 0.943 . . . . 0.0 110.406 179.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.628 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -113.86 88.64 14.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.302 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 20.4 Cg_endo -111.92 137.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 123.529 2.819 . . . . 0.0 114.686 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -74.8 79.15 2.09 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.954 ' CE1' HD11 ' A' ' 54' ' ' LEU . 1.5 t-160 -117.09 124.05 48.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.358 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.5 t80 179.78 163.61 1.03 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.901 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 85.64 154.57 0.08 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.447 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.732 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.2 pp -107.68 121.06 43.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 111.616 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -76.81 -39.0 52.85 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.87 138.26 1.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.799 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.29 103.99 4.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.583 0.23 . . . . 0.0 110.746 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 71' ' ' LEU . 4.4 pp -105.81 152.54 23.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 111.062 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -135.38 117.39 15.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.723 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -136.33 152.06 50.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.509 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.02 139.96 52.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.198 0.523 . . . . 0.0 111.397 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.467 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -105.63 163.18 17.63 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.278 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.9 Cg_endo -55.63 81.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.819 2.346 . . . . 0.0 112.15 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 4.9 t70 97.08 6.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.676 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 12.1 ttp180 -137.32 94.84 2.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.702 0.287 . . . . 0.0 110.796 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.436 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -91.96 101.66 14.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.755 HG13 HD13 ' A' ' 6' ' ' ILE . 1.9 tt -103.52 142.77 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.134 0.493 . . . . 0.0 111.283 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -123.01 118.24 27.33 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 178.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.868 HD23 ' CG2' ' A' ' 122' ' ' VAL . 6.4 tp -114.49 114.03 25.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.085 0.469 . . . . 0.0 111.542 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.417 ' HE1' HG22 ' A' ' 81' ' ' THR . 8.7 m0 -114.15 121.8 44.87 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.83 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.658 ' CE2' HG11 ' A' ' 122' ' ' VAL . 3.5 m-30 -110.27 117.41 33.57 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.236 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.732 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 16.2 m95 -105.4 148.54 27.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.223 0.535 . . . . 0.0 112.343 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.5 tp -86.14 138.42 31.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.386 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.823 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.7 t -124.11 145.49 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.712 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.88 -24.2 10.12 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.76 163.18 26.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.344 0.974 . . . . 0.0 112.306 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.723 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -157.81 123.26 4.53 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.749 178.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.63 ' O ' HG21 ' A' ' 60' ' ' ILE . 6.8 tt0 -74.5 149.39 40.3 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.165 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.62 -116.83 6.35 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.593 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 11.8 mt-10 -135.33 143.39 45.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.431 0.158 . . . . 0.0 110.697 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.642 ' CA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.43 128.76 10.59 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.816 2.344 . . . . 0.0 111.079 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.575 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 38.0 p-90 -132.25 -59.75 0.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.499 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.79 -94.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.786 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.417 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 174.77 39.63 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.786 0.327 . . . . 0.0 110.714 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.593 ' OE1' HG22 ' A' ' 21' ' ' THR . 26.4 pt-20 -57.64 -45.67 85.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.767 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 131.92 -43.06 1.32 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.248 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.37 108.2 23.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.042 0.449 . . . . 0.0 111.769 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -43.75 146.31 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.004 2.469 . . . . 0.0 112.51 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.64 177.27 17.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.048 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.78 157.38 43.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.459 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -74.49 106.33 6.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.295 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.1 ptp -120.42 163.24 18.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.13 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.4 p -79.28 114.98 18.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.509 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.771 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -63.21 -18.7 63.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.449 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 108' ' ' VAL . 21.3 t -63.08 -8.57 3.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.6 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.97 50.46 0.88 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.096 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.523 ' CD2' HD12 ' A' ' 123' ' ' ILE . 8.1 tp -62.17 150.17 39.46 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.46 115.84 22.93 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.59 -17.97 61.65 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.162 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -78.85 -49.06 13.55 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.075 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -66.93 -18.74 65.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.447 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.573 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.82 170.72 5.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.54 127.69 27.07 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.05 1.833 . . . . 0.0 112.326 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.16 -36.86 11.56 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.619 2.212 . . . . 0.0 112.528 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.57 -9.58 57.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.487 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.418 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 15.4 m-20 -105.8 19.11 21.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.776 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.555 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -66.61 -31.88 4.63 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.0 Cg_exo -44.2 -34.74 7.21 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 121.825 1.683 . . . . 0.0 113.154 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.868 ' CG2' HD23 ' A' ' 82' ' ' LEU . 39.4 t -77.96 -51.3 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.021 0.439 . . . . 0.0 110.785 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.829 HG22 ' HB2' ' A' ' 127' ' ' LYS . 26.2 mm -67.49 -31.94 54.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.42 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.49 -26.86 33.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.891 0.377 . . . . 0.0 110.657 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.12 -53.09 7.02 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.791 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.692 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.5 tm? -78.25 -31.8 49.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.761 0.315 . . . . 0.0 111.744 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.829 ' HB2' HG22 ' A' ' 123' ' ' ILE . 4.7 ttpt -53.95 -42.56 69.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.97 0.414 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -67.77 -9.22 42.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.825 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.264 179.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.828 0.346 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 145.4 55.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 pp -146.1 127.84 15.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.236 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.527 ' O ' HD12 ' A' ' 6' ' ' ILE . 25.7 mt-30 -102.58 146.95 27.4 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.281 0.562 . . . . 0.0 111.696 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.527 HD12 ' O ' ' A' ' 5' ' ' GLN . 0.8 OUTLIER -146.71 132.91 13.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.771 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.136 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.64 124.55 42.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.58 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 m -119.38 162.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.391 0.615 . . . . 0.0 112.089 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -149.51 106.23 0.32 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.904 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.035 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.72 109.88 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.713 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.34 123.06 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.805 -178.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.72 124.32 32.85 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.591 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.493 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.2 t-20 -81.41 -172.34 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.644 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 26.2 tt0 -83.34 9.18 11.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.487 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -141.36 52.24 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.156 -0.34 . . . . 0.0 111.503 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.9 p30 44.71 25.79 0.16 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 111.368 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -117.93 160.16 21.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.035 HG21 HG22 ' A' ' 10' ' ' ILE . 9.0 mt -130.26 138.04 54.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.048 0.452 . . . . 0.0 111.435 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -79.02 112.5 16.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.305 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.28 139.61 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.156 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -70.8 111.88 6.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.824 0.345 . . . . 0.0 110.606 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.803 ' HD2' HD22 ' A' ' 33' ' ' LEU . 9.3 ttp180 . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 . . . . . 0 CA--C 1.529 0.163 0 N-CA-C 111.604 0.224 . . . . 0.0 111.604 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 26.2 10.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.046 0.451 . . . . 0.0 111.3 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.803 HD22 ' HD2' ' A' ' 22' ' ' ARG . 28.1 tp -58.07 86.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.841 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.91 -175.94 3.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.112 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.753 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.63 161.58 36.94 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.177 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.7 166.7 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.069 2.513 . . . . 0.0 111.525 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 100.97 58.92 0.82 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 119.857 -1.164 . . . . 0.0 113.176 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.603 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.66 122.96 3.55 Favored Glycine 0 C--N 1.312 -0.802 0 CA-C-N 114.941 -0.63 . . . . 0.0 112.339 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.603 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 107.92 2.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.103 0.561 . . . . 0.0 112.296 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.136 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -48.83 -28.95 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.541 0.686 . . . . 0.0 110.515 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.583 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.92 -69.72 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.779 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.462 ' C ' ' O ' ' A' ' 41' ' ' GLU . 13.7 mmt 22.43 -86.18 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.868 0.73 . . . . 0.0 112.19 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.88 27.86 0.17 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.502 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.407 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 5.9 mt-10 -93.83 -177.32 4.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.827 0.346 . . . . 0.0 111.108 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.925 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.86 158.44 35.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.982 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.925 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.93 -24.69 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.809 2.339 . . . . 0.0 112.409 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -88.85 -60.23 2.01 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.48 -6.83 58.75 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.799 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.74 -54.47 42.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.76 0.314 . . . . 0.0 110.826 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.797 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.31 -46.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.977 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 47' ' ' GLU . 32.6 t -55.55 -37.62 46.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.223 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.3 -52.02 9.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.998 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.87 -23.55 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.002 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.737 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -53.79 -44.63 70.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.532 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -33.93 75.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.68 -26.12 50.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.188 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 54.2 mm-40 -108.36 4.27 24.28 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.938 HG12 HG13 ' A' ' 60' ' ' ILE . 26.0 t -134.85 -44.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.229 0.538 . . . . 0.0 110.117 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.14 -41.77 0.36 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.723 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.938 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.79 -176.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.133 0.492 . . . . 0.0 111.251 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.79 88.79 14.64 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.17 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.82 ' HG3' HG11 ' A' ' 58' ' ' VAL . 7.2 Cg_endo -110.15 149.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.322 2.681 . . . . 0.0 113.887 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 77.7 mt-30 -74.74 79.78 2.06 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.962 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.56 129.27 50.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.206 -176.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' HD1' ' A' ' 64' ' ' HIS . 3.4 t80 -176.59 -39.34 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.456 ' CB ' ' HB3' ' A' ' 86' ' ' LEU . 51.8 m -40.74 160.87 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.805 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -115.69 119.32 35.68 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.575 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -86.83 -56.34 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.262 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.539 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -172.03 144.08 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.309 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.443 ' NZ ' ' CZ3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -142.21 112.46 7.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.698 0.285 . . . . 0.0 110.768 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.792 HD21 ' HA ' ' A' ' 122' ' ' VAL . 3.7 pp -125.18 159.39 31.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.968 0.413 . . . . 0.0 111.028 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -135.35 109.93 8.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.592 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.51 ' HD2' HD13 ' A' ' 71' ' ' LEU . 30.1 p90 -125.59 151.12 46.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.746 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.12 131.29 54.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 111.114 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.468 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-85 -79.89 162.85 60.87 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.622 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.9 Cg_endo -53.6 82.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.203 2.602 . . . . 0.0 112.321 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER 100.43 11.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.895 0.878 . . . . 0.0 111.232 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.46 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 17.5 ttp180 -137.3 150.15 47.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.585 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -127.06 110.87 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.672 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.595 HD11 HD13 ' A' ' 82' ' ' LEU . 1.9 tt -120.3 120.69 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.369 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.552 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -103.02 118.65 37.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.595 HD13 HD11 ' A' ' 80' ' ' ILE . 1.1 mp -119.75 114.05 21.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.768 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.552 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.5 m0 -110.1 122.55 47.86 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.348 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.698 ' CE1' HG11 ' A' ' 122' ' ' VAL . 2.2 m-85 -109.98 109.79 20.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.919 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.707 ' NE1' HG11 ' A' ' 50' ' ' VAL . 34.2 m95 -98.02 148.95 22.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.592 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.832 HD23 ' N ' ' A' ' 87' ' ' VAL . 3.4 tt -97.83 138.5 35.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.461 0.648 . . . . 0.0 111.664 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.962 HG22 ' ND1' ' A' ' 64' ' ' HIS . 61.5 t -114.78 146.38 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.436 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.41 -25.69 10.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.477 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.4 165.36 24.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.72 0.691 . . . . 0.0 111.505 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.713 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -156.57 123.36 5.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.387 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -79.1 153.69 29.95 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.064 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.56 -131.95 49.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.566 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.4 mt-10 -123.33 144.24 43.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.51 0.195 . . . . 0.0 110.725 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.54 128.76 10.51 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.788 2.325 . . . . 0.0 111.628 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.561 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.9 p-90 -133.4 -58.91 0.88 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.604 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.07 -98.02 0.01 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.025 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 176.8 36.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 111.022 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -44.52 96.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.38 -68.5 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.111 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -110.86 106.37 57.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 111.554 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -43.58 146.27 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.016 2.477 . . . . 0.0 112.647 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.34 177.04 17.11 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.809 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.82 157.38 37.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.578 0.228 . . . . 0.0 110.568 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -60.14 106.68 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.258 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.03 163.29 17.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.3 p -80.36 114.75 19.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.47 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -80.25 -18.68 48.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.433 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.13 -14.34 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.801 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.06 53.79 0.67 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.27 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.626 HD22 HG23 ' A' ' 123' ' ' ILE . 8.5 tt -62.24 150.37 39.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -106.36 115.02 29.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.5 -17.91 61.71 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.049 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.03 -46.29 18.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.029 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -40.13 88.61 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.158 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.49 174.38 6.13 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.0 127.76 26.97 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 121.835 1.69 . . . . 0.0 112.435 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.17 -36.94 11.35 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.796 2.331 . . . . 0.0 112.557 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.33 -9.66 54.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.392 . . . . 0.0 111.361 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.452 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 13.2 m-20 -107.38 18.45 21.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.93 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 tt0 -64.78 -31.89 6.14 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.3 Cg_exo -44.09 -38.77 10.94 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 121.746 1.631 . . . . 0.0 113.206 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.792 ' HA ' HD21 ' A' ' 71' ' ' LEU . 76.8 t -77.66 -51.2 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.829 0.347 . . . . 0.0 111.828 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.626 HG23 HD22 ' A' ' 110' ' ' LEU . 32.6 mm -73.04 -43.79 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.19 -26.81 30.16 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -80.32 -53.45 6.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.505 ' HG ' ' CZ ' ' A' ' 68' ' ' PHE . 3.5 mm? -78.47 -28.46 46.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.549 ' HD3' ' HB2' ' A' ' 112' ' ' ALA . 9.9 ttpp -55.74 -42.19 75.03 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.059 0.457 . . . . 0.0 110.696 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.817 ' O ' HD12 ' A' ' 129' ' ' LEU . 62.9 ttt180 -71.45 -5.79 35.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.99 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.112 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.904 0.383 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.37 129.26 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.608 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.495 HD11 ' HB ' ' A' ' 80' ' ' ILE . 4.1 pp -146.48 139.37 25.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.913 0.387 . . . . 0.0 111.78 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.502 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 39.5 mt-30 -106.01 156.0 18.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.404 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.714 HD12 HD13 ' A' ' 82' ' ' LEU . 15.0 mt -146.74 126.51 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.357 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.905 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.17 125.2 43.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.1 m -144.7 156.49 14.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.999 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.408 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.8 124.45 1.99 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.864 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.084 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.57 112.45 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.749 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.8 OUTLIER -70.81 119.94 17.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.215 0.531 . . . . 0.0 111.381 -178.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -84.3 124.39 31.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.625 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.454 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 23.0 t30 -80.91 -172.25 3.61 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.733 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.403 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.1 tt0 -82.91 5.4 22.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.212 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -139.44 51.23 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.875 0.369 . . . . 0.0 111.503 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 45.88 25.19 0.28 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.277 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 21.3 pt-20 -119.45 141.63 48.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.084 HG21 HG22 ' A' ' 10' ' ' ILE . 10.3 mt -112.51 143.52 22.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.199 0.523 . . . . 0.0 111.749 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -90.38 121.65 32.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.352 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -121.22 134.72 63.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.058 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -70.79 111.97 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.381 . . . . 0.0 110.889 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.824 ' HB3' HD12 ' A' ' 33' ' ' LEU . 34.9 ptt85 . . . . . 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.768 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.9 t-20 . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.32 26.41 10.28 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -67.93 63.2 0.08 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.67 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -109.42 -166.93 1.15 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.445 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.788 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.42 168.23 10.47 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.487 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 59.9 Cg_endo -72.62 167.21 27.72 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.34 2.693 . . . . 0.0 113.162 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.8 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.61 -5.49 54.48 Favored Glycine 0 C--O 1.223 -0.545 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.971 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.37 149.3 50.16 Favored Glycine 0 C--N 1.315 -0.602 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.798 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 91.6 -0.98 0.17 Allowed 'General case' 0 C--N 1.342 0.247 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.905 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -49.41 -29.81 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.717 0.77 . . . . 0.0 110.584 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -43.12 -52.71 5.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.04 179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.531 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 0.4 -75.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.928 0.768 . . . . 0.0 112.564 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 176.12 35.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.979 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -93.56 -171.49 2.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.596 0.236 . . . . 0.0 111.022 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.04 152.58 38.4 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.294 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.813 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.82 -24.97 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.774 2.316 . . . . 0.0 112.491 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -104.08 -40.45 6.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.709 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -80.33 -14.18 58.58 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.763 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.95 -52.33 66.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.818 0.342 . . . . 0.0 111.089 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.704 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.0 m -78.74 -49.03 21.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 47' ' ' GLU . 39.6 t -54.85 -36.02 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.392 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -51.99 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 110.597 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.1 mm-40 -61.59 -22.04 64.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.694 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.768 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -58.48 -44.48 89.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.867 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -33.87 75.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.116 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.6 tt0 -77.13 -26.93 53.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.075 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.459 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.08 6.33 26.86 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 60' ' ' ILE . 48.2 t -133.41 -44.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.76 -40.66 0.31 Allowed Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.969 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.943 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.47 -177.55 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.084 0.469 . . . . 0.0 111.087 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.22 88.86 13.24 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.058 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.749 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.6 Cg_endo -110.09 145.63 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 123.287 2.658 . . . . 0.0 114.159 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 84.2 mt-30 -74.69 79.96 2.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.064 ' CD2' HG22 ' A' ' 87' ' ' VAL . 1.7 t-160 -121.53 131.04 53.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.436 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' HD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -177.08 -133.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.345 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 54.51 171.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.039 0.447 . . . . 0.0 111.937 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.892 HD11 ' HG2' ' A' ' 70' ' ' LYS . 7.1 tt -136.85 108.07 6.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.714 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.886 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.74 -44.58 32.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.99 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.533 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.0 tt0 -171.79 142.72 1.57 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.429 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.892 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.24 103.86 4.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.213 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.577 HD12 ' O ' ' A' ' 71' ' ' LEU . 4.4 pp -110.33 151.75 27.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.955 0.407 . . . . 0.0 111.479 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -131.43 109.94 10.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.393 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.431 ' CZ ' ' HG2' ' A' ' 121' ' ' PRO . 8.1 p90 -127.7 152.99 47.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.747 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.23 128.83 52.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.213 0.53 . . . . 0.0 111.306 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -94.19 163.38 23.55 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.416 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 9.7 Cg_endo -52.74 82.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.0 2.467 . . . . 0.0 112.142 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.4 m-20 91.32 9.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.616 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.42 93.85 2.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.616 0.246 . . . . 0.0 110.67 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 10.1 t-160 -89.8 98.78 11.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 110.673 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.584 HD11 HD12 ' A' ' 6' ' ' ILE . 2.0 tt -106.04 134.46 47.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.221 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -111.24 118.57 36.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.907 HD23 ' CG2' ' A' ' 122' ' ' VAL . 4.1 tp -111.7 113.91 26.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.017 0.437 . . . . 0.0 111.393 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -111.3 121.98 46.66 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.76 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.695 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.0 m-30 -112.73 111.24 21.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.011 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.704 ' CE2' HG11 ' A' ' 50' ' ' VAL . 14.6 m95 -96.14 149.12 21.98 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.056 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' PHE . 9.2 tp -97.63 103.31 15.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.515 0.674 . . . . 0.0 112.328 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.064 HG22 ' CD2' ' A' ' 64' ' ' HIS . 12.1 t -81.16 145.78 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.626 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.63 -26.16 8.0 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 90' ' ' TRP . 15.4 ttm-85 -161.98 165.06 27.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.676 0.671 . . . . 0.0 111.782 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.749 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -156.26 126.16 6.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.419 179.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.7 147.98 37.07 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.94 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.2 -119.7 17.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.476 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 35.3 tt0 -134.88 144.94 52.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.516 0.198 . . . . 0.0 110.856 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.509 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.39 128.83 10.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.983 2.455 . . . . 0.0 111.282 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.576 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 49.9 p-90 -135.06 -62.8 0.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.328 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.585 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.98 -100.08 0.02 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.02 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER 172.31 38.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 111.103 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -58.53 -48.44 80.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.83 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.34 -60.84 0.21 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.834 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -139.02 126.34 13.1 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.384 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -43.31 146.2 1.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.164 2.576 . . . . 0.0 112.752 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.1 177.09 17.56 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.733 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -121.17 157.32 30.46 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -76.44 105.76 7.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 110.218 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 17.2 ptm -120.93 163.3 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.019 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.499 ' HB3' HG12 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -75.54 114.88 14.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.312 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.727 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.5 OUTLIER -68.3 -18.81 64.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.569 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 106' ' ' SER . 12.1 p -54.91 -15.91 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.729 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.55 48.74 0.95 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.433 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.622 HD22 HD12 ' A' ' 123' ' ' ILE . 6.5 tt -62.28 150.42 39.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -111.13 114.88 28.45 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.546 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.35 -18.7 61.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.113 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.93 -45.58 20.2 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.949 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -66.78 -41.56 87.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.997 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.624 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -79.01 173.49 7.64 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.54 127.68 27.03 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 121.857 1.704 . . . . 0.0 112.027 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.02 -37.51 10.84 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.657 2.238 . . . . 0.0 112.667 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.64 -9.83 57.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.526 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -106.31 27.45 8.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.534 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.624 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.04 -30.99 0.95 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.2 Cg_exo -43.68 -35.01 6.06 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.966 1.777 . . . . 0.0 113.357 -178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.907 ' CG2' HD23 ' A' ' 82' ' ' LEU . 95.3 t -77.7 -51.1 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.087 0.47 . . . . 0.0 110.426 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.622 HD12 HD22 ' A' ' 110' ' ' LEU . 39.9 mm -64.61 -32.16 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.205 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.69 -27.37 39.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.9 0.381 . . . . 0.0 110.626 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -80.25 -51.26 9.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.886 HD22 ' CE2' ' A' ' 68' ' ' PHE . 23.2 tp -78.06 -28.23 48.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.609 ' HB2' HG22 ' A' ' 123' ' ' ILE . 49.6 tttm -55.27 -42.44 73.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.03 0.443 . . . . 0.0 110.599 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 -67.22 -10.08 46.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.693 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.294 179.746 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.845 0.355 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -140.08 128.72 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.1 pp -146.06 128.72 16.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 13.8 mt-30 -102.69 154.91 18.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.284 0.564 . . . . 0.0 112.204 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.524 HD13 ' CD1' ' A' ' 80' ' ' ILE . 3.2 mp -146.89 130.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.68 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.945 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.07 125.69 44.2 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.612 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m -140.28 162.24 24.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.394 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.439 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -147.58 129.88 3.35 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.057 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.594 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.7 110.54 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.731 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -70.94 121.99 21.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.996 0.427 . . . . 0.0 111.57 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.98 124.49 30.44 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.515 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.539 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 23.2 t-20 -70.88 178.26 3.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.006 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.539 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 31.6 tt0 -56.88 -17.24 8.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.76 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -122.49 -82.64 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.598 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.58 13.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -100.81 160.3 14.48 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 11' ' ' ILE . 5.2 mt -132.36 137.32 54.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.123 0.487 . . . . 0.0 111.624 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.466 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -83.48 118.29 23.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.573 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -121.28 141.42 41.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.092 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.517 HG22 ' CD ' ' A' ' 98' ' ' GLU . 5.2 p -70.75 111.74 6.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.686 0.279 . . . . 0.0 110.392 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.331 -0.228 0 CA-C-O 121.04 0.448 . . . . 0.0 111.407 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.771 0.32 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -111.83 26.28 10.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.253 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.674 ' O ' HD23 ' A' ' 33' ' ' LEU . 6.7 tt -65.67 69.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.057 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.615 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -119.82 -166.97 1.35 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.233 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.56 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.24 168.53 9.76 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.552 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.612 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 82.8 Cg_endo -78.68 167.68 22.15 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.564 2.842 . . . . 0.0 113.456 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.92 -3.67 48.84 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.407 -0.815 . . . . 0.0 114.534 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.41 158.13 31.94 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.632 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 88.17 0.34 0.41 Allowed 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.213 0.605 . . . . 0.0 112.429 179.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.945 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -49.84 -29.14 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.607 0.718 . . . . 0.0 110.526 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.617 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.62 -57.44 2.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.914 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.536 ' C ' ' O ' ' A' ' 41' ' ' GLU . 9.4 mmt 4.23 -78.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.911 0.757 . . . . 0.0 112.567 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.48 34.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.789 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -89.39 -174.16 4.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.717 0.294 . . . . 0.0 111.049 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.03 153.45 38.51 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.825 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.83 -25.28 0.97 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.828 2.352 . . . . 0.0 112.455 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.5 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -104.04 -40.33 6.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.431 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -80.32 -4.89 55.19 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.74 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.03 -57.01 13.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.869 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.846 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -78.52 -45.66 25.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.6 t -53.24 -39.75 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.237 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -78.02 -48.67 15.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.462 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.5 mm-40 -64.77 -20.05 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.596 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.887 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.2 tp -59.77 -44.39 93.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -65.0 -34.75 79.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.1 tm-20 -77.43 -27.35 52.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.087 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.467 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -108.53 5.39 25.1 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.964 HG12 HG13 ' A' ' 60' ' ' ILE . 35.1 t -134.61 -44.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.185 0.517 . . . . 0.0 110.042 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.595 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.02 -42.39 0.48 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.472 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.964 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.56 -176.48 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.016 0.436 . . . . 0.0 111.12 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -113.08 89.13 13.34 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.531 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.831 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.3 Cg_endo -107.82 143.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 123.272 2.648 . . . . 0.0 113.936 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.9 mt-30 -74.62 80.1 2.0 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 1.052 ' CD2' HG22 ' A' ' 87' ' ' VAL . 2.7 t-160 -122.64 133.32 54.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.474 -175.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.579 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -175.65 -145.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.617 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m 51.96 172.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.009 0.523 . . . . 0.0 112.138 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.863 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -140.26 122.18 15.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.62 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE2' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.55 -44.24 35.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.966 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -171.68 131.9 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.395 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -115.65 109.95 18.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.76 0.314 . . . . 0.0 110.552 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 tp -96.88 121.56 38.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.865 0.365 . . . . 0.0 110.964 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -123.14 109.69 14.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.442 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.41 ' CZ ' HG23 ' A' ' 80' ' ' ILE . 2.0 p90 -141.26 149.84 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 2.6 pt-20 -121.23 129.05 52.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.213 0.53 . . . . 0.0 111.062 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.455 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -95.69 163.27 21.73 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.52 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.1 Cg_endo -53.18 82.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.964 2.443 . . . . 0.0 112.337 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER 92.5 8.69 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.618 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.1 ttp180 -137.25 93.87 2.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.675 0.274 . . . . 0.0 110.896 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 3.2 t-160 -86.84 93.98 9.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.778 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.524 ' CD1' HD13 ' A' ' 6' ' ' ILE . 1.7 tp -101.24 111.93 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.049 0.452 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.477 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -103.82 118.81 37.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.751 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.517 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -116.35 114.19 23.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 112.023 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.477 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.9 m0 -108.53 122.48 47.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.147 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.677 ' CD1' HG11 ' A' ' 122' ' ' VAL . 1.7 m-85 -108.91 111.6 23.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.876 0.369 . . . . 0.0 110.078 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.863 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.5 m95 -94.54 148.91 21.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.704 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.579 ' O ' ' O ' ' A' ' 65' ' ' PHE . 38.0 tp -97.94 102.44 14.19 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 121.342 0.592 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 1.052 HG22 ' CD2' ' A' ' 64' ' ' HIS . 12.2 t -85.5 145.77 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.928 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.406 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 7.5 pt-20 -114.67 -24.12 8.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 7.5 tpt180 -162.61 160.76 26.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.787 0.721 . . . . 0.0 111.677 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.731 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -152.06 125.33 8.73 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.244 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -72.83 141.82 48.0 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.91 -118.92 11.98 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.53 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -131.92 142.86 46.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.552 0.215 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.2 Cg_exo -76.29 128.79 10.72 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.862 2.375 . . . . 0.0 111.412 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.613 ' HE1' HG23 ' A' ' 60' ' ' ILE . 47.6 p-90 -132.06 -62.08 0.86 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.097 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.564 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.92 -102.42 0.04 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.784 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 56' ' ' GLU . 6.7 tptp 179.33 35.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.778 0.323 . . . . 0.0 111.097 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.517 ' CD ' HG22 ' A' ' 21' ' ' THR . 16.0 pt-20 -50.85 -37.37 42.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.791 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.4 -31.93 5.78 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.848 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -128.76 97.17 27.87 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 111.449 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -43.57 146.11 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.953 2.435 . . . . 0.0 112.475 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.08 177.15 19.35 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.958 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.83 157.42 42.27 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.75 105.91 3.37 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.19 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.525 ' HE2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.72 163.31 18.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.908 179.589 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 t -73.82 114.94 12.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.412 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.576 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.53 -18.68 62.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.517 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.531 ' CG1' HD21 ' A' ' 129' ' ' LEU . 21.4 t -58.94 -12.28 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.732 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.51 53.15 0.74 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.032 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.56 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 6.0 tt -62.21 150.45 38.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.922 0.392 . . . . 0.0 110.771 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.516 ' HB3' HD13 ' A' ' 33' ' ' LEU . 3.9 t-20 -97.03 97.75 9.49 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.461 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.42 -20.32 61.44 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.965 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.14 -45.46 19.94 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.203 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.72 -40.61 88.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.551 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.4 174.24 6.34 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.06 127.79 27.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 121.844 1.696 . . . . 0.0 112.301 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 50.1 Cg_endo -69.01 -35.28 15.16 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.662 2.241 . . . . 0.0 112.505 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.7 -9.51 58.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 0.0 111.218 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -104.1 19.77 19.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.567 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -74.96 -30.57 1.02 Allowed Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.6 Cg_exo -43.19 -36.46 6.02 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 121.887 1.725 . . . . 0.0 113.196 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.677 HG11 ' CD1' ' A' ' 84' ' ' PHE . 23.7 t -77.82 -50.26 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.308 0.575 . . . . 0.0 110.264 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.684 HG22 ' HB2' ' A' ' 127' ' ' LYS . 48.6 mm -64.17 -33.9 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.701 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.58 44.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.001 0.429 . . . . 0.0 110.616 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -80.13 -50.71 9.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.739 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.0 tm? -78.12 -40.06 39.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.741 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.684 ' HB2' HG22 ' A' ' 123' ' ' ILE . 18.0 tttm -53.19 -42.7 66.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.12 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -66.98 -7.34 21.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.884 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.762 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.4 mp . . . . . 0 C--O 1.231 0.119 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.185 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.924 0.393 . . . . 0.0 110.944 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -139.99 126.59 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.606 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.752 ' CD1' HD11 ' A' ' 6' ' ' ILE . 4.0 pp -146.09 127.05 14.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.194 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.42 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 43.4 mt-30 -104.6 152.41 22.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.301 0.572 . . . . 0.0 112.006 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.2 mp -146.44 123.14 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.421 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.022 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.09 125.68 44.15 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.3 m -131.21 162.49 39.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.38 0.61 . . . . 0.0 112.051 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -137.43 111.53 0.84 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.677 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.909 HD12 HD13 ' A' ' 18' ' ' ILE . 8.5 pt -70.41 105.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-O 120.724 0.297 . . . . 0.0 110.412 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.686 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.63 125.75 30.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.778 -178.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -98.75 136.02 39.39 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.412 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.741 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.6 p-10 -96.48 -173.3 2.72 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.511 0.672 . . . . 0.0 112.018 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.46 -0.99 9.45 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.642 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.44 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 15.0 t-20 -120.69 33.28 5.63 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.625 -0.43 . . . . 0.0 112.135 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.56 13.78 2.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 111.351 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HG3' ' HB3' ' A' ' 15' ' ' ASN . 4.9 mt-10 -102.08 161.16 13.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.909 HD13 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.7 124.58 72.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.184 0.516 . . . . 0.0 112.012 -178.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -74.2 120.18 19.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.652 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -129.08 150.4 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.287 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 69.2 p -70.83 111.75 6.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.768 0.318 . . . . 0.0 110.593 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HB2' HD13 ' A' ' 33' ' ' LEU . 38.9 ttp180 . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.957 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.758 0.313 . . . . 0.0 111.113 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 34' ' ' GLU . 10.7 mttt -114.11 26.14 10.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.938 0.399 . . . . 0.0 111.219 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.486 HD13 ' HB2' ' A' ' 22' ' ' ARG . 21.7 tp -61.24 77.33 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.033 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.617 ' O ' HG22 ' A' ' 20' ' ' ILE . 2.7 mt-10 -115.75 -170.44 1.78 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.116 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.572 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.26 168.15 10.55 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.625 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.616 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 94.6 Cg_endo -84.28 166.64 12.44 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.585 2.857 . . . . 0.0 113.307 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.05 -5.93 53.52 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-N 115.73 -0.668 . . . . 0.0 114.254 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.13 161.99 18.74 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.891 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.84 1.62 0.78 Allowed 'General case' 0 C--N 1.341 0.228 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.022 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -51.82 -27.69 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.54 0.686 . . . . 0.0 110.294 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.554 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -41.1 -57.78 1.95 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.804 179.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.528 ' C ' ' O ' ' A' ' 41' ' ' GLU . 25.0 mmm 5.86 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.457 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 178.28 33.51 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.755 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -87.94 -174.13 4.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.761 0.315 . . . . 0.0 111.069 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.08 153.1 38.27 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.267 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.825 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.76 -25.41 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.873 2.382 . . . . 0.0 112.487 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.5 mp0 -104.02 -39.68 6.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.448 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -80.25 -8.48 59.48 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.803 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.68 -54.62 43.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.7 0.286 . . . . 0.0 110.744 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.79 HG12 ' HB1' ' A' ' 7' ' ' ALA . 1.4 m -78.09 -47.46 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.167 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.8 t -54.1 -37.95 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.176 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -78.38 -51.97 9.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.257 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' GLU . 1.2 mm-40 -65.14 -19.85 66.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.331 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.767 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -61.2 -44.66 96.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.683 0.277 . . . . 0.0 111.054 -179.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -35.79 82.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -77.68 -26.34 50.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.209 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 53' ' ' GLU . 7.3 mm-40 -108.32 5.34 25.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.929 HG12 HG13 ' A' ' 60' ' ' ILE . 44.7 t -134.45 -44.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.234 0.54 . . . . 0.0 109.68 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.29 -41.47 0.37 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.817 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.929 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.84 -177.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.137 0.494 . . . . 0.0 111.42 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.41 89.0 13.97 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.896 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.752 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.1 Cg_endo -109.98 150.86 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.339 2.693 . . . . 0.0 114.475 -177.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.415 ' CG ' ' HG2' ' A' ' 89' ' ' ARG . 33.7 mt-30 -74.73 79.82 2.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.952 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.77 128.0 47.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.155 -176.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.432 ' N ' ' HD1' ' A' ' 64' ' ' HIS . 1.8 t80 -176.31 -40.67 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.639 ' HB3' HD23 ' A' ' 86' ' ' LEU . 58.4 m -41.4 163.57 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.894 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.404 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.59 120.57 39.1 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.071 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.3 OUTLIER -88.56 -56.65 3.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.807 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -172.27 162.48 5.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.735 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 132.02 22.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.726 0.298 . . . . 0.0 110.774 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.684 HD22 HG23 ' A' ' 122' ' ' VAL . 3.4 tp -121.62 133.37 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.812 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -130.85 109.66 10.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.608 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.694 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.2 p90 -141.24 144.75 34.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.625 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.08 136.03 55.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.135 0.493 . . . . 0.0 111.373 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.467 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -99.58 163.04 19.28 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.32 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 12.8 Cg_endo -56.41 81.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.754 2.303 . . . . 0.0 112.217 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 9.0 t70 99.45 3.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.754 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 21.6 ttp180 -137.25 94.76 2.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.685 0.279 . . . . 0.0 110.953 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.5 t-160 -91.3 105.04 17.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 110.98 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.694 HD13 ' OH ' ' A' ' 73' ' ' TYR . 3.8 tt -106.11 132.6 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.51 118.73 31.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.541 178.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -117.03 114.25 23.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.96 0.409 . . . . 0.0 111.431 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 11.2 m0 -107.52 122.59 46.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.191 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.893 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 2.4 m-85 -108.08 109.64 21.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.039 0.447 . . . . 0.0 110.627 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.742 ' NE1' HG11 ' A' ' 50' ' ' VAL . 39.0 m95 -98.15 148.4 23.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.705 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.639 HD23 ' HB3' ' A' ' 66' ' ' SER . 56.0 tp -94.02 138.41 32.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.384 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.952 HG22 ' ND1' ' A' ' 64' ' ' HIS . 58.1 t -120.54 145.87 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.364 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -107.01 -28.5 9.99 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.45 165.49 23.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.894 0.77 . . . . 0.0 111.64 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.741 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -155.31 123.63 5.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.356 178.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.63 147.18 44.01 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.048 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.08 -121.97 25.74 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.586 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -131.88 146.29 61.13 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.579 0.228 . . . . 0.0 110.781 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.5 128.74 10.53 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.793 2.329 . . . . 0.0 111.475 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.568 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 51.4 p-90 -130.42 -61.26 0.97 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.869 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.622 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 36.87 -97.69 0.01 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.214 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.58 40.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.651 0.263 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.427 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -68.98 -25.44 64.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.075 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.42 -86.58 0.27 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.3 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 21' ' ' THR . 2.0 pt20 -108.24 115.98 57.41 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 111.847 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.63 146.19 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.04 2.493 . . . . 0.0 112.81 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -122.94 177.31 16.56 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.006 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.525 ' HG3' ' HE3' ' A' ' 105' ' ' MET . 0.4 OUTLIER -125.31 157.52 36.47 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -64.53 105.99 1.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.915 0.388 . . . . 0.0 110.09 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.525 ' HE3' ' HG3' ' A' ' 103' ' ' GLU . 5.5 ptp -120.7 152.2 38.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.8 p -74.23 118.55 17.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.55 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.79 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -73.04 -18.62 61.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.41 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 108' ' ' VAL . 21.3 t -59.64 -11.54 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.694 0.283 . . . . 0.0 111.547 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.13 54.45 0.73 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.661 HD13 HD22 ' A' ' 107' ' ' LEU . 7.0 tp -61.74 150.27 37.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 110.787 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -109.95 103.73 12.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.54 -18.86 61.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.153 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -79.0 -47.07 16.93 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.45 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.63 -40.52 88.77 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.229 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.4 174.2 6.4 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.09 127.73 26.91 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.911 1.74 . . . . 0.0 112.489 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.29 -35.48 13.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.726 2.284 . . . . 0.0 112.465 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.05 -9.75 56.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.316 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.425 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 14.6 m-20 -107.73 19.73 19.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.997 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -66.67 -31.75 4.45 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -179.079 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.8 Cg_exo -43.85 -36.57 8.06 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.797 1.665 . . . . 0.0 113.276 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.893 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 55.1 t -77.88 -51.14 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 111.738 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.833 HG22 ' HB2' ' A' ' 127' ' ' LYS . 9.5 mm -74.84 -42.0 46.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.82 -28.27 34.51 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -80.8 -53.78 6.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.51 ' HG ' ' CZ ' ' A' ' 68' ' ' PHE . 3.5 mm? -78.86 -31.12 45.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.833 ' HB2' HG22 ' A' ' 123' ' ' ILE . 15.9 tttm -54.09 -42.1 68.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.044 0.449 . . . . 0.0 110.684 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.818 ' O ' HD12 ' A' ' 129' ' ' LEU . 60.3 ttm-85 -70.41 -6.48 35.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.978 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.148 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tttt . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.83 0.347 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 139.1 35.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.812 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 pp -146.23 123.64 11.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 39.8 mt-30 -102.69 149.01 24.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.136 0.493 . . . . 0.0 111.612 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.697 HG22 ' HA ' ' A' ' 82' ' ' LEU . 2.2 tp -146.59 125.61 4.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.912 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.037 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.98 125.5 43.98 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.648 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -131.14 162.13 39.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.293 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -141.13 111.28 0.7 Allowed Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.664 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.977 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.64 109.42 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -71.18 124.92 28.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.232 0.539 . . . . 0.0 111.785 -178.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.29 121.13 31.27 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.442 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.709 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.8 p30 -81.35 -172.96 4.08 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 123.704 0.628 . . . . 0.0 111.007 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.3 tt0 -79.31 11.02 3.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -136.4 48.22 2.15 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.988 -0.445 . . . . 0.0 112.128 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 44.85 27.36 0.26 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.319 0.58 . . . . 0.0 111.071 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 105' ' ' MET . 25.9 mt-10 -122.49 161.89 22.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.005 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.977 HG21 HG22 ' A' ' 10' ' ' ILE . 6.6 mt -128.85 143.62 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.241 0.543 . . . . 0.0 111.83 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -88.62 118.42 28.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.728 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.474 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -118.29 145.89 23.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.642 HG22 ' OE2' ' A' ' 98' ' ' GLU . 1.7 p -70.72 111.95 6.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.71 0.29 . . . . 0.0 110.528 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.631 ' CB ' HD13 ' A' ' 33' ' ' LEU . 10.6 ttp180 . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.1 t30 . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.506 0.193 . . . . 0.0 111.493 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 34' ' ' GLU . 2.7 mptp? -114.07 26.08 10.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 111.196 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.631 HD13 ' CB ' ' A' ' 22' ' ' ARG . 22.4 tp -55.71 86.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.943 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -119.11 -170.86 2.0 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.084 0.469 . . . . 0.0 111.872 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.5 168.33 10.3 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.607 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.648 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 57.8 Cg_endo -72.06 166.93 28.17 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.377 2.718 . . . . 0.0 112.983 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.785 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.82 -5.76 54.03 Favored Glycine 0 C--O 1.222 -0.601 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.876 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -61.96 140.97 47.11 Favored Glycine 0 C--N 1.316 -0.571 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.262 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 96.27 3.41 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.037 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -51.86 -27.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.489 0.661 . . . . 0.0 110.638 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.09 -76.53 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.173 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 41' ' ' GLU . 44.2 mmm 24.77 -85.48 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.708 0.63 . . . . 0.0 112.316 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.66 31.85 0.11 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.809 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.3 mp0 -89.96 -172.83 3.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.662 0.268 . . . . 0.0 111.195 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.852 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.88 153.06 37.95 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.376 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.852 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -44.06 -24.81 0.96 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.704 2.27 . . . . 0.0 112.643 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.674 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.8 mt-10 -103.39 -41.21 6.08 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 12.9 mm-40 -80.2 -18.12 50.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.618 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.829 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.04 -48.59 79.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.266 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.762 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.15 -46.95 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 110.79 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.2 t -54.12 -37.5 35.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.441 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -78.07 -52.06 9.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.548 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.439 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.7 tp10 -61.14 -19.99 62.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.605 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.855 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -61.4 -44.86 96.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.047 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -69.23 -30.0 68.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.204 0.526 . . . . 0.0 109.762 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.7 tt0 -77.33 -29.57 53.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.062 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.46 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -109.08 6.67 25.19 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -178.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.902 HG12 HG13 ' A' ' 60' ' ' ILE . 46.0 t -133.41 -44.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 109.939 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.84 -39.17 0.18 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.237 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.902 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.69 -177.53 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.092 0.472 . . . . 0.0 111.33 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.43 88.99 13.99 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.953 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.695 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.5 Cg_endo -110.24 148.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.399 2.733 . . . . 0.0 114.312 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 40.3 mt-30 -74.93 79.81 2.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.997 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -124.82 128.8 49.27 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.052 -1.431 . . . . 0.0 109.664 -176.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -173.98 -49.77 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 86' ' ' LEU . 2.2 p -38.16 159.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.947 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.762 HD11 ' HG2' ' A' ' 70' ' ' LYS . 6.8 tt -119.32 116.63 26.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.96 -54.74 6.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.178 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.549 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.74 142.19 1.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.447 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.762 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -139.92 103.87 4.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.432 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.645 HD21 HG22 ' A' ' 122' ' ' VAL . 1.9 pp -111.46 160.79 16.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.548 ' HB2' HG22 ' A' ' 81' ' ' THR . 16.1 tt0 -135.14 109.89 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.653 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -129.36 123.45 31.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.336 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 11.2 pt-20 -110.07 133.87 52.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.179 0.514 . . . . 0.0 111.616 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 2.8 m-85 -74.68 163.67 66.65 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.885 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.7 Cg_endo -37.38 -29.1 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.642 2.894 . . . . 0.0 113.214 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -139.62 -39.66 0.46 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.076 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -84.75 104.38 14.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.25 -179.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.427 ' HE1' HG23 ' A' ' 81' ' ' THR . 0.5 OUTLIER -89.37 112.38 23.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.765 0.317 . . . . 0.0 110.572 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 3.2 tt -118.48 128.99 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.228 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.548 HG22 ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -113.72 118.56 34.67 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.697 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -114.28 114.17 25.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.115 0.483 . . . . 0.0 112.031 -178.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.422 ' CZ3' ' HE2' ' A' ' 70' ' ' LYS . 10.5 m0 -110.22 122.08 46.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.201 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' A' ' 122' ' ' VAL . 6.1 m-30 -112.43 111.94 23.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.7 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.617 ' CE2' HG11 ' A' ' 50' ' ' VAL . 21.1 m95 -100.56 148.98 24.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.718 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 66' ' ' SER . 45.9 tp -93.97 138.69 31.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.514 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.997 HG22 ' ND1' ' A' ' 64' ' ' HIS . 44.8 t -120.09 145.7 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.095 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.99 -24.55 10.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -163.66 164.96 23.78 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.958 0.799 . . . . 0.0 111.508 -178.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.709 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -157.24 123.54 4.89 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.94 0.4 . . . . 0.0 111.326 178.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -76.13 151.7 36.93 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.077 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.97 -122.66 28.17 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.558 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 13.6 mt-10 -132.17 147.87 67.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.516 0.198 . . . . 0.0 110.77 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.557 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.48 128.81 10.58 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.845 2.363 . . . . 0.0 111.202 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.561 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 52.5 p-90 -134.43 -64.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.539 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.596 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.85 -96.56 0.01 OUTLIER Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.143 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 173.44 38.83 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.678 0.275 . . . . 0.0 110.93 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.642 ' OE2' HG22 ' A' ' 21' ' ' THR . 15.2 pt-20 -58.45 -49.42 77.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.855 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.44 -63.56 0.36 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.967 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.92 120.21 25.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.004 0.431 . . . . 0.0 111.637 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -43.48 146.28 1.33 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.101 2.534 . . . . 0.0 112.658 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.7 177.11 17.18 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.874 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -130.29 157.43 42.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.533 0.206 . . . . 0.0 110.472 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.475 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -65.28 106.08 1.27 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.926 0.393 . . . . 0.0 110.272 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.518 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -120.83 163.21 18.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.224 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.408 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -77.32 115.96 17.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.791 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.541 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -80.05 -18.82 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.449 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.46 -12.62 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.601 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.87 54.88 0.63 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.979 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.74 HD22 HD12 ' A' ' 123' ' ' ILE . 4.6 tt -61.84 150.52 37.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -101.02 108.89 20.72 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -16.96 61.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.062 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.01 -46.82 17.4 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.184 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -66.79 -40.51 88.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.61 174.02 6.72 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.642 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.43 127.71 27.08 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 121.893 1.728 . . . . 0.0 112.321 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.88 -37.49 11.41 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.643 2.229 . . . . 0.0 112.628 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.5 -9.58 56.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 111.481 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -104.69 21.78 16.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.829 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -71.87 -31.51 1.8 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 90.9 Cg_exo -44.07 -37.33 9.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.86 1.707 . . . . 0.0 113.188 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.666 HG11 ' CD2' ' A' ' 84' ' ' PHE . 58.8 t -77.67 -51.0 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.63 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.74 HD12 HD22 ' A' ' 110' ' ' LEU . 43.1 mm -65.48 -30.61 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.33 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.86 -29.43 55.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.121 0.486 . . . . 0.0 110.493 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -78.27 -51.3 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.622 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.839 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.2 tm? -78.22 -19.91 52.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.814 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.605 ' HB2' HG22 ' A' ' 123' ' ' ILE . 4.9 ttpm? -75.18 -42.57 55.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.095 0.474 . . . . 0.0 110.51 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.0 ttm105 -67.77 -9.14 41.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.027 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.582 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 tptm . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.824 0.345 . . . . 0.0 110.948 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -140.26 138.11 34.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.594 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.848 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.9 pp -146.29 131.26 18.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.345 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.444 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 28.0 mt-30 -103.09 153.05 20.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.217 0.532 . . . . 0.0 111.965 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.848 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.0 mp -146.53 134.66 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.854 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.061 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.51 124.29 41.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.602 HG11 ' CE1' ' A' ' 84' ' ' PHE . 1.6 m -125.48 162.53 28.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.233 0.539 . . . . 0.0 112.005 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -145.95 113.5 0.69 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.146 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.946 ' CG2' HG21 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -70.69 101.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.828 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -71.04 123.35 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 121.306 0.574 . . . . 0.0 111.937 -178.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.81 123.62 34.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.482 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.492 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 12.5 t-20 -76.73 -172.31 2.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.865 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.7 tm-20 -83.15 4.05 28.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.093 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -138.41 50.85 1.87 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.346 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.71 24.42 0.33 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.384 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 23.5 pt-20 -117.74 144.4 45.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.946 HG21 ' CG2' ' A' ' 10' ' ' ILE . 6.1 mt -113.1 138.84 41.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.228 0.537 . . . . 0.0 111.754 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.27 108.29 19.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.275 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.884 HD12 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -107.86 155.89 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.141 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.714 HG23 ' HD3' ' A' ' 36' ' ' PRO . 5.8 p -71.04 111.81 6.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.686 0.279 . . . . 0.0 110.253 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.955 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.141 0 CA-C-O 120.689 0.28 . . . . 0.0 111.348 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -113.71 25.99 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 111.259 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.884 HD21 HD12 ' A' ' 20' ' ' ILE . 1.8 tt -70.59 65.83 0.32 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.605 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.86 -169.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.444 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.811 ' CD2' HD12 ' A' ' 10' ' ' ILE . 3.0 m-85 -119.13 143.75 34.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.709 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.714 ' HD3' HG23 ' A' ' 21' ' ' THR . 17.8 Cg_endo -58.23 165.98 6.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.741 2.294 . . . . 0.0 111.067 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 100.36 58.66 0.85 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 119.72 -1.228 . . . . 0.0 113.359 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -124.84 134.02 8.8 Favored Glycine 0 C--N 1.31 -0.879 0 CA-C-N 114.857 -0.672 . . . . 0.0 112.25 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 101.58 -2.47 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.061 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -50.19 -26.27 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.219 0.533 . . . . 0.0 111.017 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.513 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.59 -68.67 0.16 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.973 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.455 ' C ' ' O ' ' A' ' 41' ' ' GLU . 76.6 mmm 23.54 -86.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.831 0.707 . . . . 0.0 112.318 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.97 29.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.832 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.5 mp0 -93.66 -173.7 3.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.792 0.329 . . . . 0.0 111.068 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.905 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.0 155.44 37.61 Favored Pre-proline 0 N--CA 1.456 -0.157 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.327 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.905 ' HD2' HG22 ' A' ' 45' ' ' THR . 4.1 Cg_endo -45.24 -24.6 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.651 2.234 . . . . 0.0 112.461 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.743 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -94.23 -50.17 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -80.17 -29.55 38.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.721 0.296 . . . . 0.0 111.604 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.984 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -52.42 -45.86 66.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.91 0.386 . . . . 0.0 110.845 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.791 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -78.46 -50.55 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.898 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 47' ' ' GLU . 55.5 t -54.45 -36.78 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.875 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -52.02 9.44 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.927 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.586 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.9 mm-40 -66.93 -25.0 66.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.722 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.985 ' O ' HG23 ' A' ' 58' ' ' VAL . 12.4 tp -52.75 -45.76 67.19 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.874 0.369 . . . . 0.0 110.39 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -62.64 -26.68 68.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.84 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -71.43 -23.65 61.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.891 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.496 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.0 mm-40 -108.19 5.09 25.49 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -134.61 -44.7 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.424 0.63 . . . . 0.0 109.497 178.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.58 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 70.01 -36.6 0.4 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.276 -0.874 . . . . 0.0 114.597 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.927 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -84.4 -168.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 120.945 0.403 . . . . 0.0 110.882 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -111.73 89.29 10.87 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.603 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.633 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.3 Cg_endo -107.36 147.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.018 2.478 . . . . 0.0 113.997 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 53.8 mt-30 -74.83 80.05 2.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.959 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -123.87 129.05 50.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.481 -176.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.6 t80 179.6 163.5 0.98 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.932 0.396 . . . . 0.0 112.034 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 84.64 163.62 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.882 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.7 pp -121.8 127.55 50.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.071 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 1.5 p90 -76.81 -44.37 32.84 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.9 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.571 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 12.4 mt-10 -171.43 131.78 0.75 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.859 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -132.53 132.0 42.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.635 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 1.038 HD11 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.34 154.61 44.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.003 0.43 . . . . 0.0 111.23 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.552 ' CG ' HG23 ' A' ' 81' ' ' THR . 19.5 tt0 -131.8 109.78 10.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.377 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.511 ' OH ' HD13 ' A' ' 80' ' ' ILE . 55.4 p90 -125.97 151.87 46.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 5.6 pt-20 -120.16 140.12 51.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.361 0.6 . . . . 0.0 111.493 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.2 m-85 -103.44 162.73 19.15 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.085 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.5 Cg_endo -52.61 81.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.919 2.413 . . . . 0.0 112.174 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.2 t70 93.14 10.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.556 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -137.37 93.82 2.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.679 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.441 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.7 t-80 -85.42 93.94 8.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.745 0.307 . . . . 0.0 110.69 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.511 HD13 ' OH ' ' A' ' 73' ' ' TYR . 2.7 tt -96.7 111.99 27.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 111.397 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.578 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -99.61 118.54 36.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.676 HD23 ' HB ' ' A' ' 6' ' ' ILE . 9.9 mt -120.71 114.12 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.936 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.578 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.4 m0 -110.42 122.11 46.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.838 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.843 ' CD2' HG11 ' A' ' 122' ' ' VAL . 3.2 m-85 -106.45 133.7 50.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.045 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.791 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 11.0 m95 -117.01 148.45 41.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 65' ' ' PHE . 35.4 tp -85.9 138.24 32.17 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.319 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.803 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.5 t -124.2 145.9 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.427 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -110.44 -32.07 7.06 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.1 164.28 25.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.777 0.717 . . . . 0.0 111.843 -178.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.739 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.8 p90 -148.63 126.38 11.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.235 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.95 150.6 35.91 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.292 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.24 -129.98 48.8 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.707 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.587 ' O ' HG12 ' A' ' 60' ' ' ILE . 16.3 mt-10 -120.65 136.57 25.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.886 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.2 Cg_exo -74.46 128.85 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.573 2.182 . . . . 0.0 111.375 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.58 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 39.1 p-90 -130.22 -63.47 0.9 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.48 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.496 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 51.25 -109.51 0.79 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.603 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 168.55 41.95 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.769 0.318 . . . . 0.0 111.007 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.32 -46.31 79.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.861 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.11 -23.56 4.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.89 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.44 100.7 13.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.911 0.386 . . . . 0.0 111.306 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -43.5 143.3 2.58 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.912 2.408 . . . . 0.0 112.581 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.1 177.12 19.38 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.666 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -131.84 157.17 44.62 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -72.43 106.38 4.51 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.196 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.421 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.5 ptm -120.43 163.16 18.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.224 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.84 117.94 21.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.592 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.665 HD11 HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.77 -18.84 46.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.4 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.647 HG23 HD22 ' A' ' 129' ' ' LEU . 11.9 p -58.37 -14.65 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.611 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.33 49.95 0.91 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.785 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.896 HD23 HG23 ' A' ' 123' ' ' ILE . 10.0 tp -62.31 150.51 39.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.74 0.305 . . . . 0.0 111.098 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.69 ' CB ' HD13 ' A' ' 33' ' ' LEU . 1.9 t-20 -111.0 92.92 4.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.5 -19.93 61.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.117 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -79.06 -45.31 20.38 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -42.16 87.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.568 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.34 174.37 6.13 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.09 127.87 27.51 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 121.99 1.793 . . . . 0.0 112.173 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.82 -39.13 11.99 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.727 2.284 . . . . 0.0 112.76 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.63 -9.63 57.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.083 0.468 . . . . 0.0 111.533 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -101.83 20.46 16.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.754 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -72.84 -31.08 1.42 Allowed Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.4 Cg_exo -43.71 -36.57 7.64 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.831 1.687 . . . . 0.0 113.011 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 1.038 HG22 HD11 ' A' ' 71' ' ' LEU . 69.9 t -77.91 -51.33 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.092 0.472 . . . . 0.0 110.958 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.896 HG23 HD23 ' A' ' 110' ' ' LEU . 17.8 mm -65.24 -34.63 71.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.75 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.23 -27.74 36.56 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.472 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -80.58 -53.04 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.934 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.524 HD23 ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -78.14 -32.97 50.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.75 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.892 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.3 ttpt -53.35 -42.21 66.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.818 ' O ' HD12 ' A' ' 129' ' ' LEU . 15.2 ttt-85 -71.02 -6.17 36.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.003 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.061 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.842 0.353 . . . . 0.0 110.85 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.06 139.57 35.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.837 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.409 HD12 ' O ' ' A' ' 4' ' ' LEU . 2.8 pp -146.25 122.98 11.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -102.57 151.31 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.13 0.491 . . . . 0.0 111.378 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.632 ' CG2' HD13 ' A' ' 82' ' ' LEU . 2.0 tp -146.61 130.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.332 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.906 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.02 125.48 43.93 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m -139.93 154.8 23.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.269 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.05 120.92 2.34 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.461 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.757 HG22 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -70.35 108.43 2.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.772 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.05 124.98 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.155 0.502 . . . . 0.0 111.688 -178.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -100.7 129.25 46.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.3 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.707 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.8 p-10 -84.44 -172.87 4.41 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.43 0.634 . . . . 0.0 111.786 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 1.3 tm-20 -73.63 4.89 4.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.452 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -128.63 44.39 2.97 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.014 -0.429 . . . . 0.0 112.092 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 48.96 23.13 0.66 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 111.473 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 33.6 mt-10 -114.0 161.61 17.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.757 HG12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -115.03 139.83 39.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.577 ' CD2' HD12 ' A' ' 11' ' ' ILE . 1.8 t80 -93.41 97.56 10.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.569 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.668 HD12 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -110.01 162.22 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 71.3 p -70.59 134.95 48.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 111.133 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.654 0.264 . . . . 0.0 111.276 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.34 26.39 10.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 111.577 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 20' ' ' ILE . 1.2 tt -64.77 73.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.768 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -113.66 -172.06 2.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.063 0.459 . . . . 0.0 111.675 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.554 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.45 168.27 10.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.609 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.705 ' HG3' HD11 ' A' ' 11' ' ' ILE . 60.2 Cg_endo -72.63 166.88 28.63 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.42 2.746 . . . . 0.0 113.162 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.788 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.68 -5.33 54.15 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 116.011 -0.541 . . . . 0.0 113.99 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.582 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -65.34 132.56 35.76 Favored Glycine 0 C--N 1.315 -0.598 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.727 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 106.36 1.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.273 0.629 . . . . 0.0 112.081 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.906 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -49.16 -29.8 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.672 0.748 . . . . 0.0 110.588 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.627 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -41.45 -58.65 1.82 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.105 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.538 ' C ' ' O ' ' A' ' 41' ' ' GLU . 12.6 mmt 2.68 -78.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.656 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.42 33.27 0.07 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.031 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 13.1 mp0 -101.55 -174.96 2.72 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.617 0.246 . . . . 0.0 111.037 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.819 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -105.42 152.39 39.91 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.283 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.819 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.68 -24.57 0.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.73 2.287 . . . . 0.0 112.463 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.76 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -94.39 -50.38 5.26 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -80.42 -29.22 37.67 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.831 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -55.6 -43.88 76.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.184 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.517 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 m -78.27 -48.75 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.89 0.376 . . . . 0.0 110.233 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.7 t -57.16 -35.91 49.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.75 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.4 mmt-85 -77.94 -50.14 12.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.497 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.71 -21.99 66.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.626 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.935 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -56.88 -44.75 82.6 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.931 0.396 . . . . 0.0 110.289 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -68.36 -28.05 66.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.348 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.33 -38.65 49.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.48 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 1.3 mp0 -104.66 5.16 33.35 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.086 HG12 HG22 ' A' ' 60' ' ' ILE . 11.1 t -134.42 -43.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.048 0.451 . . . . 0.0 109.997 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.0 -35.06 0.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.706 -0.679 . . . . 0.0 114.418 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.086 HG22 HG12 ' A' ' 58' ' ' VAL . 5.4 tp -77.53 166.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.56 0.219 . . . . 0.0 110.773 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.73 89.05 1.36 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.0 Cg_endo -114.38 150.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 123.552 2.835 . . . . 0.0 114.525 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.408 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 35.0 mt-30 -74.94 79.42 2.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.935 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.39 127.61 48.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.492 -176.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -179.1 -134.12 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.634 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 55.77 166.34 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.918 0.39 . . . . 0.0 111.849 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.641 ' O ' HD23 ' A' ' 67' ' ' LEU . 6.9 tt -127.87 110.79 12.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.047 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.79 -45.25 29.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.122 0.486 . . . . 0.0 109.821 179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.52 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.3 tt0 -171.6 156.72 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.364 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.28 104.32 4.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.453 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.542 HD23 ' CE1' ' A' ' 73' ' ' TYR . 4.7 tp -96.84 135.79 38.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.889 0.376 . . . . 0.0 111.097 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -126.98 109.48 11.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.615 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.542 ' CE1' HD23 ' A' ' 71' ' ' LEU . 4.2 p90 -141.41 128.64 21.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.449 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 7.9 pt-20 -116.02 130.73 56.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 111.56 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 2.7 m-85 -71.11 163.33 66.44 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.026 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.472 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.4 Cg_endo -38.06 -29.14 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.598 2.865 . . . . 0.0 113.036 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -139.63 -38.43 0.48 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.009 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -83.86 99.85 10.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.284 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.457 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 4.1 t60 -87.01 110.33 19.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.785 0.326 . . . . 0.0 110.673 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.58 HD11 ' CD2' ' A' ' 82' ' ' LEU . 2.5 tt -115.27 137.38 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.961 0.41 . . . . 0.0 110.935 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.74 118.43 30.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.656 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.884 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -107.18 113.87 27.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.0 111.384 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 8.7 m0 -114.99 122.43 46.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.176 0.512 . . . . 0.0 110.32 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.887 ' CD1' HG11 ' A' ' 122' ' ' VAL . 3.9 m-85 -110.68 124.08 51.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.572 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.728 ' HE1' ' HB1' ' A' ' 7' ' ' ALA . 66.4 m95 -108.58 148.64 30.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.76 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.525 ' O ' ' O ' ' A' ' 65' ' ' PHE . 37.6 tp -99.53 103.21 14.93 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.448 0.642 . . . . 0.0 111.746 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.843 HG13 ' CB ' ' A' ' 64' ' ' HIS . 19.0 t -83.23 145.58 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.515 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -104.27 -50.74 3.27 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.15 165.76 24.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.488 0.586 . . . . 0.0 112.508 -178.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.707 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 24.1 p90 -133.81 159.57 40.22 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.506 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.19 102.15 14.17 Favored 'General case' 0 N--CA 1.46 0.039 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.237 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.4 -112.09 4.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.384 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.1 tt0 -131.53 135.4 26.88 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.212 . . . . 0.0 111.224 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.478 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 5.2 Cg_exo -76.5 139.6 20.68 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 111.211 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.556 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 33.4 p-90 -134.59 -63.45 0.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.19 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.667 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.77 -104.68 0.04 OUTLIER Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.308 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt 168.22 40.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.75 0.31 . . . . 0.0 110.897 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -23.68 62.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.081 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 145.3 -86.85 0.17 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.078 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.07 118.78 47.28 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.06 0.457 . . . . 0.0 111.649 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.55 146.19 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.192 2.595 . . . . 0.0 112.802 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.09 177.42 19.14 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.846 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -122.69 157.23 32.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.566 0.222 . . . . 0.0 110.436 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -68.38 106.37 2.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.976 0.417 . . . . 0.0 110.24 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.9 ptm -120.54 152.02 38.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.105 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.58 ' HB3' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -70.25 114.9 8.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.637 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.987 HD21 HD12 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -59.17 -18.5 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.66 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 106' ' ' SER . 13.7 p -52.75 -14.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.83 54.37 0.72 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.635 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.987 HD12 HD21 ' A' ' 107' ' ' LEU . 3.8 tt -61.77 150.53 36.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.886 0.374 . . . . 0.0 110.918 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.436 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -100.61 93.2 5.48 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.428 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.48 -21.42 61.21 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -79.22 -44.91 20.89 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.07 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -66.72 -40.11 88.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.372 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.569 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.37 174.39 6.09 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.8 Cg_endo -53.79 127.78 26.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.899 1.733 . . . . 0.0 112.603 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 49.6 Cg_endo -68.41 -36.11 16.44 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.885 2.39 . . . . 0.0 112.366 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.4 -9.54 58.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.07 0.462 . . . . 0.0 111.071 179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -106.02 16.66 24.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.055 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.576 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -73.44 -30.97 1.29 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.1 Cg_exo -43.57 -36.37 7.04 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.847 1.698 . . . . 0.0 113.51 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.887 HG11 ' CD1' ' A' ' 84' ' ' PHE . 17.6 t -77.88 -51.27 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.145 0.498 . . . . 0.0 110.534 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 127' ' ' LYS . 20.4 mm -65.48 -30.99 51.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.25 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.89 47.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.614 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -49.83 11.52 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.653 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.815 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.3 tm? -78.3 -28.84 47.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.405 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 123' ' ' ILE . 7.9 ttpt -55.01 -42.54 72.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.109 0.48 . . . . 0.0 110.654 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -64.05 -12.61 40.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.521 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.0 mp . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.947 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.732 ' CE ' HD23 ' A' ' 4' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.852 0.358 . . . . 0.0 110.962 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -140.11 130.17 24.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.68 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.732 HD23 ' CE ' ' A' ' 2' ' ' LYS . 3.2 pp -146.19 124.72 12.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.369 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.421 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 30.4 mt-30 -102.81 151.7 22.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.419 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.618 ' HB ' HD12 ' A' ' 82' ' ' LEU . 2.1 mp -146.53 127.09 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.904 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.894 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.77 125.63 44.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -144.36 162.16 14.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.833 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -147.76 125.62 2.17 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.692 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.091 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.84 110.92 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.764 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.53 125.31 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-O 121.178 0.513 . . . . 0.0 111.537 -178.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.92 118.93 30.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.194 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.731 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 2.9 p-10 -79.64 -172.22 3.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.331 0.586 . . . . 0.0 111.389 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.6 tm-20 -77.08 13.46 1.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.426 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 10.7 t-20 -143.25 51.89 1.37 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.214 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.17 27.62 0.22 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.023 0.439 . . . . 0.0 111.571 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' C ' ' OD1' ' A' ' 13' ' ' ASN . 23.2 mt-10 -122.94 161.75 23.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.091 HG21 HG22 ' A' ' 10' ' ' ILE . 8.1 mt -128.22 144.11 38.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.189 0.519 . . . . 0.0 112.186 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.68 115.21 26.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.446 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -112.46 133.34 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.404 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 100' ' ' GLN . 23.4 p -70.97 114.44 9.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.042 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HB3' HD13 ' A' ' 33' ' ' LEU . 1.5 ptm180 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.691 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.528 0.101 0 CA-C-O 120.679 0.276 . . . . 0.0 111.267 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.22 25.94 10.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.983 0.421 . . . . 0.0 111.574 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 33' ' ' LEU . 38.6 tp -68.68 71.72 0.21 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.449 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.704 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -109.43 -167.21 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.79 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -119.12 168.29 10.18 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.566 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.533 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 85.1 Cg_endo -84.08 167.51 12.45 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.695 2.93 . . . . 0.0 113.695 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.501 ' H ' ' CG ' ' A' ' 57' ' ' GLU . . . 102.92 -3.23 48.49 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.241 -0.89 . . . . 0.0 114.525 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -64.2 165.04 31.77 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 117.264 0.532 . . . . 0.0 113.793 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.0 0.51 0.66 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.188 0.595 . . . . 0.0 112.046 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.894 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -50.92 -28.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.675 0.75 . . . . 0.0 110.552 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.602 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.9 -58.23 2.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.161 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.0 mmt 6.96 -79.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.887 0.742 . . . . 0.0 112.579 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 179.56 34.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.03 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.466 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -93.76 -170.45 2.34 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.653 0.263 . . . . 0.0 111.045 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.834 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.68 153.19 38.03 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.314 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.834 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.9 -25.0 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.796 2.331 . . . . 0.0 112.396 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -102.57 -42.99 5.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.818 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -11.16 59.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.835 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.03 -53.97 51.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.86 0.362 . . . . 0.0 110.81 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.812 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.27 -50.14 19.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.401 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.2 t -51.75 -37.76 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.407 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -78.49 -52.19 8.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.291 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.668 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.1 mm-40 -66.0 -20.02 66.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.586 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.877 HD21 ' CD2' ' A' ' 64' ' ' HIS . 9.4 tp -55.53 -45.01 77.24 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -35.89 82.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.174 0.512 . . . . 0.0 109.713 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.1 -25.45 62.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.968 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.501 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -108.36 6.73 26.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.185 -178.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.973 HG13 HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -133.39 -44.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.064 0.459 . . . . 0.0 109.952 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.54 -37.79 0.22 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.648 -0.705 . . . . 0.0 114.456 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.973 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -86.76 -174.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 120.853 0.358 . . . . 0.0 110.919 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.78 88.64 14.36 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.498 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.539 ' HB3' ' HB2' ' A' ' 90' ' ' TRP . 5.9 Cg_endo -110.84 146.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.514 2.809 . . . . 0.0 113.811 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 37.6 mt-30 -74.79 79.83 2.09 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.877 ' CD2' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.3 132.44 55.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.867 -176.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.94 -136.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.651 -179.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 54.08 165.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.079 0.466 . . . . 0.0 111.885 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.653 ' O ' HD23 ' A' ' 67' ' ' LEU . 7.2 tt -128.02 108.84 11.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.798 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.86 -43.36 36.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.302 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 11.8 tt0 -171.27 156.11 4.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.553 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HD3' ' CE2' ' A' ' 83' ' ' TRP . 1.4 ttmm -143.27 105.73 4.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.657 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.522 HD22 HG23 ' A' ' 122' ' ' VAL . 1.1 tp -97.09 136.29 37.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.054 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -140.02 109.64 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.409 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.412 ' CE1' HD21 ' A' ' 71' ' ' LEU . 2.3 p90 -141.18 152.22 44.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.1 pt-20 -121.13 135.81 55.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.168 0.509 . . . . 0.0 111.29 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.483 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -101.12 163.21 18.39 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.183 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 10.3 Cg_endo -53.86 82.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.779 2.319 . . . . 0.0 112.068 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.0 m-20 92.96 8.81 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.659 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 20.6 ttp180 -137.3 93.83 2.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.601 0.239 . . . . 0.0 110.86 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 20.2 t-80 -90.38 107.45 19.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.67 HD11 HD13 ' A' ' 82' ' ' LEU . 3.3 tt -107.53 146.42 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.762 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.07 118.82 18.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.02 179.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.67 HD13 HD11 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -117.21 114.22 23.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.798 0.332 . . . . 0.0 111.169 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.457 ' CE2' ' HD3' ' A' ' 70' ' ' LYS . 8.5 m0 -106.93 122.23 46.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.787 ' CE2' HG11 ' A' ' 122' ' ' VAL . 2.2 m-85 -111.49 109.9 20.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.084 0.468 . . . . 0.0 111.665 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.812 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 58.8 m95 -94.81 148.71 22.01 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.82 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.5 tp -97.84 102.79 14.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.549 0.69 . . . . 0.0 111.367 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.775 HG13 ' CB ' ' A' ' 64' ' ' HIS . 18.0 t -83.53 146.29 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.441 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -108.56 -40.15 5.19 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 2.3 ptp180 -163.34 165.72 23.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.064 0.847 . . . . 0.0 112.527 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.731 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 3.3 p90 -145.44 133.35 21.27 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.453 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -81.25 121.18 25.84 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.98 -128.16 8.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.426 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.1 tt0 -123.43 139.29 31.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 O-C-N 122.886 -0.185 . . . . 0.0 110.818 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.512 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 2.6 Cg_exo -76.2 128.72 10.75 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.885 2.39 . . . . 0.0 111.514 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.523 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 61.4 p-90 -132.86 -61.08 0.85 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.06 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.83 -104.37 0.05 OUTLIER Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.256 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.24 37.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.684 0.278 . . . . 0.0 111.049 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -26.84 63.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.026 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.32 -67.6 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.939 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -121.89 110.84 32.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.989 0.423 . . . . 0.0 111.545 -179.423 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -43.64 146.16 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.973 2.449 . . . . 0.0 112.517 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.42 177.01 18.58 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.856 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -116.49 157.29 25.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.25 106.57 5.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.91 0.386 . . . . 0.0 110.476 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.8 ptm -120.18 160.71 22.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.877 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 22.3 p -73.07 115.25 12.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.928 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.765 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.7 OUTLIER -66.18 -18.92 65.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.12 -12.4 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.446 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.97 47.63 1.01 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.892 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.548 HD13 HD22 ' A' ' 107' ' ' LEU . 9.2 tp -62.01 150.12 38.96 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -122.57 118.57 28.54 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -178.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.37 -19.61 61.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.125 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -78.96 -47.27 16.64 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.996 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.84 -20.17 65.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.362 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.47 172.04 4.24 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -54.48 127.81 27.55 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.01 1.807 . . . . 0.0 112.318 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.15 -38.78 8.63 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.723 2.282 . . . . 0.0 112.652 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.84 -9.76 53.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 111.528 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.41 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 14.4 m-20 -104.71 18.59 21.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.969 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.556 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -66.66 -31.88 4.58 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 84.6 Cg_exo -44.32 -36.61 9.51 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.831 1.687 . . . . 0.0 113.504 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.787 HG11 ' CE2' ' A' ' 84' ' ' PHE . 93.0 t -77.89 -51.41 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 111.038 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.876 HG22 ' HB2' ' A' ' 127' ' ' LYS . 7.3 mm -68.68 -29.88 45.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.489 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.72 -27.0 37.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.979 0.419 . . . . 0.0 110.232 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -80.1 -51.85 8.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.684 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.715 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.5 tm? -78.03 -34.09 50.73 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.627 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.876 ' HB2' HG22 ' A' ' 123' ' ' ILE . 13.7 tttm -52.98 -42.72 65.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.002 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -69.29 -7.76 39.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.945 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.278 179.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 tptp . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.808 0.337 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -140.01 132.27 28.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 1.035 HD12 HD11 ' A' ' 6' ' ' ILE . 1.7 pp -146.18 126.18 13.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.134 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.476 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 30.1 mt-30 -102.53 154.17 19.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.254 0.55 . . . . 0.0 111.87 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 1.035 HD11 HD12 ' A' ' 4' ' ' LEU . 4.5 mp -146.27 125.28 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.581 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.051 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.82 125.7 44.43 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.2 m -140.1 162.64 24.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.202 0.525 . . . . 0.0 111.858 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -135.84 123.42 2.99 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.649 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.777 HG22 HG12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -70.91 105.02 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.75 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -70.68 126.25 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.138 0.494 . . . . 0.0 111.941 -178.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.664 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -101.65 124.99 48.21 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.097 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.624 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.4 p-10 -79.15 -172.59 3.21 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 123.77 0.669 . . . . 0.0 111.382 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.3 tm-20 -76.14 9.22 2.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.337 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -132.89 46.91 2.56 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.958 -0.464 . . . . 0.0 112.098 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.54 24.53 0.52 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 111.495 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 105' ' ' MET . 22.5 mt-10 -115.95 161.24 19.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.777 HG12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -113.68 134.02 57.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 11' ' ' ILE . 40.7 t80 -91.84 95.18 9.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.433 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -111.25 162.42 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.733 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.787 ' O ' HD12 ' A' ' 33' ' ' LEU . 70.8 p -70.63 132.68 45.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.563 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.962 -179.918 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.5 OUTLIER . . . . . 0 CA--C 1.53 0.177 0 CA-C-O 120.657 0.265 . . . . 0.0 111.087 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 26.1 10.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.941 0.401 . . . . 0.0 111.708 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 21' ' ' THR . 14.7 tp -69.01 69.51 0.18 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.555 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -110.48 -172.65 2.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.539 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.39 168.7 9.48 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.374 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.749 ' HG3' HD11 ' A' ' 11' ' ' ILE . 84.1 Cg_endo -81.28 166.96 17.96 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.528 2.818 . . . . 0.0 113.586 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.12 -5.63 53.07 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.002 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -58.94 162.99 10.79 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.942 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 81.93 2.13 1.4 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 179.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.051 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -50.34 -28.92 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.616 0.722 . . . . 0.0 110.262 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.595 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -40.89 -57.44 1.96 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.961 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER 2.93 -78.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.931 0.77 . . . . 0.0 112.522 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 176.27 35.04 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.937 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -89.9 -172.72 3.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.677 0.275 . . . . 0.0 111.057 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.817 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.6 152.29 38.08 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.203 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.817 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.77 -25.09 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.751 2.301 . . . . 0.0 112.501 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mm-40 -104.06 -39.59 6.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.378 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 2.9 mt-30 -80.37 -9.55 59.75 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.835 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -58.64 -54.76 43.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.866 0.365 . . . . 0.0 110.811 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.713 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -78.64 -46.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.47 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 40.4 t -56.53 -44.74 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.852 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 7.7 mtp180 -72.81 -46.12 54.81 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.912 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.417 ' CG ' ' OE1' ' A' ' 57' ' ' GLU . 0.9 OUTLIER -69.43 -19.88 63.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.79 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.937 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -57.91 -44.6 86.92 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.822 0.344 . . . . 0.0 110.714 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.43 -30.69 71.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.105 0.478 . . . . 0.0 109.807 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.42 -34.39 54.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.414 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.606 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.6 mp0 -108.36 6.43 26.39 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.046 HG12 HG22 ' A' ' 60' ' ' ILE . 34.3 t -133.8 -44.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.391 . . . . 0.0 110.45 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.01 -36.43 0.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.837 -0.62 . . . . 0.0 114.467 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.046 HG22 HG12 ' A' ' 58' ' ' VAL . 19.6 tt -77.37 163.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.58 0.228 . . . . 0.0 110.684 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.433 ' N ' HG12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -103.62 88.76 1.9 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.759 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.3 Cg_endo -115.12 152.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 123.558 2.839 . . . . 0.0 114.847 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.95 79.74 2.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.937 ' CD2' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -125.93 128.3 47.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.83 -176.146 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.3 t80 -176.85 -140.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.405 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 2.7 m 50.78 175.98 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.142 0.496 . . . . 0.0 112.008 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.87 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -142.99 121.17 12.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.006 179.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.92 -44.0 33.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.057 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.3 mt-10 -171.65 131.82 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.468 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.46 111.15 18.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.373 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.558 ' HB3' HG22 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -96.94 141.97 29.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.132 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.401 ' N ' ' HG ' ' A' ' 71' ' ' LEU . 6.1 tt0 -137.87 109.9 7.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.53 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.803 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.0 p90 -137.71 149.97 46.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.694 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -118.82 139.67 51.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.223 0.535 . . . . 0.0 111.525 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.504 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.6 m-85 -103.02 162.67 19.4 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.192 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.5 Cg_endo -53.65 81.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.934 2.423 . . . . 0.0 112.131 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.0 t0 93.76 8.6 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -137.32 93.67 2.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.699 0.285 . . . . 0.0 110.758 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.27 110.94 19.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.806 0.336 . . . . 0.0 110.69 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.803 HD13 ' OH ' ' A' ' 73' ' ' TYR . 3.6 tt -108.09 146.64 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.22 0.533 . . . . 0.0 111.204 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.498 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -134.18 118.53 17.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.529 178.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' A' ' 6' ' ' ILE . 2.9 tp -119.15 114.01 21.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.923 0.392 . . . . 0.0 111.254 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.498 ' HE1' HG22 ' A' ' 81' ' ' THR . 9.5 m0 -111.06 122.15 47.16 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.084 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.96 ' CD1' HG11 ' A' ' 122' ' ' VAL . 2.5 m-85 -106.12 113.3 26.75 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.977 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.87 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.7 m95 -94.72 148.35 22.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.671 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.582 HD13 ' C ' ' A' ' 86' ' ' LEU . 2.9 tm? -94.3 102.59 14.6 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 121.395 0.617 . . . . 0.0 110.592 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.895 HG22 ' CE1' ' A' ' 64' ' ' HIS . 14.9 t -89.85 145.37 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.813 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -99.94 -59.68 1.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 10.5 ptm180 -163.34 166.0 23.46 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.205 0.457 . . . . 0.0 112.22 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.815 ' HB2' HD13 ' A' ' 60' ' ' ILE . 41.9 p90 -125.79 164.7 20.12 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.634 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.779 ' C ' HD11 ' A' ' 60' ' ' ILE . 32.2 tt0 -104.13 95.83 6.24 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.01 -112.08 4.05 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.168 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.428 ' C ' HD12 ' A' ' 60' ' ' ILE . 21.0 tt0 -134.33 130.2 20.04 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.528 0.204 . . . . 0.0 111.17 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 4.8 Cg_exo -76.63 128.82 10.47 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.766 2.31 . . . . 0.0 111.372 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 6.9 p-90 -123.07 -65.7 1.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.191 0.52 . . . . 0.0 111.337 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.621 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 50.41 -117.33 4.96 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.288 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 177.57 35.96 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.72 0.295 . . . . 0.0 111.258 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -49.75 -30.33 9.25 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.942 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.4 -25.13 7.86 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.797 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.449 ' O ' HG22 ' A' ' 21' ' ' THR . 1.3 pm0 -138.86 112.31 8.22 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 117.197 0.499 . . . . 0.0 111.754 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -43.57 145.39 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.935 2.423 . . . . 0.0 112.551 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.416 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.19 177.51 19.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.855 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -144.66 157.1 44.34 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.47 106.53 0.94 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.11 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -120.2 156.13 31.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.039 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.713 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -77.38 116.05 17.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.802 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -61.65 -18.74 60.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.386 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.713 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.2 p -62.37 -3.99 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.639 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.69 48.39 0.97 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.995 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.44 HD11 HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -61.56 128.24 35.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -111.02 114.13 27.2 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.574 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -19.29 61.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.857 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -78.83 -47.69 16.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.843 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.75 -14.18 62.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.46 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.574 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -113.56 171.27 4.51 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.07 127.85 27.42 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.187 1.925 . . . . 0.0 112.373 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.99 -39.14 8.43 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.759 2.306 . . . . 0.0 112.866 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.71 -9.74 52.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.988 0.423 . . . . 0.0 111.538 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.468 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 21.7 m-20 -104.14 14.49 30.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.057 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.532 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -61.78 -32.25 9.75 Favored Pre-proline 0 N--CA 1.467 0.4 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -178.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.9 Cg_exo -44.24 -41.5 13.19 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.712 1.608 . . . . 0.0 113.458 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.96 HG11 ' CD1' ' A' ' 84' ' ' PHE . 35.8 t -77.69 -51.04 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.831 0.348 . . . . 0.0 111.059 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.562 HG13 ' CE2' ' A' ' 115' ' ' PHE . 38.2 mm -62.9 -33.77 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.403 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -29.6 54.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.955 0.407 . . . . 0.0 110.487 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -79.95 -45.21 18.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.339 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.608 HD21 HD11 ' A' ' 107' ' ' LEU . 22.9 tp -78.28 -50.08 12.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.379 . . . . 0.0 111.216 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.586 ' O ' HD13 ' A' ' 129' ' ' LEU . 6.5 ttpt -53.21 -34.9 59.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.995 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -63.6 -10.16 17.15 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 127' ' ' LYS . 10.5 mp . . . . . 0 CA--C 1.528 0.118 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.251 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.814 0.34 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 4.3 mttt -140.05 130.48 25.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.4 pp -146.19 128.36 15.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 111.162 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.449 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 46.2 mt-30 -102.85 150.52 23.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.025 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' HB ' HD12 ' A' ' 82' ' ' LEU . 4.2 mp -146.55 121.83 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.204 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.033 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.12 125.35 43.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 35' ' ' PHE . 1.3 m -139.67 162.21 26.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.576 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.39 139.3 10.55 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.933 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.992 HG22 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -83.47 112.66 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.824 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -70.81 123.66 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 121.051 0.453 . . . . 0.0 111.493 -178.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.16 124.65 35.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.858 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.477 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 13.2 t30 -81.75 -172.09 3.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.805 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -81.52 3.99 22.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.453 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -139.5 52.01 1.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.35 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 45.76 24.64 0.22 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.475 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 16.0 pt-20 -117.01 138.57 51.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.992 HG21 HG22 ' A' ' 10' ' ' ILE . 7.5 mt -105.97 139.7 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.26 0.552 . . . . 0.0 112.038 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.496 ' O ' ' CD2' ' A' ' 19' ' ' PHE . 18.4 t80 -80.93 91.3 6.0 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.393 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.5 156.81 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.919 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.484 ' O ' HD12 ' A' ' 33' ' ' LEU . 25.7 p -70.77 129.46 39.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.843 0.354 . . . . 0.0 110.709 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.811 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.712 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.714 0.292 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.34 26.09 10.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.919 0.39 . . . . 0.0 111.515 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -67.25 70.33 0.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.36 -172.66 2.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.684 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.669 ' CD1' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -110.68 166.01 11.58 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.863 0.363 . . . . 0.0 110.956 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.824 ' HG3' HD11 ' A' ' 11' ' ' ILE . 36.4 Cg_endo -65.47 166.69 18.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.415 2.743 . . . . 0.0 114.174 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.643 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.85 -5.96 54.11 Favored Glycine 0 C--O 1.225 -0.469 0 CA-C-N 114.877 -1.056 . . . . 0.0 114.027 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -57.15 155.67 16.29 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 117.337 0.569 . . . . 0.0 112.528 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.82 7.07 0.5 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.033 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -51.62 -28.43 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.715 0.769 . . . . 0.0 110.156 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.569 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -39.75 -60.64 0.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.731 179.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.528 ' C ' ' O ' ' A' ' 41' ' ' GLU . 8.7 mmt 5.8 -81.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.537 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.27 28.75 0.08 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.943 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -94.41 -174.71 3.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.773 0.321 . . . . 0.0 111.06 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.867 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.45 156.51 39.39 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.867 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.65 -24.66 0.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.799 2.333 . . . . 0.0 112.708 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -90.25 -57.73 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -80.52 -4.26 53.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.932 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.28 -57.73 11.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.97 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.79 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.2 m -79.01 -45.65 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.475 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.6 t -52.21 -38.84 25.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mmm-85 -78.15 -41.54 34.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.531 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.31 -19.89 62.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.76 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.869 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -58.59 -44.76 89.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.883 0.373 . . . . 0.0 110.402 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -32.13 70.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.052 0.453 . . . . 0.0 110.344 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.17 -31.92 55.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.499 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.519 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.05 3.96 24.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.934 HG12 HG22 ' A' ' 60' ' ' ILE . 11.3 t -134.69 -44.11 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.206 0.527 . . . . 0.0 109.934 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.16 -32.88 0.25 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.046 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.934 HG22 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.89 179.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 120.617 0.246 . . . . 0.0 110.6 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.97 88.4 10.02 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.668 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -110.78 144.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.527 2.818 . . . . 0.0 113.968 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 18.3 mt-30 -74.68 79.62 2.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 175.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.869 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.85 134.16 54.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.982 -175.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 179.97 -140.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.352 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.404 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 0.9 OUTLIER 50.33 176.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.138 0.494 . . . . 0.0 111.932 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.9 OUTLIER -143.88 123.31 13.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.043 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.6 -43.77 37.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.186 0.517 . . . . 0.0 109.658 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.1 mt-10 -171.83 131.8 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.224 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.06 109.38 17.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.782 0.325 . . . . 0.0 110.408 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.64 HD22 HG23 ' A' ' 122' ' ' VAL . 3.9 tp -96.99 131.09 44.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.126 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -133.68 109.67 9.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.368 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -141.29 131.77 25.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.9 pm0 -102.76 138.92 39.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.115 0.483 . . . . 0.0 111.228 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -106.53 163.4 17.07 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.215 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 10.3 Cg_endo -51.87 82.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.87 2.38 . . . . 0.0 112.176 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 75' ' ' PHE . 12.5 m-20 89.56 11.16 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.518 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.0 OUTLIER -137.49 93.73 2.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.263 . . . . 0.0 110.733 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 13.0 t-160 -89.72 98.98 12.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.579 HD11 HD13 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -104.27 111.91 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.532 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -103.79 118.68 37.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.686 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.579 HD13 HD11 ' A' ' 80' ' ' ILE . 1.4 tp -116.47 113.91 23.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.915 0.388 . . . . 0.0 111.722 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.532 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.8 m0 -110.31 122.55 47.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.398 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.736 ' CE1' HG11 ' A' ' 122' ' ' VAL . 1.6 m-85 -108.09 113.06 25.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.134 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.814 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.4 m95 -94.67 148.6 22.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.801 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.531 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.0 tm? -99.1 102.86 14.7 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.334 0.588 . . . . 0.0 111.355 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.843 HG13 ' CB ' ' A' ' 64' ' ' HIS . 14.6 t -84.18 146.03 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.097 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -113.63 -24.97 8.93 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.511 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -162.68 162.83 27.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.63 0.65 . . . . 0.0 111.777 -178.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.712 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -155.2 141.81 18.84 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.3 178.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.2 mt-10 -77.88 136.2 38.01 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-O 120.793 0.33 . . . . 0.0 111.383 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.94 -108.44 0.2 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.695 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 23.5 tt0 -131.25 135.78 27.68 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.473 0.178 . . . . 0.0 110.826 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.801 ' HB3' HG13 ' A' ' 58' ' ' VAL . 2.8 Cg_exo -76.04 128.85 10.97 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.801 2.334 . . . . 0.0 111.197 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.573 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 14.6 p-90 -114.15 -64.91 1.24 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.65 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.31 -103.43 0.03 OUTLIER Glycine 0 CA--C 1.52 0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.251 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 tptp 174.08 40.19 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.697 0.284 . . . . 0.0 111.261 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.44 ' HA ' ' CG ' ' A' ' 57' ' ' GLU . 21.7 pt-20 -61.86 -47.06 86.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.868 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 160.86 -120.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.101 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -75.82 123.88 88.43 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.17 0.509 . . . . 0.0 111.788 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -43.7 146.32 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.257 2.638 . . . . 0.0 112.701 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.88 177.38 18.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.989 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -126.9 157.26 39.87 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CG ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -68.47 106.11 2.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.881 0.372 . . . . 0.0 110.252 -179.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 18' ' ' ILE . 6.6 ptm -120.58 163.3 18.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.015 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.776 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -78.21 114.94 17.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.825 0.345 . . . . 0.0 110.549 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.789 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.9 OUTLIER -61.84 -18.84 61.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.238 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.6 p -61.92 -9.3 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.563 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.25 49.18 0.94 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.96 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 126' ' ' LEU . 7.4 tp -62.15 150.2 39.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -118.44 121.27 39.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.63 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.49 -21.65 61.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.269 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.7 -43.77 25.15 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.318 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.582 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.59 -37.52 85.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.402 . . . . 0.0 110.783 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.63 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.22 172.95 6.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.205 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.27 127.82 27.43 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.012 1.808 . . . . 0.0 112.036 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.15 -39.0 8.3 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.666 2.244 . . . . 0.0 112.871 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.57 -9.8 51.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.933 0.397 . . . . 0.0 111.524 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.48 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 26.0 m-20 -104.95 20.47 18.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.741 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -62.03 -31.74 8.45 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 79.8 Cg_exo -44.29 -43.89 13.17 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.771 1.647 . . . . 0.0 113.61 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.736 HG11 ' CE1' ' A' ' 84' ' ' PHE . 95.7 t -77.75 -51.52 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.775 0.321 . . . . 0.0 111.563 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.561 HG13 ' CE2' ' A' ' 115' ' ' PHE . 37.4 mm -64.74 -29.98 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.484 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.56 -32.14 66.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.985 0.421 . . . . 0.0 110.437 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -80.11 -45.58 17.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.323 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.3 tm? -78.26 -19.79 52.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.603 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 123' ' ' ILE . 6.2 ttpm? -79.14 -42.64 25.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 0.0 110.681 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -67.75 -7.85 30.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.962 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.743 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? . . . . . 0 CA--C 1.527 0.07 0 CA-C-O 120.844 0.354 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.9 OUTLIER -140.1 133.91 30.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -146.12 124.66 12.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.573 ' O ' HD13 ' A' ' 6' ' ' ILE . 48.8 mt-30 -102.66 147.9 26.24 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.273 0.559 . . . . 0.0 111.565 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 5' ' ' GLN . 33.7 mm -146.4 124.83 4.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.687 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.026 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.82 125.19 43.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m -133.51 162.2 40.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.062 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.53 126.15 2.83 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.117 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.061 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.81 108.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.374 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.719 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.03 123.73 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.038 0.447 . . . . 0.0 111.151 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.43 124.02 34.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.653 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.463 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 13.9 t30 -81.61 -172.16 3.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.051 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.83 2.94 24.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.507 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -140.19 52.34 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.346 . . . . 0.0 111.441 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.6 p30 45.96 24.35 0.23 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.397 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 16.8 pt-20 -114.68 142.58 46.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.061 HG21 HG22 ' A' ' 10' ' ' ILE . 7.3 mt -115.58 136.79 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.141 0.496 . . . . 0.0 111.623 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -83.84 111.14 18.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.593 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 105' ' ' MET . 0.2 OUTLIER -115.97 149.1 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.212 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.719 ' O ' HD12 ' A' ' 33' ' ' LEU . 13.9 p -70.84 132.4 45.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.54 ' CG ' HD13 ' A' ' 33' ' ' LEU . 30.1 ttt180 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.968 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.742 0.306 . . . . 0.0 111.075 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.28 25.94 11.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.103 0.478 . . . . 0.0 111.338 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 21' ' ' THR . 28.6 tp -62.77 84.38 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.769 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -126.13 -165.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.153 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.709 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -118.86 168.31 10.01 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.334 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.566 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 84.8 Cg_endo -79.4 167.37 21.29 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.416 2.744 . . . . 0.0 113.025 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.86 -5.65 50.88 Favored Glycine 0 C--O 1.224 -0.489 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.462 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -63.09 152.44 46.7 Favored Glycine 0 C--N 1.318 -0.436 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.585 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 91.76 3.53 0.1 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 122.827 0.451 . . . . 0.0 112.151 179.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.026 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.3 pt -52.46 -27.32 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.444 0.64 . . . . 0.0 110.379 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.528 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.78 -64.01 0.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.832 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.483 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 17.94 -83.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.448 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 178.68 35.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.867 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -92.17 -170.68 2.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.654 0.264 . . . . 0.0 111.076 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.824 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.67 153.08 38.42 Favored Pre-proline 0 N--CA 1.456 -0.131 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.824 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.74 -24.9 0.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.786 2.324 . . . . 0.0 112.454 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 51' ' ' VAL . 24.1 mt-10 -102.49 -43.86 5.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.5 -4.83 55.35 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.995 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.91 -57.3 12.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.706 0.289 . . . . 0.0 110.738 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.843 HG11 ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER -78.78 -46.22 24.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.267 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 37.6 t -55.71 -40.53 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.14 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -78.11 -51.76 9.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 1.4 mm-40 -68.54 -20.87 64.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.937 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 4.5 tp -51.18 -44.78 61.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -32.95 69.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.457 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -77.35 -29.84 53.58 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.941 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 6.0 mp0 -104.9 5.54 32.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.574 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 1.6 t -134.38 -44.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.12 0.486 . . . . 0.0 110.005 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.34 -39.98 0.28 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.336 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -77.92 -174.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.088 0.471 . . . . 0.0 111.896 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.54 87.79 26.9 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.639 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.545 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 11.7 Cg_endo -112.06 146.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 123.733 2.955 . . . . 0.0 113.968 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -74.88 79.72 2.13 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.832 ' HB2' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -121.01 130.14 53.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.227 -176.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 86' ' ' LEU . 6.1 t80 178.52 160.88 0.62 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 88.62 -165.64 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.209 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.778 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.5 pp -152.37 131.76 12.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.27 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.743 ' CE2' HD11 ' A' ' 10' ' ' ILE . 2.1 p90 -76.75 -41.81 43.44 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.773 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 13.0 mt-10 -171.12 131.46 0.79 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.583 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 132.06 55.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.754 0.312 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 122' ' ' VAL . 1.3 tp -110.66 139.14 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.99 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -138.42 109.6 6.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.504 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.705 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.1 p90 -141.52 137.25 31.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 2.3 pt-20 -121.17 132.07 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.202 0.525 . . . . 0.0 111.194 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 1.1 m-85 -83.21 163.9 48.3 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.2 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.443 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -38.68 -28.62 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.626 2.884 . . . . 0.0 113.261 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -139.77 -38.04 0.48 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.163 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 25.0 ttp180 -86.32 102.78 14.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.421 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.415 ' ND1' ' HB3' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -92.67 99.91 12.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.286 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.754 HD11 HD13 ' A' ' 82' ' ' LEU . 3.7 tt -101.23 147.95 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.066 0.46 . . . . 0.0 111.088 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.406 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -134.19 118.48 17.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.63 178.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.754 HD13 HD11 ' A' ' 80' ' ' ILE . 1.2 mp -114.58 113.51 24.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 111.31 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.406 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.0 m0 -110.97 122.45 47.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.734 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.887 ' CE2' HG11 ' A' ' 122' ' ' VAL . 2.7 m-85 -113.19 112.72 24.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.037 0.446 . . . . 0.0 110.858 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.843 ' NE1' HG11 ' A' ' 50' ' ' VAL . 25.5 m95 -95.58 148.49 22.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.648 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 65' ' ' PHE . 35.5 tp -90.23 138.84 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.745 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.832 HG13 ' HB2' ' A' ' 64' ' ' HIS . 17.9 t -123.23 144.67 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.711 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.11 -27.78 8.24 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.07 160.08 24.0 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.875 -178.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.719 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -152.92 123.24 7.13 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.962 178.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.86 150.11 32.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.324 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.59 -144.37 30.12 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.77 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.481 ' O ' HG21 ' A' ' 60' ' ' ILE . 44.7 tt0 -105.59 134.92 19.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.3 Cg_exo -76.12 128.8 10.86 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.686 2.257 . . . . 0.0 111.61 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.528 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 34.2 p-90 -124.91 -61.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.735 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 48.74 -110.53 0.73 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.88 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.29 50.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 111.075 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -35.53 64.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.498 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.26 -5.55 45.4 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.348 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -140.12 96.02 8.24 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.981 0.419 . . . . 0.0 111.445 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -43.6 144.0 2.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.913 2.408 . . . . 0.0 112.35 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.1 177.13 19.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.124 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -139.26 157.44 45.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.03 106.41 0.5 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.065 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.598 ' HB2' HD11 ' A' ' 20' ' ' ILE . 2.4 mtp -120.11 163.47 17.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.252 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.535 ' HB2' HG12 ' A' ' 108' ' ' VAL . 81.7 p -90.79 114.8 27.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.559 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -67.03 -18.53 65.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.207 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.626 HG23 HD21 ' A' ' 129' ' ' LEU . 11.9 p -53.67 -16.36 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.77 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.71 55.0 0.68 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.93 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 107' ' ' LEU . 11.1 tp -62.07 150.49 38.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.878 0.371 . . . . 0.0 110.889 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.582 ' HB3' HD23 ' A' ' 33' ' ' LEU . 1.1 t-20 -98.31 95.75 7.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.462 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.6 -21.55 61.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.084 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -79.05 -44.67 21.71 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.199 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -41.2 88.37 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.227 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.553 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.45 174.29 6.27 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.6 Cg_endo -54.05 127.82 27.26 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 121.742 1.628 . . . . 0.0 112.255 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.5 -38.97 10.18 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.759 2.306 . . . . 0.0 112.575 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.73 -9.59 55.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.023 0.44 . . . . 0.0 111.344 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -103.15 16.19 27.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -68.28 -32.67 4.08 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 91.2 Cg_exo -44.44 -33.54 6.53 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 121.778 1.652 . . . . 0.0 112.718 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.887 HG11 ' CE2' ' A' ' 84' ' ' PHE . 12.9 t -77.8 -51.51 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.003 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.882 HG22 ' HB2' ' A' ' 127' ' ' LYS . 17.3 mm -68.16 -33.61 61.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.67 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.67 -27.35 39.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.874 0.369 . . . . 0.0 110.775 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -80.54 -53.19 6.79 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.885 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.618 HD13 ' CD1' ' A' ' 68' ' ' PHE . 2.4 tp -78.23 -33.52 49.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.76 0.314 . . . . 0.0 111.628 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.882 ' HB2' HG22 ' A' ' 123' ' ' ILE . 28.3 ttpp -54.05 -42.64 69.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.026 0.441 . . . . 0.0 110.963 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -66.3 -10.09 39.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.626 HD21 HG23 ' A' ' 108' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.94 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.969 0.414 . . . . 0.0 110.963 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 138.67 38.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.368 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.563 HD11 HG13 ' A' ' 80' ' ' ILE . 3.7 pp -146.24 138.02 24.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 0.0 111.713 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.455 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 29.2 mt-30 -104.11 152.83 21.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.987 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.619 HD12 HD11 ' A' ' 80' ' ' ILE . 47.8 mt -146.35 119.53 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.274 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.047 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.86 125.68 44.36 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.677 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.8 m -132.79 162.45 39.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.478 0.656 . . . . 0.0 111.945 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.462 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -149.36 118.66 0.97 Allowed Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.92 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.063 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.27 109.76 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.716 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -70.6 119.14 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.062 0.458 . . . . 0.0 111.61 -178.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.706 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.65 118.57 23.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.75 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.535 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.1 t-20 -78.21 -172.46 2.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.589 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 10.9 tt0 -83.44 4.86 25.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.368 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -140.58 52.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 111.444 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.3 p30 46.26 23.23 0.19 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.683 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.684 ' C ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -116.42 146.89 42.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.063 HG21 HG22 ' A' ' 10' ' ' ILE . 1.5 mp -112.49 144.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.298 0.571 . . . . 0.0 112.299 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.6 OUTLIER -88.37 114.24 24.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.127 179.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.862 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -118.71 137.7 51.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 100' ' ' GLN . 6.3 p -70.84 123.01 20.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 111.033 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HB3' HD13 ' A' ' 33' ' ' LEU . 5.0 ptt85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.099 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.695 0.283 . . . . 0.0 111.41 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.25 26.14 10.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.018 0.437 . . . . 0.0 111.316 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 111' ' ' ASN . 27.2 tp -73.55 64.67 0.89 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.103 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.862 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -114.99 -173.09 2.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.789 0.328 . . . . 0.0 111.213 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.688 ' CD1' HG23 ' A' ' 10' ' ' ILE . 53.8 m-85 -90.42 159.95 40.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.677 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 97.8 Cg_endo -84.02 167.13 12.71 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.809 3.006 . . . . 0.0 111.852 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.757 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.12 -5.12 52.6 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.716 -0.754 . . . . 0.0 114.136 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.62 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -64.18 129.82 37.93 Favored Glycine 0 C--N 1.316 -0.582 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.848 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 108.97 2.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.1 0.56 . . . . 0.0 111.848 179.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.047 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.7 pt -49.05 -29.66 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.518 0.675 . . . . 0.0 110.747 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.597 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -38.16 -77.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.952 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.2 mmt 33.8 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.623 0.577 . . . . 0.0 111.885 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.0 32.93 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.663 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.479 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -89.09 -172.9 3.84 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.731 0.301 . . . . 0.0 111.132 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.833 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.64 154.04 37.66 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.288 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.833 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.76 -24.99 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.803 2.335 . . . . 0.0 112.491 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.47 -43.59 5.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.55 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 52.8 mm-40 -80.46 -4.84 55.33 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 1.039 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.15 -55.47 31.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.682 0.277 . . . . 0.0 111.035 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.713 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -78.52 -45.65 25.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.968 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.461 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 39.4 t -60.13 -44.89 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.003 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 9.2 tpp180 -78.07 -37.14 47.31 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.393 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.445 ' CG ' ' OE2' ' A' ' 57' ' ' GLU . 6.2 tp10 -78.04 -23.54 48.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.716 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.868 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -51.67 -44.42 63.07 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 120.982 0.42 . . . . 0.0 109.988 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -28.85 62.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.468 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -77.24 -30.67 54.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.314 179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.448 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 16.3 mp0 -108.22 5.85 26.13 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.581 HG11 ' HG3' ' A' ' 62' ' ' PRO . 4.0 t -134.07 -44.88 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.024 0.44 . . . . 0.0 110.101 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.607 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.11 -38.32 0.15 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.56 -0.745 . . . . 0.0 114.577 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.747 HG23 ' CD1' ' A' ' 95' ' ' TRP . 21.3 pt -77.79 -176.03 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.99 0.424 . . . . 0.0 111.575 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.25 88.28 17.98 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.348 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.67 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.8 Cg_endo -112.44 146.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.568 2.845 . . . . 0.0 113.9 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 13.1 mt-30 -74.82 80.2 2.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 175.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.868 ' NE2' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.36 136.78 54.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.578 -175.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.0 t80 178.71 -135.52 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.199 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 55.94 166.49 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.147 0.498 . . . . 0.0 111.809 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.7 tt -129.14 114.95 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.683 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -76.53 -52.91 8.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.8 tt0 -171.91 153.03 3.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.927 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.564 ' CD ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.55 129.28 19.31 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.896 HD11 HG22 ' A' ' 122' ' ' VAL . 1.1 pp -130.91 159.13 38.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.014 0.435 . . . . 0.0 111.235 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.752 ' HG3' HG22 ' A' ' 81' ' ' THR . 1.8 mp0 -133.6 120.17 20.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.042 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.435 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 1.7 p90 -141.17 147.59 38.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.595 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.13 112.32 18.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 111.34 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.4 m-85 -69.96 162.86 65.74 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.355 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.7 Cg_endo -50.3 81.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.058 2.505 . . . . 0.0 112.342 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 75' ' ' PHE . 7.0 m-20 91.15 13.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.814 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' A' ' 75' ' ' PHE . 21.3 ttp180 -137.45 102.01 4.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.613 0.244 . . . . 0.0 110.935 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -86.98 113.06 22.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.619 HD11 HD12 ' A' ' 6' ' ' ILE . 2.3 tt -120.22 118.83 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.091 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.752 HG22 ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -97.58 118.77 34.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.856 ' HG ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -113.83 114.61 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.413 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 8.8 m0 -113.35 122.38 47.21 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.965 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.1 m-30 -106.89 133.22 51.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.034 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.713 ' CE2' HG11 ' A' ' 50' ' ' VAL . 16.9 m95 -118.65 149.14 41.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.445 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 66' ' ' SER . 0.0 OUTLIER -102.07 103.79 14.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.48 0.657 . . . . 0.0 112.306 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.83 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.3 t -79.77 146.26 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.995 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -114.34 -23.99 9.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -162.43 161.01 27.05 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.623 0.647 . . . . 0.0 111.371 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.716 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -157.07 125.98 5.86 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.404 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -74.5 140.31 44.44 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.242 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.77 -130.03 47.94 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.763 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.694 ' O ' HG21 ' A' ' 60' ' ' ILE . 4.9 tt0 -121.01 137.4 26.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 93' ' ' GLU . 2.8 Cg_exo -76.18 128.9 10.89 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.702 2.268 . . . . 0.0 111.562 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.747 ' CD1' HG23 ' A' ' 60' ' ' ILE . 50.0 p-90 -119.5 -60.04 1.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.975 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.573 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.0 -103.93 0.06 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.973 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 172.28 37.36 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.097 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.416 ' HB2' HG21 ' A' ' 21' ' ' THR . 1.3 mp0 -59.25 -48.98 79.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.762 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.86 -76.9 0.14 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.83 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.43 ' O ' ' HB ' ' A' ' 21' ' ' THR . 1.8 pm0 -118.79 124.14 28.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.071 0.462 . . . . 0.0 111.318 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -43.29 145.95 1.28 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.994 2.463 . . . . 0.0 112.647 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.39 177.36 16.8 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.926 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -125.14 157.23 36.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -69.18 106.51 2.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.867 0.365 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.408 ' SD ' HD11 ' A' ' 33' ' ' LEU . 2.0 ptp -120.19 163.24 18.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.106 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.7 p -81.64 114.94 20.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.472 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.607 ' HG ' HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -68.05 -18.69 64.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.456 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.01 -19.26 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.513 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.51 55.5 0.57 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.227 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.707 HD22 ' CD1' ' A' ' 123' ' ' ILE . 2.0 tt -62.37 151.02 38.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.908 0.385 . . . . 0.0 110.967 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.587 ' HB3' HD23 ' A' ' 33' ' ' LEU . 1.6 t-20 -92.44 92.87 8.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.048 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.516 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -71.36 -18.89 62.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.153 0.501 . . . . 0.0 110.142 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.89 -44.39 22.87 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.513 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.84 -41.36 87.56 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.816 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.615 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.78 170.06 17.89 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 34' ' ' GLU . 9.3 Cg_endo -54.14 127.63 26.53 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.131 1.887 . . . . 0.0 112.791 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.13 -34.85 15.71 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.73 2.287 . . . . 0.0 111.995 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -70.33 -9.96 57.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.877 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -109.53 14.09 23.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.615 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -76.1 -30.99 0.94 Allowed Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 65.7 Cg_exo -43.61 -39.99 10.31 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.062 1.841 . . . . 0.0 113.831 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.896 HG22 HD11 ' A' ' 71' ' ' LEU . 1.5 t -77.91 -51.58 17.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.99 0.424 . . . . 0.0 111.598 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.707 ' CD1' HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.13 -29.45 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.623 -179.059 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.45 -31.34 55.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.009 0.433 . . . . 0.0 110.086 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -66.74 -47.02 73.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.155 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.848 HD13 ' O ' ' A' ' 126' ' ' LEU . 2.3 tm? -78.49 -20.03 51.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.032 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.425 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 23.0 tttm -74.48 -42.53 58.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.095 0.474 . . . . 0.0 110.445 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -64.65 -11.03 31.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.904 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.744 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.104 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.58 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.82 0.343 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.05 133.95 30.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.4 pp -146.15 121.95 10.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.401 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 32.6 mt-30 -102.89 151.32 22.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.241 0.543 . . . . 0.0 112.059 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.527 ' HB ' HD23 ' A' ' 82' ' ' LEU . 3.2 mp -146.48 128.93 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.279 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.108 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.13 125.58 43.96 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -137.13 162.16 34.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.381 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.462 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.04 127.86 2.45 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.045 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.714 HG22 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -70.76 110.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.714 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -70.93 119.72 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.891 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.92 121.01 26.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.744 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 2.5 t-20 -81.31 -172.56 3.86 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.52 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.506 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 22.2 tt0 -81.98 3.65 25.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.398 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -139.74 51.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 111.385 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.34 24.58 0.3 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.195 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 17.0 pt-20 -116.96 144.52 44.46 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.714 HG21 HG22 ' A' ' 10' ' ' ILE . 5.6 mt -116.03 145.18 22.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.172 0.511 . . . . 0.0 111.841 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.459 ' CD2' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -89.83 111.08 21.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.367 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.49 142.86 24.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.182 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.49 HG22 ' OE2' ' A' ' 98' ' ' GLU . 1.4 p -70.84 114.42 8.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 6.0 ttt85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.522 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 t30 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.695 0.283 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.1 25.98 10.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 111.403 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.543 HD13 ' CB ' ' A' ' 111' ' ' ASN . 1.2 tt -67.48 76.05 0.17 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.792 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.88 -169.0 1.65 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.933 0.397 . . . . 0.0 111.464 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.678 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.28 168.46 9.93 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.461 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.559 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 74.0 Cg_endo -77.72 167.06 24.58 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.372 2.714 . . . . 0.0 112.953 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.11 -5.45 52.94 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.71 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.44 145.28 48.76 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.302 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 89.62 9.91 0.08 Allowed 'General case' 0 C--N 1.342 0.257 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.108 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -57.84 -27.27 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.567 0.699 . . . . 0.0 110.051 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.506 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.04 -77.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.416 -1.266 . . . . 0.0 111.31 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 36.05 -87.85 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.938 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.07 33.58 0.07 OUTLIER Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.989 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.474 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -92.47 -166.23 1.5 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.54 0.21 . . . . 0.0 110.897 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.856 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.89 154.35 37.41 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.856 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.93 -24.81 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.704 2.269 . . . . 0.0 112.362 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.613 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -98.34 -49.83 4.54 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -80.71 -8.89 59.8 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.774 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -61.62 -57.24 12.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.843 0.354 . . . . 0.0 110.484 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.613 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 1.2 p -78.61 -46.61 24.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.716 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 47' ' ' GLU . 55.3 t -50.69 -38.81 17.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.754 0.312 . . . . 0.0 111.387 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -78.89 -52.2 8.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.799 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -69.59 -19.8 63.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.19 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.91 HD11 ' CE1' ' A' ' 64' ' ' HIS . 23.0 tp -58.74 -45.81 88.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.521 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -66.46 -26.69 67.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.004 0.43 . . . . 0.0 110.095 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.63 -24.57 67.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.602 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.508 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.54 5.64 25.3 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.036 HG12 HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -133.49 -44.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 68.85 -35.24 0.28 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.036 HD11 HG12 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -77.95 -172.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.893 0.377 . . . . 0.0 110.909 -179.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.02 88.82 12.65 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.412 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.675 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.3 Cg_endo -108.36 149.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 123.28 2.653 . . . . 0.0 113.787 -177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.552 ' HG2' ' HB3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.88 81.16 4.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 175.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.91 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -125.61 134.98 51.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.087 -175.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.506 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.6 t80 179.83 -142.83 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.657 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t 50.82 175.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.975 0.51 . . . . 0.0 111.95 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.843 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -141.88 124.9 16.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.02 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.97 -51.14 11.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.985 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 mt-10 -171.73 131.64 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.35 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.26 119.46 39.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.791 0.329 . . . . 0.0 110.64 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.691 ' CB ' HG22 ' A' ' 122' ' ' VAL . 0.5 OUTLIER -99.64 123.67 44.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.863 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -122.52 109.56 14.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.793 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.548 ' OH ' HD13 ' A' ' 80' ' ' ILE . 1.8 p90 -141.43 137.59 32.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.486 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.464 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 2.5 pt-20 -121.24 125.21 46.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.156 0.503 . . . . 0.0 111.462 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 2.6 m-85 -71.92 163.4 67.06 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.895 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.471 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.8 Cg_endo -39.28 -27.76 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.434 2.756 . . . . 0.0 112.97 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -139.78 -37.08 0.49 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.209 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 33.2 ttp180 -85.91 103.42 14.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.489 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.464 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 9.4 t-160 -91.15 100.27 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 110.425 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.548 HD13 ' OH ' ' A' ' 73' ' ' TYR . 6.2 tt -101.88 146.2 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.091 0.472 . . . . 0.0 111.252 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.523 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -134.15 118.74 18.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.696 179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.527 HD23 ' HB ' ' A' ' 6' ' ' ILE . 13.5 mt -121.17 114.2 21.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.992 0.425 . . . . 0.0 111.763 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.523 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.7 m0 -109.44 122.06 46.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.774 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' A' ' 122' ' ' VAL . 7.7 m-30 -107.21 114.72 28.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.843 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 23.8 m95 -94.35 148.24 22.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.044 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.547 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.5 tm? -98.48 102.91 14.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.454 0.645 . . . . 0.0 111.463 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.82 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.3 t -82.36 145.74 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.03 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -114.79 -23.56 9.11 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.552 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 8.6 ttt180 -162.59 164.54 26.68 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.507 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.714 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -157.14 124.42 5.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.248 178.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -75.19 146.25 41.4 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.116 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.65 -130.44 48.32 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.574 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 60' ' ' ILE . 44.3 mt-10 -121.52 141.43 33.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -75.63 131.52 13.67 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.827 2.351 . . . . 0.0 111.143 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 41.0 p-90 -133.49 -65.76 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.58 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.23 -96.8 0.01 OUTLIER Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.876 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.45 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER 173.36 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.645 0.26 . . . . 0.0 111.341 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.49 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -56.06 -43.99 78.46 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.804 0.335 . . . . 0.0 110.866 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.49 -82.88 0.25 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.717 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 111.54 48.7 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.917 0.389 . . . . 0.0 111.389 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -43.42 146.21 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.003 2.469 . . . . 0.0 112.625 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.21 177.19 16.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.808 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -139.21 157.28 46.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -60.33 106.57 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.92 0.39 . . . . 0.0 110.086 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.3 mtm -120.09 163.37 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.159 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.97 114.87 23.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.409 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -69.62 -18.71 63.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.529 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.42 -14.82 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.673 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.98 53.52 0.7 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.154 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.437 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 4.7 tt -62.4 150.59 39.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.008 0.432 . . . . 0.0 110.948 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.543 ' CB ' HD13 ' A' ' 33' ' ' LEU . 1.1 t-20 -95.35 93.47 7.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.439 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 123' ' ' ILE . . . -72.29 -20.71 61.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.014 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -45.22 20.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.128 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.79 -39.98 87.96 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.369 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.564 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.44 173.99 6.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.08 127.8 27.19 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.918 1.745 . . . . 0.0 112.607 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 52.1 Cg_endo -69.15 -35.16 15.0 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.752 2.301 . . . . 0.0 112.353 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.9 -9.63 58.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.074 0.464 . . . . 0.0 111.168 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -105.76 17.62 23.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.949 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.0 -31.05 0.96 Allowed Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 80.0 Cg_exo -43.55 -34.28 5.13 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.877 1.718 . . . . 0.0 113.064 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.691 HG22 ' CB ' ' A' ' 71' ' ' LEU . 16.0 t -77.96 -47.28 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.275 0.56 . . . . 0.0 110.253 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.678 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 35.6 mm -68.9 -31.28 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.413 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.05 -26.88 40.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.936 0.398 . . . . 0.0 110.344 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -47.71 14.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.345 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.575 HD13 ' O ' ' A' ' 126' ' ' LEU . 2.4 tm? -78.18 -45.95 21.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 111.329 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.589 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.8 tttm -52.68 -42.27 64.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.127 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -63.93 -8.07 10.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.971 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.337 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . 0.527 ' HE3' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.849 0.357 . . . . 0.0 110.93 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.05 132.04 27.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.527 HD23 ' HE3' ' A' ' 2' ' ' LYS . 3.1 pp -146.14 127.14 14.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.376 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.406 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 14.9 mt-30 -102.65 154.48 19.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.062 0.458 . . . . 0.0 111.46 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.601 ' HB ' HD12 ' A' ' 82' ' ' LEU . 1.8 mp -146.42 119.12 2.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.835 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.04 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.93 125.69 44.33 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.1 m -134.76 162.44 38.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.312 0.577 . . . . 0.0 112.041 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.7 111.12 0.9 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.277 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -70.47 103.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.689 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.41 125.76 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.23 -178.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -100.47 139.32 36.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.123 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.669 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.9 p-10 -98.74 -173.37 2.51 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.523 0.678 . . . . 0.0 112.234 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.49 -3.96 13.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.869 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.473 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 58.1 t30 -120.11 37.54 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.97 15.94 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 0.0 111.579 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 15' ' ' ASN . 1.2 mm-40 -102.02 161.2 13.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.838 HG12 HG22 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.47 131.26 73.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.164 0.506 . . . . 0.0 111.801 -178.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -83.09 116.51 22.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.717 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.671 HD12 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.27 147.22 33.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.556 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 29.2 p -70.78 111.91 6.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.263 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.841 -179.658 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.5 t-20 . . . . . 0 CA--C 1.529 0.173 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.37 26.09 10.53 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 111.777 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.671 HD21 HD12 ' A' ' 20' ' ' ILE . 2.6 tt -67.19 66.17 0.07 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.044 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -106.86 -170.17 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.223 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.665 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.21 168.33 10.15 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.541 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.567 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 97.0 Cg_endo -84.12 166.55 12.74 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.433 2.755 . . . . 0.0 113.001 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.572 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.01 -6.08 53.75 Favored Glycine 0 C--O 1.225 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 114.096 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.79 167.45 15.45 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.509 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.67 1.5 1.21 Allowed 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.448 0.299 . . . . 0.0 111.795 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.04 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -52.8 -27.06 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.495 0.665 . . . . 0.0 110.433 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.55 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -40.21 -61.44 0.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.025 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.509 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 11.07 -81.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.907 0.754 . . . . 0.0 112.467 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.0 32.33 0.09 OUTLIER Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.862 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.1 mp0 -93.48 -172.94 3.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.653 0.263 . . . . 0.0 111.191 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.853 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -101.59 153.64 37.76 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.323 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.853 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.98 -24.82 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.809 2.339 . . . . 0.0 112.615 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.622 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -100.93 -43.68 5.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -80.09 -20.84 44.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.714 0.292 . . . . 0.0 111.644 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.835 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.38 -48.48 76.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.814 0.34 . . . . 0.0 111.036 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.798 HG12 ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.29 -47.87 23.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.3 t -59.66 -44.11 92.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.59 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.407 ' NH1' ' HB3' ' A' ' 52' ' ' ARG . 17.9 mtp-105 -73.25 -41.15 64.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 110.821 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 57' ' ' GLU . 4.6 tp10 -73.5 -19.73 60.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.819 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.759 HD11 ' CE1' ' A' ' 64' ' ' HIS . 5.9 tp -60.04 -44.65 94.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.733 0.301 . . . . 0.0 110.962 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.69 -36.19 82.92 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.38 -24.66 50.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.911 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 12.0 mm-40 -108.26 5.75 25.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.649 -0.421 . . . . 0.0 112.03 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.886 HG12 HG13 ' A' ' 60' ' ' ILE . 60.1 t -134.16 -44.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.48 -40.04 0.28 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.091 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.886 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.74 -177.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.132 0.492 . . . . 0.0 111.217 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.82 88.71 14.57 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.914 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.703 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.1 Cg_endo -111.49 145.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.415 2.744 . . . . 0.0 114.207 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.6 mt-30 -74.92 79.93 2.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.759 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.34 129.56 53.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.389 -176.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 66' ' ' SER . 2.0 t80 179.91 166.02 1.21 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.709 ' HB3' HD21 ' A' ' 86' ' ' LEU . 50.9 m 82.92 152.18 0.1 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.407 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.3 pp -107.66 134.68 50.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 111.973 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.684 ' CE2' HD12 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -81.94 -44.89 16.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.538 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -171.93 131.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.098 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.614 ' HE2' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -135.79 103.88 5.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.691 0.281 . . . . 0.0 110.733 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -111.66 169.37 8.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.104 0.478 . . . . 0.0 111.467 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.772 ' N ' HD22 ' A' ' 71' ' ' LEU . 8.2 tt0 -137.84 124.89 21.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.674 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.1 p90 -138.11 120.06 15.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.796 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -94.7 139.35 31.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 111.423 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.488 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 2.2 m-85 -103.94 162.47 19.82 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.218 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.9 Cg_endo -54.18 82.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.95 2.433 . . . . 0.0 112.117 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.7 t70 94.84 7.07 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.543 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.425 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.4 OUTLIER -137.26 93.72 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 110.592 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 11.5 t-160 -85.69 99.36 11.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.762 0.315 . . . . 0.0 110.871 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.674 HD13 ' OH ' ' A' ' 73' ' ' TYR . 4.2 tt -103.04 135.5 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 118.78 31.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.356 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.66 HD13 HD11 ' A' ' 80' ' ' ILE . 1.1 mp -113.08 114.06 26.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.897 0.379 . . . . 0.0 111.727 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 9.7 m0 -111.6 122.04 46.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.743 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.654 ' CE1' HG11 ' A' ' 122' ' ' VAL . 1.7 m-85 -109.68 109.94 20.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.469 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.843 ' O ' HD12 ' A' ' 10' ' ' ILE . 19.8 m95 -95.91 148.79 22.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.76 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 66' ' ' SER . 1.4 pp -95.69 138.77 32.89 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.162 0.506 . . . . 0.0 111.709 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.752 HG13 ' CB ' ' A' ' 64' ' ' HIS . 38.4 t -123.33 145.66 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.368 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -113.82 -21.63 10.58 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.92 160.16 24.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.707 0.685 . . . . 0.0 111.473 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.689 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.06 122.61 4.69 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.254 179.022 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -75.82 150.69 37.64 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.138 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.48 -129.92 47.21 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.526 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -125.21 145.8 51.86 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.507 0.194 . . . . 0.0 110.653 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.461 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.48 128.74 10.53 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.761 2.307 . . . . 0.0 111.573 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.556 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -132.34 -59.91 0.91 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.838 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.634 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 36.77 -97.89 0.01 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.195 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tttp 178.43 38.8 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.7 0.285 . . . . 0.0 111.153 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -60.51 -49.05 79.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.263 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 143.28 -49.83 0.71 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.262 -0.97 . . . . 0.0 113.345 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.77 118.98 16.86 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.124 0.488 . . . . 0.0 111.966 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -43.79 146.37 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.211 2.608 . . . . 0.0 112.807 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.97 177.23 17.45 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.092 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 105' ' ' MET . 1.6 mt-10 -137.43 157.79 45.82 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.306 0.242 . . . . 0.0 110.383 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -65.0 106.39 1.24 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.75 0.31 . . . . 0.0 110.259 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -120.0 157.14 29.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.796 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.439 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.4 p -75.63 114.93 14.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.666 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.86 ' O ' HD13 ' A' ' 107' ' ' LEU . 2.5 tm? -75.38 -18.77 59.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.503 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.9 p -59.16 -12.58 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.737 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.79 54.3 0.62 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.367 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.598 HD22 HD12 ' A' ' 123' ' ' ILE . 9.2 tt -62.0 150.36 38.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.595 0.236 . . . . 0.0 110.554 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.59 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -108.19 115.88 30.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -18.9 61.73 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.012 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -79.09 -47.83 15.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.881 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.507 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -66.86 -17.39 64.87 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.645 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.45 173.67 3.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.17 127.92 27.78 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 121.938 1.759 . . . . 0.0 112.405 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.0 Cg_endo -69.04 -38.32 9.56 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.756 2.304 . . . . 0.0 112.664 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.94 -9.72 56.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.977 0.418 . . . . 0.0 111.308 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . 0.474 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 29.2 m-20 -104.42 15.3 28.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.922 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -63.32 -31.59 7.01 Favored Pre-proline 0 N--CA 1.467 0.381 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 71.3 Cg_exo -43.78 -40.38 11.13 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.793 1.662 . . . . 0.0 113.54 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.715 HG22 ' CD1' ' A' ' 71' ' ' LEU . 74.6 t -78.0 -51.55 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.379 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.665 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 38.7 mm -66.13 -31.88 55.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.595 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.86 -32.33 60.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.862 0.363 . . . . 0.0 110.676 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -80.44 -46.16 16.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.52 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 107' ' ' LEU . 0.4 OUTLIER -78.34 -19.77 52.78 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.399 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.566 ' HB2' HG22 ' A' ' 123' ' ' ILE . 22.2 tttm -74.31 -42.45 59.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.128 0.489 . . . . 0.0 110.593 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -68.29 -8.95 44.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.936 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.786 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.15 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.621 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.115 0 CA-C-O 120.873 0.368 . . . . 0.0 110.977 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.35 131.23 26.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.489 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.4 pp -146.15 140.55 26.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.908 0.385 . . . . 0.0 111.661 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.717 ' C ' HD12 ' A' ' 6' ' ' ILE . 30.9 mt-30 -104.67 152.86 21.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.213 0.53 . . . . 0.0 111.255 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.738 ' HB ' HD12 ' A' ' 82' ' ' LEU . 4.4 mp -146.18 116.36 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.51 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 1.012 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.33 133.07 52.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.3 m -144.61 162.73 14.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.013 0.435 . . . . 0.0 111.773 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -139.22 115.15 1.08 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.855 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.02 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -71.28 107.25 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.715 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.16 127.29 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.93 0.395 . . . . 0.0 111.132 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.08 123.45 33.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.622 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 12.3 t-20 -78.28 -172.16 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.117 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -82.18 -3.1 54.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.106 -1.406 . . . . 0.0 112.271 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -129.96 36.37 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.64 7.59 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.743 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 17.8 pt-20 -100.85 153.05 19.81 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.02 HG21 HG22 ' A' ' 10' ' ' ILE . 4.8 mt -115.89 140.56 37.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.17 0.509 . . . . 0.0 111.994 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -89.26 102.14 14.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.436 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -115.29 162.13 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.263 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.581 HG22 ' OE2' ' A' ' 98' ' ' GLU . 5.8 p -71.07 121.2 17.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.786 0.327 . . . . 0.0 110.759 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.807 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.574 0.226 . . . . 0.0 111.28 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.43 25.98 10.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 0.0 111.799 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 21' ' ' THR . 22.1 tp -76.36 78.79 3.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.272 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.52 -166.63 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.52 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.619 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.52 168.36 10.26 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.157 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.631 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 71.7 Cg_endo -77.5 166.9 25.19 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.238 2.625 . . . . 0.0 112.903 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.579 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.31 -5.58 52.46 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.71 -0.677 . . . . 0.0 114.242 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.51 156.44 42.64 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 117.176 0.488 . . . . 0.0 112.844 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.75 -1.06 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.034 0.534 . . . . 0.0 111.875 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 1.012 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -53.37 -26.01 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.375 0.607 . . . . 0.0 110.929 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.99 -62.85 0.75 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.913 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.495 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.2 mtm 12.24 -83.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.562 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.59 31.68 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.816 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.412 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.13 -169.4 2.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.671 0.272 . . . . 0.0 111.043 -179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.904 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -113.62 164.69 15.21 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.451 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.904 ' HD2' HG22 ' A' ' 45' ' ' THR . 6.7 Cg_endo -47.63 -24.62 4.71 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.017 2.478 . . . . 0.0 112.72 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -95.99 -55.24 3.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -80.55 -4.61 54.62 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.73 -58.02 8.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.811 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.812 HG11 ' NE1' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -79.5 -45.53 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.332 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.0 t -53.46 -39.75 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.724 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -78.13 -42.92 30.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.848 0.356 . . . . 0.0 111.231 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.3 mm-40 -74.22 -19.84 60.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.049 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.804 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -60.57 -44.83 95.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.48 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -35.81 78.28 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.76 -28.03 50.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.124 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 33.4 mm-40 -105.34 5.01 31.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 54' ' ' LEU . 4.1 t -134.87 -44.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.29 -38.94 0.21 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.049 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.643 HG23 ' CD1' ' A' ' 95' ' ' TRP . 22.8 pt -82.02 -176.18 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 120.985 0.422 . . . . 0.0 111.582 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.87 88.41 21.09 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.321 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HB3' ' HB2' ' A' ' 90' ' ' TRP . 12.3 Cg_endo -109.92 153.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.459 2.773 . . . . 0.0 113.833 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 89' ' ' ARG . 89.8 mt-30 -74.85 79.93 2.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.928 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -126.2 127.45 45.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.283 -176.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.9 t80 -177.86 158.85 1.32 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 78.01 -168.39 0.05 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.291 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.84 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -144.49 137.57 27.0 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.852 -179.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.886 ' CD1' HD23 ' A' ' 126' ' ' LEU . 2.5 p90 -76.75 -41.58 44.36 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . 5.5 mt-10 -171.76 131.45 0.69 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.696 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.49 120.81 42.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.0 111.201 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.734 HD22 ' CE2' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -104.68 122.22 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.026 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -130.68 113.64 14.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.971 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.734 ' CE2' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -141.24 153.38 45.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.378 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.1 pt-20 -121.17 127.06 51.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.343 0.592 . . . . 0.0 111.187 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 77' ' ' ASP . 1.0 OUTLIER -96.51 163.43 20.53 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.554 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.0 Cg_endo -53.18 81.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.032 2.488 . . . . 0.0 112.255 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.2 t70 93.4 8.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.532 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.44 93.86 2.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.633 0.254 . . . . 0.0 110.758 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 5.2 t-160 -93.27 95.7 9.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 111.103 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.641 ' HA ' HD12 ' A' ' 4' ' ' LEU . 0.5 OUTLIER -100.35 111.99 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.132 179.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -97.26 118.1 32.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.738 HD12 ' HB ' ' A' ' 6' ' ' ILE . 1.7 mp -110.09 113.82 26.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.094 0.473 . . . . 0.0 111.179 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 8.5 m0 -112.5 122.27 47.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.324 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.927 ' CE2' HG11 ' A' ' 122' ' ' VAL . 3.2 m-85 -116.58 113.16 22.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.013 0.435 . . . . 0.0 110.591 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.84 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.8 m95 -94.58 148.3 22.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.566 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 86' ' ' LEU . 2.3 pp -93.97 138.25 32.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.928 HG22 ' ND1' ' A' ' 64' ' ' HIS . 48.8 t -123.26 145.33 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.546 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -109.51 -28.2 9.03 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.79 165.57 22.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.968 0.804 . . . . 0.0 111.789 -178.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.715 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -152.93 126.02 8.52 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.145 178.357 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -76.88 146.4 37.69 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.409 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.57 -126.64 32.24 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.811 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.606 ' O ' HG21 ' A' ' 60' ' ' ILE . 4.0 tt0 -124.4 126.59 25.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.427 0.156 . . . . 0.0 110.582 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.496 ' CA ' HD13 ' A' ' 60' ' ' ILE . 13.7 Cg_exo -72.09 128.62 14.14 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.754 2.303 . . . . 0.0 111.2 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.643 ' CD1' HG23 ' A' ' 60' ' ' ILE . 17.1 p-90 -114.78 -61.43 1.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.016 0.436 . . . . 0.0 111.415 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.82 -114.02 1.39 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.904 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.61 74.61 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.927 0.394 . . . . 0.0 110.857 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.581 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -96.44 -29.22 14.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.013 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.2 -103.06 0.45 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.115 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.86 115.53 47.21 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.0 111.612 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -43.66 146.12 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.986 2.457 . . . . 0.0 112.718 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.88 177.69 18.69 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.36 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -133.16 157.26 45.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.607 0.242 . . . . 0.0 110.652 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -63.56 106.72 0.99 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.417 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtm -119.83 163.05 18.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.666 ' HB2' HG12 ' A' ' 108' ' ' VAL . 7.7 p -81.2 114.92 20.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.817 HD11 HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -69.86 -18.66 63.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.208 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.6 p -56.45 -14.29 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.402 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.53 56.76 0.6 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.843 HD23 HD12 ' A' ' 123' ' ' ILE . 9.9 tp -61.73 150.25 37.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.854 0.359 . . . . 0.0 110.861 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 2.3 t-20 -97.22 106.9 19.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.531 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -24.16 61.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -79.17 -47.18 16.5 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.271 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.466 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.79 -14.21 62.37 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.869 -179.125 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.549 ' CZ ' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -113.64 173.43 2.87 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.46 127.86 27.72 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 121.837 1.691 . . . . 0.0 111.974 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.97 -38.89 8.85 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.681 2.254 . . . . 0.0 112.613 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.41 -9.6 54.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.945 0.402 . . . . 0.0 111.572 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -103.54 19.96 18.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.871 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.59 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -70.45 -32.03 2.49 Favored Pre-proline 0 N--CA 1.466 0.349 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.2 Cg_exo -44.31 -34.27 7.01 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 121.971 1.781 . . . . 0.0 112.899 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.927 HG11 ' CE2' ' A' ' 84' ' ' PHE . 24.5 t -77.59 -51.48 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.066 0.46 . . . . 0.0 110.977 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.873 HG22 ' HB2' ' A' ' 127' ' ' LYS . 12.9 mm -61.67 -38.98 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.885 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.56 -29.6 51.65 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.684 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -80.69 -52.22 7.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.631 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.886 HD23 ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -74.82 -43.06 56.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.405 -179.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.873 ' HB2' HG22 ' A' ' 123' ' ' ILE . 40.9 tttt -52.05 -42.61 63.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.128 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -64.49 -9.48 19.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.963 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.815 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.784 0.326 . . . . 0.0 110.886 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.43 144.12 32.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.776 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.0 pp -146.07 137.72 24.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.075 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . 0.586 ' C ' HD12 ' A' ' 6' ' ' ILE . 14.6 mt-30 -106.2 152.86 22.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.229 0.537 . . . . 0.0 111.852 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.776 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.3 mp -146.75 129.79 8.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.866 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.916 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.04 125.18 43.43 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -144.52 162.03 14.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.91 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.03 143.06 10.11 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.741 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.983 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -92.7 111.57 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.926 HG23 HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -71.1 113.45 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-O 121.283 0.563 . . . . 0.0 110.64 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.19 126.9 32.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.422 -178.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.538 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -83.91 -172.51 4.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.951 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.464 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 16.8 tp10 -78.89 -4.78 51.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.317 -1.31 . . . . 0.0 112.603 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -127.91 44.47 2.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.787 0.327 . . . . 0.0 111.613 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.03 19.58 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.539 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 10.0 pt-20 -114.77 142.76 46.09 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.983 HG21 HG22 ' A' ' 10' ' ' ILE . 11.3 mt -109.92 144.1 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.298 0.571 . . . . 0.0 112.213 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 11.2 t80 -88.86 93.69 9.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.897 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.619 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -112.47 149.39 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.536 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 3.1 p -70.93 111.87 6.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.506 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 21.9 ptt-85 . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.818 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.1 OUTLIER . . . . . 0 CA--C 1.53 0.195 0 N-CA-C 111.665 0.246 . . . . 0.0 111.665 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.08 26.09 10.59 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.881 0.372 . . . . 0.0 111.55 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 111' ' ' ASN . 5.1 tt -61.64 79.26 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.647 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -123.43 -173.23 2.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.112 0.482 . . . . 0.0 111.973 -179.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.739 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.45 168.21 10.54 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.634 -179.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.553 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 68.7 Cg_endo -74.87 167.09 27.85 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.465 2.777 . . . . 0.0 113.043 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.784 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.85 -5.51 53.76 Favored Glycine 0 C--O 1.222 -0.656 0 CA-C-N 115.87 -0.605 . . . . 0.0 114.155 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -62.21 145.65 49.4 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.941 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 92.06 2.01 0.11 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.916 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -51.41 -28.86 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.572 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.59 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.55 -60.8 1.6 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.143 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.513 ' C ' ' O ' ' A' ' 41' ' ' GLU . 8.9 mmm 10.28 -81.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.848 0.718 . . . . 0.0 112.633 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.43 27.98 0.13 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.083 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -103.97 -173.45 2.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.695 0.283 . . . . 0.0 110.999 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.886 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -108.85 155.91 39.92 Favored Pre-proline 0 N--CA 1.456 -0.159 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.886 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.49 -24.5 0.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.674 2.249 . . . . 0.0 112.406 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.9 tt0 -86.83 -60.27 2.03 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -80.67 -21.62 41.2 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.733 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -56.81 -48.77 77.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.675 0.274 . . . . 0.0 110.97 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.558 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.35 -50.72 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.754 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 47' ' ' GLU . 49.9 t -51.14 -35.66 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.773 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -48.71 15.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.537 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.7 mm-40 -65.77 -19.77 66.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.669 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.902 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -58.43 -44.8 89.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.939 0.4 . . . . 0.0 110.774 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -30.96 67.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.13 0.491 . . . . 0.0 109.989 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -77.36 -32.61 55.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.523 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.514 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.16 5.9 26.3 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.091 HG12 HG22 ' A' ' 60' ' ' ILE . 12.5 t -133.91 -43.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.48 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 65.78 -33.12 0.14 Allowed Glycine 0 C--N 1.33 0.244 0 N-CA-C 114.655 0.622 . . . . 0.0 114.655 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 1.091 HG22 HG12 ' A' ' 58' ' ' VAL . 20.0 tt -77.6 165.62 2.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.584 0.231 . . . . 0.0 110.776 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.452 ' N ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -105.19 88.26 2.41 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 12.0 Cg_endo -114.36 150.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 123.568 2.846 . . . . 0.0 114.39 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -74.69 79.93 2.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.927 ' CE1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.52 129.4 49.66 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.724 -175.539 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.546 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -177.85 -138.57 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.779 -179.148 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 85' ' ' TRP . 0.5 OUTLIER 51.01 173.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.823 0.449 . . . . 0.0 111.719 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.813 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -131.88 125.82 32.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.115 0.484 . . . . 0.0 111.101 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -78.59 -55.87 4.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.022 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.691 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -172.27 131.7 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.328 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.623 ' CD ' HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -114.19 118.71 34.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.712 0.291 . . . . 0.0 110.688 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.712 ' HB3' HG22 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -107.7 129.68 55.0 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.967 0.413 . . . . 0.0 111.047 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -115.92 110.05 18.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.176 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.666 ' CD1' HD23 ' A' ' 71' ' ' LEU . 2.8 p90 -136.33 143.64 44.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.052 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -121.27 118.18 28.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.808 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 2.6 m-85 -69.91 163.01 64.5 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.633 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.69 83.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.187 2.591 . . . . 0.0 112.239 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 17.4 t0 97.14 14.39 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.108 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.527 ' HB3' ' HB2' ' A' ' 75' ' ' PHE . 0.2 OUTLIER -137.39 149.18 46.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.308 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -131.49 112.84 13.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.767 0.318 . . . . 0.0 110.658 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.554 HD11 HD23 ' A' ' 82' ' ' LEU . 3.1 tt -120.65 112.0 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.352 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.51 118.89 32.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.735 HD22 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.86 114.55 22.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.978 0.418 . . . . 0.0 111.913 -178.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.4 m0 -108.84 122.33 46.96 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.119 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.781 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 1.9 m-85 -106.91 118.18 36.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.755 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.813 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 68.1 m95 -94.75 148.27 22.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.223 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.546 ' O ' ' O ' ' A' ' 65' ' ' PHE . 44.0 tp -99.03 102.98 14.88 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 121.449 0.642 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.927 HG22 ' CE1' ' A' ' 64' ' ' HIS . 7.4 t -86.13 145.68 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.277 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -100.7 -52.25 3.38 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.21 165.65 24.15 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.479 0.582 . . . . 0.0 112.463 -178.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.679 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 33.0 p90 -129.73 160.14 34.31 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.319 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.832 ' O ' HD11 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -100.83 93.35 5.49 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.868 0.366 . . . . 0.0 111.422 -179.146 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' ' NE1' ' A' ' 90' ' ' TRP . . . 100.31 -110.24 3.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.011 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.531 ' C ' HD12 ' A' ' 60' ' ' ILE . 19.9 tt0 -135.3 127.03 17.71 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.447 0.165 . . . . 0.0 111.075 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.7 Cg_exo -75.4 153.13 39.67 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.704 2.269 . . . . 0.0 110.888 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.548 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 19.0 p-90 -150.27 -62.81 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.707 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.39 -99.91 0.02 OUTLIER Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.948 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.7 32.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.441 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -63.52 -21.99 66.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.187 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.45 -123.1 2.81 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.098 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.409 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.7 OUTLIER -75.9 132.52 74.23 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.159 0.504 . . . . 0.0 111.702 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -43.39 146.26 1.26 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.105 2.536 . . . . 0.0 112.646 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.12 177.65 16.43 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.828 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.09 157.03 46.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.6 OUTLIER -66.21 106.29 1.63 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.619 ' SD ' HD11 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -120.31 163.19 18.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.22 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.7 p -82.37 114.83 21.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.473 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.765 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -68.47 -18.68 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.43 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.22 -10.8 2.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.804 0.335 . . . . 0.0 111.438 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.76 55.1 0.72 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.677 HD22 HD11 ' A' ' 107' ' ' LEU . 7.5 tp -61.43 150.2 36.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.407 -0.397 . . . . 0.0 110.828 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.486 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -104.18 95.61 6.09 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.597 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . . . -72.51 -18.76 61.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.874 177.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -79.06 -47.11 16.76 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.365 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.7 OUTLIER -66.7 -39.25 87.99 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.244 -179.163 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.525 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.39 174.43 6.04 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.4 Cg_endo -53.89 127.69 26.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.859 1.706 . . . . 0.0 112.497 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.8 Cg_endo -69.11 -34.93 15.59 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.753 2.302 . . . . 0.0 112.465 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -71.37 -9.57 58.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.008 0.433 . . . . 0.0 111.125 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -106.79 18.64 21.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.852 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 tt0 -70.38 -31.37 2.22 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.5 Cg_exo -43.7 -36.08 7.14 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.83 1.687 . . . . 0.0 113.395 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.781 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 59.3 t -78.04 -51.31 18.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 111.903 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.83 HG22 ' HB2' ' A' ' 127' ' ' LYS . 3.9 mm -77.08 -39.78 29.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.8 -26.88 26.08 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.48 -53.9 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.49 ' HG ' ' CE2' ' A' ' 68' ' ' PHE . 1.4 mm? -79.26 -30.3 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.665 0.269 . . . . 0.0 111.564 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.83 ' HB2' HG22 ' A' ' 123' ' ' ILE . 9.7 ttpt -54.03 -42.13 68.8 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.135 0.493 . . . . 0.0 110.338 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -67.46 -6.11 17.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.815 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.03 179.774 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 tttm . . . . . 0 C--O 1.232 0.182 0 CA-C-O 120.825 0.345 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.17 128.27 22.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.777 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.425 ' C ' HD12 ' A' ' 4' ' ' LEU . 4.0 pp -146.33 142.64 28.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.544 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -102.88 153.58 20.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.34 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.65 HD12 HD11 ' A' ' 80' ' ' ILE . 40.5 mt -146.33 116.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.959 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.954 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.55 144.25 50.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -145.76 162.44 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.931 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.68 108.04 0.51 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.698 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 1.077 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.73 108.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.774 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -71.72 121.96 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.92 0.391 . . . . 0.0 111.443 -179.004 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -84.86 121.93 28.43 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.093 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.562 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -79.63 -171.67 2.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.731 0.777 . . . . 0.0 111.68 179.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.438 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 1.6 tm-20 -82.0 15.53 2.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.343 -1.299 . . . . 0.0 113.105 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 54.8 t30 -144.76 43.97 1.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 54.13 17.82 1.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 105' ' ' MET . 2.3 mt-10 -116.81 160.68 20.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.077 HG21 HG22 ' A' ' 10' ' ' ILE . 5.9 mt -121.33 139.7 47.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.201 0.524 . . . . 0.0 111.458 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PHE . . . . . 0.564 ' CD1' ' C ' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -88.49 98.57 11.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.87 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.777 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -113.79 162.46 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.741 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.736 HG22 ' OE2' ' A' ' 98' ' ' GLU . 8.0 p -70.58 145.72 50.57 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.669 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.6 ttt-85 . . . . . 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.068 -179.684 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 10.9 t-20 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.706 0.288 . . . . 0.0 111.403 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 26.26 10.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.908 0.385 . . . . 0.0 111.934 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.1 tt -68.97 67.22 0.15 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.67 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.53 -167.77 1.3 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.343 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.777 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.36 168.06 10.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.44 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.774 ' HG3' HD11 ' A' ' 11' ' ' ILE . 84.2 Cg_endo -84.19 166.76 12.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.398 2.732 . . . . 0.0 113.224 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.28 -5.7 55.58 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.751 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -67.59 166.93 41.87 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.254 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.74 1.58 1.19 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.661 0.384 . . . . 0.0 111.871 179.575 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.954 HG21 ' HB3' ' A' ' 7' ' ' ALA . 3.4 pt -50.84 -28.6 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.516 0.674 . . . . 0.0 110.562 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.531 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.07 -63.43 0.61 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.878 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.521 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 11.15 -84.0 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.895 0.747 . . . . 0.0 112.625 179.368 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.74 29.26 0.08 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.913 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -168.23 1.98 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.734 0.302 . . . . 0.0 110.971 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.824 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -101.49 153.1 38.07 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.28 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.824 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.86 -25.17 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.852 2.368 . . . . 0.0 112.49 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mm-40 -103.99 -41.27 5.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.482 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -80.27 -5.71 56.68 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.93 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.1 -55.25 36.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.329 . . . . 0.0 110.836 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.725 HG12 ' HB1' ' A' ' 7' ' ' ALA . 2.0 m -78.33 -46.7 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.305 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 27.8 t -55.13 -36.91 41.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.342 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -78.19 -52.03 9.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.874 0.368 . . . . 0.0 110.616 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HB2' HG22 ' A' ' 40' ' ' ILE . 1.8 mm-40 -60.28 -21.88 62.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.672 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.959 HD21 ' CD2' ' A' ' 64' ' ' HIS . 1.4 tp -60.29 -45.05 94.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.024 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -30.58 71.42 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.5 -27.85 51.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.419 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.56 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.64 6.97 26.34 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.945 HG12 HG13 ' A' ' 60' ' ' ILE . 12.4 t -133.38 -44.3 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.049 0.452 . . . . 0.0 110.545 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.619 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 54.52 13.89 4.47 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 114.781 0.673 . . . . 0.0 114.781 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.945 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.08 -167.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 118.002 0.901 . . . . 0.0 110.796 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . 0.469 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -111.13 88.65 8.77 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.535 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.655 ' HG3' HG11 ' A' ' 58' ' ' VAL . 25.2 Cg_endo -113.69 137.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 123.733 2.956 . . . . 0.0 114.413 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 33.6 mt-30 -74.83 79.23 2.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.959 ' CD2' HD21 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -117.9 130.61 56.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.873 -176.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 66' ' ' SER . 2.3 t80 -176.43 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 86' ' ' LEU . 65.8 m -33.57 157.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.035 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tt -117.54 123.21 45.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.38 . . . . 0.0 110.95 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -82.36 -56.31 3.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.272 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.3 tt0 -171.66 159.22 5.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.429 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.1 108.44 5.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.756 0.312 . . . . 0.0 110.691 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.832 HD21 ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -96.81 146.23 25.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.674 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -138.96 109.89 6.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.763 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.832 ' CD1' HD21 ' A' ' 71' ' ' LEU . 2.4 p90 -141.17 153.01 45.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.677 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 4.2 pt-20 -121.25 133.81 55.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.158 0.504 . . . . 0.0 111.251 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.488 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -97.12 163.15 20.58 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.27 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.4 Cg_endo -54.99 81.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.82 2.346 . . . . 0.0 112.181 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.3 t70 96.25 6.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.647 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 9.5 ttp180 -137.38 93.95 2.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.677 0.275 . . . . 0.0 110.908 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -88.84 104.7 17.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.834 0.349 . . . . 0.0 110.487 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.65 HD11 HD12 ' A' ' 6' ' ' ILE . 2.2 tt -110.25 130.87 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.292 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.14 118.59 37.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.509 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -108.62 114.19 27.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.033 0.444 . . . . 0.0 111.862 -178.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TRP . . . . . 0.412 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 9.2 m0 -114.32 122.42 46.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.906 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.777 ' CD2' HG11 ' A' ' 122' ' ' VAL . 8.9 m-30 -114.05 116.94 29.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.762 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.725 ' NE1' HG11 ' A' ' 50' ' ' VAL . 20.0 m95 -106.64 148.34 28.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.83 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 66' ' ' SER . 48.1 tp -93.03 138.55 31.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.441 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.822 HG13 ' HB2' ' A' ' 64' ' ' HIS . 36.5 t -121.4 145.7 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.248 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.77 -15.71 11.86 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -163.33 162.3 25.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.594 1.088 . . . . 0.0 112.353 -179.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.562 ' CH2' ' CB ' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -157.66 123.45 4.66 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 178.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.562 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.55 146.52 32.57 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.551 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.0 -120.79 24.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.21 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 41.1 mt-10 -135.06 135.06 22.2 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.4 0.143 . . . . 0.0 110.931 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PRO . . . . . 0.7 ' CA ' HD11 ' A' ' 60' ' ' ILE . 2.9 Cg_exo -76.41 128.96 10.74 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.017 2.478 . . . . 0.0 111.224 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . 0.619 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 11.6 p-90 -129.72 -61.35 1.01 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.118 0.485 . . . . 0.0 111.733 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 40.68 -95.52 0.01 OUTLIER Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.101 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 168.24 69.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.909 0.385 . . . . 0.0 110.71 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.736 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -95.06 -38.65 10.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.696 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.18 -125.55 1.46 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.732 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.417 ' O ' ' HB ' ' A' ' 21' ' ' THR . 12.0 mp0 -78.59 126.51 82.67 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 111.414 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -43.43 144.08 2.14 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.006 2.47 . . . . 0.0 112.797 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.4 ' CA ' ' HE1' ' A' ' 19' ' ' PHE . . . -134.09 177.53 19.06 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.295 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -124.12 157.46 34.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.499 0.19 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -59.38 106.86 0.49 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.784 0.326 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -120.46 159.12 25.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.606 ' HB2' HG12 ' A' ' 108' ' ' VAL . 2.4 p -75.13 118.19 17.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.498 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . 0.763 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -71.42 -18.59 62.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.429 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 106' ' ' SER . 10.8 p -61.29 -12.08 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.653 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.47 50.81 0.85 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.192 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.883 HD11 ' CG2' ' A' ' 123' ' ' ILE . 1.0 OUTLIER -61.94 150.61 37.22 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.739 0.304 . . . . 0.0 111.054 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 1.2 t-20 -108.94 108.98 19.94 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.475 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.45 -18.03 61.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.161 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.98 -47.97 15.32 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -66.97 -29.26 69.07 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.46 -179.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.6 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -89.87 173.47 5.8 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.52 127.85 27.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 121.84 1.693 . . . . 0.0 112.283 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.0 Cg_endo -69.14 -35.96 13.43 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.657 2.238 . . . . 0.0 112.636 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -72.01 -9.75 58.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.982 0.42 . . . . 0.0 111.41 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -106.63 23.0 14.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLU . . . . . 0.6 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.13 -30.66 0.9 Allowed Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.3 Cg_exo -43.19 -35.13 4.82 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.971 1.78 . . . . 0.0 113.466 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.777 HG11 ' CD2' ' A' ' 84' ' ' PHE . 37.6 t -77.86 -51.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.266 0.555 . . . . 0.0 110.381 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.883 ' CG2' HD11 ' A' ' 110' ' ' LEU . 33.4 mm -64.93 -32.3 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.321 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -27.17 39.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.885 0.374 . . . . 0.0 110.77 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.22 -50.83 9.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.623 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.681 HD12 ' CD2' ' A' ' 110' ' ' LEU . 2.8 tm? -78.08 -27.04 48.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.399 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HB2' HG22 ' A' ' 123' ' ' ILE . 53.1 tttp -54.94 -42.38 72.21 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.158 0.504 . . . . 0.0 110.464 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 -63.74 -12.96 39.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.593 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 126' ' ' LEU . 2.6 mp . . . . . 0 C--O 1.231 0.085 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.042 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 mmm . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.786 0.327 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.41 106.44 16.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -139.97 142.85 36.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 1.067 HD12 HD11 ' A' ' 6' ' ' ILE . 0.9 OUTLIER -146.04 134.48 21.96 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.986 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.466 ' C ' HD12 ' A' ' 6' ' ' ILE . 15.6 mt-30 -102.63 152.86 20.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.35 0.595 . . . . 0.0 111.937 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.067 HD11 HD12 ' A' ' 4' ' ' LEU . 4.7 mp -146.5 126.82 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.643 179.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.048 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.9 125.56 44.14 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.6 m -133.78 162.58 39.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 C-N-CA 120.169 -0.612 . . . . 0.0 112.131 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.451 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.69 116.04 0.99 Allowed Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.818 179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.021 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.91 109.05 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.712 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -71.15 126.67 31.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.94 0.4 . . . . 0.0 111.613 -178.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -91.18 123.0 34.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.474 -179.966 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.5 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.0 t-20 -79.91 -172.45 3.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.622 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.45 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.1 tm-20 -81.8 4.29 22.72 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.463 -1.244 . . . . 0.0 112.418 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -139.5 51.83 1.74 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.806 0.336 . . . . 0.0 111.324 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.2 p30 45.78 24.32 0.21 Allowed 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.439 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.436 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 21.4 pt-20 -115.86 137.45 52.09 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.021 HG21 HG22 ' A' ' 10' ' ' ILE . 7.3 mt -105.88 139.59 26.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.324 0.583 . . . . 0.0 112.146 -178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.489 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 1.1 t80 -85.31 112.43 20.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.331 179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.534 HG21 ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -128.73 149.93 33.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.921 179.907 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.699 HG22 ' OE2' ' A' ' 98' ' ' GLU . 31.2 p -70.63 111.5 6.16 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 36.6 ttp180 -134.04 119.74 19.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.224 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 15.3 mtp180 47.71 26.15 0.82 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.526 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.745 ' HB2' ' HG2' ' A' ' 100' ' ' GLN . . . 46.6 -168.78 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.823 0.344 . . . . 0.0 111.445 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.41 ' HB2' ' HB2' ' A' ' 101' ' ' PRO . . . -91.12 -29.77 17.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.061 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -162.33 33.62 0.11 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.824 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.605 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . . . -96.21 -167.63 1.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.99 -36.22 6.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.34 86.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.917 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -79.72 -19.35 49.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.456 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -96.37 31.17 2.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.348 . . . . 0.0 110.995 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 34' ' ' GLU . 3.1 tmtm? -106.29 26.3 9.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.336 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.611 HD13 ' HB3' ' A' ' 111' ' ' ASN . 2.7 tt -63.11 74.67 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.775 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.433 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.3 OUTLIER -117.32 -173.27 2.38 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.014 0.435 . . . . 0.0 111.844 -179.444 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.657 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -119.33 168.49 9.9 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.632 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.623 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 95.3 Cg_endo -81.92 166.74 16.8 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.437 2.758 . . . . 0.0 113.306 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.629 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.73 -5.77 54.32 Favored Glycine 0 CA--C 1.522 0.53 0 CA-C-N 115.607 -0.724 . . . . 0.0 114.384 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -59.25 159.8 18.59 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 117.23 0.515 . . . . 0.0 113.332 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.11 -2.19 0.73 Allowed 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 178.895 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.048 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -49.97 -27.91 4.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 121.544 0.688 . . . . 0.0 110.823 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.561 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -43.53 -61.49 1.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.678 -1.146 . . . . 0.0 111.253 179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.516 ' C ' ' O ' ' A' ' 41' ' ' GLU . 7.4 mmt 9.64 -81.1 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.612 0 O-C-N 123.826 0.703 . . . . 0.0 112.582 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.34 32.64 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.985 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.424 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -92.51 -170.67 2.54 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 120.713 0.292 . . . . 0.0 111.06 -179.847 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.844 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -101.22 152.95 38.04 Favored Pre-proline 0 C--N 1.332 -0.171 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.284 179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.844 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.89 -24.78 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.782 2.321 . . . . 0.0 112.618 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.632 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.0 mp0 -102.18 -42.21 6.13 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -80.3 -18.39 49.4 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.674 0.25 . . . . 0.0 111.674 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.802 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -57.41 -49.93 74.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.792 0.33 . . . . 0.0 111.06 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.793 HG12 ' CB ' ' A' ' 7' ' ' ALA . 0.7 OUTLIER -78.45 -47.87 23.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.719 179.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.6 t -56.7 -36.02 47.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.934 -0.576 . . . . 0.0 111.247 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.33 -52.01 9.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.649 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.467 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.0 mm-40 -63.43 -22.1 66.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.689 179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.782 HD21 ' CD2' ' A' ' 64' ' ' HIS . 1.3 tp -58.38 -44.99 89.15 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.755 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -67.65 -31.33 71.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.187 0.518 . . . . 0.0 109.681 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.1 tm-20 -77.4 -25.77 51.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.243 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.27 5.84 26.02 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -178.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.752 ' O ' HG23 ' A' ' 60' ' ' ILE . 3.2 t -134.29 -45.1 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.987 0.423 . . . . 0.0 110.111 178.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.587 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 62.4 -20.4 0.06 OUTLIER Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.768 -0.651 . . . . 0.0 114.664 179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.752 HG23 ' O ' ' A' ' 58' ' ' VAL . 0.1 OUTLIER -88.73 -176.06 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 CA-C-O 120.961 0.41 . . . . 0.0 111.629 -179.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.485 ' N ' HG13 ' A' ' 60' ' ' ILE . 0.7 OUTLIER -115.49 87.9 18.16 Favored Pre-proline 0 N--CA 1.441 -0.877 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.162 179.736 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.674 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 2.6 Cg_endo -113.28 145.59 0.03 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 123.611 2.874 . . . . 0.0 113.789 -177.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.453 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 36.3 mt-30 -74.9 79.89 2.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 175.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.989 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -122.05 126.98 49.67 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.172 -1.377 . . . . 0.0 111.072 -176.054 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.489 ' O ' ' O ' ' A' ' 86' ' ' LEU . 3.1 t80 179.77 166.91 1.2 Allowed 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.77 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 1.7 m 87.31 155.39 0.07 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.644 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.738 HD13 ' HD3' ' A' ' 70' ' ' LYS . 1.4 pp -110.85 137.41 48.53 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.953 0.406 . . . . 0.0 111.308 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.53 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -91.21 -37.55 13.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.019 179.584 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.53 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.2 tt0 -171.77 144.42 1.8 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.626 -0.716 . . . . 0.0 110.45 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.738 ' HD3' HD13 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.2 132.12 22.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.345 179.535 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.79 HD21 HG22 ' A' ' 122' ' ' VAL . 2.4 pp -141.0 151.09 43.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.996 0.426 . . . . 0.0 111.336 -179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HB2' HG23 ' A' ' 81' ' ' THR . 16.4 tt0 -129.93 109.94 11.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.467 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -128.22 149.75 50.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.739 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -121.15 129.48 53.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.18 0.514 . . . . 0.0 111.22 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.7 m-85 -78.81 163.21 61.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.546 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.482 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.3 Cg_endo -50.72 83.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.227 2.618 . . . . 0.0 112.238 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.482 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 21.1 m-20 93.98 15.45 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.339 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.505 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 10.5 ttp180 -137.43 150.21 47.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.365 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -126.95 113.47 16.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.825 0.345 . . . . 0.0 111.006 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.909 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 2.0 tt -124.22 119.44 56.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.977 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.46 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -106.35 118.82 37.64 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.035 -0.529 . . . . 0.0 109.82 179.029 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.741 HD23 ' HB ' ' A' ' 6' ' ' ILE . 11.5 mt -118.39 114.36 22.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.964 0.412 . . . . 0.0 111.798 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.46 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.5 m0 -107.64 122.31 46.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.009 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.631 ' CE2' HG11 ' A' ' 122' ' ' VAL . 3.2 m-30 -104.54 120.16 40.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.033 0.444 . . . . 0.0 110.513 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.707 ' CE2' HG11 ' A' ' 50' ' ' VAL . 16.6 m95 -106.23 149.09 27.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.049 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.68 HD13 ' N ' ' A' ' 87' ' ' VAL . 3.5 tm? -95.52 138.6 32.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.551 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.989 HG22 ' ND1' ' A' ' 64' ' ' HIS . 39.1 t -123.4 145.85 29.71 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.769 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.117 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -110.57 -26.71 9.32 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.3 OUTLIER -162.51 161.71 27.1 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 118.491 0.587 . . . . 0.0 111.41 -178.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.702 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -156.91 124.74 5.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.266 178.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.537 ' O ' HD12 ' A' ' 60' ' ' ILE . 75.3 mt-10 -73.14 142.69 47.45 Favored 'General case' 0 C--O 1.231 0.096 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.254 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.15 -143.38 26.11 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.704 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.454 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.2 tt0 -107.52 138.01 19.84 Favored Pre-proline 0 C--N 1.329 -0.296 0 N-CA-C 110.402 -0.221 . . . . 0.0 110.402 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.598 ' HA ' HG21 ' A' ' 60' ' ' ILE . 6.6 Cg_exo -74.89 128.97 12.0 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.82 2.347 . . . . 0.0 111.598 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.674 ' CD1' HG22 ' A' ' 60' ' ' ILE . 52.0 p-90 -121.23 -62.62 1.41 Allowed 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.642 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.93 -97.68 0.01 OUTLIER Glycine 0 CA--C 1.52 0.393 0 C-N-CA 121.096 -0.573 . . . . 0.0 113.21 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 tttt 173.59 39.43 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 120.724 0.297 . . . . 0.0 111.096 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.699 ' OE2' HG22 ' A' ' 21' ' ' THR . 15.7 pt-20 -57.87 -49.39 76.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.798 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 148.86 -68.08 0.36 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.466 -0.874 . . . . 0.0 113.118 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.745 ' HG2' ' HB2' ' A' ' 24' ' ' ALA . 1.4 mt-30 -117.72 113.27 38.26 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.033 0.444 . . . . 0.0 111.746 -179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.41 ' HB2' ' HB2' ' A' ' 25' ' ' ALA . 53.6 Cg_exo -43.6 146.15 1.47 Allowed 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.077 2.518 . . . . 0.0 112.686 179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.17 177.39 17.69 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.811 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 21.6 tp10 -124.4 157.18 35.72 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.467 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.8 OUTLIER -67.65 106.44 2.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.91 0.386 . . . . 0.0 110.17 -179.891 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -120.23 163.22 18.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.211 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.5 t -83.43 114.84 21.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.444 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.602 ' O ' HD13 ' A' ' 107' ' ' LEU . 0.2 OUTLIER -60.66 -18.77 55.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.458 -179.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 108' ' ' VAL . 21.2 t -62.89 -8.85 3.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.656 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -133.64 51.68 0.84 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.738 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.671 HD23 HD12 ' A' ' 123' ' ' ILE . 6.9 tp -62.18 150.16 39.55 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.652 0.263 . . . . 0.0 110.688 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.611 ' HB3' HD13 ' A' ' 33' ' ' LEU . 1.3 t-20 -107.26 97.31 7.08 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.48 -22.58 61.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.211 178.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -78.98 -44.91 21.38 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.401 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.62 -42.74 86.31 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.199 -179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.529 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.55 174.32 6.23 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.614 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.5 Cg_endo -54.07 127.74 26.97 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.889 1.726 . . . . 0.0 112.233 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -69.03 -36.28 13.06 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.679 2.252 . . . . 0.0 112.503 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.617 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -71.13 -9.67 58.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.42 . . . . 0.0 111.339 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.5 m-20 -104.37 21.61 16.33 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.798 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -73.22 -31.29 1.4 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 -179.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.8 Cg_exo -43.83 -32.97 4.68 Favored 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 121.833 1.689 . . . . 0.0 113.003 -178.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.79 HG22 HD21 ' A' ' 71' ' ' LEU . 50.0 t -78.02 -51.1 18.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.121 0.486 . . . . 0.0 110.504 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.895 HG22 ' HB2' ' A' ' 127' ' ' LYS . 23.4 mm -69.17 -30.73 47.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.623 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.78 -27.61 42.68 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.906 0.384 . . . . 0.0 110.628 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.6 mmtp -80.43 -53.11 6.89 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.941 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.717 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.5 tm? -78.19 -33.19 50.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.771 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.895 ' HB2' HG22 ' A' ' 123' ' ' ILE . 31.0 ttpt -53.41 -42.84 67.41 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.133 0.492 . . . . 0.0 110.837 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.24 -7.36 29.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.83 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.528 0.1 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.32 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.909 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A 5011 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 5012 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 tmm? . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.842 0.353 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 15.0 tttm -91.23 146.15 24.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.99 126.76 20.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.439 HD11 " H1'" ' A' ' 131' ' ' 8OG . 3.1 pp -146.1 122.49 10.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.939 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.5 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 14.2 mt-30 -102.85 155.37 18.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.41 0.624 . . . . 0.0 112.391 -179.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.606 HD11 " H4'" ' A' ' 131' ' ' 8OG . 3.6 mp -146.99 129.72 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.536 178.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.994 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.67 125.38 44.02 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.515 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.9 m -144.28 162.27 14.86 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.254 -0.578 . . . . 0.0 111.718 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.446 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -149.65 132.14 3.92 Favored Glycine 0 N--CA 1.445 -0.705 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.006 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.059 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.85 114.49 8.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.736 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.1 mt -71.38 123.24 25.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-O 120.96 0.409 . . . . 0.0 111.513 -178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.405 ' HA ' HG13 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -84.95 122.86 29.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.684 -179.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.465 ' CG ' ' CH2' ' A' ' 90' ' ' TRP . 14.7 t30 -82.34 -172.21 3.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.027 -0.988 . . . . 0.0 112.087 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.401 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.3 tt0 -81.61 0.99 35.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.085 -1.416 . . . . 0.0 112.431 -179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -139.74 52.16 1.71 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.798 0.332 . . . . 0.0 111.432 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 47.56 21.17 0.22 Allowed 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.588 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -111.79 153.28 26.78 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.059 HG21 HG22 ' A' ' 10' ' ' ILE . 4.9 mt -123.61 141.87 42.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.351 0.596 . . . . 0.0 112.438 -178.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.472 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.3 OUTLIER -87.13 117.86 26.15 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.917 179.268 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.789 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -129.04 145.2 36.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.567 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.458 HG22 ' O ' ' A' ' 100' ' ' GLN . 68.4 p -70.78 111.84 6.53 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.23 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.464 ' HG3' HD12 ' A' ' 33' ' ' LEU . 21.4 ttp180 -142.37 144.93 33.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.046 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.571 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.1 OUTLIER 47.71 -109.75 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.033 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 168.4 -170.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.857 0.36 . . . . 0.0 111.007 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -104.89 -30.42 9.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.848 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -132.8 -45.94 0.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.733 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -71.75 -166.11 0.19 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.032 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.464 ' CE1' ' HB3' ' A' ' 30' ' ' ALA . 83.8 t60 -95.62 -86.54 0.3 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.894 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 46.47 29.09 0.83 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.837 0.351 . . . . 0.0 111.382 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.464 ' HB3' ' CE1' ' A' ' 28' ' ' HIS . . . -58.22 -23.21 54.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.5 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -106.29 30.32 6.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.779 0.323 . . . . 0.0 111.318 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.407 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.22 26.04 10.6 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.409 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.893 HD13 ' HB3' ' A' ' 111' ' ' ASN . 7.2 tt -64.01 74.76 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.88 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.789 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.8 OUTLIER -123.59 -171.22 2.27 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.896 0.379 . . . . 0.0 111.5 -179.599 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.721 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.3 168.58 9.68 Favored Pre-proline 0 CA--C 1.531 0.219 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.619 -179.524 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.515 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 92.0 Cg_endo -82.66 167.37 14.95 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.689 2.926 . . . . 0.0 113.307 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.14 -5.24 52.65 Favored Glycine 0 CA--C 1.521 0.46 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.067 179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.82 166.51 17.4 Favored Glycine 0 CA--C 1.521 0.452 0 C-N-CA 121.274 -0.488 . . . . 0.0 113.263 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.29 0.25 1.38 Allowed 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 179.104 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.994 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -49.9 -29.07 4.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.682 0.753 . . . . 0.0 110.542 179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.596 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -44.07 -60.37 1.9 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.964 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 8.05 -80.27 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.928 0.767 . . . . 0.0 112.511 179.451 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -178.66 32.71 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.844 -0.694 . . . . 0.0 112.725 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 3.6 mp0 -88.58 -174.11 4.43 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.796 0.331 . . . . 0.0 111.078 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.843 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -96.8 153.79 38.55 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.239 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.843 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.86 -25.18 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.805 2.337 . . . . 0.0 112.496 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.539 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mt-10 -104.02 -40.31 6.24 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.398 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -80.25 -6.79 58.46 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.859 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.52 -56.01 24.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.896 0.379 . . . . 0.0 110.812 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.784 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.28 -48.33 23.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.872 179.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.4 t -51.44 -35.8 16.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.016 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.24 -52.26 8.93 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.255 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.506 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.3 mm-40 -66.27 -22.69 66.31 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.707 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 58' ' ' VAL . 10.9 tp -58.01 -44.3 87.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.697 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.43 -28.41 61.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.055 0.455 . . . . 0.0 109.885 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -77.1 -28.07 54.34 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.972 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.487 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.7 mp0 -108.39 6.94 26.8 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -178.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.936 HG12 HG13 ' A' ' 60' ' ' ILE . 60.9 t -133.18 -44.01 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 179.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.609 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.85 -39.12 0.24 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.573 -0.74 . . . . 0.0 114.264 178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.936 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.34 -176.16 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 120.959 0.409 . . . . 0.0 110.847 -179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -113.31 88.77 13.32 Favored Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.694 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.744 ' HG3' HG11 ' A' ' 58' ' ' VAL . 2.8 Cg_endo -110.46 143.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.446 0 C-N-CA 123.402 2.735 . . . . 0.0 113.679 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 33.3 mt-30 -74.67 79.9 2.02 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 105.434 -2.061 . . . . 0.0 105.434 175.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.817 ' CB ' HG13 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -122.37 132.08 54.2 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.089 -1.414 . . . . 0.0 111.165 -175.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -179.82 -133.55 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.294 -179.788 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.465 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.5 OUTLIER 55.23 167.72 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.017 0.437 . . . . 0.0 111.754 179.398 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.682 ' O ' HD23 ' A' ' 67' ' ' LEU . 6.7 tt -131.7 108.73 9.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.897 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.536 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.85 -44.29 32.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.037 0.446 . . . . 0.0 110.253 179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.536 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.8 tt0 -171.6 156.89 4.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.316 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.09 106.24 4.55 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.644 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.823 ' HB2' HG22 ' A' ' 122' ' ' VAL . 0.2 OUTLIER -96.77 124.88 40.88 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.916 0.389 . . . . 0.0 111.284 -179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -123.42 109.96 14.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.413 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.602 ' CD1' HD23 ' A' ' 71' ' ' LEU . 1.8 p90 -138.55 149.55 45.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.828 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.463 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 3.7 pt-20 -121.11 122.15 39.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.089 0.471 . . . . 0.0 111.248 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.491 ' O ' ' N ' ' A' ' 77' ' ' ASP . 4.5 m-85 -84.99 162.86 48.23 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.482 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.456 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.7 Cg_endo -50.81 81.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 123.011 2.474 . . . . 0.0 112.224 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 75' ' ' PHE . 12.3 m-20 89.58 12.88 0.06 Allowed 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.554 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 24.3 ttp180 -137.35 93.7 2.84 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.705 0.288 . . . . 0.0 110.786 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.463 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.8 t-80 -81.49 110.74 17.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.957 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.571 ' CG2' ' N2 ' ' A' ' 131' ' ' 8OG . 1.8 tp -114.0 118.52 58.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.913 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.519 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -111.72 118.77 36.53 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.763 179.12 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.44 HD23 ' HB ' ' A' ' 6' ' ' ILE . 11.8 mt -122.25 114.29 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.929 0.395 . . . . 0.0 111.873 -179.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.519 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.3 m0 -106.99 122.32 46.21 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.057 178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.596 ' CD2' HG11 ' A' ' 122' ' ' VAL . 3.5 m-30 -103.98 112.99 26.2 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.776 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.784 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 44.4 m95 -94.68 148.68 22.03 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.212 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.8 tp -99.85 103.05 14.63 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.453 0.644 . . . . 0.0 111.324 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.817 HG13 ' CB ' ' A' ' 64' ' ' HIS . 11.6 t -80.84 146.08 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.687 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.303 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -113.77 -26.23 8.3 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 7.1 tpt180 -162.64 162.05 26.85 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 118.416 0.553 . . . . 0.0 111.44 -178.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.722 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -155.85 124.32 5.9 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.449 178.779 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -73.07 140.34 47.13 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.914 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.34 -121.68 26.35 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 2.1 tt0 -132.84 142.13 43.61 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.506 0.193 . . . . 0.0 110.783 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.494 ' CA ' HD11 ' A' ' 60' ' ' ILE . 3.5 Cg_exo -75.8 128.84 11.16 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.824 2.349 . . . . 0.0 111.178 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.662 ' HE1' HG23 ' A' ' 60' ' ' ILE . 18.4 p-90 -126.24 -64.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.489 -0.484 . . . . 0.0 112.262 -179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.506 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.57 -94.9 0.01 OUTLIER Glycine 0 CA--C 1.52 0.399 0 CA-C-N 115.817 -0.629 . . . . 0.0 113.062 -178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.419 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.5 OUTLIER 170.99 37.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 120.674 0.273 . . . . 0.0 111.35 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -50.33 -29.96 11.04 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.638 0.256 . . . . 0.0 110.794 179.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.09 -28.77 7.44 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.533 -0.841 . . . . 0.0 113.741 179.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.458 ' O ' HG22 ' A' ' 21' ' ' THR . 1.0 OUTLIER -140.03 106.04 6.77 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 117.206 0.503 . . . . 0.0 112.003 -179.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -43.56 146.28 1.4 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 123.112 2.541 . . . . 0.0 112.66 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -133.81 177.29 19.19 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.664 -0.779 . . . . 0.0 113.1 -179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.27 157.42 44.45 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.441 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -68.68 105.98 2.47 Favored 'General case' 0 N--CA 1.463 0.216 0 C-N-CA 120.706 -0.398 . . . . 0.0 110.183 -179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.7 ptp -120.52 163.29 18.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.012 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.33 114.98 16.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.474 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.836 ' O ' HD13 ' A' ' 107' ' ' LEU . 1.4 tm? -71.42 -18.74 62.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.407 -179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.41 HG22 ' O ' ' A' ' 108' ' ' VAL . 10.8 p -58.0 -13.63 2.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.619 179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.48 55.16 0.63 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.967 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.724 HD22 HD12 ' A' ' 123' ' ' ILE . 4.8 tt -61.95 150.54 37.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.896 0.379 . . . . 0.0 110.742 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.893 ' HB3' HD13 ' A' ' 33' ' ' LEU . 2.8 t-20 -95.22 100.07 11.92 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.48 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -20.93 61.34 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.14 178.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.98 -45.15 20.88 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.087 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.411 ' HB3' ' HB2' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.78 -41.0 88.4 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.241 -179.426 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.487 ' CB ' ' HD2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -78.37 174.2 6.4 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.08 127.56 26.2 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 121.82 1.68 . . . . 0.0 112.301 -178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.403 ' O ' ' HB3' ' A' ' 120' ' ' GLU . 52.6 Cg_endo -69.27 -34.66 15.7 Favored 'Trans proline' 0 C--N 1.349 0.577 0 C-N-CA 122.762 2.308 . . . . 0.0 112.415 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.766 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -72.49 -9.56 58.7 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.377 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -103.38 20.54 17.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.955 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.549 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -70.29 -31.16 2.15 Favored Pre-proline 0 CA--C 1.536 0.43 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -178.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.549 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 90.2 Cg_exo -43.99 -37.81 9.67 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 121.704 1.603 . . . . 0.0 113.429 -178.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.823 HG22 ' HB2' ' A' ' 71' ' ' LEU . 52.2 t -77.81 -51.02 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.185 0.517 . . . . 0.0 110.6 179.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.724 HD12 HD22 ' A' ' 110' ' ' LEU . 43.1 mm -66.19 -30.03 48.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.563 -179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -29.99 57.76 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.967 0.413 . . . . 0.0 110.254 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -78.25 -50.79 11.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.509 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.858 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.4 tm? -78.41 -19.93 52.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.831 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.646 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.5 tttt -74.45 -42.61 58.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.235 0.54 . . . . 0.0 110.522 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.74 -9.97 42.22 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.01 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.696 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.138 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.639 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.766 ' O6 ' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A 5023 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A 5024 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.6 ptm . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.783 0.325 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.5 tptm -103.63 147.11 27.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.881 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -139.81 129.04 23.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.721 179.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.808 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.3 pp -146.2 136.93 24.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.329 -179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.749 ' C ' HD12 ' A' ' 6' ' ' ILE . 22.1 mt-30 -106.64 153.63 22.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.126 0.489 . . . . 0.0 111.648 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.808 HD11 ' CD1' ' A' ' 4' ' ' LEU . 4.3 mp -146.32 118.84 2.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.695 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.074 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.94 125.83 44.53 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -140.08 162.6 24.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.559 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.431 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.58 125.69 2.7 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.134 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.818 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.81 107.26 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.723 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.23 125.33 29.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-O 120.898 0.38 . . . . 0.0 111.496 -178.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.05 124.44 34.29 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.581 -179.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.472 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 13.5 t30 -79.32 -172.22 3.09 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.834 179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -82.57 -1.54 51.02 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.353 -1.294 . . . . 0.0 112.411 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -129.1 36.15 4.21 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.844 0.312 . . . . 0.0 111.844 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 63.99 7.29 3.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.601 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 19.2 pt-20 -100.95 146.11 27.8 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.818 HG21 HG22 ' A' ' 10' ' ' ILE . 6.4 mt -110.61 138.7 37.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 111.833 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.493 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.2 OUTLIER -86.14 122.52 30.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.686 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.681 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -126.42 162.2 30.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.113 -0.494 . . . . 0.0 109.804 179.33 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.593 HG22 ' OE1' ' A' ' 98' ' ' GLU . 11.7 p -70.52 154.86 41.44 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.701 0.286 . . . . 0.0 110.392 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 3.8 ttt180 -148.04 104.71 3.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.854 0.359 . . . . 0.0 111.197 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.9 ttm180 50.33 -103.18 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.225 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.71 -67.62 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.839 0.352 . . . . 0.0 111.038 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -175.64 -40.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 38.5 p30 -140.02 -175.4 4.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.925 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 63.67 158.23 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -79.83 87.86 5.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.978 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.6 mmt -142.75 41.09 1.56 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.828 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -71.64 -8.91 57.04 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.68 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.8 OUTLIER -94.91 27.92 2.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.632 0.253 . . . . 0.0 111.273 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 8.0 tptt -114.16 25.96 10.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.045 0.45 . . . . 0.0 111.66 -179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 2.2 tt -70.72 72.42 0.53 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.582 179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.681 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -106.73 -167.71 1.32 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.995 0.426 . . . . 0.0 111.913 -179.355 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.541 ' HB2' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -119.37 168.51 9.88 Favored Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.488 -179.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.615 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 91.4 Cg_endo -80.39 167.34 19.39 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.524 2.816 . . . . 0.0 113.327 -179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.639 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.45 -5.79 52.24 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-N 115.594 -0.73 . . . . 0.0 114.006 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.48 163.22 18.35 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.207 -0.52 . . . . 0.0 112.852 179.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.53 -0.18 0.91 Allowed 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 122.803 0.441 . . . . 0.0 112.1 179.51 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.074 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -50.83 -28.83 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.63 0.728 . . . . 0.0 110.424 179.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.602 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -42.38 -54.65 3.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.266 -1.334 . . . . 0.0 110.934 179.737 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.536 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 0.9 -75.33 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 O-C-N 123.966 0.791 . . . . 0.0 112.546 179.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 173.04 35.51 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.806 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.423 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.13 -172.47 3.67 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.777 0.323 . . . . 0.0 111.08 -179.841 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.838 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -96.44 153.03 39.01 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.309 179.851 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.838 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.84 -25.03 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.781 2.32 . . . . 0.0 112.52 179.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.53 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.3 mt-10 -104.04 -39.38 6.58 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.569 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -80.11 -12.87 59.63 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.685 0.254 . . . . 0.0 111.685 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.843 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.45 -52.75 64.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.875 0.369 . . . . 0.0 110.806 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.949 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.37 -48.34 22.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.21 179.829 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 47' ' ' GLU . 36.3 t -57.1 -38.47 60.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.675 -178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -74.79 -52.06 12.46 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.786 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.533 ' HB2' HG22 ' A' ' 40' ' ' ILE . 2.9 mm-40 -63.08 -20.06 65.0 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.722 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.954 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.3 tp -60.46 -44.68 95.63 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.905 0.383 . . . . 0.0 110.926 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -68.54 -30.08 68.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.064 179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -77.3 -25.63 51.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.678 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.47 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.85 6.65 25.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -178.388 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.979 HG12 HG13 ' A' ' 60' ' ' ILE . 10.0 t -133.81 -44.04 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.029 0.442 . . . . 0.0 110.721 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.575 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 56.67 6.33 1.63 Allowed Glycine 0 CA--C 1.525 0.665 0 N-CA-C 114.846 0.699 . . . . 0.0 114.846 178.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.979 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.37 -166.8 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 118.087 0.943 . . . . 0.0 110.406 179.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.628 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.6 OUTLIER -113.86 88.64 14.56 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.302 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.542 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 20.4 Cg_endo -111.92 137.33 0.04 OUTLIER 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 123.529 2.819 . . . . 0.0 114.686 -177.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -74.8 79.15 2.09 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.954 ' CE1' HD11 ' A' ' 54' ' ' LEU . 1.5 t-160 -117.09 124.05 48.28 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 113.901 -1.5 . . . . 0.0 110.358 -176.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.556 ' O ' ' O ' ' A' ' 86' ' ' LEU . 4.5 t80 179.78 163.61 1.03 Allowed 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.901 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.461 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 85.64 154.57 0.08 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.447 179.661 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.732 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.2 pp -107.68 121.06 43.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.89 0.376 . . . . 0.0 111.616 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.531 ' CD1' ' HB3' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -76.81 -39.0 52.85 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.87 138.26 1.05 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.799 179.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.29 103.99 4.2 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.583 0.23 . . . . 0.0 110.746 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.549 HD12 ' C ' ' A' ' 71' ' ' LEU . 4.4 pp -105.81 152.54 23.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.932 0.396 . . . . 0.0 111.062 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -135.38 117.39 15.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.723 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -136.33 152.06 50.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.509 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.02 139.96 52.58 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.198 0.523 . . . . 0.0 111.397 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.467 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.4 OUTLIER -105.63 163.18 17.63 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.278 179.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.53 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.9 Cg_endo -55.63 81.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.819 2.346 . . . . 0.0 112.15 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.53 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 4.9 t70 97.08 6.0 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.676 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.574 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 12.1 ttp180 -137.32 94.84 2.98 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.702 0.287 . . . . 0.0 110.796 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.436 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 0.7 OUTLIER -91.96 101.66 14.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.836 0.351 . . . . 0.0 110.744 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.755 HG13 HD13 ' A' ' 6' ' ' ILE . 1.9 tt -103.52 142.77 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.134 0.493 . . . . 0.0 111.283 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -123.01 118.24 27.33 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.939 -0.764 . . . . 0.0 108.939 178.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.868 HD23 ' CG2' ' A' ' 122' ' ' VAL . 6.4 tp -114.49 114.03 25.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.085 0.469 . . . . 0.0 111.542 -178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.417 ' HE1' HG22 ' A' ' 81' ' ' THR . 8.7 m0 -114.15 121.8 44.87 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.83 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.658 ' CE2' HG11 ' A' ' 122' ' ' VAL . 3.5 m-30 -110.27 117.41 33.57 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.236 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.732 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 16.2 m95 -105.4 148.54 27.01 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.223 0.535 . . . . 0.0 112.343 -178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.556 ' O ' ' O ' ' A' ' 65' ' ' PHE . 28.5 tp -86.14 138.42 31.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.386 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.823 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.7 t -124.11 145.49 31.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.672 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.712 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -111.88 -24.2 10.12 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.542 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -162.76 163.18 26.87 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 119.344 0.974 . . . . 0.0 112.306 -178.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.723 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -157.81 123.26 4.53 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.749 178.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.63 ' O ' HG21 ' A' ' 60' ' ' ILE . 6.8 tt0 -74.5 149.39 40.3 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 120.447 -0.501 . . . . 0.0 111.165 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 53.62 -116.83 6.35 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.593 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 11.8 mt-10 -135.33 143.39 45.28 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.431 0.158 . . . . 0.0 110.697 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.642 ' CA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -76.43 128.76 10.59 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.816 2.344 . . . . 0.0 111.079 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.575 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 38.0 p-90 -132.25 -59.75 0.92 Allowed 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.499 ' N ' ' CE3' ' A' ' 95' ' ' TRP . . . 42.79 -94.04 0.01 OUTLIER Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.804 -0.634 . . . . 0.0 112.786 -178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.417 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER 174.77 39.63 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.786 0.327 . . . . 0.0 110.714 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.593 ' OE1' HG22 ' A' ' 21' ' ' THR . 26.4 pt-20 -57.64 -45.67 85.17 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.767 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 131.92 -43.06 1.32 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.53 -0.843 . . . . 0.0 113.248 179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.37 108.2 23.84 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.042 0.449 . . . . 0.0 111.769 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_exo -43.75 146.31 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.004 2.469 . . . . 0.0 112.51 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -128.64 177.27 17.88 Favored Glycine 0 CA--C 1.518 0.263 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.048 -179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -130.78 157.38 43.0 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.383 -0.228 . . . . 0.0 110.383 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.459 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -74.49 106.33 6.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.902 0.382 . . . . 0.0 110.295 -179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 10.1 ptp -120.42 163.24 18.19 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.13 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 16.4 p -79.28 114.98 18.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.509 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.771 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -63.21 -18.7 63.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.449 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 108' ' ' VAL . 21.3 t -63.08 -8.57 3.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.6 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -132.97 50.46 0.88 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.096 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.523 ' CD2' HD12 ' A' ' 123' ' ' ILE . 8.1 tp -62.17 150.17 39.46 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 110.388 -0.227 . . . . 0.0 110.388 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -122.46 115.84 22.93 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.573 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.59 -17.97 61.65 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.162 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -78.85 -49.06 13.55 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.075 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.5 OUTLIER -66.93 -18.74 65.52 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.447 -179.574 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.573 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.82 170.72 5.39 Favored Pre-proline 0 C--N 1.329 -0.308 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.452 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.54 127.69 27.07 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.05 1.833 . . . . 0.0 112.326 -178.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -69.16 -36.86 11.56 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.619 2.212 . . . . 0.0 112.528 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.682 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.57 -9.58 57.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.487 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.418 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 15.4 m-20 -105.8 19.11 21.07 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.776 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.555 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -66.61 -31.88 4.63 Favored Pre-proline 0 CA--C 1.534 0.343 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.0 Cg_exo -44.2 -34.74 7.21 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 121.825 1.683 . . . . 0.0 113.154 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.868 ' CG2' HD23 ' A' ' 82' ' ' LEU . 39.4 t -77.96 -51.3 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.021 0.439 . . . . 0.0 110.785 179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.829 HG22 ' HB2' ' A' ' 127' ' ' LYS . 26.2 mm -67.49 -31.94 54.9 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.349 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.42 -179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.49 -26.86 33.98 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.891 0.377 . . . . 0.0 110.657 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.12 -53.09 7.02 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.791 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.692 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.5 tm? -78.25 -31.8 49.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.761 0.315 . . . . 0.0 111.744 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.829 ' HB2' HG22 ' A' ' 123' ' ' ILE . 4.7 ttpt -53.95 -42.56 69.02 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.97 0.414 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -67.77 -9.22 42.17 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.825 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.264 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.682 ' O6 ' ' HB1' ' A' ' 118' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A 5035 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A 5036 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 120.84 0.352 . . . . 0.0 111.219 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.4 ttpm? -109.49 102.98 11.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.75 145.4 55.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.943 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.503 HD11 " O4'" ' A' ' 131' ' ' 8OG . 2.8 pp -146.1 127.84 15.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.236 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.527 ' O ' HD12 ' A' ' 6' ' ' ILE . 25.7 mt-30 -102.58 146.95 27.4 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-O 121.281 0.562 . . . . 0.0 111.696 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.929 HD13 " H4'" ' A' ' 131' ' ' 8OG . 0.8 OUTLIER -146.71 132.91 13.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.771 179.033 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.136 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.64 124.55 42.44 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.58 ' HA ' ' HA3' ' A' ' 37' ' ' GLY . 1.4 m -119.38 162.45 17.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.391 0.615 . . . . 0.0 112.089 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.434 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -149.51 106.23 0.32 Allowed Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.132 -0.94 . . . . 0.0 111.904 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.035 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.72 109.88 3.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.713 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.34 123.06 24.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.805 -178.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -86.72 124.32 32.85 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.591 -179.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.493 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.2 t-20 -81.41 -172.34 3.76 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.644 179.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 26.2 tt0 -83.34 9.18 11.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.602 -1.181 . . . . 0.0 112.487 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -141.36 52.24 1.56 Allowed 'General case' 0 C--N 1.331 -0.215 0 O-C-N 122.156 -0.34 . . . . 0.0 111.503 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.9 p30 44.71 25.79 0.16 Allowed 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.997 0.427 . . . . 0.0 111.368 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -117.93 160.16 21.91 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.035 HG21 HG22 ' A' ' 10' ' ' ILE . 9.0 mt -130.26 138.04 54.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 121.048 0.452 . . . . 0.0 111.435 -179.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.475 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -79.02 112.5 16.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.305 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.28 139.61 36.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.156 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.7 p -70.8 111.88 6.58 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.824 0.345 . . . . 0.0 110.606 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.803 ' HD2' HD22 ' A' ' 33' ' ' LEU . 9.3 ttp180 -124.4 119.13 28.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.776 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 19.2 ttm180 50.77 -106.76 0.25 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.769 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 173.45 37.74 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 111.179 179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 52.1 25.1 3.03 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.498 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.1 p30 176.62 162.55 0.41 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.884 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 62.49 -166.26 0.22 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.118 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 22.6 t-160 -118.12 113.53 21.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.869 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.23 34.37 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.846 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.2 -8.93 57.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.587 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -78.69 -1.68 35.6 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.604 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.11 26.2 10.49 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.046 0.451 . . . . 0.0 111.3 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.803 HD22 ' HD2' ' A' ' 22' ' ' ARG . 28.1 tp -58.07 86.36 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.841 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.91 -175.94 3.56 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.112 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.753 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.63 161.58 36.94 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.177 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -52.7 166.7 0.76 Allowed 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.069 2.513 . . . . 0.0 111.525 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 8' ' ' VAL . . . 100.97 58.92 0.82 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 119.857 -1.164 . . . . 0.0 113.176 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.603 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -131.66 122.96 3.55 Favored Glycine 0 C--N 1.312 -0.802 0 CA-C-N 114.941 -0.63 . . . . 0.0 112.339 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.603 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 107.92 2.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.103 0.561 . . . . 0.0 112.296 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.136 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -48.83 -28.95 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-O 121.541 0.686 . . . . 0.0 110.515 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.583 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -41.92 -69.72 0.13 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.608 -1.178 . . . . 0.0 110.779 179.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.462 ' C ' ' O ' ' A' ' 41' ' ' GLU . 13.7 mmt 22.43 -86.18 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 123.868 0.73 . . . . 0.0 112.19 179.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -166.88 27.86 0.17 Allowed Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.991 -0.623 . . . . 0.0 112.502 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.407 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 5.9 mt-10 -93.83 -177.32 4.31 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.827 0.346 . . . . 0.0 111.108 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.925 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -110.86 158.44 35.71 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.982 179.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.925 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.5 Cg_endo -43.93 -24.69 0.88 Allowed 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.809 2.339 . . . . 0.0 112.409 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.5 OUTLIER -88.85 -60.23 2.01 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.558 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -80.48 -6.83 58.75 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.799 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.74 -54.47 42.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.76 0.314 . . . . 0.0 110.826 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.797 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.31 -46.55 25.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.977 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 47' ' ' GLU . 32.6 t -55.55 -37.62 46.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.223 -179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -78.3 -52.02 9.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.998 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -64.87 -23.55 67.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.002 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.737 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -53.79 -44.63 70.28 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.532 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.91 -33.93 75.13 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.433 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -77.68 -26.12 50.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.188 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.457 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 54.2 mm-40 -108.36 4.27 24.28 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.938 HG12 HG13 ' A' ' 60' ' ' ILE . 26.0 t -134.85 -44.5 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.229 0.538 . . . . 0.0 110.117 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.14 -41.77 0.36 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.723 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.938 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.79 -176.48 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 121.133 0.492 . . . . 0.0 111.251 -179.562 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.79 88.79 14.64 Favored Pre-proline 0 N--CA 1.444 -0.758 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.17 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.82 ' HG3' HG11 ' A' ' 58' ' ' VAL . 7.2 Cg_endo -110.15 149.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.289 0 C-N-CA 123.322 2.681 . . . . 0.0 113.887 -177.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.477 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 77.7 mt-30 -74.74 79.78 2.06 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.962 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -123.56 129.27 50.94 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.305 -1.316 . . . . 0.0 110.206 -176.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' N ' ' HD1' ' A' ' 64' ' ' HIS . 3.4 t80 -176.59 -39.34 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.887 0.699 . . . . 0.0 112.887 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.456 ' CB ' ' HB3' ' A' ' 86' ' ' LEU . 51.8 m -40.74 160.87 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.526 -0.761 . . . . 0.0 111.805 -178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -115.69 119.32 35.68 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.575 -179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.539 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -86.83 -56.34 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.262 179.721 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.539 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -172.03 144.08 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.309 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.443 ' NZ ' ' CZ3' ' A' ' 83' ' ' TRP . 0.0 OUTLIER -142.21 112.46 7.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.698 0.285 . . . . 0.0 110.768 179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.792 HD21 ' HA ' ' A' ' 122' ' ' VAL . 3.7 pp -125.18 159.39 31.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.968 0.413 . . . . 0.0 111.028 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -135.35 109.93 8.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.592 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.51 ' HD2' HD13 ' A' ' 71' ' ' LEU . 30.1 p90 -125.59 151.12 46.87 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.746 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -121.12 131.29 54.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 111.114 179.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.468 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.8 m-85 -79.89 162.85 60.87 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.622 179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.499 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.9 Cg_endo -53.6 82.5 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 123.203 2.602 . . . . 0.0 112.321 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.499 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.3 OUTLIER 100.43 11.51 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 123.895 0.878 . . . . 0.0 111.232 -179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.601 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 17.5 ttp180 -137.3 150.15 47.58 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.585 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 34.6 m-70 -127.06 110.87 13.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 110.672 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.96 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 1.9 tt -120.3 120.69 63.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.369 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.552 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -103.02 118.65 37.29 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 178.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.595 HD13 HD11 ' A' ' 80' ' ' ILE . 1.1 mp -119.75 114.05 21.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.907 0.384 . . . . 0.0 111.768 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.552 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.5 m0 -110.1 122.55 47.86 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.348 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.698 ' CE1' HG11 ' A' ' 122' ' ' VAL . 2.2 m-85 -109.98 109.79 20.5 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.919 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.707 ' NE1' HG11 ' A' ' 50' ' ' VAL . 34.2 m95 -98.02 148.95 22.98 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.592 -179.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.832 HD23 ' N ' ' A' ' 87' ' ' VAL . 3.4 tt -97.83 138.5 35.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.461 0.648 . . . . 0.0 111.664 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.962 HG22 ' ND1' ' A' ' 64' ' ' HIS . 61.5 t -114.78 146.38 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.882 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.436 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -108.41 -25.69 10.85 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.477 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -163.4 165.36 24.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 118.72 0.691 . . . . 0.0 111.505 -179.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.713 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -156.57 123.36 5.16 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.387 178.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -79.1 153.69 29.95 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.064 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.56 -131.95 49.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.566 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.476 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 12.4 mt-10 -123.33 144.24 43.3 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 120.51 0.195 . . . . 0.0 110.725 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.498 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.54 128.76 10.51 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.788 2.325 . . . . 0.0 111.628 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.561 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 60.9 p-90 -133.4 -58.91 0.88 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.604 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.594 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.07 -98.02 0.01 OUTLIER Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.025 -179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.433 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 176.8 36.38 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.721 0.296 . . . . 0.0 111.022 -179.994 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -44.52 96.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.882 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.38 -68.5 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.111 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -110.86 106.37 57.6 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.957 0.408 . . . . 0.0 111.554 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -43.58 146.27 1.41 Allowed 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.016 2.477 . . . . 0.0 112.647 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.34 177.04 17.11 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.809 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.82 157.38 37.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.578 0.228 . . . . 0.0 110.568 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.411 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.5 OUTLIER -60.14 106.68 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.888 0.375 . . . . 0.0 110.258 -179.759 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -120.03 163.29 17.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.93 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 5.3 p -80.36 114.75 19.49 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.47 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.497 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -80.25 -18.68 48.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.433 -179.698 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 19.6 t -57.13 -14.34 2.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.801 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.06 53.79 0.67 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.27 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.626 HD22 HG23 ' A' ' 123' ' ' ILE . 8.5 tt -62.24 150.37 39.21 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 110.371 -0.233 . . . . 0.0 110.371 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -106.36 115.02 29.48 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.5 -17.91 61.71 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.049 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -79.03 -46.29 18.46 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.029 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -40.13 88.61 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.158 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.569 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.49 174.38 6.13 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.496 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.0 127.76 26.97 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 121.835 1.69 . . . . 0.0 112.435 -178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.17 -36.94 11.35 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.796 2.331 . . . . 0.0 112.557 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.858 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -69.33 -9.66 54.35 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.924 0.392 . . . . 0.0 111.361 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.452 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 13.2 m-20 -107.38 18.45 21.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.93 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.552 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.5 tt0 -64.78 -31.89 6.14 Favored Pre-proline 0 N--CA 1.466 0.37 0 N-CA-C 113.791 1.034 . . . . 0.0 113.791 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.552 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.3 Cg_exo -44.09 -38.77 10.94 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 121.746 1.631 . . . . 0.0 113.206 -178.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.792 ' HA ' HD21 ' A' ' 71' ' ' LEU . 76.8 t -77.66 -51.2 18.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.829 0.347 . . . . 0.0 111.828 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.626 HG23 HD22 ' A' ' 110' ' ' LEU . 32.6 mm -73.04 -43.79 57.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.19 -26.81 30.16 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 ttpp -80.32 -53.45 6.62 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.505 ' HG ' ' CZ ' ' A' ' 68' ' ' PHE . 3.5 mm? -78.47 -28.46 46.52 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.671 0.248 . . . . 0.0 111.671 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.549 ' HD3' ' HB2' ' A' ' 112' ' ' ALA . 9.9 ttpp -55.74 -42.19 75.03 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.059 0.457 . . . . 0.0 110.696 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.817 ' O ' HD12 ' A' ' 129' ' ' LEU . 62.9 ttt180 -71.45 -5.79 35.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.99 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.112 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.96 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A 5047 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A 5048 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.5 mtm . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.791 0.329 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -105.99 135.0 48.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.904 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.37 129.26 23.29 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.608 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.847 HD13 " O4'" ' A' ' 131' ' ' 8OG . 4.1 pp -146.48 139.37 25.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.913 0.387 . . . . 0.0 111.78 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.502 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 39.5 mt-30 -106.01 156.0 18.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.404 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.714 HD12 HD13 ' A' ' 82' ' ' LEU . 15.0 mt -146.74 126.51 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.357 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.905 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.17 125.2 43.3 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.1 m -144.7 156.49 14.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.999 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.408 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -146.8 124.45 1.99 Allowed Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.864 179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.084 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.57 112.45 5.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.749 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.8 OUTLIER -70.81 119.94 17.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 121.215 0.531 . . . . 0.0 111.381 -178.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.445 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -84.3 124.39 31.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.625 -179.466 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.454 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 23.0 t30 -80.91 -172.25 3.61 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.733 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.403 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 4.1 tt0 -82.91 5.4 22.0 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.45 -1.25 . . . . 0.0 112.212 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -139.44 51.23 1.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.875 0.369 . . . . 0.0 111.503 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 45.88 25.19 0.28 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.277 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 21.3 pt-20 -119.45 141.63 48.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.084 HG21 HG22 ' A' ' 10' ' ' ILE . 10.3 mt -112.51 143.52 22.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.199 0.523 . . . . 0.0 111.749 -179.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.468 ' CE1' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -90.38 121.65 32.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.352 179.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.633 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -121.22 134.72 63.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.058 179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.2 t -70.79 111.97 6.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.901 0.381 . . . . 0.0 110.889 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.824 ' HB3' HD12 ' A' ' 33' ' ' LEU . 34.9 ptt85 -136.68 131.35 33.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.768 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 30' ' ' ALA . 2.0 tpp180 53.4 -111.45 0.61 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.748 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.524 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 173.13 -167.96 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.819 0.342 . . . . 0.0 111.002 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -109.39 26.56 10.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.081 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -179.64 -41.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.811 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -73.93 -169.05 0.68 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.087 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -139.55 98.91 3.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.957 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 24.0 mmt -155.35 60.05 0.63 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.799 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . . . -65.14 -13.75 58.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.555 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.9 t-20 -84.17 6.92 20.68 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.598 -0.273 . . . . 0.0 111.688 -179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.408 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.32 26.41 10.28 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -179.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.824 HD12 ' HB3' ' A' ' 22' ' ' ARG . 0.4 OUTLIER -67.93 63.2 0.08 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.67 179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.633 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -109.42 -166.93 1.15 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.445 -179.554 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.788 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.42 168.23 10.47 Favored Pre-proline 0 CA--C 1.531 0.213 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.487 -179.361 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 35' ' ' PHE . 59.9 Cg_endo -72.62 167.21 27.72 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.34 2.693 . . . . 0.0 113.162 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.8 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.61 -5.49 54.48 Favored Glycine 0 C--O 1.223 -0.545 0 CA-C-N 115.603 -0.726 . . . . 0.0 113.971 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.37 149.3 50.16 Favored Glycine 0 C--N 1.315 -0.602 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.798 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.495 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 91.6 -0.98 0.17 Allowed 'General case' 0 C--N 1.342 0.247 0 N-CA-C 112.886 0.698 . . . . 0.0 112.886 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.905 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -49.41 -29.81 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.717 0.77 . . . . 0.0 110.584 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.61 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.7 OUTLIER -43.12 -52.71 5.33 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.04 179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.531 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 0.4 -75.03 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 O-C-N 123.928 0.768 . . . . 0.0 112.564 179.555 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 176.12 35.26 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.979 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.465 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -93.56 -171.49 2.63 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.596 0.236 . . . . 0.0 111.022 -179.948 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.813 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.04 152.58 38.4 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.294 179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.813 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.82 -24.97 0.88 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.774 2.316 . . . . 0.0 112.491 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.576 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.6 OUTLIER -104.08 -40.45 6.17 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.709 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 24.6 mm100 -80.33 -14.18 58.58 Favored 'General case' 0 C--N 1.332 -0.161 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.763 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.95 -52.33 66.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.818 0.342 . . . . 0.0 111.089 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.704 HG11 ' CE2' ' A' ' 85' ' ' TRP . 2.0 m -78.74 -49.03 21.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.632 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 47' ' ' GLU . 39.6 t -54.85 -36.02 35.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.392 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.02 -51.99 9.49 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 110.597 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.461 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 3.1 mm-40 -61.59 -22.04 64.86 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.694 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.768 HD11 ' CE1' ' A' ' 64' ' ' HIS . 0.4 OUTLIER -58.48 -44.48 89.35 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.867 179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.68 -33.87 75.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.116 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.4 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.6 tt0 -77.13 -26.93 53.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.075 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.459 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.08 6.33 26.86 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -178.634 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.943 HG12 HG13 ' A' ' 60' ' ' ILE . 48.2 t -133.41 -44.09 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.57 -0.529 . . . . 0.0 109.57 178.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.76 -40.66 0.31 Allowed Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.574 -0.739 . . . . 0.0 113.969 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.943 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.47 -177.55 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.084 0.469 . . . . 0.0 111.087 -179.623 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.22 88.86 13.24 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.058 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.749 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.6 Cg_endo -110.09 145.63 0.05 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 123.287 2.658 . . . . 0.0 114.159 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 84.2 mt-30 -74.69 79.96 2.03 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 175.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.064 ' CD2' HG22 ' A' ' 87' ' ' VAL . 1.7 t-160 -121.53 131.04 53.91 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.292 -1.322 . . . . 0.0 111.436 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.501 ' N ' ' HD2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -177.08 -133.57 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.345 -179.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 54.51 171.49 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 121.039 0.447 . . . . 0.0 111.937 179.243 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.892 HD11 ' HG2' ' A' ' 70' ' ' LYS . 7.1 tt -136.85 108.07 6.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.714 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.886 ' CE2' HD22 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.74 -44.58 32.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.261 -0.427 . . . . 0.0 109.99 179.802 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.533 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 3.0 tt0 -171.79 142.72 1.57 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.429 179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.892 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.24 103.86 4.19 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.213 179.638 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.577 ' O ' HD12 ' A' ' 71' ' ' LEU . 4.4 pp -110.33 151.75 27.04 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.955 0.407 . . . . 0.0 111.479 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -131.43 109.94 10.67 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.393 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.431 ' CZ ' ' HG2' ' A' ' 121' ' ' PRO . 8.1 p90 -127.7 152.99 47.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.747 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 3.6 pt-20 -121.23 128.83 52.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.213 0.53 . . . . 0.0 111.306 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.489 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -94.19 163.38 23.55 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.416 179.72 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.489 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 9.7 Cg_endo -52.74 82.91 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.0 2.467 . . . . 0.0 112.142 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.468 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.4 m-20 91.32 9.68 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.616 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.666 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.1 OUTLIER -137.42 93.85 2.86 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.616 0.246 . . . . 0.0 110.67 179.484 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 10.1 t-160 -89.8 98.78 11.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.863 0.363 . . . . 0.0 110.673 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.988 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 2.0 tt -106.04 134.46 47.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.221 -179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -111.24 118.57 36.28 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.907 HD23 ' CG2' ' A' ' 122' ' ' VAL . 4.1 tp -111.7 113.91 26.59 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.017 0.437 . . . . 0.0 111.393 -179.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -111.3 121.98 46.66 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.76 179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.695 ' CD2' HG11 ' A' ' 122' ' ' VAL . 4.0 m-30 -112.73 111.24 21.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.011 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.704 ' CE2' HG11 ' A' ' 50' ' ' VAL . 14.6 m95 -96.14 149.12 21.98 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.056 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 65' ' ' PHE . 9.2 tp -97.63 103.31 15.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.515 0.674 . . . . 0.0 112.328 -178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.064 HG22 ' CD2' ' A' ' 64' ' ' HIS . 12.1 t -81.16 145.78 8.39 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.569 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.626 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -114.63 -26.16 8.0 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.454 ' CG ' ' N ' ' A' ' 90' ' ' TRP . 15.4 ttm-85 -161.98 165.06 27.98 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 118.676 0.671 . . . . 0.0 111.782 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.749 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.7 OUTLIER -156.26 126.16 6.43 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.419 179.035 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -76.7 147.98 37.07 Favored 'General case' 0 C--O 1.231 0.087 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.94 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 57.2 -119.7 17.24 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.476 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 35.3 tt0 -134.88 144.94 52.61 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.516 0.198 . . . . 0.0 110.856 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.509 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.7 Cg_exo -76.39 128.83 10.67 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.983 2.455 . . . . 0.0 111.282 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.576 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 49.9 p-90 -135.06 -62.8 0.71 Allowed 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.284 -0.566 . . . . 0.0 112.328 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.585 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 42.98 -100.08 0.02 OUTLIER Glycine 0 CA--C 1.521 0.42 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.02 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.2 OUTLIER 172.31 38.64 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.767 0.318 . . . . 0.0 111.103 -179.946 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -58.53 -48.44 80.85 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.486 -0.325 . . . . 0.0 110.83 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 167.34 -60.84 0.21 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.494 -0.86 . . . . 0.0 112.834 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -139.02 126.34 13.1 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.119 0.485 . . . . 0.0 111.384 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -43.31 146.2 1.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.292 0 C-N-CA 123.164 2.576 . . . . 0.0 112.752 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -127.1 177.09 17.56 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.733 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -121.17 157.32 30.46 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.461 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -76.44 105.76 7.68 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.927 0.394 . . . . 0.0 110.218 -179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 17.2 ptm -120.93 163.3 18.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.019 179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.499 ' HB3' HG12 ' A' ' 108' ' ' VAL . 0.5 OUTLIER -75.54 114.88 14.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.312 179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.727 ' O ' HD13 ' A' ' 107' ' ' LEU . 0.5 OUTLIER -68.3 -18.81 64.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.569 -179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.499 HG12 ' HB3' ' A' ' 106' ' ' SER . 12.1 p -54.91 -15.91 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.729 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -131.55 48.74 0.95 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.433 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.622 HD22 HD12 ' A' ' 123' ' ' ILE . 6.5 tt -62.28 150.42 39.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.676 0.274 . . . . 0.0 110.452 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.422 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -111.13 114.88 28.45 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.546 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.35 -18.7 61.74 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.113 178.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.93 -45.58 20.2 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.949 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -66.78 -41.56 87.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.997 -179.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.624 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -79.01 173.49 7.64 Favored Pre-proline 0 C--N 1.328 -0.365 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 179.435 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.54 127.68 27.03 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 121.857 1.704 . . . . 0.0 112.027 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.02 -37.51 10.84 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.657 2.238 . . . . 0.0 112.667 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.542 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.64 -9.83 57.91 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.526 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 15.1 m-20 -106.31 27.45 8.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.534 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.624 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.04 -30.99 0.95 Allowed Pre-proline 0 CA--C 1.535 0.372 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -178.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.2 Cg_exo -43.68 -35.01 6.06 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 121.966 1.777 . . . . 0.0 113.357 -178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.907 ' CG2' HD23 ' A' ' 82' ' ' LEU . 95.3 t -77.7 -51.1 18.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.087 0.47 . . . . 0.0 110.426 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.622 HD12 HD22 ' A' ' 110' ' ' LEU . 39.9 mm -64.61 -32.16 56.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.205 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.69 -27.37 39.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.9 0.381 . . . . 0.0 110.626 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.6 mptt -80.25 -51.26 9.13 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.688 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.886 HD22 ' CE2' ' A' ' 68' ' ' PHE . 23.2 tp -78.06 -28.23 48.85 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.722 0.296 . . . . 0.0 111.602 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.609 ' HB2' HG22 ' A' ' 123' ' ' ILE . 49.6 tttm -55.27 -42.44 73.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.03 0.443 . . . . 0.0 110.599 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 23.9 ttt85 -67.22 -10.08 46.84 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.693 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.231 0.096 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.294 179.746 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.988 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A 5059 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A 5060 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 ptt? . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.882 0.372 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.9 tppt? -78.43 138.57 38.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -140.08 128.72 23.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.861 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.484 HD11 " H1'" ' A' ' 131' ' ' 8OG . 3.1 pp -146.06 128.72 16.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.116 -179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.474 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 13.8 mt-30 -102.69 154.91 18.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.284 0.564 . . . . 0.0 112.204 -179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.608 HD11 " H4'" ' A' ' 131' ' ' 8OG . 3.2 mp -146.89 130.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.68 179.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.945 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.07 125.69 44.2 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 178.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.612 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.7 m -140.28 162.24 24.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 C-N-CA 120.497 -0.481 . . . . 0.0 111.394 -179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.439 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -147.58 129.88 3.35 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.057 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.594 ' O ' ' HB ' ' A' ' 87' ' ' VAL . 0.5 OUTLIER -70.7 110.54 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.456 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.731 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -70.94 121.99 21.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.996 0.427 . . . . 0.0 111.57 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -82.98 124.49 30.44 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.515 -179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.539 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 23.2 t-20 -70.88 178.26 3.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.924 -1.034 . . . . 0.0 112.006 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.539 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 31.6 tt0 -56.88 -17.24 8.71 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.345 -1.298 . . . . 0.0 112.76 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -122.49 -82.64 0.65 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.598 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -154.58 13.81 0.42 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.414 ' HG2' ' HB3' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -100.81 160.3 14.48 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 178.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.694 HG23 ' O ' ' A' ' 11' ' ' ILE . 5.2 mt -132.36 137.32 54.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.123 0.487 . . . . 0.0 111.624 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.466 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -83.48 118.29 23.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.573 179.822 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -121.28 141.42 41.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.092 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.517 HG22 ' CD ' ' A' ' 98' ' ' GLU . 5.2 p -70.75 111.74 6.43 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.686 0.279 . . . . 0.0 110.392 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.41 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.7 OUTLIER -137.68 129.4 28.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.04 0.448 . . . . 0.0 111.407 -179.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 50.07 24.0 1.28 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.484 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 25' ' ' ALA . . . 46.23 28.69 0.71 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.668 0.27 . . . . 0.0 111.512 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 81.89 -47.09 0.2 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.192 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 177.32 82.01 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.37 . . . . 0.0 110.82 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -135.22 -79.33 0.44 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.222 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -166.21 -55.88 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.37 81.9 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -75.96 -8.93 58.09 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.672 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.0 31.13 2.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.771 0.32 . . . . 0.0 111.124 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -111.83 26.28 10.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.253 -179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.674 ' O ' HD23 ' A' ' 33' ' ' LEU . 6.7 tt -65.67 69.77 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.057 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.615 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.2 OUTLIER -119.82 -166.97 1.35 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.233 -179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.56 ' HB3' ' HD2' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -119.24 168.53 9.76 Favored Pre-proline 0 CA--C 1.531 0.212 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.552 -179.56 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.612 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 82.8 Cg_endo -78.68 167.68 22.15 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.564 2.842 . . . . 0.0 113.456 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.92 -3.67 48.84 Favored Glycine 0 CA--C 1.523 0.542 0 CA-C-N 115.407 -0.815 . . . . 0.0 114.534 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.469 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.41 158.13 31.94 Favored Glycine 0 CA--C 1.524 0.607 0 C-N-CA 121.225 -0.512 . . . . 0.0 113.632 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 88.17 0.34 0.41 Allowed 'General case' 0 C--N 1.342 0.262 0 C-N-CA 123.213 0.605 . . . . 0.0 112.429 179.145 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.945 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -49.84 -29.14 4.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.607 0.718 . . . . 0.0 110.526 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.617 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -42.62 -57.44 2.7 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.52 -1.218 . . . . 0.0 110.914 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.536 ' C ' ' O ' ' A' ' 41' ' ' GLU . 9.4 mmt 4.23 -78.42 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 O-C-N 123.911 0.757 . . . . 0.0 112.567 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 177.48 34.53 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.789 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.437 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -89.39 -174.16 4.27 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.717 0.294 . . . . 0.0 111.049 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.03 153.45 38.51 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.248 179.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.825 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.83 -25.28 0.97 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.828 2.352 . . . . 0.0 112.455 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.5 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -104.04 -40.33 6.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.431 179.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mm-40 -80.32 -4.89 55.19 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 111.792 0.293 . . . . 0.0 111.792 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.74 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -62.03 -57.01 13.26 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.808 0.337 . . . . 0.0 110.869 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.846 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.6 OUTLIER -78.52 -45.66 25.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.949 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 47' ' ' GLU . 44.6 t -53.24 -39.75 36.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.237 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -78.02 -48.67 15.64 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.462 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.5 mm-40 -64.77 -20.05 66.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.596 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.887 HD11 ' CE1' ' A' ' 64' ' ' HIS . 1.2 tp -59.77 -44.39 93.89 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.921 0.391 . . . . 0.0 110.427 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -65.0 -34.75 79.19 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 178.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.483 ' O ' ' N ' ' A' ' 97' ' ' LYS . 1.1 tm-20 -77.43 -27.35 52.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.087 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.467 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 0.5 OUTLIER -108.53 5.39 25.1 Favored 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.391 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.964 HG12 HG13 ' A' ' 60' ' ' ILE . 35.1 t -134.61 -44.2 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.185 0.517 . . . . 0.0 110.042 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.595 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 70.02 -42.39 0.48 Allowed Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.538 -0.756 . . . . 0.0 113.472 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.964 HG13 HG12 ' A' ' 58' ' ' VAL . 0.1 OUTLIER -77.56 -176.48 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-O 121.016 0.436 . . . . 0.0 111.12 -179.967 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.1 p -113.08 89.13 13.34 Favored Pre-proline 0 N--CA 1.442 -0.857 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.531 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.831 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.3 Cg_endo -107.82 143.85 0.07 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.323 0 C-N-CA 123.272 2.648 . . . . 0.0 113.936 -177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.9 mt-30 -74.62 80.1 2.0 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 1.052 ' CD2' HG22 ' A' ' 87' ' ' VAL . 2.7 t-160 -122.64 133.32 54.53 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.041 -1.436 . . . . 0.0 111.474 -175.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.579 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.0 OUTLIER -175.65 -145.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.617 -179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.6 m 51.96 172.18 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.009 0.523 . . . . 0.0 112.138 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.863 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -140.26 122.18 15.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.62 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.518 ' CE2' HD23 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.55 -44.24 35.64 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.45 . . . . 0.0 109.966 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -171.68 131.9 0.72 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.395 179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.2 pttm -115.65 109.95 18.47 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.76 0.314 . . . . 0.0 110.552 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.8 tp -96.88 121.56 38.88 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.865 0.365 . . . . 0.0 110.964 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -123.14 109.69 14.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.442 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.41 ' CZ ' HG23 ' A' ' 80' ' ' ILE . 2.0 p90 -141.26 149.84 41.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.882 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.448 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 2.6 pt-20 -121.23 129.05 52.99 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.213 0.53 . . . . 0.0 111.062 179.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.455 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 1.0 OUTLIER -95.69 163.27 21.73 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.52 179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.495 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.1 Cg_endo -53.18 82.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.964 2.443 . . . . 0.0 112.337 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.495 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 0.9 OUTLIER 92.5 8.69 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.618 179.937 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.566 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 4.1 ttp180 -137.25 93.87 2.87 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.675 0.274 . . . . 0.0 110.896 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.448 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 3.2 t-160 -86.84 93.98 9.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.778 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.561 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 1.7 tp -101.24 111.93 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-O 121.049 0.452 . . . . 0.0 110.889 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.477 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -103.82 118.81 37.58 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.751 179.213 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.517 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -116.35 114.19 23.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.933 0.397 . . . . 0.0 112.023 -178.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.477 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.9 m0 -108.53 122.48 47.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.147 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.677 ' CD1' HG11 ' A' ' 122' ' ' VAL . 1.7 m-85 -108.91 111.6 23.38 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.876 0.369 . . . . 0.0 110.078 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.863 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.5 m95 -94.54 148.91 21.77 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.704 -178.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.579 ' O ' ' O ' ' A' ' 65' ' ' PHE . 38.0 tp -97.94 102.44 14.19 Favored 'General case' 0 CA--C 1.527 0.073 0 CA-C-O 121.342 0.592 . . . . 0.0 111.262 -179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 1.052 HG22 ' CD2' ' A' ' 64' ' ' HIS . 12.2 t -85.5 145.77 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 115.274 -0.875 . . . . 0.0 110.928 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.406 ' CA ' ' HB2' ' A' ' 12' ' ' ARG . 7.5 pt-20 -114.67 -24.12 8.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 -178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.495 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 7.5 tpt180 -162.61 160.76 26.21 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 118.787 0.721 . . . . 0.0 111.677 -178.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.731 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.8 OUTLIER -152.06 125.33 8.73 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.244 178.621 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 50.7 tt0 -72.83 141.82 48.0 Favored 'General case' 0 C--O 1.23 0.067 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.91 -118.92 11.98 Favored Glycine 0 C--N 1.331 0.264 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.53 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -131.92 142.86 46.7 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.552 0.215 . . . . 0.0 110.773 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.2 Cg_exo -76.29 128.79 10.72 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.862 2.375 . . . . 0.0 111.412 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.613 ' HE1' HG23 ' A' ' 60' ' ' ILE . 47.6 p-90 -132.06 -62.08 0.86 Allowed 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 120.46 -0.496 . . . . 0.0 112.097 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.564 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.92 -102.42 0.04 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.784 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.483 ' N ' ' O ' ' A' ' 56' ' ' GLU . 6.7 tptp 179.33 35.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.778 0.323 . . . . 0.0 111.097 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.517 ' CD ' HG22 ' A' ' 21' ' ' THR . 16.0 pt-20 -50.85 -37.37 42.87 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.791 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 116.4 -31.93 5.78 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.848 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -128.76 97.17 27.87 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.005 0.431 . . . . 0.0 111.449 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -43.57 146.11 1.46 Allowed 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.953 2.435 . . . . 0.0 112.475 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.08 177.15 19.35 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.958 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -129.83 157.42 42.27 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.268 -0.271 . . . . 0.0 110.268 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -70.75 105.91 3.37 Favored 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 120.622 -0.431 . . . . 0.0 110.19 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.525 ' HE2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -120.72 163.31 18.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.908 179.589 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 2.1 t -73.82 114.94 12.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.412 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.576 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.53 -18.68 62.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.517 -179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.531 ' CG1' HD21 ' A' ' 129' ' ' LEU . 21.4 t -58.94 -12.28 2.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.732 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -137.51 53.15 0.74 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.032 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.56 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 6.0 tt -62.21 150.45 38.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.922 0.392 . . . . 0.0 110.771 -179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.516 ' HB3' HD13 ' A' ' 33' ' ' LEU . 3.9 t-20 -97.03 97.75 9.49 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.461 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.42 -20.32 61.44 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.965 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.14 -45.46 19.94 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.203 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.72 -40.61 88.47 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.274 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.551 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.4 174.24 6.34 Favored Pre-proline 0 C--N 1.326 -0.416 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.641 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.2 Cg_endo -54.06 127.79 27.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 121.844 1.696 . . . . 0.0 112.301 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.41 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 50.1 Cg_endo -69.01 -35.28 15.16 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.662 2.241 . . . . 0.0 112.505 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.581 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -72.7 -9.51 58.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.016 0.436 . . . . 0.0 111.218 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -104.1 19.77 19.5 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.796 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.567 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.0 OUTLIER -74.96 -30.57 1.02 Allowed Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -179.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.567 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.6 Cg_exo -43.19 -36.46 6.02 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 121.887 1.725 . . . . 0.0 113.196 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.677 HG11 ' CD1' ' A' ' 84' ' ' PHE . 23.7 t -77.82 -50.26 20.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.308 0.575 . . . . 0.0 110.264 178.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.684 HG22 ' HB2' ' A' ' 127' ' ' LYS . 48.6 mm -64.17 -33.9 65.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.701 -179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.58 44.53 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.001 0.429 . . . . 0.0 110.616 179.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.4 tptm -80.13 -50.71 9.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.739 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 129' ' ' LEU . 2.0 tm? -78.12 -40.06 39.33 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.741 -179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.684 ' HB2' HG22 ' A' ' 123' ' ' ILE . 18.0 tttm -53.19 -42.7 66.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.12 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 4.3 ttp180 -66.98 -7.34 21.68 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.884 178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.762 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.4 mp . . . . . 0 C--O 1.231 0.119 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.185 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.652 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A 5071 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A 5072 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.755 0.312 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.64 147.18 27.94 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.944 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -139.99 126.59 20.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.606 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.752 ' CD1' HD11 ' A' ' 6' ' ' ILE . 4.0 pp -146.09 127.05 14.54 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.194 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.42 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 43.4 mt-30 -104.6 152.41 22.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.301 0.572 . . . . 0.0 112.006 -179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.752 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.2 mp -146.44 123.14 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.421 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.022 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.09 125.68 44.15 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.616 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.3 m -131.21 162.49 39.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.38 0.61 . . . . 0.0 112.051 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -137.43 111.53 0.84 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.077 -0.965 . . . . 0.0 111.677 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.909 HD12 HD13 ' A' ' 18' ' ' ILE . 8.5 pt -70.41 105.99 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-O 120.724 0.297 . . . . 0.0 110.412 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.686 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -71.63 125.75 30.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.778 -178.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.532 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -98.75 136.02 39.39 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.412 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.741 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.6 p-10 -96.48 -173.3 2.72 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.511 0.672 . . . . 0.0 112.018 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -70.46 -0.99 9.45 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 114.885 -1.052 . . . . 0.0 113.642 -178.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.44 ' HB3' ' HG3' ' A' ' 17' ' ' GLU . 15.0 t-20 -120.69 33.28 5.63 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.625 -0.43 . . . . 0.0 112.135 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 58.56 13.78 2.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 111.351 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' HG3' ' HB3' ' A' ' 15' ' ' ASN . 4.9 mt-10 -102.08 161.16 13.89 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.909 HD13 HD12 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.7 124.58 72.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.184 0.516 . . . . 0.0 112.012 -178.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -74.2 120.18 19.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.652 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -129.08 150.4 34.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.287 179.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 69.2 p -70.83 111.75 6.5 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.768 0.318 . . . . 0.0 110.593 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' HB2' HD13 ' A' ' 33' ' ' LEU . 38.9 ttp180 -126.57 126.3 43.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.957 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.876 ' CZ ' ' HB2' ' A' ' 30' ' ' ALA . 2.3 ttm180 48.87 -102.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.162 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 177.73 -177.42 0.2 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.754 0.312 . . . . 0.0 111.045 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -102.74 29.69 5.19 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.123 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -170.02 -54.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.031 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -178.86 132.4 0.12 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.147 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 179.6 -169.01 0.11 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.81 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.5 mmm -71.17 106.47 3.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.876 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . . . -64.98 -18.85 65.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.354 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.01 30.59 2.67 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.113 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 34' ' ' GLU . 10.7 mttt -114.11 26.14 10.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.938 0.399 . . . . 0.0 111.219 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.486 HD13 ' HB2' ' A' ' 22' ' ' ARG . 21.7 tp -61.24 77.33 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.033 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.617 ' O ' HG22 ' A' ' 20' ' ' ILE . 2.7 mt-10 -115.75 -170.44 1.78 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.116 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.572 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.26 168.15 10.55 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.625 -179.516 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.616 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 94.6 Cg_endo -84.28 166.64 12.44 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 123.585 2.857 . . . . 0.0 113.307 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.607 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.05 -5.93 53.52 Favored Glycine 0 C--O 1.225 -0.427 0 CA-C-N 115.73 -0.668 . . . . 0.0 114.254 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -60.13 161.99 18.74 Favored Glycine 0 C--N 1.319 -0.382 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.891 179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.84 1.62 0.78 Allowed 'General case' 0 C--N 1.341 0.228 0 N-CA-C 112.285 0.476 . . . . 0.0 112.285 179.417 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.022 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -51.82 -27.69 8.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.54 0.686 . . . . 0.0 110.294 178.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.554 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.4 OUTLIER -41.1 -57.78 1.95 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.804 179.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.528 ' C ' ' O ' ' A' ' 41' ' ' GLU . 25.0 mmm 5.86 -80.02 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.457 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 178.28 33.51 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.755 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.408 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -87.94 -174.13 4.57 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.761 0.315 . . . . 0.0 111.069 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.825 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.08 153.1 38.27 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.267 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.825 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.76 -25.41 0.96 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.873 2.382 . . . . 0.0 112.487 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' O ' HG23 ' A' ' 51' ' ' VAL . 3.5 mp0 -104.02 -39.68 6.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.448 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -80.25 -8.48 59.48 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 111.753 0.279 . . . . 0.0 111.753 -179.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.803 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.68 -54.62 43.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.7 0.286 . . . . 0.0 110.744 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.79 HG12 ' HB1' ' A' ' 7' ' ' ALA . 1.4 m -78.09 -47.46 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.167 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.8 t -54.1 -37.95 36.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.176 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -78.38 -51.97 9.28 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.257 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 57' ' ' GLU . 1.2 mm-40 -65.14 -19.85 66.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.331 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.767 HD21 ' NE2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -61.2 -44.66 96.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.683 0.277 . . . . 0.0 111.054 -179.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.6 -35.79 82.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -77.68 -26.34 50.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.353 -0.84 . . . . 0.0 111.209 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 53' ' ' GLU . 7.3 mm-40 -108.32 5.34 25.46 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 112.273 0.472 . . . . 0.0 112.273 -178.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.929 HG12 HG13 ' A' ' 60' ' ' ILE . 44.7 t -134.45 -44.33 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.234 0.54 . . . . 0.0 109.68 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.568 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 69.29 -41.47 0.37 Allowed Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.308 -0.86 . . . . 0.0 113.817 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.929 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.84 -177.58 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-O 121.137 0.494 . . . . 0.0 111.42 -179.504 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.41 89.0 13.97 Favored Pre-proline 0 N--CA 1.443 -0.776 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.896 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.752 ' HG3' HG11 ' A' ' 58' ' ' VAL . 6.1 Cg_endo -109.98 150.86 0.06 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.315 0 C-N-CA 123.339 2.693 . . . . 0.0 114.475 -177.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.415 ' CG ' ' HG2' ' A' ' 89' ' ' ARG . 33.7 mt-30 -74.73 79.82 2.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 176.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.952 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -125.77 128.0 47.03 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.155 -176.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.432 ' N ' ' HD1' ' A' ' 64' ' ' HIS . 1.8 t80 -176.31 -40.67 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -178.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.639 ' HB3' HD23 ' A' ' 86' ' ' LEU . 58.4 m -41.4 163.57 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.894 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.404 ' C ' ' CD2' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -116.59 120.57 39.1 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.071 179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.3 OUTLIER -88.56 -56.65 3.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.807 -179.856 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -172.27 162.48 5.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.735 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.35 132.02 22.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.726 0.298 . . . . 0.0 110.774 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.684 HD22 HG23 ' A' ' 122' ' ' VAL . 3.4 tp -121.62 133.37 54.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.812 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -130.85 109.66 10.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.608 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.694 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.2 p90 -141.24 144.75 34.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.625 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 4.0 pt-20 -121.08 136.03 55.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.135 0.493 . . . . 0.0 111.373 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.467 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -99.58 163.04 19.28 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.54 -0.755 . . . . 0.0 110.32 179.795 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.551 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 12.8 Cg_endo -56.41 81.5 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.754 2.303 . . . . 0.0 112.217 -179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.551 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 9.0 t70 99.45 3.84 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.754 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.563 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 21.6 ttp180 -137.25 94.76 2.98 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.685 0.279 . . . . 0.0 110.953 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.42 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 3.5 t-160 -91.3 105.04 17.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.813 0.34 . . . . 0.0 110.98 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.968 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 3.8 tt -106.11 132.6 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.91 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.444 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.51 118.73 31.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.541 178.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.577 HD23 HD11 ' A' ' 80' ' ' ILE . 0.1 OUTLIER -117.03 114.25 23.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.96 0.409 . . . . 0.0 111.431 -179.156 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 11.2 m0 -107.52 122.59 46.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.191 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.893 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 2.4 m-85 -108.08 109.64 21.13 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.039 0.447 . . . . 0.0 110.627 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.742 ' NE1' HG11 ' A' ' 50' ' ' VAL . 39.0 m95 -98.15 148.4 23.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.705 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.639 HD23 ' HB3' ' A' ' 66' ' ' SER . 56.0 tp -94.02 138.41 32.14 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.384 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.952 HG22 ' ND1' ' A' ' 64' ' ' HIS . 58.1 t -120.54 145.87 26.28 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.849 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.364 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 64.8 tt0 -107.01 -28.5 9.99 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.45 165.49 23.78 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 118.894 0.77 . . . . 0.0 111.64 -179.189 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.741 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -155.31 123.63 5.91 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.356 178.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -73.63 147.18 44.01 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.048 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.08 -121.97 25.74 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.586 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -131.88 146.29 61.13 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.579 0.228 . . . . 0.0 110.781 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.531 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.0 Cg_exo -76.5 128.74 10.53 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.793 2.329 . . . . 0.0 111.475 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.568 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 51.4 p-90 -130.42 -61.26 0.97 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.412 -0.515 . . . . 0.0 111.869 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.622 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 36.87 -97.69 0.01 OUTLIER Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.08 -0.581 . . . . 0.0 113.214 -179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.58 40.23 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.651 0.263 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.427 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -68.98 -25.44 64.53 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.075 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.42 -86.58 0.27 Allowed Glycine 0 C--N 1.332 0.332 0 C-N-CA 120.366 -0.921 . . . . 0.0 113.3 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.406 ' O ' ' HB ' ' A' ' 21' ' ' THR . 2.0 pt20 -108.24 115.98 57.41 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.992 0.425 . . . . 0.0 111.847 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -43.63 146.19 1.48 Allowed 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.04 2.493 . . . . 0.0 112.81 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -122.94 177.31 16.56 Favored Glycine 0 CA--C 1.52 0.376 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.006 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.525 ' HG3' ' HE3' ' A' ' 105' ' ' MET . 0.4 OUTLIER -125.31 157.52 36.47 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.408 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -64.53 105.99 1.06 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.915 0.388 . . . . 0.0 110.09 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.525 ' HE3' ' HG3' ' A' ' 103' ' ' GLU . 5.5 ptp -120.7 152.2 38.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.8 p -74.23 118.55 17.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.55 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.79 HD23 ' CG2' ' A' ' 18' ' ' ILE . 0.5 OUTLIER -73.04 -18.62 61.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.41 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 108' ' ' VAL . 21.3 t -59.64 -11.54 2.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.694 0.283 . . . . 0.0 111.547 179.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.13 54.45 0.73 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.661 HD13 HD22 ' A' ' 107' ' ' LEU . 7.0 tp -61.74 150.27 37.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.765 0.317 . . . . 0.0 110.787 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -109.95 103.73 12.54 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -178.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.54 -18.86 61.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.153 177.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -79.0 -47.07 16.93 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.45 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.485 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.63 -40.52 88.77 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.229 -179.28 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.4 174.2 6.4 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.09 127.73 26.91 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.911 1.74 . . . . 0.0 112.489 -178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.29 -35.48 13.92 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.726 2.284 . . . . 0.0 112.465 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.846 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.05 -9.75 56.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.316 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.425 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 14.6 m-20 -107.73 19.73 19.74 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.997 -179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.565 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.5 OUTLIER -66.67 -31.75 4.45 Favored Pre-proline 0 CA--C 1.534 0.35 0 N-CA-C 113.761 1.023 . . . . 0.0 113.761 -179.079 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.8 Cg_exo -43.85 -36.57 8.06 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 121.797 1.665 . . . . 0.0 113.276 -178.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.893 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 55.1 t -77.88 -51.14 18.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.905 0.383 . . . . 0.0 111.738 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.833 HG22 ' HB2' ' A' ' 127' ' ' LYS . 9.5 mm -74.84 -42.0 46.85 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.82 -28.27 34.51 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 111.922 0.342 . . . . 0.0 111.922 -178.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -80.8 -53.78 6.19 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.51 ' HG ' ' CZ ' ' A' ' 68' ' ' PHE . 3.5 mm? -78.86 -31.12 45.49 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.833 ' HB2' HG22 ' A' ' 123' ' ' ILE . 15.9 tttm -54.09 -42.1 68.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.044 0.449 . . . . 0.0 110.684 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.818 ' O ' HD12 ' A' ' 129' ' ' LEU . 60.3 ttm-85 -70.41 -6.48 35.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.978 178.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.32 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.148 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.968 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A 5083 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A 5084 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.7 ptm . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.768 0.318 . . . . 0.0 111.143 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -107.9 134.6 50.59 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.869 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.08 139.1 35.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.812 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.402 HD21 ' N3 ' ' A' ' 131' ' ' 8OG . 2.8 pp -146.23 123.64 11.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.155 -179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.406 ' HB2' ' HB3' ' A' ' 41' ' ' GLU . 39.8 mt-30 -102.69 149.01 24.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.136 0.493 . . . . 0.0 111.612 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.697 HG22 ' HA ' ' A' ' 82' ' ' LEU . 2.2 tp -146.59 125.61 4.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.912 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.037 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.98 125.5 43.98 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.648 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -131.14 162.13 39.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.102 -0.639 . . . . 0.0 112.293 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -141.13 111.28 0.7 Allowed Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.664 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.977 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.64 109.42 3.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 179.838 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -71.18 124.92 28.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.232 0.539 . . . . 0.0 111.785 -178.496 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.29 121.13 31.27 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.442 -179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.709 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.8 p30 -81.35 -172.96 4.08 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 123.704 0.628 . . . . 0.0 111.007 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.42 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 4.3 tt0 -79.31 11.02 3.15 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -136.4 48.22 2.15 Favored 'General case' 0 N--CA 1.464 0.252 0 O-C-N 121.988 -0.445 . . . . 0.0 112.128 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 44.85 27.36 0.26 Allowed 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.319 0.58 . . . . 0.0 111.071 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.518 ' HB3' ' O ' ' A' ' 105' ' ' MET . 25.9 mt-10 -122.49 161.89 22.75 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.005 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.977 HG21 HG22 ' A' ' 10' ' ' ILE . 6.6 mt -128.85 143.62 40.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.241 0.543 . . . . 0.0 111.83 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.466 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -88.62 118.42 28.27 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.728 179.786 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.474 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -118.29 145.89 23.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.134 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.642 HG22 ' OE2' ' A' ' 98' ' ' GLU . 1.7 p -70.72 111.95 6.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.71 0.29 . . . . 0.0 110.528 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.631 ' CB ' HD13 ' A' ' 33' ' ' LEU . 10.6 ttp180 -123.02 123.15 40.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.95 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 6.2 ttp180 53.08 -102.51 0.14 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.915 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 174.45 -68.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.839 0.352 . . . . 0.0 110.968 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -170.59 -42.11 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.09 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.8 p-10 -160.79 38.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.947 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -133.0 132.44 41.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.048 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.22 87.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.036 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.0 mmt -155.08 28.42 0.41 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.827 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.11 -13.01 60.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.535 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -84.35 4.41 31.38 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.493 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' O ' ' N ' ' A' ' 34' ' ' GLU . 2.7 mptp? -114.07 26.08 10.6 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.967 0.413 . . . . 0.0 111.196 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.631 HD13 ' CB ' ' A' ' 22' ' ' ARG . 22.4 tp -55.71 86.23 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.943 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.8 OUTLIER -119.11 -170.86 2.0 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.084 0.469 . . . . 0.0 111.872 -179.34 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.624 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.5 168.33 10.3 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.607 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.648 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 57.8 Cg_endo -72.06 166.93 28.17 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.377 2.718 . . . . 0.0 112.983 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.785 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.82 -5.76 54.03 Favored Glycine 0 C--O 1.222 -0.601 0 CA-C-N 115.914 -0.585 . . . . 0.0 113.876 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -61.96 140.97 47.11 Favored Glycine 0 C--N 1.316 -0.571 0 C-N-CA 121.161 -0.543 . . . . 0.0 113.262 179.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.522 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 96.27 3.41 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 178.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.037 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -51.86 -27.38 8.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 121.489 0.661 . . . . 0.0 110.638 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.556 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.09 -76.53 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.173 -179.808 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.436 ' C ' ' O ' ' A' ' 41' ' ' GLU . 44.2 mmm 24.77 -85.48 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.708 0.63 . . . . 0.0 112.316 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -172.66 31.85 0.11 Allowed Glycine 0 C--N 1.333 0.382 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.809 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.446 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.3 mp0 -89.96 -172.83 3.66 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.662 0.268 . . . . 0.0 111.195 -179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.852 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -100.88 153.06 37.95 Favored Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.376 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.852 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -44.06 -24.81 0.96 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.704 2.27 . . . . 0.0 112.643 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.674 ' O ' HG23 ' A' ' 51' ' ' VAL . 4.8 mt-10 -103.39 -41.21 6.08 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 12.9 mm-40 -80.2 -18.12 50.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.589 0.233 . . . . 0.0 111.618 -179.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.829 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -58.04 -48.59 79.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.266 -179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.762 HG12 ' HB1' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -78.15 -46.95 25.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.999 0.428 . . . . 0.0 110.79 179.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 47' ' ' GLU . 45.2 t -54.12 -37.5 35.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.441 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 0.7 OUTLIER -78.07 -52.06 9.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.83 0.348 . . . . 0.0 110.548 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.439 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.7 tp10 -61.14 -19.99 62.16 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.605 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.855 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.7 OUTLIER -61.4 -44.86 96.41 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.047 -179.806 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -69.23 -30.0 68.05 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.204 0.526 . . . . 0.0 109.762 179.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.402 ' O ' ' N ' ' A' ' 97' ' ' LYS . 2.7 tt0 -77.33 -29.57 53.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.062 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.4 OUTLIER -109.08 6.67 25.19 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 112.835 0.679 . . . . 0.0 112.835 -178.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.902 HG12 HG13 ' A' ' 60' ' ' ILE . 46.0 t -133.41 -44.56 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.934 0.397 . . . . 0.0 109.939 179.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.84 -39.17 0.18 Allowed Glycine 0 N--CA 1.448 -0.534 0 CA-C-N 115.7 -0.682 . . . . 0.0 114.237 178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.902 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.69 -177.53 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.092 0.472 . . . . 0.0 111.33 -179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.43 88.99 13.99 Favored Pre-proline 0 N--CA 1.445 -0.679 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.953 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.695 ' HG3' HG11 ' A' ' 58' ' ' VAL . 5.5 Cg_endo -110.24 148.68 0.05 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.399 2.733 . . . . 0.0 114.312 -177.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.439 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 40.3 mt-30 -74.93 79.81 2.16 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 175.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.997 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -124.82 128.8 49.27 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.052 -1.431 . . . . 0.0 109.664 -176.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -173.98 -49.77 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.475 ' O ' ' N ' ' A' ' 86' ' ' LEU . 2.2 p -38.16 159.64 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.63 -0.713 . . . . 0.0 111.947 -178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.762 HD11 ' HG2' ' A' ' 70' ' ' LYS . 6.8 tt -119.32 116.63 26.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.96 -54.74 6.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.178 179.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.549 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 1.6 tt0 -171.74 142.19 1.52 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.447 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.762 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -139.92 103.87 4.74 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.432 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.645 HD21 HG22 ' A' ' 122' ' ' VAL . 1.9 pp -111.46 160.79 16.79 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.88 0.371 . . . . 0.0 111.174 -179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.548 ' HB2' HG22 ' A' ' 81' ' ' THR . 16.1 tt0 -135.14 109.89 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.653 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -129.36 123.45 31.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.336 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.425 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 11.2 pt-20 -110.07 133.87 52.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.179 0.514 . . . . 0.0 111.616 -179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.525 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 2.8 m-85 -74.68 163.67 66.65 Favored Pre-proline 0 N--CA 1.45 -0.438 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.885 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.7 Cg_endo -37.38 -29.1 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.642 2.894 . . . . 0.0 113.214 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -139.62 -39.66 0.46 Allowed 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.076 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.7 OUTLIER -84.75 104.38 14.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.25 -179.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.427 ' HE1' HG23 ' A' ' 81' ' ' THR . 0.5 OUTLIER -89.37 112.38 23.47 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.765 0.317 . . . . 0.0 110.572 179.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.951 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 3.2 tt -118.48 128.99 75.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.228 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.548 HG22 ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -113.72 118.56 34.67 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.57 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.697 ' HA ' HG22 ' A' ' 6' ' ' ILE . 0.2 OUTLIER -114.28 114.17 25.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.115 0.483 . . . . 0.0 112.031 -178.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.422 ' CZ3' ' HE2' ' A' ' 70' ' ' LYS . 10.5 m0 -110.22 122.08 46.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.201 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' A' ' 122' ' ' VAL . 6.1 m-30 -112.43 111.94 23.14 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.7 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.617 ' CE2' HG11 ' A' ' 50' ' ' VAL . 21.1 m95 -100.56 148.98 24.19 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.718 -179.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 66' ' ' SER . 45.9 tp -93.97 138.69 31.8 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.514 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.997 HG22 ' ND1' ' A' ' 64' ' ' HIS . 44.8 t -120.09 145.7 26.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.801 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.095 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -110.99 -24.55 10.3 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 -178.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.504 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.7 OUTLIER -163.66 164.96 23.78 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 118.958 0.799 . . . . 0.0 111.508 -178.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.709 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 0.2 OUTLIER -157.24 123.54 4.89 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.94 0.4 . . . . 0.0 111.326 178.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -76.13 151.7 36.93 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.077 -179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.97 -122.66 28.17 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.558 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 13.6 mt-10 -132.17 147.87 67.5 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 120.516 0.198 . . . . 0.0 110.77 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.557 ' HA ' HD11 ' A' ' 60' ' ' ILE . 4.3 Cg_exo -76.48 128.81 10.58 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.845 2.363 . . . . 0.0 111.202 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.561 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 52.5 p-90 -134.43 -64.32 0.68 Allowed 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.139 -0.624 . . . . 0.0 112.539 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.596 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.85 -96.56 0.01 OUTLIER Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.934 -0.65 . . . . 0.0 113.143 -179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.402 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 173.44 38.83 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.678 0.275 . . . . 0.0 110.93 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.642 ' OE2' HG22 ' A' ' 21' ' ' THR . 15.2 pt-20 -58.45 -49.42 77.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.855 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 153.44 -63.56 0.36 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.967 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -124.92 120.21 25.52 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.004 0.431 . . . . 0.0 111.637 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -43.48 146.28 1.33 Allowed 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.101 2.534 . . . . 0.0 112.658 179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -125.7 177.11 17.18 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.874 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -130.29 157.43 42.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.533 0.206 . . . . 0.0 110.472 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.475 ' HB3' ' ND2' ' A' ' 13' ' ' ASN . 1.0 OUTLIER -65.28 106.08 1.27 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.926 0.393 . . . . 0.0 110.272 -179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.518 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -120.83 163.21 18.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.224 179.773 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.408 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -77.32 115.96 17.53 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.791 179.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.541 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -80.05 -18.82 49.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.449 -179.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -59.46 -12.62 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.601 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.87 54.88 0.63 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.979 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.74 HD22 HD12 ' A' ' 123' ' ' ILE . 4.6 tt -61.84 150.52 37.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.717 0.294 . . . . 0.0 110.544 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -101.02 108.89 20.72 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.48 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.557 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -16.96 61.84 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.062 178.09 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -79.01 -46.82 17.4 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.184 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.4 OUTLIER -66.79 -40.51 88.15 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 -179.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.557 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -78.61 174.02 6.72 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.642 179.715 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.43 127.71 27.08 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 121.893 1.728 . . . . 0.0 112.321 -179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -68.88 -37.49 11.41 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.643 2.229 . . . . 0.0 112.628 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.778 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.5 -9.58 56.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.97 0.414 . . . . 0.0 111.481 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 25.2 m-20 -104.69 21.78 16.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.829 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.559 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.8 OUTLIER -71.87 -31.51 1.8 Allowed Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -178.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.559 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 90.9 Cg_exo -44.07 -37.33 9.47 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.86 1.707 . . . . 0.0 113.188 -178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.666 HG11 ' CD2' ' A' ' 84' ' ' PHE . 58.8 t -77.67 -51.0 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.12 0.486 . . . . 0.0 110.63 179.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.74 HD12 HD22 ' A' ' 110' ' ' LEU . 43.1 mm -65.48 -30.61 50.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.33 -179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.86 -29.43 55.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.121 0.486 . . . . 0.0 110.493 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.3 mttm -78.27 -51.3 10.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.622 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.839 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.2 tm? -78.22 -19.91 52.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.814 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.605 ' HB2' HG22 ' A' ' 123' ' ' ILE . 4.9 ttpm? -75.18 -42.57 55.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.095 0.474 . . . . 0.0 110.51 -179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 24.0 ttm105 -67.77 -9.14 41.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.027 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.688 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.157 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.582 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.951 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A 5095 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A 5096 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.4 tpp . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.776 0.322 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 10.5 tptm -98.97 141.19 32.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.948 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.5 OUTLIER -140.26 138.11 34.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.594 179.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.848 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.9 pp -146.29 131.26 18.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.345 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.444 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 28.0 mt-30 -103.09 153.05 20.69 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.217 0.532 . . . . 0.0 111.965 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.848 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.0 mp -146.53 134.66 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.854 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.061 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.51 124.29 41.96 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.602 HG11 ' CE1' ' A' ' 84' ' ' PHE . 1.6 m -125.48 162.53 28.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 121.233 0.539 . . . . 0.0 112.005 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.438 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -145.95 113.5 0.69 Allowed Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.146 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.946 ' CG2' HG21 ' A' ' 18' ' ' ILE . 1.0 OUTLIER -70.69 101.13 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.828 ' O ' HG23 ' A' ' 18' ' ' ILE . 0.5 OUTLIER -71.04 123.35 24.97 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.181 0 CA-C-O 121.306 0.574 . . . . 0.0 111.937 -178.374 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.81 123.62 34.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.482 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.492 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 12.5 t-20 -76.73 -172.31 2.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.08 -0.963 . . . . 0.0 111.865 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.408 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 4.7 tm-20 -83.15 4.05 28.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.316 -1.311 . . . . 0.0 112.093 -179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 53.7 t-20 -138.41 50.85 1.87 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.346 . . . . 0.0 111.551 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.71 24.42 0.33 Allowed 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.384 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 23.5 pt-20 -117.74 144.4 45.33 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.946 HG21 ' CG2' ' A' ' 10' ' ' ILE . 6.1 mt -113.1 138.84 41.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.228 0.537 . . . . 0.0 111.754 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -91.27 108.29 19.78 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.275 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.884 HD12 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -107.86 155.89 8.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.141 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.714 HG23 ' HD3' ' A' ' 36' ' ' PRO . 5.8 p -71.04 111.81 6.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.686 0.279 . . . . 0.0 110.253 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.421 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 0.0 OUTLIER -124.87 129.67 50.87 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.955 -179.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 13.6 ttm180 48.01 -104.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.885 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 175.07 -166.93 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.794 0.331 . . . . 0.0 110.97 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.52 -30.85 42.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.091 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -166.17 81.23 0.28 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -155.73 -171.17 3.66 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -123.07 31.26 6.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.93 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.96 50.23 1.02 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.855 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -52.72 -22.51 5.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.607 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.61 31.25 1.38 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.348 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.1 tptm -113.71 25.99 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.056 0.455 . . . . 0.0 111.259 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.884 HD21 HD12 ' A' ' 20' ' ' ILE . 1.8 tt -70.59 65.83 0.32 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.605 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.86 -169.27 1.53 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.444 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.811 ' CD2' HD12 ' A' ' 10' ' ' ILE . 3.0 m-85 -119.13 143.75 34.67 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.709 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.714 ' HD3' HG23 ' A' ' 21' ' ' THR . 17.8 Cg_endo -58.23 165.98 6.46 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.741 2.294 . . . . 0.0 111.067 178.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.582 ' HA3' ' O ' ' A' ' 7' ' ' ALA . . . 100.36 58.66 0.85 Allowed Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 119.72 -1.228 . . . . 0.0 113.359 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.58 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -124.84 134.02 8.8 Favored Glycine 0 C--N 1.31 -0.879 0 CA-C-N 114.857 -0.672 . . . . 0.0 112.25 179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 101.58 -2.47 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.061 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -50.19 -26.27 3.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.219 0.533 . . . . 0.0 111.017 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.513 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.59 -68.67 0.16 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.045 -0.98 . . . . 0.0 110.973 179.884 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.455 ' C ' ' O ' ' A' ' 41' ' ' GLU . 76.6 mmm 23.54 -86.67 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 O-C-N 123.831 0.707 . . . . 0.0 112.318 179.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.97 29.15 0.13 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.832 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.434 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.5 mp0 -93.66 -173.7 3.25 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.792 0.329 . . . . 0.0 111.068 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.905 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -105.0 155.44 37.61 Favored Pre-proline 0 N--CA 1.456 -0.157 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.327 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.905 ' HD2' HG22 ' A' ' 45' ' ' THR . 4.1 Cg_endo -45.24 -24.6 1.57 Allowed 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.651 2.234 . . . . 0.0 112.461 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.743 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -94.23 -50.17 5.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -80.17 -29.55 38.73 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.721 0.296 . . . . 0.0 111.604 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.984 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -52.42 -45.86 66.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.91 0.386 . . . . 0.0 110.845 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.791 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -78.46 -50.55 18.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.898 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.743 HG23 ' O ' ' A' ' 47' ' ' GLU . 55.5 t -54.45 -36.78 35.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.875 -178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 -52.02 9.44 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.875 -0.33 . . . . 0.0 110.927 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.586 ' CB ' HG22 ' A' ' 40' ' ' ILE . 2.9 mm-40 -66.93 -25.0 66.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.722 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.985 ' O ' HG23 ' A' ' 58' ' ' VAL . 12.4 tp -52.75 -45.76 67.19 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 120.874 0.369 . . . . 0.0 110.39 -179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -62.64 -26.68 68.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.84 178.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.6 OUTLIER -71.43 -23.65 61.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.891 179.4 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.496 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 2.0 mm-40 -108.19 5.09 25.49 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.985 HG23 ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -134.61 -44.7 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.424 0.63 . . . . 0.0 109.497 178.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.58 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 70.01 -36.6 0.4 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.276 -0.874 . . . . 0.0 114.597 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.927 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.3 OUTLIER -84.4 -168.32 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 120.945 0.403 . . . . 0.0 110.882 -179.495 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.9 p -111.73 89.29 10.87 Favored Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.603 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.633 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 9.3 Cg_endo -107.36 147.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.298 0 C-N-CA 123.018 2.478 . . . . 0.0 113.997 -178.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 53.8 mt-30 -74.83 80.05 2.11 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 176.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.959 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -123.87 129.05 50.38 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.481 -176.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.6 t80 179.6 163.5 0.98 Allowed 'General case' 0 N--CA 1.454 -0.227 0 CA-C-O 120.932 0.396 . . . . 0.0 112.034 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 84.64 163.62 0.1 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.882 179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.782 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.7 pp -121.8 127.55 50.71 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.071 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.657 ' CE2' ' HB3' ' A' ' 84' ' ' PHE . 1.5 p90 -76.81 -44.37 32.84 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 120.526 -0.469 . . . . 0.0 109.9 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.571 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 12.4 mt-10 -171.43 131.78 0.75 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.859 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.606 ' HG2' HD13 ' A' ' 67' ' ' LEU . 0.9 OUTLIER -132.53 132.0 42.16 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.592 -0.277 . . . . 0.0 110.635 179.983 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 1.038 HD11 HG22 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -127.34 154.61 44.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.003 0.43 . . . . 0.0 111.23 -179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.552 ' CG ' HG23 ' A' ' 81' ' ' THR . 19.5 tt0 -131.8 109.78 10.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.377 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.511 ' OH ' HD13 ' A' ' 80' ' ' ILE . 55.4 p90 -125.97 151.87 46.45 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.604 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.441 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 5.6 pt-20 -120.16 140.12 51.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.361 0.6 . . . . 0.0 111.493 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.487 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.2 m-85 -103.44 162.73 19.15 Favored Pre-proline 0 N--CA 1.45 -0.43 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.085 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.51 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.5 Cg_endo -52.61 81.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.919 2.413 . . . . 0.0 112.174 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 3.2 t70 93.14 10.3 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.556 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.602 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.5 OUTLIER -137.37 93.82 2.86 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.679 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.441 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 1.7 t-80 -85.42 93.94 8.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.745 0.307 . . . . 0.0 110.69 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.991 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 2.7 tt -96.7 111.99 27.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.982 0.42 . . . . 0.0 111.397 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.578 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -99.61 118.54 36.37 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 178.208 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.676 HD23 ' HB ' ' A' ' 6' ' ' ILE . 9.9 mt -120.71 114.12 21.2 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.631 -0.428 . . . . 0.0 111.936 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.578 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.4 m0 -110.42 122.11 46.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.838 178.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.843 ' CD2' HG11 ' A' ' 122' ' ' VAL . 3.2 m-85 -106.45 133.7 50.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.045 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.791 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 11.0 m95 -117.01 148.45 41.45 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 112.578 0.585 . . . . 0.0 112.578 -178.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 65' ' ' PHE . 35.4 tp -85.9 138.24 32.17 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.319 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.803 HG13 ' CB ' ' A' ' 64' ' ' HIS . 20.5 t -124.2 145.9 30.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.427 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -110.44 -32.07 7.06 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.1 164.28 25.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 118.777 0.717 . . . . 0.0 111.843 -178.795 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.739 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.8 p90 -148.63 126.38 11.83 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.235 178.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -76.95 150.6 35.91 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.292 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 56.24 -129.98 48.8 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.707 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.587 ' O ' HG12 ' A' ' 60' ' ' ILE . 16.3 mt-10 -120.65 136.57 25.48 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 110.421 -0.214 . . . . 0.0 110.421 179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.886 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.2 Cg_exo -74.46 128.85 12.28 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 122.573 2.182 . . . . 0.0 111.375 179.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.58 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 39.1 p-90 -130.22 -63.47 0.9 Allowed 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 120.315 -0.554 . . . . 0.0 112.48 -179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.496 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 51.25 -109.51 0.79 Allowed Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.603 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 168.55 41.95 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 120.769 0.318 . . . . 0.0 111.007 -179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.32 -46.31 79.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.784 0.326 . . . . 0.0 110.861 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 130.11 -23.56 4.62 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.89 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.44 100.7 13.66 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 120.911 0.386 . . . . 0.0 111.306 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -43.5 143.3 2.58 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.912 2.408 . . . . 0.0 112.581 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.1 177.12 19.38 Favored Glycine 0 CA--C 1.518 0.223 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.666 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -131.84 157.17 44.62 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 110.432 -0.21 . . . . 0.0 110.432 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.415 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.0 OUTLIER -72.43 106.38 4.51 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 120.819 -0.353 . . . . 0.0 110.196 -179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.421 ' O ' ' N ' ' A' ' 18' ' ' ILE . 8.5 ptm -120.43 163.16 18.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.224 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.84 117.94 21.92 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.592 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.665 HD11 HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -59.77 -18.84 46.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.4 -179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.647 HG23 HD22 ' A' ' 129' ' ' LEU . 11.9 p -58.37 -14.65 4.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.611 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.33 49.95 0.91 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.953 -0.642 . . . . 0.0 111.785 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.896 HD23 HG23 ' A' ' 123' ' ' ILE . 10.0 tp -62.31 150.51 39.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.74 0.305 . . . . 0.0 111.098 -179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.69 ' CB ' HD13 ' A' ' 33' ' ' LEU . 1.9 t-20 -111.0 92.92 4.23 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.635 0.605 . . . . 0.0 112.635 -178.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.522 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.5 -19.93 61.45 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.117 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -79.06 -45.31 20.38 Favored 'General case' 0 CA--C 1.529 0.173 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.394 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.61 -42.16 87.29 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.112 -179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.568 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.34 174.37 6.13 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.694 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.09 127.87 27.51 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 121.99 1.793 . . . . 0.0 112.173 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -67.82 -39.13 11.99 Favored 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.727 2.284 . . . . 0.0 112.76 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.462 ' CB ' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.63 -9.63 57.45 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.083 0.468 . . . . 0.0 111.533 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 44.5 m-20 -101.83 20.46 16.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.754 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.57 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -72.84 -31.08 1.42 Allowed Pre-proline 0 N--CA 1.468 0.429 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 -178.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.4 Cg_exo -43.71 -36.57 7.64 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 121.831 1.687 . . . . 0.0 113.011 -178.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 1.038 HG22 HD11 ' A' ' 71' ' ' LEU . 69.9 t -77.91 -51.33 18.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.092 0.472 . . . . 0.0 110.958 179.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.896 HG23 HD23 ' A' ' 110' ' ' LEU . 17.8 mm -65.24 -34.63 71.82 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.47 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.75 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.23 -27.74 36.56 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.472 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -80.58 -53.04 6.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.934 179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.524 HD23 ' CD1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -78.14 -32.97 50.62 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.75 -179.1 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.892 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.3 ttpt -53.35 -42.21 66.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.978 0.418 . . . . 0.0 110.984 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.818 ' O ' HD12 ' A' ' 129' ' ' LEU . 15.2 ttt-85 -71.02 -6.17 36.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.003 178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.464 0.251 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.061 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.991 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A 5107 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A 5108 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.3 mtp . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.756 0.312 . . . . 0.0 111.265 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.85 146.62 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.417 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.06 139.57 35.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.837 179.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.412 HD11 " H1'" ' A' ' 131' ' ' 8OG . 2.8 pp -146.25 122.98 11.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.194 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -102.57 151.31 22.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.13 0.491 . . . . 0.0 111.378 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.673 HD13 " H4'" ' A' ' 131' ' ' 8OG . 2.0 tp -146.61 130.84 10.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.332 179.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.906 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.02 125.48 43.93 Favored 'General case' 0 CA--C 1.51 -0.569 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m -139.93 154.8 23.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.269 -178.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.05 120.92 2.34 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.461 179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.757 HG22 HG12 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -70.35 108.43 2.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.772 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.05 124.98 28.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.155 0.502 . . . . 0.0 111.688 -178.146 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.648 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -100.7 129.25 46.58 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.3 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.707 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.8 p-10 -84.44 -172.87 4.41 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.43 0.634 . . . . 0.0 111.786 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' CG ' ' O ' ' A' ' 14' ' ' GLU . 1.3 tm-20 -73.63 4.89 4.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.026 -0.988 . . . . 0.0 113.452 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -128.63 44.39 2.97 Favored 'General case' 0 C--N 1.328 -0.368 0 O-C-N 122.014 -0.429 . . . . 0.0 112.092 -179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 48.96 23.13 0.66 Allowed 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.973 0.416 . . . . 0.0 111.473 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.432 ' HB2' ' OD1' ' A' ' 13' ' ' ASN . 33.6 mt-10 -114.0 161.61 17.47 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.243 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.757 HG12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -115.03 139.83 39.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 -178.497 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.577 ' CD2' HD12 ' A' ' 11' ' ' ILE . 1.8 t80 -93.41 97.56 10.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.569 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.668 HD12 HD21 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -110.01 162.22 7.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.253 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.449 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 71.3 p -70.59 134.95 48.09 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -129.48 100.51 5.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.332 . . . . 0.0 111.133 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.904 ' HD3' ' HB2' ' A' ' 30' ' ' ALA . 21.6 ttp180 48.82 -95.79 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.24 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.57 -38.7 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.047 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -169.49 -52.02 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.059 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -169.24 -49.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.905 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -117.4 90.3 3.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.03 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -169.09 -164.49 0.47 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.798 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.0 mtt -65.15 77.83 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.843 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.904 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . . . -71.42 -13.04 61.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.687 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.2 OUTLIER -95.65 23.14 6.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.276 -179.797 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.34 26.39 10.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.807 0.337 . . . . 0.0 111.577 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.668 HD21 HD12 ' A' ' 20' ' ' ILE . 1.2 tt -64.77 73.23 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.768 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -113.66 -172.06 2.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.063 0.459 . . . . 0.0 111.675 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.554 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.45 168.27 10.4 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.609 -179.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.705 ' HG3' HD11 ' A' ' 11' ' ' ILE . 60.2 Cg_endo -72.63 166.88 28.63 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 123.42 2.746 . . . . 0.0 113.162 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.788 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.68 -5.33 54.15 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-N 116.011 -0.541 . . . . 0.0 113.99 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.582 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -65.34 132.56 35.76 Favored Glycine 0 C--N 1.315 -0.598 0 C-N-CA 121.094 -0.574 . . . . 0.0 112.727 179.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.582 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 106.36 1.19 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.273 0.629 . . . . 0.0 112.081 179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.906 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -49.16 -29.8 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.672 0.748 . . . . 0.0 110.588 179.329 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.627 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -41.45 -58.65 1.82 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.338 -1.301 . . . . 0.0 111.105 179.935 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.538 ' C ' ' O ' ' A' ' 41' ' ' GLU . 12.6 mmt 2.68 -78.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.656 179.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.4 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.42 33.27 0.07 OUTLIER Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.595 -0.812 . . . . 0.0 113.031 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.43 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 13.1 mp0 -101.55 -174.96 2.72 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 120.617 0.246 . . . . 0.0 111.037 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.819 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -105.42 152.39 39.91 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.283 179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.819 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.68 -24.57 0.75 Allowed 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.73 2.287 . . . . 0.0 112.463 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.76 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -94.39 -50.38 5.26 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.58 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.8 mm-40 -80.42 -29.22 37.67 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -178.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.831 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -55.6 -43.88 76.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.184 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.517 HG11 ' CE2' ' A' ' 85' ' ' TRP . 1.4 m -78.27 -48.75 22.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.89 0.376 . . . . 0.0 110.233 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.76 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.7 t -57.16 -35.91 49.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.75 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 12.4 mmt-85 -77.94 -50.14 12.77 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.497 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -63.71 -21.99 66.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.626 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.935 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -56.88 -44.75 82.6 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.931 0.396 . . . . 0.0 110.289 179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -68.36 -28.05 66.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.348 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -77.33 -38.65 49.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.48 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.452 ' HB3' ' CB ' ' A' ' 36' ' ' PRO . 1.3 mp0 -104.66 5.16 33.35 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.086 HG12 HG22 ' A' ' 60' ' ' ILE . 11.1 t -134.42 -43.63 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.048 0.451 . . . . 0.0 109.997 178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.0 -35.06 0.24 Allowed Glycine 0 N--CA 1.452 -0.266 0 CA-C-N 115.706 -0.679 . . . . 0.0 114.418 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.086 HG22 HG12 ' A' ' 58' ' ' VAL . 5.4 tp -77.53 166.28 2.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 120.56 0.219 . . . . 0.0 110.773 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -101.73 89.05 1.36 Allowed Pre-proline 0 N--CA 1.448 -0.558 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.792 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.0 Cg_endo -114.38 150.01 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.478 0 C-N-CA 123.552 2.835 . . . . 0.0 114.525 -176.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.408 ' HB2' ' HG2' ' A' ' 89' ' ' ARG . 35.0 mt-30 -74.94 79.42 2.16 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 105.43 -2.063 . . . . 0.0 105.43 175.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.935 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -123.39 127.61 48.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.492 -176.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.525 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -179.1 -134.12 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.634 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.428 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.4 OUTLIER 55.77 166.34 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.918 0.39 . . . . 0.0 111.849 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.641 ' O ' HD23 ' A' ' 67' ' ' LEU . 6.9 tt -127.87 110.79 12.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.047 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.79 -45.25 29.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.122 0.486 . . . . 0.0 109.821 179.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.52 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 5.3 tt0 -171.6 156.72 4.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.364 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.428 ' HG2' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.28 104.32 4.25 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.453 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.542 HD23 ' CE1' ' A' ' 73' ' ' TYR . 4.7 tp -96.84 135.79 38.3 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.889 0.376 . . . . 0.0 111.097 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -126.98 109.48 11.96 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.615 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.542 ' CE1' HD23 ' A' ' 71' ' ' LEU . 4.2 p90 -141.41 128.64 21.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.449 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.457 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 7.9 pt-20 -116.02 130.73 56.94 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.105 0.478 . . . . 0.0 111.56 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 2.7 m-85 -71.11 163.33 66.44 Favored Pre-proline 0 N--CA 1.45 -0.46 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.026 179.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.472 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 2.4 Cg_endo -38.06 -29.14 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.598 2.865 . . . . 0.0 113.036 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -139.63 -38.43 0.48 Allowed 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.009 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 75' ' ' PHE . 0.9 OUTLIER -83.86 99.85 10.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.284 -179.673 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.457 ' CG ' ' HB3' ' A' ' 74' ' ' GLU . 4.1 t60 -87.01 110.33 19.99 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.785 0.326 . . . . 0.0 110.673 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.987 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 2.5 tt -115.27 137.38 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-O 120.961 0.41 . . . . 0.0 110.935 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.468 ' O ' HG22 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.74 118.43 30.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.656 178.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.884 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -107.18 113.87 27.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.794 0.331 . . . . 0.0 111.384 -179.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.488 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 8.7 m0 -114.99 122.43 46.2 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.176 0.512 . . . . 0.0 110.32 179.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.887 ' CD1' HG11 ' A' ' 122' ' ' VAL . 3.9 m-85 -110.68 124.08 51.25 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.572 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.728 ' HE1' ' HB1' ' A' ' 7' ' ' ALA . 66.4 m95 -108.58 148.64 30.03 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.76 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.525 ' O ' ' O ' ' A' ' 65' ' ' PHE . 37.6 tp -99.53 103.21 14.93 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.448 0.642 . . . . 0.0 111.746 -179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.843 HG13 ' CB ' ' A' ' 64' ' ' HIS . 19.0 t -83.23 145.58 8.2 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.515 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -104.27 -50.74 3.27 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.15 165.76 24.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.488 0.586 . . . . 0.0 112.508 -178.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.707 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 24.1 p90 -133.81 159.57 40.22 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.506 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -94.19 102.15 14.17 Favored 'General case' 0 N--CA 1.46 0.039 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.237 -179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.4 -112.09 4.02 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.57 -0.824 . . . . 0.0 112.384 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.432 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 22.1 tt0 -131.53 135.4 26.88 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-O 120.546 0.212 . . . . 0.0 111.224 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.478 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 5.2 Cg_exo -76.5 139.6 20.68 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.856 2.371 . . . . 0.0 111.211 179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.556 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 33.4 p-90 -134.59 -63.45 0.71 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.486 -0.485 . . . . 0.0 112.19 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.667 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 39.77 -104.68 0.04 OUTLIER Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.614 -0.721 . . . . 0.0 113.308 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.4 mtmt 168.22 40.22 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.75 0.31 . . . . 0.0 110.897 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -59.11 -23.68 62.32 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.081 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 145.3 -86.85 0.17 Allowed Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.349 -0.929 . . . . 0.0 113.078 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -111.07 118.78 47.28 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 121.06 0.457 . . . . 0.0 111.649 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.55 146.19 1.42 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.192 2.595 . . . . 0.0 112.802 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.09 177.42 19.14 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.846 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -122.69 157.23 32.74 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.566 0.222 . . . . 0.0 110.436 179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.444 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -68.38 106.37 2.48 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.976 0.417 . . . . 0.0 110.24 -179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 6.9 ptm -120.54 152.02 38.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.105 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.58 ' HB3' HG12 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -70.25 114.9 8.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.637 179.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.987 HD21 HD12 ' A' ' 110' ' ' LEU . 1.0 OUTLIER -59.17 -18.5 36.81 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.66 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.58 HG12 ' HB3' ' A' ' 106' ' ' SER . 13.7 p -52.75 -14.41 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -136.83 54.37 0.72 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.635 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.987 HD12 HD21 ' A' ' 107' ' ' LEU . 3.8 tt -61.77 150.53 36.7 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.886 0.374 . . . . 0.0 110.918 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.436 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -100.61 93.2 5.48 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -178.537 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.428 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.48 -21.42 61.21 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 177.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -79.22 -44.91 20.89 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.07 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.2 OUTLIER -66.72 -40.11 88.26 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.372 -179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.569 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.37 174.39 6.09 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.606 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.8 Cg_endo -53.79 127.78 26.91 Favored 'Trans proline' 0 C--N 1.346 0.402 0 C-N-CA 121.899 1.733 . . . . 0.0 112.603 -178.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.429 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 49.6 Cg_endo -68.41 -36.11 16.44 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.885 2.39 . . . . 0.0 112.366 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.802 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -71.4 -9.54 58.32 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.07 0.462 . . . . 0.0 111.071 179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.9 m-20 -106.02 16.66 24.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.055 -179.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.576 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.4 OUTLIER -73.44 -30.97 1.29 Allowed Pre-proline 0 CA--C 1.533 0.325 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -179.224 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 74.1 Cg_exo -43.57 -36.37 7.04 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 121.847 1.698 . . . . 0.0 113.51 -178.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.887 HG11 ' CD1' ' A' ' 84' ' ' PHE . 17.6 t -77.88 -51.27 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.145 0.498 . . . . 0.0 110.534 178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.527 HG22 ' HB2' ' A' ' 127' ' ' LYS . 20.4 mm -65.48 -30.99 51.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.25 -179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.94 -27.89 47.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.614 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.69 -49.83 11.52 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.653 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.815 HD13 ' O ' ' A' ' 126' ' ' LEU . 3.3 tm? -78.3 -28.84 47.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.405 -179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.527 ' HB2' HG22 ' A' ' 123' ' ' ILE . 7.9 ttpt -55.01 -42.54 72.68 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.109 0.48 . . . . 0.0 110.654 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -64.05 -12.61 40.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.521 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.685 HD12 ' O ' ' A' ' 126' ' ' LEU . 5.0 mp . . . . . 0 C--O 1.232 0.151 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.947 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.987 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A 5119 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A 5120 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 mmt . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.738 0.304 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.732 ' CE ' HD23 ' A' ' 4' ' ' LEU . 0.6 OUTLIER -109.97 144.45 38.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.962 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt -140.11 130.17 24.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.68 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.732 HD23 ' CE ' ' A' ' 2' ' ' LYS . 3.2 pp -146.19 124.72 12.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.369 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.421 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 30.4 mt-30 -102.81 151.7 22.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.419 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.618 ' HB ' HD12 ' A' ' 82' ' ' LEU . 2.1 mp -146.53 127.09 6.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.904 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.894 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . . . -124.77 125.63 44.35 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 178.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -144.36 162.16 14.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.833 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.461 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -147.76 125.62 2.17 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.692 179.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.091 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.84 110.92 4.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.769 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.764 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -71.53 125.31 29.78 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 CA-C-O 121.178 0.513 . . . . 0.0 111.537 -178.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.624 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -90.92 118.93 30.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.194 -179.661 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.731 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 2.9 p-10 -79.64 -172.22 3.19 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.331 0.586 . . . . 0.0 111.389 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.6 tm-20 -77.08 13.46 1.09 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.582 0.956 . . . . 0.0 113.582 -177.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.426 ' H ' ' ND2' ' A' ' 13' ' ' ASN . 10.7 t-20 -143.25 51.89 1.37 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.393 -0.523 . . . . 0.0 112.214 -179.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 44.17 27.62 0.22 Allowed 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.023 0.439 . . . . 0.0 111.571 179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' C ' ' OD1' ' A' ' 13' ' ' ASN . 23.2 mt-10 -122.94 161.75 23.59 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.091 HG21 HG22 ' A' ' 10' ' ' ILE . 8.1 mt -128.22 144.11 38.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.189 0.519 . . . . 0.0 112.186 -178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -88.68 115.21 26.05 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.446 179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.704 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -112.46 133.34 58.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.404 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 100' ' ' GLN . 23.4 p -70.97 114.44 9.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.042 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HB3' HD13 ' A' ' 33' ' ' LEU . 1.5 ptm180 -121.78 131.58 54.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.691 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.529 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 6.9 ttm180 47.22 -103.9 0.1 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.813 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.552 ' HB3' ' CB ' ' A' ' 27' ' ' ALA . . . 170.54 -166.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 0.0 110.915 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.21 -29.94 34.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.165 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -148.18 33.4 0.81 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.109 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.552 ' CB ' ' HB3' ' A' ' 24' ' ' ALA . . . -103.58 167.73 9.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.062 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -117.29 37.63 3.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.999 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.1 mtt -116.03 68.46 0.72 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.912 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -60.58 -19.03 56.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.458 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.29 31.09 2.58 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.267 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.22 25.94 10.69 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.983 0.421 . . . . 0.0 111.574 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.49 ' O ' ' HG ' ' A' ' 33' ' ' LEU . 38.6 tp -68.68 71.72 0.21 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.449 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.704 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -109.43 -167.21 1.18 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.175 -179.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.79 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -119.12 168.29 10.18 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.566 -179.384 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.533 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 85.1 Cg_endo -84.08 167.51 12.45 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.695 2.93 . . . . 0.0 113.695 -179.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.501 ' H ' ' CG ' ' A' ' 57' ' ' GLU . . . 102.92 -3.23 48.49 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.241 -0.89 . . . . 0.0 114.525 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -64.2 165.04 31.77 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 117.264 0.532 . . . . 0.0 113.793 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 86.0 0.51 0.66 Allowed 'General case' 0 C--N 1.342 0.253 0 C-N-CA 123.188 0.595 . . . . 0.0 112.046 179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.894 ' CG2' ' HB3' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -50.92 -28.41 6.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.675 0.75 . . . . 0.0 110.552 179.002 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.602 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.9 -58.23 2.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.161 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.0 mmt 6.96 -79.35 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.887 0.742 . . . . 0.0 112.579 179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 179.56 34.92 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.541 -0.837 . . . . 0.0 113.03 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.466 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -93.76 -170.45 2.34 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.653 0.263 . . . . 0.0 111.045 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.834 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -98.68 153.19 38.03 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.314 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.834 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.9 -25.0 0.92 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.796 2.331 . . . . 0.0 112.396 179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -102.57 -42.99 5.75 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.818 -179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -80.38 -11.16 59.73 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.787 0.292 . . . . 0.0 111.787 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.835 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.03 -53.97 51.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.86 0.362 . . . . 0.0 110.81 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.812 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.27 -50.14 19.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.914 179.401 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 47' ' ' GLU . 41.2 t -51.75 -37.76 21.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.407 -178.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 -78.49 -52.19 8.89 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.291 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.668 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 2.1 mm-40 -66.0 -20.02 66.05 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.586 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.877 HD21 ' CD2' ' A' ' 64' ' ' HIS . 9.4 tp -55.53 -45.01 77.24 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.282 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.6 -35.89 82.14 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.174 0.512 . . . . 0.0 109.713 179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -71.1 -25.45 62.61 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.968 178.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.501 ' CG ' ' H ' ' A' ' 37' ' ' GLY . 0.6 OUTLIER -108.36 6.73 26.67 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.782 -0.644 . . . . 0.0 112.185 -178.724 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.973 HG13 HD12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -133.39 -44.88 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.064 0.459 . . . . 0.0 109.952 179.288 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.523 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.54 -37.79 0.22 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.648 -0.705 . . . . 0.0 114.456 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.973 HD12 HG13 ' A' ' 58' ' ' VAL . 0.6 OUTLIER -86.76 -174.68 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 120.853 0.358 . . . . 0.0 110.919 -179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -113.78 88.64 14.36 Favored Pre-proline 0 N--CA 1.442 -0.844 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.498 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.539 ' HB3' ' HB2' ' A' ' 90' ' ' TRP . 5.9 Cg_endo -110.84 146.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.374 0 C-N-CA 123.514 2.809 . . . . 0.0 113.811 -177.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.418 ' HB2' ' CG ' ' A' ' 89' ' ' ARG . 37.6 mt-30 -74.79 79.83 2.09 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 105.623 -1.991 . . . . 0.0 105.623 175.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.877 ' CD2' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -119.3 132.44 55.89 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.268 -1.333 . . . . 0.0 110.867 -176.446 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -178.94 -136.84 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.651 -179.466 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.471 ' HB2' ' HB3' ' A' ' 86' ' ' LEU . 0.8 OUTLIER 54.08 165.15 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.079 0.466 . . . . 0.0 111.885 179.33 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.653 ' O ' HD23 ' A' ' 67' ' ' LEU . 7.2 tt -128.02 108.84 11.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.798 179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.528 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.86 -43.36 36.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.302 179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 11.8 tt0 -171.27 156.11 4.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.553 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.457 ' HD3' ' CE2' ' A' ' 83' ' ' TRP . 1.4 ttmm -143.27 105.73 4.44 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.657 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.522 HD22 HG23 ' A' ' 122' ' ' VAL . 1.1 tp -97.09 136.29 37.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 111.054 -179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -140.02 109.64 6.3 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.409 179.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.412 ' CE1' HD21 ' A' ' 71' ' ' LEU . 2.3 p90 -141.18 152.22 44.46 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.829 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.44 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 4.1 pt-20 -121.13 135.81 55.1 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.168 0.509 . . . . 0.0 111.29 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.483 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -101.12 163.21 18.39 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.183 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 10.3 Cg_endo -53.86 82.82 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.779 2.319 . . . . 0.0 112.068 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 6.0 m-20 92.96 8.81 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.659 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.546 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 20.6 ttp180 -137.3 93.83 2.86 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.601 0.239 . . . . 0.0 110.86 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.44 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 20.2 t-80 -90.38 107.45 19.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 110.962 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.938 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 3.3 tt -107.53 146.42 13.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.762 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.433 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.1 OUTLIER -134.07 118.82 18.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.02 179.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.67 HD13 HD11 ' A' ' 80' ' ' ILE . 1.0 OUTLIER -117.21 114.22 23.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.798 0.332 . . . . 0.0 111.169 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.457 ' CE2' ' HD3' ' A' ' 70' ' ' LYS . 8.5 m0 -106.93 122.23 46.01 Favored 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.787 ' CE2' HG11 ' A' ' 122' ' ' VAL . 2.2 m-85 -111.49 109.9 20.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.084 0.468 . . . . 0.0 111.665 -179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.812 ' CZ2' HG11 ' A' ' 50' ' ' VAL . 58.8 m95 -94.81 148.71 22.01 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.82 -179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' O ' ' O ' ' A' ' 65' ' ' PHE . 17.5 tp -97.84 102.79 14.64 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 121.549 0.69 . . . . 0.0 111.367 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.775 HG13 ' CB ' ' A' ' 64' ' ' HIS . 18.0 t -83.53 146.29 7.13 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.668 0 CA-C-N 114.937 -1.029 . . . . 0.0 111.441 179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -108.56 -40.15 5.19 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -178.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.624 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 2.3 ptp180 -163.34 165.72 23.78 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 119.064 0.847 . . . . 0.0 112.527 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.731 ' CH2' ' HB3' ' A' ' 13' ' ' ASN . 3.3 p90 -145.44 133.35 21.27 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.453 179.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -81.25 121.18 25.84 Favored 'General case' 0 C--O 1.231 0.105 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.98 -128.16 8.55 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.426 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 4.1 tt0 -123.43 139.29 31.62 Favored Pre-proline 0 C--N 1.33 -0.268 0 O-C-N 122.886 -0.185 . . . . 0.0 110.818 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.512 ' HG3' ' CE2' ' A' ' 90' ' ' TRP . 2.6 Cg_exo -76.2 128.72 10.75 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.885 2.39 . . . . 0.0 111.514 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.523 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 61.4 p-90 -132.86 -61.08 0.85 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.06 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.614 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 41.83 -104.37 0.05 OUTLIER Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.834 -0.698 . . . . 0.0 113.256 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 175.24 37.91 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.684 0.278 . . . . 0.0 111.049 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.28 -26.84 63.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.026 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.32 -67.6 0.56 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.939 179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.419 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.0 OUTLIER -121.89 110.84 32.96 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.989 0.423 . . . . 0.0 111.545 -179.423 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_exo -43.64 146.16 1.5 Allowed 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.973 2.449 . . . . 0.0 112.517 179.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -130.42 177.01 18.58 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.856 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -116.49 157.29 25.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.664 0.269 . . . . 0.0 110.56 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.496 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -74.25 106.57 5.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.91 0.386 . . . . 0.0 110.476 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 4.8 ptm -120.18 160.71 22.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.877 179.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 17' ' ' GLU . 22.3 p -73.07 115.25 12.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.928 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.765 ' O ' HD13 ' A' ' 107' ' ' LEU . 0.7 OUTLIER -66.18 -18.92 65.65 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.214 -179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.4 t -61.12 -12.4 5.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.446 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -126.97 47.63 1.01 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.954 -0.641 . . . . 0.0 111.892 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.548 HD13 HD22 ' A' ' 107' ' ' LEU . 9.2 tp -62.01 150.12 38.96 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -122.57 118.57 28.54 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 -178.657 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.593 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.37 -19.61 61.59 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.125 178.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -78.96 -47.27 16.64 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.996 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.84 -20.17 65.88 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.362 -179.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.593 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.47 172.04 4.24 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.469 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.6 Cg_endo -54.48 127.81 27.55 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.01 1.807 . . . . 0.0 112.318 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -69.15 -38.78 8.63 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.723 2.282 . . . . 0.0 112.652 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.847 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -68.84 -9.76 53.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.915 0.388 . . . . 0.0 111.528 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.41 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 14.4 m-20 -104.71 18.59 21.98 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.969 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.556 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 mt-10 -66.66 -31.88 4.58 Favored Pre-proline 0 CA--C 1.534 0.361 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.556 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 84.6 Cg_exo -44.32 -36.61 9.51 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.831 1.687 . . . . 0.0 113.504 -178.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.787 HG11 ' CE2' ' A' ' 84' ' ' PHE . 93.0 t -77.89 -51.41 17.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 111.038 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.876 HG22 ' HB2' ' A' ' 127' ' ' LYS . 7.3 mm -68.68 -29.88 45.25 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.369 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.489 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.72 -27.0 37.49 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.979 0.419 . . . . 0.0 110.232 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.5 mptp? -80.1 -51.85 8.5 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.684 179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.715 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.5 tm? -78.03 -34.09 50.73 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.627 -179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.876 ' HB2' HG22 ' A' ' 123' ' ' ILE . 13.7 tttm -52.98 -42.72 65.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.002 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 49.0 ttt85 -69.29 -7.76 39.97 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.945 178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.157 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.278 179.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.938 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A 5131 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A 5132 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 tpt . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.867 0.365 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -99.7 145.27 27.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.998 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -140.01 132.27 28.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.823 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 1.035 HD12 HD11 ' A' ' 6' ' ' ILE . 1.7 pp -146.18 126.18 13.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.134 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.476 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 30.1 mt-30 -102.53 154.17 19.37 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.254 0.55 . . . . 0.0 111.87 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 1.035 HD11 HD12 ' A' ' 4' ' ' LEU . 4.5 mp -146.27 125.28 5.06 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.581 179.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.051 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.82 125.7 44.43 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.2 m -140.1 162.64 24.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.202 0.525 . . . . 0.0 111.858 -178.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.415 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -135.84 123.42 2.99 Favored Glycine 0 N--CA 1.445 -0.726 0 CA-C-N 115.243 -0.889 . . . . 0.0 111.649 179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.777 HG22 HG12 ' A' ' 18' ' ' ILE . 0.8 OUTLIER -70.91 105.02 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.75 HG23 HG11 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -70.68 126.25 30.58 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.138 0.494 . . . . 0.0 111.941 -178.053 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.664 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -101.65 124.99 48.21 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.097 179.71 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.624 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 6.4 p-10 -79.15 -172.59 3.21 Favored 'General case' 0 N--CA 1.462 0.16 0 O-C-N 123.77 0.669 . . . . 0.0 111.382 179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.418 ' O ' ' CG ' ' A' ' 14' ' ' GLU . 1.3 tm-20 -76.14 9.22 2.64 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.204 -0.907 . . . . 0.0 113.337 -178.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -132.89 46.91 2.56 Favored 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.958 -0.464 . . . . 0.0 112.098 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.54 24.53 0.52 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.055 0.455 . . . . 0.0 111.495 179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HB3' ' O ' ' A' ' 105' ' ' MET . 22.5 mt-10 -115.95 161.24 19.12 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.234 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.777 HG12 HG22 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -113.68 134.02 57.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -178.655 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.434 ' N ' ' O ' ' A' ' 11' ' ' ILE . 40.7 t80 -91.84 95.18 9.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.433 179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.468 HD13 HD11 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -111.25 162.42 8.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.859 0.362 . . . . 0.0 110.733 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.787 ' O ' HD12 ' A' ' 33' ' ' LEU . 70.8 p -70.63 132.68 45.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.563 179.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 4.8 ttt-85 -119.75 105.25 10.96 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.962 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 19.0 ttp85 56.15 -100.7 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.971 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 27' ' ' ALA . . . -179.21 -167.73 0.11 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.828 0.347 . . . . 0.0 111.019 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -100.27 -41.79 6.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.111 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -112.58 -36.07 5.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 24' ' ' ALA . . . -59.96 -179.14 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.09 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -138.73 31.45 2.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.936 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.6 tpt -96.09 86.81 4.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.919 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -68.62 -11.79 60.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.557 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.5 OUTLIER -94.52 29.36 2.29 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.657 0.265 . . . . 0.0 111.087 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.2 26.1 10.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.941 0.401 . . . . 0.0 111.708 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.787 HD12 ' O ' ' A' ' 21' ' ' THR . 14.7 tp -69.01 69.51 0.18 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.555 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -110.48 -172.65 2.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.539 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.597 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.39 168.7 9.48 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.374 -179.418 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.749 ' HG3' HD11 ' A' ' 11' ' ' ILE . 84.1 Cg_endo -81.28 166.96 17.96 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 123.528 2.818 . . . . 0.0 113.586 -179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.12 -5.63 53.07 Favored Glycine 0 C--O 1.225 -0.45 0 CA-C-N 115.429 -0.805 . . . . 0.0 114.002 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.481 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -58.94 162.99 10.79 Favored Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.942 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.481 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 81.93 2.13 1.4 Allowed 'General case' 0 N--CA 1.462 0.134 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 179.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.051 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -50.34 -28.92 5.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.616 0.722 . . . . 0.0 110.262 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.595 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.3 OUTLIER -40.89 -57.44 1.96 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.219 -1.355 . . . . 0.0 110.961 179.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.532 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.5 OUTLIER 2.93 -78.14 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.931 0.77 . . . . 0.0 112.522 179.337 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 176.27 35.04 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.937 -179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.2 mp0 -89.9 -172.72 3.63 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.677 0.275 . . . . 0.0 111.057 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.817 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.6 152.29 38.08 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.203 179.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.817 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.3 Cg_endo -43.77 -25.09 0.89 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.751 2.301 . . . . 0.0 112.501 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.479 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.5 mm-40 -104.06 -39.59 6.5 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.378 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.413 ' O ' ' HB2' ' A' ' 52' ' ' ARG . 2.9 mt-30 -80.37 -9.55 59.75 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 111.708 0.262 . . . . 0.0 111.708 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.835 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -58.64 -54.76 43.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.866 0.365 . . . . 0.0 110.811 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.713 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -78.64 -46.54 24.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.47 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.503 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 40.4 t -56.53 -44.74 81.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.852 -178.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 48' ' ' GLN . 7.7 mtp180 -72.81 -46.12 54.81 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.912 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.417 ' CG ' ' OE1' ' A' ' 57' ' ' GLU . 0.9 OUTLIER -69.43 -19.88 63.78 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.79 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.937 HD21 ' CD2' ' A' ' 64' ' ' HIS . 0.9 OUTLIER -57.91 -44.6 86.92 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.822 0.344 . . . . 0.0 110.714 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -65.43 -30.69 71.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.105 0.478 . . . . 0.0 109.807 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -77.42 -34.39 54.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.414 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.606 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 1.6 mp0 -108.36 6.43 26.39 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 112.95 0.722 . . . . 0.0 112.95 -178.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.046 HG12 HG22 ' A' ' 60' ' ' ILE . 34.3 t -133.8 -44.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.922 0.391 . . . . 0.0 110.45 179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.01 -36.43 0.19 Allowed Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 115.837 -0.62 . . . . 0.0 114.467 178.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.046 HG22 HG12 ' A' ' 58' ' ' VAL . 19.6 tt -77.37 163.17 3.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 120.58 0.228 . . . . 0.0 110.684 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.433 ' N ' HG12 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -103.62 88.76 1.9 Allowed Pre-proline 0 N--CA 1.449 -0.492 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.759 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 4.3 Cg_endo -115.12 152.57 0.03 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 123.558 2.839 . . . . 0.0 114.847 -176.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -74.95 79.74 2.16 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.937 ' CD2' HD21 ' A' ' 54' ' ' LEU . 0.1 OUTLIER -125.93 128.3 47.32 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.633 -1.167 . . . . 0.0 110.83 -176.146 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.551 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.3 t80 -176.85 -140.93 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.405 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 2.7 m 50.78 175.98 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 121.142 0.496 . . . . 0.0 112.008 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.87 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -142.99 121.17 12.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.006 179.481 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.92 -44.0 33.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.057 179.861 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.3 mt-10 -171.65 131.82 0.72 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.468 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.46 111.15 18.28 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.373 179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.558 ' HB3' HG22 ' A' ' 122' ' ' VAL . 0.8 OUTLIER -96.94 141.97 29.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.913 0.387 . . . . 0.0 111.132 -179.445 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.401 ' N ' ' HG ' ' A' ' 71' ' ' LEU . 6.1 tt0 -137.87 109.9 7.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.53 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.803 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.0 p90 -137.71 149.97 46.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.694 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -118.82 139.67 51.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.223 0.535 . . . . 0.0 111.525 -179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.504 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 1.6 m-85 -103.02 162.67 19.4 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.192 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.5 Cg_endo -53.65 81.93 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.934 2.423 . . . . 0.0 112.131 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.515 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.0 t0 93.76 8.6 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.509 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.592 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 33.9 ttp180 -137.32 93.67 2.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.699 0.285 . . . . 0.0 110.758 179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -85.27 110.94 19.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.806 0.336 . . . . 0.0 110.69 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.979 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 3.6 tt -108.09 146.64 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.22 0.533 . . . . 0.0 111.204 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.498 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -134.18 118.53 17.76 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.529 178.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.708 HD12 ' HB ' ' A' ' 6' ' ' ILE . 2.9 tp -119.15 114.01 21.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.923 0.392 . . . . 0.0 111.254 -179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.498 ' HE1' HG22 ' A' ' 81' ' ' THR . 9.5 m0 -111.06 122.15 47.16 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.084 179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.96 ' CD1' HG11 ' A' ' 122' ' ' VAL . 2.5 m-85 -106.12 113.3 26.75 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.977 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.87 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.7 m95 -94.72 148.35 22.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.671 -178.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.582 ' C ' HD13 ' A' ' 86' ' ' LEU . 2.9 tm? -94.3 102.59 14.6 Favored 'General case' 0 N--CA 1.457 -0.12 0 CA-C-O 121.395 0.617 . . . . 0.0 110.592 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.895 HG22 ' CE1' ' A' ' 64' ' ' HIS . 14.9 t -89.85 145.37 7.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.813 -179.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -99.94 -59.68 1.67 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.664 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 10.5 ptm180 -163.34 166.0 23.46 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 118.205 0.457 . . . . 0.0 112.22 -178.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.815 ' HB2' HD13 ' A' ' 60' ' ' ILE . 41.9 p90 -125.79 164.7 20.12 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.634 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.779 ' C ' HD11 ' A' ' 60' ' ' ILE . 32.2 tt0 -104.13 95.83 6.24 Favored 'General case' 0 C--O 1.23 0.046 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 104.01 -112.08 4.05 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.168 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.428 ' C ' HD12 ' A' ' 60' ' ' ILE . 21.0 tt0 -134.33 130.2 20.04 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-O 120.528 0.204 . . . . 0.0 111.17 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.453 ' HG3' ' CD2' ' A' ' 90' ' ' TRP . 4.8 Cg_exo -76.63 128.82 10.47 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.766 2.31 . . . . 0.0 111.372 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.551 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 6.9 p-90 -123.07 -65.7 1.07 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.191 0.52 . . . . 0.0 111.337 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.621 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 50.41 -117.33 4.96 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.468 -0.787 . . . . 0.0 113.288 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 177.57 35.96 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 120.72 0.295 . . . . 0.0 111.258 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.43 ' HA ' ' HG3' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -49.75 -30.33 9.25 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.942 179.696 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 119.4 -25.13 7.86 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.461 -0.876 . . . . 0.0 113.797 178.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.449 ' O ' HG22 ' A' ' 21' ' ' THR . 1.3 pm0 -138.86 112.31 8.22 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 117.197 0.499 . . . . 0.0 111.754 -179.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_exo -43.57 145.39 1.73 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.935 2.423 . . . . 0.0 112.551 179.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.416 ' O ' ' CE2' ' A' ' 19' ' ' PHE . . . -134.19 177.51 19.1 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.855 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -144.66 157.1 44.34 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -63.47 106.53 0.94 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.754 -0.379 . . . . 0.0 110.11 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.467 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.2 OUTLIER -120.2 156.13 31.75 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.039 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.713 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.0 OUTLIER -77.38 116.05 17.65 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.853 179.633 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.802 ' O ' HD13 ' A' ' 107' ' ' LEU . 0.9 OUTLIER -61.65 -18.74 60.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.386 -179.953 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.713 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.2 p -62.37 -3.99 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.639 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -128.69 48.39 0.97 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.872 -0.68 . . . . 0.0 111.995 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.44 HD11 HD12 ' A' ' 123' ' ' ILE . 0.1 OUTLIER -61.56 128.24 35.31 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.6 OUTLIER -111.02 114.13 27.2 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -178.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.574 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -19.29 61.67 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.857 178.21 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -78.83 -47.69 16.14 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.843 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.455 ' HB2' ' HB3' ' A' ' 111' ' ' ASN . 0.2 OUTLIER -66.75 -14.18 62.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.46 -179.634 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.574 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -113.56 171.27 4.51 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.567 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.453 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.07 127.85 27.42 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.187 1.925 . . . . 0.0 112.373 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -68.99 -39.14 8.43 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.759 2.306 . . . . 0.0 112.866 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.832 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -68.71 -9.74 52.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.988 0.423 . . . . 0.0 111.538 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.468 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 21.7 m-20 -104.14 14.49 30.36 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.057 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.532 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -61.78 -32.25 9.75 Favored Pre-proline 0 N--CA 1.467 0.4 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -178.503 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.532 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 82.9 Cg_exo -44.24 -41.5 13.19 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 121.712 1.608 . . . . 0.0 113.458 -178.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.96 HG11 ' CD1' ' A' ' 84' ' ' PHE . 35.8 t -77.69 -51.04 18.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.831 0.348 . . . . 0.0 111.059 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.562 HG13 ' CE2' ' A' ' 115' ' ' PHE . 38.2 mm -62.9 -33.77 62.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.403 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -29.6 54.18 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.955 0.407 . . . . 0.0 110.487 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 tptm -79.95 -45.21 18.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.339 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.608 HD21 HD11 ' A' ' 107' ' ' LEU . 22.9 tp -78.28 -50.08 12.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.897 0.379 . . . . 0.0 111.216 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.586 ' O ' HD13 ' A' ' 129' ' ' LEU . 6.5 ttpt -53.21 -34.9 59.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.995 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -63.6 -10.16 17.15 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.586 HD13 ' O ' ' A' ' 127' ' ' LYS . 10.5 mp . . . . . 0 CA--C 1.528 0.118 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.251 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.979 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A 5143 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A 5144 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.811 0.338 . . . . 0.0 111.18 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.3 tppt? -75.89 138.31 40.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.903 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 4.3 mttt -140.05 130.48 25.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.848 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.654 ' O ' HD12 ' A' ' 4' ' ' LEU . 3.4 pp -146.19 128.36 15.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.975 0.417 . . . . 0.0 111.162 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.449 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 46.2 mt-30 -102.85 150.52 23.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.025 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.552 ' HB ' HD12 ' A' ' 82' ' ' LEU . 4.2 mp -146.55 121.83 2.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.204 178.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.033 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.12 125.35 43.6 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 35' ' ' PHE . 1.3 m -139.67 162.21 26.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 C-N-CA 120.318 -0.553 . . . . 0.0 111.576 -179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -136.39 139.3 10.55 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.933 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.992 HG22 HG21 ' A' ' 18' ' ' ILE . 0.3 OUTLIER -83.47 112.66 21.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 179.262 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.824 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.8 OUTLIER -70.81 123.66 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.234 0 CA-C-O 121.051 0.453 . . . . 0.0 111.493 -178.61 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.16 124.65 35.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.858 -179.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.477 ' HB2' ' CH2' ' A' ' 90' ' ' TRP . 13.2 t30 -81.75 -172.09 3.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.24 -0.891 . . . . 0.0 111.805 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -81.52 3.99 22.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.317 -1.311 . . . . 0.0 112.453 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -139.5 52.01 1.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.882 -0.327 . . . . 0.0 111.35 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 45.76 24.64 0.22 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.475 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.472 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 16.0 pt-20 -117.01 138.57 51.48 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.992 HG21 HG22 ' A' ' 10' ' ' ILE . 7.5 mt -105.97 139.7 26.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.26 0.552 . . . . 0.0 112.038 -178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.496 ' CD2' ' O ' ' A' ' 19' ' ' PHE . 18.4 t80 -80.93 91.3 6.0 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.393 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.5 156.81 10.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.919 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.484 ' O ' HD12 ' A' ' 33' ' ' LEU . 25.7 p -70.77 129.46 39.17 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.843 0.354 . . . . 0.0 110.709 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.811 ' HA ' HD12 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -128.48 102.26 6.55 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.712 179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.545 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 16.8 ttm105 61.3 -112.49 0.49 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.445 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.545 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 171.67 -166.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.799 0.333 . . . . 0.0 110.938 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.27 28.46 4.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.062 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.52 -80.23 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -179.41 -65.69 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.179 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -57.5 176.88 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.128 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.5 mmt 61.69 35.32 17.04 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.12 -8.92 56.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.749 -179.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -96.55 24.72 5.67 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.714 0.292 . . . . 0.0 111.176 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -114.34 26.09 10.54 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.919 0.39 . . . . 0.0 111.515 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER -67.25 70.33 0.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.967 179.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.36 -172.66 2.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.684 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.669 ' CD1' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -110.68 166.01 11.58 Favored Pre-proline 0 CA--C 1.532 0.257 0 CA-C-O 120.863 0.363 . . . . 0.0 110.956 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.824 ' HG3' HD11 ' A' ' 11' ' ' ILE . 36.4 Cg_endo -65.47 166.69 18.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 123.415 2.743 . . . . 0.0 114.174 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.643 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.85 -5.96 54.11 Favored Glycine 0 C--O 1.225 -0.469 0 CA-C-N 114.877 -1.056 . . . . 0.0 114.027 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.507 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -57.15 155.67 16.29 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 117.337 0.569 . . . . 0.0 112.528 178.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 84.82 7.07 0.5 Allowed 'General case' 0 C--N 1.341 0.198 0 N-CA-C 112.076 0.399 . . . . 0.0 112.076 179.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.033 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.6 pt -51.62 -28.43 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.715 0.769 . . . . 0.0 110.156 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.569 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -39.75 -60.64 0.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.731 179.337 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.528 ' C ' ' O ' ' A' ' 41' ' ' GLU . 8.7 mmt 5.8 -81.28 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.537 179.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.27 28.75 0.08 OUTLIER Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.943 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -94.41 -174.71 3.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.773 0.321 . . . . 0.0 111.06 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.867 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -109.45 156.51 39.39 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.867 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.65 -24.66 0.74 Allowed 'Trans proline' 0 N--CA 1.463 -0.306 0 C-N-CA 122.799 2.333 . . . . 0.0 112.708 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.474 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -90.25 -57.73 2.74 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -179.668 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -80.52 -4.26 53.24 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.932 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -59.28 -57.73 11.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.014 0.435 . . . . 0.0 110.97 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.79 HG11 ' NE1' ' A' ' 85' ' ' TRP . 1.2 m -79.01 -45.65 24.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.475 179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 47' ' ' GLU . 38.6 t -52.21 -38.84 25.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.099 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.8 mmm-85 -78.15 -41.54 34.55 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.531 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.31 -19.89 62.26 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.76 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.869 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.2 OUTLIER -58.59 -44.76 89.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.883 0.373 . . . . 0.0 110.402 179.935 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -32.13 70.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.052 0.453 . . . . 0.0 110.344 179.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -77.17 -31.92 55.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.499 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.05 3.96 24.54 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -178.479 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.934 HG12 HG22 ' A' ' 60' ' ' ILE . 11.3 t -134.69 -44.11 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 121.206 0.527 . . . . 0.0 109.934 178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.16 -32.88 0.25 Allowed Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.388 -0.824 . . . . 0.0 114.046 179.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.934 HG22 HG12 ' A' ' 58' ' ' VAL . 0.2 OUTLIER -77.89 179.2 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 120.617 0.246 . . . . 0.0 110.6 -179.799 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -111.97 88.4 10.02 Favored Pre-proline 0 N--CA 1.444 -0.743 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.668 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 5.6 Cg_endo -110.78 144.22 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 123.527 2.818 . . . . 0.0 113.968 -177.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 18.3 mt-30 -74.68 79.62 2.03 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.144 -2.169 . . . . 0.0 105.144 175.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.869 ' NE2' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.85 134.16 54.88 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.982 -175.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.499 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.1 t80 179.97 -140.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.352 -179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.404 ' O ' ' CE3' ' A' ' 85' ' ' TRP . 0.9 OUTLIER 50.33 176.43 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.138 0.494 . . . . 0.0 111.932 179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.814 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.9 OUTLIER -143.88 123.31 13.14 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.043 179.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -76.6 -43.77 37.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.186 0.517 . . . . 0.0 109.658 179.587 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.1 mt-10 -171.83 131.8 0.69 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.224 179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.06 109.38 17.43 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.782 0.325 . . . . 0.0 110.408 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.64 HD22 HG23 ' A' ' 122' ' ' VAL . 3.9 tp -96.99 131.09 44.15 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.126 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.3 tt0 -133.68 109.67 9.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.368 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -141.29 131.77 25.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.941 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.9 pm0 -102.76 138.92 39.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.115 0.483 . . . . 0.0 111.228 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.477 ' O ' ' N ' ' A' ' 77' ' ' ASP . 0.7 OUTLIER -106.53 163.4 17.07 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.215 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 10.3 Cg_endo -51.87 82.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.87 2.38 . . . . 0.0 112.176 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 75' ' ' PHE . 12.5 m-20 89.56 11.16 0.07 Allowed 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.518 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.617 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.0 OUTLIER -137.49 93.73 2.84 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.653 0.263 . . . . 0.0 110.733 179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.433 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 13.0 t-160 -89.72 98.98 12.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.826 0.346 . . . . 0.0 110.857 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.585 ' HB ' ' N3 ' ' A' ' 131' ' ' 8OG . 0.6 OUTLIER -104.27 111.91 35.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.532 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.2 OUTLIER -103.79 118.68 37.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.686 179.044 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.579 HD13 HD11 ' A' ' 80' ' ' ILE . 1.4 tp -116.47 113.91 23.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.915 0.388 . . . . 0.0 111.722 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.532 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.8 m0 -110.31 122.55 47.94 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.398 179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.736 ' CE1' HG11 ' A' ' 122' ' ' VAL . 1.6 m-85 -108.09 113.06 25.94 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.134 179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.814 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 24.4 m95 -94.67 148.6 22.1 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.801 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.531 ' C ' HD13 ' A' ' 86' ' ' LEU . 3.0 tm? -99.1 102.86 14.7 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 121.334 0.588 . . . . 0.0 111.355 -179.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.843 HG13 ' CB ' ' A' ' 64' ' ' HIS . 14.6 t -84.18 146.03 7.36 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.684 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.097 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -113.63 -24.97 8.93 Favored 'General case' 0 CA--C 1.537 0.46 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -178.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.511 ' HG3' ' N ' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -162.68 162.83 27.1 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 118.63 0.65 . . . . 0.0 111.777 -178.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.712 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -155.2 141.81 18.84 Favored 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.3 178.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.448 ' O ' HG12 ' A' ' 60' ' ' ILE . 12.2 mt-10 -77.88 136.2 38.01 Favored 'General case' 0 C--N 1.337 0.065 0 CA-C-O 120.793 0.33 . . . . 0.0 111.383 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 44.94 -108.44 0.2 Allowed Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.963 -0.637 . . . . 0.0 112.695 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 23.5 tt0 -131.25 135.78 27.68 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.473 0.178 . . . . 0.0 110.826 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.801 ' HB3' HG13 ' A' ' 58' ' ' VAL . 2.8 Cg_exo -76.04 128.85 10.97 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.801 2.334 . . . . 0.0 111.197 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.573 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 14.6 p-90 -114.15 -64.91 1.24 Allowed 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.127 0.418 . . . . 0.0 112.127 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.65 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 40.31 -103.43 0.03 OUTLIER Glycine 0 CA--C 1.52 0.386 0 CA-C-N 115.635 -0.711 . . . . 0.0 113.251 -179.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 2.5 tptp 174.08 40.19 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.242 0 CA-C-O 120.697 0.284 . . . . 0.0 111.261 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.44 ' HA ' ' CG ' ' A' ' 57' ' ' GLU . 21.7 pt-20 -61.86 -47.06 86.72 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.868 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG3' ' A' ' 98' ' ' GLU . . . 160.86 -120.31 0.94 Allowed Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.423 -0.894 . . . . 0.0 113.101 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -75.82 123.88 88.43 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.17 0.509 . . . . 0.0 111.788 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_exo -43.7 146.32 1.5 Allowed 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 123.257 2.638 . . . . 0.0 112.701 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -131.88 177.38 18.7 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.989 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -126.9 157.26 39.87 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.453 ' CG ' ' ND2' ' A' ' 13' ' ' ASN . 0.0 OUTLIER -68.47 106.11 2.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.881 0.372 . . . . 0.0 110.252 -179.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.425 ' O ' ' N ' ' A' ' 18' ' ' ILE . 6.6 ptm -120.58 163.3 18.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.015 179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.776 ' HB2' HG12 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -78.21 114.94 17.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.825 0.345 . . . . 0.0 110.549 179.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.789 ' O ' HD13 ' A' ' 107' ' ' LEU . 0.9 OUTLIER -61.84 -18.84 61.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.238 -179.798 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.776 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.6 p -61.92 -9.3 3.23 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.645 -0.252 . . . . 0.0 111.563 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -130.25 49.18 0.94 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.96 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.628 HD23 HD12 ' A' ' 126' ' ' LEU . 7.4 tp -62.15 150.2 39.35 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.253 -0.277 . . . . 0.0 110.253 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -118.44 121.27 39.89 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 -178.383 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.63 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.49 -21.65 61.17 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.269 178.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -78.7 -43.77 25.15 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.318 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.582 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.59 -37.52 85.09 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.943 0.402 . . . . 0.0 110.783 -179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.63 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -88.22 172.95 6.89 Favored Pre-proline 0 C--N 1.328 -0.359 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.205 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.5 Cg_endo -54.27 127.82 27.43 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.012 1.808 . . . . 0.0 112.036 -179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -69.15 -39.0 8.3 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 122.666 2.244 . . . . 0.0 112.871 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.435 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -68.57 -9.8 51.8 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.933 0.397 . . . . 0.0 111.524 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.48 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 26.0 m-20 -104.95 20.47 18.75 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.741 -179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.539 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.2 OUTLIER -62.03 -31.74 8.45 Favored Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 -178.642 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.539 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 79.8 Cg_exo -44.29 -43.89 13.17 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 121.771 1.647 . . . . 0.0 113.61 -178.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.736 HG11 ' CE1' ' A' ' 84' ' ' PHE . 95.7 t -77.75 -51.52 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.775 0.321 . . . . 0.0 111.563 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.561 HG13 ' CE2' ' A' ' 115' ' ' PHE . 37.4 mm -64.74 -29.98 48.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.484 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -57.56 -32.14 66.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.985 0.421 . . . . 0.0 110.437 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -80.11 -45.58 17.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.323 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.819 ' O ' HD13 ' A' ' 126' ' ' LEU . 3.3 tm? -78.26 -19.79 52.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.603 -179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.462 ' N ' ' O ' ' A' ' 123' ' ' ILE . 6.2 ttpm? -79.14 -42.64 25.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.143 0.497 . . . . 0.0 110.681 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -67.75 -7.85 30.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.962 178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.597 HD13 ' CD2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.743 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.678 ' OP1' " O3'" ' A' ' 131' ' ' 8OG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A 5155 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A 5156 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 ttp . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.901 0.381 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -109.97 126.42 53.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.825 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.402 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.9 OUTLIER -140.1 133.91 30.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 pp -146.12 124.66 12.44 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.089 -179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.573 ' O ' HD13 ' A' ' 6' ' ' ILE . 48.8 mt-30 -102.66 147.9 26.24 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-O 121.273 0.559 . . . . 0.0 111.565 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.573 HD13 ' O ' ' A' ' 5' ' ' GLN . 33.7 mm -146.4 124.83 4.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.687 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.026 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.82 125.19 43.61 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.566 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.5 m -133.51 162.2 40.03 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.062 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.426 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.53 126.15 2.83 Favored Glycine 0 N--CA 1.443 -0.849 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.117 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.061 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -74.81 108.06 6.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.374 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.719 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.03 123.73 25.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.038 0.447 . . . . 0.0 111.151 -178.994 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.449 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -89.43 124.02 34.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.653 -179.461 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.463 ' N ' ' CZ3' ' A' ' 90' ' ' TRP . 13.9 t30 -81.61 -172.16 3.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.051 179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 -80.83 2.94 24.27 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.182 -1.372 . . . . 0.0 112.507 -179.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -140.19 52.34 1.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.828 0.346 . . . . 0.0 111.441 -179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.6 p30 45.96 24.35 0.23 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.397 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 16.8 pt-20 -114.68 142.58 46.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.061 HG21 HG22 ' A' ' 10' ' ' ILE . 7.3 mt -115.58 136.79 51.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.141 0.496 . . . . 0.0 111.623 -178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.458 ' CE2' ' HB2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -83.84 111.14 18.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.593 179.78 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.598 HD11 ' HB2' ' A' ' 105' ' ' MET . 0.2 OUTLIER -115.97 149.1 18.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.212 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.719 ' O ' HD12 ' A' ' 33' ' ' LEU . 13.9 p -70.84 132.4 45.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.553 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.54 ' CG ' HD13 ' A' ' 33' ' ' LEU . 30.1 ttt180 -137.76 110.49 7.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.968 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 17.4 ttm105 56.52 -113.61 0.78 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.81 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -177.55 36.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.834 0.349 . . . . 0.0 111.172 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 57.07 27.65 13.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.244 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -178.44 159.97 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.829 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.36 90.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.215 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 -167.76 90.95 0.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.867 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER 61.19 70.97 0.58 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -74.72 -14.53 60.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.432 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -96.35 31.06 2.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.075 -179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -112.28 25.94 11.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.103 0.478 . . . . 0.0 111.338 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 21' ' ' THR . 28.6 tp -62.77 84.38 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.769 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -126.13 -165.92 1.5 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.153 -179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.709 ' CD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -118.86 168.31 10.01 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.334 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.566 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 84.8 Cg_endo -79.4 167.37 21.29 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.416 2.744 . . . . 0.0 113.025 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.609 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.86 -5.65 50.88 Favored Glycine 0 C--O 1.224 -0.489 0 CA-C-N 115.719 -0.673 . . . . 0.0 114.462 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -63.09 152.44 46.7 Favored Glycine 0 C--N 1.318 -0.436 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.585 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 91.76 3.53 0.1 Allowed 'General case' 0 C--N 1.342 0.279 0 C-N-CA 122.827 0.451 . . . . 0.0 112.151 179.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.026 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.3 pt -52.46 -27.32 10.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.444 0.64 . . . . 0.0 110.379 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.528 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.78 -64.01 0.42 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.832 179.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.483 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 17.94 -83.78 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.448 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . 178.68 35.64 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.867 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.464 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -92.17 -170.68 2.59 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.654 0.264 . . . . 0.0 111.076 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.824 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -97.67 153.08 38.42 Favored Pre-proline 0 N--CA 1.456 -0.131 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 179.923 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.824 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.74 -24.9 0.83 Allowed 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.786 2.324 . . . . 0.0 112.454 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 51' ' ' VAL . 24.1 mt-10 -102.49 -43.86 5.52 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.592 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -80.5 -4.83 55.35 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.995 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.91 -57.3 12.28 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 120.706 0.289 . . . . 0.0 110.738 -179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.843 HG11 ' NE1' ' A' ' 85' ' ' TRP . 0.6 OUTLIER -78.78 -46.22 24.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.267 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.463 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 37.6 t -55.71 -40.53 61.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.193 -0.458 . . . . 0.0 112.14 -178.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -78.11 -51.76 9.78 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.78 0.324 . . . . 0.0 111.221 -179.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 49' ' ' ALA . 1.4 mm-40 -68.54 -20.87 64.57 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.937 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' A' ' 50' ' ' VAL . 4.5 tp -51.18 -44.78 61.58 Favored 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.72 -32.95 69.67 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.457 178.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -77.35 -29.84 53.58 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.941 179.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 6.0 mp0 -104.9 5.54 32.99 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.574 ' N ' ' HA3' ' A' ' 96' ' ' GLY . 1.6 t -134.38 -44.89 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.12 0.486 . . . . 0.0 110.005 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.528 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.34 -39.98 0.28 Allowed Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.643 -0.708 . . . . 0.0 114.336 179.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.481 HG21 ' O ' ' A' ' 93' ' ' GLU . 0.2 OUTLIER -77.92 -174.13 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 121.088 0.471 . . . . 0.0 111.896 -178.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.54 87.79 26.9 Favored Pre-proline 0 N--CA 1.439 -0.977 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.639 179.295 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.545 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 11.7 Cg_endo -112.06 146.21 0.04 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.281 0 C-N-CA 123.733 2.955 . . . . 0.0 113.968 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -74.88 79.72 2.13 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 176.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.832 ' HB2' HG13 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -121.01 130.14 53.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 113.821 -1.536 . . . . 0.0 110.227 -176.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.586 ' O ' ' O ' ' A' ' 86' ' ' LEU . 6.1 t80 178.52 160.88 0.62 Allowed 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.472 ' CB ' ' O ' ' A' ' 65' ' ' PHE . 0.3 OUTLIER 88.62 -165.64 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.209 179.213 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.778 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 2.5 pp -152.37 131.76 12.92 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.27 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.743 ' CE2' HD11 ' A' ' 10' ' ' ILE . 2.1 p90 -76.75 -41.81 43.44 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 120.501 -0.48 . . . . 0.0 109.773 179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 13.0 mt-10 -171.12 131.46 0.79 Allowed 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.583 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.35 132.06 55.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.754 0.312 . . . . 0.0 110.852 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 122' ' ' VAL . 1.3 tp -110.66 139.14 46.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.99 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -138.42 109.6 6.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.504 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.705 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.1 p90 -141.52 137.25 31.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.415 ' HB3' ' ND1' ' A' ' 79' ' ' HIS . 2.3 pt-20 -121.17 132.07 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.202 0.525 . . . . 0.0 111.194 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.498 ' HB2' ' O ' ' A' ' 78' ' ' ARG . 1.1 m-85 -83.21 163.9 48.3 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.2 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.443 ' HD2' ' CD1' ' A' ' 75' ' ' PHE . 1.9 Cg_endo -38.68 -28.62 0.14 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 123.626 2.884 . . . . 0.0 113.261 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 31.3 p-10 -139.77 -38.04 0.48 Allowed 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.163 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.538 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 25.0 ttp180 -86.32 102.78 14.3 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.421 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.415 ' ND1' ' HB3' ' A' ' 74' ' ' GLU . 0.6 OUTLIER -92.67 99.91 12.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.46 -0.337 . . . . 0.0 110.286 179.696 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 1.0 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 3.7 tt -101.23 147.95 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 CA-C-O 121.066 0.46 . . . . 0.0 111.088 -179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.406 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.1 OUTLIER -134.19 118.48 17.68 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.63 178.915 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.754 HD13 HD11 ' A' ' 80' ' ' ILE . 1.2 mp -114.58 113.51 24.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.881 0.372 . . . . 0.0 111.31 -179.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.406 ' HE1' HG22 ' A' ' 81' ' ' THR . 11.0 m0 -110.97 122.45 47.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.734 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.887 ' CE2' HG11 ' A' ' 122' ' ' VAL . 2.7 m-85 -113.19 112.72 24.25 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.037 0.446 . . . . 0.0 110.858 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.843 ' NE1' HG11 ' A' ' 50' ' ' VAL . 25.5 m95 -95.58 148.49 22.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.648 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.586 ' O ' ' O ' ' A' ' 65' ' ' PHE . 35.5 tp -90.23 138.84 31.2 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.745 -179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.832 HG13 ' HB2' ' A' ' 64' ' ' HIS . 17.9 t -123.23 144.67 32.0 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.711 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -112.11 -27.78 8.24 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.514 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.07 160.08 24.0 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 119.922 -0.711 . . . . 0.0 111.875 -178.938 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.719 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.6 OUTLIER -152.92 123.24 7.13 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.962 178.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.86 150.11 32.31 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.324 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 54.59 -144.37 30.12 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.77 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.481 ' O ' HG21 ' A' ' 60' ' ' ILE . 44.7 tt0 -105.59 134.92 19.47 Favored Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 110.334 -0.247 . . . . 0.0 110.334 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.458 ' HB2' ' CE2' ' A' ' 19' ' ' PHE . 3.3 Cg_exo -76.12 128.8 10.86 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.686 2.257 . . . . 0.0 111.61 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.528 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 34.2 p-90 -124.91 -61.57 1.29 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.518 -0.473 . . . . 0.0 111.735 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.574 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 48.74 -110.53 0.73 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.453 -0.88 . . . . 0.0 112.88 -179.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 179.29 50.01 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.81 0.338 . . . . 0.0 111.075 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -35.53 64.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.498 179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 104.26 -5.55 45.4 Favored Glycine 0 CA--C 1.519 0.315 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.348 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -140.12 96.02 8.24 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 120.981 0.419 . . . . 0.0 111.445 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -43.6 144.0 2.38 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.913 2.408 . . . . 0.0 112.35 179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -134.1 177.13 19.37 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.124 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -139.26 157.44 45.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -60.03 106.41 0.5 Allowed 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.065 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.598 ' HB2' HD11 ' A' ' 20' ' ' ILE . 2.4 mtp -120.11 163.47 17.64 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.252 -179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.535 ' HB2' HG12 ' A' ' 108' ' ' VAL . 81.7 p -90.79 114.8 27.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.559 179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -67.03 -18.53 65.4 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.207 -179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.626 HG23 HD21 ' A' ' 129' ' ' LEU . 11.9 p -53.67 -16.36 1.15 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.77 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.71 55.0 0.68 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.93 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 107' ' ' LEU . 11.1 tp -62.07 150.49 38.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.878 0.371 . . . . 0.0 110.889 -179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.582 ' HB3' HD23 ' A' ' 33' ' ' LEU . 1.1 t-20 -98.31 95.75 7.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.462 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.6 -21.55 61.11 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.084 178.051 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -79.05 -44.67 21.71 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.199 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -66.71 -41.2 88.37 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.227 -179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.553 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.45 174.29 6.27 Favored Pre-proline 0 C--N 1.327 -0.399 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 179.449 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.6 Cg_endo -54.05 127.82 27.26 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 121.742 1.628 . . . . 0.0 112.255 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -68.5 -38.97 10.18 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.759 2.306 . . . . 0.0 112.575 -179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.48 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -69.73 -9.59 55.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.023 0.44 . . . . 0.0 111.344 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -103.15 16.19 27.26 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.029 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.568 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -68.28 -32.67 4.08 Favored Pre-proline 0 N--CA 1.466 0.346 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -179.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 91.2 Cg_exo -44.44 -33.54 6.53 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 121.778 1.652 . . . . 0.0 112.718 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.887 HG11 ' CE2' ' A' ' 84' ' ' PHE . 12.9 t -77.8 -51.51 17.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.982 0.42 . . . . 0.0 111.003 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.882 HG22 ' HB2' ' A' ' 127' ' ' LYS . 17.3 mm -68.16 -33.61 61.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.67 -178.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.67 -27.35 39.48 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.874 0.369 . . . . 0.0 110.775 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.9 mmtt -80.54 -53.19 6.79 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.885 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.618 HD13 ' CD1' ' A' ' 68' ' ' PHE . 2.4 tp -78.23 -33.52 49.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.76 0.314 . . . . 0.0 111.628 -179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.882 ' HB2' HG22 ' A' ' 123' ' ' ILE . 28.3 ttpp -54.05 -42.64 69.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.026 0.441 . . . . 0.0 110.963 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.6 ttm180 -66.3 -10.09 39.16 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.694 178.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.626 HD21 HG23 ' A' ' 108' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.94 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 1.0 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A 5167 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A 5168 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.398 0 CA-C-O 120.794 0.33 . . . . 0.0 111.173 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.418 ' HG2' ' HA ' ' A' ' 78' ' ' ARG . 0.2 OUTLIER -74.0 147.39 42.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.963 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.32 138.67 38.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.368 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.744 HD13 " O4'" ' A' ' 131' ' ' 8OG . 3.7 pp -146.24 138.02 24.88 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.947 0.403 . . . . 0.0 111.713 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.455 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 29.2 mt-30 -104.11 152.83 21.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.987 179.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.704 HD11 " O4'" ' A' ' 131' ' ' 8OG . 47.8 mt -146.35 119.53 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.274 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.047 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.86 125.68 44.36 Favored 'General case' 0 CA--C 1.512 -0.498 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.677 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.8 m -132.79 162.45 39.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-O 121.478 0.656 . . . . 0.0 111.945 -178.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.462 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -149.36 118.66 0.97 Allowed Glycine 0 N--CA 1.442 -0.958 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.92 179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.063 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -70.27 109.76 3.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.461 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.716 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.7 OUTLIER -70.6 119.14 16.26 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 CA-C-O 121.062 0.458 . . . . 0.0 111.61 -178.478 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.706 ' HG2' HD11 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -82.65 118.57 23.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.75 -179.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.535 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 2.1 t-20 -78.21 -172.46 2.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.589 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.492 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 10.9 tt0 -83.44 4.86 25.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.571 -1.195 . . . . 0.0 112.368 -179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -140.58 52.15 1.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.837 0.351 . . . . 0.0 111.444 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 17.3 p30 46.26 23.23 0.19 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.683 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.684 ' C ' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -116.42 146.89 42.18 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.063 HG21 HG22 ' A' ' 10' ' ' ILE . 1.5 mp -112.49 144.34 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.298 0.571 . . . . 0.0 112.299 -178.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.45 ' CD1' ' HG2' ' A' ' 94' ' ' PRO . 0.6 OUTLIER -88.37 114.24 24.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.127 179.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.862 HG22 ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -118.71 137.7 51.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.236 179.902 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.43 ' HB ' ' O ' ' A' ' 100' ' ' GLN . 6.3 p -70.84 123.01 20.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.822 0.344 . . . . 0.0 111.033 -179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.566 ' HB3' HD13 ' A' ' 33' ' ' LEU . 5.0 ptt85 -148.2 154.13 39.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.099 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.756 ' CZ ' ' HB2' ' A' ' 30' ' ' ALA . 1.4 ttm180 45.24 -107.42 0.13 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.22 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.496 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 172.86 -52.49 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.88 0.372 . . . . 0.0 110.892 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -175.98 -40.43 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.066 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -172.77 100.26 0.14 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.852 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 61.99 110.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 63.5 t60 -177.37 -70.4 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.902 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.4 67.1 0.95 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.816 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.756 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . . . -60.89 -17.88 53.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.544 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -93.92 24.65 4.09 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.695 0.283 . . . . 0.0 111.41 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -114.25 26.14 10.51 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.018 0.437 . . . . 0.0 111.316 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.587 HD23 ' HB3' ' A' ' 111' ' ' ASN . 27.2 tp -73.55 64.67 0.89 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.103 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.862 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -114.99 -173.09 2.25 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.789 0.328 . . . . 0.0 111.213 179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.688 ' CD1' HG23 ' A' ' 10' ' ' ILE . 53.8 m-85 -90.42 159.95 40.45 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 112.514 0.561 . . . . 0.0 112.514 -178.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.677 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 97.8 Cg_endo -84.02 167.13 12.71 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.809 3.006 . . . . 0.0 111.852 179.072 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.757 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.12 -5.12 52.6 Favored Glycine 0 CA--C 1.523 0.572 0 C-N-CA 120.716 -0.754 . . . . 0.0 114.136 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.62 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -64.18 129.82 37.93 Favored Glycine 0 C--N 1.316 -0.582 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.848 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.62 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 108.97 2.31 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.1 0.56 . . . . 0.0 111.848 179.514 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.047 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.7 pt -49.05 -29.66 3.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.518 0.675 . . . . 0.0 110.747 179.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.597 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -38.16 -77.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.541 -1.209 . . . . 0.0 110.952 -179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.2 mmt 33.8 -85.27 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 O-C-N 123.623 0.577 . . . . 0.0 111.885 179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -175.0 32.93 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.663 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.479 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 1.3 mp0 -89.09 -172.9 3.84 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.731 0.301 . . . . 0.0 111.132 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.833 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.64 154.04 37.66 Favored Pre-proline 0 C--N 1.332 -0.17 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.288 179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.833 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.7 Cg_endo -43.76 -24.99 0.85 Allowed 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.803 2.335 . . . . 0.0 112.491 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.47 -43.59 5.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.55 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.405 ' O ' ' CB ' ' A' ' 52' ' ' ARG . 52.8 mm-40 -80.46 -4.84 55.33 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 1.039 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -61.15 -55.47 31.98 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.682 0.277 . . . . 0.0 111.035 -179.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.713 HG11 ' CE2' ' A' ' 85' ' ' TRP . 0.7 OUTLIER -78.52 -45.65 25.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.968 179.729 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.461 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 39.4 t -60.13 -44.89 96.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.003 -178.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.405 ' CB ' ' O ' ' A' ' 48' ' ' GLN . 9.2 tpp180 -78.07 -37.14 47.31 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.771 -0.372 . . . . 0.0 111.393 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.445 ' CG ' ' OE2' ' A' ' 57' ' ' GLU . 6.2 tp10 -78.04 -23.54 48.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.716 179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.868 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -51.67 -44.42 63.07 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 120.982 0.42 . . . . 0.0 109.988 179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.05 -28.85 62.91 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.468 178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 97' ' ' LYS . 0.9 OUTLIER -77.24 -30.67 54.6 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.314 179.447 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.448 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 16.3 mp0 -108.22 5.85 26.13 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -178.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.581 HG11 ' HG3' ' A' ' 62' ' ' PRO . 4.0 t -134.07 -44.88 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.024 0.44 . . . . 0.0 110.101 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.607 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 66.11 -38.32 0.15 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.56 -0.745 . . . . 0.0 114.577 178.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.747 HG23 ' CD1' ' A' ' 95' ' ' TRP . 21.3 pt -77.79 -176.03 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 120.99 0.424 . . . . 0.0 111.575 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -115.25 88.28 17.98 Favored Pre-proline 0 N--CA 1.446 -0.643 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.348 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.67 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 4.8 Cg_endo -112.44 146.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 123.568 2.845 . . . . 0.0 113.9 -177.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.513 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 13.1 mt-30 -74.82 80.2 2.1 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 175.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.868 ' NE2' HD21 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.36 136.78 54.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.134 -1.394 . . . . 0.0 111.578 -175.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.44 ' O ' ' O ' ' A' ' 86' ' ' LEU . 2.0 t80 178.71 -135.52 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.199 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.544 ' HB3' ' HB3' ' A' ' 86' ' ' LEU . 0.1 OUTLIER 55.94 166.49 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.147 0.498 . . . . 0.0 111.809 179.3 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 4.7 tt -129.14 114.95 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.683 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.1 OUTLIER -76.53 -52.91 8.86 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.528 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.603 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.8 tt0 -171.91 153.03 3.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.927 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.564 ' CD ' HD11 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -143.55 129.28 19.31 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 110.095 -0.335 . . . . 0.0 110.095 179.492 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.896 HD11 HG22 ' A' ' 122' ' ' VAL . 1.1 pp -130.91 159.13 38.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.014 0.435 . . . . 0.0 111.235 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.752 ' HG3' HG22 ' A' ' 81' ' ' THR . 1.8 mp0 -133.6 120.17 20.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.042 -179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.435 ' N ' ' CD1' ' A' ' 73' ' ' TYR . 1.7 p90 -141.17 147.59 38.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.595 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -121.13 112.32 18.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.106 0.479 . . . . 0.0 111.34 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.504 ' O ' ' N ' ' A' ' 77' ' ' ASP . 2.4 m-85 -69.96 162.86 65.74 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.355 179.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 8.7 Cg_endo -50.3 81.37 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.058 2.505 . . . . 0.0 112.342 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 75' ' ' PHE . 7.0 m-20 91.15 13.32 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.814 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.606 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 21.3 ttp180 -137.45 102.01 4.66 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.613 0.244 . . . . 0.0 110.935 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -86.98 113.06 22.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.779 0.323 . . . . 0.0 110.904 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.995 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 2.3 tt -120.22 118.83 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.091 -179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.752 HG22 ' HG3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -97.58 118.77 34.83 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 178.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.856 ' HG ' HG21 ' A' ' 122' ' ' VAL . 0.0 OUTLIER -113.83 114.61 26.51 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -178.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.413 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 8.8 m0 -113.35 122.38 47.21 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.793 -0.64 . . . . 0.0 109.965 178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.603 ' HB2' ' O ' ' A' ' 69' ' ' GLU . 4.1 m-30 -106.89 133.22 51.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.034 179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.713 ' CE2' HG11 ' A' ' 50' ' ' VAL . 16.9 m95 -118.65 149.14 41.91 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.445 -178.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.544 ' HB3' ' HB3' ' A' ' 66' ' ' SER . 0.0 OUTLIER -102.07 103.79 14.39 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 121.48 0.657 . . . . 0.0 112.306 -178.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.83 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.3 t -79.77 146.26 8.02 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.614 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.995 179.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -114.34 -23.99 9.12 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.513 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -162.43 161.01 27.05 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 118.623 0.647 . . . . 0.0 111.371 -179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.716 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.2 OUTLIER -157.07 125.98 5.86 Favored 'General case' 0 N--CA 1.456 -0.152 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.404 179.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -74.5 140.31 44.44 Favored 'General case' 0 C--O 1.231 0.092 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.242 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.77 -130.03 47.94 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.763 179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.694 ' O ' HG21 ' A' ' 60' ' ' ILE . 4.9 tt0 -121.01 137.4 26.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.462 -0.199 . . . . 0.0 110.462 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 93' ' ' GLU . 2.8 Cg_exo -76.18 128.9 10.89 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.702 2.268 . . . . 0.0 111.562 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.747 ' CD1' HG23 ' A' ' 60' ' ' ILE . 50.0 p-90 -119.5 -60.04 1.77 Allowed 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.975 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.573 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.0 -103.93 0.06 OUTLIER Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.973 -179.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER 172.28 37.36 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.722 0.296 . . . . 0.0 111.097 -179.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.416 ' HB2' HG21 ' A' ' 21' ' ' THR . 1.3 mp0 -59.25 -48.98 79.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.802 0.334 . . . . 0.0 110.762 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 165.86 -76.9 0.14 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.83 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.43 ' O ' ' HB ' ' A' ' 21' ' ' THR . 1.8 pm0 -118.79 124.14 28.58 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.071 0.462 . . . . 0.0 111.318 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_exo -43.29 145.95 1.28 Allowed 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.994 2.463 . . . . 0.0 112.647 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.39 177.36 16.8 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.926 -179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -125.14 157.23 36.9 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.417 -0.216 . . . . 0.0 110.417 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.457 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.7 OUTLIER -69.18 106.51 2.87 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.867 0.365 . . . . 0.0 110.322 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.408 ' SD ' HD11 ' A' ' 33' ' ' LEU . 2.0 ptp -120.19 163.24 18.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.106 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 23.7 p -81.64 114.94 20.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.472 179.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.607 ' HG ' HG21 ' A' ' 10' ' ' ILE . 0.2 OUTLIER -68.05 -18.69 64.76 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.456 -179.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.7 p -54.01 -19.26 2.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.513 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -143.51 55.5 0.57 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.227 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.707 HD22 ' CD1' ' A' ' 123' ' ' ILE . 2.0 tt -62.37 151.02 38.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.908 0.385 . . . . 0.0 110.967 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.587 ' HB3' HD23 ' A' ' 33' ' ' LEU . 1.6 t-20 -92.44 92.87 8.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.092 -0.504 . . . . 0.0 112.048 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.516 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -71.36 -18.89 62.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.153 0.501 . . . . 0.0 110.142 178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -78.89 -44.39 22.87 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.513 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.84 -41.36 87.56 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.816 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.615 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -78.78 170.06 17.89 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.497 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 34' ' ' GLU . 9.3 Cg_endo -54.14 127.63 26.53 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.131 1.887 . . . . 0.0 112.791 -177.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.13 -34.85 15.71 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.73 2.287 . . . . 0.0 111.995 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.678 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -70.33 -9.96 57.64 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.877 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -109.53 14.09 23.66 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.183 179.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.615 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.3 OUTLIER -76.1 -30.99 0.94 Allowed Pre-proline 0 N--CA 1.466 0.334 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -179.291 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 65.7 Cg_exo -43.61 -39.99 10.31 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.062 1.841 . . . . 0.0 113.831 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.896 HG22 HD11 ' A' ' 71' ' ' LEU . 1.5 t -77.91 -51.58 17.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.99 0.424 . . . . 0.0 111.598 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.707 ' CD1' HD22 ' A' ' 110' ' ' LEU . 0.4 OUTLIER -69.13 -29.45 42.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.623 -179.059 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.45 -31.34 55.31 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.009 0.433 . . . . 0.0 110.086 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -66.74 -47.02 73.55 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.155 179.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.848 ' O ' HD13 ' A' ' 126' ' ' LEU . 2.3 tm? -78.49 -20.03 51.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.032 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.425 ' CD ' ' HB3' ' A' ' 112' ' ' ALA . 23.0 tttm -74.48 -42.53 58.85 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.095 0.474 . . . . 0.0 110.445 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 61.8 ttp85 -64.65 -11.03 31.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.904 178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.744 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.104 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.58 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.995 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A 5179 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A 5180 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.486 1.351 0 CA-C-O 120.842 0.353 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.13 119.87 32.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.894 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.05 133.95 30.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.876 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 4' ' ' LEU . 3.4 pp -146.15 121.95 10.58 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.099 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.401 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 32.6 mt-30 -102.89 151.32 22.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.241 0.543 . . . . 0.0 112.059 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.553 HD11 " H4'" ' A' ' 131' ' ' 8OG . 3.2 mp -146.48 128.93 8.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.279 179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.108 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.13 125.58 43.96 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.559 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -137.13 162.16 34.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 120.313 -0.555 . . . . 0.0 111.381 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.462 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.04 127.86 2.45 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.045 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.714 HG22 HG21 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -70.76 110.8 4.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.639 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.714 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -70.93 119.72 17.64 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.891 -179.168 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.92 121.01 26.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.744 -179.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 14' ' ' GLU . 2.5 t-20 -81.31 -172.56 3.86 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.52 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.506 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 22.2 tt0 -81.98 3.65 25.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.743 -1.117 . . . . 0.0 112.398 -179.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 36.4 t30 -139.74 51.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.823 0.344 . . . . 0.0 111.385 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 46.34 24.58 0.3 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.195 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 17.0 pt-20 -116.96 144.52 44.46 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.714 HG21 HG22 ' A' ' 10' ' ' ILE . 5.6 mt -116.03 145.18 22.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.172 0.511 . . . . 0.0 111.841 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.459 ' CD2' ' HG2' ' A' ' 94' ' ' PRO . 0.0 OUTLIER -89.83 111.08 21.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.367 179.52 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.45 ' CG2' ' CD2' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -113.49 142.86 24.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.182 179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.49 HG22 ' OE2' ' A' ' 98' ' ' GLU . 1.4 p -70.84 114.42 8.89 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 110.231 -0.285 . . . . 0.0 110.231 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.412 ' HA ' ' HA ' ' A' ' 33' ' ' LEU . 6.0 ttt85 -130.33 136.27 48.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.522 -179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.582 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 29.4 mtp180 51.74 -113.26 0.72 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.35 -0.387 . . . . 0.0 110.086 -179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 166.27 -176.44 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.31 -31.52 62.51 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.72 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -139.63 -176.22 4.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.549 179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.88 -159.66 0.29 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.918 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -104.52 -84.2 0.49 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.664 -0.244 . . . . 0.0 110.917 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER 47.6 29.29 1.41 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.802 0.334 . . . . 0.0 111.129 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -58.62 -23.27 58.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.577 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -97.66 29.78 3.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.142 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -114.1 25.98 10.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.092 0.472 . . . . 0.0 111.403 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.543 HD13 ' CB ' ' A' ' 111' ' ' ASN . 1.2 tt -67.48 76.05 0.17 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.792 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -118.88 -169.0 1.65 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.933 0.397 . . . . 0.0 111.464 -179.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.678 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.28 168.46 9.93 Favored Pre-proline 0 CA--C 1.53 0.199 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.461 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.559 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 74.0 Cg_endo -77.72 167.06 24.58 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 123.372 2.714 . . . . 0.0 112.953 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.611 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.11 -5.45 52.94 Favored Glycine 0 C--O 1.224 -0.514 0 CA-C-N 115.644 -0.707 . . . . 0.0 113.71 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.44 145.28 48.76 Favored Glycine 0 C--N 1.315 -0.595 0 C-N-CA 121.184 -0.532 . . . . 0.0 113.302 179.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 89.62 9.91 0.08 Allowed 'General case' 0 C--N 1.342 0.257 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 178.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.108 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.1 pt -57.84 -27.27 30.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.567 0.699 . . . . 0.0 110.051 178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.506 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -37.04 -77.92 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.416 -1.266 . . . . 0.0 111.31 -179.919 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 36.05 -87.85 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.938 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.07 33.58 0.07 OUTLIER Glycine 0 C--N 1.335 0.5 0 C-N-CA 120.608 -0.806 . . . . 0.0 112.989 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.474 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.2 OUTLIER -92.47 -166.23 1.5 Allowed 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.54 0.21 . . . . 0.0 110.897 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.856 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -98.89 154.35 37.41 Favored Pre-proline 0 N--CA 1.456 -0.157 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.856 ' HD2' HG22 ' A' ' 45' ' ' THR . 2.1 Cg_endo -43.93 -24.81 0.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.704 2.269 . . . . 0.0 112.362 179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.613 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -98.34 -49.83 4.54 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.046 0.388 . . . . 0.0 112.046 -179.511 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -80.71 -8.89 59.8 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.774 ' CB ' HD12 ' A' ' 40' ' ' ILE . . . -61.62 -57.24 12.81 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.843 0.354 . . . . 0.0 110.484 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.613 ' O ' ' HB2' ' A' ' 54' ' ' LEU . 1.2 p -78.61 -46.61 24.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.553 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.716 179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 47' ' ' GLU . 55.3 t -50.69 -38.81 17.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 120.754 0.312 . . . . 0.0 111.387 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -78.89 -52.2 8.63 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.799 -179.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.413 ' CG ' ' HA ' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -69.59 -19.8 63.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.19 -179.777 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.91 HD11 ' CE1' ' A' ' 64' ' ' HIS . 23.0 tp -58.74 -45.81 88.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.521 -179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.445 ' O ' ' N ' ' A' ' 59' ' ' GLY . 0.0 OUTLIER -66.46 -26.69 67.32 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.004 0.43 . . . . 0.0 110.095 178.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -65.63 -24.57 67.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.602 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.508 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.54 5.64 25.3 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 -178.915 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.036 HG12 HD11 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -133.49 -44.28 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.138 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.562 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 68.85 -35.24 0.28 Allowed Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 115.251 0.86 . . . . 0.0 115.251 178.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.036 HD11 HG12 ' A' ' 58' ' ' VAL . 0.5 OUTLIER -77.95 -172.79 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-O 120.893 0.377 . . . . 0.0 110.909 -179.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -113.02 88.82 12.65 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.412 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.675 ' CB ' ' HA ' ' A' ' 90' ' ' TRP . 7.3 Cg_endo -108.36 149.3 0.07 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 123.28 2.653 . . . . 0.0 113.787 -177.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.552 ' HG2' ' HB3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -77.88 81.16 4.31 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 175.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.91 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -125.61 134.98 51.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.087 -175.449 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.506 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.6 t80 179.83 -142.83 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.657 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 3.1 t 50.82 175.98 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 122.975 0.51 . . . . 0.0 111.95 179.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.843 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -141.88 124.9 16.22 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.02 179.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.469 ' CE2' ' HB2' ' A' ' 126' ' ' LEU . 0.0 OUTLIER -76.97 -51.14 11.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.52 . . . . 0.0 109.985 179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 1.7 mt-10 -171.73 131.64 0.7 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.35 179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.26 119.46 39.3 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.791 0.329 . . . . 0.0 110.64 179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.691 ' CB ' HG22 ' A' ' 122' ' ' VAL . 0.5 OUTLIER -99.64 123.67 44.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.863 -179.834 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -122.52 109.56 14.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.927 0.394 . . . . 0.0 110.793 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.548 ' OH ' HD13 ' A' ' 80' ' ' ILE . 1.8 p90 -141.43 137.59 32.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.486 179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.464 ' HB3' ' CD2' ' A' ' 79' ' ' HIS . 2.5 pt-20 -121.24 125.21 46.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.156 0.503 . . . . 0.0 111.462 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.471 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 2.6 m-85 -71.92 163.4 67.06 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.895 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.471 ' HD2' ' CD2' ' A' ' 75' ' ' PHE . 1.8 Cg_endo -39.28 -27.76 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.434 2.756 . . . . 0.0 112.97 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -139.78 -37.08 0.49 Allowed 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.209 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.552 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 33.2 ttp180 -85.91 103.42 14.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.489 -179.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.464 ' CD2' ' HB3' ' A' ' 74' ' ' GLU . 9.4 t-160 -91.15 100.27 13.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.846 0.355 . . . . 0.0 110.425 179.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.893 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 6.2 tt -101.88 146.2 10.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.091 0.472 . . . . 0.0 111.252 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.523 HG22 ' HE1' ' A' ' 83' ' ' TRP . 0.3 OUTLIER -134.15 118.74 18.01 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.696 179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.527 HD23 ' HB ' ' A' ' 6' ' ' ILE . 13.5 mt -121.17 114.2 21.08 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.992 0.425 . . . . 0.0 111.763 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.523 ' HE1' HG22 ' A' ' 81' ' ' THR . 10.7 m0 -109.44 122.06 46.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.774 178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.666 ' CD2' HG11 ' A' ' 122' ' ' VAL . 7.7 m-30 -107.21 114.72 28.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.873 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.843 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 23.8 m95 -94.35 148.24 22.41 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.044 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.547 HD13 ' C ' ' A' ' 86' ' ' LEU . 3.5 tm? -98.48 102.91 14.79 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.454 0.645 . . . . 0.0 111.463 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.82 HG13 ' CB ' ' A' ' 64' ' ' HIS . 13.3 t -82.36 145.74 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.663 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.03 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -114.79 -23.56 9.11 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.552 ' HB3' ' HG2' ' A' ' 63' ' ' GLN . 8.6 ttt180 -162.59 164.54 26.68 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.369 -0.532 . . . . 0.0 111.507 -179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.714 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.4 OUTLIER -157.14 124.42 5.24 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.248 178.631 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -75.19 146.25 41.4 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.116 -179.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.65 -130.44 48.32 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.574 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.52 ' O ' HG12 ' A' ' 60' ' ' ILE . 44.3 mt-10 -121.52 141.43 33.45 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 110.62 -0.141 . . . . 0.0 110.62 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.596 ' HA ' HD11 ' A' ' 60' ' ' ILE . 2.7 Cg_exo -75.63 131.52 13.67 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.827 2.351 . . . . 0.0 111.143 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.562 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 41.0 p-90 -133.49 -65.76 0.67 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.58 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 45.23 -96.8 0.01 OUTLIER Glycine 0 CA--C 1.521 0.41 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.876 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.45 ' H ' ' HA ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER 173.36 36.47 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 120.645 0.26 . . . . 0.0 111.341 -179.843 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.49 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -56.06 -43.99 78.46 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.804 0.335 . . . . 0.0 110.866 179.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.49 -82.88 0.25 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.717 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.88 111.54 48.7 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 120.917 0.389 . . . . 0.0 111.389 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -43.42 146.21 1.3 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.003 2.469 . . . . 0.0 112.625 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -124.21 177.19 16.82 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.808 -179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -139.21 157.28 46.2 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.4 OUTLIER -60.33 106.57 0.55 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.92 0.39 . . . . 0.0 110.086 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.409 ' O ' ' N ' ' A' ' 18' ' ' ILE . 2.3 mtm -120.09 163.37 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.159 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.97 114.87 23.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.409 179.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 107' ' ' LEU . 0.2 OUTLIER -69.62 -18.71 63.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.529 -179.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.42 -14.82 3.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.673 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.98 53.52 0.7 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.154 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.437 HD11 ' CZ ' ' A' ' 35' ' ' PHE . 4.7 tt -62.4 150.59 39.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.008 0.432 . . . . 0.0 110.948 -179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.543 ' CB ' HD13 ' A' ' 33' ' ' LEU . 1.1 t-20 -95.35 93.47 7.27 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.439 -179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.506 ' HB2' HG21 ' A' ' 123' ' ' ILE . . . -72.29 -20.71 61.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.014 178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.08 -45.22 20.53 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.128 179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -66.79 -39.98 87.96 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.369 -179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.564 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.44 173.99 6.75 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.3 Cg_endo -54.08 127.8 27.19 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 121.918 1.745 . . . . 0.0 112.607 -178.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 52.1 Cg_endo -69.15 -35.16 15.0 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 122.752 2.301 . . . . 0.0 112.353 -179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.787 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -71.9 -9.63 58.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.074 0.464 . . . . 0.0 111.168 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 40.0 m-20 -105.76 17.62 23.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.949 -179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.574 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -76.0 -31.05 0.96 Allowed Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -179.185 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 80.0 Cg_exo -43.55 -34.28 5.13 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 121.877 1.718 . . . . 0.0 113.064 -178.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.691 HG22 ' CB ' ' A' ' 71' ' ' LEU . 16.0 t -77.96 -47.28 25.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.275 0.56 . . . . 0.0 110.253 178.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.678 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 35.6 mm -68.9 -31.28 49.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.244 -0.889 . . . . 0.0 111.413 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -55.05 -26.88 40.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.936 0.398 . . . . 0.0 110.344 179.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.93 -47.71 14.58 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.345 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.575 HD13 ' O ' ' A' ' 126' ' ' LEU . 2.4 tm? -78.18 -45.95 21.78 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.893 0.378 . . . . 0.0 111.329 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.589 ' HB2' HG22 ' A' ' 123' ' ' ILE . 8.8 tttm -52.68 -42.27 64.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.127 -179.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -63.93 -8.07 10.19 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.971 178.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.11 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.337 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.893 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A 5191 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A 5192 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.3 ttp . . . . . 0 N--CA 1.486 1.361 0 CA-C-O 120.862 0.363 . . . . 0.0 111.179 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.527 ' HE3' HD23 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -109.81 146.95 34.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.93 179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.458 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.05 132.04 27.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.856 179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.527 HD23 ' HE3' ' A' ' 2' ' ' LYS . 3.1 pp -146.14 127.14 14.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.376 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.406 ' H ' ' HB3' ' A' ' 41' ' ' GLU . 14.9 mt-30 -102.65 154.48 19.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.062 0.458 . . . . 0.0 111.46 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.601 ' HB ' HD12 ' A' ' 82' ' ' LEU . 1.8 mp -146.42 119.12 2.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.835 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.04 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -124.93 125.69 44.33 Favored 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.567 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.1 m -134.76 162.44 38.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.312 0.577 . . . . 0.0 112.041 -178.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -134.7 111.12 0.9 Allowed Glycine 0 N--CA 1.443 -0.895 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.277 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.843 HD12 ' O ' ' A' ' 85' ' ' TRP . 0.4 OUTLIER -70.47 103.18 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 -179.657 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.689 HG22 ' HE3' ' A' ' 90' ' ' TRP . 0.9 OUTLIER -71.41 125.76 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.23 -178.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.479 ' HA ' ' HA ' ' A' ' 18' ' ' ILE . 0.0 OUTLIER -100.47 139.32 36.32 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.123 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.669 ' HB3' ' CH2' ' A' ' 90' ' ' TRP . 3.9 p-10 -98.74 -173.37 2.51 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 121.523 0.678 . . . . 0.0 112.234 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -68.49 -3.96 13.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.779 -1.101 . . . . 0.0 113.869 -178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.473 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 58.1 t30 -120.11 37.54 4.2 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -178.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 53.97 15.94 0.98 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.886 0.374 . . . . 0.0 111.579 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 15' ' ' ASN . 1.2 mm-40 -102.02 161.2 13.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.838 HG12 HG22 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.47 131.26 73.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.164 0.506 . . . . 0.0 111.801 -178.64 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.2 OUTLIER -83.09 116.51 22.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.717 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.671 HD12 HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -129.27 147.22 33.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.556 179.97 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.401 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 29.2 p -70.78 111.91 6.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.263 179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 29.1 ttm180 -122.97 126.65 47.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.841 -179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 0.0 OUTLIER 48.97 -106.74 0.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.641 179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 168.44 -167.37 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.813 0.34 . . . . 0.0 110.742 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -98.19 24.79 6.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.08 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.3 p30 179.55 164.09 1.0 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.821 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 58.54 -168.1 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.057 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -96.75 -99.79 0.18 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.817 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.1 mtp 47.05 41.53 11.32 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-O 120.899 0.38 . . . . 0.0 111.137 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -72.14 -8.76 56.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.774 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 2.5 t-20 -91.26 25.25 2.6 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.37 26.09 10.53 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.757 0.313 . . . . 0.0 111.777 -179.783 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.671 HD21 HD12 ' A' ' 20' ' ' ILE . 2.6 tt -67.19 66.17 0.07 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.044 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.497 ' O ' HG22 ' A' ' 20' ' ' ILE . 0.4 OUTLIER -106.86 -170.17 1.67 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.223 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.665 ' HZ ' HD11 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -119.21 168.33 10.15 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.541 -179.487 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.567 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 97.0 Cg_endo -84.12 166.55 12.74 Favored 'Trans proline' 0 N--CA 1.462 -0.363 0 C-N-CA 123.433 2.755 . . . . 0.0 113.001 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.572 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.01 -6.08 53.75 Favored Glycine 0 C--O 1.225 -0.453 0 CA-C-N 115.894 -0.594 . . . . 0.0 114.096 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -61.79 167.45 15.45 Favored Glycine 0 CA--C 1.52 0.348 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.509 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.67 1.5 1.21 Allowed 'General case' 0 C--N 1.34 0.163 0 C-N-CA 122.448 0.299 . . . . 0.0 111.795 179.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.04 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -52.8 -27.06 11.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.495 0.665 . . . . 0.0 110.433 179.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.55 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.2 OUTLIER -40.21 -61.44 0.89 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 114.596 -1.184 . . . . 0.0 111.025 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.509 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.0 OUTLIER 11.07 -81.66 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 O-C-N 123.907 0.754 . . . . 0.0 112.467 179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -176.0 32.33 0.09 OUTLIER Glycine 0 C--N 1.331 0.298 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.862 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.454 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 2.1 mp0 -93.48 -172.94 3.06 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 120.653 0.263 . . . . 0.0 111.191 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.853 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -101.59 153.64 37.76 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.323 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.853 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.9 Cg_endo -43.98 -24.82 0.93 Allowed 'Trans proline' 0 N--CA 1.462 -0.329 0 C-N-CA 122.809 2.339 . . . . 0.0 112.615 179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.622 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -100.93 -43.68 5.99 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.461 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -80.09 -20.84 44.19 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.714 0.292 . . . . 0.0 111.644 -179.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.835 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -56.38 -48.48 76.78 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.814 0.34 . . . . 0.0 111.036 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.798 HG12 ' HB1' ' A' ' 7' ' ' ALA . 1.0 OUTLIER -78.29 -47.87 23.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.964 179.697 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 47' ' ' GLU . 40.3 t -59.66 -44.11 92.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.59 -178.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.407 ' NH1' ' HB3' ' A' ' 52' ' ' ARG . 17.9 mtp-105 -73.25 -41.15 64.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.93 0.395 . . . . 0.0 110.821 -179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.441 ' O ' ' N ' ' A' ' 57' ' ' GLU . 4.6 tp10 -73.5 -19.73 60.85 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.819 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.759 HD11 ' CE1' ' A' ' 64' ' ' HIS . 5.9 tp -60.04 -44.65 94.51 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.733 0.301 . . . . 0.0 110.962 -179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -65.69 -36.19 82.92 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -77.38 -24.66 50.54 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.911 179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' HG3' ' HA2' ' A' ' 37' ' ' GLY . 12.0 mm-40 -108.26 5.75 25.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 120.649 -0.421 . . . . 0.0 112.03 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.886 HG12 HG13 ' A' ' 60' ' ' ILE . 60.1 t -134.16 -44.26 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 178.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 68.48 -40.04 0.28 Allowed Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.332 -0.849 . . . . 0.0 114.091 178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.886 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -77.74 -177.78 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-O 121.132 0.492 . . . . 0.0 111.217 -179.359 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -113.82 88.71 14.57 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.914 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.703 ' HG3' HG11 ' A' ' 58' ' ' VAL . 3.1 Cg_endo -111.49 145.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.365 0 C-N-CA 123.415 2.744 . . . . 0.0 114.207 -177.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.547 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 32.6 mt-30 -74.92 79.93 2.15 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.759 ' CE1' HD11 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -121.34 129.56 53.14 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.094 -1.412 . . . . 0.0 110.389 -176.501 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.525 ' O ' ' HB2' ' A' ' 66' ' ' SER . 2.0 t80 179.91 166.02 1.21 Allowed 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.709 ' HB3' HD21 ' A' ' 86' ' ' LEU . 50.9 m 82.92 152.18 0.1 Allowed 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.407 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.692 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 1.3 pp -107.66 134.68 50.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 0.0 111.973 -178.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.684 ' CE2' HD12 ' A' ' 126' ' ' LEU . 0.0 OUTLIER -81.94 -44.89 16.15 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 178.973 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.538 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -171.93 131.68 0.67 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.098 178.805 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.614 ' HE2' HD22 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -135.79 103.88 5.56 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.691 0.281 . . . . 0.0 110.733 -179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.772 HD22 ' N ' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -111.66 169.37 8.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.104 0.478 . . . . 0.0 111.467 -179.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.772 ' N ' HD22 ' A' ' 71' ' ' LEU . 8.2 tt0 -137.84 124.89 21.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.443 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.674 ' OH ' HD13 ' A' ' 80' ' ' ILE . 2.1 p90 -138.11 120.06 15.44 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.796 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 0.3 OUTLIER -94.7 139.35 31.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.06 0.457 . . . . 0.0 111.423 -179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.488 ' CD2' ' HD2' ' A' ' 76' ' ' PRO . 2.2 m-85 -103.94 162.47 19.82 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.218 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.527 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 10.9 Cg_endo -54.18 82.11 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.95 2.433 . . . . 0.0 112.117 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.527 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.7 t70 94.84 7.07 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.543 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.52 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.4 OUTLIER -137.26 93.72 2.85 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.576 0.227 . . . . 0.0 110.592 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.458 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 11.5 t-160 -85.69 99.36 11.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.762 0.315 . . . . 0.0 110.871 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.942 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 4.2 tt -103.04 135.5 40.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.981 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.72 118.78 31.81 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.356 178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.66 HD13 HD11 ' A' ' 80' ' ' ILE . 1.1 mp -113.08 114.06 26.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.897 0.379 . . . . 0.0 111.727 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.507 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 9.7 m0 -111.6 122.04 46.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.743 178.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.654 ' CE1' HG11 ' A' ' 122' ' ' VAL . 1.7 m-85 -109.68 109.94 20.83 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.469 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.843 ' O ' HD12 ' A' ' 10' ' ' ILE . 19.8 m95 -95.91 148.79 22.26 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.76 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.709 HD21 ' HB3' ' A' ' 66' ' ' SER . 1.4 pp -95.69 138.77 32.89 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 121.162 0.506 . . . . 0.0 111.709 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.752 HG13 ' CB ' ' A' ' 64' ' ' HIS . 38.4 t -123.33 145.66 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.733 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.368 -179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -113.82 -21.63 10.58 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.547 ' HB3' ' HB2' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -162.92 160.16 24.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.707 0.685 . . . . 0.0 111.473 -179.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.689 ' HE3' HG22 ' A' ' 11' ' ' ILE . 0.1 OUTLIER -157.06 122.61 4.69 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.254 179.022 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 -75.82 150.69 37.64 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.138 -179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 55.48 -129.92 47.21 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.526 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -125.21 145.8 51.86 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.507 0.194 . . . . 0.0 110.653 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.461 ' HA ' HD11 ' A' ' 60' ' ' ILE . 3.8 Cg_exo -76.48 128.74 10.53 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.761 2.307 . . . . 0.0 111.573 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.556 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 56.7 p-90 -132.34 -59.91 0.91 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.838 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.634 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 36.77 -97.89 0.01 OUTLIER Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.093 -0.575 . . . . 0.0 113.195 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.3 tttp 178.43 38.8 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.7 0.285 . . . . 0.0 111.153 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 98' ' ' GLU . 0.0 OUTLIER -60.51 -49.05 79.12 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.263 179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 143.28 -49.83 0.71 Allowed Glycine 0 CA--C 1.52 0.369 0 C-N-CA 120.262 -0.97 . . . . 0.0 113.345 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -131.77 118.98 16.86 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.124 0.488 . . . . 0.0 111.966 -179.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -43.79 146.37 1.55 Allowed 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.211 2.608 . . . . 0.0 112.807 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -126.97 177.23 17.45 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.723 -0.751 . . . . 0.0 113.092 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 105' ' ' MET . 1.6 mt-10 -137.43 157.79 45.82 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 122.306 0.242 . . . . 0.0 110.383 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.409 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.1 OUTLIER -65.0 106.39 1.24 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.75 0.31 . . . . 0.0 110.259 -179.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.45 ' HG2' ' O ' ' A' ' 103' ' ' GLU . 0.1 OUTLIER -120.0 157.14 29.47 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.796 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.439 ' HB2' HG12 ' A' ' 108' ' ' VAL . 1.4 p -75.63 114.93 14.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.666 179.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.86 ' O ' HD13 ' A' ' 107' ' ' LEU . 2.5 tm? -75.38 -18.77 59.87 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.503 -179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.439 HG12 ' HB2' ' A' ' 106' ' ' SER . 11.9 p -59.16 -12.58 3.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.737 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -141.79 54.3 0.62 Allowed Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.367 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.598 HD22 HD12 ' A' ' 123' ' ' ILE . 9.2 tt -62.0 150.36 38.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.595 0.236 . . . . 0.0 110.554 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.59 ' N ' HD23 ' A' ' 110' ' ' LEU . 0.7 OUTLIER -108.19 115.88 30.94 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -178.581 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.549 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.34 -18.9 61.73 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.012 178.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -79.09 -47.83 15.43 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.881 179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.507 ' HB3' HD12 ' A' ' 33' ' ' LEU . 0.1 OUTLIER -66.86 -17.39 64.87 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.645 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.549 ' CD1' ' HA ' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -106.45 173.67 3.02 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.399 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.17 127.92 27.78 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 121.938 1.759 . . . . 0.0 112.405 -178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.418 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.0 Cg_endo -69.04 -38.32 9.56 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.756 2.304 . . . . 0.0 112.664 -179.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.836 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -69.94 -9.72 56.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.977 0.418 . . . . 0.0 111.308 179.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.474 ' C ' ' HD2' ' A' ' 121' ' ' PRO . 29.2 m-20 -104.42 15.3 28.46 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.922 -179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.545 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.3 OUTLIER -63.32 -31.59 7.01 Favored Pre-proline 0 N--CA 1.467 0.381 0 N-CA-C 114.121 1.156 . . . . 0.0 114.121 -178.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.545 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 71.3 Cg_exo -43.78 -40.38 11.13 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.793 1.662 . . . . 0.0 113.54 -178.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.715 HG22 ' CD1' ' A' ' 71' ' ' LEU . 74.6 t -78.0 -51.55 17.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.915 0.388 . . . . 0.0 111.379 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.665 HD11 ' HZ ' ' A' ' 35' ' ' PHE . 38.7 mm -66.13 -31.88 55.63 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.595 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.86 -32.33 60.56 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.862 0.363 . . . . 0.0 110.676 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -80.44 -46.16 16.41 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.52 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.788 HD11 HD11 ' A' ' 107' ' ' LEU . 0.4 OUTLIER -78.34 -19.77 52.78 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.399 -179.703 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.566 ' HB2' HG22 ' A' ' 123' ' ' ILE . 22.2 tttm -74.31 -42.45 59.47 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.128 0.489 . . . . 0.0 110.593 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 43.9 ttt180 -68.29 -8.95 44.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.936 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.786 HD22 ' O ' ' A' ' 126' ' ' LEU . 0.1 OUTLIER . . . . . 0 CA--C 1.529 0.15 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.621 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.942 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A 5203 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A 5204 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ttm . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.795 0.331 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.22 140.17 31.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.433 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.0 OUTLIER -140.35 131.23 26.0 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.489 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.641 HD12 ' HA ' ' A' ' 80' ' ' ILE . 1.4 pp -146.15 140.55 26.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.908 0.385 . . . . 0.0 111.661 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.717 ' C ' HD12 ' A' ' 6' ' ' ILE . 30.9 mt-30 -104.67 152.86 21.97 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.213 0.53 . . . . 0.0 111.255 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.738 ' HB ' HD12 ' A' ' 82' ' ' LEU . 4.4 mp -146.18 116.36 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.51 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 1.012 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.33 133.07 52.72 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 178.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.631 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.3 m -144.61 162.73 14.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.013 0.435 . . . . 0.0 111.773 -179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.441 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -139.22 115.15 1.08 Allowed Glycine 0 N--CA 1.447 -0.62 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.855 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.02 HG22 HG21 ' A' ' 18' ' ' ILE . 0.0 OUTLIER -71.28 107.25 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.715 HG22 ' HE3' ' A' ' 90' ' ' TRP . 1.0 OUTLIER -71.16 127.29 32.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.93 0.395 . . . . 0.0 111.132 -179.189 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -90.08 123.45 33.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.622 -179.594 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.49 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 12.3 t-20 -78.28 -172.16 2.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 114.795 -1.093 . . . . 0.0 112.117 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -82.18 -3.1 54.27 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.106 -1.406 . . . . 0.0 112.271 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 60.8 t30 -129.96 36.37 4.04 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.901 0.334 . . . . 0.0 111.901 -179.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.64 7.59 3.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.743 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.44 ' O ' ' HB2' ' A' ' 13' ' ' ASN . 17.8 pt-20 -100.85 153.05 19.81 Favored 'General case' 0 C--O 1.221 -0.4 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.02 HG21 HG22 ' A' ' 10' ' ' ILE . 4.8 mt -115.89 140.56 37.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.17 0.509 . . . . 0.0 111.994 -178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.49 ' C ' ' CD1' ' A' ' 19' ' ' PHE . 0.3 OUTLIER -89.26 102.14 14.8 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.436 179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.619 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -115.29 162.13 13.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.263 179.531 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.581 HG22 ' OE2' ' A' ' 98' ' ' GLU . 5.8 p -71.07 121.2 17.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.786 0.327 . . . . 0.0 110.759 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -98.38 172.31 7.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.807 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.931 ' CZ ' ' HB2' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -62.41 -10.16 10.57 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.449 179.896 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 23' ' ' ARG . . . 80.42 3.0 1.86 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.709 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . 50.46 29.92 4.28 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.739 0.304 . . . . 0.0 111.321 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -107.49 13.87 26.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.397 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 53.34 30.15 9.78 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.77 0.319 . . . . 0.0 111.33 179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -97.71 -68.85 0.78 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.926 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -124.09 92.69 3.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.923 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.931 ' HB2' ' CZ ' ' A' ' 23' ' ' ARG . . . -78.44 -8.91 59.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.608 -179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.3 OUTLIER -113.07 25.38 11.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.574 0.226 . . . . 0.0 111.28 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.43 25.98 10.61 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.96 0.41 . . . . 0.0 111.799 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.469 HD12 ' O ' ' A' ' 21' ' ' THR . 22.1 tp -76.36 78.79 3.11 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.272 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -114.52 -166.63 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.045 0.45 . . . . 0.0 111.52 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.619 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.52 168.36 10.26 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.157 -179.596 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.631 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 71.7 Cg_endo -77.5 166.9 25.19 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.238 2.625 . . . . 0.0 112.903 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.579 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 102.31 -5.58 52.46 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-N 115.71 -0.677 . . . . 0.0 114.242 179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -63.51 156.44 42.64 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 117.176 0.488 . . . . 0.0 112.844 179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.491 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 93.75 -1.06 0.09 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.034 0.534 . . . . 0.0 111.875 179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 1.012 HG21 ' HB3' ' A' ' 7' ' ' ALA . 1.2 pt -53.37 -26.01 11.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.375 0.607 . . . . 0.0 110.929 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.495 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.99 -62.85 0.75 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.913 179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.495 ' C ' ' O ' ' A' ' 41' ' ' GLU . 2.2 mtm 12.24 -83.68 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.527 -0.761 . . . . 0.0 112.562 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -179.59 31.68 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.816 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.412 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -89.13 -169.4 2.5 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.671 0.272 . . . . 0.0 111.043 -179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.904 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.0 OUTLIER -113.62 164.69 15.21 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-N 116.477 -0.329 . . . . 0.0 110.451 -179.939 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.904 ' HD2' HG22 ' A' ' 45' ' ' THR . 6.7 Cg_endo -47.63 -24.62 4.71 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.017 2.478 . . . . 0.0 112.72 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.529 ' O ' HG23 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -95.99 -55.24 3.04 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 112.519 0.562 . . . . 0.0 112.519 -179.016 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -80.55 -4.61 54.62 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -178.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.626 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -62.73 -58.02 8.92 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.734 -0.386 . . . . 0.0 110.811 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.812 HG11 ' NE1' ' A' ' 85' ' ' TRP . 0.8 OUTLIER -79.5 -45.53 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.332 179.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 47' ' ' GLU . 48.0 t -53.46 -39.75 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.724 -178.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -78.13 -42.92 30.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.848 0.356 . . . . 0.0 111.231 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.457 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 4.3 mm-40 -74.22 -19.84 60.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.049 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.804 HD21 ' NE2' ' A' ' 64' ' ' HIS . 1.0 OUTLIER -60.57 -44.83 95.74 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.48 -179.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -61.26 -35.81 78.28 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -77.76 -28.03 50.5 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.124 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 33.4 mm-40 -105.34 5.01 31.5 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -178.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.549 ' HB ' ' O ' ' A' ' 54' ' ' LEU . 4.1 t -134.87 -44.85 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.583 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 67.29 -38.94 0.21 Allowed Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.36 -0.836 . . . . 0.0 114.049 179.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.643 HG23 ' CD1' ' A' ' 95' ' ' TRP . 22.8 pt -82.02 -176.18 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 120.985 0.422 . . . . 0.0 111.582 -179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -115.87 88.41 21.09 Favored Pre-proline 0 N--CA 1.444 -0.772 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.321 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HB3' ' HB2' ' A' ' 90' ' ' TRP . 12.3 Cg_endo -109.92 153.73 0.06 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.459 2.773 . . . . 0.0 113.833 -177.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.413 ' H ' ' HG3' ' A' ' 89' ' ' ARG . 89.8 mt-30 -74.85 79.93 2.12 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 176.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.928 ' ND1' HG22 ' A' ' 87' ' ' VAL . 0.2 OUTLIER -126.2 127.45 45.7 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.431 -1.259 . . . . 0.0 110.283 -176.944 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.507 ' O ' ' O ' ' A' ' 86' ' ' LEU . 1.9 t80 -177.86 158.85 1.32 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.446 ' HB3' ' CD2' ' A' ' 86' ' ' LEU . 0.2 OUTLIER 78.01 -168.39 0.05 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.291 179.181 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.84 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -144.49 137.57 27.0 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.852 -179.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.886 ' CD1' HD23 ' A' ' 126' ' ' LEU . 2.5 p90 -76.75 -41.58 44.36 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 179.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HB2' ' HD1' ' A' ' 68' ' ' PHE . 5.5 mt-10 -171.76 131.45 0.69 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.696 177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.49 120.81 42.29 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.817 0.341 . . . . 0.0 111.201 -179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.734 HD22 ' CE2' ' A' ' 73' ' ' TYR . 0.6 OUTLIER -104.68 122.22 45.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.026 179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -130.68 113.64 14.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.971 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.734 ' CE2' HD22 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -141.24 153.38 45.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.955 179.378 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 79' ' ' HIS . 2.1 pt-20 -121.17 127.06 51.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.343 0.592 . . . . 0.0 111.187 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.453 ' O ' ' N ' ' A' ' 77' ' ' ASP . 1.0 OUTLIER -96.51 163.43 20.53 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.554 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.516 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.0 Cg_endo -53.18 81.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.032 2.488 . . . . 0.0 112.255 179.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.516 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 5.2 t70 93.4 8.61 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.532 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.63 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.1 OUTLIER -137.44 93.86 2.86 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.633 0.254 . . . . 0.0 110.758 179.582 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 5.2 t-160 -93.27 95.7 9.52 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.797 0.332 . . . . 0.0 111.103 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.71 HD13 ' C4 ' ' A' ' 131' ' ' 8OG . 0.5 OUTLIER -100.35 111.99 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.132 179.835 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.423 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -97.26 118.1 32.95 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.017 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.738 HD12 ' HB ' ' A' ' 6' ' ' ILE . 1.7 mp -110.09 113.82 26.82 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.094 0.473 . . . . 0.0 111.179 -179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 7' ' ' ALA . 8.5 m0 -112.5 122.27 47.2 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.324 179.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.927 ' CE2' HG11 ' A' ' 122' ' ' VAL . 3.2 m-85 -116.58 113.16 22.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.013 0.435 . . . . 0.0 110.591 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.84 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 20.8 m95 -94.58 148.3 22.4 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.566 -178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.549 ' C ' HD12 ' A' ' 86' ' ' LEU . 2.3 pp -93.97 138.25 32.28 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.671 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.928 HG22 ' ND1' ' A' ' 64' ' ' HIS . 48.8 t -123.26 145.33 30.37 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.546 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -109.51 -28.2 9.03 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -163.79 165.57 22.88 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.968 0.804 . . . . 0.0 111.789 -178.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.715 ' HE3' HG22 ' A' ' 11' ' ' ILE . 1.0 OUTLIER -152.93 126.02 8.52 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.145 178.357 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -76.88 146.4 37.69 Favored 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.409 -179.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 52.57 -126.64 32.24 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.811 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.606 ' O ' HG21 ' A' ' 60' ' ' ILE . 4.0 tt0 -124.4 126.59 25.45 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 120.427 0.156 . . . . 0.0 110.582 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.496 ' CA ' HD13 ' A' ' 60' ' ' ILE . 13.7 Cg_exo -72.09 128.62 14.14 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.754 2.303 . . . . 0.0 111.2 179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.643 ' CD1' HG23 ' A' ' 60' ' ' ILE . 17.1 p-90 -114.78 -61.43 1.75 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.016 0.436 . . . . 0.0 111.415 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.533 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 46.82 -114.02 1.39 Allowed Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.904 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.61 74.61 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.927 0.394 . . . . 0.0 110.857 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.581 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -96.44 -29.22 14.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.013 -179.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.2 -103.06 0.45 Allowed Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.115 179.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.86 115.53 47.21 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.0 111.612 -179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -43.66 146.12 1.54 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.986 2.457 . . . . 0.0 112.718 179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -132.88 177.69 18.69 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.36 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -133.16 157.26 45.81 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.607 0.242 . . . . 0.0 110.652 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.425 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.2 OUTLIER -63.56 106.72 0.99 Allowed 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.417 ' O ' ' N ' ' A' ' 18' ' ' ILE . 1.5 mtm -119.83 163.05 18.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.032 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.666 ' HB2' HG12 ' A' ' 108' ' ' VAL . 7.7 p -81.2 114.92 20.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.855 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.817 HD11 HD22 ' A' ' 110' ' ' LEU . 0.2 OUTLIER -69.86 -18.66 63.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.208 179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 106' ' ' SER . 12.6 p -56.45 -14.29 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.402 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -140.53 56.76 0.6 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.843 HD23 HD12 ' A' ' 123' ' ' ILE . 9.9 tp -61.73 150.25 37.33 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.854 0.359 . . . . 0.0 110.861 -179.289 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.448 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 2.3 t-20 -97.22 106.9 19.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.531 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.41 -24.16 61.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.957 178.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -79.17 -47.18 16.5 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.271 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.466 ' HB3' ' CB ' ' A' ' 33' ' ' LEU . 0.2 OUTLIER -66.79 -14.21 62.37 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.869 -179.125 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.549 ' CZ ' HG13 ' A' ' 123' ' ' ILE . 0.0 OUTLIER -113.64 173.43 2.87 Favored Pre-proline 0 C--N 1.329 -0.326 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.0 Cg_endo -54.46 127.86 27.72 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 121.837 1.691 . . . . 0.0 111.974 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -68.97 -38.89 8.85 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.681 2.254 . . . . 0.0 112.613 -179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.632 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -69.41 -9.6 54.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.945 0.402 . . . . 0.0 111.572 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 30.9 m-20 -103.54 19.96 18.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.871 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.59 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 0.0 OUTLIER -70.45 -32.03 2.49 Favored Pre-proline 0 N--CA 1.466 0.349 0 N-CA-C 113.233 0.827 . . . . 0.0 113.233 -179.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 83.2 Cg_exo -44.31 -34.27 7.01 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 121.971 1.781 . . . . 0.0 112.899 -179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.927 HG11 ' CE2' ' A' ' 84' ' ' PHE . 24.5 t -77.59 -51.48 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.066 0.46 . . . . 0.0 110.977 179.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.873 HG22 ' HB2' ' A' ' 127' ' ' LYS . 12.9 mm -61.67 -38.98 81.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.885 -178.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.56 -29.6 51.65 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.684 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 tmtt? -80.69 -52.22 7.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.631 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.886 HD23 ' CD1' ' A' ' 68' ' ' PHE . 0.6 OUTLIER -74.82 -43.06 56.62 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.405 -179.261 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.873 ' HB2' HG22 ' A' ' 123' ' ' ILE . 40.9 tttt -52.05 -42.61 63.26 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.128 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 44.9 ttt-85 -64.49 -9.48 19.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.963 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 126' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.138 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.815 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.71 ' C4 ' HD13 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A 5215 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A 5216 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 mmm . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.812 0.339 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.55 103.1 13.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.886 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.43 144.12 32.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.901 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.776 ' CD1' HD11 ' A' ' 6' ' ' ILE . 3.0 pp -146.07 137.72 24.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.075 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.586 ' C ' HD12 ' A' ' 6' ' ' ILE . 14.6 mt-30 -106.2 152.86 22.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.229 0.537 . . . . 0.0 111.852 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.776 HD11 ' CD1' ' A' ' 4' ' ' LEU . 5.3 mp -146.75 129.79 8.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.414 -0.812 . . . . 0.0 110.866 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.916 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.04 125.18 43.43 Favored 'General case' 0 CA--C 1.512 -0.493 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 178.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.553 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 2.0 m -144.52 162.03 14.44 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 C-N-CA 119.812 -0.755 . . . . 0.0 111.91 -179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.466 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -151.03 143.06 10.11 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.741 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.983 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -92.7 111.57 24.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.926 HG23 HG11 ' A' ' 87' ' ' VAL . 0.3 OUTLIER -71.1 113.45 7.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.269 0 CA-C-O 121.283 0.563 . . . . 0.0 110.64 -179.451 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.732 ' O ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -82.19 126.9 32.61 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.422 -178.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.538 ' ND2' ' CZ2' ' A' ' 90' ' ' TRP . 1.9 t-20 -83.91 -172.51 4.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.951 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.464 ' H ' ' CG ' ' A' ' 13' ' ' ASN . 16.8 tp10 -78.89 -4.78 51.42 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.317 -1.31 . . . . 0.0 112.603 -179.043 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 34.9 t30 -127.91 44.47 2.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.787 0.327 . . . . 0.0 111.613 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 53.03 19.58 1.42 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.539 179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' O ' ' CB ' ' A' ' 13' ' ' ASN . 10.0 pt-20 -114.77 142.76 46.09 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.267 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.983 HG21 HG22 ' A' ' 10' ' ' ILE . 11.3 mt -109.92 144.1 18.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.298 0.571 . . . . 0.0 112.213 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.508 ' CD1' ' O ' ' A' ' 19' ' ' PHE . 11.2 t80 -88.86 93.69 9.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.897 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.619 HD11 ' SD ' ' A' ' 105' ' ' MET . 0.0 OUTLIER -112.47 149.39 15.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.536 -179.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' LEU . 3.1 p -70.93 111.87 6.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.506 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.437 ' HB3' ' HG ' ' A' ' 33' ' ' LEU . 21.9 ptt-85 -139.42 137.11 35.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.818 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.868 ' HD3' ' HB2' ' A' ' 30' ' ' ALA . 10.8 tpt180 52.44 -110.41 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.746 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.498 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 173.4 -170.63 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.841 0.353 . . . . 0.0 110.98 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.25 -30.58 34.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.971 179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -171.41 35.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.831 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -124.97 -175.37 3.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.128 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -113.46 83.93 1.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.914 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.3 tpp -142.12 29.99 1.62 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.795 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.868 ' HB2' ' HD3' ' A' ' 23' ' ' ARG . . . -60.5 -18.81 54.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.421 -179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 0.1 OUTLIER -84.24 8.36 16.12 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.665 -179.767 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' O ' ' N ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -114.08 26.09 10.59 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.881 0.372 . . . . 0.0 111.55 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 111' ' ' ASN . 5.1 tt -61.64 79.26 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.647 179.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 32' ' ' LYS . 0.3 OUTLIER -123.43 -173.23 2.68 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.112 0.482 . . . . 0.0 111.973 -179.364 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.739 ' HD2' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER -119.45 168.21 10.54 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.634 -179.08 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.553 ' O ' ' HB ' ' A' ' 8' ' ' VAL . 68.7 Cg_endo -74.87 167.09 27.85 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.465 2.777 . . . . 0.0 113.043 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.784 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.85 -5.51 53.76 Favored Glycine 0 C--O 1.222 -0.656 0 CA-C-N 115.87 -0.605 . . . . 0.0 114.155 179.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 39' ' ' LYS . . . -62.21 145.65 49.4 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.941 179.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.487 ' CB ' ' O ' ' A' ' 38' ' ' GLY . 0.1 OUTLIER 92.06 2.01 0.11 Allowed 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 178.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.916 HG21 ' HB3' ' A' ' 7' ' ' ALA . 0.9 OUTLIER -51.41 -28.86 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.619 0.723 . . . . 0.0 110.572 179.315 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.59 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -43.55 -60.8 1.6 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.47 -1.241 . . . . 0.0 111.143 -179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.513 ' C ' ' O ' ' A' ' 41' ' ' GLU . 8.9 mmm 10.28 -81.64 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 O-C-N 123.848 0.718 . . . . 0.0 112.633 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 41' ' ' GLU . . . -169.43 27.98 0.13 Allowed Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.083 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.428 ' CB ' ' HA ' ' A' ' 49' ' ' ALA . 0.3 OUTLIER -103.97 -173.45 2.31 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.695 0.283 . . . . 0.0 110.999 -179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.886 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.1 OUTLIER -108.85 155.91 39.92 Favored Pre-proline 0 N--CA 1.456 -0.159 0 N-CA-C 110.037 -0.356 . . . . 0.0 110.037 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.886 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.6 Cg_endo -43.49 -24.5 0.65 Allowed 'Trans proline' 0 N--CA 1.461 -0.393 0 C-N-CA 122.674 2.249 . . . . 0.0 112.406 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.686 ' O ' HG23 ' A' ' 51' ' ' VAL . 2.9 tt0 -86.83 -60.27 2.03 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 -179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 15.7 pt20 -80.67 -21.62 41.2 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.733 ' HB1' ' HB ' ' A' ' 40' ' ' ILE . . . -56.81 -48.77 77.2 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.675 0.274 . . . . 0.0 110.97 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.558 HG11 ' CZ2' ' A' ' 85' ' ' TRP . 0.2 OUTLIER -78.35 -50.72 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.754 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 47' ' ' GLU . 49.9 t -51.14 -35.66 15.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.773 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -48.71 15.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.537 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.497 ' HG3' ' HA ' ' A' ' 40' ' ' ILE . 5.7 mm-40 -65.77 -19.77 66.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.669 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.902 HD11 ' NE2' ' A' ' 64' ' ' HIS . 0.3 OUTLIER -58.43 -44.8 89.27 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.939 0.4 . . . . 0.0 110.774 -179.919 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.62 -30.96 67.75 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.13 0.491 . . . . 0.0 109.989 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -77.36 -32.61 55.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.523 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.514 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.16 5.9 26.3 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.786 0.661 . . . . 0.0 112.786 -178.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.091 HG12 HG22 ' A' ' 60' ' ' ILE . 12.5 t -133.91 -43.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.816 0.341 . . . . 0.0 110.48 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.548 ' HA3' ' CE2' ' A' ' 95' ' ' TRP . . . 65.78 -33.12 0.14 Allowed Glycine 0 C--N 1.33 0.244 0 N-CA-C 114.655 0.622 . . . . 0.0 114.655 178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 1.091 HG22 HG12 ' A' ' 58' ' ' VAL . 20.0 tt -77.6 165.62 2.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-O 120.584 0.231 . . . . 0.0 110.776 -179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.452 ' N ' HG12 ' A' ' 60' ' ' ILE . 0.6 OUTLIER -105.19 88.26 2.41 Favored Pre-proline 0 N--CA 1.446 -0.675 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 178.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.728 ' HD3' ' O ' ' A' ' 60' ' ' ILE . 12.0 Cg_endo -114.36 150.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 123.568 2.846 . . . . 0.0 114.39 -176.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -74.69 79.93 2.04 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 105.19 -2.152 . . . . 0.0 105.19 175.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.927 ' CE1' HG22 ' A' ' 87' ' ' VAL . 0.1 OUTLIER -125.52 129.4 49.66 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.601 -1.181 . . . . 0.0 111.724 -175.539 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.546 ' O ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -177.85 -138.57 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.779 -179.148 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.426 ' O ' ' HB3' ' A' ' 85' ' ' TRP . 0.5 OUTLIER 51.01 173.73 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 122.823 0.449 . . . . 0.0 111.719 179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.813 ' HA ' ' HA ' ' A' ' 85' ' ' TRP . 0.3 OUTLIER -131.88 125.82 32.67 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.115 0.484 . . . . 0.0 111.101 179.544 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.52 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -78.59 -55.87 4.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.022 179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.691 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -172.27 131.7 0.62 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.328 178.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.623 ' CD ' HD13 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -114.19 118.71 34.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.712 0.291 . . . . 0.0 110.688 179.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.712 ' HB3' HG22 ' A' ' 122' ' ' VAL . 1.0 OUTLIER -107.7 129.68 55.0 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 120.967 0.413 . . . . 0.0 111.047 -179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -115.92 110.05 18.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.176 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.666 ' CD1' HD23 ' A' ' 71' ' ' LEU . 2.8 p90 -136.33 143.64 44.23 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.052 -179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -121.27 118.18 28.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.808 179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.527 ' HB2' ' HB3' ' A' ' 78' ' ' ARG . 2.6 m-85 -69.91 163.01 64.5 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.633 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.539 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 9.4 Cg_endo -51.69 83.48 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.187 2.591 . . . . 0.0 112.239 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 17.4 t0 97.14 14.39 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.108 -179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.55 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 0.2 OUTLIER -137.39 149.18 46.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.308 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 25.1 m-70 -131.49 112.84 13.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.767 0.318 . . . . 0.0 110.658 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.873 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 3.1 tt -120.65 112.0 34.31 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.352 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.51 118.89 32.36 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.735 HD22 ' HB ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -119.86 114.55 22.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.978 0.418 . . . . 0.0 111.913 -178.822 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 46' ' ' PRO . 10.4 m0 -108.84 122.33 46.96 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.119 179.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.781 ' CZ ' HG11 ' A' ' 122' ' ' VAL . 1.9 m-85 -106.91 118.18 36.02 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.755 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.813 ' HA ' ' HA ' ' A' ' 67' ' ' LEU . 68.1 m95 -94.75 148.27 22.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.223 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.546 ' O ' ' O ' ' A' ' 65' ' ' PHE . 44.0 tp -99.03 102.98 14.88 Favored 'General case' 0 N--CA 1.46 0.071 0 CA-C-O 121.449 0.642 . . . . 0.0 110.854 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.927 HG22 ' CE1' ' A' ' 64' ' ' HIS . 7.4 t -86.13 145.68 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 CA-C-N 114.892 -1.049 . . . . 0.0 112.277 -179.315 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.1 mt-10 -100.7 -52.25 3.38 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 114.123 1.157 . . . . 0.0 114.123 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 12' ' ' ARG . 0.0 OUTLIER -163.21 165.65 24.15 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 118.479 0.582 . . . . 0.0 112.463 -178.335 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.679 ' HA ' ' CB ' ' A' ' 62' ' ' PRO . 33.0 p90 -129.73 160.14 34.31 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.319 178.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.832 ' O ' HD11 ' A' ' 60' ' ' ILE . 0.5 OUTLIER -100.83 93.35 5.49 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-O 120.868 0.366 . . . . 0.0 111.422 -179.146 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' O ' ' NE1' ' A' ' 90' ' ' TRP . . . 100.31 -110.24 3.89 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.011 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.531 ' C ' HD12 ' A' ' 60' ' ' ILE . 19.9 tt0 -135.3 127.03 17.71 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 120.447 0.165 . . . . 0.0 111.075 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.52 ' HD3' ' NE1' ' A' ' 90' ' ' TRP . 2.7 Cg_exo -75.4 153.13 39.67 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.704 2.269 . . . . 0.0 110.888 179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.548 ' CE2' ' HA3' ' A' ' 59' ' ' GLY . 19.0 p-90 -150.27 -62.81 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.707 ' HA3' ' N ' ' A' ' 58' ' ' VAL . . . 44.39 -99.91 0.02 OUTLIER Glycine 0 CA--C 1.52 0.402 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.948 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.7 32.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.807 0.337 . . . . 0.0 111.164 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.441 ' HB2' HG21 ' A' ' 21' ' ' THR . 0.0 OUTLIER -63.52 -21.99 66.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.187 179.904 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.45 -123.1 2.81 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.098 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.409 ' O ' ' HB ' ' A' ' 21' ' ' THR . 0.7 OUTLIER -75.9 132.52 74.23 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.159 0.504 . . . . 0.0 111.702 -179.485 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -43.39 146.26 1.26 Allowed 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 123.105 2.536 . . . . 0.0 112.646 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -119.12 177.65 16.43 Favored Glycine 0 CA--C 1.52 0.358 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.828 -179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -140.09 157.03 46.28 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.25 -0.278 . . . . 0.0 110.25 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.46 ' CD1' ' N ' ' A' ' 104' ' ' TRP . 0.6 OUTLIER -66.21 106.29 1.63 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.878 -0.415 . . . . 0.0 109.878 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.619 ' SD ' HD11 ' A' ' 20' ' ' ILE . 0.6 OUTLIER -120.31 163.19 18.2 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.22 -179.676 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 56.7 p -82.37 114.83 21.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.473 179.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.765 ' HB2' HD12 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -68.47 -18.68 64.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.43 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.3 t -60.22 -10.8 2.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.804 0.335 . . . . 0.0 111.438 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -135.76 55.1 0.72 Allowed Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.677 HD22 HD11 ' A' ' 107' ' ' LEU . 7.5 tp -61.43 150.2 36.2 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.407 -0.397 . . . . 0.0 110.828 -179.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.486 ' HB3' HD13 ' A' ' 33' ' ' LEU . 0.5 OUTLIER -104.18 95.61 6.09 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.34 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.597 ' HB2' ' HD3' ' A' ' 127' ' ' LYS . . . -72.51 -18.76 61.62 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.874 177.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -79.06 -47.11 16.76 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.365 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.7 OUTLIER -66.7 -39.25 87.99 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.244 -179.163 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.525 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.1 OUTLIER -78.39 174.43 6.04 Favored Pre-proline 0 C--N 1.326 -0.43 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.623 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 9.4 Cg_endo -53.89 127.69 26.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 121.859 1.706 . . . . 0.0 112.497 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.8 Cg_endo -69.11 -34.93 15.59 Favored 'Trans proline' 0 C--N 1.351 0.663 0 C-N-CA 122.753 2.302 . . . . 0.0 112.465 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.848 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -71.37 -9.57 58.37 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.008 0.433 . . . . 0.0 111.125 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -106.79 18.64 21.58 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.852 -179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.563 ' N ' ' CD ' ' A' ' 121' ' ' PRO . 1.7 tt0 -70.38 -31.37 2.22 Favored Pre-proline 0 N--CA 1.466 0.343 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 -178.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.563 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 75.5 Cg_exo -43.7 -36.08 7.14 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 121.83 1.687 . . . . 0.0 113.395 -178.323 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.781 HG11 ' CZ ' ' A' ' 84' ' ' PHE . 59.3 t -78.04 -51.31 18.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.911 0.386 . . . . 0.0 111.903 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.83 HG22 ' HB2' ' A' ' 127' ' ' LYS . 3.9 mm -77.08 -39.78 29.48 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -53.8 -26.88 26.08 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.48 -53.9 6.17 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.49 ' HG ' ' CE2' ' A' ' 68' ' ' PHE . 1.4 mm? -79.26 -30.3 43.01 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.665 0.269 . . . . 0.0 111.564 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.83 ' HB2' HG22 ' A' ' 123' ' ' ILE . 9.7 ttpt -54.03 -42.13 68.8 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.135 0.493 . . . . 0.0 110.338 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 28.4 ttm180 -67.46 -6.11 17.96 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.815 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 N--CA 1.456 -0.149 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.03 179.774 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.873 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A 5227 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A 5228 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.7 ttm . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.8 0.333 . . . . 0.0 111.196 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.9 tttm -109.96 141.05 43.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.956 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.477 ' HA ' ' HB3' ' A' ' 79' ' ' HIS . 0.1 OUTLIER -140.17 128.27 22.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.777 179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.668 HD13 " O4'" ' A' ' 131' ' ' 8OG . 4.0 pp -146.33 142.64 28.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.544 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -102.88 153.58 20.05 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.34 179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.77 HD11 " O4'" ' A' ' 131' ' ' 8OG . 40.5 mt -146.33 116.64 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.959 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.954 ' HB3' HG21 ' A' ' 40' ' ' ILE . . . -125.55 144.25 50.65 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 36' ' ' PRO . 1.4 m -145.76 162.44 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.041 -0.664 . . . . 0.0 111.931 179.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.429 ' N ' HG23 ' A' ' 8' ' ' VAL . . . -142.68 108.04 0.51 Allowed Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.698 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 1.077 HG22 HG21 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -70.73 108.77 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.774 HD11 ' HG3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -71.72 121.96 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.92 0.391 . . . . 0.0 111.443 -179.004 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . 0.555 ' HB2' ' O ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -84.86 121.93 28.43 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.093 179.783 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.562 ' CB ' ' CH2' ' A' ' 90' ' ' TRP . 0.1 OUTLIER -79.63 -171.67 2.92 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.731 0.777 . . . . 0.0 111.68 179.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.438 ' N ' ' CG ' ' A' ' 13' ' ' ASN . 1.6 tm-20 -82.0 15.53 2.26 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.343 -1.299 . . . . 0.0 113.105 -178.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.402 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 54.8 t30 -144.76 43.97 1.36 Allowed 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 54.13 17.82 1.56 Allowed 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.448 ' HB3' ' O ' ' A' ' 105' ' ' MET . 2.3 mt-10 -116.81 160.68 20.46 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.077 HG21 HG22 ' A' ' 10' ' ' ILE . 5.9 mt -121.33 139.7 47.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.201 0.524 . . . . 0.0 111.458 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.564 ' C ' ' CD1' ' A' ' 19' ' ' PHE . 0.2 OUTLIER -88.49 98.57 11.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.87 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.777 HG22 ' HA ' ' A' ' 35' ' ' PHE . 0.4 OUTLIER -113.79 162.46 11.91 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.741 178.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.736 HG22 ' OE2' ' A' ' 98' ' ' GLU . 8.0 p -70.58 145.72 50.57 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.669 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 40.6 ttt-85 -148.14 96.24 2.6 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.068 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.505 ' HD2' ' HB2' ' A' ' 30' ' ' ALA . 11.6 ttp180 55.21 -92.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.226 179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 23' ' ' ARG . . . 173.71 -32.35 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.239 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 24' ' ' ALA . . . 72.86 20.21 3.65 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.224 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.4 p30 178.93 37.24 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.807 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . 179.6 -166.58 0.07 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.021 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -93.03 -164.42 1.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.782 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.0 mtt 64.3 61.14 0.9 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.857 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.505 ' HB2' ' HD2' ' A' ' 23' ' ' ARG . . . -86.91 -8.92 56.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.65 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.49 ' HA ' ' O ' ' A' ' 114' ' ' ASP . 10.9 t-20 -99.1 28.71 4.26 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.706 0.288 . . . . 0.0 111.403 -179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.28 26.26 10.41 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.908 0.385 . . . . 0.0 111.934 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.469 ' O ' ' HB2' ' A' ' 115' ' ' PHE . 3.1 tt -68.97 67.22 0.15 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.67 179.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.53 -167.77 1.3 Allowed 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.343 -179.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.777 ' HA ' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -119.36 168.06 10.78 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.44 -179.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.774 ' HG3' HD11 ' A' ' 11' ' ' ILE . 84.2 Cg_endo -84.19 166.76 12.57 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.398 2.732 . . . . 0.0 113.224 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 40' ' ' ILE . . . 101.28 -5.7 55.58 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.509 -0.769 . . . . 0.0 113.751 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 39' ' ' LYS . . . -67.59 166.93 41.87 Favored Glycine 0 CA--C 1.519 0.289 0 C-N-CA 121.564 -0.351 . . . . 0.0 113.254 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 38' ' ' GLY . 0.0 OUTLIER 82.74 1.58 1.19 Allowed 'General case' 0 C--N 1.34 0.17 0 C-N-CA 122.661 0.384 . . . . 0.0 111.871 179.575 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.954 HG21 ' HB3' ' A' ' 7' ' ' ALA . 3.4 pt -50.84 -28.6 6.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.516 0.674 . . . . 0.0 110.562 179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.531 ' N ' HG13 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -40.07 -63.43 0.61 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.496 -1.229 . . . . 0.0 110.878 179.738 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.521 ' C ' ' O ' ' A' ' 41' ' ' GLU . 0.2 OUTLIER 11.15 -84.0 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 O-C-N 123.895 0.747 . . . . 0.0 112.625 179.368 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -175.74 29.26 0.08 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.913 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.95 -168.23 1.98 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.734 0.302 . . . . 0.0 110.971 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.824 HG22 ' HD2' ' A' ' 46' ' ' PRO . 0.2 OUTLIER -101.49 153.1 38.07 Favored Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.28 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.824 ' HD2' HG22 ' A' ' 45' ' ' THR . 1.8 Cg_endo -43.86 -25.17 0.95 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.852 2.368 . . . . 0.0 112.49 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.447 ' O ' HG23 ' A' ' 51' ' ' VAL . 1.2 mm-40 -103.99 -41.27 5.91 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.482 -179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 20.3 mt-30 -80.27 -5.71 56.68 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.755 0.28 . . . . 0.0 111.755 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.93 ' HB1' HD12 ' A' ' 40' ' ' ILE . . . -60.1 -55.25 36.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.792 0.329 . . . . 0.0 110.836 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.725 HG12 ' HB1' ' A' ' 7' ' ' ALA . 2.0 m -78.33 -46.7 25.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.305 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.49 ' N ' ' CG2' ' A' ' 50' ' ' VAL . 27.8 t -55.13 -36.91 41.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.342 -179.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -78.19 -52.03 9.31 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.874 0.368 . . . . 0.0 110.616 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.516 ' HB2' HG22 ' A' ' 40' ' ' ILE . 1.8 mm-40 -60.28 -21.88 62.46 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.672 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.959 HD21 ' CD2' ' A' ' 64' ' ' HIS . 1.4 tp -60.29 -45.05 94.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.024 -179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -30.58 71.42 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -77.5 -27.85 51.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.419 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.56 ' C ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -108.64 6.97 26.34 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.447 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.945 HG12 HG13 ' A' ' 60' ' ' ILE . 12.4 t -133.38 -44.3 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.049 0.452 . . . . 0.0 110.545 179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.619 ' HA3' ' CZ2' ' A' ' 95' ' ' TRP . . . 54.52 13.89 4.47 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 114.781 0.673 . . . . 0.0 114.781 178.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.945 HG13 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -127.08 -167.46 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 118.002 0.901 . . . . 0.0 110.796 179.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . 0.469 HG23 ' CB ' ' A' ' 91' ' ' GLU . 0.5 OUTLIER -111.13 88.65 8.77 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.535 -179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.655 ' HG3' HG11 ' A' ' 58' ' ' VAL . 25.2 Cg_endo -113.69 137.88 0.03 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.606 0 C-N-CA 123.733 2.956 . . . . 0.0 114.413 -177.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 89' ' ' ARG . 33.6 mt-30 -74.83 79.23 2.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 104.788 -2.301 . . . . 0.0 104.788 175.235 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.959 ' CD2' HD21 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -117.9 130.61 56.34 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 113.587 -1.642 . . . . 0.0 109.873 -176.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.431 ' O ' ' O ' ' A' ' 66' ' ' SER . 2.3 t80 -176.43 -56.19 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.545 ' O ' ' N ' ' A' ' 86' ' ' LEU . 65.8 m -33.57 157.05 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.035 -178.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 tt -117.54 123.21 45.71 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.897 0.38 . . . . 0.0 110.95 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 69' ' ' GLU . 0.2 OUTLIER -82.36 -56.31 3.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.272 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.521 ' N ' ' CD1' ' A' ' 68' ' ' PHE . 6.3 tt0 -171.66 159.22 5.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.429 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.1 108.44 5.02 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.756 0.312 . . . . 0.0 110.691 179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.832 HD21 ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -96.81 146.23 25.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.674 -179.87 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -138.96 109.89 6.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.763 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.832 ' CD1' HD21 ' A' ' 71' ' ' LEU . 2.4 p90 -141.17 153.01 45.12 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.677 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' HB3' ' CG ' ' A' ' 79' ' ' HIS . 4.2 pt-20 -121.25 133.81 55.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.158 0.504 . . . . 0.0 111.251 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.488 ' CD1' ' HD2' ' A' ' 76' ' ' PRO . 0.3 OUTLIER -97.12 163.15 20.58 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.27 179.766 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 77' ' ' ASP . 11.4 Cg_endo -54.99 81.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.82 2.346 . . . . 0.0 112.181 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 76' ' ' PRO . 2.3 t70 96.25 6.52 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 115.373 -0.831 . . . . 0.0 111.647 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.633 ' NH2' ' N1 ' ' A' ' 131' ' ' 8OG . 9.5 ttp180 -137.38 93.95 2.87 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.677 0.275 . . . . 0.0 110.908 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.477 ' HB3' ' HA ' ' A' ' 3' ' ' LYS . 0.7 OUTLIER -88.84 104.7 17.17 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.834 0.349 . . . . 0.0 110.487 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.991 HD12 ' C4 ' ' A' ' 131' ' ' 8OG . 2.2 tt -110.25 130.87 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.292 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -109.14 118.59 37.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 178.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.509 HD12 ' CE1' ' A' ' 84' ' ' PHE . 0.0 OUTLIER -108.62 114.19 27.8 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.033 0.444 . . . . 0.0 111.862 -178.756 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TRP . . . . . 0.412 ' N ' ' CD1' ' A' ' 83' ' ' TRP . 9.2 m0 -114.32 122.42 46.66 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.906 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.777 ' CD2' HG11 ' A' ' 122' ' ' VAL . 8.9 m-30 -114.05 116.94 29.96 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.762 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.725 ' NE1' HG11 ' A' ' 50' ' ' VAL . 20.0 m95 -106.64 148.34 28.45 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.83 -179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.545 ' N ' ' O ' ' A' ' 66' ' ' SER . 48.1 tp -93.03 138.55 31.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.441 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.822 HG13 ' HB2' ' A' ' 64' ' ' HIS . 36.5 t -121.4 145.7 27.57 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.653 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.248 -179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -114.77 -15.71 11.86 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 114.9 1.445 . . . . 0.0 114.9 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' A' ' 62' ' ' PRO . 0.1 OUTLIER -163.33 162.3 25.0 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.594 1.088 . . . . 0.0 112.353 -179.053 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.562 ' CH2' ' CB ' ' A' ' 13' ' ' ASN . 0.5 OUTLIER -157.66 123.45 4.66 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.882 178.289 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.562 ' O ' HG21 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -79.55 146.52 32.57 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 120.481 -0.488 . . . . 0.0 110.551 -179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.0 -120.79 24.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.21 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.403 ' HA ' ' HD3' ' A' ' 94' ' ' PRO . 41.1 mt-10 -135.06 135.06 22.2 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.4 0.143 . . . . 0.0 110.931 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . 0.7 ' CA ' HD11 ' A' ' 60' ' ' ILE . 2.9 Cg_exo -76.41 128.96 10.74 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 123.017 2.478 . . . . 0.0 111.224 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . 0.619 ' CZ2' ' HA3' ' A' ' 59' ' ' GLY . 11.6 p-90 -129.72 -61.35 1.01 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.118 0.485 . . . . 0.0 111.733 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' ' C ' ' A' ' 57' ' ' GLU . . . 40.68 -95.52 0.01 OUTLIER Glycine 0 CA--C 1.522 0.469 0 CA-C-N 115.093 -0.958 . . . . 0.0 113.101 -178.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 168.24 69.34 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 120.909 0.385 . . . . 0.0 110.71 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.736 ' OE2' HG22 ' A' ' 21' ' ' THR . 0.0 OUTLIER -95.06 -38.65 10.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.696 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 161.18 -125.55 1.46 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.732 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.417 ' O ' ' HB ' ' A' ' 21' ' ' THR . 12.0 mp0 -78.59 126.51 82.67 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.112 0.482 . . . . 0.0 111.414 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -43.43 144.08 2.14 Favored 'Trans proline' 0 N--CA 1.464 -0.264 0 C-N-CA 123.006 2.47 . . . . 0.0 112.797 179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.4 ' CA ' ' HE1' ' A' ' 19' ' ' PHE . . . -134.09 177.53 19.06 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.295 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -124.12 157.46 34.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.499 0.19 . . . . 0.0 110.823 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -59.38 106.86 0.49 Allowed 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.784 0.326 . . . . 0.0 110.189 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.448 ' O ' ' HB3' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -120.46 159.12 25.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.084 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.606 ' HB2' HG12 ' A' ' 108' ' ' VAL . 2.4 p -75.13 118.19 17.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.498 179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . 0.763 HD23 ' HB ' ' A' ' 18' ' ' ILE . 0.2 OUTLIER -71.42 -18.59 62.33 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.429 -179.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.606 HG12 ' HB2' ' A' ' 106' ' ' SER . 10.8 p -61.29 -12.08 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.653 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -134.47 50.81 0.85 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.894 -0.669 . . . . 0.0 112.192 179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.883 HD11 ' CG2' ' A' ' 123' ' ' ILE . 1.0 OUTLIER -61.94 150.61 37.22 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 120.739 0.304 . . . . 0.0 111.054 -179.799 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' A' ' 114' ' ' ASP . 1.2 t-20 -108.94 108.98 19.94 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -178.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.475 ' HA ' ' CD1' ' A' ' 115' ' ' PHE . . . -72.45 -18.03 61.73 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.161 178.262 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -78.98 -47.97 15.32 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.9 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.49 ' O ' ' HA ' ' A' ' 31' ' ' ASN . 0.1 OUTLIER -66.97 -29.26 69.07 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.46 -179.465 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.6 ' HZ ' ' HA ' ' A' ' 120' ' ' GLU . 0.0 OUTLIER -89.87 173.47 5.8 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 115' ' ' PHE . 10.3 Cg_endo -54.52 127.85 27.73 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 121.84 1.693 . . . . 0.0 112.283 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.415 ' O ' ' HB2' ' A' ' 120' ' ' GLU . 51.0 Cg_endo -69.14 -35.96 13.43 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.657 2.238 . . . . 0.0 112.636 -179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.559 ' HB1' ' O6 ' ' A' ' 131' ' ' 8OG . . . -72.01 -9.75 58.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.982 0.42 . . . . 0.0 111.41 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -106.63 23.0 14.97 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.701 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.6 ' HA ' ' HZ ' ' A' ' 115' ' ' PHE . 0.0 OUTLIER -76.13 -30.66 0.9 Allowed Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 120' ' ' GLU . 77.3 Cg_exo -43.19 -35.13 4.82 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 121.971 1.78 . . . . 0.0 113.466 -178.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.777 HG11 ' CD2' ' A' ' 84' ' ' PHE . 37.6 t -77.86 -51.17 18.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.266 0.555 . . . . 0.0 110.381 178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.883 ' CG2' HD11 ' A' ' 110' ' ' LEU . 33.4 mm -64.93 -32.3 57.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.276 -0.874 . . . . 0.0 111.321 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -54.75 -27.17 39.14 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.885 0.374 . . . . 0.0 110.77 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -80.22 -50.83 9.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.623 -179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.681 HD12 ' CD2' ' A' ' 110' ' ' LEU . 2.8 tm? -78.08 -27.04 48.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.779 0.323 . . . . 0.0 111.399 -179.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.475 ' HB2' HG22 ' A' ' 123' ' ' ILE . 53.1 tttp -54.94 -42.38 72.21 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 121.158 0.504 . . . . 0.0 110.464 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 54.9 ttp85 -63.74 -12.96 39.4 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.593 178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.668 HD12 ' O ' ' A' ' 126' ' ' LEU . 2.6 mp . . . . . 0 C--O 1.231 0.085 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.042 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ' MG' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' 8OG . . . . . 0.991 ' C4 ' HD12 ' A' ' 80' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A 5239 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A 5240 ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_